FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Huang, CL
   Wang, YM
   Li, XW
   Ren, LL
   Zhao, JP
   Hu, Y
   Zhang, L
   Fan, GH
   Xu, JY
   Gu, XY
   Cheng, ZS
   Yu, T
   Xia, JA
   Wei, Y
   Wu, WJ
   Xie, XL
   Yin, W
   Li, H
   Liu, M
   Xiao, Y
   Gao, H
   Guo, L
   Xie, JG
   Wang, GF
   Jiang, RM
   Gao, ZC
   Jin, Q
   Wang, JW
   Cao, B
AF Huang, Chaolin
   Wang, Yeming
   Li, Xingwang
   Ren, Lili
   Zhao, Jianping
   Hu, Yi
   Zhang, Li
   Fan, Guohui
   Xu, Jiuyang
   Gu, Xiaoying
   Cheng, Zhenshun
   Yu, Ting
   Xia, Jiaan
   Wei, Yuan
   Wu, Wenjuan
   Xie, Xuelei
   Yin, Wen
   Li, Hui
   Liu, Min
   Xiao, Yan
   Gao, Hong
   Guo, Li
   Xie, Jungang
   Wang, Guangfa
   Jiang, Rongmeng
   Gao, Zhancheng
   Jin, Qi
   Wang, Jianwei
   Cao, Bin
TI Clinical features of patients infected with 2019 novel coronavirus in
   Wuhan, China
SO LANCET
LA English
DT Article
ID EAST RESPIRATORY SYNDROME; INFLAMMATORY CYTOKINES; SARS
AB Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.
   Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.
   Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49.0 years (IQR 41.0-58.0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8.0 days [IQR 5.0-13.0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNF alpha.
   Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Huang, Chaolin; Zhang, Li; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei] Jin Yin tan Hosp, Wuhan, Peoples R China.
   [Wang, Yeming; Fan, Guohui; Gu, Xiaoying; Li, Hui; Cao, Bin] China Japan Friendship Hosp, Ctr Resp Med, Natl Clin Res Ctr Resp Dis, Dept Pulm & Crit Care Med, Beijing, Peoples R China.
   [Fan, Guohui; Gu, Xiaoying] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.
   [Liu, Min] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China.
   [Wang, Yeming; Fan, Guohui; Gu, Xiaoying; Li, Hui; Cao, Bin] Chinese Acad Med Sci, Inst Resp Med, Peking Union Med Coll, Beijing, Peoples R China.
   [Wang, Yeming; Li, Hui; Cao, Bin] Capital Med Univ, Dept Resp Med, Beijing, Peoples R China.
   [Li, Xingwang; Jiang, Rongmeng] Capital Med Univ, Beijing Ditan Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China.
   [Ren, Lili; Xiao, Yan; Guo, Li; Jin, Qi; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, NHC Key Lab Syst Biol Pathogens & Christophe Meri, Inst Pathogen Biol, Beijing 100730, Peoples R China.
   [Gao, Hong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China.
   [Zhao, Jianping; Xie, Jungang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China.
   [Hu, Yi; Yin, Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pulm & Crit Care Med, Cent Hosp Wuhan, Wuhan, Peoples R China.
   [Xu, Jiuyang] Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   [Cheng, Zhenshun] Wuhan Univ, Resp Med, Zhongnan Hosp, Wuhan, Peoples R China.
   [Wang, Guangfa] Peking Univ First Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China.
   [Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China.
   [Cao, Bin] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing, Peoples R China.
RP Wang, JW (reprint author), Chinese Acad Med Sci & Peking Union Med Coll, NHC Key Lab Syst Biol Pathogens & Christophe Meri, Inst Pathogen Biol, Beijing 100730, Peoples R China.; Cao, B (reprint author), China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China.
EM wangjw28@163.com; caobin_ben@163.com
RI Ribeiro, Nuno/AAH-2299-2020
FU Ministry of Science and Technology [2020YFC0841300]; Chinese Academy of
   Medical Sciences (CAMS) Innovation Fund for Medical Sciences [CIFMS
   2018-I2M-1-003]; National Science Grant for Distinguished Young Scholars
   [81425001/H0104]; National Key Research and Development Program of China
   [2018YFC1200102]; Beijing Science and Technology Project
   [Z19110700660000]; CAMS Innovation Fund for Medical Sciences
   [2016-I2M-1-014]; National Mega-projects for Infectious Diseases in
   China [2017ZX10103004, 2018ZX10305409]
FX This work is funded by the Special Project for Emergency of the Ministry
   of Science and Technology (2020YFC0841300) Chinese Academy of Medical
   Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS
   2018-I2M-1-003), a National Science Grant for Distinguished Young
   Scholars (81425001/H0104), the National Key Research and Development
   Program of China (2018YFC1200102), The Beijing Science and Technology
   Project (Z19110700660000), CAMS Innovation Fund for Medical Sciences
   (2016-I2M-1-014), and National Mega-projects for Infectious Diseases in
   China (2017ZX10103004 and 2018ZX10305409). We acknowledge all
   health-care workers involved in the diagnosis and treatment of patients
   in Wuhan; we thank the Chinese National Health Commission for
   coordinating data collection for patients with 2019-nCoV infection; we
   thank WHO and the International Severe Acute Respiratory and Emerging
   Infections Consortium (ISARIC) for sharing data collection templates
   publicly on the website; and we thank Prof Chen Wang and Prof George F
   Gao for guidance in study design and interpretation of results.
CR Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   CDC, 2020, 1 TRAV REL CAS 2019
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716
   Gao Chang, 2020, Crit Care Med, V48, P451, DOI 10.1097/CCM.0000000000004207
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067
   Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group, 2012, KDIGO CLIN PRACTICE
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lansbury L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub3
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Richman DD, 2016, CLIN VIROLOGY
   Sanz F, 2011, EUR RESP J S55, V38, P2492
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Tan W, 2019, NOVEL CORONAVIRUS GE
   Wang Manli, 2013, Virologica Sinica, V28, P315, DOI 10.1007/s12250-013-3402-x
   WHO, 2003, SUMM PROB SARS CAS O
   WHO, 2020, NOVEL CORONAVIR 0114
   WHO, 2020, NOVEL CORONAVIR 0112
   WHO, 2020, NOVEL CORONAVIR 0117
   WHO, 2020, NOVEL CORONAVIR 0121
   WHO, 2020, CLIN MAN SEV AC RESP
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 37
TC 150
Z9 150
U1 505
U2 505
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 15
PY 2020
VL 395
IS 10223
BP 497
EP 506
DI 10.1016/S0140-6736(20)30183-5
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA KN1CG
UT WOS:000514576900032
PM 31986264
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhu, N
   Zhang, DY
   Wang, WL
   Li, XW
   Yang, B
   Song, JD
   Zhao, X
   Huang, BY
   Shi, WF
   Lu, RJ
   Niu, PH
   Zhan, FX
   Ma, XJ
   Wang, DY
   Xu, WB
   Wu, GZ
   Gao, GGF
   Tan, WJ
AF Zhu, Na
   Zhang, Dingyu
   Wang, Wenling
   Li, Xingwang
   Yang, Bo
   Song, Jingdong
   Zhao, Xiang
   Huang, Baoying
   Shi, Weifeng
   Lu, Roujian
   Niu, Peihua
   Zhan, Faxian
   Ma, Xuejun
   Wang, Dayan
   Xu, Wenbo
   Wu, Guizhen
   Gao, George F.
   Tan, Wenjie
CA China Novel Coronavirus
TI A Novel Coronavirus from Patients with Pneumonia in China, 2019
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID RESPIRATORY SYNDROME; EPIDEMIOLOGY; SARS
AB In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.)
   The authors report the emergence and isolation of a previously unknown betacoronavirus, the seventh member of the family of coronaviruses that infect humans, in Wuhan, China. Findings in three patients are described.
C1 [Zhu, Na; Wang, Wenling; Zhao, Xiang; Huang, Baoying; Lu, Roujian; Niu, Peihua; Ma, Xuejun; Wang, Dayan; Xu, Wenbo; Wu, Guizhen; Gao, George F.; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing, Peoples R China.
   [Li, Xingwang] Capital Med Univ, Beijing Ditan Hosp, Dept Infect Dis, Beijing, Peoples R China.
   [Zhang, Dingyu] Chinese Acad Sci, Wuhan Jinyintan Hosp, Wuhan, Hubei, Peoples R China.
   [Yang, Bo; Zhan, Faxian] Chinese Acad Sci, Hubei Prov Ctr Dis Control & Prevent, Div Viral Dis Detect, Wuhan, Hubei, Peoples R China.
   [Tan, Wenjie] Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan, Hubei, Peoples R China.
   [Shi, Weifeng] Shandong First Med Univ, Jinan, Shandong, Peoples R China.
   [Shi, Weifeng] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China.
RP Wu, GZ; Tan, WJ (reprint author), China CDC, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, 155 Changbai Rd, Beijing 102206, Peoples R China.; Gao, GGF (reprint author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
EM wugz@ivdc.chinacdc.cn; gaof@im.ac.cn; tanwj@ivdc.chinacdc.cn
FU National Key Research and Development Program of China [2016YFD0500301];
   National Major Project for Control and Prevention of Infectious Disease
   in China [2018ZX10101002]
FX This work was supported by grants from the National Key Research and
   Development Program of China (2016YFD0500301) and the National Major
   Project for Control and Prevention of Infectious Disease in China
   (2018ZX10101002).
CR Armstrong GL, 2019, NEW ENGL J MED, V381, P2569, DOI 10.1056/NEJMsr1813907
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025
   Jonsdottir HR, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0479-5
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Liu GS, 2019, BIOMED ENVIRON SCI, V32, P438, DOI 10.3967/bes2019.058
   Masters P.S., 2013, FIELDS VIROLOGY, P825
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tan W, 2020, CHINA CDC WEEKLY, V2, P61
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Wuhan Municipal Health Commission, 2019, REP CLUST PNEUM UNKN
   Wuhan Municipal Health Commission, 2020, REP NOV COR INF PNEU
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
NR 17
TC 102
Z9 101
U1 381
U2 381
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD FEB 20
PY 2020
VL 382
IS 8
BP 727
EP 733
DI 10.1056/NEJMoa2001017
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ7SF
UT WOS:000517119800008
PM 31978945
OA Bronze
DA 2020-04-03
ER

PT J
AU Chan, JFW
   Yuan, SF
   Kok, KH
   To, KKW
   Chu, H
   Yang, J
   Xing, FF
   Liu, JL
   Yip, CCY
   Poon, RWS
   Tsoi, HW
   Lo, SKF
   Chan, KH
   Poon, VKM
   Chan, WM
   Ip, JD
   Cai, JP
   Cheng, VCC
   Chen, HL
   Hui, CKM
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Yuan, Shuofeng
   Kok, Kin-Hang
   To, Kelvin Kai-Wang
   Chu, Hin
   Yang, Jin
   Xing, Fanfan
   Liu, Jieling
   Yip, Cyril Chik-Yan
   Poon, Rosana Wing-Shan
   Tsoi, Hoi-Wah
   Lo, Simon Kam-Fai
   Chan, Kwok-Hung
   Poon, Vincent Kwok-Man
   Chan, Wan-Mui
   Ip, Jonathan Daniel
   Cai, Jian-Piao
   Cheng, Vincent Chi-Chung
   Chen, Honglin
   Hui, Christopher Kim-Ming
   Yuen, Kwok-Yung
TI A familial cluster of pneumonia associated with the 2019 novel
   coronavirus indicating person-to-person transmission: a study of a
   family cluster
SO LANCET
LA English
DT Article
ID RESPIRATORY SYNDROME CORONAVIRUS; VIRAL LOAD; COMMUNITY OUTBREAK;
   SYNDROME SARS; BETACORONAVIRUS; INVOLVEMENT; DISCOVERY; SUPPORTS;
   SAMPLES; VIRUS
AB Background An ongoing outbreak of pneumonia associated with a novel coronavirus was reported in Wuhan city, Hubei province, China. Affected patients were geographically linked with a local wet market as a potential source. No data on person-to-person or nosocomial transmission have been published to date.
   Methods In this study, we report the epidemiological, clinical, laboratory, radiological, and microbiological findings of five patients in a family cluster who presented with unexplained pneumonia after returning to Shenzhen, Guangdong province, China, after a visit to Wuhan, and an additional family member who did not travel to Wuhan. Phylogenetic analysis of genetic sequences from these patients were done.
   Findings From Jan 10, 2020, we enrolled a family of six patients who travelled to Wuhan from Shenzhen between Dec 29, 2019 and Jan 4, 2020. Of six family members who travelled to Wuhan, five were identified as infected with the novel coronavirus. Additionally, one family member, who did not travel to Wuhan, became infected with the virus after several days of contact with four of the family members. None of the family members had contacts with Wuhan markets or animals, although two had visited a Wuhan hospital. Five family members (aged 36-66 years) presented with fever, upper or lower respiratory tract symptoms, or diarrhoea, or a combination of these 3-6 days after exposure. They presented to our hospital (The University of Hong Kong-Shenzhen Hospital, Shenzhen) 6-10 days after symptom onset. They and one asymptomatic child (aged 10 years) had radiological ground-glass lung opacities. Older patients (aged >60 years) had more systemic symptoms, extensive radiological ground-glass lung changes, lymphopenia, thrombocytopenia, and increased C-reactive protein and lactate dehydrogenase levels. The nasopharyngeal or throat swabs of these six patients were negative for known respiratory microbes by point-of-care multiplex RT-PCR, but five patients (four adults and the child) were RT-PCR positive for genes encoding the internal RNA-dependent RNA polymerase and surface Spike protein of this novel coronavirus, which were confirmed by Sanger sequencing. Phylogenetic analysis of these five patients' RT-PCR amplicons and two full genomes by next-generation sequencing showed that this is a novel coronavirus, which is closest to the bat severe acute respiatory syndrome (SARS)-related coronaviruses found in Chinese horseshoe bats.
   Interpretation Our findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Chan, Jasper Fuk-Woo; Yuan, Shuofeng; Kok, Kin-Hang; To, Kelvin Kai-Wang; Chu, Hin; Yip, Cyril Chik-Yan; Poon, Rosana Wing-Shan; Tsoi, Hoi-Wah; Chan, Kwok-Hung; Poon, Vincent Kwok-Man; Chan, Wan-Mui; Cai, Jian-Piao; Cheng, Vincent Chi-Chung; Chen, Honglin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol,Pokfulam, State Key Lab Emerging Infect Dis,Carol Yu Ctr In, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Yang, Jin; Xing, Fanfan; Liu, Jieling; Lo, Simon Kam-Fai; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen 518009, Guangdong, Peoples R China.
   [Hui, Christopher Kim-Ming] Univ Hong Kong, Shenzhen Hosp, Dept Med, Shenzhen, Guangdong, Peoples R China.
RP Yuen, KY (reprint author), Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen 518009, Guangdong, Peoples R China.
EM kyyuen@hku.hk
FU Shaw Foundation Hong Kong; Michael Seak-Kan Tong; Respiratory Viral
   Research Foundation; Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund
   Limited; Hong Kong Hainan Commercial Association South China
   Microbiology Research Fund; Sanming Project of Medicine in Shenzhen,
   China [SZSM201911014, SZSM201612096]; High Level-Hospital Program,
   Health Commission of Guangdong Province, China
FX This study was partly supported by the Shaw Foundation Hong Kong;
   Michael Seak-Kan Tong; Respiratory Viral Research Foundation; Hui Ming,
   Hui Hoy and Chow Sin Lan Charity Fund Limited; Marina Man-Wai Lee; the
   Hong Kong Hainan Commercial Association South China Microbiology
   Research Fund; Sanming Project of Medicine in Shenzhen, China
   (SZSM201911014 and SZSM201612096); and the High Level-Hospital Program,
   Health Commission of Guangdong Province, China.
CR Centre for Health Protection of the Hong Kong Special Administrative Region Government, 2020, CHP PROV FURTH INF C
   Centre for Health Protection of the Hong Kong Special Administrative Region Government, 2019, CHP CLOS MON CLUST P
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan KH, 2017, ADV VIROL, DOI 10.1155/2017/1324276
   Che XY, 2006, CLIN INFECT DIS, V43, pE1, DOI 10.1086/504943
   Che XY, 2005, J INFECT DIS, V191, P2033, DOI 10.1086/430355
   Cheng VCC, 2004, CLIN INFECT DIS, V38, P467, DOI 10.1086/382681
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cohen J., 2020, CHINESE RES REVEAL D
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058
   Juan D., 2020, CHINADAILY
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Lau SKP, 2015, J VIROL, V89, P10532, DOI 10.1128/JVI.01048-15
   Lau SKP, 2015, J VIROL, V89, P3076, DOI 10.1128/JVI.02420-14
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI 10.1053/S0016-5085(03)01215-0
   Lewandowski K, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00963-19
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Memish ZA, 2014, J INFECT DIS, V210, P1590, DOI 10.1093/infdis/jiu292
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   To KKW, 2019, CLIN MICROBIOL INFEC, V25, P372, DOI 10.1016/j.cmi.2018.06.009
   To KKW, 2017, J GEN VIROL, V98, P1004, DOI 10.1099/jgv.0.000766
   To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664
   Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986
   Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966
NR 30
TC 81
Z9 80
U1 197
U2 197
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 15
PY 2020
VL 395
IS 10223
BP 514
EP 523
DI 10.1016/S0140-6736(20)30154-9
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA KN1CG
UT WOS:000514576900034
PM 31986261
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhou, P
   Yang, XL
   Wang, XG
   Hu, B
   Zhang, L
   Zhang, W
   Si, HR
   Zhu, Y
   Li, B
   Huang, CL
   Chen, HD
   Chen, J
   Luo, Y
   Guo, H
   Jiang, RD
   Liu, MQ
   Chen, Y
   Shen, XR
   Wang, X
   Zheng, XS
   Zhao, K
   Chen, QJ
   Deng, F
   Liu, LL
   Yan, B
   Zhan, FX
   Wang, YY
   Xiao, GF
   Shi, ZL
AF Zhou, Peng
   Yang, Xing-Lou
   Wang, Xian-Guang
   Hu, Ben
   Zhang, Lei
   Zhang, Wei
   Si, Hao-Rui
   Zhu, Yan
   Li, Bei
   Huang, Chao-Lin
   Chen, Hui-Dong
   Chen, Jing
   Luo, Yun
   Guo, Hua
   Jiang, Ren-Di
   Liu, Mei-Qin
   Chen, Ying
   Shen, Xu-Rui
   Wang, Xi
   Zheng, Xiao-Shuang
   Zhao, Kai
   Chen, Quan-Jiao
   Deng, Fei
   Liu, Lin-Lin
   Yan, Bing
   Zhan, Fa-Xian
   Wang, Yan-Yi
   Xiao, Geng-Fu
   Shi, Zheng-Li
TI A pneumonia outbreak associated with a new coronavirus of probable bat
   origin
SO NATURE
LA English
DT Article
ID SARS; IDENTIFICATION
AB Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats(1-4). Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans(5-7). Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.
C1 [Zhou, Peng; Yang, Xing-Lou; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Yan, Bing; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.
   [Wang, Xian-Guang; Huang, Chao-Lin; Chen, Hui-Dong] Wuhan Jin Yin Tan Hosp, Wuhan, Peoples R China.
   [Si, Hao-Rui; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Liu, Lin-Lin; Zhan, Fa-Xian] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China.
RP Shi, ZL (reprint author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.
EM zlshi@wh.iov.cn
FU Strategic Priority Research Program of the Chinese Academy of Sciences
   (CAS) [XDB29010101, XDB29010104]; China Natural Science Foundation for
   excellent scholars [81822028, 31770175, 31800142]; Mega-Project for
   Infectious Disease from Minister of Science and Technology of the
   People's Republic of China [2018ZX10305409-004-001]; Youth innovation
   promotion association of CAS [2019328]
FX We thank P. Zhang and A. Du from the WIV core facility centre for their
   help with producing transmission electron microscopy micrographs; H.-Z.
   Liu and P. Yu from WIV for bioinformatics analysis. This work was
   jointly supported by the Strategic Priority Research Program of the
   Chinese Academy of Sciences (CAS) (XDB29010101 to Z.-L.S. and
   XDB29010104 to P.Z.), China Natural Science Foundation for excellent
   scholars (81822028 to P.Z., 31770175 to Z.-L.S. and 31800142 to B.H.),
   Mega-Project for Infectious Disease from Minister of Science and
   Technology of the People's Republic of China (2018ZX10305409-004-001 to
   P.Z.), Youth innovation promotion association of CAS (2019328 to
   X.-L.Y.).
CR Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY, DOI DOI 10.1101/2020.02.07.937862V1
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005
   Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7
   WHO, 2020, WHO DIR GEN REM MED
   Wuhan Municipal Health Commission, 2020, PRESS STAT REL NOV C
   Yang L, 2013, EMERG INFECT DIS, V19, P989, DOI 10.3201/eid1906.121648
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 16
TC 75
Z9 75
U1 168
U2 168
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR
PY 2020
VL 579
IS 7798
BP 270
EP +
DI 10.1038/s41586-020-2012-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KU0CC
UT WOS:000519378900030
PM 32015507
OA Other Gold
DA 2020-04-03
ER

PT J
AU Zhou, P
   Yang, XL
   Wang, XG
   Hu, B
   Zhang, L
   Zhang, W
   Si, HR
   Zhu, Y
   Li, B
   Huang, CL
   Chen, HD
   Chen, J
   Luo, Y
   Guo, H
   Jiang, RD
   Liu, MQ
   Chen, Y
   Shen, XR
   Wang, X
   Zheng, XS
   Zhao, K
   Chen, QJ
   Deng, F
   Liu, LL
   Yan, B
   Zhan, FX
   Wang, YY
   Xiao, GF
   Shi, ZL
AF Zhou, Peng
   Yang, Xing-Lou
   Wang, Xian-Guang
   Hu, Ben
   Zhang, Lei
   Zhang, Wei
   Si, Hao-Rui
   Zhu, Yan
   Li, Bei
   Huang, Chao-Lin
   Chen, Hui-Dong
   Chen, Jing
   Luo, Yun
   Guo, Hua
   Jiang, Ren-Di
   Liu, Mei-Qin
   Chen, Ying
   Shen, Xu-Rui
   Wang, Xi
   Zheng, Xiao-Shuang
   Zhao, Kai
   Chen, Quan-Jiao
   Deng, Fei
   Liu, Lin-Lin
   Yan, Bing
   Zhan, Fa-Xian
   Wang, Yan-Yi
   Xiao, Geng-Fu
   Shi, Zheng-Li
TI A pneumonia outbreak associated with a new coronavirus of probable bat
   origin
SO NATURE
LA English
DT Article; Early Access
ID SARS; IDENTIFICATION
AB Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats(1-4). Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans(5-7). Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.
   Characterization of full-length genome sequences from patients infected with a new coronavirus (2019-nCoV) shows that the sequences are nearly identical and indicates that the virus is related to a bat coronavirus.
C1 [Zhou, Peng; Yang, Xing-Lou; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Yan, Bing; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li] Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.
   [Wang, Xian-Guang; Huang, Chao-Lin; Chen, Hui-Dong] Wuhan Jin Yin Tan Hosp, Wuhan, Peoples R China.
   [Si, Hao-Rui; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Liu, Lin-Lin; Zhan, Fa-Xian] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China.
RP Shi, ZL (reprint author), Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.
EM zlshi@wh.iov.cn
FU Strategic Priority Research Program of the Chinese Academy of Sciences
   (CAS) [XDB29010101, XDB29010104]; China Natural Science
   FoundationNational Natural Science Foundation of China [81822028,
   31770175, 31800142]; Mega-Project for Infectious Disease
   [2018ZX10305409-004-001]; Youth innovation promotion association of CAS
   [2019328]
FX We thank P. Zhang and A. Du from the WIV core facility centre for their
   help with producing transmission electron microscopy micrographs; H.-Z.
   Liu and P. Yu from WIV for bioinformatics analysis. This work was
   jointly supported by the Strategic Priority Research Program of the
   Chinese Academy of Sciences (CAS) (XDB29010101 to Z.-L.S. and
   XDB29010104 to P.Z.), China Natural Science Foundation for excellent
   scholars (81822028 to P.Z., 31770175 to Z.-L.S. and 31800142 to B.H.),
   Mega-Project for Infectious Disease from Minister of Science and
   Technology of the People's Republic of China (2018ZX10305409-004-001 to
   P.Z.), Youth innovation promotion association of CAS (2019328 to
   X.-L.Y.).
CR Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY, DOI DOI 10.1101/2020.02.07.937862V1
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005
   Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7
   WHO, 2020, WHO DIR GEN REM MED
   Wuhan Municipal Health Commission, 2020, PRESS STAT REL NOV C
   Yang L, 2013, EMERG INFECT DIS, V19, P989, DOI 10.3201/eid1906.121648
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 16
TC 75
Z9 75
U1 168
U2 168
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
DI 10.1038/s41586-020-2012-7
EA FEB 2020
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KS1VQ
UT WOS:000518098100001
PM 32015507
OA Other Gold
DA 2020-04-03
ER

PT J
AU Chen, NS
   Zhou, M
   Dong, X
   Qu, JM
   Gong, FY
   Han, Y
   Qiu, Y
   Wang, JL
   Liu, Y
   Wei, Y
   Xia, JA
   Yu, T
   Zhang, XX
   Zhang, L
AF Chen, Nanshan
   Zhou, Min
   Dong, Xuan
   Qu, Jieming
   Gong, Fengyun
   Han, Yang
   Qiu, Yang
   Wang, Jingli
   Liu, Ying
   Wei, Yuan
   Xia, Jia'an
   Yu, Ting
   Zhang, Xinxin
   Zhang, Li
TI Epidemiological and clinical characteristics of 99 cases of 2019 novel
   coronavirus pneumonia in Wuhan, China: a descriptive study
SO LANCET
LA English
DT Article
ID RESPIRATORY SYNDROME CORONAVIRUS; MERS; OUTBREAK; SARS; COV
AB Background In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.
   Methods In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020.
   Findings Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market. The average age of the patients was 55.5 years (SD 13.1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient). According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneu-mothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure.
   Interpretation The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Chen, Nanshan; Dong, Xuan; Wei, Yuan; Xia, Jia'an; Yu, Ting; Zhang, Li] Wuhan Jinyintan Hosp, TB & Resp Dept, Wuhan 430023, Peoples R China.
   [Gong, Fengyun; Wang, Jingli] Wuhan Jinyintan Hosp, Infect Dis Dept, Wuhan, Peoples R China.
   [Han, Yang] Wuhan Jinyintan Hosp, Sci & Educ Dept, Wuhan, Peoples R China.
   [Liu, Ying] Wuhan Jinyintan Hosp, Off Drug Clin Trial Inst, Wuhan, Peoples R China.
   [Zhou, Min; Qu, Jieming] Shanghai Jiao Tong Univ, Sch Med, Dept Resp & Crit Care Med, Ruijin Hosp, Shanghai, Peoples R China.
   [Zhou, Min; Qu, Jieming] Shanghai Jiao Tong Univ, Sch Med, Inst Resp Dis, Shanghai, Peoples R China.
   [Zhang, Xinxin] Shanghai Jiao Tong Univ, Sch Med, Res Lab Clin Virol, Ruijin Hosp, Shanghai 200025, Peoples R China.
   [Zhang, Xinxin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Shanghai 200025, Peoples R China.
   [Zhang, Xinxin] Shanghai Jiao Tong Univ, Sch Med, Clin Res Ctr, Ruijin Hosp North, Shanghai, Peoples R China.
   [Han, Yang; Qiu, Yang] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan, Peoples R China.
RP Zhang, L (reprint author), Wuhan Jinyintan Hosp, TB & Resp Dept, Wuhan 430023, Peoples R China.; Zhang, XX (reprint author), Shanghai Jiao Tong Univ, Sch Med, Res Lab Clin Virol, Ruijin Hosp, Shanghai 200025, Peoples R China.; Zhang, XX (reprint author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Shanghai 200025, Peoples R China.
EM zhangx@shsmu.edu.cn; zhangli080806@163.com
RI Ribeiro, Nuno/AAH-2299-2020
FU National Key R&D Program of China [2017YFC1309700]
FX This study was funded by the National Key R&D Program of China (number
   2017YFC1309700). We thank all patients involved in the study.
CR Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Dryden M, 2015, CLIN MICROBIOL INFEC, V21, pS27, DOI 10.1016/j.cmi.2015.03.024
   Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584
   Guo LX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02752
   Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x
   Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16
   Wang XF, 2014, CLIN RESPIR J, V8, P410, DOI 10.1111/crj.12087
   WHO, 2020, CLIN MAN SEV AC RESP
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
NR 24
TC 70
Z9 70
U1 177
U2 177
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 15
PY 2020
VL 395
IS 10223
BP 507
EP 513
DI 10.1016/S0140-6736(20)30211-7
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA KN1CG
UT WOS:000514576900033
PM 32007143
OA Bronze
DA 2020-04-03
ER

PT J
AU Lu, RJ
   Zhao, X
   Li, J
   Niu, PH
   Yang, B
   Wu, HL
   Wang, WL
   Song, H
   Huang, BY
   Zhu, N
   Bi, YH
   Ma, XJ
   Zhan, FX
   Wang, L
   Hu, T
   Zhou, H
   Hu, ZH
   Zhou, WM
   Zhao, L
   Chen, J
   Meng, Y
   Wang, J
   Lin, Y
   Yuan, JY
   Xie, ZH
   Ma, JM
   Liu, WJ
   Wang, DY
   Xu, WB
   Holmes, EC
   Gao, GF
   Wu, GZ
   Chen, WJ
   Shi, WF
   Tan, WJ
AF Lu, Roujian
   Zhao, Xiang
   Li, Juan
   Niu, Peihua
   Yang, Bo
   Wu, Honglong
   Wang, Wenling
   Song, Hao
   Huang, Baoying
   Zhu, Na
   Bi, Yuhai
   Ma, Xuejun
   Zhan, Faxian
   Wang, Liang
   Hu, Tao
   Zhou, Hong
   Hu, Zhenhong
   Zhou, Weimin
   Zhao, Li
   Chen, Jing
   Meng, Yao
   Wang, Ji
   Lin, Yang
   Yuan, Jianying
   Xie, Zhihao
   Ma, Jinmin
   Liu, William J.
   Wang, Dayan
   Xu, Wenbo
   Holmes, Edward C.
   Gao, George F.
   Wu, Guizhen
   Chen, Weijun
   Shi, Weifeng
   Tan, Wenjie
TI Genomic characterisation and epidemiology of 2019 novel coronavirus:
   implications for virus origins and receptor binding
SO LANCET
LA English
DT Article
ID MERS-COV; SARS CORONAVIRUS; DOMAIN; TOOL
AB Background In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed.
   Methods We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus.
   Findings The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99.98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues.
   Interpretation 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensinconverting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation.
C1 [Lu, Roujian; Zhao, Xiang; Niu, Peihua; Wang, Wenling; Huang, Baoying; Zhu, Na; Ma, Xuejun; Zhou, Weimin; Zhao, Li; Meng, Yao; Wang, Ji; Liu, William J.; Wang, Dayan; Xu, Wenbo; Gao, George F.; Wu, Guizhen; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.
   [Li, Juan; Zhou, Hong; Shi, Weifeng] Shandong First Med Univ & Shandong Acad Med Sci, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
   [Yang, Bo; Zhan, Faxian] Hubei Prov Ctr Dis Control & Prevent, Div Viral Dis Detect, Wuhan, Peoples R China.
   [Wu, Honglong; Lin, Yang; Yuan, Jianying; Xie, Zhihao; Ma, Jinmin; Chen, Weijun] BGI PathoGenesis Pharmaceut Technol, Shenzhen, Peoples R China.
   [Song, Hao] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Bi, Yuhai; Wang, Liang; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Bi, Yuhai; Wang, Liang; Gao, George F.] Chinese Acad Sci, CAS TWAS Ctr Excellence Emerging Infect Dis CEEID, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Hu, Zhenhong] Peoples Liberat Army Gen Hosp, Cent Theater, Wuhan, Peoples R China.
   [Chen, Jing; Tan, Wenjie] Wenzhou Med Univ, Minist Educ, Key Lab Lab Med, Wenzhou, Peoples R China.
   [Chen, Jing; Tan, Wenjie] Wenzhou Med Univ, Sch Lab Med & Life Sci, Inst Med Virol, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.
   [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Shi, Weifeng] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Affiliated Hosp 1, Jinan, Peoples R China.
   [Tan, Wenjie] Chinese Acad Sci, Ctr Biosafety Mega Sci, Beijing, Peoples R China.
RP Tan, WJ (reprint author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.; Shi, WF (reprint author), Shandong First Med Univ & Shandong Acad Med Sci, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
EM wfshi@sdfmu.edu.cn; tanwj@ivdc.chinacdc.cn
FU National Key Research and Development Program of China; National Major
   Project for Control and Prevention of Infectious Disease in China;
   Chinese Academy of SciencesChinese Academy of Sciences; Shandong First
   Medical University
FX National Key Research and Development Program of China, National Major
   Project for Control and Prevention of Infectious Disease in China,
   Chinese Academy of Sciences, Shandong First Medical University.
CR Alagaili A.N., 2014, MBIO, V5, DOI DOI 10.1128/MBIO.00884-14
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ismail MM, 2003, AVIAN DIS, V47, P515, DOI 10.1637/5917
   Lee JY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2576-5
   Lee J, 2016, J THEOR BIOL, V408, P118, DOI 10.1016/j.jtbi.2016.08.009
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121
   Niu PH, 2016, VIROL SIN, V31, P85, DOI 10.1007/s12250-015-3653-9
   Nurk Sergey, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P158, DOI 10.1007/978-3-642-37195-0_13
   Pan M, 2016, J INFECTION, V72, P52, DOI 10.1016/j.jinf.2015.06.009
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tan W, 2020, CHINA CDC WEEKLY, V2, P61
   Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92
   Wang QH, 2016, ANTIVIR RES, V133, P165, DOI 10.1016/j.antiviral.2016.07.015
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595
   Zhou P., 2020, BIORXIV, DOI [10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952, 10.1101/2020.01.22.914952.]
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 37
TC 44
Z9 43
U1 199
U2 199
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 22
PY 2020
VL 395
IS 10224
BP 565
EP 574
DI 10.1016/S0140-6736(20)30251-8
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA KN5AJ
UT WOS:000514849400027
PM 32007145
OA Bronze
DA 2020-04-03
ER

PT J
AU Wu, JT
   Leung, K
   Leung, GM
AF Wu, Joseph T.
   Leung, Kathy
   Leung, Gabriel M.
TI Nowcasting and forecasting the potential domestic and international
   spread of the 2019-nCoV outbreak originating in Wuhan, China: a
   modelling study
SO LANCET
LA English
DT Article
ID EAST RESPIRATORY SYNDROME; HUMAN CORONAVIRUSES 229E; HONG-KONG;
   TRANSMISSION DYNAMICS; SARS; EPIDEMIC; OC43; IMPACT
AB Background Since Dec 31, 2019, the Chinese city of Wuhan has reported an outbreak of atypical pneumonia caused by the 2019 novel coronavirus (2019-nCoV). Cases have been exported to other Chinese cities, as well as internationally, threatening to trigger a global outbreak. Here, we provide an estimate of the size of the epidemic in Wuhan on the basis of the number of cases exported from Wuhan to cities outside mainland China and forecast the extent of the domestic and global public health risks of epidemics, accounting for social and non-pharmaceutical prevention interventions.
   Methods We used data from Dec 31, 2019, to Jan 28, 2020, on the number of cases exported from Wuhan internationally (known days of symptom onset from Dec 25, 2019, to Jan 19, 2020) to infer the number of infections in Wuhan from Dec 1, 2019, to Jan 25, 2020. Cases exported domestically were then estimated. We forecasted the national and global spread of 2019-nCoV, accounting for the effect of the metropolitan-wide quarantine of Wuhan and surrounding cities, which began Jan 23-24, 2020. We used data on monthly flight bookings from the Official Aviation Guide and data on human mobility across more than 300 prefecture-level cities in mainland China from the Tencent database. Data on confirmed cases were obtained from the reports published by the Chinese Center for Disease Control and Prevention. Serial interval estimates were based on previous studies of severe acute respiratory syndrome coronavirus (SARS-CoV). A susceptible-exposed-infectious-recovered metapopulation model was used to simulate the epidemics across all major cities in China. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credibile interval (CrI).
   Findings In our baseline scenario, we estimated that the basic reproductive number for 2019-nCoV was 2.68 (95% CrI 2.47-2.86) and that 75 815 individuals (95% CrI 37 304-130 330) have been infected in Wuhan as of Jan 25, 2020. The epidemic doubling time was 6.4 days (95% CrI 5.8-7.1). We estimated that in the baseline scenario, Chongqing, Beijing, Shanghai, Guangzhou, and Shenzhen had imported 461 (95% CrI 227-805), 113 (57-193), 98 (49-168), 111 (56-191), and 80 (40-139) infections from Wuhan, respectively. If the transmissibility of 2019-nCoV were similar everywhere domestically and over time, we inferred that epidemics are already growing exponentially in multiple major cities of China with a lag time behind the Wuhan outbreak of about 1-2 weeks.
   Interpretation Given that 2019-nCoV is no longer contained within Wuhan, other major Chinese cities are probably sustaining localised outbreaks. Large cities overseas with close transport links to China could also become outbreak epicentres, unless substantial public health interventions at both the population and personal levels are implemented immediately. Independent self-sustaining outbreaks in major cities globally could become inevitable because of substantial exportation of presymptomatic cases and in the absence of large-scale public health interventions. Preparedness plans and mitigation interventions should be readied for quick deployment globally. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Wu, Joseph T.; Leung, Kathy; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China.
RP Wu, JT (reprint author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China.
EM joewu@hku.hk
RI Wu, Joseph Tsz Kei/C-4450-2009; Leung, Kathy/D-5605-2017
OI Wu, Joseph Tsz Kei/0000-0002-3155-5987; Leung,
   Kathy/0000-0003-4777-388X; Leung, Gabriel/0000-0002-2503-6283
FU Health and Medical Research Fund from the Government of the Hong Kong
   Special Administrative Region
FX We thank Chi-Kin Lam and Miky Wong from School of Public Health, The
   University of Hong Kong (Hong Kong, China) for technical support. This
   research was supported by a commissioned grant from the Health and
   Medical Research Fund from the Government of the Hong Kong Special
   Administrative Region.
CR Abbad A, 2019, EUROSURVEILLANCE, V24
   Al Kahlout RA, 2019, J IMMUNOL RES, DOI 10.1155/2019/1386740
   [Anonymous], 2019, PEOPLES DAILY ONLINE
   Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Centers for Disease Control and Prevention, 2005, FREQ ASK QUEST SARS
   Chan CM, 2009, J CLIN VIROL, V45, P54, DOI 10.1016/j.jcv.2009.02.011
   Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Desai AN, 2019, HEALTH SECUR, V17, P268, DOI 10.1089/hs.2019.0022
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10
   GILL EP, 1994, J CLIN MICROBIOL, V32, P2372, DOI 10.1128/JCM.32.10.2372-2376.1994
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Imai N, 2020, MRC CTR GLOBAL INFEC, V1-3
   Jia N, 2009, TROP MED INT HEALTH, V14, P21, DOI 10.1111/j.1365-3156.2008.02147.x
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Lau EHY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-50
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Leung GM, 2006, EPIDEMIOL INFECT, V134, P211, DOI 10.1017/S0950268805004826
   Li Q, 2020, CHINA CDC WEEKLY, V2, P79
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Matsuno AK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217744
   McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Park JE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5484-8
   Patrick David M, 2006, Can J Infect Dis Med Microbiol, V17, P330
   Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276
   Pushkar D, 2010, PSYCHOL RES PROG, P5
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [DOI 10.1101/2020.01.23.20018549, 10.1101/2020.01.23.20018549]
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   State Administration for Market Regulation, 2020, ANN STAT ADM MARK SU
   T Liu, 2020, BIORXIV, DOI [https://doi.org/10.1101/2020.01.25.919787, 10.1101/2020.01.25.919787, DOI 10.1101/2020.01.25.919787]
   Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005
   Virlogeux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35839
   Walsh EE, 2013, J INFECT DIS, V208, P1634, DOI 10.1093/infdis/jit393
   Wang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02344-z
   Zhang SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191789
   Zhao S, 2020, BIORXIV, DOI [10.1101/2020.01.23.916395 (preprint)., DOI 10.1101/2020.01.23.916395]
NR 46
TC 34
Z9 35
U1 112
U2 112
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 29
PY 2020
VL 395
IS 10225
BP 689
EP 697
DI 10.1016/S0140-6736(20)30260-9
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ2JO
UT WOS:000516755200027
PM 32014114
OA Bronze
DA 2020-04-03
ER

PT J
AU Holshue, ML
   DeBolt, C
   Lindquist, S
   Lofy, KH
   Wiesman, J
   Bruce, H
   Spitters, C
   Ericson, K
   Wilkerson, S
   Tural, A
   Diaz, G
   Cohn, A
   Fox, L
   Patel, A
   Gerber, SI
   Kim, L
   Tong, SX
   Lu, XY
   Lindstrom, S
   Pallansch, MA
   Weldon, WC
   Biggs, HM
   Uyeki, TM
   Pillai, SK
AF Holshue, Michelle L.
   DeBolt, Chas
   Lindquist, Scott
   Lofy, Kathy H.
   Wiesman, John
   Bruce, Hollianne
   Spitters, Christopher
   Ericson, Keith
   Wilkerson, Sara
   Tural, Ahmet
   Diaz, George
   Cohn, Amanda
   Fox, LeAnne
   Patel, Anita
   Gerber, Susan I.
   Kim, Lindsay
   Tong, Suxiang
   Lu, Xiaoyan
   Lindstrom, Steve
   Pallansch, Mark A.
   Weldon, William C.
   Biggs, Holly M.
   Uyeki, Timothy M.
   Pillai, Satish K.
CA Washington State-nCoV Case Invest
TI First Case of 2019 Novel Coronavirus in the United States
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
AB A healthy 35 year-old man who had visited Wuhan, China, presented with cough and fever that progressed to pneumonia. This report describes the diagnosis, clinical course, and management of the condition. The case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels.
   An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
C1 [Holshue, Michelle L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Cohn, Amanda; Fox, LeAnne; Patel, Anita] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Gerber, Susan I.; Kim, Lindsay; Tong, Suxiang; Lu, Xiaoyan; Lindstrom, Steve; Pallansch, Mark A.; Weldon, William C.; Biggs, Holly M.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.
   [Pillai, Satish K.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA.
   [Holshue, Michelle L.; DeBolt, Chas; Lindquist, Scott; Lofy, Kathy H.; Wiesman, John] Washington State Dept Hlth, Shoreline, WA USA.
   [Bruce, Hollianne; Spitters, Christopher] Snohomish Hlth Dist, Everett, WA USA.
   [Ericson, Keith] Providence Med Grp, Everett, WA USA.
   [Wilkerson, Sara; Tural, Ahmet; Diaz, George] Providence Reg Med Ctr, Everett, WA USA.
   [Spitters, Christopher] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
RP Holshue, ML (reprint author), Washington State Dept Hlth Publ Hlth Labs, 1610 NE 150th St, Shoreline, WA 98155 USA.
EM michelle.holshue@doh.wa.gov
CR Centers for Disease Control and Prevention, 2020, INT GUID HEALTHC PRO
   Centers for Disease Control and Prevention, 2020, INFECT CONTROL
   Centers for Disease Control and Prevention, 2020, 2019 NOV COR
   Centers for Disease Control and Prevention, 2020, 2019 NOV COR 2019 NC
   Centers for Disease Control and Prevention, 2020, REAL TIM RT PCR PAN
   Centers for Disease Control and Prevention, 2020, INT GUID COLL HANDL
   Chan JF, 2020, LANCET
   Chen N, 2020, LANCET, V2020
   Huang C, 2020, LANCET
   Johns Hopkins University CSSE, WUH COR 2019 NCOV GL
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Washington State Department of Health, NOV COR OUTBR 2020
   World Health Organization, 2020, PNEUM UNK CAUS CHIN
   World Health Organization, 2020, NOV COR CHIN
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 17
TC 25
Z9 25
U1 90
U2 90
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 5
PY 2020
VL 382
IS 10
BP 929
EP 936
DI 10.1056/NEJMoa2001191
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT7TC
UT WOS:000519214900008
PM 32004427
OA Bronze
DA 2020-04-03
ER

PT J
AU Wu, F
   Zhao, S
   Yu, B
   Chen, YM
   Wang, W
   Song, ZG
   Hu, Y
   Tao, ZW
   Tian, JH
   Pei, YY
   Yuan, ML
   Zhang, YL
   Dai, FH
   Liu, Y
   Wang, QM
   Zheng, JJ
   Xu, L
   Holmes, EC
   Zhang, YZ
AF Wu, Fan
   Zhao, Su
   Yu, Bin
   Chen, Yan-Mei
   Wang, Wen
   Song, Zhi-Gang
   Hu, Yi
   Tao, Zhao-Wu
   Tian, Jun-Hua
   Pei, Yuan-Yuan
   Yuan, Ming-Li
   Zhang, Yu-Ling
   Dai, Fa-Hui
   Liu, Yi
   Wang, Qi-Min
   Zheng, Jiao-Jiao
   Xu, Lin
   Holmes, Edward C.
   Zhang, Yong-Zhen
TI A new coronavirus associated with human respiratory disease in China
SO NATURE
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; SARS-LIKE CORONAVIRUS; MAXIMUM-LIKELIHOOD;
   VIRUS; BATS; IDENTIFICATION; PERFORMANCE; DIVERSITY; HKU1
AB Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health(1-3). Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing(4) of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV'). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China(5). This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.
C1 [Wu, Fan; Chen, Yan-Mei; Song, Zhi-Gang; Pei, Yuan-Yuan; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Zhao, Su; Hu, Yi; Tao, Zhao-Wu; Yuan, Ming-Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Dept Pulm & Crit Care Med, Wuhan, Peoples R China.
   [Yu, Bin; Tian, Jun-Hua] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China.
   [Wang, Wen; Zhang, Yong-Zhen] China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.
   [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Zhang, Yong-Zhen] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
RP Zhang, YZ (reprint author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Zhang, YZ (reprint author), China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.; Zhang, YZ (reprint author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
EM zhangyongzhen@shphc.org.cn
FU Special National Project on investigation of basic resources of China
   [SQ2019FY010009]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81861138003, 31930001]; ARC
   Australian Laureate FellowshipAustralian Research Council [FL170100022]
FX This study was supported by the Special National Project on
   investigation of basic resources of China (grant SQ2019FY010009) and the
   National Natural Science Foundation of China (grants 81861138003 and
   31930001). E.C.H. is supported by an ARC Australian Laureate Fellowship
   (FL170100022).
CR Bermingham A, 2012, EUROSURVEILLANCE, V17, P6
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.93786, DOI 10.1101/2020.02.07.93786]
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lin XD, 2017, VIROLOGY, V507, P1, DOI 10.1016/j.virol.2017.03.019
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268
   McMullan LK, 2019, LANCET INFECT DIS, V19, P1023, DOI 10.1016/S1473-3099(19)30291-9
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang W, 2017, J VIROL, V91, DOI [10.1128/JVI.00764-17, 10.1128/jvi.00764-17]
   Wang W, 2015, VIROLOGY, V474, P19, DOI 10.1016/j.virol.2014.10.017
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   WHO, 2020, WHO DIR GEN REM MED
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3
   Yadav PD, 2019, EMERG INFECT DIS, V25, P1003, DOI 10.3201/eid2505.181076
   Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 43
TC 19
Z9 19
U1 88
U2 88
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR
PY 2020
VL 579
IS 7798
BP 265
EP +
DI 10.1038/s41586-020-2008-3
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KU0CC
UT WOS:000519378900029
PM 32015508
OA Other Gold
DA 2020-04-03
ER

PT J
AU Wu, F
   Zhao, S
   Yu, B
   Chen, YM
   Wang, W
   Song, ZG
   Hu, Y
   Tao, ZW
   Tian, JH
   Pei, YY
   Yuan, ML
   Zhang, YL
   Dai, FH
   Liu, Y
   Wang, QM
   Zheng, JJ
   Xu, L
   Holmes, EC
   Zhang, YZ
AF Wu, Fan
   Zhao, Su
   Yu, Bin
   Chen, Yan-Mei
   Wang, Wen
   Song, Zhi-Gang
   Hu, Yi
   Tao, Zhao-Wu
   Tian, Jun-Hua
   Pei, Yuan-Yuan
   Yuan, Ming-Li
   Zhang, Yu-Ling
   Dai, Fa-Hui
   Liu, Yi
   Wang, Qi-Min
   Zheng, Jiao-Jiao
   Xu, Lin
   Holmes, Edward C.
   Zhang, Yong-Zhen
TI A new coronavirus associated with human respiratory disease in China
SO NATURE
LA English
DT Article; Early Access
ID MULTIPLE SEQUENCE ALIGNMENT; SARS-LIKE CORONAVIRUS; MAXIMUM-LIKELIHOOD;
   VIRUS; BATS; IDENTIFICATION; PERFORMANCE; DIVERSITY; HKU1
AB Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health(1-3). Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing(4) of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV'). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China(5). This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.
   Phylogenetic and metagenomic analyses of the complete viral genome of a new coronavirus from the family Coronaviridae reveal that the virus is closely related to a group of SARS-like coronaviruses found in bats in China.
C1 [Wu, Fan; Chen, Yan-Mei; Song, Zhi-Gang; Pei, Yuan-Yuan; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Zhao, Su; Hu, Yi; Tao, Zhao-Wu; Yuan, Ming-Li] Huazhong Univ Sci & Technol, Dept Pulm & Crit Care Med, Tongji Med Coll, Cent Hosp Wuhan, Wuhan, Peoples R China.
   [Yu, Bin; Tian, Jun-Hua] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China.
   [Wang, Wen; Zhang, Yong-Zhen] China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.
   [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Zhang, Yong-Zhen] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
RP Zhang, YZ (reprint author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Zhang, YZ (reprint author), China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.; Zhang, YZ (reprint author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
EM zhangyongzhen@shphc.org.cn
FU Special National Project on investigation of basic resources of China
   [SQ2019FY010009]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81861138003, 31930001]; ARC
   Australian Laureate FellowshipAustralian Research Council [FL170100022]
FX This study was supported by the Special National Project on
   investigation of basic resources of China (grant SQ2019FY010009) and the
   National Natural Science Foundation of China (grants 81861138003 and
   31930001). E.C.H. is supported by an ARC Australian Laureate Fellowship
   (FL170100022).
CR Bermingham A, 2012, EUROSURVEILLANCE, V17, P6
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.93786, DOI 10.1101/2020.02.07.93786]
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lin XD, 2017, VIROLOGY, V507, P1, DOI 10.1016/j.virol.2017.03.019
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268
   McMullan LK, 2019, LANCET INFECT DIS, V19, P1023, DOI 10.1016/S1473-3099(19)30291-9
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang W, 2017, J VIROL, V91, DOI [10.1128/JVI.00764-17, 10.1128/jvi.00764-17]
   Wang W, 2015, VIROLOGY, V474, P19, DOI 10.1016/j.virol.2014.10.017
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   WHO, 2020, WHO DIR GEN REM MED
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3
   Yadav PD, 2019, EMERG INFECT DIS, V25, P1003, DOI 10.3201/eid2505.181076
   Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 43
TC 19
Z9 19
U1 88
U2 88
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
DI 10.1038/s41586-020-2008-3
EA FEB 2020
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KS1VQ
UT WOS:000518098100002
PM 32015508
OA Other Gold
DA 2020-04-03
ER

PT J
AU Wan, YS
   Shang, J
   Graham, R
   Baric, RS
   Li, F
AF Wan, Yushun
   Shang, Jian
   Graham, Rachel
   Baric, Ralph S.
   Li, Fang
TI Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis
   Based on Decade-Long Structural Studies of SARS Coronavirus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE 2019-nCoV; SARS coronavirus; angiotensin-converting enzyme 2; animal
   reservoir; cross-species transmission; human-to-human transmission
ID ACUTE-RESPIRATORY-SYNDROME; FUNCTIONAL RECEPTOR; BINDING DOMAIN; SPIKE
   PROTEIN; PALM CIVET; MECHANISMS; TRANSMISSION; REPLICATION; ADAPTATION;
   EVOLUTION
AB Recently, a novel coronavirus (2019-nCoV) has emerged from Wuhan, China, causing symptoms in humans similar to those caused by severe acute respiratory syndrome coronavirus (SARS-CoV). Since the SARS-CoV outbreak in 2002, extensive structural analyses have revealed key atomic-level interactions between the SARS-CoV spike protein receptor-binding domain (RBD) and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. Here, we analyzed the potential receptor usage by 2019-nCoV, based on the rich knowledge about SARS-CoV and the newly released sequence of 2019-nCoV. First, the sequence of 2019-nCoV RBD, including its receptor-binding motif (RBM) that directly contacts ACE2, is similar to that of SARS-CoV, strongly suggesting that 2019-nCoV uses ACE2 as its receptor. Second, several critical residues in 2019-nCoV RBM (particularly GIn493) provide favorable interactions with human ACE2, consistent with 2019-nCoV's capacity for human cell infection. Third, several other critical residues in 2019-nCoV RBM (particularly Asn501) are compatible with, but not ideal for, binding human ACE2, suggesting that 2019-nCoV has acquired some capacity for human-to-human transmission. Last, while phylogenetic analysis indicates a bat origin of 2019-nCoV, 2019-nCoV also potentially recognizes ACE2 from a diversity of animal species (except mice and rats), implicating these animal species as possible intermediate hosts or animal models for 2019-nCoV infections. These analyses provide insights into the receptor usage, cell entry, host cell infectivity and animal origin of 2019-nCoV and may help epidemic surveillance and preventive measures against 2019-nCoV.
   IMPORTANCE The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002 to 2003. Our decade-long structural studies on the receptor recognition by SARS-CoV have identified key interactions between SARS-CoV spike protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-tohuman transmissions of SARS-CoV. One of the goals of SARS-CoV research was to build an atomic-level iterative framework of virus-receptor interactions to facilitate epidemic surveillance, predict species-specific receptor usage, and identify potential animal hosts and animal models of viruses. Based on the sequence of 2019-nCoV spike protein, we apply this predictive framework to provide novel insights into the receptor usage and likely host range of 2019-nCoV. This study provides a robust test of this reiterative framework, providing the basic, translational, and public health research communities with predictive insights that may help study and battle this novel 2019-nCoV.
C1 [Wan, Yushun; Shang, Jian; Li, Fang] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Graham, Rachel; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP Li, F (reprint author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
EM lifang@umn.edu
OI Shang, Jian/0000-0003-2600-6059
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI089728, R01AI110700]
FX This work was supported by NIH grants R01AI089728 and R01AI110700 (to
   F.L. and R.S.B.). We
CR Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6
   Hu B, 2017, BLOOD, V130
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Letko M, 2020, BIORXIV, DOI [10.1101/2020.01.22.915660., DOI 10.1101/2020.01.22.915660]
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14
   Li F, 2013, ANTIVIR RES, V100, P246, DOI 10.1016/j.antiviral.2013.08.014
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006
   Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640
   Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004
   Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445
   Liu L, 2007, J VIROL, V81, P4694, DOI 10.1128/JVI.02389-06
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06
   Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 33
TC 18
Z9 17
U1 71
U2 71
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2020
VL 94
IS 7
AR e00127-20
DI 10.1128/JVI.00127-20
PG 9
WC Virology
SC Virology
GA KW0CT
UT WOS:000520841800001
PM 31996437
OA Bronze
DA 2020-04-03
ER

PT J
AU Corman, VM
   Landt, O
   Kaiser, M
   Molenkamp, R
   Meijer, A
   Chu, DKW
   Bleicker, T
   Brunink, S
   Schneider, J
   Schmidt, ML
   Mulders, DGJC
   Haagmans, BL
   van der Veer, B
   van den Brink, S
   Wijsman, L
   Goderski, G
   Romette, JL
   Ellis, J
   Zambon, M
   Peiris, M
   Goossens, H
   Reusken, C
   Koopmans, MPG
   Drosten, C
AF Corman, Victor M.
   Landt, Olfert
   Kaiser, Marco
   Molenkamp, Richard
   Meijer, Adam
   Chu, Daniel K. W.
   Bleicker, Tobias
   Bruenink, Sebastian
   Schneider, Julia
   Schmidt, Marie Luisa
   Mulders, Daphne G. J. C.
   Haagmans, Bart L.
   van der Veer, Bas
   van den Brink, Sharon
   Wijsman, Lisa
   Goderski, Gabriel
   Romette, Jean-Louis
   Ellis, Joanna
   Zambon, Maria
   Peiris, Malik
   Goossens, Herman
   Reusken, Chantal
   Koopmans, Marion P. G.
   Drosten, Christian
TI Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
SO EUROSURVEILLANCE
LA English
DT Article
ID CLASSIFICATION
AB Background: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global ( EVAg), a European Union infrastructure project. Conclusion: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
C1 [Corman, Victor M.; Bleicker, Tobias; Bruenink, Sebastian; Schneider, Julia; Schmidt, Marie Luisa; Drosten, Christian] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Corman, Victor M.; Bleicker, Tobias; Bruenink, Sebastian; Schneider, Julia; Schmidt, Marie Luisa; Drosten, Christian] German Ctr Infect Res DZIF, Berlin, Germany.
   [Landt, Olfert; Kaiser, Marco] Tib Molbiol, Berlin, Germany.
   [Molenkamp, Richard; Mulders, Daphne G. J. C.; Haagmans, Bart L.; Koopmans, Marion P. G.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Meijer, Adam; van der Veer, Bas; van den Brink, Sharon; Wijsman, Lisa; Goderski, Gabriel; Reusken, Chantal] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [Peiris, Malik] Univ Hong Kong, Hong Kong, Peoples R China.
   [Romette, Jean-Louis] Univ Aix Marseille, Marseille, France.
   [Ellis, Joanna; Zambon, Maria] Publ Hlth England, London, England.
   [Goossens, Herman] Univ Antwerp, Vaccine & Infect Dis Inst, Dept Med Microbiol, Antwerp, Belgium.
RP Drosten, C (reprint author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.; Drosten, C (reprint author), German Ctr Infect Res DZIF, Berlin, Germany.
EM christian.drosten@charite.de
RI Ribeiro, Nuno/AAH-2299-2020; Corman, Victor Max/K-1319-2019
OI Corman, Victor Max/0000-0002-3605-0136; Haagmans,
   Bart/0000-0001-6221-2015
FU European Union DG Research through project Prepare [GA602525]; European
   Union DG Research through project Compare [GA643476]; European Union DG
   Research through project EVAg [GA653316]; European Union DG SANCO
   through EVD-LabNet; German Ministry of Research through project RAPID
   [01KI1723A]; German Ministry of Research through project DZIF
   [301-4-7-01.703]
FX This work was funded by European Union DG Research through projects
   Prepare (GA602525), Compare (GA643476), and EVAg (GA653316); by European
   Union DG SANCO through EVD-LabNet, as well as by the German Ministry of
   Research through projects RAPID (01KI1723A) and DZIF (301-4-7-01.703).
CR Abbott A, 2003, NATURE, V423, P114, DOI 10.1038/423114a
   Alleweldt F, 2017, REV SCI TECH OIE, V36, P311, DOI 10.20506/rst.36.1.2631
   Corman VM, 2013, EUROSURVEILLANCE, V18, P10
   Corman VM, 2012, EUROSURVEILLANCE, V17, P2
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Groot RJ, 2012, VIRUS TAXONOMY, P806
   Domingo C, 2018, EUROSURVEILLANCE, V23, P11, DOI 10.2807/1560-7917.ES.2018.23.28.1800341
   Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013
   Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Gobat Nina, 2019, ERJ Open Res, V5, DOI 10.1183/23120541.00227-2018
   Muth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33487-8
   Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104
   Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Romette JL, 2018, ANTIVIR RES, V158, P127, DOI 10.1016/j.antiviral.2018.07.017
   WHO (World Health Organization), 2020, COR
   World Health Organization, 2020, 1 WHO
   Zhang Y-Z, NOVEL 2019 CORONAVIR
NR 22
TC 17
Z9 17
U1 161
U2 161
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 23
PY 2020
VL 25
IS 3
BP 23
EP 30
DI 10.2807/1560-7917.ES.2020.25.3.2000045
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA KF6OZ
UT WOS:000509360400005
PM 31992387
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Ji, W
   Wang, W
   Zhao, XF
   Zai, JJ
   Li, XG
AF Ji, Wei
   Wang, Wei
   Zhao, Xiaofang
   Zai, Junjie
   Li, Xingguang
TI Cross-species transmission of the newly identified coronavirus 2019-nCoV
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE 2019-nCoV; codon usage bias; cross-species transmission; phylogenetic
   analysis; recombination
ID NATURAL-POPULATIONS; RECOMBINATION; VIRUS; FEVER; SARS
AB The current outbreak of viral pneumonia in the city of Wuhan, China, was caused by a novel coronavirus designated 2019-nCoV by the World Health Organization, as determined by sequencing the viral RNA genome. Many initial patients were exposed to wildlife animals at the Huanan seafood wholesale market, where poultry, snake, bats, and other farm animals were also sold. To investigate possible virus reservoir, we have carried out comprehensive sequence analysis and comparison in conjunction with relative synonymous codon usage (RSCU) bias among different animal species based on the 2019-nCoV sequence. Results obtained from our analyses suggest that the 2019-nCoV may appear to be a recombinant virus between the bat coronavirus and an origin-unknown coronavirus. The recombination may occurred within the viral spike glycoprotein, which recognizes a cell surface receptor. Additionally, our findings suggest that 2019-nCoV has most similar genetic information with bat coronovirus and most similar codon usage bias with snake. Taken together, our results suggest that homologous recombination may occur and contribute to the 2019-nCoV cross-species transmission.
C1 [Ji, Wei] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.
   [Wang, Wei] Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Spleen & Stomach Dis, Nanning, Peoples R China.
   [Zhao, Xiaofang] Guangxi Univ Chinese Med, Ruikang Hosp, Dept Sci & Technol, Nanning, Peoples R China.
   [Zai, Junjie] Ningbo Univ, Sch Med, Immunol Innovat Team, Ningbo, Peoples R China.
   [Li, Xingguang] Wuhan Univ Bioengn, Hubei Engn Res Ctr Viral Vector, Wuhan, Peoples R China.
RP Ji, W (reprint author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.
EM j102938@126.com
RI zorlu, taha/AAH-6820-2020
FU Natural Science Foundation of Guangxi Province of ChinaNational Natural
   Science Foundation of Guangxi Province [2017GXNSFAA198080]; Project of
   Guangxi Health Committee [Z20191111]; K.C. Wong Magna Fund
CR Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71
   Bollyky PL, 1996, J MOL EVOL, V42, P97, DOI 10.1007/BF02198834
   Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820
   CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989
   Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0
   Cunha CB, 2014, VIRULENCE, V5, P650, DOI 10.4161/viru.32077
   Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Howe H, 2019, BIOMEDICAL INFORM CA, P267
   Howley DMKP, 2013, FIELDS VIROLOGY, V1, p830P
   Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   MacLachlan NJ, 2017, FENNERS VET VIROLOGY, P393
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   Wikipedia, 2020, MAN BAND KRAIT
   Wikipedia, 2020, CHIN COBR
   World Health Organization, 2019, COR
   World Health Organization, 2003, CONS DOC EP SEV AC R
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Zhang NR, 2020, J MED VIROL, V92, P408, DOI 10.1002/jmv.25674
NR 28
TC 15
Z9 15
U1 433
U2 433
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2020
VL 92
IS 4
SI SI
BP 433
EP 440
DI 10.1002/jmv.25682
PG 8
WC Virology
SC Virology
GA KM6QU
UT WOS:000514263400007
PM 31967321
OA Bronze
DA 2020-04-03
ER

PT J
AU Chan, JFW
   Kok, KH
   Zhu, Z
   Chu, H
   To, KKW
   Yuan, SF
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Kok, Kin-Hang
   Zhu, Zheng
   Chu, Hin
   To, Kelvin Kai-Wang
   Yuan, Shuofeng
   Yuen, Kwok-Yung
TI Genomic characterization of the 2019 novel human-pathogenic coronavirus
   isolated from a patient with atypical pneumonia after visiting Wuhan
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Coronavirus; Wuhan; SARS; emerging; genome; respiratory; virus;
   bioinformatics
ID RESPIRATORY SYNDROME CORONAVIRUS; PROTEIN; EXPRESSION
AB A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization. We performed bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes. Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.
C1 [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Chu, Hin; To, Kelvin Kai-Wang; Yuan, Shuofeng] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Yuen, Kwok-Yung] Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen, Guangdong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Zhu, Zheng; Chu, Hin; To, Kelvin Kai-Wang; Yuan, Shuofeng; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Chu, Hin; To, Kelvin Kai-Wang; Yuan, Shuofeng; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
RP Kok, KH (reprint author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (reprint author), Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen, Guangdong, Peoples R China.; Kok, KH; Yuen, KY (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.; Kok, KH; Yuen, KY (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
EM kyyuen@hku.hk; kyyuen@hku.hk
RI Chan, Jasper Fuk-Woo/D-8007-2013
OI Chan, Jasper Fuk-Woo/0000-0001-6336-6657
FU Respiratory Viral Research Foundation Limited; Chow Sin Lan Charity Fund
   Limited, Chan Yin Chuen Memorial Charitable Foundation; Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund;
   Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases and Research Capability on Antimicrobial Resistance
   for Department of Health of the Hong Kong Special Administrative Region
   Government [T11/707/15]; Research Grants Council, Hong Kong Special
   Administrative RegionHong Kong Research Grants Council; Sanming Project
   of Medicine in Shenzhen, China [SZSM201911014]; Health Commission of
   Guangdong Province, China
FX This study was partly supported by the donations of Michael Seak-Kan
   Tong, Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy
   and Chow Sin Lan Charity Fund Limited, Chan Yin Chuen Memorial
   Charitable Foundation, Marina Man-Wai Lee, and the Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund; and
   funding from the Consultancy Service for Enhancing Laboratory
   Surveillance of Emerging Infectious Diseases and Research Capability on
   Antimicrobial Resistance for Department of Health of the Hong Kong
   Special Administrative Region Government; the ThemeBased Research Scheme
   (T11/707/15) of the Research Grants Council, Hong Kong Special
   Administrative Region; Sanming Project of Medicine in Shenzhen, China
   (No. SZSM201911014); and the High Level-Hospital Program, Health
   Commission of Guangdong Province, China.
CR [Anonymous], S CHINA MORNING POST
   Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Khan S, 2006, VIRUS RES, V122, P20, DOI 10.1016/j.virusres.2006.06.005
   Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lau SKP, 2015, J VIROL, V89, P10532, DOI 10.1128/JVI.01048-15
   Oostra M, 2007, J VIROL, V81, P13876, DOI 10.1128/JVI.01631-07
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   World Health Organization, NOV COR
   World Health Organization, NOV COR THAIL EX CHI
   Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580
   Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025
   Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]
   Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005
   Zhou P, 2012, J GEN VIROL, V93, P275, DOI 10.1099/vir.0.033589-0
   Zuckerkandl H, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6
NR 27
TC 15
Z9 15
U1 186
U2 186
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 221
EP 236
DI 10.1080/22221751.2020.1719902
PG 16
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KH1BL
UT WOS:000510381600001
PM 31987001
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Kim, JY
   Choe, PG
   Oh, Y
   Oh, KJ
   Kim, J
   Park, SJ
   Park, JH
   Na, HK
   Oh, MD
AF Kim, Jin Yong
   Choe, Pyoeng Gyun
   Oh, Yoonju
   Oh, Kyung Joong
   Kim, Jinsil
   Park, So Jeong
   Park, Ji Hye
   Na, Hye Kyoung
   Oh, Myoung-don
TI The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea
   from Wuhan, China: Implication for Infection Prevention and Control
   Measures
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Coronavirus; 2019-nCoV; Pneumonia; Outbreak; Radiography
AB In December 2019, a viral pneumonia outbreak caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the epidemiological and clinical features of the first patient with 2019-nCoV pneumonia imported into Korea from Wuhan. This report suggests that in the early phase of 2019-nCoV pneumonia, chest radiography would miss patients with pneumonia and highlights taking travel history is of paramount importance for early detection and isolation of 2019-nCoV cases.
C1 [Kim, Jin Yong; Oh, Yoonju] Incheon Med Ctr, Dept Internal Med, Incheon, South Korea.
   [Kim, Jin Yong; Kim, Jinsil; Park, So Jeong; Park, Ji Hye] Incheon Med Ctr, Infect Control Off, Incheon, South Korea.
   [Kim, Jin Yong; Na, Hye Kyoung] Incheon Med Ctr, Designated Isolat Unit, Incheon, South Korea.
   [Choe, Pyoeng Gyun; Oh, Myoung-don] Seoul Natl Univ, Dept Internal Med, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.
   [Oh, Kyung Joong] Incheon Med Ctr, Dept Radiol, Incheon, South Korea.
RP Oh, MD (reprint author), Seoul Natl Univ, Dept Internal Med, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.
EM mdohmd@snu.ac.kr
OI Choe, Pyoeng Gyun/0000-0001-6794-7918; Kim, Jin
   Yong/0000-0002-4306-1597; Na, Hye Kyoung/0000-0002-3524-9581
CR Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001
   Hale MJ, 2012, EMERG INFECT DIS, V18, P866, DOI 10.3201/eid1805.111080
   Huang C, 2020, LANCET
   Kang CK, 2017, J KOREAN MED SCI, V32, P744, DOI 10.3346/jkms.2017.32.5.744
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Rothe C, 2020, N ENGL J MED
   World Health Organization, 2019, 12 WHO
   Zhu N, 2019, N ENGL J MED
NR 9
TC 9
Z9 9
U1 32
U2 32
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD FEB 10
PY 2020
VL 35
IS 5
AR e61
DI 10.3346/jkms.2020.35.e61
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL9YT
UT WOS:000513774200007
PM 32030925
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Wang, WE
   Tang, JM
   Wei, FQ
AF Wang, Weier
   Tang, Jianming
   Wei, Fangqiang
TI Updated understanding of the outbreak of 2019 novel coronavirus
   (2019-nCoV) in Wuhan, China
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE coronavirus; epidemiology; infection
ID RESPIRATORY SYNDROME; SARS
AB To help health workers and the public recognize and deal with the 2019 novel coronavirus (2019-nCoV) quickly, effectively, and calmly with an updated understanding. A comprehensive search from Chinese and worldwide official websites and announcements was performed between 1 December 2019 and 9:30 am 26 January 2020 (Beijing time). A latest summary of 2019-nCoV and the current outbreak was drawn. Up to 24 pm, 25 January 2020, a total of 1975 cases of 2019-nCoV infection were confirmed in mainland China with a total of 56 deaths having occurred. The latest mortality was approximately 2.84% with a total of 2684 cases still suspected. The China National Health Commission reported the details of the first 17 deaths up to 24 pm, 22 January 2020. The deaths included 13 males and 4 females. The median age of the people who died was 75 (range 48-89) years. Fever (64.7%) and cough (52.9%) were the most common first symptoms among those who died. The median number of days from the occurence of the first symptom to death was 14.0 (range 6-41) days, and it tended to be shorter among people aged 70 years or more (11.5 [range 6-19] days) than those aged less than 70 years (20 [range 10-41] days; P = .033). The 2019-nCoV infection is spreading and its incidence is increasing nationwide. The first deaths occurred mostly in elderly people, among whom the disease might progress faster. The public should still be cautious in dealing with the virus and pay more attention to protecting the elderly people from the virus.
C1 [Wang, Weier; Wei, Fangqiang] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310014, Zhejiang, Peoples R China.
   [Wang, Weier] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou, Zhejiang, Peoples R China.
   [Tang, Jianming] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Hangzhou 310014, Zhejiang, Peoples R China.
RP Wei, FQ (reprint author), Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310014, Zhejiang, Peoples R China.; Tang, JM (reprint author), Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Hangzhou 310014, Zhejiang, Peoples R China.
EM 15900792812@163.com; wdfwfq@126.com
RI Ribeiro, Nuno/AAH-2299-2020
OI Wei, Fangqiang/0000-0003-0871-2275
CR [Anonymous], 2020, Nature, V577, P450, DOI 10.1038/d41586-020-00153-x
   [Anonymous], 2020, CHINA YOUTH DAILYS B
   Centers for Disease Control and Prevention, 2020, UPD INT GUID OUTBR 2
   Centers for Disease Control and Prevention, 2020, INT 2019 NOV COR 201
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   China Disease Prevention and Control Center, PREV CONTR PNEUM NOV
   Feng D, 2009, TROP MED INT HEALTH, V14, P28, DOI 10.1111/j.1365-3156.2008.02188.x
   Huang C, 2020, LANCET, DOI [10.1016/S0140-6736(20)30183-5A, DOI 10.1016/S0140-6736(20)30183-5A]
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Luo G, 2020, J MED VIROL, V92, P399, DOI 10.1002/jmv.25683
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   WHO, 2003, AC RESP SYNDR CHIN U
   WHO, 2020, M INT HLTH REG 2005
   WHO, HOM CAR PAT SUSP NOV
   WHO, MIDDL E RESP SYNDR C
   WHO, SUMM PROB SARS CAS O
   World Health Organization, INF PREV CONTR HLTH
   World Health Organization (WHO), COR
   XINHUANET, 2020, XINHUANET
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
NR 23
TC 8
Z9 8
U1 139
U2 139
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2020
VL 92
IS 4
SI SI
BP 441
EP 447
DI 10.1002/jmv.25689
EA FEB 2020
PG 7
WC Virology
SC Virology
GA KM6QU
UT WOS:000512727900001
PM 31994742
OA Bronze
DA 2020-04-03
ER

PT J
AU Backer, JA
   Klinkenberg, D
   Wallinga, J
AF Backer, Jantien A.
   Klinkenberg, Don
   Wallinga, Jacco
TI Incubation period of 2019 novel coronavirus (2019-nCoV) infections among
   travellers from Wuhan, China, 20-28 January 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID RESPIRATORY SYNDROME
AB A novel coronavirus (2019-nCoV) is causing an outbreak of viral pneumonia that started in Wuhan, China. Using the travel history and symptom onset of 88 confirmed cases that were detected outside Wuhan in the early outbreak phase, we estimate the mean incubation period to be 6.4 days (95% credible interval: 5.6-7.7), ranging from 2.1 to 11.1 days (2.5th to 97.5th percentile). These values should help inform 2019-nCoV case definitions and appropriate quarantine durations.
C1 [Backer, Jantien A.; Klinkenberg, Don; Wallinga, Jacco] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Wallinga, Jacco] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands.
RP Backer, JA (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
EM jantien.backer@rivm.nl
RI Ribeiro, Nuno/AAH-2299-2020
FU Netherlands Ministry of Health, Welfare and Sport
FX The study was financed by the Netherlands Ministry of Health, Welfare
   and Sport.
CR Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cowling BJ, 2007, EPIDEMIOLOGY, V18, P253, DOI 10.1097/01.ede.0000254660.07942.fb
   Department of Error, 2004, LANCET, V364
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   European Centre for Disease Prevention and Control (ECDC), 2020, Q NOV COR
   Imai N, 2020, REPORT 3 TRANSMISSIB
   Imai ND, 2020, REPORT 2 ESTIMATING
   Lau EHY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-50
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Leung K, 2020, LANCET
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   T Liu, 2020, BIORXIV, DOI [https://doi.org/10.1101/2020.01.25.919787, 10.1101/2020.01.25.919787, DOI 10.1101/2020.01.25.919787]
   Virlogeux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35839
   World Health Organization (WHO), 2020, WHO STAT REG CLUST P
   Zhao S, 2020, INT J INFECT DIS
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 19
TC 8
Z9 8
U1 15
U2 15
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 6
PY 2020
VL 25
IS 5
BP 10
EP 15
AR 2000062
DI 10.2807/1560-7917.ES.2020.25.5.2000062
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KM9CH
UT WOS:000514438600003
PM 32046819
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Gralinski, LE
   Menachery, VD
AF Gralinski, Lisa E.
   Menachery, Vineet D.
TI Return of the Coronavirus: 2019-nCoV
SO VIRUSES-BASEL
LA English
DT Article
DE 2019-nCoV; novel CoV; emerging viruses; Wuhan; Wuhan pneumonia;
   coronavirus; emerging viruses; SARS-CoV; MERS-CoV
ID RESPIRATORY-SYNDROME CORONAVIRUS; SARS; MERS; INFECTION; RECEPTOR;
   RHESUS; TRACT
AB The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
C1 [Gralinski, Lisa E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA.
   [Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Menachery, Vineet D.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Menachery, VD (reprint author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Menachery, VD (reprint author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM lgralins@email.unc.edu; Vimenach@utmb.edu
RI Ribeiro, Nuno/AAH-2299-2020
OI Menachery, Vineet/0000-0001-8803-7606
CR Al-Tawfiq JA, 2019, TRAVEL MED INFECT DI, V27, P27, DOI 10.1016/j.tmaid.2018.12.003
   [Anonymous], STRAITS TIMES
   Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105
   Bedford T., GENOMIC EPIDEMIOLOGY
   CIDRAP, MERS COV
   CIDRAP, SARS SEV AC RESP SYN
   Cockrell AS, 2014, J VIROL, V88, P5195, DOI 10.1128/JVI.03764-13
   de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110
   Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152
   Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058
   Imai Natsuko, ESTIMATING POTENTIAL
   Ji W, 2020, J MED VIROL
   Kahn N., 2020, WALL STREET J
   Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Letko MMV, 2020, FUNCTIONAL ASSESSMEN
   Li WH, 2007, VIROLOGY, V367, P367, DOI 10.1016/j.virol.2007.04.035
   McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030
   Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Park D, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001214
   Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10
   Rahman A, 2019, AM J PUBLIC HEALTH, V109, P1288, DOI [10.21, 10.2105/AJPH.2019.305186]
   Rambaut A, 2020, PRELIMINARY PHYLOGEN
   Rivers TM, 1937, J BACTERIOL, V33, P1
   Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005
   Robertson D., NCOVS RELATIONSHIP B
   Shi Z.-L., 2020, DISCOVERY NOVEL CORO
   Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020
   van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14
   Virological.org, NOV 2019 COR GEN
   Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7
   Wen X., 15 MED STAFF WUHAN C
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   World Health Organization, LAB TEST 2019 NOV CO
   World Health Organization, WHO STAT REG CLUST P
   World Health Organization, NOV COR JAP EX CHIN
   Wuhan Municipal Health Commision, WUH MUN COMM HLTH HL
   Wuhan Municipal Health Commision, WUH MUN HLTH HLTH CO
   Xu YB, 2020, SCI CHINA LIFE SCI, V63, P450, DOI 10.1007/s11427-019-1630-2
   Zeng LP, 2016, J VIROL, V90, P6573, DOI 10.1128/JVI.03079-15
NR 46
TC 8
Z9 8
U1 102
U2 102
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 135
DI 10.3390/v12020135
PG 8
WC Virology
SC Virology
GA KH2ZS
UT WOS:000510516800001
PM 31991541
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Riou, J
   Althaus, CL
AF Riou, Julien
   Althaus, Christian L.
TI Pattern of early human-to-human transmission of Wuhan 2019 novel
   coronavirus (2019-nCoV), December 2019 to January 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia. We estimated the basic reproduction number Ro of 2019-nCoV to be around 2.2 (90% high density interval: 1.4-3.8), indicating the potential for sustained human-to-human transmission. Transmission characteristics appear to be of similar magnitude to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and pandemic influenza, indicating a risk of global spread.
C1 [Riou, Julien; Althaus, Christian L.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
RP Riou, J (reprint author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
EM julien.riou@ispm.unibe.ch
RI Ribeiro, Nuno/AAH-2299-2020
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [174281]
FX JR is funded by the Swiss National Science Foundation (grant 174281).
CR Althaus CL, 2015, LANCET INFECT DIS, V15, P507, DOI 10.1016/S1473-3099(15)70135-0
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cowling BJ, 2008, EPIDEMIOL INFECT, V136, P562, DOI 10.1017/S0950268807008722
   Fraser C, 2011, AM J EPIDEMIOL, V174, P505, DOI 10.1093/aje/kwr122
   Huang C, 2020, LANCET, VS0140- 6736(20)30183-5, DOI [10.1016/S0140-6736(20)30154-9, DOI 10.1016/S0140-6736(20)30154-9]
   Imai N, 2020, 2 IMP COLL
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Oh MD, 2015, J KOREAN MED SCI, V30, P1701, DOI 10.3346/jkms.2015.30.11.1701
   Organization WH, 2020, 9 WHO
   R Core Team, 2018, R LANG ENV STAT COMP
   Rambaut A, 2020, PRELIMINARY PHYLOGEN
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Zhou P., 2020, BIORXIV, DOI [10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952, 10.1101/2020.01.22.914952.]
NR 16
TC 8
Z9 8
U1 89
U2 89
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 30
PY 2020
VL 25
IS 4
BP 7
EP 11
DI 10.2807/1560-7917.ES.2020.25.4.2000058
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KH4IF
UT WOS:000510607800002
PM 32019669
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Chung, M
   Bernheim, A
   Mei, XY
   Zhang, N
   Huang, MQ
   Zeng, XJ
   Cui, JF
   Xu, WJ
   Yang, Y
   Fayad, ZA
   Jacobi, A
   Li, KW
   Li, SL
   Shan, H
AF Chung, Michael
   Bernheim, Adam
   Mei, Xueyan
   Zhang, Ning
   Huang, Mingqian
   Zeng, Xianjun
   Cui, Jiufa
   Xu, Wenjian
   Yang, Yang
   Fayad, Zahi A.
   Jacobi, Adam
   Li, Kunwei
   Li, Shaolin
   Shan, Hong
TI CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
SO RADIOLOGY
LA English
DT Article
ID ACUTE RESPIRATORY SYNDROME; INFECTION; PATTERN
AB In this retrospective case series, chest CT scans of 21 symptomatic patients from China infected with the 2019 novel coronavirus(2019-nCoV) were reviewed, with emphasis on identifying and characterizing the most common findings. Typical CT findings included bilateral pulmonary parenchymal ground-glass and consolidative pulmonary opacities, sometimes with a rounded morphology and a peripheral lung distribution. Notably, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy were absent. Follow-up imaging in a subset of patients during the study time window often demonstrated mild or moderate progression of disease, as manifested by increasing extent and density of lung opacities. (C) RSNA, 2020
C1 [Chung, Michael; Bernheim, Adam; Huang, Mingqian; Fayad, Zahi A.; Jacobi, Adam] Icahn Sch Med Mt Sinai, Dept Diagnost Mol & Intervent Radiol, New York, NY 10029 USA.
   [Mei, Xueyan; Yang, Yang; Fayad, Zahi A.] Icahn Sch Med Mt Sinai, BioMed Engn & Imaging Inst, New York, NY 10029 USA.
   [Zhang, Ning; Zeng, Xianjun] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.
   [Cui, Jiufa; Xu, Wenjian] Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Peoples R China.
   [Li, Kunwei; Li, Shaolin; Shan, Hong] Sun Yat Sen Univ, Affiliated Hosp 5, Guangdong Prov Key Lab Biomed Imaging, Dept Radiol, 52 East Meihua Rd, Zhuhai 519000, Guangdong, Peoples R China.
RP Shan, H (reprint author), Sun Yat Sen Univ, Affiliated Hosp 5, Guangdong Prov Key Lab Biomed Imaging, Dept Radiol, 52 East Meihua Rd, Zhuhai 519000, Guangdong, Peoples R China.
EM Shanhong@mail.sysu.edu.cn
OI Yang, Yang/0000-0002-2841-4243; Mei, Xueyan/0000-0001-7224-7318; Huang,
   Mingqian/0000-0002-5734-0191
CR Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021
   [Anonymous], 2020, 8 WHO
   [Anonymous], MIDDL EASTR SYNDR CO
   [Anonymous], 2020, NOV COR 2019 NCOV
   Choi WJ, 2016, KOREAN J RADIOL, V17, P166, DOI 10.3348/kjr.2016.17.1.166
   Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712
   Huang C, 2020, LANCET
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Ooi GC, 2004, RADIOLOGY, V230, P836, DOI 10.1148/radiol.2303030853
   Paul NS, 2004, RADIOGRAPHICS, V24, P553, DOI 10.1148/rg.242035193
   Wong KT, 2003, RADIOLOGY, V228, P401, DOI 10.1148/radiol.2282030593
   World Health Organization, 2004, SUMM PROB SARS CAS O
   World Health Organization, 2020, NOV COR CHIN
NR 13
TC 7
Z9 8
U1 23
U2 23
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD APR
PY 2020
VL 295
IS 1
BP 202
EP 207
DI 10.1148/radiol.2020200230
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KV1EC
UT WOS:000520166000034
PM 32017661
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhao, S
   Lin, QY
   Ran, JJ
   Musa, SS
   Yang, GP
   Wang, WM
   Lou, YJ
   Gao, DZ
   Yang, L
   He, DH
   Wang, MH
AF Zhao, Shi
   Lin, Qianyin
   Ran, Jinjun
   Musa, Salihu S.
   Yang, Guangpu
   Wang, Weiming
   Lou, Yijun
   Gao, Daozhou
   Yang, Lin
   He, Daihai
   Wang, Maggie H.
TI Preliminary estimation of the basic reproduction number of novel
   coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven
   analysis in the early phase of the outbreak
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Basic reproduction number; Novel coronavirus (2019-nCoV)
ID ACUTE RESPIRATORY SYNDROME; SPREAD
AB Backgrounds: An ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia hit a major city in China, Wuhan, December 2019 and subsequently reached other provinces/regions of China and other countries. We present estimates of the basic reproduction number, R-0, of 2019-nCoV in the early phase of the outbreak.
   Methods: Accounting for the impact of the variations in disease reporting rate, we modelled the epidemic curve of 2019-nCoV cases time series, in mainland China from January 10 to January 24, 2020, through the exponential growth. With the estimated intrinsic growth rate (gamma), we estimated R-0 by using the serial intervals (SI) of two other well-known coronavirus diseases, MERS and SARS, as approximations for the true unknown SI.
   Findings: The early outbreak data largely follows the exponential growth. We estimated that the mean R-0 ranges from 2.24 (95%CI: 1.96-2.55) to 3.58 (95%CI: 2.89-4.39) associated with 8-fold to 2-fold increase in the reporting rate. We demonstrated that changes in reporting rate substantially affect estimates of R-0.
   Conclusion: The mean estimate of R-0 for the 2019-nCoV ranges from 2.24 to 3.58, and is significantly larger than 1. Our findings indicate the potential of 2019-nCoV to cause outbreaks. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.
   [Lin, Qianyin] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.
   [Ran, Jinjun] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China.
   [Musa, Salihu S.; Lou, Yijun; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
   [Yang, Guangpu] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China.
   [Yang, Guangpu] Chinese Univ Hong Kong, SH Ho Scoliosis Res Lab, Joint Scoliosis Res Ctr, Hong Kong, Peoples R China.
   [Yang, Guangpu] Nanjing Univ, Hong Kong, Peoples R China.
   [Wang, Weiming] Huaiyin Normal Univ, Sch Math & Stat, Huaian, Peoples R China.
   [Gao, Daozhou] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
RP Zhao, S (reprint author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.; Zhao, S (reprint author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.; He, DH (reprint author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
EM shi.zhao@link.cuhk.edu.hk; qianying.lin@connect.polyu.hk;
   jimran@connect.hku.hk; salihu-sabiu.musa@connect.polyu.hk;
   kennethgpy@link.cuhk.edu.hk; weimingwang2003@163.com;
   yijun.lou@polyu.edu.hk; dzgao@shnu.edu.cn; l.yang@polyu.edu.hk;
   daihai.he@polyu.edu.hk; maggiew@cuhk.edu.hk
OI He, Daihai/0000-0003-3253-654X; Wang, Weiming/0000-0002-7562-8260; Musa,
   Salihu Sabiu/0000-0001-6335-2335
FU General Research Fund of the Research Grants Council (RGC) of Hong Kong,
   China [15205119]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [61672013]; Huaian Key Laboratory
   for Infectious Diseases Control and Prevention, Huaian, Jiangsu, China
   [HAP201704]
FX DH was supported by General Research Fund (Grant Number 15205119) of the
   Research Grants Council (RGC) of Hong Kong, China. WW was supported by
   National Natural Science Foundation of China (Grant Number 61672013) and
   Huaian Key Laboratory for Infectious Diseases Control and Prevention
   (Grant Number HAP201704), Huaian, Jiangsu, China.
CR Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Bauch CT, 2005, EPIDEMIOLOGY, V16, P791, DOI 10.1097/01.ede.0000181633.80269.4c
   Bogoch II, 2020, J TRAVEL MED, DOI [10.1093/jtm/taaa1008, DOI 10.1093/JTM/TAAA1008]
   Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092
   de Silva UC, 2009, EUROSURVEILLANCE, V14, P11
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Hubei provincial government, 2020, STRENGTH NEW COR INF
   Imai N, 2020, ESTIMATING POTENTIAL
   Leung K, 2020, NOWCASTING FORECASTI
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   National Health Commission of the People's Republic of China, 2020, DEF SUSP CAS UN PNEU
   Read JM, 2020, NOVEL CORONAVIRUS 20
   Riou J, 2020, PATTERN EARLY HUMAN
   Shen M, 2020, MODELLING EPIDEMIC T
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   World Health Organization, 2020, LAB TEST 2019 NOV CO
   Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216
   Zhao S, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3602-9
NR 21
TC 7
Z9 7
U1 29
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2020
VL 92
BP 214
EP 217
DI 10.1016/j.ijid.2020.01.050
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KT7KI
UT WOS:000519191900034
PM 32007643
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Lu, HZ
AF Lu, Hongzhou
TI Drug treatment options for the 2019-new coronavirus (2019-nCoV)
SO BIOSCIENCE TRENDS
LA English
DT Article
DE 2019-nCoV; Coronaviruses; pneumonia
ID RESPIRATORY SYNDROME CORONAVIRUS
AB As of January 22, 2020, a total of 571 cases of the 2019-new coronavirus (2019-nCoV) have been reported in 25 provinces (districts and cities) in China. At present, there is no vaccine or antiviral treatment for human and animal coronavirus, so that identifying the drug treatment options as soon as possible is critical for the response to the 2019-nCoV outbreak. Three general methods, which include existing broad-spectrum antiviral drugs using standard assays, screening of a chemical library containing many existing compounds or databases, and the redevelopment of new specific drugs based on the genome and biophysical understanding of individual coronaviruses, are used to discover the potential antiviral treatment of human pathogen coronavirus. Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), arbidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV. However, the efficacy and safety of these drugs for 2019-nCoV still need to be further confirmed by clinical experiments.
C1 [Lu, Hongzhou] Fudan Univ, Sci Res Ctr, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Lu, Hongzhou] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China.
   [Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai, Peoples R China.
RP Lu, HZ (reprint author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, 2901 Caolang Rd, Shanghai 201508, Peoples R China.
EM luhongzhou@fudan.edu.cn
FU 13th Five-Year National Science and Technology Major Project from
   Ministry of Science and Technology of the People's Republic of China
   [2017ZX09304027]
FX This research was funded by the 13th Five-Year National Science and
   Technology Major Project from Ministry of Science and Technology of the
   People's Republic of China (Grant No.: 2017ZX09304027).
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Bleibtreu A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3223-5
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896
   Chow EJ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2491-9
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16
   Ding YW, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1585-7
   Imai Natsuko, ESTIMATING POTENTIAL
   Ji S, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109652
   Kim Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005531
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   National Health Commission of the People's Republic of China, NOT PRINT DISTR DIAG
   National Health Commission of the People's Republic of China, PNEUM EP IT NEW COR
   Pang Y, 2019, J VIS COMMUN IMAGE R, V65, DOI 10.1016/j.jvcir.2019.102676
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 18
TC 7
Z9 7
U1 64
U2 64
PU IRCA-BSSA
PI TOKYO
PA PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003,
   JAPAN
SN 1881-7815
EI 1881-7823
J9 BIOSCI TRENDS
JI BioSci. Trends
PD FEB
PY 2020
VL 14
IS 1
BP 69
EP 71
DI 10.5582/bst.2020.01020
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU2OR
UT WOS:000519548300011
PM 31996494
OA Bronze
DA 2020-04-03
ER

PT J
AU Song, FX
   Shi, NN
   Shan, F
   Zhang, ZY
   Shen, J
   Lu, HZ
   Ling, Y
   Jiang, YB
   Shi, YX
AF Song, Fengxiang
   Shi, Nannan
   Shan, Fei
   Zhang, Zhiyong
   Shen, Jie
   Lu, Hongzhou
   Ling, Yun
   Jiang, Yebin
   Shi, Yuxin
TI Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
SO RADIOLOGY
LA English
DT Article
ID INFLUENZA-A
AB Background: The chest CT findings of patients with 2019 Novel Coronavirus (2019-nCoV) pneumonia have not previously beendescribed in detail.
   Purpose: To investigate the clinical, laboratory, and imaging findings of emerging 2019-nCoV pneumonia in humans.
   Materials and Methods: Fifty-one patients (25 men and 26 women; age range 16-76 years) with laboratory-confirmed 2019-nCoV infection by using real-time reverse transcription polymerase chain reaction underwent thin-section CT. The imaging findings, clinical data, and laboratory data were evaluated.
   Results: Fifty of 51 patients (98%) had a history of contact with individuals from the endemic center in Wuhan, China. Fever (49 of 51, 96%) and cough (24 of 51, 47%) were the most common symptoms. Most patients had a normal white blood cell count (37 of 51, 73%), neutrophil count (44 of 51, 86%), and either normal (17 of 51, 35%) or reduced (33 of 51, 65%) lymphocytecount. CT images showed pure ground-glass opacity (GGO) in 39 of 51 (77%) patients and GGO with reticular and/or interlobular septal thickening in 38 of 51 (75%) patients. GGO with consolidation was present in 30 of 51 (59%) patients,and pure consolidation was present in 28 of 51 (55%) patients. Forty-four of 51 (86%) patients had bilateral lung involvement,while 41 of 51 (80%) involved the posterior part of the lungs and 44 of 51 (86%) were peripheral. There were more consolidated lung lesions in patients 5 days or more from disease onset to CT scan versus 4 days or fewer ( 431 of 712 lesions vs 129 of 612 lesions; P,.001). Patients older than 50 years had more consolidated lung lesions than did those aged 50 years or younger (212 of 470 vs 198 of 854; P,.001). Follow-up CT in 13 patients showed improvement in seven (54%) patients and progression in four (31%) patients.
   Conclusion: Patients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posteri or lungson CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia. (C) RSNA, 2020
C1 [Song, Fengxiang; Shi, Nannan; Shan, Fei; Zhang, Zhiyong; Shen, Jie; Shi, Yuxin] Shanghai Publ Hlth Clin Ctr, Dept Radiol, 2501 Caolang Rd, Shanghai 201508, Peoples R China.
   [Lu, Hongzhou; Ling, Yun] Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, 2501 Caolang Rd, Shanghai 201508, Peoples R China.
   [Zhang, Zhiyong] Fudan Univ, Dept Principals Off, Shanghai, Peoples R China.
   [Jiang, Yebin] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA.
   [Shi, Yuxin] Shanghai Key Lab Mol Imaging, Shanghai, Peoples R China.
RP Shi, YX (reprint author), Shanghai Publ Hlth Clin Ctr, Dept Radiol, 2501 Caolang Rd, Shanghai 201508, Peoples R China.; Shi, YX (reprint author), Shanghai Key Lab Mol Imaging, Shanghai, Peoples R China.
EM shiyuxin@shphc.org.cn
OI Yun, Ling/0000-0002-4289-3594
CR Chen N, 2020, LANCET, V2020
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Huang C, 2020, LANCET
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Lei J, 2020, RADIOLOGY
   Li HY, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010194, 10.1097/md.0000000000010194]
   Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53
   Richman DD, 2016, CLIN VIROLOGY
   Wang QL, 2013, RADIOLOGY, V268, P882, DOI 10.1148/radiol.13130988
   Wong KT, 2004, J COMPUT ASSIST TOMO, V28, P790, DOI 10.1097/00004728-200411000-00010
   World Health Organization, 2020, NOV COR THAIL EXCH
   World Health Organization, 2020, NOV COR JAP EXCH
   World Health Organization, 2020, NOV COR REP KOR EXCH
   Yuan Y, 2012, INFLUENZA OTHER RESP, V6, pe114, DOI 10.1111/j.1750-2659.2012.00368.x
   Zhu N, 2019, N ENGL J MED, V2020
NR 16
TC 6
Z9 7
U1 18
U2 18
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD APR
PY 2020
VL 295
IS 1
BP 210
EP 217
DI 10.1148/radiol.2020200274
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KV1EC
UT WOS:000520166000036
PM 32027573
OA Bronze
DA 2020-04-03
ER

PT J
AU Pan, YY
   Guan, HX
   Zhou, SC
   Wang, YJ
   Li, Q
   Zhu, TT
   Hu, QJ
   Xia, LM
AF Pan, Yueying
   Guan, Hanxiong
   Zhou, Shuchang
   Wang, Yujin
   Li, Qian
   Zhu, Tingting
   Hu, Qiongjie
   Xia, Liming
TI Initial CT findings and temporal changes in patients with the novel
   coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan,
   China
SO EUROPEAN RADIOLOGY
LA English
DT Article; Early Access
DE Coronavirus infections; Tomography; x-ray computed; Pneumonia; viral;
   Thorax; Lung diseases
AB Objectives The purpose of this study was to observe the imaging characteristics of the novel coronavirus pneumonia. Methods Sixty-three confirmed patients were enrolled from December 30, 2019 to January 31, 2020. High-resolution CT (HRCT) of the chest was performed. The number of affected lobes, ground glass nodules (GGO), patchy/punctate ground glass opacities, patchy consolidation, fibrous stripes and irregular solid nodules in each patient's chest CT image were recorded. Additionally, we performed imaging follow-up of these patients. Results CT images of 63 confirmed patients were collected. M/F ratio: 33/30. The mean age was 44.9 +/- 15.2 years. The mean number of affected lobes was 3.3 +/- 1.8. Nineteen (30.2%) patients had one affected lobe, five (7.9%) patients had two affected lobes, four (6.3%) patients had three affected lobes, seven (11.1%) patients had four affected lobes while 28 (44.4%) patients had 5 affected lobes. Fifty-four (85.7%) patients had patchy/punctate ground glass opacities, 14 (22.2%) patients had GGO, 12 (19.0%) patients had patchy consolidation, 11 (17.5%) patients had fibrous stripes and 8 (12.7%) patients had irregular solid nodules. Fifty-four (85.7%) patients progressed, including single GGO increased, enlarged and consolidated; fibrous stripe enlarged, while solid nodules increased and enlarged. Conclusions Imaging changes in novel viral pneumonia are rapid. The manifestations of the novel coronavirus pneumonia are diverse. Imaging changes of typical viral pneumonia and some specific imaging features were observed. Therefore, we need to strengthen the recognition of image changes to help clinicians to diagnose quickly and accurately.
C1 [Pan, Yueying; Guan, Hanxiong; Zhou, Shuchang; Wang, Yujin; Li, Qian; Zhu, Tingting; Hu, Qiongjie; Xia, Liming] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Wuhan 430030, Peoples R China.
RP Hu, QJ; Xia, LM (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Wuhan 430030, Peoples R China.
EM qjhu@outlook.com; lmxia@tjh.tjmu.edu.cn
OI Xia, Liming/0000-0001-8481-3380
CR Chan JF, 2020, LANCET, VS0140-6736, P30154
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Huang C, 2020, LANCET, VS0140-6736, P30183
   Tan W, 2020, CHINA CDC WEEKLY, V2, P61
   Wang C, 2020, LANCET, VS0140-6736, P30185
NR 5
TC 6
Z9 6
U1 18
U2 18
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0938-7994
EI 1432-1084
J9 EUR RADIOL
JI Eur. Radiol.
DI 10.1007/s00330-020-06731-x
EA FEB 2020
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KP2UX
UT WOS:000516098100004
PM 32055945
OA Green Accepted, Bronze
DA 2020-04-03
ER

PT J
AU Jin, YH
   Cai, L
   Cheng, ZS
   Cheng, H
   Deng, T
   Fan, YP
   Fang, C
   Huang, D
   Huang, LQ
   Huang, Q
   Han, Y
   Hu, B
   Hu, F
   Li, BH
   Li, YR
   Liang, K
   Lin, LK
   Luo, LS
   Ma, J
   Ma, LL
   Peng, ZY
   Pan, YB
   Pan, ZY
   Ren, XQ
   Sun, HM
   Wang, Y
   Wang, YY
   Weng, H
   Wei, CJ
   Wu, DF
   Xia, J
   Xiong, Y
   Xu, HB
   Yao, XM
   Yuan, YF
   Ye, TS
   Zhang, XC
   Zhang, YW
   Zhang, YG
   Zhang, HM
   Zhao, Y
   Zhao, MJ
   Zi, H
   Zeng, XT
   Wang, YY
   Wang, XH
AF Jin, Ying-Hui
   Cai, Lin
   Cheng, Zhen-Shun
   Cheng, Hong
   Deng, Tong
   Fan, Yi-Pin
   Fang, Cheng
   Huang, Di
   Huang, Lu-Qi
   Huang, Qiao
   Han, Yong
   Hu, Bo
   Hu, Fen
   Li, Bing-Hui
   Li, Yi-Rong
   Liang, Ke
   Lin, Li-Kai
   Luo, Li-Sha
   Ma, Jing
   Ma, Lin-Lu
   Peng, Zhi-Yong
   Pan, Yun-Bao
   Pan, Zhen-Yu
   Ren, Xue-Qun
   Sun, Hui-Min
   Wang, Ying
   Wang, Yun-Yun
   Weng, Hong
   Wei, Chao-Jie
   Wu, Dong-Fang
   Xia, Jian
   Xiong, Yong
   Xu, Hai-Bo
   Yao, Xiao-Mei
   Yuan, Yu-Feng
   Ye, Tai-Sheng
   Zhang, Xiao-Chun
   Zhang, Ying-Wen
   Zhang, Yin-Gao
   Zhang, Hua-Min
   Zhao, Yan
   Zhao, Ming-Juan
   Zi, Hao
   Zeng, Xian-Tao
   Wang, Yong-Yan
   Wang, Xing-Huan
TI A rapid advice guideline for the diagnosis and treatment of 2019 novel
   coronavirus (2019-nCoV) infected pneumonia (standard version)
SO MILITARY MEDICAL RESEARCH
LA English
DT Article
DE 2019 novel coronavirus; 2019-nCoV; Respiratory disease; Pneumonia;
   Infectious diseases; Rapid advice guideline; Clinical practice
   guideline; Evidence-based medicine
ID MERS; LOPINAVIR/RITONAVIR; RIBAVIRIN
AB In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.
C1 [Jin, Ying-Hui; Deng, Tong; Fang, Cheng; Huang, Di; Huang, Qiao; Li, Bing-Hui; Luo, Li-Sha; Ma, Lin-Lu; Wang, Yun-Yun; Weng, Hong; Zhao, Ming-Juan; Zi, Hao; Zeng, Xian-Tao; Wang, Xing-Huan] Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based & Translat Med, Wuhan 430071, Peoples R China.
   [Cai, Lin; Han, Yong; Lin, Li-Kai; Yuan, Yu-Feng; Zhang, Yin-Gao; Wang, Xing-Huan] Wuhan Univ, Inst Hosp Management, Wuhan 430071, Peoples R China.
   [Cheng, Zhen-Shun; Wei, Chao-Jie] Wuhan Univ, Dept Resp Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Cheng, Hong; Wu, Dong-Fang] Wuhan Univ, Dept Pharm, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Deng, Tong; Li, Bing-Hui; Ren, Xue-Qun; Zi, Hao] Henan Univ, Inst Evidence Based Med & Knowledge Translat, Kaifeng 475000, Peoples R China.
   [Fan, Yi-Pin; Huang, Lu-Qi; Zhang, Hua-Min; Wang, Yong-Yan] China Acad Chinese Med Sci, Beijing 100700, Peoples R China.
   [Fan, Yi-Pin; Huang, Lu-Qi; Zhang, Hua-Min; Wang, Yong-Yan] China Ctr Evidence Based Tradit Chinese Med CCEBT, Beijing 100700, Peoples R China.
   [Hu, Bo; Hu, Fen; Ma, Jing; Peng, Zhi-Yong] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Li, Yi-Rong; Pan, Yun-Bao] Wuhan Univ, Dept Clin Lab, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Liang, Ke; Xiong, Yong] Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Pan, Zhen-Yu] Wuhan Univ, Div Med Affairs, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Sun, Hui-Min] Wuhan Univ, Div Nursing Affairs, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Wang, Ying] Wuhan Univ, Off Nosocomial Infect Control, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Xia, Jian; Zhao, Yan] Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Xu, Hai-Bo; Zhang, Xiao-Chun] Wuhan Univ, Dept Radiol, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Yao, Xiao-Mei] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.
   [Ye, Tai-Sheng; Zhang, Ying-Wen] McMaster Univ, Dept Tradit Chinese Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Zeng, Xian-Tao] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China.
RP Zeng, XT; Wang, XH (reprint author), Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based & Translat Med, Wuhan 430071, Peoples R China.; Wang, YY (reprint author), China Acad Chinese Med Sci, Beijing 100700, Peoples R China.
EM zengxiantao1128@163.com; wangyyanpublic@bta.net.cn;
   wangxinghuan1965@163.com
OI xiong, yong/0000-0003-0678-4064; Weng, Hong/0000-0001-7795-5671
FU Entrusted Project of National Center for Medical Service Administration,
   National Health and Family Planning Commission China [[2019]099]; First
   Level Funding of the Second Medical Leading Talent Project in Hubei
   Province; Special Project for Emergency of the Ministry of Science and
   Technology [2020YFC0841300]
FX This work was supported (in part) by the Entrusted Project of National
   Center for Medical Service Administration, National Health and Family
   Planning Commission China (No. [2019]099), the First Level Funding of
   the Second Medical Leading Talent Project in Hubei Province, and the
   Special Project for Emergency of the Ministry of Science and Technology
   (2020YFC0841300).
CR [Anonymous], 2020, WHO ADVICE INT TRAVE
   [Anonymous], 2020, CDC TRAVELERS HLTH N
   [Anonymous], 2020, NOTICE ISSUANCE PROG
   [Anonymous], 2013, GRADE HDB
   [Anonymous], 2020, INFECT PREVENTION CO
   [Anonymous], 2020, INF OFF HOLD PRESS C
   [Anonymous], 2020, PROGRAM PREVENTION C
   [Anonymous], 2020, HOME CARE PATIENTS S
   Brigitte M, 2015, CRIT CARE MED, V43, P308
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Health Emergency Office of National Health Commission of the PRC, UPD EP NOV COR 2019
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang H, 2020, ZHONGHUA JIZHEN YIXU, V29, P182
   Jin YH, 2020, YIXUE XINZHI, V30, P35, DOI [10.12173/j.issn.1004-5511.2020.01.09, DOI 10.12173/J.ISSN.1004-5511.2020.01.09]
   Khan PA, 2018, INT J PHARM SCI RES, V9, P2616, DOI 10.13040/IJPSR.0975-8232.9(7).2616-25
   Kim JY, 2015, INFECT CHEMOTHER, V47, P278, DOI 10.3947/ic.2015.47.4.278
   Lai ST, 2005, EUR J CLIN MICROBIOL, V24, P583, DOI 10.1007/s10096-005-0004-z
   Legault K, 2018, J THROMB HAEMOST, V16, P1656, DOI 10.1111/jth.14192
   Li L, 2020, YIXUE XINZHI, V30, P4
   Meng Qing-hua, 2003, Zhonghua Yufang Yixue Zazhi, V37, P233
   Norris SL, 2013, WHO RAPID ADVICE GUI
   Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Schunemann HJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4606
   Wang W, 2020, YIXUE XINZHI, V30, P7
   Wang Y, 2020, ADVICE GUIDELINE REC
   WHO, 2019, WHO HDB GUIDELINE DE
   Xiao Jian-zhong, 2004, Zhonghua Nei Ke Za Zhi, V43, P179
   Zhao Zi-wen, 2003, Zhonghua Yi Xue Za Zhi, V83, P713
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 37
TC 6
Z9 6
U1 28
U2 28
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-7467
EI 2054-9369
J9 MILITARY MED RES
JI MILITARY MED. RES.
PD FEB 6
PY 2020
VL 7
IS 1
AR 4
DI 10.1186/s40779-020-0233-6
PG 23
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT4NS
UT WOS:000518992100001
PM 32029004
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Nkengasong, J
AF Nkengasong, John
TI China's response to a novel coronavirus stands in stark contrast to the
   2002 SARS outbreak response
SO NATURE MEDICINE
LA English
DT Article; Early Access
AB The strengthening of the Chinese Center for Disease Control and Prevention has been a turning point in outbreak responses in the area. This represents very welcome progress and development for global health security and diplomacy.
C1 [Nkengasong, John] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.
RP Nkengasong, J (reprint author), Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.
EM nkengasongj@africa-union.org
RI Ribeiro, Nuno/AAH-2299-2020
CR Cheung E., 2020, S CHINA MORNING POST
   CNN, 2003, CNN
   Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234
   Juan D, 2020, CHINA DAILY
   Lai L, 2020, STRAITS TIMES
   Lee J.-W., 2004, LEARNING SARS PREPAR
   Levine J, 2020, NEW YORK POST
   Li CY, 2016, AM J PUBLIC HEALTH, V106, P2093, DOI 10.2105/AJPH.2016.303508
   Mukherjee S, 2017, INDIAN J DERMATOL, V62, P459, DOI 10.4103/ijd.IJD_379_17
   Reuters, 2020, REUTERS
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   WebMD, 2004, SARS TIM OUTBR
   Wee S.-L, 2020, NY TIMES
   World Health Organization, 2020, NOV COR CHIN
   World Population Review, 2020, WUH POP 2020
   Zhou Y, 2019, QUARTZ AFRICA   0728
NR 16
TC 6
Z9 6
U1 36
U2 36
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
DI 10.1038/s41591-020-0771-1
EA JAN 2020
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA KH3NI
UT WOS:000510552300004
PM 31988464
OA Bronze
DA 2020-04-03
ER

PT J
AU Paraskevis, D
   Kostaki, EG
   Magiorkinis, G
   Panayiotakopoulos, G
   Sourvinos, G
   Tsiodras, S
AF Paraskevis, D.
   Kostaki, E. G.
   Magiorkinis, G.
   Panayiotakopoulos, G.
   Sourvinos, G.
   Tsiodras, S.
TI Full-genome evolutionary analysis of the novel corona virus (2019-nCoV)
   rejects the hypothesis of emergence as a result of a recent
   recombination event
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Novel coronavirus; Genomic sequence analysis; Phylogenetic analysis;
   Recombination; Origin; Molecular epidemiology
ID RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; COV
AB Background: A novel coronavirus (2019-nCoV) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in China. Our objectives were to characterize the genetic relationships of the 2019-nCoV and to search for putative recombination within the subgenus of sarbecovirus.
   Methods: Putative recombination was investigated by RDP4 and Simplot v3.5.1 and discordant phylogenetic clustering in individual genomic fragments was confirmed by phylogenetic analysis using maximum likelihood and Bayesian methods.
   Results: Our analysis suggests that the 2019-nCoV although closely related to BatCoV RaTG13 sequence throughout the genome (sequence similarity 96.3%), shows discordant clustering with the Bat_SARS-like coronavirus sequences. Specifically, in the 5'-part spanning the first 11,498 nucleotides and the last 3'-part spanning 24,341-30,696 positions, 2019-nCoV and RaTG13 formed a single cluster with Bat_SARS-like coronavirus sequences, whereas in the middle region spanning the 3'-end of ORF1a, the ORF1b and almost half of the spike regions, 2019-nCoV and RaTG13 grouped in a separate distant lineage within the sarbecovirus branch.
   Conclusions: The levels of genetic similarity between the 2019-nCoV and RaTG13 suggest that the latter does not provide the exact variant that caused the outbreak in humans, but the hypothesis that 2019-nCoV has originated from bats is very likely. We show evidence that the novel coronavirus (2019-nCov) is not-mosaic consisting in almost half of its genome of a distinct lineage within the betacoronavirus. These genomic features and their potential association with virus characteristics and virulence in humans need further attention.
C1 [Paraskevis, D.; Kostaki, E. G.; Magiorkinis, G.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece.
   [Panayiotakopoulos, G.] NPHO, Athens, Greece.
   [Sourvinos, G.] Univ Crete, Sch Med, Lab Clin Virol, Iraklion, Greece.
   [Tsiodras, S.] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece.
RP Paraskevis, D (reprint author), Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, 75 Mikras Asias St, Athens 11527, Greece.
EM dparask@med.uoa.gr
RI Ribeiro, Nuno/AAH-2299-2020
OI Paraskevis, Dimitrios/0000-0001-6167-7152; Kostaki,
   Evangelia/0000-0002-3346-0930
CR Al Hajjar S, 2013, ANN SAUDI MED, V33, P427, DOI 10.5144/0256-4947.2013.427
   Alagaili AN, 2014, MBIO, V5, DOI 10.1128/mBio.00884-14
   Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   ECDC, 2020, ECDC TECHN REP
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946
   Ji W, 2020, INT J INFECT DIS, V91, P264
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Magiorkinis G, 2004, J MED VIROL, V74, P369, DOI 10.1002/jmv.20187
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Stecher Glen, 2020, Mol Biol Evol, V37, P1237, DOI 10.1093/molbev/msz312
   Swofford DL, 2003, PAUP PHYLOGENETIC AN
   WHO, 2018, ANN REV DIS PRIOR RE
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou P, 2020, DISCOVERY NOVEL CORO
   Zhu N, 2019, N ENGL J MED, V2020
NR 31
TC 5
Z9 5
U1 484
U2 484
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2020
VL 79
AR 104212
DI 10.1016/j.meegid.2020.104212
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KH7YP
UT WOS:000510866400018
PM 32004758
OA Bronze
DA 2020-04-03
ER

PT J
AU Lim, J
   Jeon, S
   Shin, HY
   Kim, MJ
   Seong, YM
   Lee, WJ
   Choe, KW
   Kang, YM
   Lee, B
   Park, SJ
AF Lim, Jaegyun
   Jeon, Seunghyun
   Shin, Hyun-Young
   Kim, Moon Jung
   Seong, Yu Min
   Lee, Wang Jun
   Choe, Kang-Won
   Kang, Yu Min
   Lee, Baeckseung
   Park, Sang-Joon
TI Case of the Index Patient Who Caused Tertiary Transmission of
   Coronavirus Disease 2019 in Korea: the Application of
   Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by
   Quantitative RT-PCR
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Coronavirus; COVID-19; Pneumonia; Tertiary Infection; Viral Load; Real
   Time Reverse-Transcriptase Polymerase Chain Reaction
AB Since mid-December of 2019, coronavirus disease 2019 (COVID-19) has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. As secondary transmissions have occurred and the speed of transmission is accelerating, there are rising concerns about community infections. The 54-year old male is the third patient diagnosed with COVID-19 in Korea. He is a worker for a clothing business and had mild respiratory symptoms and intermittent fever in the beginning of hospitalization, and pneumonia symptoms on chest computerized tomography scan on day 6 of admission. This patient caused one case of secondary transmission and three cases of tertiary transmission. Hereby, we report the clinical findings of the index patient who was the first to cause tertiary transmission outside China. Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, beta-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.
C1 [Lim, Jaegyun; Kim, Moon Jung] Hanyang Univ, Myongji Hosp, Coll Med, Dept Lab Med, Goyang, South Korea.
   [Jeon, Seunghyun] Myongji Hosp, New Horizon Canc Inst, Goyang, South Korea.
   [Shin, Hyun-Young] Hanyang Univ, Myongji Hosp, Coll Med, Dept Family Med, Goyang, South Korea.
   [Seong, Yu Min] Myongji Hosp, Dept Internal Med, Goyang, South Korea.
   [Lee, Wang Jun] Myongji Hosp, Dept Gen Surg, Goyang, South Korea.
   [Choe, Kang-Won; Kang, Yu Min] Myongji Hosp, Dept Infect Dis, Goyang, South Korea.
   [Lee, Baeckseung] CancerROP, 173 Digital Ro, Seoul 08511, South Korea.
   [Park, Sang-Joon] Myongji Hosp, Dept Pulm & Crit Care Med, 55 Havasu Ro,14 Beon Gil, Goyang 10475, South Korea.
RP Lee, B (reprint author), CancerROP, 173 Digital Ro, Seoul 08511, South Korea.; Park, SJ (reprint author), Myongji Hosp, Dept Pulm & Crit Care Med, 55 Havasu Ro,14 Beon Gil, Goyang 10475, South Korea.
EM baeckseung@gmail.com; drjoseph@mjh.or.kr
RI Ribeiro, Nuno/AAH-2299-2020
OI Lim, Jaegyun/0000-0002-3553-0058; Shin, Hyun-Young/0000-0001-7261-3365;
   Kim, Moon Jung/0000-0003-4148-9116; Kang, Yu Min/0000-0002-4368-9878
CR Chang D, 2020, JAMA
   Hamer M, 2019, BRAIN BEHAV IMMUN, V76, P280, DOI 10.1016/j.bbi.2018.12.011
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Li Q, 2020, N ENGL J MED
   Rothe C, 2020, N ENGL J MED
NR 5
TC 5
Z9 5
U1 77
U2 77
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD FEB 17
PY 2020
VL 35
IS 6
AR e79
DI 10.3346/jkms.2020.35.e79
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA KN4NN
UT WOS:000514815500010
PM 32056407
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Reusken, CBEM
   Broberg, EK
   Haagmans, B
   Meijer, A
   Corman, VM
   Papa, A
   Charrel, R
   Drosten, C
   Koopmans, M
   Leitmeyer, K
AF Reusken, Chantal B. E. M.
   Broberg, Eeva K.
   Haagmans, Bart
   Meijer, Adam
   Corman, Victor M.
   Papa, Anna
   Charrel, Remi
   Drosten, Christian
   Koopmans, Marion
   Leitmeyer, Katrin
CA EVD-LabNet
   ERLI-Net
TI Laboratory readiness and response for novel coronavirus (2019-nCoV) in
   expert laboratories in 30 EU/EEA countries, January 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID ZIKA VIRUS; QUALITY
AB Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
C1 [Reusken, Chantal B. E. M.; Haagmans, Bart; Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Rotterdam, Netherlands.
   [Reusken, Chantal B. E. M.; Meijer, Adam] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
   [Broberg, Eeva K.; Leitmeyer, Katrin] European Ctr Dis Prevent & Control, Solna, Sweden.
   [Corman, Victor M.; Drosten, Christian] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Corman, Victor M.; Drosten, Christian] German Ctr Infect Res DZIF, Berlin, Germany.
   [Papa, Anna] Aristotle Univ Thessaloniki, Med Sch, Dept Microbiol, Thessaloniki, Greece.
   [Charrel, Remi] Aix Marseille Univ, Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
RP Reusken, CBEM (reprint author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Rotterdam, Netherlands.; Reusken, CBEM (reprint author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
EM chantal.reusken@rivm.nl
RI Corman, Victor Max/K-1319-2019; Ribeiro, Nuno/AAH-2299-2020
OI Corman, Victor Max/0000-0002-3605-0136; Haagmans,
   Bart/0000-0001-6221-2015
CR Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Chinazzi M, PRELIMINARY ASSESSME
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   European Centre for Disease Control and Prevention (ECDC), NOV COR
   European Centre for Disease Control and Prevention (ECDC), NOV COR CAS DEF EUR
   Hadjinicolaou AV, 2011, ARCH VIROL, V156, P671, DOI 10.1007/s00705-010-0906-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lai S, PRELIMINARY RISK ANA
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057
   Romette JL, 2018, ANTIVIR RES, V158, P127, DOI 10.1016/j.antiviral.2018.07.017
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Tan W, 2020, CHINA CDC WEEKLY, V2, P61
   World Health Organization, NOV COR 2019 NCOV TE
NR 15
TC 5
Z9 5
U1 11
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 13
PY 2020
VL 25
IS 6
BP 7
EP 12
AR 2000082
DI 10.2807/1560-7917.ES.2020.25.6.2000082
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KM9CR
UT WOS:000514439600002
PM 32046815
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Tang, B
   Wang, X
   Li, Q
   Bragazzi, NL
   Tang, SY
   Xiao, YN
   Wu, JH
AF Tang, Biao
   Wang, Xia
   Li, Qian
   Bragazzi, Nicola Luigi
   Tang, Sanyi
   Xiao, Yanni
   Wu, Jianhong
TI Estimation of the Transmission Risk of the 2019-nCoV and Its Implication
   for Public Health Interventions
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE coronavirus; infection management and control; travel restriction;
   mathematical model; SEIR model
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; SARS; OUTBREAK; MODELS; NUMBER
AB Since the emergence of the first cases in Wuhan, China, the novel coronavirus (2019-nCoV) infection has been quickly spreading out to other provinces and neighboring countries. Estimation of the basic reproduction number by means of mathematical modeling can be helpful for determining the potential and severity of an outbreak and providing critical information for identifying the type of disease interventions and intensity. A deterministic compartmental model was devised based on the clinical progression of the disease, epidemiological status of the individuals, and intervention measures. The estimations based on likelihood and model analysis show that the control reproduction number may be as high as 6.47 (95% CI 5.71-7.23). Sensitivity analyses show that interventions, such as intensive contact tracing followed by quarantine and isolation, can effectively reduce the control reproduction number and transmission risk, with the effect of travel restriction adopted by Wuhan on 2019-nCoV infection in Beijing being almost equivalent to increasing quarantine by a 100 thousand baseline value. It is essential to assess how the expensive, resource-intensive measures implemented by the Chinese authorities can contribute to the prevention and control of the 2019-nCoV infection, and how long they should be maintained. Under the most restrictive measures, the outbreak is expected to peak within two weeks (since 23 January 2020) with a significant low peak value. With travel restriction (no imported exposed individuals to Beijing), the number of infected individuals in seven days will decrease by 91.14% in Beijing, compared with the scenario of no travel restriction.
C1 [Tang, Biao; Xiao, Yanni; Wu, Jianhong] Xi An Jiao Tong Univ, Interdisciplinary Res Ctr Math & Life Sci, Xian 710049, Peoples R China.
   [Tang, Biao; Li, Qian; Bragazzi, Nicola Luigi; Wu, Jianhong] York Univ, Lab Ind & Appl Math, Dept Math & Stat, Toronto, ON M3J 1P3+, Canada.
   [Li, Qian; Tang, Sanyi] Shaanxi Normal Univ, Sch Math & Informat Sci, Xian 710119, Peoples R China.
   [Li, Qian; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
   [Wu, Jianhong] York Univ, Fields CQAM Lab Math Publ Hlth, Toronto, ON M3J 1P3, Canada.
RP Wu, JH (reprint author), Xi An Jiao Tong Univ, Interdisciplinary Res Ctr Math & Life Sci, Xian 710049, Peoples R China.; Wu, JH (reprint author), York Univ, Lab Ind & Appl Math, Dept Math & Stat, Toronto, ON M3J 1P3+, Canada.; Wu, JH (reprint author), York Univ, Fields CQAM Lab Math Publ Hlth, Toronto, ON M3J 1P3, Canada.
EM btang66@yorku.ca; xiawang@snnu.edu.cn; crystallee@stu.xjtu.edu.cn;
   robertobragazzi@gmail.com; sanyitang219@hotmail.com;
   yxiao@mail.xjtu.edu.cn; wujh@yorku.ca
RI Bragazzi, Nicola/G-1672-2011
OI Bragazzi, Nicola/0000-0001-8409-868X; Tang, Sanyi/0000-0002-3324-746X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11631012, 61772017]; Canada Research Chair
   ProgramCanada Research Chairs [230720]; Natural Sciences and Engineering
   Research Council of CanadaNatural Sciences and Engineering Research
   Council of Canada [105588-2011]
FX This research was funded by the National Natural Science Foundation of
   China (grant numbers: 11631012 (YX, ST), 61772017 (ST)), and by the
   Canada Research Chair Program (grant number: 230720 (JW) and the Natural
   Sciences and Engineering Research Council of Canada (Grant number:
   105588-2011 (JW).
CR Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Castillo-Chavez C, 2003, JAMA-J AM MED ASSOC, V290, P2876, DOI 10.1001/jama.290.21.2876
   Chen T., 2020, BIORXIV, DOI [10.1101/2020.01.19.911669v1, DOI 10.1101/2020.01.19.911669V1]
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng VCC, 2020, J HOSP INFECT, V104, P254, DOI 10.1016/j.jhin.2020.01.010
   Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Egger Matthias, 2017, F1000Res, V6, P1584, DOI 10.12688/f1000research.12367.1
   Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9
   Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hui DSC, 2019, INFECT DIS CLIN N AM, V33, P869, DOI 10.1016/j.idc.2019.07.001
   Imai N., REPORT 2 ESTIMATING
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Kwok KO, 2019, COMPUT STRUCT BIOTEC, V17, P186, DOI 10.1016/j.csbj.2019.01.003
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Fisman David, 2014, PLoS Curr, V6, DOI [10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]
   PARRY J, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/bmj.m236
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Tang SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010911
   White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136
   Willman M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121119
   World Health Organization, SIT REP
   World Health Organization, NOV COR CHIN DIS OUT
   World Health Organization (WHO), COR
   Xiao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07838
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
NR 30
TC 5
Z9 5
U1 21
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 462
DI 10.3390/jcm9020462
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000174
PM 32046137
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zhao, S
   Musa, SS
   Lin, QY
   Ran, JJ
   Yang, GP
   Wang, WM
   Lou, YJ
   Yang, L
   Gao, DZ
   He, DH
   Wang, MH
AF Zhao, Shi
   Musa, Salihu S.
   Lin, Qianying
   Ran, Jinjun
   Yang, Guangpu
   Wang, Weiming
   Lou, Yijun
   Yang, Lin
   Gao, Daozhou
   He, Daihai
   Wang, Maggie H.
TI Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases
   in China in the First Half of January 2020: A Data-Driven Modelling
   Analysis of the Early Outbreak
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE novel coronavirus; outbreak; modelling; underreporting; reproduction
   number; China
AB Background: In December 2019, an outbreak of respiratory illness caused by a novel coronavirus (2019-nCoV) emerged in Wuhan, China and has swiftly spread to other parts of China and a number of foreign countries. The 2019-nCoV cases might have been under-reported roughly from 1 to 15 January 2020, and thus we estimated the number of unreported cases and the basic reproduction number, R-0, of 2019-nCoV. Methods: We modelled the epidemic curve of 2019-nCoV cases, in mainland China from 1 December 2019 to 24 January 2020 through the exponential growth. The number of unreported cases was determined by the maximum likelihood estimation. We used the serial intervals (SI) of infection caused by two other well-known coronaviruses (CoV), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) CoVs, as approximations of the unknown SI for 2019-nCoV to estimate R-0. Results: We confirmed that the initial growth phase followed an exponential growth pattern. The under-reporting was likely to have resulted in 469 (95% CI: 403-540) unreported cases from 1 to 15 January 2020. The reporting rate after 17 January 2020 was likely to have increased 21-fold (95% CI: 18-25) in comparison to the situation from 1 to 17 January 2020 on average. We estimated the R-0 of 2019-nCoV at 2.56 (95% CI: 2.49-2.63). Conclusion: The under-reporting was likely to have occurred during the first half of January 2020 and should be considered in future investigation.
C1 [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong 999077, Peoples R China.
   [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518060, Peoples R China.
   [Musa, Salihu S.; Lou, Yijun; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong 999077, Peoples R China.
   [Lin, Qianying] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI USA.
   [Ran, Jinjun] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong 999077, Peoples R China.
   [Yang, Guangpu] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong 999077, Peoples R China.
   [Yang, Guangpu] Chinese Univ Hong Kong & Nanjing Univ, Joint Scoliosis Res Ctr, SH Ho Scoliosis Res Lab, Hong Kong 999077, Peoples R China.
   [Wang, Weiming] Huaiyin Normal Univ, Sch Math & Stat, Huaian 223300, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong 999077, Peoples R China.
   [Gao, Daozhou] Shanghai Normal Univ, Dept Math, Shanghai 200234, Peoples R China.
RP Zhao, S (reprint author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong 999077, Peoples R China.; Zhao, S (reprint author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518060, Peoples R China.; He, DH (reprint author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong 999077, Peoples R China.; Wang, WM (reprint author), Huaiyin Normal Univ, Sch Math & Stat, Huaian 223300, Peoples R China.
EM zhaoshi.cmsa@gmail.com; salihu-sabiu.musa@connect.polyu.hk;
   qianying@umich.edu; jimran@connect.hku.hk; kennethgpy@link.cuhk.edu.hk;
   weimingwang2003@163.com; yijun.lou@polyu.edu.hk; l.yang@polyu.edu.hk;
   dzgao@shnu.edu.cn; daihai.he@polyu.edu.hk; maggiew@cuhk.edu.hk
OI He, Daihai/0000-0003-3253-654X; Wang, Weiming/0000-0002-7562-8260; Musa,
   Salihu Sabiu/0000-0001-6335-2335
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [61672013]; Huaian Key Laboratory for Infectious
   Diseases Control and Prevention [HAP201704]
FX This research was supported by the National Natural Science Foundation
   of China (Grant number 61672013) and the Huaian Key Laboratory for
   Infectious Diseases Control and Prevention (Grant number HAP201704).
CR Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Bauch CT, 2005, EPIDEMIOLOGY, V16, P791, DOI 10.1097/01.ede.0000181633.80269.4c
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092
   de Silva UC, 2009, EUROSURVEILLANCE, V14, P11
   Fan JQ, 2005, BERNOULLI, V11, P1031, DOI 10.3150/bj/1137421639
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imai Natsuko, ESTIMATING POTENTIAL
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Read J.M., 2020, NOVEL CORONAVIRUS 20, DOI [10.1136/adc.2006.098996, DOI 10.1136/ADC.2006.098996]
   Riou J., 2020, BIORXIV, DOI [10.1101/2020.01.23.917351, DOI 10.1101/2020.01.23.917351]
   Shen M, 2020, BIORXIV, DOI [10.1101/2020.01.23.916726, DOI 10.1101/2020.01.23.916726]
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wu F, 2020, BIORXIV, DOI [10.1101/2020.01.24.919183., DOI 10.1101/2020.01.24.919183]
   Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044
   Zhao S, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3602-9
   Zhou P., 2020, BIORXIV, DOI [10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952, 10.1101/2020.01.22.914952.]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 20
TC 5
Z9 5
U1 13
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 388
DI 10.3390/jcm9020388
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000100
PM 32024089
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Wu, P
   Hao, XX
   Lau, EHY
   Wong, JY
   Leung, KSM
   Wu, JT
   Cowling, BJ
   Leung, GM
AF Wu, Peng
   Hao, Xinxin
   Lau, Eric H. Y.
   Wong, Jessica Y.
   Leung, Kathy S. M.
   Wu, Joseph T.
   Cowling, Benjamin J.
   Leung, Gabriel M.
TI Real-time tentative assessment of the epidemiological characteristics of
   novel coronavirus infections in Wuhan, China, as at 22 January 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID ACUTE-RESPIRATORY-SYNDROME; CASE-FATALITY RATIO; MERS-COV OUTBREAK;
   SOUTH-KOREA
AB A novel coronavirus (2019-nCoV) causing severe acute respiratory disease emerged recently in Wuhan, China. Information on reported cases strongly indicates human-to-human spread, and the most recent information is increasingly indicative of sustained human-to-human transmission. While the overall severity profile among cases may change as more mild cases are identified, we estimate a risk of fatality among hospitalised cases at 14% (95% confidence interval: 3.9-32%).
C1 [Wu, Peng; Hao, Xinxin; Lau, Eric H. Y.; Wong, Jessica Y.; Leung, Kathy S. M.; Wu, Joseph T.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO,Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China.
RP Cowling, BJ (reprint author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO,Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China.
EM bcowling@hku.hk
RI Ribeiro, Nuno/AAH-2299-2020; Leung, Kathy/D-5605-2017; Lau,
   Eric/C-4487-2009; Wu, Joseph Tsz Kei/C-4450-2009
OI Leung, Kathy/0000-0003-4777-388X; Lau, Eric/0000-0002-6688-9637; Wu,
   Joseph Tsz Kei/0000-0002-3155-5987
FU Health and Medical Research Fund, Food and Health Bureau, Government of
   the Hong Kong Special Administrative Region
FX This project was supported by a commissioned grant from the Health and
   Medical Research Fund, Food and Health Bureau, Government of the Hong
   Kong Special Administrative Region.
CR Amer H, 2018, AM J INFECT CONTROL, V46, P1022, DOI 10.1016/j.ajic.2018.02.023
   [Anonymous], 2020, BEIJING NEWS
   Cauchemez S., 2013, Eurosurveillance, V18, P20503
   Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399
   CDC, 2020, 1 TRAV REL CAS 2019
   Cheung J., 2020, THE STANDARD    0116
   Chinese National Health Commission (NHC), 2020, EXP ANSW REP QUEST P
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Cowling BJ, 2006, ARCH INTERN MED, V166, P1505, DOI 10.1001/archinte.166.14.1505
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Hui DS, 2017, CLIN CHEST MED, V38, P71, DOI 10.1016/j.ccm.2016.11.007
   Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Lau EHY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-50
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Taiwan Centers for Disease Control (CDC), 2020, TAIW TIM ID 1 IMP CA
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   World Health Organization, 2019, MERS SIT UPD
   World Health Organization, 2020, NOV COR THAIL EXCH
   World Health Organization Regional Office for the Western Pacific ( WHO/ Pacific), 2020, WHO W PAC TWITT FEED
   World Health Organization ( WHO), 2020, WHO STAT REG CLUST P
   Wuhan Municipal Health Commission, 2020, QUEST ANSW PENUM DUE
   Wuhan Municipal Health Commission, 2020, REP UN VIR PNEUM
   Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6
NR 29
TC 5
Z9 5
U1 81
U2 81
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 23
PY 2020
VL 25
IS 3
BP 4
EP 9
DI 10.2807/1560-7917.ES.2020.25.3.2000044
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KF6OZ
UT WOS:000509360400002
PM 31992388
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Chen, LJ
   Liu, WY
   Zhang, Q
   Xu, K
   Ye, GM
   Wu, WC
   Sun, ZY
   Liu, F
   Wu, KL
   Zhong, B
   Mei, Y
   Zhang, WX
   Chen, Y
   Li, YR
   Shi, M
   Lan, K
   Liu, YL
AF Chen, Liangjun
   Liu, Weiyong
   Zhang, Qi
   Xu, Ke
   Ye, Guangming
   Wu, Weichen
   Sun, Ziyong
   Liu, Fang
   Wu, Kailang
   Zhong, Bo
   Mei, Yi
   Zhang, Wenxia
   Chen, Yu
   Li, Yirong
   Shi, Mang
   Lan, Ke
   Liu, Yingle
TI RNA based mNGS approach identifies a novel human coronavirus from two
   individual pneumonia cases in 2019 Wuhan outbreak
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE 2019-nCoV; Wuhan pneumonia; metagenomic next-generation sequencing;
   phylogenetic analyses; virus evolution
AB From December 2019, an outbreak of unusual pneumonia was reported in Wuhan with many cases linked to Huanan Seafood Market that sells seafood as well as live exotic animals. We investigated two patients who developed acute respiratory syndromes after independent contact history with this market. The two patients shared common clinical features including fever, cough, and multiple ground-glass opacities in the bilateral lung field with patchy infiltration. Here, we highlight the use of a low-input metagenomic next-generation sequencing (mNGS) approach on RNA extracted from bronchoalveolar lavage fluid (BALF). It rapidly identified a novel coronavirus (named 2019-nCoV according to World Health Organization announcement) which was the sole pathogens in the sample with very high abundance level (1.5% and 0.62% of total RNA sequenced). The entire viral genome is 29,881 nt in length (GenBank MN988668 and MN988669, Sequence Read Archive database Bioproject accession PRJNA601736) and is classified into beta-coronavirus genus. Phylogenetic analysis indicates that 2019-nCoV is close to coronaviruses (CoVs) circulating in Rhinolophus (Horseshoe bats), such as 98.7% nucleotide identity to partial RdRp gene of bat coronavirus strain BtCoV/4991 (GenBank KP876546, 370 nt sequence of RdRp and lack of other genome sequence) and 87.9% nucleotide identity to bat coronavirus strain bat-SL-CoVZC45 and bat-SL-CoVZXC21. Evolutionary analysis based on ORF1a/1b, S, and N genes also suggests 2019-nCoV is more likely a novel CoV independently introduced from animals to humans.
C1 [Chen, Liangjun; Zhang, Qi; Xu, Ke; Liu, Fang; Wu, Kailang; Zhong, Bo; Mei, Yi; Zhang, Wenxia; Chen, Yu; Lan, Ke; Liu, Yingle] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan, Peoples R China.
   [Chen, Liangjun; Ye, Guangming; Li, Yirong] Wuhan Univ, Dept Lab Med, Zhongnan Hosp, Wuhan, Peoples R China.
   [Liu, Weiyong; Sun, Ziyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan, Peoples R China.
   [Wu, Weichen; Shi, Mang] Sun Yat Sen Univ, Sch Med, Guangzhou, Peoples R China.
RP Chen, Y; Lan, K; Liu, YL (reprint author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan, Peoples R China.; Li, YR (reprint author), Wuhan Univ, Dept Lab Med, Zhongnan Hosp, Wuhan, Peoples R China.; Shi, M (reprint author), Sun Yat Sen Univ, Sch Med, Guangzhou, Peoples R China.
EM chenyu@whu.edu.cn; liyirong838@163.com; shim23@mail.sysu.edu.cn;
   klan@whu.edu.cn; mvlwu@whu.edu.cn
FU National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103005]; National Key Research and Development Program of China
   [2018YFE0204500]; National Science and Technology Major Project
   [2018ZX10733403]
FX This work was supported by the National Mega Project on Major Infectious
   Disease Prevention under [grant number 2017ZX10103005]; National Key
   Research and Development Program of China under [grant number
   2018YFE0204500]; and National Science and Technology Major Project under
   [grant number 2018ZX10733403].
CR Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Jiang SB, 2020, EMERG MICROBES INFEC, V9, P275, DOI 10.1080/22221751.2020.1723441
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Shi M, 2018, VIRUS RES, V243, P83, DOI 10.1016/j.virusres.2017.10.016
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
NR 12
TC 5
Z9 5
U1 103
U2 103
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 313
EP 319
DI 10.1080/22221751.2020.1725399
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KK1XQ
UT WOS:000512543700001
PM 32020836
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Wrapp, D
   Wang, NS
   Corbett, KS
   Goldsmith, JA
   Hsieh, CL
   Abiona, O
   Graham, BS
   McLellan, JS
AF Wrapp, Daniel
   Wang, Nianshuang
   Corbett, Kizzmekia S.
   Goldsmith, Jory A.
   Hsieh, Ching-Lin
   Abiona, Olubukola
   Graham, Barney S.
   McLellan, Jason S.
TI Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
SO SCIENCE
LA English
DT Article
ID FUSION PROTEIN; CORONAVIRUS; CLEAVAGE; RECEPTOR; SYSTEM
AB The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.
C1 [Wrapp, Daniel; Wang, Nianshuang; Goldsmith, Jory A.; Hsieh, Ching-Lin; McLellan, Jason S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
   [Corbett, Kizzmekia S.; Abiona, Olubukola; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP McLellan, JS (reprint author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
EM jmclellan@austin.utexas.edu
OI McLellan, Jason/0000-0003-3991-542X; Wrapp, Daniel/0000-0002-0538-9647
FU National Institutes of Health (NIH)/National Institute of Allergy and
   Infectious Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01-AI127521]; NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); University of Texas College of Natural Sciences;
   Cancer Prevention and Research Institute of Texas (CPRIT) [RR160023]
FX This work was supported in part by a National Institutes of Health
   (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)
   grant awarded to J.S.M. (R01-AI127521) and by intramural funding from
   NIAID to B.S.G. The Sauer Structural Biology Laboratory is supported by
   the University of Texas College of Natural Sciences and by award
   RR160023 from the Cancer Prevention and Research Institute of Texas
   (CPRIT).
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106
   Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08
   Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Coutard B., 2020, ANTIVIR RES, V176
   Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
   Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383
   Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152
   Hoffmann M., 2020, BIORXIV, DOI [10.1101/2020.01.31.929042., DOI 10.1101/2020.01.31.929042]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li Q., 2020, ENGL J MED
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lu R., 2020, LANCET
   Lu R., 2020, LANCET, DOI [10.1016/S0140-6736(20)30251-8, DOI 10.1016/S0140-6736(20)30251-8MEDLINE]
   Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200
   Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]
   Ramirez-Aportela E, 2020, BIOINFORMATICS, V36, P765, DOI 10.1093/bioinformatics/btz671
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236
   Tegunov D, 2019, NAT METHODS, V16, P1146, DOI 10.1038/s41592-019-0580-y
   Tian X., 2020, BIORXIV, V9, P382
   Tian Xiaolong, 2020, Emerg Microbes Infect, V9, P382, DOI 10.1080/22221751.2020.1729069
   Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028
   Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114
   Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293
   Wan Y., 2020, J VIROL
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wrapp D, 2019, J VIROL, V93, DOI 10.1128/JVI.00923-19
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 45
TC 4
Z9 4
U1 19
U2 19
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAR 13
PY 2020
VL 367
IS 6483
BP 1260
EP +
DI 10.1126/science.abb2507
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KU9DP
UT WOS:000520023800044
PM 32075877
OA Bronze
DA 2020-04-03
ER

PT J
AU Chen, JL
AF Chen, Jieliang
TI Pathogenicity and transmissibility of 2019-nCoV-A quick overview and
   comparison with other emerging viruses
SO MICROBES AND INFECTION
LA English
DT Article
DE Novel coronavirus infection; Case fatality rate; Basic reproduction
   number (R-o); ACE2; SARS
ID CORONAVIRUS; PNEUMONIA; OUTBREAK; CHINA; SARS
AB A zoonotic coronavirus, tentatively labeled as 2019-nCoV by the World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted. (C) 2020 The Author(s). Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Chen, Jieliang] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
RP Chen, JL (reprint author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
EM jieliangchen@fudan.edu.cn
CR Bauch CT, 2013, LANCET, V382, P662, DOI 10.1016/S0140-6736(13)61504-4
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang SB, 2020, EMERG MICROBES INFEC, V9, P275, DOI 10.1080/22221751.2020.1723441
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [DOI 10.1101/2020.01.23.20018549, 10.1101/2020.01.23.20018549]
   Shen M, 2020, BIORXIV, DOI [10.1101/2020.01.23.916726, DOI 10.1101/2020.01.23.916726]
   van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   WHO, 2020, STAT M INT HLTH REG
   Yu F, 2020, MICROBES INFECT, V22, P74, DOI 10.1016/j.micinf.2020.01.003
   Zhao S, 2020, BIORXIV, DOI [10.1016/j.ijid.2020.01.050, DOI 10.1016/J.IJID.2020.01.050]
   Zhou P., 2020, BIORXIV, DOI [10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952, 10.1101/2020.01.22.914952.]
NR 19
TC 4
Z9 4
U1 31
U2 31
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2020
VL 22
IS 2
SI SI
BP 69
EP 71
DI 10.1016/j.micinf.2020.01.004
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KU8UJ
UT WOS:000519987000001
PM 32032682
OA Other Gold
DA 2020-04-03
ER

PT J
AU Xu, XW
   Wu, XX
   Jiang, XG
   Xu, KJ
   Ying, LJ
   Ma, CL
   Li, SB
   Wang, HY
   Zhang, S
   Gao, HN
   Sheng, JF
   Cai, HL
   Qiu, YQ
   Li, LJ
AF Xu, Xiao-Wei
   Wu, Xiao-Xin
   Jiang, Xian-Gao
   Xu, Kai-Jin
   Ying, Ling-Jun
   Ma, Chun-Lian
   Li, Shi-Bo
   Wang, Hua-Ying
   Zhang, Sheng
   Gao, Hai-Nv
   Sheng, Ji-Fang
   Cai, Hong-Liu
   Qiu, Yun-Qing
   Li, Lan-Juan
TI Clinical findings in a group of patients infected with the 2019 novel
   coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case
   series
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
AB OBJECTIVE
   To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019).
   DESIGN
   Retrospective case series.
   SETTING
   Seven hospitals in Zhejiang province, China.
   PARTICIPANTS
   62 patients admitted to hospital with laboratory confirmed SARS-Cov-2 infection. Data were collected from 10 January 2020 to 26 January 2020.
   MAIN OUTCOME MEASURES
   Clinical data, collected using a standardised case report form, such as temperature, history of exposure, incubation period. If information was not clear, the working group in Hangzhou contacted the doctor responsible for treating the patient for clarification.
   RESULTS
   Of the 62 patients studied (median age 41 years), only one was admitted to an intensive care unit, and no patients died during the study. According to research, none of the infected patients in Zhejiang province were ever exposed to the Huanan seafood market, the original source of the virus; all studied cases were infected by human to human transmission. The most common symptoms at onset of illness were fever in 48 (77%) patients, cough in 50 (81%), expectoration in 35 (56%), headache in 21 (34%), myalgia or fatigue in 32 (52%), diarrhoea in 3 (8%), and haemoptysis in 2 (3%). Only two patients (3%) developed shortness of breath on admission. The median time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days.
   CONCLUSION
   As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.
C1 [Xu, Xiao-Wei; Wu, Xiao-Xin; Xu, Kai-Jin; Sheng, Ji-Fang; Cai, Hong-Liu; Qiu, Yun-Qing; Li, Lan-Juan] Zhejiang Univ, Affiliated Hosp 1, Coll Med,State Key Lab Diag & Treatment Infect Di, Natl Clin Res Ctr Infect Dis,Collaborat Innovat C, Hangzhou 310003, Zhejiang, Peoples R China.
   [Jiang, Xian-Gao] Wenzhou Cent Hosp, Dept Infect Dis, Wenzhou, Zhejiang, Peoples R China.
   [Ying, Ling-Jun] Enze Hosp, Taizhou Enze Med Ctr Grp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China.
   [Ma, Chun-Lian] First Peoples Hosp Wenling, Dept Infect Dis, Wenling, Zhejiang, Peoples R China.
   [Li, Shi-Bo] Wenzhou Med Univ, Affiliated Zhoushan Hosp, Dept Infect Dis, Zhoushan, Zhejiang, Peoples R China.
   [Wang, Hua-Ying] Ningbo Univ, Affiliated Yinzhou Hosp, Yinzhou Peoples Hosp, Coll Med,Dept Resp & Crit Care Med, Ningbo, Zhejiang, Peoples R China.
   [Zhang, Sheng] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China.
   [Gao, Hai-Nv] Zhejiang Shuren Univ, ShuLan Hangzhou Hosp, Shulan Int Med Coll, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China.
RP Li, LJ (reprint author), Zhejiang Univ, Affiliated Hosp 1, Coll Med,State Key Lab Diag & Treatment Infect Di, Natl Clin Res Ctr Infect Dis,Collaborat Innovat C, Hangzhou 310003, Zhejiang, Peoples R China.
EM ljli@zju.edu.cn
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   WHO, MIDDL E RESP SYNDR C
   WHO, 2020, CLIN MAN SEV AC RESP
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 15
TC 4
Z9 4
U1 66
U2 66
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 19
PY 2020
VL 368
AR m606
DI 10.1136/bmj.m606
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA KO0KS
UT WOS:000515235300008
PM 32075786
OA Other Gold
DA 2020-04-03
ER

PT J
AU Benvenuto, D
   Giovanetti, M
   Ciccozzi, A
   Spoto, S
   Angeletti, S
   Ciccozzi, M
AF Benvenuto, Domenico
   Giovanetti, Marta
   Ciccozzi, Alessandra
   Spoto, Silvia
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The 2019-new coronavirus epidemic: Evidence for virus evolution
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE coronavirus; epidemiology; macromolecular design; SARS coronavirus
AB There is a worldwide concern about the new coronavirus 2019-nCoV as a global public health threat. In this article, we provide a preliminary evolutionary and molecular epidemiological analysis of this new virus. A phylogenetic tree has been built using the 15 available whole genome sequences of 2019-nCoV, 12 whole genome sequences of 2019-nCoV, and 12 highly similar whole genome sequences available in gene bank (five from the severe acute respiratory syndrome, two from Middle East respiratory syndrome, and five from bat SARS-like coronavirus). Fast unconstrained Bayesian approximation analysis shows that the nucleocapsid and the spike glycoprotein have some sites under positive pressure, whereas homology modeling revealed some molecular and structural differences between the viruses. The phylogenetic tree showed that 2019-nCoV significantly clustered with bat SARS-like coronavirus sequence isolated in 2015, whereas structural analysis revealed mutation in Spike Glycoprotein and nucleocapsid protein. From these results, the new 2019-nCoV is distinct from SARS virus, probably trasmitted from bats after mutation conferring ability to infect humans.
C1 [Benvenuto, Domenico; Ciccozzi, Alessandra] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Giovanetti, Marta; Ciccozzi, Massimo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Spoto, Silvia] Univ Campus Biomed Rome, Internal Med Unit, Rome, Italy.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
RP Angeletti, S (reprint author), Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
EM s.angeletti@unicampus.it
RI ciccozzi, massimo/C-6484-2016
OI ciccozzi, massimo/0000-0003-3866-9239; Benvenuto,
   Domenico/0000-0003-3833-2927
CR Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Chakraborty S, 2017, GENE, V604, P48, DOI 10.1016/j.gene.2016.11.023
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Schrodinger L. L. C., 2015, PYMOL MOL GRAPH SYST
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007
NR 19
TC 4
Z9 4
U1 117
U2 117
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2020
VL 92
IS 4
SI SI
BP 455
EP 459
DI 10.1002/jmv.25688
EA FEB 2020
PG 5
WC Virology
SC Virology
GA KM6QU
UT WOS:000511536300001
PM 31994738
OA Bronze
DA 2020-04-03
ER

PT J
AU Killerby, ME
   Biggs, HM
   Midgley, CM
   Gerber, SI
   Watson, JT
AF Killerby, Marie E.
   Biggs, Holly M.
   Midgley, Claire M.
   Gerber, Susan I.
   Watson, John T.
TI Middle East Respiratory Syndrome Coronavirus Transmission
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MERS-COV INFECTION; DROMEDARY CAMELS; SAUDI-ARABIA; RISK-FACTORS;
   OUTBREAK; WORKERS; HUMANS; VIRUS; TRACT
AB Middle East respiratory syndrome coronavirus (MERS-CoV) infection causes a spectrum of respiratory illness, from asymptomatic to mild to fatal. MERS-CoV is transmitted sporadically from dromedary camels to humans and occasionally through human-to-human contact. Current epidemiologic evidence supports a major role in transmission for direct contact with live camels or humans with symptomatic MERS, but little evidence suggests the possibility of transmission from camel products or asymptomatic MERS cases. Because a proportion of case-patients do not report direct contact with camels or with persons who have symptomatic MERS, further research is needed to conclusively determine additional mechanisms of transmission, to inform public health practice, and to refine current precautionary recommendations.
C1 [Killerby, Marie E.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Killerby, Marie E.; Biggs, Holly M.; Midgley, Claire M.; Gerber, Susan I.; Watson, John T.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H24-5, Atlanta, GA 30329 USA.
RP Killerby, ME (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H24-5, Atlanta, GA 30329 USA.
EM lxo9@cdc.gov
CR Adney DR, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080230
   Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280
   Al Hammadi ZM, 2015, EMERG INFECT DIS, V21, P2197, DOI 10.3201/eid2112.151132
   Alagaili A.N., 2014, MBIO, V5, DOI DOI 10.1128/MBIO.00884-14
   Ali MA, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.130
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340
   Alshukairi AN, 2018, MBIO, V9, DOI [10.1128/mBio.01985-18, 10.1128/mbio.01985-18]
   Assiri A, 2016, EMERG INFECT DIS, V22, P32, DOI 10.3201/eid2201.151370
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Azhar EI, 2014, MBIO, V5, DOI 10.1128/mBio.01450-14
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Balkhy HH, 2016, INFECT CONT HOSP EP, V37, P1147, DOI 10.1017/ice.2016.132
   Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115
   Conzade R, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080425
   Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14
   Dighe A, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100350
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/eLife.31257, 10.7554/elife.37324]
   Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, DOI 10.3402/iee.v5.28305
   Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004
   Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283
   Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401
   Hemida MG, 2014, EMERG INFECT DIS, V20, P1231, DOI 10.3201/eid2007.140571
   Hemida MG, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.44
   Kandeil A, 2019, EMERG MICROBES INFEC, V8, P103, DOI 10.1080/22221751.2018.1560235
   Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070
   Khudhair A, 2019, EMERG INFECT DIS, V25, P927, DOI 10.3201/eid2505.181728
   Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Meyer B, 2016, EMERG INFECT DIS, V22, P2171, DOI 10.3201/eid2212.160382
   Miguel E, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.13.30498
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Munyua P, 2017, AM J TROP MED HYG, V96, P1318, DOI 10.4269/ajtmh.16-0880
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Paden CR, 2018, ZOONOSES PUBLIC HLTH, V65, P322, DOI 10.1111/zph.12435
   Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663
   Reusken CB, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.23.20829
   Reusken CBEM, 2016, CURR OPIN VIROL, V16, P55, DOI 10.1016/j.coviro.2016.01.004
   Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608
   Sikkema RS, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800345X, 10.1017/s0950268819000669]
   Sikkema RS, 2017, J INFECT DIS, V215, P1702, DOI 10.1093/infdis/jix174
   van Doremalen N, 2017, VECTOR-BORNE ZOONOT, V17, P155, DOI 10.1089/vbz.2016.2062
   van Doremalen N, 2014, EMERG INFECT DIS, V20, P1263, DOI 10.3201/eid2007.140500
   Wernery U, 2017, VET J, V220, P75, DOI 10.1016/j.tvjl.2016.12.020
   Wernery U, 2015, EMERG INFECT DIS, V21, P1019, DOI 10.3201/eid2106.150038
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Yusof MF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.89
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 50
TC 4
Z9 4
U1 5
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2020
VL 26
IS 2
BP 191
EP 198
DI 10.3201/eid2602.190697
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA KH1WI
UT WOS:000510436500001
PM 31961300
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Morse, JS
   Lalonde, T
   Xu, SQ
   Liu, WR
AF Morse, Jared S.
   Lalonde, Tyler
   Xu, Shiqing
   Liu, Wenshe Ray
TI Learning from the Past: Possible Urgent Prevention and Treatment Options
   for Severe Acute Respiratory Infections Caused by 2019-nCoV
SO CHEMBIOCHEM
LA English
DT Article
DE antiviral agents; coronavirus; 2019-nCoV; SARS; spike proteins; RdRp;
   3CLpro
ID PAPAIN-LIKE PROTEASE; RECEPTOR-BINDING DOMAIN; SARS-CORONAVIRUS;
   AURINTRICARBOXYLIC ACID; SPIKE PROTEIN; COV; VACCINE; POTENT;
   IDENTIFICATION; RIBAVIRIN
AB With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes. Although little is known about the virus, an examination of the genome sequence shows strong homology with its better-studied cousin, SARS-CoV. The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides. Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homology to SARS-CoV. Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV. We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics.
C1 [Morse, Jared S.; Lalonde, Tyler; Xu, Shiqing; Liu, Wenshe Ray] Texas A&M Univ, Dept Chem, Texas A&M Drug Discovery Lab, College Stn, TX 77843 USA.
RP Xu, SQ; Liu, WR (reprint author), Texas A&M Univ, Dept Chem, Texas A&M Drug Discovery Lab, College Stn, TX 77843 USA.
EM shiqing.xu@tamu.edu; wliu@chem.tamu.edu
RI Liu, wenshe/O-4425-2014
OI Liu, wenshe/0000-0002-7078-6534
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01GM121584,
   R01GM127575]; Cancer Prevention & Research Institute of Texas
   [RP170797]; Welch FoundationThe Welch Foundation [A1715]
FX Research support in the Texas A&M Drug Discovery Center is provided by
   the National Institutes of Health (grants R01GM121584 and R01GM127575),
   the Cancer Prevention & Research Institute of Texas (grant RP170797),
   and the Welch Foundation (grant A1715). We thank Sunshine Zea Leeuwon
   for providing assistance in designing all the figures.
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V20, P42, DOI 10.1016/j.ijid.2013.12.003
   [Anonymous], 2019, ANGEW CHEM, V131, P16051
   Baez-Santos YM, 2015, ANTIVIR RES, V115, P21, DOI 10.1016/j.antiviral.2014.12.015
   Baranov PV, 2005, VIROLOGY, V332, P498, DOI 10.1016/j.virol.2004.11.038
   Cavanagh D, 2003, AVIAN PATHOL, V32, P567, DOI 10.1080/03079450310001621198
   Chen Xin, 2009, Antivir Chem Chemother, V19, P151
   Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011
   Chiou HE, 2005, CHEST, V128, P263, DOI 10.1378/chest.128.1.263
   CUSHMAN M, 1991, J MED CHEM, V34, P329, DOI 10.1021/jm00105a052
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115
   GONZALEZ RG, 1979, BIOCHIM BIOPHYS ACTA, V562, P534, DOI 10.1016/0005-2787(79)90116-3
   Han DP, 2006, VIROLOGY, V350, P15, DOI 10.1016/j.virol.2006.01.029
   He RT, 2004, BIOCHEM BIOPH RES CO, V320, P1199, DOI 10.1016/j.bbrc.2004.06.076
   He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106
   Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014
   Holmes KV, 2003, J CLIN INVEST, V111, P1605, DOI [10.1172/JCI200318819, 10.1172/JCI18819]
   Hu HB, 2005, J COMB CHEM, V7, P648, DOI 10.1021/cc0500607
   Jiang SB, 2005, EMERG INFECT DIS, V11, P1016, DOI 10.3201/1107.050219
   Kim Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005531
   Kim Y, 2015, J VIROL, V89, P4942, DOI 10.1128/JVI.03688-14
   Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3
   Kumar V, 2017, ANTIVIR RES, V141, P101, DOI 10.1016/j.antiviral.2017.02.007
   Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004
   Li CC, 2019, DRUG DISCOV TODAY, V24, P726, DOI 10.1016/j.drudis.2019.01.018
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Liu W, 2014, BIOORGAN MED CHEM, V22, P292, DOI 10.1016/j.bmc.2013.11.028
   MCLAFFERTY MA, 1993, GENE, V128, P29, DOI 10.1016/0378-1119(93)90149-W
   Muller MP, 2007, PHARMACOTHERAPY, V27, P494, DOI 10.1592/phco.27.4.494
   Navas-Martin S, 2004, J NEUROVIROL, V10, P75, DOI 10.1080/13550280490280292
   ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411
   Palei S, 2019, CHEMBIOCHEM, V20, P72, DOI 10.1002/cbic.201800552
   Park JY, 2016, J ENZYM INHIB MED CH, V31, P23, DOI 10.3109/14756366.2014.1003215
   Park JY, 2012, BIOL PHARM BULL, V35, P2036, DOI 10.1248/bpb.b12-00623
   Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113
   Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI 10.1586/ERV.09.43
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565
   Song YH, 2014, BIOL PHARM BULL, V37, P1021, DOI 10.1248/bpb.b14-00026
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Taylor DR, 2006, VACCINE, V24, P863, DOI 10.1016/j.vaccine.2005.08.102
   Wang XSS, 2019, ANGEW CHEM INT EDIT, V58, P15904, DOI 10.1002/anie.201908713
   Xiao WW, 2010, MOL CANCER THER, V9, P2714, DOI 10.1158/1535-7163.MCT-10-0308
   Xu X, 2003, NUCLEIC ACIDS RES, V31, P7117, DOI 10.1093/nar/gkg916
   Yap YL, 2005, COMPUT BIOL CHEM, V29, P212, DOI 10.1016/j.compbiolchem.2005.04.006
   Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011
   Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853
NR 48
TC 3
Z9 3
U1 44
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD MAR 2
PY 2020
VL 21
IS 5
BP 730
EP 738
DI 10.1002/cbic.202000047
EA FEB 2020
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA KR0RR
UT WOS:000515400100001
PM 32022370
OA Bronze
DA 2020-04-03
ER

PT J
AU Letko, M
   Marzi, A
   Munster, V
AF Letko, Michael
   Marzi, Andrea
   Munster, Vincent
TI Functional assessment of cell entry and receptor usage for SARS-CoV-2
   and other lineage B betacoronaviruses
SO NATURE MICROBIOLOGY
LA English
DT Article; Early Access
ID CORONAVIRUS SPIKE PROTEIN; SARS-LIKE CORONAVIRUS; TO-HUMAN TRANSMISSION;
   MERS-COV; ACTIVATION; VIRUS; CLEAVAGE; RECOMBINATION; RESERVOIRS;
   EVOLUTION
AB This study describes the development of an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recently emerged SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. Using it, they confirm human ACE2 as the receptor for SARs-CoV-2 and show that host protease processing during viral entry is a significant barrier for viral entry.
   Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
C1 [Letko, Michael; Marzi, Andrea; Munster, Vincent] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.
RP Letko, M; Munster, V (reprint author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.
EM michael.letko@wsu.edu; vincent.munster@nih.gov
RI ; Munster, Vincent/I-7607-2018
OI Marzi, Andrea/0000-0003-0186-9587; Munster, Vincent/0000-0002-2288-3196;
   Letko, Michael/0000-0002-7640-2861
FU Intramural Research program of the National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
FX We thank A. Schountz for generously sharing primary Artibeus cells, as
   well as M. Muller for providing the Rhinolophus cells used in this
   study. We also acknowledge F. Wu, S. Zhao, B. Yu, Y.-M. Chen, W. Wang,
   Y. Hu, Z.-G. Song, Z.-W. Tao, J.-H. Tian, Y.-Y. Pei, M. L. Yuan, Y.-L.
   Zhang, F.-H. Dai, Y. Liu, Q.-M. Wang, J.-J. Zheng, L. Xu, E. C. Holmes
   and Y.-Z. Zhang, as well as the Wuhan Institute of Virology, Chinese
   Academy of Medical Sciences and Peking Union Medical College, Chinese
   Center for Disease Control and Prevention, and Wuhan Jinyintan Hospital
   for rapidly providing the genome sequence for SARS-CoV-2 and other
   essential outbreak information to the scientific community. This work
   was supported by the Intramural Research program of the National
   Institute of Allergy and Infectious Diseases.
CR Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280
   Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]
   Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105
   Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106
   Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082
   Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09
   Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Letko M, 2018, CELL REP, V24, P1730, DOI 10.1016/j.celrep.2018.07.045
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   LIAO CL, 1992, J VIROL, V66, P6117, DOI 10.1128/JVI.66.10.6117-6124.1992
   Marzi A, 2011, J INFECT DIS, V204, pS1066, DOI 10.1093/infdis/jir348
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10
   Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021
   Muth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33487-8
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Seifert Stephanie N, 2019, J Infect Dis, DOI 10.1093/infdis/jiz429
   Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10
   Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028
   Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293
   Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041
   Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 37
TC 3
Z9 3
U1 30
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
DI 10.1038/s41564-020-0688-y
EA FEB 2020
PG 17
WC Microbiology
SC Microbiology
GA KO4AW
UT WOS:000515490500001
PM 32094589
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, ZW
   Chen, XR
   Lu, YF
   Chen, FF
   Zhang, W
AF Wang, Zhenwei
   Chen, Xiaorong
   Lu, Yunfei
   Chen, Feifei
   Zhang, Wei
TI Clinical characteristics and therapeutic procedure for four cases with
   2019 novel coronavirus pneumonia receiving combined Chinese and Western
   medicine treatment
SO BIOSCIENCE TRENDS
LA English
DT Article
DE 2019-nCoV; lopinavir; ritonavir; atbidol; Shufeng Jiedu Capsule
AB Pneumonia associated with the 2019 novel coronavirus (2019-nCoV) is continuously and rapidly circulating at present. No effective antiviral treatment has been verified thus far. We report here the clinical characteristics and therapeutic procedure for four patients with mild or severe 2019-nCoV pneumonia admitted to Shanghai Public Health Clinical Center. All the patients were given antiviral treatment including lopinavir/ritonavir (Kaletra (R)), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine) and other necessary support care. After treatment, three patients gained significant improvement in pneumonia associated symptoms, two of whom were confirmed 2019-nCoV negative and discharged, and one of whom was virus negative at the first test. The remaining patient with severe pneumonia had shown signs of improvement by the cutoff date for data collection. Results obtained in the current study may provide clues for treatment of 2019-nCoV pneumonia. The efficacy of antiviral treatment including lopinavir/ritonavir, arbidol, and SFJDC warrants further verification in future study.
C1 [Wang, Zhenwei] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Resp Dis, Shanghai, Peoples R China.
   [Chen, Xiaorong; Lu, Yunfei] Shanghai Publ Hlth Clin Ctr, Dept Tradit Chinese Med, Shanghai, Peoples R China.
   [Chen, Feifei; Zhang, Wei] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Resp Dis, Shanghai, Peoples R China.
RP Zhang, W (reprint author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Resp Dis, Shanghai, Peoples R China.
EM zhangw1190@sina.com
FU Shanghai Municipal Key Clinical Specialty [shslczdzk05101]; Shanghai Key
   Clinical Laboratory of Internal Medicine of Traditional Chinese Medicine
   [14DZ2273200]
FX The study is supported by Shanghai Municipal Key Clinical Specialty
   (shslczdzk05101) and Shanghai Key Clinical Laboratory of Internal
   Medicine of Traditional Chinese Medicine (14DZ2273200).
CR [Anonymous], NOT 2019 NCOV INF
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Su B, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01472
   Wang YT, 2017, BIOMED PHARMACOTHER, V91, P393, DOI 10.1016/j.biopha.2017.04.091
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 8
TC 3
Z9 3
U1 38
U2 38
PU IRCA-BSSA
PI TOKYO
PA PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003,
   JAPAN
SN 1881-7815
EI 1881-7823
J9 BIOSCI TRENDS
JI BioSci. Trends
PD FEB
PY 2020
VL 14
IS 1
BP 64
EP 68
DI 10.5582/bst.2020.01030
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU2OR
UT WOS:000519548300010
PM 32037389
OA Bronze
DA 2020-04-03
ER

PT J
AU Menachery, VD
   Dinnon, KH
   Yount, BL
   McAnarney, ET
   Gralinski, LE
   Hale, A
   Graham, RL
   Scobey, T
   Anthony, SJ
   Wang, LS
   Graham, B
   Randell, SH
   Lipkin, WI
   Baric, RS
AF Menachery, Vineet D.
   Dinnon, Kenneth H., III
   Yount, Boyd L., Jr.
   McAnarney, Eileen T.
   Gralinski, Lisa E.
   Hale, Andrew
   Graham, Rachel L.
   Scobey, Trevor
   Anthony, Simon J.
   Wang, Lingshu
   Graham, Barney
   Randell, Scott H.
   Lipkin, W. Ian
   Baric, Ralph S.
TI Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE MERS-CoV; PDF2180; coronavirus; emergence; spike; zoonotic
ID RESPIRATORY SYNDROME CORONAVIRUS; PORCINE EPIDEMIC DIARRHEA; SARS-LIKE
   CORONAVIRUS; TO-HUMAN TRANSMISSION; REVERSE GENETICS; MERS; VIRUS;
   PATHOGENESIS; PROTEIN; REPLICATION
AB Traditionally, the emergence of coronaviruses (CoVs) has been attributed to a gain in receptor binding in a new host. Our previous work with severe acute respiratory syndrome (SARS)-like viruses argued that bats already harbor CoVs with the ability to infect humans without adaptation. These results suggested that additional barriers limit the emergence of zoonotic CoV. In this work, we describe overcoming host restriction of two Middle East respiratory syndrome (MERS)-like bat CoVs using exogenous protease treatment. We found that the spike protein of PDF2180-CoV, a MERS-like virus found in a Ugandan bat, could mediate infection of Vero and human cells in the presence of exogenous trypsin. We subsequently show that the bat virus spike can mediate the infection of human gut cells but is unable to infect human lung cells. Using receptor-blocking antibodies, we show that infection with the PDF2180 spike does not require MERS-CoV receptor DPP4 and antibodies developed against the MERS spike receptor-binding domain and S2 portion are ineffective in neutralizing the PDF2180 chimera. Finally, we found that the addition of exogenous trypsin also rescues HKU5-CoV, a second bat group 2c CoV. Together, these results indicate that proteolytic cleavage of the spike, not receptor binding, is the primary infection barrier for these two group 2c CoVs. Coupled with receptor binding, proteolytic activation offers a new parameter to evaluate the emergence potential of bat CoVs and offers a means to recover previously unrecoverable zoonotic CoV strains.
   IMPORTANCE Overall, our studies demonstrate that proteolytic cleavage is the primary barrier to infection for a subset of zoonotic coronaviruses. Moving forward, the results argue that both receptor binding and proteolytic cleavage of the spike are critical factors that must be considered for evaluating the emergence potential and risk posed by zoonotic coronaviruses. In addition, the findings also offer a novel means to recover previously uncultivable zoonotic coronavirus strains and argue that other tissues, including the digestive tract, could be a site for future coronavirus emergence events in humans.
C1 [Menachery, Vineet D.; McAnarney, Eileen T.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Menachery, Vineet D.; Dinnon, Kenneth H., III; Yount, Boyd L., Jr.; McAnarney, Eileen T.; Gralinski, Lisa E.; Graham, Rachel L.; Scobey, Trevor; Baric, Ralph S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Dinnon, Kenneth H., III; Hale, Andrew; Baric, Ralph S.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Anthony, Simon J.; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA.
   [Anthony, Simon J.; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Wang, Lingshu; Graham, Barney] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Randell, Scott H.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.
   [Randell, Scott H.] Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, Chapel Hill, NC 27515 USA.
RP Baric, RS (reprint author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Baric, RS (reprint author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM Rbaric@email.unc.edu
OI Menachery, Vineet/0000-0001-8803-7606
FU United States Agency for International Development (USAID) Emerging
   Pandemic Threats PREDICT projectUnited States Agency for International
   Development (USAID) [GHN-A-OO-09-00010-00]; National Institute of
   Allergy and Infectious Disease of the NIH [U19AI109761, AI110700,
   R00AG049092]; National Institute of Aging of the NIH [U19AI109761,
   AI110700, R00AG049092]; National Institute of Diabetes and Digestive and
   Kidney DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [NIH DK065988]
FX The research described in this work was supported by grants from the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats PREDICT project (cooperative agreement number
   GHN-A-OO-09-00010-00) and from the National Institute of Allergy and
   Infectious Disease and the National Institute of Aging of the NIH under
   awards U19AI109761 and AI110700 to R.S.B. and R00AG049092 to V.D.M. HAE
   cultures were supported by the National Institute of Diabetes and
   Digestive and Kidney Disease under award NIH DK065988 to S.H.R.
CR Agnihothram S, 2018, J VIROL, V92, DOI [10.1128/JVI.00027-18, 10.1128/jvi.00027-18]
   Agnihothram S, 2014, MBIO, V5, DOI 10.1128/mBio.00047-14
   Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609
   Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13
   Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]
   Banach BS, 2009, J VIROL METHODS, V156, P19, DOI 10.1016/j.jviromet.2008.10.022
   Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105
   Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z
   Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11
   Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093
   CLARK SM, 1981, J VIROL, V39, P816, DOI 10.1128/JVI.39.3.816-822.1981
   Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112
   Cunningham AA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0162
   de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Earnest JT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006546
   GALLAGHER TM, 1992, VIROLOGY, V191, P517, DOI 10.1016/0042-6822(92)90223-C
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09
   HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12
   Johnson BA, 2018, VIROLOGY, V517, P30, DOI 10.1016/j.virol.2017.12.009
   Kleine-Weber H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34859-w
   KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6
   Li K, 2017, P NATL ACAD SCI USA, V114, pE3119, DOI 10.1073/pnas.1619109114
   Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114
   Luczo JM, 2015, REV MED VIROL, V25, P406, DOI 10.1002/rmv.1846
   Luo CM, 2018, J VIROL, V92, DOI 10.1128/JVI.00116-18
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Menachery VD, 2019, BIORXIV, DOI [10.1101/768663., DOI 10.1101/768663.]
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09
   ROIVAINEN M, 1987, J VIROL, V61, P3749, DOI 10.1128/JVI.61.12.3749-3753.1987
   Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110
   Sheahan T, 2008, J VIROL, V82, P8721, DOI 10.1128/JVI.00818-08
   Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07
   Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013
   Sims AC, 2013, J VIROL, V87, P3885, DOI 10.1128/JVI.02520-12
   Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1
   Tekes G, 2016, ADV VIRUS RES, V96, P193, DOI 10.1016/bs.aivir.2016.08.002
   Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14
   Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng LP, 2016, J VIROL, V90, P6573, DOI 10.1128/JVI.03079-15
   Zhang XS, 2007, VIROLOGY, V358, P424, DOI 10.1016/j.virol.2006.08.051
   Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18
   Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
NR 59
TC 2
Z9 2
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01774-19
DI 10.1128/JVI.01774-19
PG 15
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000022
PM 31801868
OA Bronze
DA 2020-04-03
ER

PT J
AU Yu, F
   Du, LY
   Ojcius, DM
   Pan, CG
   Jiang, SB
AF Yu, Fei
   Du, Lanying
   Ojcius, David M.
   Pan, Chungen
   Jiang, Shibo
TI Measures for diagnosing and treating infections by a novel coronavirus
   responsible for a pneumonia outbreak originating in Wuhan, China
SO MICROBES AND INFECTION
LA English
DT Article
DE 2019-nCoV; Diagnosis; Preventive; Therapeutic
ID EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; HUMAN
   MONOCLONAL-ANTIBODIES; SPIKE PROTEIN; SARS-COV; MERS-COV; NEUTRALIZING
   ANTIBODY; POSTEXPOSURE EFFICACY; CROSS-NEUTRALIZATION; FUNCTIONAL
   RECEPTOR
AB On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries. Therefore, combating this new virus and stopping the epidemic is a matter of urgency. Here, we focus on advances in research and development of fast diagnosis methods, as well as potential prophylactics and therapeutics to prevent or treat 2019-nCoV infection. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Yu, Fei] Hebei Agr Univ, Coll Life & Sci, Baoding, Peoples R China.
   [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley Kimball Res Inst, New York, NY 10021 USA.
   [Ojcius, David M.] Univ Pacific, Sch Dent, Dept Biomed Sci, San Francisco, CA 94115 USA.
   [Pan, Chungen] Guangdong Haid Grp Co Ltd, Haid Res Inst, Guangdong Haid Inst Anim Husb & Vet, Guangzhou, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
RP Pan, CG (reprint author), Guangdong Haid Grp Co Ltd, Haid Res Inst, 5 Eighth St,Fu Ping Rd, Guangzhou 511400, Peoples R China.; Jiang, SB (reprint author), Fudan Univ, Sch Basic Med Sci, 131 Dong An Rd,Fuzing Bldg, Shanghai 200032, Peoples R China.
EM chungenp@163.com; shibojiang@fudan.edu.cn
CR Abd El Wahed A, 2013, PLOS CURR, V5
   Aburizaiza AS, 2014, J INFECT DIS, V209, P243, DOI 10.1093/infdis/jit589
   Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688
   Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005
   Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010
   Buchholz UJ, 2004, P NATL ACAD SCI USA, V101, P9804, DOI 10.1073/pnas.0403492101
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan KH, 2013, J INFECTION, V67, P130, DOI 10.1016/j.jinf.2013.03.015
   Chen JFW, 2020, EMERG MICROB INFECT, V9
   Chen WH, 2014, HUM VACC IMMUNOTHER, V10, P648, DOI 10.4161/hv.27464
   Chen Z, 2017, J INFECT DIS, V215, P1807, DOI 10.1093/infdis/jix209
   Chi H, 2017, VACCINE, V35, P2069, DOI 10.1016/j.vaccine.2017.02.063
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112
   Coughlin MM, 2012, REV MED VIROL, V22, P2, DOI 10.1002/rmv.706
   Du LY, 2015, EXPERT OPIN BIOL TH, V15, P1647, DOI 10.1517/14712598.2015.1092518
   Du LY, 2013, J INFECTION, V67, P348, DOI 10.1016/j.jinf.2013.05.002
   Dyall J, 2017, DRUGS, V77, P1935, DOI 10.1007/s40265-017-0830-1
   Fett C, 2013, J VIROL, V87, P6551, DOI 10.1128/JVI.00087-13
   Go YY, 2017, J MOL DIAGN, V19, P817, DOI 10.1016/j.jmoldx.2017.06.007
   Gross AE, 2015, ANN PHARMACOTHER, V49, P1125, DOI 10.1177/1060028015597449
   Hashemzadeh MS, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.23874
   He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085
   He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908
   He YX, 2005, VIROLOGY, V334, P74, DOI 10.1016/j.virol.2005.01.034
   He YX, 2004, BIOCHEM BIOPH RES CO, V325, P445, DOI 10.1016/j.bbrc.2004.10.052
   He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106
   Huang P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01101
   Islam MS, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090841
   Jiang S, 2020, EMERG MICROB INFECT, V9
   JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0
   Koo B, 2018, BIOSENS BIOELECTRON, V119, P79, DOI 10.1016/j.bios.2018.08.007
   Lee SH, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02166
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7
   Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006
   Liu YV, 2011, VACCINE, V29, P6606, DOI 10.1016/j.vaccine.2011.06.111
   Lokugamage KG, 2008, VACCINE, V26, P797, DOI 10.1016/j.vaccine.2007.11.092
   Long BR, 2019, MOL THER-METH CLIN D, V13, P440, DOI 10.1016/j.omtm.2019.03.006
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Lu H, 2020, J MED VIROL, V92
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13
   Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026
   Mehand MS, 2018, ANTIVIR RES, V159, P63, DOI 10.1016/j.antiviral.2018.09.009
   Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X
   Munster VJ, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0029-1
   Noh JY, 2017, ARCH VIROL, V162, P1617, DOI 10.1007/s00705-017-3281-9
   OLSEN CW, 1993, VET MICROBIOL, V36, P1, DOI 10.1016/0378-1135(93)90126-R
   OLSEN CW, 1993, J GEN VIROL, V74, P745, DOI 10.1099/0022-1317-74-4-745
   Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Qiu HJ, 2016, ANTIVIR RES, V132, P141, DOI 10.1016/j.antiviral.2016.06.003
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reusken C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.14.20441
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shirato K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-139
   Sui JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000197
   Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111
   Teengam P, 2017, ANAL CHEM, V89, P5428, DOI 10.1021/acs.analchem.7b00255
   Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080
   Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15
   Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18
   Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044874
   Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580
   Xiu LS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01510
   Xu JY, 2019, EMERG MICROBES INFEC, V8, P841, DOI 10.1080/22221751.2019.1624482
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zeng LP, 2017, SCI CHINA LIFE SCI, V60, P1399, DOI 10.1007/s11427-017-9189-3
   Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134
   Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266
NR 72
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2020
VL 22
IS 2
SI SI
BP 74
EP 79
DI 10.1016/j.micinf.2020.01.003
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KU8UJ
UT WOS:000519987000003
PM 32017984
OA Bronze
DA 2020-04-03
ER

PT J
AU Qin, CX
   Liu, F
   Yen, TC
   Lan, XL
AF Qin, Chunxia
   Liu, Fang
   Yen, Tzu-Chen
   Lan, Xiaoli
TI F-18-FDG PET/CT findings of COVID-19: a series of four highly suspected
   cases
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
LA English
DT Article; Early Access
DE COVID-19; SARS-CoV-2; Infection; Acute respiratory disease; F-18-FDG
   PET; CT; Ground-glass opacities; Consolidative opacities
AB Purpose The aim of this case series is to illustrate the F-18-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China. Methods We describe the F-18-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients' medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19. Results All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high F-18-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism. Conclusions Although F-18-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.
C1 [Qin, Chunxia; Liu, Fang; Lan, Xiaoli] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.
   [Qin, Chunxia; Liu, Fang; Lan, Xiaoli] Hubei Prov Key Lab Mol Imaging, Wuhan 430022, Peoples R China.
   [Yen, Tzu-Chen] Linkou Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan.
   [Yen, Tzu-Chen] Linkou Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan.
   [Yen, Tzu-Chen] Chang Gung Univ, Taoyuan, Taiwan.
RP Lan, XL (reprint author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.; Lan, XL (reprint author), Hubei Prov Key Lab Mol Imaging, Wuhan 430022, Peoples R China.; Yen, TC (reprint author), Linkou Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan.; Yen, TC (reprint author), Linkou Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan.; Yen, TC (reprint author), Chang Gung Univ, Taoyuan, Taiwan.
EM yentc1110@gmail.com; xiaoli_lan@hust.edu.cn
OI Lan, Xiaoli/0000-0002-7263-7399
CR [Anonymous], 2020, NATURE NEWS
   Center for Disease Central and Prevention, 2020, 2019 NOV COR WUH CHI
   Chefer S, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0143-x
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jacobson FL, 2018, J SURG ONCOL, V117, P457, DOI 10.1002/jso.24975
   Jonsson CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040094
   Prabhu M, 2020, CLIN NUCL MED, V45, pE15, DOI 10.1097/RLU.0000000000002758
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 10
TC 2
Z9 2
U1 13
U2 13
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1619-7070
EI 1619-7089
J9 EUR J NUCL MED MOL I
JI Eur. J. Nucl. Med. Mol. Imaging
DI 10.1007/s00259-020-04734-w
EA FEB 2020
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KR2AC
UT WOS:000517419500001
PM 32088847
OA Bronze, Green Accepted
DA 2020-04-03
ER

PT J
AU Li, XG
   Zai, JJ
   Wang, XM
   Li, Y
AF Li, Xingguang
   Zai, Junjie
   Wang, Xiaomei
   Li, Yi
TI Potential of large "first generation" human-to-human transmission of
   2019-nCoV
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE 2019-nCoV; Bangkok; outbreak; TMRCA; Wuhan
ID RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; PERFORMANCE;
   ALGORITHMS; INFECTION; EVOLUTION; CAMELS; GENOME; BATS
AB To investigate the genetic diversity, time origin, and evolutionary history of the 2019-nCoV outbreak in China and Thailand, a total of 12 genome sequences of the virus with known sampling date (24 December 2019 and 13 January 2020) and geographic location (primarily Wuhan city, Hubei Province, China, but also Bangkok, Thailand) were analyzed. Phylogenetic and likelihood-mapping analyses of these genome sequences were performed. On the basis of our results, the star-like signal and topology of 2019-nCoV may be indicative of potentially large "first generation" human-to-human virus transmission. We estimated that 2019-nCoV likely originated in Wuhan on 9 November 2019 (95% credible interval: 25 September 2019 and 19 December 2019), and that Wuhan is the major hub for the spread of the 2019-nCoV outbreak in China and elsewhere. Our results could be useful for designing effective prevention strategies for 2019-nCoV in China and beyond.
C1 [Li, Xingguang; Wang, Xiaomei; Li, Yi] Wuhan Univ Bioengn, Hubei Engn Res Ctr Viral Vector, Wuhan 430415, Peoples R China.
   [Zai, Junjie] Ningbo Univ, Sch Med, Immunol Innovat Team, Ningbo, Peoples R China.
RP Li, XG; Li, Y (reprint author), Wuhan Univ Bioengn, Hubei Engn Res Ctr Viral Vector, Wuhan 430415, Peoples R China.
EM xingguanglee@hotmail.com; liyi@whsw.edu.cn
RI Ribeiro, Nuno/AAH-2299-2020
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470268]; K. C. Wong Magna Fund in Ningbo
   University
FX National Natural Science Foundation of China, Grant/Award Number:
   31470268; K. C. Wong Magna Fund in Ningbo University
CR Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082
   CHINESE SME, 2004, SCIENCE, V303, P1666, DOI DOI 10.1126/SCIENCE.1092002
   Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299
   Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2018, ELIFE, V7, DOI 10.7554/eLife.37324
   Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Schmidt Heiko A, 2007, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0606s17
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao ZM, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-21
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 29
TC 2
Z9 2
U1 28
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2020
VL 92
IS 4
SI SI
BP 448
EP 454
DI 10.1002/jmv.25693
EA FEB 2020
PG 7
WC Virology
SC Virology
GA KM6QU
UT WOS:000513291800001
PM 31997390
OA Bronze
DA 2020-04-03
ER

PT J
AU Quilty, BJ
   Clifford, S
   Flasche, S
   Eggo, RM
   Liu, Y
   Diamond, C
   Edmunds, WJ
   Funk, S
   Gimma, A
   Munday, JD
   Gibbs, H
   Bosse, NI
   Abbott, S
   Russell, TW
   Klepac, P
   Jit, M
   Hellewell, J
AF Quilty, Billy J.
   Clifford, Sam
   Flasche, Stefan
   Eggo, Rosalind M.
   Liu, Yang
   Diamond, Charlie
   Edmunds, W. John
   Funk, Sebastian
   Gimma, Amy
   Munday, James D.
   Gibbs, Hamish
   Bosse, Nikos, I
   Abbott, Sam
   Russell, Timothy W.
   Klepac, Petra
   Jit, Mark
   Hellewell, Joel
CA CMMID NCoV Working Grp
TI Effectiveness of airport screening at detecting travellers infected with
   novel coronavirus (2019-nCoV)
SO EUROSURVEILLANCE
LA English
DT Article
ID SARS
AB We evaluated effectiveness of thermal passenger screening for 2019-nCoV infection at airport exit and entry to inform public health decision-making. In our baseline scenario, we estimated that 46% (95% confidence interval: 36 to 58) of infected travellers would not be detected, depending on incubation period, sensitivity of exit and entry screening, and proportion of asymptomatic cases. Airport screening is unlikely to detect a sufficient proportion of 2019-nCoV infected travellers to avoid entry of infected travellers.
C1 [Quilty, Billy J.; Clifford, Sam; Flasche, Stefan; Eggo, Rosalind M.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, London, England.
RP Quilty, BJ (reprint author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, London, England.
EM Billy.Quilty@lshtm.ac.uk
RI Ribeiro, Nuno/AAH-2299-2020
OI Quilty, Billy/0000-0002-9094-3728
FU Sir Henry Dale Fellowship - Wellcome Trust [208812/Z/17/Z]; Sir Henry
   Dale Fellowship - Royal Society [208812/Z/17/Z]; HDR UK Innovation
   Fellowship [MR/S003975/1]; National Institute for Health Research (NIHR)
   using UK aid from the UK Government [16/137/109]
FX SF and SC are supported by a Sir Henry Dale Fellowship jointly funded by
   the Wellcome Trust and the Royal Society (Grant number 208812/Z/17/Z).;
   RME acknowledges an HDR UK Innovation Fellowship (Grant number
   MR/S003975/1).; BJQ was funded by the National Institute for Health
   Research (NIHR) (16/137/109) using UK aid from the UK Government to
   support global health research. The views expressed in this publication
   are those of the author(s) and not necessarily those of the NHS, the
   NIHR or the UK Department of Health and Social Care.
CR [Anonymous], REUTERS
   Chan JF, 2020, LANCET
   Department of Health, COR LAT INF ADV
   DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265
   European Centre for Disease Prevention and Control (ECDC), 2020, ADV TRAV OUTBR NOV C
   GitHub, TRAV SCREEN GITHUB R
   Gostic KM, 2015, ELIFE, V4, DOI 10.7554/eLife.05564
   Imperial College London, NEWS WUHAN CORONAVIR
   Kucharski AJ, 2020, EARLY DYNAMICS TRANS, DOI [10.1101/2020.01.31.20019901, DOI 10.1101/2020.01.31.20019901]
   Li Q, 2020, NEW ENGL J MED
   Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202
   Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A
   Priest PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014490
   Samaan G, 2004, MED J AUSTRALIA, V180, P220, DOI 10.5694/j.1326-5377.2004.tb05889.x
   San Francisco International Airport, PASS ARR WUH CHIN AR
   World Health Organization, 2020, NOV COR 2019 NCOV SI
NR 16
TC 2
Z9 2
U1 5
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 6
PY 2020
VL 25
IS 5
BP 4
EP 9
AR 2000080
DI 10.2807/1560-7917.ES.2020.25.5.2000080
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KM9CH
UT WOS:000514438600002
PM 32046816
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Pullano, G
   Pinotti, F
   Valdano, E
   Boelle, PY
   Poletto, C
   Colizza, V
AF Pullano, Giulia
   Pinotti, Francesco
   Valdano, Eugenio
   Boelle, Pierre-Yves
   Poletto, Chiara
   Colizza, Vittoria
TI Novel coronavirus (2019-nCoV) early-stage importation risk to Europe,
   January 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB As at 27 January 2020, 42 novel coronavirus (2019-nCoV) cases were confirmed outside China. We estimate the risk of case importation to Europe from affected areas in China via air travel. We consider travel restrictions in place, three reported cases in France, one in Germany. Estimated risk in Europe remains high. The United Kingdom, Germany and France are at highest risk. Importation from Beijing and Shanghai would lead to higher and widespread risk for Europe.
C1 [Pullano, Giulia; Pinotti, Francesco; Boelle, Pierre-Yves; Poletto, Chiara; Colizza, Vittoria] Sorbonne Univ, IPLESP, INSERM, Paris, France.
   [Valdano, Eugenio] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Biomed Modeling, Los Angeles, CA 90095 USA.
RP Colizza, V (reprint author), Sorbonne Univ, IPLESP, INSERM, Paris, France.
EM vittoria.colizza@inserm.fr
RI Ribeiro, Nuno/AAH-2299-2020
FU ANR project DATAREDUXFrench National Research Agency (ANR)
   [ANR-19-CE46-0008-03]; H2020 MOOD project
FX This study was partially supported by the ANR project DATAREDUX
   (ANR-19-CE46-0008-03) to VC; the H2020 MOOD project to VC, CP, PYB.
CR [Anonymous], 2020, CHANNEL NEWS ASIA
   Australian Government Department of Health, 2020, UPD NOV COR JAN 28 2
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Chinazzi M, PRELIMINARY ASSESSME
   ECDC, 2020, ECDC STAT FOLL REP C
   European Centre for Disease Prevention and Control (ECDC), 2020, OUTBR AC RESP SYNDR
   Johns Hopkins University Center for Systems Science and Engineering, 2020, WUH COR 2019 NCOV GL
   Korea Centers for Disease Control & Prevention, 2020, 4 IMP CAS 2019 NOV C
   Lai S, PRELIMINARY RISK ANA
   Mobs Lab, SIT REP MAINL CHIN D
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   World Health Organization, 2020, NOV COR CHIN
NR 12
TC 2
Z9 2
U1 35
U2 35
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 30
PY 2020
VL 25
IS 4
BP 2
EP 6
DI 10.2807/1560-7917.ES.2020.25.4.2000057
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KH4IF
UT WOS:000510607800001
PM 32019667
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Arabi, YM
   Asiri, AY
   Assiri, AM
   Jokhdar, HAA
   Alothman, A
   Balkhy, HH
   AlJohani, S
   Al Harbi, S
   Kojan, S
   Al Jeraisy, M
   Deeb, AM
   Memish, ZA
   Ghazal, S
   Al Faraj, S
   Al-Hameed, F
   AlSaedi, A
   Mandourah, Y
   Al Mekhlafi, GA
   Sherbeeni, NM
   Elzein, FE
   Almotairi, A
   Al Bshabshe, A
   Kharaba, A
   Jose, J
   Al Harthy, A
   Al Sulaiman, M
   Mady, A
   Fowler, RA
   Hayden, FG
   Al-Dawood, A
   Abdelzaher, M
   Bajhmom, W
   Hussein, MA
AF Arabi, Yaseen M.
   Asiri, Ayed Y.
   Assiri, Abdullah M.
   Aziz Jokhdar, Hani A.
   Alothman, Adel
   Balkhy, Hanan H.
   AlJohani, Sameera
   Al Harbi, Shmeylan
   Kojan, Suleiman
   Al Jeraisy, Majed
   Deeb, Ahmad M.
   Memish, Ziad A.
   Ghazal, Sameeh
   Al Faraj, Sarah
   Al-Hameed, Fahad
   AlSaedi, Asim
   Mandourah, Yasser
   Al Mekhlafi, Ghaleb A.
   Sherbeeni, Nisreen Murad
   Elzein, Fatehi Elnour
   Almotairi, Abdullah
   Al Bshabshe, Ali
   Kharaba, Ayman
   Jose, Jesna
   Al Harthy, Abdulrahman
   Al Sulaiman, Mohammed
   Mady, Ahmed
   Fowler, Robert A.
   Hayden, Frederick G.
   Al-Dawood, Abdulaziz
   Abdelzaher, Mohamed
   Bajhmom, Wail
   Hussein, Mohamed A.
CA Saudi Critical Care Trials Grp
TI Treatment of Middle East respiratory syndrome with a combination of
   lopinavir/ritonavir and interferon-beta 1b (MIRACLE trial): statistical
   analysis plan for a recursive two-stage group sequential randomized
   controlled trial
SO TRIALS
LA English
DT Article
DE Coronavirus; MERS; Antiviral; Clinical trial; Lopinavir; ritonavir;
   Interferon-beta 1b; Statistical analysis plan; Protocol
ID INTERIM ANALYSES
AB The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-beta 1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-beta 1b provided with standard supportive care, compared to placebo provided with standard supportive care, in hospitalized patients with laboratory-confirmed MERS. The MIRACLE trial is designed as a recursive, two-stage, group sequential, multicenter, placebo-controlled, double-blind randomized controlled trial. The aim of this article is to describe the statistical analysis plan for the MIRACLE trial. The primary outcome is 90-day mortality. The primary analysis will follow the intention-to-treat principle. The MIRACLE trial is the first randomized controlled trial for MERS treatment.
C1 [Arabi, Yaseen M.; Alothman, Adel; Balkhy, Hanan H.; AlJohani, Sameera; Kojan, Suleiman; Al-Dawood, Abdulaziz] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   [Arabi, Yaseen M.; Al-Dawood, Abdulaziz] Minist Natl Guard Hlth Affairs, Intens Care Dept, ICU 1425,POB 22490, Riyadh 11426, Saudi Arabia.
   [Asiri, Ayed Y.; Ghazal, Sameeh; Al Faraj, Sarah] Prince Mohammed bin Abdulaziz Hosp, Riyadh, Saudi Arabia.
   [Assiri, Abdullah M.] Minist Hlth, Infect Prevent & Control, Prevent Hlth, Riyadh, Saudi Arabia.
   [Aziz Jokhdar, Hani A.] Minist Hlth, Publ Hlth, Riyadh, Saudi Arabia.
   [Alothman, Adel; Kojan, Suleiman] Minist Natl Guard Hlth Affairs, Dept Med, Riyadh, Saudi Arabia.
   [Balkhy, Hanan H.] Minist Natl Guard Hlth Affairs, Dept Infect Prevent & Control, Riyadh, Saudi Arabia.
   [AlJohani, Sameera] Minist Natl Guard Hlth Affairs, Dept Pathol & Lab Med, Riyadh, Saudi Arabia.
   [Al Harbi, Shmeylan; Al Jeraisy, Majed] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Pharm, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   [Al Harbi, Shmeylan; Al Jeraisy, Majed] Minist Natl Guard Hlth Affairs, Pharmaceut Care Dept, Riyadh, Saudi Arabia.
   [Deeb, Ahmad M.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Res Off, Riyadh, Saudi Arabia.
   [Deeb, Ahmad M.; Hussein, Mohamed A.] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Prince Mohammed bin Abdulaziz Hosp, Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Al-Hameed, Fahad; AlSaedi, Asim] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia.
   [Al-Hameed, Fahad] Minist Natl Guard Hlth Affairs, Intens Care Dept, Jeddah, Saudi Arabia.
   [AlSaedi, Asim] Minist Natl Guard Hlth Affairs, Dept Infect Prevent & Control, Jeddah, Saudi Arabia.
   [Mandourah, Yasser] Prince Sultan Mil Med City, Minist Def, Mil Med Serv, Riyadh, Saudi Arabia.
   [Al Mekhlafi, Ghaleb A.] Prince Sultan Mil Med City, Dept Intens Care Serv, Riyadh, Saudi Arabia.
   [Sherbeeni, Nisreen Murad; Elzein, Fatehi Elnour] Prince Sultan Mil Med City, Infect Dis Div, Riyadh, Saudi Arabia.
   [Almotairi, Abdullah] King Fahad Med City, Dept Crit Care Med, Riyadh, Saudi Arabia.
   [Al Bshabshe, Ali] King Khalid Univ, Aseer Cent Hosp, Dept Crit Care Med, Abha, Saudi Arabia.
   [Kharaba, Ayman] King Fahad Hosp, Ohoud Hosp, Dept Crit Care, Al Madinah Al Monawarah, Saudi Arabia.
   [Jose, Jesna; Hussein, Mohamed A.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Biostat & Bioinformat, Riyadh, Saudi Arabia.
   [Al Harthy, Abdulrahman] King Saud Med City, Intens Care Unit, Riyadh, Saudi Arabia.
   [Al Sulaiman, Mohammed] King Saud Med City, Infect Dis, Riyadh, Saudi Arabia.
   [Mady, Ahmed] King Saud Med City, Intens Care Dept, Riyadh, Saudi Arabia.
   [Mady, Ahmed] Tanta Univ Hosp, Dept Anesthesiol & Intens Care, Tanta, Egypt.
   [Fowler, Robert A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Fowler, Robert A.] Sunnybrook Med Ctr, Dept Crit Care Med, Bayview Ave,Room D478, Toronto, ON, Canada.
   [Fowler, Robert A.] Sunnybrook Med Ctr, Dept Med, 2075 Bayview Ave,Room D478, Toronto, ON, Canada.
   [Hayden, Frederick G.] Univ Virginia, Sch Med, Int Severe Acute Resp & Emerging Infect Consortiu, Div Infect Dis & Int Hlth,Dept Med, Charlottesville, VA 22908 USA.
   [Abdelzaher, Mohamed] King Abdullah Med Complex, Crit Care Med Dept, Jeddah, Saudi Arabia.
   [Abdelzaher, Mohamed] Cairo Univ Hosp, Crit Care Med Dept, Cairo, Egypt.
   [Bajhmom, Wail] Minist Hlth, King Fahad Gen Hosp, Internal Med Dept, Jeddah, Saudi Arabia.
RP Arabi, YM (reprint author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Arabi, YM (reprint author), Minist Natl Guard Hlth Affairs, Intens Care Dept, ICU 1425,POB 22490, Riyadh 11426, Saudi Arabia.
EM arabi@ngha.med.sa
OI Arabi, Yaseen/0000-0001-5735-6241
FU King Abdullah International Medical Research Center, Riyadh, Kingdom of
   Saudi Arabia
FX The MIRACLE trial is funded by King Abdullah International Medical
   Research Center, Riyadh, Kingdom of Saudi Arabia. The study sponsor does
   not have any role in the study design, collection, management, analysis
   or interpretation of the data, or in writing the report.
CR Arabi Yaseen M, 2019, Clin Infect Dis, DOI 10.1093/cid/ciz544
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Chang M, 2014, CH CRC BIOSTAT SER, P1
   Gamble C, 2017, JAMA-J AM MED ASSOC, V318, P2337, DOI 10.1001/jama.2017.18556
   Liu Q, 2004, SEQUENTIAL ANAL, V23, P317
   Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.jclinepi.2010.03.004]
   Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908
   Schafer H, 2001, STAT MED, V20, P3741, DOI 10.1002/sim.1136
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Srivastava DK, 2007, BIOMETRICAL J, V49, P351, DOI 10.1002/bimj.200610265
   US Food and Drug Administration (FDA), 2012, DRAFT GUID IND ENR S
   Wassmer G, 2001, DRUG INF J, V35, P1131, DOI 10.1177/009286150103500410
NR 14
TC 2
Z9 2
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD JAN 3
PY 2020
VL 21
IS 1
AR 8
DI 10.1186/s13063-019-3846-x
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KL6OE
UT WOS:000513539700001
PM 31900204
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Jo, S
   Kim, S
   Shin, DH
   Kim, MS
AF Jo, Seri
   Kim, Suwon
   Shin, Dong Hae
   Kim, Mi-Sun
TI Inhibition of SARS-CoV 3CL protease by flavonoids
SO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
LA English
DT Article
DE SARS-CoV; SARS-CoV 3CLpro; flavonoid; FRET; inhibitory compounds
ID RESPIRATORY-SYNDROME; 3C-LIKE PROTEASE; CORONAVIRUS; DERIVATIVES;
   INSIGHTS; DRUGS
AB There were severe panics caused by Severe Acute Respiratory Syndrome (SARS) and Middle-East Respiratory Syndrome-Coronavirus. Therefore, researches targeting these viruses have been required. Coronaviruses (CoVs) have been rising targets of some flavonoids. The antiviral activity of some flavonoids against CoVs is presumed directly caused by inhibiting 3C-like protease (3CLpro). Here, we applied a flavonoid library to systematically probe inhibitory compounds against SARS-CoV 3CLpro. Herbacetin, rhoifolin and pectolinarin were found to efficiently block the enzymatic activity of SARS-CoV 3CLpro. The interaction of the three flavonoids was confirmed using a tryptophan-based fluorescence method, too. An induced-fit docking analysis indicated that S1, S2 and S3 ' sites are involved in binding with flavonoids. The comparison with previous studies showed that Triton X-100 played a critical role in objecting false positive or overestimated inhibitory activity of flavonoids. With the systematic analysis, the three flavonoids are suggested to be templates to design functionally improved inhibitors.
C1 Ewha W Univ, Coll Pharm, Seoul, South Korea.
   Ewha W Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.
RP Shin, DH; Kim, MS (reprint author), Ewha W Univ, Dept Pharm, Seoul 03760, South Korea.
EM dhshin55@ewha.ac.kr; shfwk31@ewha.ac.kr
FU National Research Foundation of Korea - Ministry of Education, Science
   and Technology, Republic of Korea (MEST) [2018R1D1A1B07050781, 2018R1
   D1A1B07050942]; Brain Korea 21 (BK21) ProjectMinistry of Education &
   Human Resources Development (MOEHRD), Republic of Korea
FX This work was supported by the Basic Science Research Programmes,
   2018R1D1A1B07050781 to DHS and 2018R1 D1A1B07050942 to MK, funded by the
   National Research Foundation of Korea grant granted by the Ministry of
   Education, Science and Technology, Republic of Korea (MEST). S. Jo was
   supported by Brain Korea 21 (BK21) Project.
CR Burak M, 1999, TURK KLIN TIP BILIM, V19, P296
   Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001
   Chuck CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027228
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613
   Juca MM, 2020, NAT PROD RES, V34, P692, DOI 10.1080/14786419.2018.1493588
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13
   Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098
   Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9
   Lau JTF, 2005, EMERG INFECT DIS, V11, P417
   Lee YK, 2009, BRAIN RES, V1250, P164, DOI 10.1016/j.brainres.2008.10.012
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lin H, 2009, SPECTROCHIM ACTA A, V73, P936, DOI 10.1016/j.saa.2009.04.025
   Liu YC, 2005, BIOCHEM BIOPH RES CO, V333, P194, DOI 10.1016/j.bbrc.2005.05.095
   Mesel-Lemoine M, 2012, J VIROL, V86, P7577, DOI 10.1128/JVI.00269-12
   Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521
   Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774
   Ren ZL, 2013, PROTEIN CELL, V4, P248, DOI 10.1007/s13238-013-2841-3
   Ryu YB, 2010, BIOORGAN MED CHEM, V18, P7940, DOI 10.1016/j.bmc.2010.09.035
   Schwarz S, 2014, PLANTA MED, V80, P177, DOI 10.1055/s-0033-1360277
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Thi THN, 2012, BIOTECHNOL LETT, V34, P831, DOI 10.1007/s10529-011-0845-8
   Wu AD, 2015, VIRUS RES, V208, P56, DOI 10.1016/j.virusres.2015.05.018
   Yang LY, 2017, NAT PROD RES, V31, P487, DOI 10.1080/14786419.2016.1190719
   Zakaryan H, 2017, ARCH VIROL, V162, P2539, DOI 10.1007/s00705-017-3417-y
NR 30
TC 2
Z9 2
U1 40
U2 40
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1475-6366
EI 1475-6374
J9 J ENZYM INHIB MED CH
JI J. Enzym. Inhib. Med. Chem.
PD JAN 1
PY 2020
VL 35
IS 1
BP 145
EP 151
DI 10.1080/14756366.2019.1690480
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA JM6VB
UT WOS:000496348600001
PM 31724441
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zaher, NH
   Mostafa, MI
   Altaher, AY
AF Zaher, Nashwa Hafez
   Mostafa, Mohammed Ismail
   Altaher, Abdullah Yousef
TI Design, synthesis and molecular docking of novel triazole derivatives as
   potential CoV helicase inhibitors
SO ACTA PHARMACEUTICA
LA English
DT Article
DE triazole derivatives; anti-MERS-CoV activity; MERS-CoV helicase; docking
ID ACUTE RESPIRATORY SYNDROME; REPLICATION INHIBITOR; CORONAVIRUS; SARS;
   HEPATITIS
AB Middle East respiratory syndrome coronavirus (MERS-CoV) had emerged and spread because of the worldwide travel and inefficient healthcare provided for the infected patients in several countries. Herein we investigated the anti-MERS-CoV activity of newly synthesized sixteen halogenated triazole compounds through the inhibition of helicase activity using the FRET assay. All new compounds underwent justification for their target structures via microanalytical and spectral data. SAR studies were performed. Biological results revealed that the most potent compounds were 4-(cyclopent-1-en-3-ylamino)-5-(2-(4-iodophenyl)hydrazinyl)-4H-1,2,4-triazole-3-thiol (16) and 4-(cyclopent-1-en-3-ylamino)-5-[2-(4-chlorophenyl)hydrazinyl]-4H-1,2,4-triazole-3-thiol (12). In silico molecular docking of the most potent compounds was performed to the active binding site of MERS-CoV helicase nsp13. Molecular docking results are in agreement with experimental findings.
C1 [Zaher, Nashwa Hafez] EAEA, NCRRT, Radiat Drug Res Dept, Cairo, Egypt.
   [Mostafa, Mohammed Ismail] Cairo Univ, Coll Vet Med, Dept Pharmacol, Gizah, Egypt.
   [Altaher, Abdullah Yousef] King Faisal Univ, Coll Vet Med, Dept Physiol Biochem & Pharmacol, Al Hasa, Saudi Arabia.
RP Zaher, NH (reprint author), EAEA, NCRRT, Radiat Drug Res Dept, Cairo, Egypt.
EM nashwazah@hotmail.com
FU deanship of Scientific Research at King Faisal University [160002]
FX Authors would like to express their gratitude to Egyptian Atomic Energy
   Authority (EAEA), National Center for Radiation Research and Technology
   (NCRRT), Drug Radiation Research Department, drug chemistry lab, for the
   accommodation of the chemical synthetic part of this work. Authors would
   like also to extend their sincere appreciation to the deanship of
   Scientific Research at King Faisal University for its funding of this
   research through the research Project no. 160002.
CR Abdel-Hamid MK, 2007, BIOORGAN MED CHEM, V15, P6975, DOI 10.1016/j.bmc.2007.07.044
   Adedeji AO, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00235-16
   Adedeji AO, 2014, CURR OPIN VIROL, V8, P45, DOI 10.1016/j.coviro.2014.06.002
   Adedeji AO, 2014, ANTIMICROB AGENTS CH, V58, P4894, DOI 10.1128/AAC.02994-14
   Adedeji AO, 2012, ANTIMICROB AGENTS CH, V56, P4718, DOI 10.1128/AAC.00957-12
   Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072
   Dheer D, 2017, BIOORG CHEM, V71, P30, DOI 10.1016/j.bioorg.2017.01.010
   Fadda AA, 2008, TURK J CHEM, V32, P259
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   He YW, 2014, EUR J MED CHEM, V76, P245, DOI 10.1016/j.ejmech.2014.02.029
   Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Penttinen PM, 2013, EUROSURVEILLANCE, V18, P11, DOI 10.2807/1560-7917.ES2013.18.39.20596
   Porter DJT, 1998, J BIOL CHEM, V273, P7390, DOI 10.1074/jbc.273.13.7390
   Qian L, 2018, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON ROBOTICS, CONTROL AND AUTOMATION ENGINEERING (RAE 2018) AND INTERNATIONAL CONFERENCE ON ADVANCED MECHANICAL AND ELECTRICAL ENGINEERING (AMEE 2018), P132, DOI 10.1145/3303714.3303721
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200
   Tanner JA, 2005, CHEM BIOL, V12, P303, DOI 10.1016/j.chembiol.2005.01.006
   World Health Organization, 2018, MERS COV GLOB SUMM A
   Wu ZY, 2014, CHEMMEDCHEM, V9, P1546, DOI 10.1002/cmdc.201400075
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao JY, 2012, BIOORG MED CHEM LETT, V22, P2321, DOI 10.1016/j.bmcl.2012.01.056
NR 25
TC 1
Z9 1
U1 250
U2 250
PU HRVATSKO FARMACEUTSKO DRUSTOV (HFD)-CROATION PHARMACEUTICAL SOC
PI ZAGREB
PA MASARYKOVA 2, 10000 ZAGREB, CROATIA
SN 1330-0075
EI 1846-9558
J9 ACTA PHARMACEUT
JI Acta Pharm.
PD JUN
PY 2020
VL 70
IS 2
BP 145
EP 159
DI 10.2478/acph-2020-0024
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KD6PH
UT WOS:000507986300002
PM 31955138
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Leng, ZK
   Zhu, RJ
   Hou, W
   Feng, YM
   Yang, YL
   Han, Q
   Shan, GL
   Meng, FY
   Du, DS
   Wang, SH
   Fan, JF
   Wang, WJ
   Deng, LC
   Shi, HB
   Li, HJ
   Hu, ZJ
   Zhang, FC
   Gao, JM
   Liu, HJ
   Li, XX
   Zhao, YY
   Yin, K
   He, XJ
   Gao, ZC
   Wang, YB
   Yang, B
   Jin, RH
   Stambler, I
   Lim, LW
   Su, HX
   Moskalev, A
   Cano, A
   Chakrabarti, S
   Min, KJ
   Ellison-Hughes, G
   Caruso, C
   Jin, KL
   Zhao, RC
AF Leng, Zikuan
   Zhu, Rongjia
   Hou, Wei
   Feng, Yingmei
   Yang, Yanlei
   Han, Qin
   Shan, Guangliang
   Meng, Fanyan
   Du, Dongshu
   Wang, Shihua
   Fan, Junfen
   Wang, Wenjing
   Deng, Luchan
   Shi, Hongbo
   Li, Hongjun
   Hu, Zhongjie
   Zhang, Fengchun
   Gao, Jinming
   Liu, Hongjian
   Li, Xiaoxia
   Zhao, Yangyang
   Yin, Kan
   He, Xijing
   Gao, Zhengchao
   Wang, Yibin
   Yang, Bo
   Jin, Ronghua
   Stambler, Ilia
   Lim, Lee Wei
   Su, Huanxing
   Moskalev, Alexey
   Cano, Antonio
   Chakrabarti, Sasanka
   Min, Kyung-Jin
   Ellison-Hughes, Georgina
   Caruso, Calogero
   Jin, Kunlin
   Zhao, Robert Chunhua
TI Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome
   of Patients with COVID-19 Pneumonia
SO AGING AND DISEASE
LA English
DT Article
DE COVID-19; ACE2 negative; mesenchymal stem cells; cell transplantation;
   immunomodulation; function recovery
ID REGULATORY DENDRITIC CELLS; STROMAL CELLS; SARS CORONAVIRUS; INDUCE;
   GENERATION; PROTEIN
AB A coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak in Wuhan, China. Preventing and reversing the cytokine storm may be the key to save the patients with severe COVID-19 pneumonia. Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function. This study aims to investigate whether MSC transplantation improves the outcome of 7 enrolled patients with COVID-19 pneumonia in Beijing YouAn Hospital, China, from Jan 23, 2020 to Feb 16, 2020. The clinical outcomes, as well as changes of inflammatory and immune function levels and adverse effects of 7 enrolled patients were assessed for 14 days after MSC injection. MSCs could cure or significantly improve the functional outcomes of seven patients without observed adverse effects. The pulmonary function and symptoms of these seven patients were significantly improved in 2 days after MSC transplantation. Among them, two common and one severe patient were recovered and discharged in 10 days after treatment. After treatment, the peripheral lymphocytes were increased, the C-reactive protein decreased, and the overactivated cytokine-secreting immune cells CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells disappeared in 3-6 days. In addition, a group of CD14+CD11c+CD11b(mid) regulatory DC cell population dramatically increased. Meanwhile, the level of TNF-alpha was significantly decreased, while IL-10 increased in MSC treatment group compared to the placebo control group. Furthermore, the gene expression profile showed MSCs were ACE2 - and TMPRSS2 - which indicated MSCs are free from COVID-19 infection. Thus, the intravenous transplantation of MSCs was safe and effective for treatment in patients with COVID-19 pneumonia, especially for the patients in critically severe condition.
C1 [Leng, Zikuan; Meng, Fanyan; Du, Dongshu; Zhao, Robert Chunhua] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.
   [Zhu, Rongjia; Han, Qin; Shan, Guangliang; Wang, Shihua; Fan, Junfen; Deng, Luchan; Zhao, Yangyang; Zhao, Robert Chunhua] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Sch Basic Med, Beijing, Peoples R China.
   [Hou, Wei; Feng, Yingmei; Wang, Wenjing; Shi, Hongbo; Li, Hongjun; Hu, Zhongjie; Jin, Ronghua] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.
   [Yang, Yanlei; Zhang, Fengchun; Gao, Jinming] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.
   [Leng, Zikuan; Liu, Hongjian] Zhengzhou Univ, Dept Orthopaed, Affiliated Hosp 1, Zhengzhou, Peoples R China.
   [Li, Xiaoxia; Yin, Kan] Qingdao Univ, Sch Basic Med, Inst Stem Cell & Regenerat Med, Qingdao, Shandong, Peoples R China.
   [He, Xijing; Gao, Zhengchao; Wang, Yibin] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Xian, Peoples R China.
   [Yang, Bo] Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou, Peoples R China.
   [Stambler, Ilia; Lim, Lee Wei; Su, Huanxing; Moskalev, Alexey; Cano, Antonio; Min, Kyung-Jin; Ellison-Hughes, Georgina; Caruso, Calogero; Jin, Kunlin; Zhao, Robert Chunhua] UNESCO, Execut Comm Antiaging & Dis Prevent Framework Sci, Paris, France.
   [Stambler, Ilia; Lim, Lee Wei; Su, Huanxing; Moskalev, Alexey; Cano, Antonio; Min, Kyung-Jin; Ellison-Hughes, Georgina; Caruso, Calogero; Jin, Kunlin; Zhao, Robert Chunhua] Int Soc Aging & Dis, Ft Worth, TX USA.
   [Stambler, Ilia] Tel Aviv Univ, Geriatr Med Ctr Shmuel Harofe, Sackler Sch Med, Tel Aviv, Israel.
   [Lim, Lee Wei] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China.
   [Su, Huanxing] Univ Macau, Inst Chinese Med Sci, Taipa, Macao, Peoples R China.
   [Moskalev, Alexey] Russian Acad Sci, Inst Biol, Komi Sci Ctr, Syktyvkar, Russia.
   [Cano, Antonio] Univ Valencia, Dept Pediat Obstet & Gynecol, Valencia, Spain.
   [Chakrabarti, Sasanka] Maharishi Markandeshwar Deemed Univ, Mullana Ambala, India.
   [Min, Kyung-Jin] Inha Univ, Dept Biol Sci, Incheon, South Korea.
   [Ellison-Hughes, Georgina] Kings Coll London, Fac Life Sci & Med, London, England.
   [Caruso, Calogero] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, Palermo, Italy.
   [Jin, Kunlin] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA.
RP Zhao, RC (reprint author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Jin, RH (reprint author), Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.; Jin, KL (reprint author), Univ North Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA.; Liu, HJ (reprint author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China.
EM hongjianmd@126.com; jin_eagle@sina.com; kunlin.Jin@unthsc.edu;
   zhaochunhua@vip.163.com
FU National Key Research and Development Program of China [2016YFA0101000,
   2018YFE0114200]; CAMS Innovation Fund for Medical Sciences
   [2017-I2M-3-007]; 111 ProjectMinistry of Education, China - 111 Project
   [B18007]; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81971324, 81672313, 81700782, 81972523,
   81771349]
FX This work was supported by the National Key Research and Development
   Program of China (2016YFA0101000, 2018YFE0114200), CAMS Innovation Fund
   for Medical Sciences (2017-I2M-3-007) and the 111 Project (B18007),
   National Natural Science Foundation of China (81971324, 81672313,
   81700782, 81972523, 81771349).
CR Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238
   Chen L, 2007, STEM CELLS DEV, V16, P719, DOI 10.1089/scd.2007.0065
   Chen N, 2020, LANCET LONDON ENGLAN
   Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2
   Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hashmi S, 2016, LANCET HAEMATOL, V3, pE45, DOI 10.1016/S2352-3026(15)00224-0
   Hoffmann M, 2020, 929042 BIORXIV
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18
   Kamen D.L., 2018, ARCH DIS CHILD, V5, pA46
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26
   Liu XX, 2015, J IMMUNOL, V194, P4298, DOI 10.4049/jimmunol.1402641
   Liu XX, 2012, J IMMUNOL, V189, P1182, DOI 10.4049/jimmunol.1102996
   Lu R, 2020, LANCET LONDON ENGLAN
   Munster VJ, 2020, NEW ENGLAND J MED
   Sproston NR, 2018, FRONT IMMUNOL, V9
   Wang D, 2020, JAMA
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]
   Xu X, SCI CHINA LIFE SCI
   Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 27
TC 1
Z9 1
U1 0
U2 0
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD APR
PY 2020
VL 11
IS 2
BP 216
EP 228
DI 10.14336/AD.2020.0228
PG 13
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA KU9FE
UT WOS:000520029200001
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Gilbert, M
   Pullano, G
   Pinotti, F
   Valdano, E
   Poletto, C
   Boelle, PY
   D'Ortenzio, E
   Yazdanpanah, Y
   Eholie, SP
   Altmann, M
   Gutierrez, B
   Kraemer, MUG
   Colizza, V
AF Gilbert, Marius
   Pullano, Giulia
   Pinotti, Francesco
   Valdano, Eugenio
   Poletto, Chiara
   Boelle, Pierre-Yves
   D'Ortenzio, Eric
   Yazdanpanah, Yazdan
   Eholie, Serge Paul
   Altmann, Mathias
   Gutierrez, Bernardo
   Kraemer, Moritz U. G.
   Colizza, Vittoria
TI Preparedness and vulnerability of African countries against importations
   of COVID-19: a modelling study
SO LANCET
LA English
DT Article
AB Background The novel coronavirus disease 2019 (COVID-19) epidemic has spread from China to 25 countries. Local cycles of transmission have already occurred in 12 countries after case importation. In Africa, Egypt has so far confirmed one case. The management and control of COVID-19 importations heavily rely on a country's health capacity. Here we evaluate the preparedness and vulnerability of African countries against their risk of importation of COVID-19.
   Methods We used data on the volume of air travel departing from airports in the infected provinces in China and directed to Africa to estimate the risk of importation per country. We determined the country's capacity to detect and respond to cases with two indicators: preparedness, using the WHO International Health Regulations Monitoring and Evaluation Framework; and vulnerability, using the Infectious Disease Vulnerability Index. Countries were clustered according to the Chinese regions contributing most to their risk.
   Findings Countries with the highest importation risk (ie, Egypt, Algeria, and South Africa) have moderate to high capacity to respond to outbreaks. Countries at moderate risk (ie, Nigeria, Ethiopia, Sudan, Angola, Tanzania, Ghana, and Kenya) have variable capacity and high vulnerability. We identified three clusters of countries that share the same exposure to the risk originating from the provinces of Guangdong, Fujian, and the city of Beijing, respectively.
   Interpretation Many countries in Africa are stepping up their preparedness to detect and cope with COVID-19 importations. Resources, intensified surveillance, and capacity building should be urgently prioritised in countries with moderate risk that might be ill-prepared to detect imported cases and to limit onward transmission. Funding EU Framework Programme for Research and Innovation Horizon 2020, Agence Nationale de la Recherche. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Gilbert, Marius] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium.
   [Pullano, Giulia; Pinotti, Francesco; Poletto, Chiara; Boelle, Pierre-Yves; Colizza, Vittoria] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France.
   [Pullano, Giulia] Orange Experience Design Lab Chatillion, Sociol & Econ Networks & Serv Lab, Paris, France.
   [Valdano, Eugenio] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Biomed Modeling, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.
   [D'Ortenzio, Eric; Yazdanpanah, Yazdan] Univ Paris, INSERM, Infect, Antimicrobials,Modelling,Evolut, Paris, France.
   [D'Ortenzio, Eric; Yazdanpanah, Yazdan] Bichat Claude Bernard Hosp, AP HP, Paris, France.
   [Eholie, Serge Paul] Ctr Hosp Univ Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire.
   [Eholie, Serge Paul] Univ Felix Houphouet Boigny, Unite Format & Rech Sci Med, Dept Dermatol Infectiol, Abidjan, Cote Ivoire.
   [Altmann, Mathias] INSERM U1219, IDLIC Malad Infect Pays Ressources Limitees, Bordeaux, France.
   [Altmann, Mathias] Univ Bordeaux, Bordeaux Populat Hlth, Bordeaux, France.
   [Gutierrez, Bernardo; Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Grp, Boston, MA USA.
RP Colizza, V (reprint author), Sorbonne Univ, INSERM, IPLESP, F-75012 Paris, France.
EM vittoria.colizza@inserm.fr
FU ANR project DATAREDUXFrench National Research Agency (ANR)
   [ANR-19-CE46-0008-03]; EU grant MOOD [H2020-874850]; Municipality of
   Paris through the programme Emergence(s); Branco Weiss Fellowship;
   African coaLition for Epidemic Research, Response and Training (ALERRT),
   EDCTP2, EU [RIA2016E-1612]
FX We thank WHO for input on the use of the SPAR and Joint External
   Evaluation data, Laura Di Domenico and Ernesto Ortega for help with data
   collection, Sally Blower for useful input on the study, and REACTing
   (https://reacting.inserm.fr/) for useful discussions. This study was
   partially supported by the ANR project DATAREDUX (ANR-19-CE46-0008-03)
   to VC; the EU grant MOOD (H2020-874850) to MG, CP, MUGK, P-YB, and VC;
   the Municipality of Paris through the programme Emergence(s) to CP and
   FP; the Branco Weiss Fellowship to MUGK; and the African coaLition for
   Epidemic Research, Response and Training (ALERRT), EDCTP2, EU
   (RIA2016E-1612) to SPE and MA.
CR Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Chinazzi M, 2020, EFFECT TRAVEL RESTRI, DOI [10.1101/ 2020.02.09.20021261, DOI 10.1101/2020.02.09.20021261, 10.1101/2020.02.09.20021261]
   City Population, 2020, CHIN PROV MAJ CIT
   Civil Aviation Administration of China, 2019, 2018 CIV AV AIRP PRO
   Lai S, PRELIMINARY RISK ANA
   Le Monde, 2020, CORONAVIRUS AFRIQUE
   M'Bida A, 2020, JEUNE AFRIQUE
   Manning CD, 1999, FDN STAT NATURAL LAN
   Marston BJ, 2017, EMERG INFECT DIS S, V23
   Moore M, 2016, IDENTIFYING FUTURE D
   Nkengasong J, 2020, NAT MED, DOI 10.1038/s41591-020-0771-1
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Poljansek K, 2018, 29603 EUR EN
   Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057
   Sambala EZ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3466-1
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Steenhuysen J, 2020, REUTERS
   WHO, 2020, 22 WHO
   WHO, 2018, JOINT EXT EV TOOL IN
   WHO, EL STAT PART SELF AS
   WHO Emergency Committee, 2020, 2 M INT HLTH REG 200
   WHO. International health regulations, 2018, INT HLTH REG 2005 ST
   WHO Regional Office for Africa, 2020, WHO RAMPS PREP NOV C
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zhou Y., QUARTZ AFRICA
NR 26
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 14
PY 2020
VL 395
IS 10227
BP 871
EP 877
DI 10.1016/S0140-6736(20)30411-6
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU9DZ
UT WOS:000520024900035
PM 32087820
OA Bronze
DA 2020-04-03
ER

PT J
AU Goo, J
   Jeong, Y
   Park, YS
   Yang, E
   Jung, DI
   Rho, S
   Park, U
   Sung, H
   Park, PG
   Choi, JA
   Seo, SH
   Cho, NH
   Lee, H
   Lee, JM
   Kim, JO
   Song, M
AF Goo, Junghyun
   Jeong, Yuji
   Park, Young-Shin
   Yang, Eunji
   Jung, Dae-Im
   Rho, Semi
   Park, Uni
   Sung, Hyeyeong
   Park, Pil-Gu
   Choi, Jung-ah
   Seo, Sang Hwan
   Cho, Nam Hyuck
   Lee, Hyeja
   Lee, Jae Myun
   Kim, Jae-Ouk
   Song, Manki
TI Characterization of novel monoclonal antibodies against MERS-coronavirus
   spike protein
SO VIRUS RESEARCH
LA English
DT Article
DE MERS-CoV; Monoclonal antibody; Neutralizing antibody; Pseudovirus;
   Neutralization; Epitope
ID EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; SOUTH-KOREA; SINGLE
   PATIENT; COV; NEUTRALIZATION; IMMUNOGENICITY; TRANSMISSION; VACCINE
AB Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary infection, with similar to 35 % mortality. Spike glycoprotein (S) of MERS-CoV is a key target for vaccines and therapeutics because S mediates viral entry and membrane-fusion to host cells. Here, four different S subunit proteins, receptor-binding domain (RBD; 358-606 aa), S1 (1-751 aa), S2 (752-1296 aa), and S Delta TM (1-1296 aa), were generated using the baculoviral system and immunized in mice to develop neutralizing antibodies. We developed 77 hybridomas and selected five neutralizing mAbs by immunization with S Delta TM against MERS-CoV EMC/2012 strain S-pseudotyped lentivirus. However, all five monoclonal antibodies (mAb) did not neutralize the pseudotyped V534A mutation. Additionally, one mAb RBD-14F8 did not show neutralizing activity against pseudoviruses with amino acid substitution of L506 F or D509 G (Englandl strain, EMC/2012 L506 F, and EMC/2012 D509 G), and RBD-43E4 mAb could not neutralize the pseudotyped 1529 T mutation, while three other neutralizing mAbs showed broad neutralizing activity. This implies that the mutation in residue 506-509, 529, and 534 of S is critical to generate neutralization escape variants of MERS-CoV. Interestingly, all five neutralizing mAbs have binding affinity to RBD, although most mAbs generated by RBD did not have neutralizing activity. Additionally, chimeric antibodies of RBD-14F8 and RBD-43E4 with human Fc and light chain showed neutralizing effect against wild type MERS-CoV KOR/KNIH/002, similar to the original mouse mAbs. Thus, our mAbs can be utilized for the identification of specific mutations of MERS-CoV.
C1 [Goo, Junghyun; Jeong, Yuji; Park, Young-Shin; Yang, Eunji; Jung, Dae-Im; Rho, Semi; Choi, Jung-ah; Seo, Sang Hwan; Kim, Jae-Ouk; Song, Manki] Int Vaccine Inst, Sci Unit, Seoul, South Korea.
   [Park, Uni; Cho, Nam Hyuck] Dept Microbiol & Immunol, Seoul, South Korea.
   [Park, Uni; Cho, Nam Hyuck] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Cho, Nam Hyuck] Seoul Natl Univ, Inst Endem Dis, Med Res Ctr, Seoul, South Korea.
   [Cho, Nam Hyuck] Bundang Hosp, Seoul, South Korea.
   [Lee, Hyeja] NKMAX Co Ltd, Seongnam, South Korea.
   [Lee, Jae Myun] Yonsei Univ, Inst Immunol & Immunol Dis, Brain Korea PLUS Project Med Sci 21, Dept Microbiol & Immunol, Seoul, South Korea.
RP Kim, JO; Song, M (reprint author), Int Vaccine Inst, Sci Unit, Seoul, South Korea.
EM jokim@ivi.int; mksong@ivi.int
FU Ministry of Health and Welfare, Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea [HI15C2971]
FX This work was supported by a grant from the Ministry of Health and
   Welfare, Republic of Korea (HI15C2971).
CR Chen YZ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.50
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Dang VT, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/716961
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Wit E, 2018, ANTIVIR RES, V156, P64, DOI 10.1016/j.antiviral.2018.06.006
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401
   Kim DW, 2016, EMERG INFECT DIS, V22, P100, DOI 10.3201/eid2201.151055
   Kim JO, 2007, J VIROL, V81, P1444, DOI 10.1128/JVI.01790-06
   Kim JO, 2015, CLIN VACCINE IMMUNOL, V22, P381, DOI 10.1128/CVI.00661-14
   Kim Y, 2016, MBIO, V7, DOI 10.1128/mBio.00019-16
   Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16
   Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359
   Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Park SH, 2016, INFECT CHEMOTHER, V48, P99, DOI 10.3947/ic.2016.48.2.99
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432
   Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   Yang E, 2015, J MICROBIOL BIOTECHN, V25, P280, DOI 10.4014/jmb.1410.10035
   Yang JS, 2015, EMERG INFECT DIS, V21, P2084, DOI 10.3201/eid2111.151016
   Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14
   Yu XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13133
   Zhang SY, 2018, CELL REP, V24, P441, DOI 10.1016/j.celrep.2018.06.041
NR 30
TC 1
Z9 1
U1 48
U2 48
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAR 12
PY 2020
VL 278
AR 197863
DI 10.1016/j.virusres.2020.197863
PG 10
WC Virology
SC Virology
GA KO3DZ
UT WOS:000515429400011
PM 31945421
OA Other Gold
DA 2020-04-03
ER

PT J
AU Dey, SK
   Rahman, MM
   Siddiqi, UR
   Howlader, A
AF Dey, Samrat K.
   Rahman, Md. Mahbubur
   Siddiqi, Umme R.
   Howlader, Arpita
TI Analyzing the epidemiological outbreak of COVID-19: A visual exploratory
   data analysis approach
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE China; coronavirus; COVID-19; data analysis; SARS-CoV-2; visualization
AB There is an obvious concern globally regarding the fact about the emerging coronavirus 2019 novel coronavirus (2019-nCoV) as a worldwide public health threat. As the outbreak of COVID-19 causes by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) progresses within China and beyond, rapidly available epidemiological data are needed to guide strategies for situational awareness and intervention. The recent outbreak of pneumonia in Wuhan, China, caused by the SARS-CoV-2 emphasizes the importance of analyzing the epidemiological data of this novel virus and predicting their risks of infecting people all around the globe. In this study, we present an effort to compile and analyze epidemiological outbreak information on COVID-19 based on the several open datasets on 2019-nCoV provided by the Johns Hopkins University, World Health Organization, Chinese Center for Disease Control and Prevention, National Health Commission, and DXY. An exploratory data analysis with visualizations has been made to understand the number of different cases reported (confirmed, death, and recovered) in different provinces of China and outside of China. Overall, at the outset of an outbreak like this, it is highly important to readily provide information to begin the evaluation necessary to understand the risks and begin containment activities.
C1 [Dey, Samrat K.] DIU, Dept Comp Sci & Engn, Dhaka 1205, Bangladesh.
   [Rahman, Md. Mahbubur] MIST, Dept Comp Sci & Engn, Dhaka, Bangladesh.
   [Siddiqi, Umme R.] Shaheed Suhrawardy Med Coll ShSMC, Dept Physiol, Dhaka, Bangladesh.
   [Howlader, Arpita] PSTU, Dept Comp & Commun Engn, Dumki, Bangladesh.
RP Dey, SK (reprint author), DIU, Dept Comp Sci & Engn, Dhaka 1205, Bangladesh.
EM sopnil.samrat@gmail.com
OI Dey, Samrat Kumar/0000-0002-7999-8576
CR Centers for Disease Control and Prevention, 2019, 2019 NOV COR 2019 NC
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Gorbalenya AE, 2020, ACUTE RESP SYNDROME, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Lauren G, 2020, CORONAVIRUS COVID 19
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   World Health Organization, 2020, NOV COR CHIN
   Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e56
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 11
TC 1
Z9 1
U1 140
U2 140
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25743
EA MAR 2020
PG 7
WC Virology
SC Virology
GA KT5ZV
UT WOS:000519094100001
PM 32124990
OA Bronze
DA 2020-04-03
ER

PT J
AU Cheng, SC
   Chang, YC
   Chiang, YLF
   Chien, YC
   Cheng, MT
   Yang, CH
   Huang, CH
   Hsu, YN
AF Cheng, Shao-Chung
   Chang, Yuan-Chia
   Chiang, Yu-Long Fan
   Chien, Yu-Chan
   Cheng, Mingte
   Yang, Chin-Hua
   Huang, Chia-Husn
   Hsu, Yuan-Nian
TI First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE COVID-19; First case; Pneumonia; Taiwan
ID ACUTE RESPIRATORY SYNDROME
AB An outbreak of respiratory illness proved to be infected by a 2019 novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19), was notified first in Wuhan, China, and has spread rapidly in China and to other parts of the world. Herein, we reported the first confirmed case of novel coronavirus pneumonia (NCP) imported from China in Taiwan. This case report revealed a natural course of NCP with self-recovery, which may be a good example in comparison with medical treatments. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Cheng, Shao-Chung] Taoyuan Gen Hosp, Dept Internal Med, Div Pulm Med, Sinwu Branch,Minist Hlth & Welf, Taoyuan, Taiwan.
   [Chang, Yuan-Chia; Chien, Yu-Chan; Yang, Chin-Hua] Taoyuan Gen Hosp, Dept Radiol, Minist Hlth & Welf, Taoyuan, Taiwan.
   [Chiang, Yu-Long Fan] Taoyuan Gen Hosp, Dept Internal Med, Sinwu Branch, Minist Hlth & Welf, Taoyuan, Taiwan.
   [Cheng, Mingte] Taoyuan Gen Hosp, Dept Orthoped Surg, Sinwu Branch, Minist Hlth & Welf, Taoyuan, Taiwan.
   [Yang, Chin-Hua] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan.
   [Yang, Chin-Hua] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.
   [Huang, Chia-Husn] Taoyuan Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Sinwu Branch,Minist Hlth & Welf, Taoyuan, Taiwan.
   [Hsu, Yuan-Nian] Taoyuan Gen Hosp, Dept Family Med, Minist Hlth & Welf, Taoyuan, Taiwan.
   [Huang, Chia-Husn; Hsu, Yuan-Nian] 1492 Zhongshan Rd, Taoyuan 33004, Taiwan.
RP Huang, CH (reprint author), Taoyuan Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Sinwu Branch,Minist Hlth & Welf, Taoyuan, Taiwan.; Hsu, YN (reprint author), Taoyuan Gen Hosp, Dept Family Med, Minist Hlth & Welf, Taoyuan, Taiwan.; Huang, CH; Hsu, YN (reprint author), 1492 Zhongshan Rd, Taoyuan 33004, Taiwan.
EM 4719@mail.tygh.gov.tw; kingjen@mail.tygh.gov.tw
CR Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Chang YC, 2005, RADIOLOGY, V236, P1067, DOI 10.1148/radiol.2363040958
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI 10.1007/s00330-019-06574-1
   He WJ, 2020, NEURORADIOLOGY, DOI 10.1007/s00234-020-02361-8
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Liu P, 2020, RADIOLOGY, V295, P19, DOI 10.1148/radiol.2020200257
   Pan YY, 2020, EUR RADIOL, DOI 10.1007/s00330-020-06713-z
   Shi HS, 2020, RADIOLOGY, V295, P20, DOI 10.1148/radiol.2020200269
   Song FX, 2020, RADIOLOGY, V295, P210, DOI 10.1148/radiol.2020200274
   Song JY, 2011, INFLUENZA OTHER RESP, V5, pR535, DOI 10.1111/j.1750-2659.2011.00269.x
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   World Health Organization, 2020, 28 WHO
   Zhou F, 2018, RESP MED, V134, P86, DOI 10.1016/j.rmed.2017.11.017
NR 16
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD MAR
PY 2020
VL 119
IS 3
BP 747
EP 751
DI 10.1016/j.jfma.2020.02.007
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU4OD
UT WOS:000519688100012
PM 32113824
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Elkholy, AA
   Grant, R
   Assiri, A
   Elhakim, M
   Malik, MR
   Van Kerkhove, MD
AF Elkholy, Amgad A.
   Grant, Rebecca
   Assiri, Abdullah
   Elhakim, Mohamed
   Malik, Mamunur R.
   Van Kerkhove, Maria D.
TI MERS-CoV infection among healthcare workers and risk factors for death:
   Retrospective analysis of all laboratory-confirmed cases reported to WHO
   from 2012 to 2 June 2018
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE MERS-CoV; Nosocomial infection; Infection prevention and control
ID EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; SAUDI-ARABIA; OUTBREAK;
   CONTAMINATION; RIYADH
AB Background: Approximately half of the reported laboratory-confirmed infections of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in healthcare settings, and healthcare workers constitute over one third of all secondary infections. This study aimed to describe secondary cases of MERS-CoV infection among healthcare workers and to identify risk factors for death.
   Methods: A retrospective analysis was conducted on epidemiological data of laboratory-confirmed MERS-CoV cases reported to the World Health Organization from September 2012 to 2 June 2018. We compared all secondary cases among healthcare workers with secondary cases among non-healthcare workers. Multivariable logistic regression identified risk factors for death.
   Results: Of the 2223 laboratory-confirmed MERS-CoV cases reported to WHO, 415 were healthcare workers and 1783 were non-healthcare workers. Compared with non-healthcare workers cases, healthcare workers cases were younger (P < 0.001), more likely to be female (P < 0.001), non-nationals (P < 0.001) and asymptomatic (P < 0.001), and have fewer comorbidities (P < 0.001) and higher rates of survival (P < 0.001). Year of infection (2013-2018) and having no comorbidities were independent protective factors against death among secondary healthcare workers cases.
   Conclusion: Being able to protect healthcare workers from high threat respiratory pathogens, such as MERS-CoV is important for being able to reduce secondary transmission of MERS-CoV in healthcare-associated outbreaks. By extension, reducing infection in healthcare workers improves continuity of care for all patients within healthcare facilities. (C) 2019 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Elkholy, Amgad A.; Elhakim, Mohamed; Malik, Mamunur R.] WHO Reg Off Eastern Mediterranean, Infect Hazard Management Unit, Dept Hlth Emergencies, Cairo, Egypt.
   [Grant, Rebecca] Inst Pasteur, Ctr Global Hlth, Paris, France.
   [Grant, Rebecca; Van Kerkhove, Maria D.] WHO, Dept Infect Hazard Management, WHO Hlth Emergencies Programme, Ave Appia 20, CH-1202 Geneva, Switzerland.
   [Assiri, Abdullah] Minist Hlth, Riyadh, Saudi Arabia.
RP Van Kerkhove, MD (reprint author), WHO, Dept Infect Hazard Management, WHO Hlth Emergencies Programme, Ave Appia 20, CH-1202 Geneva, Switzerland.
EM vankerkhovem@who.int
OI Assiri, Abdullah/0000-0002-5605-2876; Van Kerkhove,
   Maria/0000-0002-6135-0018
FU World Health OrganizationWorld Health Organization [001]
CR Al Hosani FI, 2016, EMERG INFECT DIS, V22, P1162, DOI 10.3201/eid2207.160040
   Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359
   Al-Gethamy M, 2015, CLIN INFECT DIS
   Alfaraj SH, 2018, AM J INFECT CONTROL, V46, P165, DOI 10.1016/j.ajic.2017.08.010
   Arabi YM, 2017, CRIT CARE MED, V45, P1683, DOI 10.1097/CCM.0000000000002621
   Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Bin SY, 2016, CLIN INFECT DIS, V62, P755, DOI 10.1093/cid/civ1020
   Chan-Yeung M, 2004, INT J OCCUP ENV HEAL, V10, P421, DOI 10.1179/oeh.2004.10.4.421
   Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812
   Fagbo SF, 2015, EMERG INFECT DIS, V21, P1981, DOI 10.3201/eid2111.150944
   Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4
   Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12
   Ki M, 2015, EPIDEMIOL HLTH, V37, DOI DOI 10.4178/epih/e2015033
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Memish ZA, 2014, INT J INFECT DIS, V29, P307, DOI 10.1016/j.ijid.2014.10.002
   Moon SY, 2017, CLIN INFECT DIS, V64, P1457, DOI 10.1093/cid/cix170
   Omrani AS, 2013, INT J INFECT DIS
   Park HY, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.25.21169
   Seddiq N, 2017, CASE REP INFECT DIS, DOI 10.1155/2017/1262838
   van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590
   WHO, 2017, MIDDL E RESP SYNDR C
   WHO, 2008, INT HLTH REG 2005
   WHO MERS-CoV Research Group, 2013, PLOS CURR, V5
   World Health Organization (WHO), 2017, WHO MERS COV GLOB SU
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 26
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAR
PY 2020
VL 13
IS 3
SI SI
BP 418
EP 422
DI 10.1016/j.jiph.2019.04.011
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KU3LD
UT WOS:000519610600008
PM 31056437
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Goodrich, EL
   Mittel, LD
   Glaser, A
   Ness, SL
   Radcliffe, RM
   Divers, TJ
AF Goodrich, E. L.
   Mittel, L. D.
   Glaser, A.
   Ness, S. L.
   Radcliffe, R. M.
   Divers, T. J.
TI Novel findings from a beta coronavirus outbreak on an American Miniature
   Horse breeding farm in upstate New York
SO EQUINE VETERINARY EDUCATION
LA English
DT Article
DE horse; diagnosis; clinical signs; beta coronavirus; American Miniature
   Horse
ID EQUINE CORONAVIRUS; INFECTION
AB This case report describes an outbreak and novel findings associated with a beta coronavirus (BCoV) infection that occurred on an American Miniature Horse (AMH) breeding farm in upstate New York, in January and February of 2013. Twenty-nine AMH and one donkey were present on the farm when the outbreak occurred. One 10-year-old Quarter Horse mare, stabled at a separate location and owned by an employee of the farm, also tested positive. A polymerase chain reaction (PCR) assay for the detection of BCoV was performed at the Animal Health Diagnostic Center (AHDC) at Cornell on all faecal samples. The PCR assay used detects multiple beta coronaviruses, including, but not limited to, equine enteric coronavirus (ECoV). Novel findings regarding this BCoV infection in horses were recognised in this outbreak study. To the authors' knowledge, this is the largest outbreak of BCoV described thus far in a closed herd on a single premise. The case fatality rate was 0% unlike that described in a previous outbreak of ECoV involving miniature horses and a miniature donkey (Fielding et al. 2015). The morbidity rate was lower in this outbreak than in previously described studies (Oue et al. 2013; Pusterla et al. 2013). This outbreak also demonstrated the potential for BCoV transmission via farm personnel. The duration of shedding of virus in the faeces among some asymptomatic horses in this outbreak was longer than previously described clinical cases of ECoV (Pusterla et al. 2013; Nemoto et al. 2014). This study suggests that asymptomatic animals may play a role in the maintenance of BCoV during an outbreak; therefore, the need for diagnostic testing of both clinically affected and apparently clinically normal horses on a premises followed by appropriate biosecurity and control measures.
C1 [Goodrich, E. L.; Mittel, L. D.; Glaser, A.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA.
   [Ness, S. L.; Radcliffe, R. M.; Divers, T. J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.
RP Goodrich, EL (reprint author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA.
EM elg25@cornell.edu
FU Animal Health Diagnostic Center at Cornell
FX The Animal Health Diagnostic Center at Cornell provided funding for the
   majority of the diagnostic testing involved with this outbreak
   investigation.
CR Davis E, 2000, J VET DIAGN INVEST, V12, P153, DOI 10.1177/104063870001200210
   Fielding CL, 2015, J VET INTERN MED, V29, P307, DOI 10.1111/jvim.12480
   Giannitti F, 2015, VET PATHOL, V52, P1148, DOI 10.1177/0300985814568683
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P2093, DOI 10.1111/tbed.12630
   Kooijman LJ, 2016, J VET DIAGN INVEST, V28, P414, DOI 10.1177/1040638716649643
   Miszczak F, 2014, VET MICROBIOL, V171, P206, DOI 10.1016/j.vetmic.2014.03.031
   Nemoto M, 2014, ARCH VIROL, V159, P3329, DOI 10.1007/s00705-014-2205-1
   Oue Y, 2013, J VET MED SCI, V75, P1261, DOI 10.1292/jvms.13-0056
   Oue Y, 2011, VET MICROBIOL, V150, P41, DOI 10.1016/j.vetmic.2011.01.004
   Pusterla N, 2015, VET REC, V177, DOI 10.1136/vr.103263
   Pusterla N, 2013, VET MICROBIOL, V162, P228, DOI 10.1016/j.vetmic.2012.10.014
   Slovis NM, 2014, EQUINE VET J, V46, P311, DOI 10.1111/evj.12119
NR 12
TC 1
Z9 1
U1 10
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0957-7734
EI 2042-3292
J9 EQUINE VET EDUC
JI Equine Vet. Educ.
PD MAR
PY 2020
VL 32
IS 3
DI 10.1111/eve.12938
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA KL1IG
UT WOS:000513184100010
OA Bronze
DA 2020-04-03
ER

PT J
AU Koenig, KL
   Bey, CK
   McDonald, EC
AF Koenig, Kristi L.
   Bey, Christian K.
   McDonald, Eric C.
TI 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel
   Emerging Coronavirus
SO WESTERN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
ID INITIAL DETECTION; PUBLIC-HEALTH; MANAGEMENT; TERRORISM
AB 2019 Novel Coronavirus (2019-nCoV) is an emerging infectious disease closely related to MERS-CoV and SARS-CoV that was first reported in Wuhan City, Hubei Province, China in December 2019. As of January 2020, cases of 2019-nCoV are continuing to be reported in other Eastern Asian countries as well as in the United States, Europe, Australia, and numerous other countries. An unusually high volume of domestic and international travel corresponding to the beginning of the 2020 Chinese New Year complicated initial identification and containment of infected persons. Due to the rapidly rising number of cases and reported deaths, all countries should be considered at risk of imported 2019-nCoV. Therefore, it is essential for prehospital, clinic, and emergency department personnel to be able to rapidly assess 2019-nCoV risk and take immediate actions if indicated. The Identify-Isolate-Inform (31) Tool, originally conceived for the initial detection and management of Ebola virus and later adjusted for other infectious agents, can be adapted for any emerging infectious disease. This paper reports a modification of the 31 Tool for use in the initial detection and management of patients under investigation for 2019-nCoV. After initial assessment for symptoms and epidemiological risk factors, including travel to affected areas and exposure to confirmed 2019-nCoV patients within 14 days, patients are classified in a risk-stratified system. Upon confirmation of a suspected 2019-nCoV case, affected persons must immediately be placed in airborne infection isolation and the appropriate public health agencies notified. This modified 31 Tool will assist emergency and primary care clinicians, as well as out-of-hospital providers, in effectively managing persons with suspected or confirmed 2019-nCoV.
C1 [Koenig, Kristi L.] Hlth & Human Serv Agcy, Cty San Diego, Emergency Med Serv, 6255 Mission Gorge Rd, San Diego, CA 92120 USA.
   [Koenig, Kristi L.] Univ Calif Irvine, Dept Emergency Med, Orange, CA 92668 USA.
   [Bey, Christian K.] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [McDonald, Eric C.] Hlth & Human Serv Agcy, Cty San Diego, Publ Hlth Serv, San Diego, CA 92120 USA.
RP Koenig, KL (reprint author), Hlth & Human Serv Agcy, Cty San Diego, Emergency Med Serv, 6255 Mission Gorge Rd, San Diego, CA 92120 USA.
EM kristi.koenig@sdcounty.ca.gov
CR Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38
   Centers for Disease Control, 2019 NOV COR
   Centers for Disease Control and Prevention, 2019, 2019 COR
   Centers for Disease Control and Prevention, 2019 NOV COR INT GUI
   Centers for Disease Control and Prevention, 2019 NOV COR GUID CL
   Centers for Disease Control and Prevention, EM PREP RESP HAN0042
   Chen N, 2020, LANCET, V2020
   Cheng TA, 2020, WEST J EMERG MED, V21, P191, DOI 10.5811/westjem.2020.1.46120
   Cyranoski D, 2017, NATURE, V542, P399, DOI 10.1038/nature.2017.21487
   Gamage SD, 2016, KOENIG SCHULTZS DISA
   Huang C, 2020, LANCET
   Koenig KL, 2008, AM J EMERG MED, V26, P71, DOI 10.1016/j.ajem.2007.07.004
   Koenig KL, 2007, AM J EMERG MED, V25, P185, DOI 10.1016/j.ajem.2006.06.012
   Koenig KL, 2019, WEST J EMERG MED, V20, P191, DOI 10.5811/westjem.2018.11.40023
   Koenig KL, 2017, WEST J EMERG MED, V18, P1000, DOI 10.5811/westjem.2017.10.35983
   Koenig KL, 2016, WEST J EMERG MED, V17, P490, DOI 10.5811/westjem.2016.6.30793
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Koenig KL, 2015, WEST J EMERG MED, V16, P619, DOI 10.5811/westjem.2015.7.27915
   Koenig KL, 2015, WEST J EMERG MED, V16, P212, DOI 10.5811/westjem.2015.3.25678
   Koenig KL, 2015, DISASTER MED PUBLIC, V9, P86, DOI 10.1017/dmp.2014.125
   Koenig KL, 2015, DISASTER MED PUBLIC, V9, P57, DOI 10.1017/dmp.2014.120
   Koenig KL, 2015, ANN EMERG MED, V65, P330, DOI 10.1016/j.annemergmed.2014.12.003
   Koenig KL, 2014, WEST J EMERG MED, V15, P728, DOI 10.5811/westjem.2014.9.24011
   Koenig KL, 2009, ANN ACAD MED SINGAP, V38, P1026
   Munster V.J, 2020, N ENGL J MED
   Paules CI, 2020, JAMA
   Rothe C, 2020, N ENGL J MED
   Woodside J, 2013, GUIDE INFECT PREVENT
   World Health Organization, DIS OUTBR NEWS DONS
   World Health Organization, SURV CAS DEF HUM INF
   Wu BB, 2020, FRESEN ENVIRON BULL, V29, P206
NR 31
TC 1
Z9 1
U1 23
U2 23
PU WESTJEM
PI ORANGE
PA C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01,
   ORANGE, CA 92868 USA
SN 1936-900X
EI 1936-9018
J9 WEST J EMERG MED
JI West. J. Emerg. Med.
PD MAR
PY 2020
VL 21
IS 2
BP 184
EP 190
DI 10.5811/westjem.2020.1.46760
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA KR7TG
UT WOS:000517818500001
PM 32191174
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Lai, CC
   Shih, TP
   Ko, WC
   Tang, HJ
   Hsueh, PR
AF Lai, Chih-Cheng
   Shih, Tzu-Ping
   Ko, Wen-Chien
   Tang, Hung-Jen
   Hsueh, Po-Ren
TI Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
   coronavirus disease-2019 (COVID-19): The epidemic and the challenges
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE 2019-nCoV; SARS-CoV-2; COVID-19; China; Epidemic; Remdesivir
ID PNEUMONIA; WUHAN; OUTBREAK; CHINA
AB The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond. (C) 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [Lai, Chih-Cheng] Kaohsiung Vet Gen Hosp, Dept Internal Med, Tainan Branch, Tainan, Taiwan.
   [Shih, Tzu-Ping] Kaohsiung Vet Gen Hosp, Dept Family Med, Tainan Branch, Tainan, Taiwan.
   [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan, Taiwan.
   [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan 71004, Taiwan.
   [Hsueh, Po-Ren] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Coll Med, Taipei, Taiwan.
   [Hsueh, Po-Ren] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan.
RP Hsueh, PR (reprint author), Natl Taiwan Univ Hosp, Dept Lab Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.; Hsueh, PR (reprint author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.
EM hsporen@ntu.edu.tw
OI HSUEH, PO-REN/0000-0002-7502-9225
CR Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Biscayart C, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101567
   Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7
   Casanova LM, 2010, APPL ENVIRON MICROB, V76, P2712, DOI 10.1128/AEM.02291-09
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chang De, 2020, JAMA, DOI 10.1001/jama.2020.1623
   Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen ZM, 2020, WORLD J PEDIATR, DOI 10.1007/s12519-020-00345-5
   Chou CC, 2019, J MICROBIOL IMMUNOL, V52, P172, DOI 10.1016/j.jmii.2018.11.004
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hung HM, 2019, J MICROBIOL IMMUNOL, V52, P233, DOI 10.1016/j.jmii.2018.08.009
   Jiang SB, 2020, EMERG MICROBES INFEC, V9, P275, DOI 10.1080/22221751.2020.1723441
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Lee JY, 2019, J MICROBIOL IMMUNOL, V52, P838, DOI 10.1016/j.jmii.2019.05.014
   Lee Kyoung Hwa, 2019, J Microbiol Immunol Infect, DOI 10.1016/j.jmii.2019.05.007
   Lee SH, 2019, J MICROBIOL IMMUNOL, V52, P920, DOI 10.1016/j.jmii.2019.10.009
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lin GL, 2019, J MICROBIOL IMMUNOL, V52, P215, DOI 10.1016/j.jmii.2018.07.005
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Patel Anita, 2020, MMWR Morb Mortal Wkly Rep, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Ren Li-Li, 2020, Chin Med J (Engl), DOI 10.1097/CM9.0000000000000722
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Ryu S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020006
   Song FX, 2020, RADIOLOGY, V295, P210, DOI 10.1148/radiol.2020200274
   Su IC, 2019, J MICROBIOL IMMUNOL, V52, P365, DOI 10.1016/j.jmii.2018.05.007
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   World Health Organization (WHO), NOV COR 2019 NCOV
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e56
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 48
TC 1
Z9 1
U1 34
U2 34
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD MAR
PY 2020
VL 55
IS 3
AR UNSP 105924
DI 10.1016/j.ijantimicag.2020.105924
PG 9
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA KT2ON
UT WOS:000518855500030
PM 32081636
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhang, DH
   Wu, KL
   Zhang, X
   Deng, SQ
   Peng, B
AF Zhang, Deng-hai
   Wu, Kun-lun
   Zhang, Xue
   Deng, Sheng-qiong
   Peng, Bin
TI In silico screening of Chinese herbal medicines with the potential to
   directly inhibit 2019 novel coronavirus
SO JOURNAL OF INTEGRATIVE MEDICINE-JIM
LA English
DT Article
DE 2019-nCoV; Wuhan coronavirus; Drugs; Chinese herbal; Pneumonia; Natural
   compounds; Molecular docking; Network pharmacology
ID PAPAIN-LIKE PROTEASE; SARS-COV 3CL(PRO); ANTIVIRAL ACTIVITIES; DESIGN;
   DERIVATIVES
AB Objective: In this study we execute a rational screen to identify Chinese medical herbs that are commonly used in treating viral respiratory infections and also contain compounds that might directly inhibit 2019 novel coronavirus (2019-nCoV), an ongoing novel coronavirus that causes pneumonia.
   Methods: There were two main steps in the screening process. In the first step we conducted a literature search for natural compounds that had been biologically confirmed as against sever acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus. Resulting compounds were cross-checked for listing in the Traditional Chinese Medicine Systems Pharmacology Database. Compounds meeting both requirements were subjected to absorption, distribution, metabolism and excretion (ADME) evaluation to verify that oral administration would be effective. Next, a docking analysis was used to test whether the compound had the potential for direct 2019-nCoV protein interaction. In the second step we searched Chinese herbal databases to identify plants containing the selected compounds. Plants containing 2 or more of the compounds identified in our screen were then checked against the catalogue for classic herbal usage. Finally, network pharmacology analysis was used to predict the general in vivo effects of each selected herb.
   Results: Of the natural compounds screened, 13 that exist in traditional Chinese medicines were also found to have potential anti-2019-nCoV activity. Further, 125 Chinese herbs were found to contain 2 or more of these 13 compounds. Of these 125 herbs, 26 are classically catalogued as treating viral respiratory infections. Network pharmacology analysis predicted that the general in vivo roles of these 26 herbal plants were related to regulating viral infection, immune/inflammation reactions and hypoxia response.
   Conclusion: Chinese herbal treatments classically used for treating viral respiratory infection might contain direct anti-2019-nCoV compounds. (C) 2020 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.
C1 [Zhang, Deng-hai; Zhang, Xue; Peng, Bin] Secondary Mil Med Univ, Shanghai Pudong Gongli Hosp, Shanghai Hlth Commiss Key Lab Artificial Intellig, Sino French Cooperat Cent Lab, Shanghai 200135, Peoples R China.
   [Wu, Kun-lun] Secondary Mil Med Univ, Shanghai Pudong Gongli Hosp, Dept Tradit Chinese Med, Shanghai 200135, Peoples R China.
   [Deng, Sheng-qiong] Secondary Mil Med Univ, Shanghai Pudong Gongli Hosp, Dept Res Affair Management, Shanghai 200135, Peoples R China.
RP Zhang, DH (reprint author), Secondary Mil Med Univ, Shanghai Pudong Gongli Hosp, Shanghai Hlth Commiss Key Lab Artificial Intellig, Sino French Cooperat Cent Lab, Shanghai 200135, Peoples R China.
EM shanghai_zhang@hotmail.com
FU Shanghai Leading Talent Grants in Medicine [2019LG26]; Shanghai
   Traditional Chinese Medicine Content Construction Innovation Project
   [ZY3-CCCX-3-7001]; Shanghai Gongil Hospital [GLBH2017002]
FX This work is supported by Shanghai Leading Talent Grants in Medicine
   (No. 2019LG26), Shanghai Traditional Chinese Medicine Content
   Construction Innovation Project (No. ZY3-CCCX-3-7001) and Postdoctoral
   Funding of Shanghai Gongil Hospital (No. GLBH2017002).
CR Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959
   Chen LL, 2006, BIOORGAN MED CHEM, V14, P8295, DOI 10.1016/j.bmc.2006.09.014
   Chen Z, 2004, PHYTOTHER RES, V18, P592, DOI 10.1002/ptr.1485
   Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008
   Hu W, 2019, EVID-BASED COMPL ALT, DOI 10.1155/2019/5276865
   Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012
   Kesel AJ, 2005, CURR MED CHEM, V12, P2095, DOI 10.2174/0929867054637644
   Kim JY, 2018, INT J ANTIMICROB AG, V52, P730, DOI 10.1016/j.ijantimicag.2018.05.003
   Lai LH, 2006, CURR PHARM DESIGN, V12, P4555, DOI 10.2174/138161206779010396
   Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu B, 2005, J COMPUT CHEM, V26, P484, DOI 10.1002/jcc.20186
   Mukherjee P, 2011, J CHEM INF MODEL, V51, P1376, DOI 10.1021/ci1004916
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Park JY, 2017, J ENZYM INHIB MED CH, V32, P504, DOI 10.1080/14756366.2016.1265519
   Park JY, 2016, J ENZYM INHIB MED CH, V31, P23, DOI 10.3109/14756366.2014.1003215
   Park JY, 2013, BIOORGAN MED CHEM, V21, P3730, DOI 10.1016/j.bmc.2013.04.026
   Park JY, 2012, BIOORGAN MED CHEM, V20, P5928, DOI 10.1016/j.bmc.2012.07.038
   Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103
   Rizvi SMD, 2013, EXCLI J, V12, P831
   Ryu YB, 2010, BIOORG MED CHEM LETT, V20, P1873, DOI 10.1016/j.bmcl.2010.01.152
   Shen L, 2019, J VIROL, V93, DOI 10.1128/JVI.00023-19
   Song YH, 2014, BIOL PHARM BULL, V37, P1021, DOI 10.1248/bpb.b14-00026
   Tian H Y, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, pE001, DOI 10.3760/cma.j.issn.0253-9624.2020.0001
   Wang SQ, 2007, AMINO ACIDS, V33, P129, DOI 10.1007/s00726-006-0403-1
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   World Health Organization, 2020, EM COMM REG OUTBR NO
   Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101
   Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200
   Zhang WJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00743
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 32
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2095-4964
J9 J INTEGR MED-JIM
JI J. Integr. Med.-JIM
PD MAR
PY 2020
VL 18
IS 2
BP 152
EP 158
DI 10.1016/j.joim.2020.02.005
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA KU8WN
UT WOS:000519993900006
PM 32113846
OA Other Gold
DA 2020-04-03
ER

PT J
AU Xu, X
   Yu, CC
   Qu, J
   Zhang, LG
   Jiang, SF
   Huang, DY
   Chen, BH
   Zhang, ZP
   Guan, WH
   Ling, ZK
   Jiang, R
   Hu, TL
   Ding, Y
   Lin, L
   Gan, QX
   Luo, LP
   Tang, XP
   Liu, JX
AF Xu, Xi
   Yu, Chengcheng
   Qu, Jing
   Zhang, Lieguang
   Jiang, Songfeng
   Huang, Deyang
   Chen, Bihua
   Zhang, Zhiping
   Guan, Wanhua
   Ling, Zhoukun
   Jiang, Rui
   Hu, Tianli
   Ding, Yan
   Lin, Lin
   Gan, Qingxin
   Luo, Liangping
   Tang, Xiaoping
   Liu, Jinxin
TI Imaging and clinical features of patients with 2019 novel coronavirus
   SARS-CoV-2
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
LA English
DT Article; Early Access
DE 2019 novel coronavirus pneumonia; COVID-19; SARS-CoV-2; Infection;
   Imaging features; Computed tomography; Ground glass opacification
ID PNEUMONIA
AB Background The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2, also called 2019-nCoV) recently break out in Wuhan, China, and was named as COVID-19. With the spread of the disease, similar cases have also been confirmed in other regions of China. We aimed to report the imaging and clinical characteristics of these patients infected with SARS-CoV-2 in Guangzhou, China. Methods All patients with laboratory-identified SARS-CoV-2 infection by real-time polymerase chain reaction (PCR) were collected between January 23, 2020, and February 4, 2020, in a designated hospital (Guangzhou Eighth People's Hospital). This analysis included 90 patients (39 men and 51 women; median age, 50 years (age range, 18-86 years). All the included SARS-CoV-2-infected patients underwent non-contrast enhanced chest computed tomography (CT). We analyzed the clinical characteristics of the patients, as well as the distribution characteristics, pattern, morphology, and accompanying manifestations of lung lesions. In addition, after 1-6 days (mean 3.5 days), follow-up chest CT images were evaluated to assess radiological evolution. Findings The majority of infected patients had a history of exposure in Wuhan or to infected patients and mostly presented with fever and cough. More than half of the patients presented bilateral, multifocal lung lesions, with peripheral distribution, and 53 (59%) patients had more than two lobes involved. Of all included patients, COVID-19 pneumonia presented with ground glass opacities in 65 (72%), consolidation in 12 (13%), crazy paving pattern in 11 (12%), interlobular thickening in 33 (37%), adjacent pleura thickening in 50 (56%), and linear opacities combined in 55 (61%). Pleural effusion, pericardial effusion, and lymphadenopathy were uncommon findings. In addition, baseline chest CT did not show any abnormalities in 21 patients (23%), but 3 patients presented bilateral ground glass opacities on the second CT after 3-4 days. Conclusion SARS-CoV-2 infection can be confirmed based on the patient's history, clinical manifestations, imaging characteristics, and laboratory tests. Chest CT examination plays an important role in the initial diagnosis of the novel coronavirus pneumonia. Multiple patchy ground glass opacities in bilateral multiple lobular with periphery distribution are typical chest CT imaging features of the COVID-19 pneumonia.
C1 [Xu, Xi; Luo, Liangping] Jinan Univ, Dept Med Imaging Ctr, Affiliated Hosp 1, 613,Huangpu Rd West, Guangzhou 510630, Guangdong, Peoples R China.
   [Yu, Chengcheng; Qu, Jing; Zhang, Lieguang; Jiang, Songfeng; Huang, Deyang; Chen, Bihua; Zhang, Zhiping; Guan, Wanhua; Ling, Zhoukun; Jiang, Rui; Hu, Tianli; Ding, Yan; Lin, Lin; Gan, Qingxin; Tang, Xiaoping; Liu, Jinxin] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Radiol, 8,Huaying Rd, Guangzhou 510060, Guangdong, Peoples R China.
RP Luo, LP (reprint author), Jinan Univ, Dept Med Imaging Ctr, Affiliated Hosp 1, 613,Huangpu Rd West, Guangzhou 510630, Guangdong, Peoples R China.; Tang, XP; Liu, JX (reprint author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Radiol, 8,Huaying Rd, Guangzhou 510060, Guangdong, Peoples R China.
EM tluolp@jnu.edu.cn; xtang@21cn.com; Liujx83710378@126.com
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chong S, 2010, BRIT J RADIOL, V83, P585, DOI 10.1259/bjr/51409455
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Das KM, 2016, AM J ROENTGENOL, V206, P1193, DOI 10.2214/AJR.15.15363
   Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712
   Heymann DL, 2020, LANCET, V395, P469, DOI 10.1016/S0140-6736(20)30184-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Ooi GC, 2003, RESPIROLOGY, V8, pS15, DOI 10.1046/j.1440-1843.2003.00519.x
   Richman DD, 2016, CLIN VIROLOGY
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 15
TC 1
Z9 1
U1 70
U2 70
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1619-7070
EI 1619-7089
J9 EUR J NUCL MED MOL I
JI Eur. J. Nucl. Med. Mol. Imaging
DI 10.1007/s00259-020-04735-9
EA FEB 2020
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KQ4YX
UT WOS:000516931000001
PM 32107577
OA Bronze
DA 2020-04-03
ER

PT J
AU Xu, H
   Zhong, L
   Deng, JX
   Peng, JK
   Dan, HX
   Zeng, X
   Li, TW
   Chen, QM
AF Xu, Hao
   Zhong, Liang
   Deng, Jiaxin
   Peng, Jiakuan
   Dan, Hongxia
   Zeng, Xin
   Li, Taiwen
   Chen, Qianming
TI High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of
   oral mucosa
SO INTERNATIONAL JOURNAL OF ORAL SCIENCE
LA English
DT Article
ID FUNCTIONAL RECEPTOR; CORONAVIRUS; SARS; CARCINOMA
AB It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life.
C1 [Xu, Hao; Zhong, Liang; Deng, Jiaxin; Peng, Jiakuan; Dan, Hongxia; Zeng, Xin; Li, Taiwen; Chen, Qianming] Sichuan Univ, Res Unit Oral Carcinogenesis & Management, Natl Clin Res Ctr Oral Dis, Chinese Acad Med Sci,State Key Lab Oral Dis,West, Chengdu, Sichuan, Peoples R China.
RP Li, TW; Chen, QM (reprint author), Sichuan Univ, Res Unit Oral Carcinogenesis & Management, Natl Clin Res Ctr Oral Dis, Chinese Acad Med Sci,State Key Lab Oral Dis,West, Chengdu, Sichuan, Peoples R China.
EM litaiwen@scu.edu.cn; qmchen@scu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81520108009, 81991502, 81771081, 81991500]; 111
   Project of MOE [B14038]
FX This study was supported by grants from the National Natural Science
   Foundation of China (81520108009, 81991502, 81771081, and 81991500), the
   111 Project of MOE (B14038), China.
CR Chai X, 2020, SPECIFIC ACE2 EXPRES, DOI DOI 10.1101/2020.02.03.931766V1
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754
   Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182
   Guan Wj, 2020, CLIN CHARACTERISTICS, DOI DOI 10.1101/2020.02.06.20020974V1
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Li J, 2015, EBIOMEDICINE, V2, P851, DOI 10.1016/j.ebiom.2015.07.004
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Peixoto Andrea P, 2011, J Oral Sci, V53, P451
   Ren XF, 2006, J GEN VIROL, V87, P1691, DOI 10.1099/vir.0.81749-0
   Rostom R, 2017, FEBS LETT, V591, P2213, DOI 10.1002/1873-3468.12684
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang D, 2020, JAMA
   Wang Z, 2009, EUR J CANCER, V45, P490, DOI 10.1016/j.ejca.2008.11.012
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Zhang H, 2020, DIGESTIVE SYSTEM IS, DOI [10.1101/2020.01.30.927806, DOI 10.1101/2020.01.30.927806V1]
   Zhao Y, 2020, SINGLE CELL RNA EXPR, DOI DOI 10.1101/2020.01.26.919985V1
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou Xin, 2020, Front Med, DOI 10.1007/s11684-020-0754-0
NR 25
TC 1
Z9 1
U1 16
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1674-2818
EI 2049-3169
J9 INT J ORAL SCI
JI Int. J. Oral Sci.
PD FEB 24
PY 2020
VL 12
IS 1
AR 8
DI 10.1038/s41368-020-0074-x
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KP9IS
UT WOS:000516545000001
PM 32094336
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Oh, SH
   Lee, SY
   Han, C
AF Oh, Sang-Hwa
   Lee, Seo Yoon
   Han, Changhyun
TI The Effects of Social Media Use on Preventive Behaviors during
   Infectious Disease Outbreaks: The Mediating Role of Self-relevant
   Emotions and Public Risk Perception
SO HEALTH COMMUNICATION
LA English
DT Article; Early Access
ID COGNITIVE APPRAISAL; PERCEIVED RISK; HEALTH THREATS; FEAR APPEALS;
   INFORMATION; COMMUNICATION; ANGER; MESSAGES; JUDGMENT; CRISIS
AB While there has been increasing attention to the role of social media during infectious disease outbreaks, relatively little is known about the underlying mechanisms by which social media use affects risk perception and preventive behaviors during such outbreaks. Using data collected during the 2015 Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreak in South Korea, this study explores the relationships among social media use, risk perception, and preventive behaviors by examining the mediating role of two self-relevant emotions: fear and anger. The findings demonstrate that social media use is positively related to both of these emotions, which are also positively related to the public's risk perception. The findings also indicate that social media use can significantly increase preventive behaviors via the two self-relevant emotions and the public's risk perception.
C1 [Oh, Sang-Hwa; Lee, Seo Yoon] Univ Illinois, Coll Media, Charles H Sandage Dept Advertising, 119 Gregory Hall,MC 462, Urbana, IL 61801 USA.
   [Han, Changhyun] Sogang Univ, Sch Media Arts & Sci, Seoul, South Korea.
RP Oh, SH (reprint author), Univ Illinois, Coll Media, Charles H Sandage Dept Advertising, 119 Gregory Hall,MC 462, Urbana, IL 61801 USA.
EM sanghwa2@illinois.edu
CR Ali K, 2019, SCI COMMUN, V41, P314, DOI 10.1177/1075547019846124
   Chae J, 2019, COMMUN RES, V46, P597, DOI 10.1177/0093650216644021
   Chalmers RP, 2012, J STAT SOFTW, V48, P1
   Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007
   Choe Sang-Hun, 2015, NY TIMES
   Choi DH, 2017, COMPUT HUM BEHAV, V72, P422, DOI 10.1016/j.chb.2017.03.004
   Chong M, 2018, HEALTH COMMUN, V33, P14, DOI 10.1080/10410236.2016.1242031
   Ding H., 2010, CHINA MEDIA RESEARCH, V6, P80
   Do H. J., 2016, 2016 INT C BIG DAT S
   Dunlop S, 2008, MEDIA PSYCHOL, V11, P52, DOI 10.1080/15213260701853112
   El-Toukhy S, 2015, J HEALTH COMMUN, V20, P499, DOI 10.1080/10810730.2014.989342
   Frijda, 1986, EMOTIONS STUDIES EMO
   Fung TKF, 2011, J HEALTH COMMUN, V16, P889, DOI 10.1080/10810730.2011.561913
   Griffin RJ, 2008, SCI COMMUN, V29, P285, DOI 10.1177/1075547007312309
   Hartmann P, 2014, INT J ADVERT, V33, P741, DOI 10.2501/IJA-33-4-741-765
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   IZARD CE, 1977, HUMAN EMOTIONS
   Jang K, 2019, HEALTH COMMUN, V34, P991, DOI 10.1080/10410236.2018.1449552
   Janis IL, 1967, ADV EXPT SOCIAL PSYC, P166, DOI DOI 10.1016/S0065-2601(08)60344-5
   Jin Y, 2012, J PUBLIC RELAT RES, V24, P266, DOI 10.1080/1062726X.2012.676747
   Johnson R., 2007, APPL MULTIVARIATE ST
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012
   Kim K., 2015, ENEWSTODAY      1210
   Kim S., 2015, JOURNALISM BROAD AUG
   Korean Ministry of Health and Welfare, 2016, USITC PUBL, V11-1352000-001644-01
   LaTour MS, 2003, PSYCHOL MARKET, V20, P377, DOI 10.1002/mar.10078
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819
   Lazarus RS, 1994, PASSION REASON MAKIN
   Lee MJ, 2016, COMPUT HUM BEHAV, V65, P479, DOI 10.1016/j.chb.2016.09.007
   Lee ST, 2013, HEALTH COMMUN, V28, P119, DOI 10.1080/10410236.2012.658550
   Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433
   Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763
   Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146
   Lin L, 2017, J PUBLIC HEALTH-UK, V39, P282, DOI 10.1093/pubmed/fdw028
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Maxwell TA, 2003, GOV INFORM Q, V20, P233, DOI 10.1016/S0740-624X(03)00039-X
   Miles A, 2008, CANCER EPIDEM BIOMAR, V17, P1872, DOI 10.1158/1055-9965.EPI-08-0074
   Myrick JG, 2015, HEALTH COMMUN, V30, P820, DOI 10.1080/10410236.2013.845729
   Nabi R. L., 2002, PERSUASION HDB DEV T, P289
   Nabi RL, 1999, COMMUN THEOR, V9, P292, DOI 10.1111/j.1468-2885.1999.tb00172.x
   Ofoghi B, 2016, BIOCOMPUT-PAC SYM, P504
   Oh SH, 2015, ASIAN J COMMUN, V25, P14, DOI 10.1080/01292986.2014.989240
   Paek HJ, 2016, HEALTH COMMUN, V31, P1051, DOI 10.1080/10410236.2015.1037419
   Parmer J, 2016, HEALTH COMMUN, V31, P1215, DOI 10.1080/10410236.2015.1049728
   Pew Research Center, 2018, SOCIAL MEDIA USE 201
   Popova L, 2017, HEALTH EDUC BEHAV, V44, P598, DOI 10.1177/1090198116683169
   Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Rimal RN, 1999, COMMUN RES, V26, P322, DOI 10.1177/009365099026003003
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006
   SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813
   Smith SW, 2010, HEALTH COMMUN, V25, P737, DOI 10.1080/10410236.2010.521916
   SNYDER LB, 1995, HEALTH COMMUN, V7, P125, DOI 10.1207/s15327027hc0702_3
   So J, 2016, COMMUN MONOGR, V83, P120, DOI 10.1080/03637751.2015.1044257
   Song J, 2017, CYBERPSYCH BEH SOC N, V20, P22, DOI 10.1089/cyber.2016.0126
   Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973
   Toppenberg-Pejcic D, 2019, HEALTH COMMUN, V34, P437, DOI 10.1080/10410236.2017.1405488
   Turner MM, 2007, PUBLIC RELAT REV, V33, P114, DOI 10.1016/j.pubrev.2006.11.013
   Turner MM, 2012, COMMUN Q, V60, P545, DOI 10.1080/01463373.2012.705780
   van der Pligt J, 1996, EUR PSYCHOL, V1, P34, DOI 10.1027/1016-9040.1.1.34
   WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146
   Westerman D, 2014, J COMPUT-MEDIAT COMM, V19, P171, DOI 10.1111/jcc4.12041
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   Won T., 2015, KOR GEOSP INF SOC C
   World Health Organization, 2018, HLTH TOP MIDDL E RES
   Wurz A, 2013, J HEALTH COMMUN, V18, P1566, DOI 10.1080/10810730.2013.840698
   Yang JZ, 2018, J RISK RES, V21, P834, DOI 10.1080/13669877.2016.1247378
   Yoo W, 2020, HEALTH COMMUN, V35, P99, DOI 10.1080/10410236.2018.1545169
   Yoo W, 2016, COMPUT HUM BEHAV, V62, P34, DOI 10.1016/j.chb.2016.03.058
   You M, 2017, SCI COMMUN, V39, P313, DOI 10.1177/1075547017705392
NR 76
TC 1
Z9 1
U1 20
U2 20
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
DI 10.1080/10410236.2020.1724639
EA FEB 2020
PG 10
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA KM9IF
UT WOS:000514454100001
PM 32064932
OA Bronze
DA 2020-04-03
ER

PT J
AU Stoecklin, SB
   Rolland, P
   Silue, Y
   Mailles, A
   Campese, C
   Simondon, A
   Mechain, M
   Meurice, L
   Nguyen, M
   Bassi, C
   Yamani, E
   Behillil, S
   Ismael, S
   Nguyen, D
   Malvy, D
   Lescure, FX
   Georges, S
   Lazarus, C
   Tabai, A
   Stempfelet, M
   Enouf, V
   Coignard, B
   Levy-Bruhl, D
   Filleul, L
   Vandentorren, S
   Spaccaferri, G
   Prouvost, H
   Albert, M
   Barbet, M
   Brisebarre, A
   Donati, F
   van der Werf, S
   Ardoin, A
   Dreyer, M
   Tararbit, K
   Amodeo, M
   Couaillier, E
   Fabre, P
   Ha Bold, D
   Che, D
   Bendjelloul, G
   Lallemant, MB
   Charachon, V
   Deconinck, L
   Descamps, D
   Gerard, S
   Houhou, N
   Le Hingrat, Q
   Lolom, I
   Lucet, JC
   Pourbaix, A
   Valayer, S
   Yazdanpana, Y
   Boyer, A
   Clouzeau, B
   Combes, X
   Desclaux, A
   Dindart, JM
   Duvignaud, A
   Garrigue, I
   Gruson, D
   Lafon, ME
   Perreau, P
   Pistone, T
   Poteau, M
   Tentillier, E
   Mathieu, P
AF Stoecklin, Sibylle Bernard
   Rolland, Patrick
   Silue, Yassoungo
   Mailles, Alexandra
   Campese, Christine
   Simondon, Anne
   Mechain, Matthieu
   Meurice, Laure
   Nguyen, Mathieu
   Bassi, Clement
   Yamani, Estelle
   Behillil, Sylvie
   Ismael, Sophie
   Nguyen, Duc
   Malvy, Denis
   Lescure, Francois Xavier
   Georges, Scarlett
   Lazarus, Clement
   Tabai, Anouk
   Stempfelet, Morgane
   Enouf, Vincent
   Coignard, Bruno
   Levy-Bruhl, Daniel
   Filleul, Laurent
   Vandentorren, Stephanie
   Spaccaferri, Guillaume
   Prouvost, Helene
   Albert, Melanie
   Barbet, Marion
   Brisebarre, Angela
   Donati, Flora
   van der Werf, Sylvie
   Ardoin, Alexis
   Dreyer, Marion
   Tararbit, Karim
   Amodeo, Matthieu
   Couaillier, Elodie
   Fabre, Pascal
   Ha Bold, Daniel
   Che, Didier
   Bendjelloul, Gisele
   Lallemant, Marine Billaudelle
   Charachon, Valentine
   Deconinck, Laurene
   Descamps, Diane
   Gerard, Sandrine
   Houhou, Nadirha
   Le Hingrat, Quentin
   Lolom, Isabelle
   Lucet, Jean-Christophe
   Pourbaix, Annabelle
   Valayer, Simon
   Yazdanpana, Yazdan
   Boyer, Alexandre
   Clouzeau, Benjamin
   Combes, Xavier
   Desclaux, Arnaud
   Dindart, Jean-Michel
   Duvignaud, Alexandre
   Garrigue, Isabelle
   Gruson, Didier
   Lafon, Marie-Edith
   Perreau, Pauline
   Pistone, Thierry
   Poteau, Maxime
   Tentillier, Eric
   Mathieu, Pauline
CA Invest Team
TI First cases of coronavirus disease 2019 (COVID-19) in France:
   surveillance, investigations and control measures, January 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.
C1 [Stoecklin, Sibylle Bernard; Mailles, Alexandra; Campese, Christine; Georges, Scarlett; Coignard, Bruno; Levy-Bruhl, Daniel; Che, Didier] Sante Publ France, Direct Malad Infect, St Maurice, France.
   [Rolland, Patrick] Sante Publ France, Direct Reg, St Maurice, France.
   [Silue, Yassoungo; Bassi, Clement] Sante Publ France, Direct Reg, Cellule Reg Ile France, Paris, France.
   [Simondon, Anne; Yamani, Estelle; van der Werf, Sylvie; Ardoin, Alexis; Dreyer, Marion; Tararbit, Karim] Agence Reg Sante Ile France, Paris, France.
   [Mechain, Matthieu; Nguyen, Mathieu; Amodeo, Matthieu; Couaillier, Elodie; Fabre, Pascal; Ha Bold, Daniel] Agence Reg Sante Nouvelle Aquitaine, Bordeaux, France.
   [Meurice, Laure; Filleul, Laurent; Vandentorren, Stephanie] Sante Publ France, Direct Reg, Cellule Reg Nouvelle Aquitaine, Bordeaux, France.
   [Behillil, Sylvie; Enouf, Vincent; Albert, Melanie; Barbet, Marion; Brisebarre, Angela; Donati, Flora; van der Werf, Sylvie] Inst Pasteur, Ctr Natl Reference Virus Infect Resp, Dont Grippe, Paris, France.
   [Ismael, Sophie; Lescure, Francois Xavier; Bendjelloul, Gisele; Lallemant, Marine Billaudelle; Charachon, Valentine; Deconinck, Laurene; Descamps, Diane; Gerard, Sandrine; Houhou, Nadirha; Le Hingrat, Quentin; Lolom, Isabelle; Lucet, Jean-Christophe; Pourbaix, Annabelle; Valayer, Simon; Yazdanpana, Yazdan] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France.
   [Nguyen, Duc; Malvy, Denis] CHU Bordeaux, Serv Malad Infect & Trop, Bordeaux GeoSentinel Site, Bordeaux, France.
   [Malvy, Denis] Univ Bordeaux, UMR 1219, Bordeaux, France.
   [Lescure, Francois Xavier] Univ Paris, INSERM, IAME, Paris, France.
   [Lazarus, Clement; Mathieu, Pauline] Minist Solidarites & Sante, Direct Gen Sante, Ctr Operationnel Recept & Regulat Urgences Sanit, Paris, France.
   [Tabai, Anouk; Stempfelet, Morgane] Sante Publ France, Direct Alerte & Crise, St Maurice, France.
   [Spaccaferri, Guillaume] Sante Publ France, Direct Reg, Cellule Reg Auvergne Rhone Alpes, Lyon, France.
   [Prouvost, Helene] Sante Publ France, Direct Reg, Cellule Reg Hauts France, Lille, France.
   [Boyer, Alexandre; Clouzeau, Benjamin; Combes, Xavier; Desclaux, Arnaud; Dindart, Jean-Michel; Duvignaud, Alexandre; Garrigue, Isabelle; Gruson, Didier; Lafon, Marie-Edith; Perreau, Pauline; Pistone, Thierry; Poteau, Maxime; Tentillier, Eric] CHU Bordeaux, Bordeaux GeoSentinel Site, Bordeaux, France.
RP Stoecklin, SB (reprint author), Sante Publ France, Direct Malad Infect, St Maurice, France.
EM sibylle.bernard-stoecklin@santepubUquefrance.fr
RI Ribeiro, Nuno/AAH-2299-2020
OI ARDOIN, Alexis/0000-0001-9506-5672
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   ECDC, 2020, NOV COR
   European Centre for Disease Prevention and Control (ECDC), 2020, OUTBR AC RESP SYNDR
   European Centre for Disease Prevention and Control (ECDC), 2020, RISK ASS GUID INF DI
   European Centre for Disease Prevention and Control (ECDC), 2020, PUBL HLTH MAN PERS H
   Haut Conseil de la sante publique (HCSP), 2015, DEF CLASS CAS POSS C
   Imai N., 2020, 3 IMP COLL LOND
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu T, 2020, TRANSMISSION DYNAMIC, V2020, P2025
   Riou J, PATTERN EARLY HUMAN
   World Health Organization (WHO), 2020, 1 FEW X FFX CAS CONT
   World Health Organization (WHO), GO DAT MAN COMPL DAT
   World Health Organization ( WHO), 2020, NOV COR CHIN DIS OUT
   Wu JT, 2020, LANCET
NR 15
TC 1
Z9 1
U1 40
U2 40
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 13
PY 2020
VL 25
IS 6
BP 20
EP 26
AR 2000094
DI 10.2807/1560-7917.ES.2020.25.6.2000094
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA KM9CR
UT WOS:000514439600004
PM 32070465
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Giovanetti, M
   Benvenuto, D
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Benvenuto, Domenico
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The first two cases of 2019-nCoV in Italy: Where they come from?
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE epidemiology; engineering and technology; infection; macromolecular
   design
AB A novel Coronavirus, 2019-nCoV, has been identified as the causal pathogen of an ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and has since spread to other countries worldwide, included Europe and very recently Italy. In this short report, phylogenetic reconstruction was used to better understand the transmission dynamics of the virus from its first introduction in China focusing on the more recent evidence of infection in a couple of Chinese tourists arrived in Italy on 23rd January 2020 and labeled as Coronavirus Italian cases. A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019-nCoV plus two closely related bat strains (SARS-like CoV) available in GenBank. Bayesian time-scaled phylogenetic analysis was implemented in BEAST 1.10.4. The Bayesian phylogenetic reconstruction showed that 2019-2020 nCoV firstly introduced in Wuhan on 25 November 2019, started epidemic transmission reaching many countries worldwide, including Europe and Italy where the two strains isolated dated back 19 January 2020, the same that the Chinese tourists arrived in Italy. Strains isolated outside China were intermixed with strains isolated in China as evidence of likely imported cases in Rome, Italy, and Europe, as well. In conclusion, this report suggests that further spread of 2019-nCoV epidemic was supported by human mobility and that quarantine of suspected or diagnosed cases is useful to prevent further transmission. Viral genome phylogenetic analysis represents a useful tool for the evaluation of transmission dynamics and preventive action.
C1 [Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Benvenuto, Domenico; Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
RP Angeletti, S (reprint author), Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
EM s.angeletti@unicampus.it
RI Ribeiro, Nuno/AAH-2299-2020; ciccozzi, massimo/C-6484-2016
OI ciccozzi, massimo/0000-0003-3866-9239; Benvenuto,
   Domenico/0000-0003-3833-2927
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Benvenuto D, 2020, J MED VIROL, V92, P455, DOI 10.1002/jmv.25688
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 13
TC 1
Z9 1
U1 43
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 518
EP 521
DI 10.1002/jmv.25699
EA FEB 2020
PG 4
WC Virology
SC Virology
GA KU3AY
UT WOS:000512724700001
PM 32022275
OA Bronze
DA 2020-04-03
ER

PT J
AU Boldog, P
   Tekeli, T
   Vizi, Z
   Denes, A
   Bartha, FA
   Rost, G
AF Boldog, Peter
   Tekeli, Tamas
   Vizi, Zsolt
   Denes, Attila
   Bartha, Ferenc A.
   Rost, Gergely
TI Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE novel coronavirus; transmission; risk assessment; interventions; travel;
   outbreak; COVID-19; compartmental model; branching process
AB We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number Rloc). We found that in countries with low connectivity to China but with relatively high Rloc, the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low Rloc benefit the most from policies that further reduce Rloc. Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.
C1 [Boldog, Peter; Tekeli, Tamas; Vizi, Zsolt; Denes, Attila; Bartha, Ferenc A.; Rost, Gergely] Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary.
RP Denes, A (reprint author), Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary.
EM boldogpeter@gmail.com; tekeli.tamas@gmail.com; zsvizi@math.u-szeged.hu;
   denesa@math.u-szeged.hu; barfer@math.u-szeged.hu; rost@math.u-szeged.hu
RI Ribeiro, Nuno/AAH-2299-2020
FU NKFIH [KKP 129877, FK 124016, PD 128363]; Janos Bolyai Research
   Scholarship of the Hungarian Academy of SciencesHungarian Academy of
   Sciences;  [EFOP-3.6.1-16-2016-00008];  [20391-3/2018/FEKUSTRAT]
FX G.R. was supported by EFOP-3.6.1-16-2016-00008. F.B. was supported by
   NKFIH KKP 129877. T.T. was supported by NKFIH FK 124016. A.D. was
   supported by NKFIH PD 128363 and by the Janos Bolyai Research
   Scholarship of the Hungarian Academy of Sciences. P.B. was supported by
   20391-3/2018/FEKUSTRAT.
CR Arnot M., 2020, THE NEW YORK TIMES
   Backer J.A., 2020, INCUBATION PERIOD 20, DOI [10.1101/2020.01.27.20018986, DOI 10.1101/2020.01.27.20018986]
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Bolyai Institute University of Szeged, 2020, RISK ASS NOV COR 201
   Bowser DA, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab41b4
   Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006
   CDC, 2020, 2019 NOV COR PREV TR
   Cheng VCC, 2020, J HOSP INFECT, V104, P254, DOI 10.1016/j.jhin.2020.01.010
   Chinazzi M., 2020, LAB MODEL BIOL SOC T
   Fisman DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083622
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imai N., 2020, 3 IMP COLL LOND
   Imai N, 2020, 2 IMP COLL LOND
   JHU IDD Team, 2020, 2019 NCOV GLOB CAS C
   Kucharski A., 2020, CMMID NCOV WORKING G
   Lauer S., 2020, UNSW SYDNEY RCITI TE
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Linton NM, 2020, EPIDEMIOLOGICAL CHAR, DOI [10.1101/2020.01.26.20018754, DOI 10.1101/2020.01.26.20018754]
   Liu T., 2020, TRANSMISSION DYNAMIC, DOI [10.1101/2020.01.25.919787, DOI 10.1101/2020.01.25.919787]
   Majumder M., 2020, EARLY TRANSMISSIBILI, DOI [10.2139/ssrn.3524675, DOI 10.2139/SSRN.3524675]
   National Health Commission of the People's Republic of China, 2020, WORK BEG MOB HOSP WU
   National Health Commission of the People's Republic of China, 2020, MED FLOOD HUB FIGHT
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020419
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   NPR, 2020, CHIN AUTH BEG QUAR W
   Park SW, 2020, RECONCILING EARLY OU, DOI [10.1101/2020.01.30.20019877, DOI 10.1101/2020.01.30.20019877]
   PARRY J, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/bmj.m56
   Quilty B., 2020, CMMID NCOV WORKING G
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [DOI 10.1101/2020.01.23.20018549, 10.1101/2020.01.23.20018549]
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Riou J., 2020, PATTERN EARLY HUMAN, DOI [10.1101/2020.01.23.917351, DOI 10.1101/2020.01.23.917351]
   Shen M., 2020, MODELLING EPIDEMIC T
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
   WHO, 2020, NOV COR THAIL EX CHI
   WHO, 2020, STAT REG CLUST PNEUM
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
   Zheng Q., 2020, JHU IDD TEAM REAL TI
NR 39
TC 1
Z9 1
U1 9
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 571
DI 10.3390/jcm9020571
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000283
PM 32093043
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Cong, YY
   Ulasli, M
   Schepers, H
   Mauthe, M
   V'kovski, P
   Kriegenburg, F
   Thiel, V
   de Haan, CAM
   Reggiori, F
AF Cong, Yingying
   Ulasli, Mustafa
   Schepers, Hein
   Mauthe, Mario
   V'kovski, Philip
   Kriegenburg, Franziska
   Thiel, Volker
   de Haan, Cornelis A. M.
   Reggiori, Fulvio
TI Nucleocapsid Protein Recruitment to Replication-Transcription Complexes
   Plays a Crucial Role in Coronaviral Life Cycle
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE coronavirus; nucleocapsid N protein; replication-transcription
   complexes; viral mRNA synthesis
ID MOUSE HEPATITIS-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS;
   INFECTIOUS-BRONCHITIS VIRUS; N-TERMINAL DOMAIN; MURINE CORONAVIRUS;
   RNA-BINDING; PHOSPHORYLATION; MEMBRANE; MULTIMERIZATION; NUCLEOPROTEIN
AB Coronavirus (CoV) nucleocapsid (N) proteins are key for incorporating genomic RNA into progeny viral particles. In infected cells, N proteins are present at the replication-transcription complexes (RTCs), the sites of CoV RNA synthesis. It has been shown that N proteins are important for viral replication and that the one of mouse hepatitis virus (MHV), a commonly used model CoV, interacts with nonstructural protein 3 (nsp3), a component of the RTCs. These two aspects of the CoV life cycle, however, have not been linked. We found that the MHV N protein binds exclusively to nsp3 and not other RTC components by using a systematic yeast two-hybrid approach, and we identified two distinct regions in the N protein that redundantly mediate this interaction. A selective N protein variant carrying point mutations in these two regions fails to bind nsp3 in vitro, resulting in inhibition of its recruitment to RTCs in vivo. Furthermore, in contrast to the wild-type N protein, this N protein variant impairs the stimulation of genomic RNA and viral mRNA transcription in vivo and in vitro, which in turn leads to impairment of MHV replication and progeny production. Altogether, our results show that N protein recruitment to RTCs, via binding to nsp3, is an essential step in the CoV life cycle because it is critical for optimal viral RNA synthesis.
   IMPORTANCE CoVs have long been regarded as relatively harmless pathogens for humans. Severe respiratory tract infection outbreaks caused by severe acute respiratory syndrome CoV and Middle East respiratory syndrome CoV, however, have caused high pathogenicity and mortality rates in humans. These outbreaks highlighted the relevance of being able to control CoV infections. We used a model CoV, MHV, to investigate the importance of the recruitment of N protein, a central component of CoV virions, to intracellular platforms where CoVs replicate, transcribe, and translate their genomes. By identifying the principal binding partner at these intracellular platforms and generating a specific mutant, we found that N protein recruitment to these locations is crucial for promoting viral RNA synthesis. Moreover, blocking this recruitment strongly inhibits viral infection. Thus, our results explain an important aspect of the CoV life cycle and reveal an interaction of viral proteins that could be targeted in antiviral therapies.
C1 [Cong, Yingying; Schepers, Hein; Mauthe, Mario; Kriegenburg, Franziska; Reggiori, Fulvio] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Groningen, Netherlands.
   [Ulasli, Mustafa; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.
   [V'kovski, Philip; Thiel, Volker] Inst Virol & Immunol, Bern, Switzerland.
   [V'kovski, Philip; Thiel, Volker] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Virol Div, Utrecht, Netherlands.
RP Reggiori, F (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Groningen, Netherlands.
EM f.m.reggiori@umcg.nl
RI Reggiori, Fulvio/U-8327-2019
OI Reggiori, Fulvio/0000-0003-2652-2686
FU SNF Sinergia [CRSII3_154421]; ZonMW VICI [016.130.606]; Chinese
   Scholarship CouncilChina Scholarship Council [CSC 201406610008]
FX ;This work was supported by SNF Sinergia (grant CRSII3_154421) and ZonMW
   VICI (grant 016.130.606) grants to F.R. Y.C. was supported by a Chinese
   Scholarship Council PhD fellowship (grant CSC 201406610008). The funders
   had no role in study design, data collection and interpretation, or the
   decision to submit the work for publication.
CR Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004
   Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13
   Brockway SM, 2003, J VIROL, V77, P10515, DOI 10.1128/JVI.77.19.10515-10527.2003
   Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9
   Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069
   Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005
   Cong YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06062-w
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005
   de Haan CAM, 2003, J VIROL, V77, P11312, DOI 10.1128/JVI.77.21.11312-11323.2003
   de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412
   Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999
   Emery V C, 1992, Methods Mol Biol, V8, P287, DOI 10.1385/0-89603-191-8:287
   Eriksson Klara Kristin, 2008, V454, P237, DOI 10.1007/978-1-59745-181-9_18
   Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002
   Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040
   Gui M, 2017, PROTEIN CELL, V8, P219, DOI 10.1007/s13238-016-0352-8
   Hagemeijer MC, 2012, VIRUSES-BASEL, V4, P3245, DOI 10.3390/v4113245
   Hagemeijer MC, 2010, J VIROL, V84, P2134, DOI 10.1128/JVI.01716-09
   Hurst KR, 2013, J VIROL, V87, P9159, DOI 10.1128/JVI.01275-13
   Hurst KR, 2010, J VIROL, V84, P10276, DOI 10.1128/JVI.01287-10
   James P, 1996, GENETICS, V144, P1425
   Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06
   Keane SC, 2013, J VIROL, V87, P3502, DOI 10.1128/JVI.03112-12
   Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226
   Krupovic M, 2017, P NATL ACAD SCI USA, V114, pE2401, DOI 10.1073/pnas.1621061114
   Kuo L, 2016, J VIROL, V90, P4357, DOI 10.1128/JVI.03212-15
   Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016
   Ma YL, 2010, PROTEIN CELL, V1, P688, DOI 10.1007/s13238-010-0079-x
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06
   Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06
   Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005
   Schiller JJ, 1998, VIROLOGY, V242, P288, DOI 10.1006/viro.1997.9010
   SCHWARZ B, 1990, J VIROL, V64, P4784, DOI 10.1128/JVI.64.10.4784-4791.1990
   Sims AC, 2000, J VIROL, V74, P5647, DOI 10.1128/JVI.74.12.5647-5654.2000
   Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05
   Spencer KA, 2008, VIROLOGY, V370, P373, DOI 10.1016/j.virol.2007.08.016
   Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027
   Tatar G, 2016, CURR COMPUT-AID DRUG, V12, P98, DOI 10.2174/1573409912666160226131253
   Thiel V, 2001, J VIROL, V75, P6676, DOI 10.1128/JVI.75.14.6676-6681.2001
   Ulasli M, 2010, CELL MICROBIOL, V12, P844, DOI 10.1111/j.1462-5822.2010.01437.x
   V'kovski P, 2019, ELIFE, V8, DOI 10.7554/eLife.42037
   van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999
   van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054
   Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10
   Verheije MH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000088
   von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009
   Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200
   Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035
   Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09
NR 58
TC 1
Z9 1
U1 9
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2020
VL 94
IS 4
AR e01925-19
DI 10.1128/JVI.01925-19
PG 21
WC Virology
SC Virology
GA KH7ZA
UT WOS:000510867500027
PM 31776274
OA Bronze
DA 2020-04-03
ER

PT J
AU Grunewald, ME
   Shaban, MG
   Mackin, SR
   Fehr, AR
   Perlman, S
AF Grunewald, Matthew E.
   Shaban, Mohamed G.
   Mackin, Samantha R.
   Fehr, Anthony R.
   Perlman, Stanley
TI Murine Coronavirus Infection Activates the Aryl Hydrocarbon Receptor in
   an Indoleamine 2,3-Dioxygenase-Independent Manner, Contributing to
   Cytokine Modulation and Proviral TCDD-Inducible-PARP Expression
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE AhR; IDO1; TiPARP; coronavirus; mouse hepatitis virus
ID MOUSE HEPATITIS-VIRUS; DENDRITIC CELLS; AH RECEPTOR; IDO EXPRESSION; I
   INTERFERON; CROSS-TALK; T-CELLS; TRYPTOPHAN; LIGAND; INDUCTION
AB The aryl hydrocarbon receptor (AhR) is a cytoplasmic receptor/transcription factor that modulates several cellular and immunological processes following activation by pathogen-associated stimuli, though its role during virus infection is largely unknown. Here, we show that AhR is activated in cells infected with mouse hepatitis virus (MHV), a coronavirus (CoV), and contributes to the upregulation of downstream effector TCDD-inducible poly(ADP-ribose) polymerase (TiPARP) during infection. Knockdown of TiPARP reduced viral replication and increased interferon expression, suggesting that TiPARP functions in a proviral manner during MHV infection. We also show that MHV replication induced the expression of other genes known to be downstream of AhR in macrophages and dendritic cells and in livers of infected mice. Further, we found that chemically inhibiting or activating AhR reciprocally modulated the expression levels of cytokines induced by infection, specifically, interleukin 1 beta (IL-1 beta), IL-10, and tumor necrosis factor alpha (TNF-alpha), consistent with a role for AhR activation in the host response to MHV infection. Furthermore, while indoleamine 2,3-dioxygenase (IDO1) drives AhR activation in other settings, MHV infection induced equal expression of downstream genes in wild-type (WT) and IDO1(-/-) macrophages, suggesting an alternative pathway of AhR activation. In summary, we show that coronaviruses elicit AhR activation by an IDO1-independent pathway, contributing to upregulation of downstream effectors, including the proviral factor TiPARP, and to modulation of cytokine gene expression, and we identify a previously unappreciated role for AhR signaling in CoV pathogenesis.
   IMPORTANCE Coronaviruses are a family of positive-sense RNA viruses with human and agricultural significance. Characterizing the mechanisms by which coronavirus infection dictates pathogenesis or counters the host immune response would provide targets for the development of therapeutics. Here, we show that the aryl hydrocarbon receptor (AhR) is activated in cells infected with a prototypic coronavirus, mouse hepatitis virus (MHV), resulting in the expression of several effector genes. AhR is important for modulation of the host immune response to MHV and plays a role in the expression of TiPARP, which we show is required for maximal viral replication. Taken together, our findings highlight a previously unidentified role for AhR in regulating coronavirus replication and the immune response to the virus.
C1 [Grunewald, Matthew E.; Shaban, Mohamed G.; Mackin, Samantha R.; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.
   [Fehr, Anthony R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.
RP Perlman, S (reprint author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.
EM stanley-perlman@uiowa.edu
OI Fehr, Anthony/0000-0003-1560-1573
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [ROI NS36592, CoBRE P20 GM113117-02,
   K22 AI134993-01]; University of Kansas
FX This study was supported in part by grants from the NIH (ROI NS36592
   [S.P.], CoBRE P20 GM113117-02 [A.R.F.], and K22 AI134993-01 [A.R.F.])
   and the University of Kansas (A.R.F.).
CR Ahmed S, 2015, J BIOL CHEM, V290, P16824, DOI 10.1074/jbc.M115.660100
   Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912
   Bankoti J, 2010, TOXICOL APPL PHARM, V246, P18, DOI 10.1016/j.taap.2010.03.013
   Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343
   Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323
   Bittinger MA, 2003, MOL PHARMACOL, V64, P550, DOI 10.1124/mol.64.3.550
   Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306
   Fehr AR, 2016, MBIO, V7, DOI 10.1128/mBio.01721-16
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915
   Grunewald ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007756
   Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012
   Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p
   Ireland DDC, 2008, J VIROL, V82, P300, DOI 10.1128/JVI.01794-07
   Kashuba EV, 2006, J BIOL CHEM, V281, P1215, DOI 10.1074/jbc.M509036200
   Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832
   Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560
   Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07
   Kueck T, 2018, ELIFE, V7, DOI 10.7554/eLife.38867
   Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615
   Litzenburger UM, 2014, ONCOTARGET, V5, P1038, DOI 10.18632/oncotarget.1637
   Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987
   Masuda K, 2011, INT IMMUNOL, V23, P637, DOI 10.1093/intimm/dxr072
   Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457
   Metz R, 2012, ONCOIMMUNOLOGY, V1, P1460, DOI 10.4161/onci.21716
   Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20
   Murakami Y, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/391984
   Navas S, 2003, J VIROL, V77, P4972, DOI 10.1128/JVI.77.8.4972-4978.2003
   Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102
   Ohashi H, 2018, J BIOL CHEM, V293, P19559, DOI 10.1074/jbc.RA118.005033
   Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491
   Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19
   Pallotta MT, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00497
   Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814
   Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880
   Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107
   Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109
   Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08
   Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8
   Salazar F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43337
   Salisbury RL, 2015, TOXICOL SCI, V148, P443, DOI 10.1093/toxsci/kfv193
   Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187
   Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09
   Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899
   Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881
   Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020
   Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032
   Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578
   Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036
   Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109
   Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200
   Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422
   Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002
   Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217
   Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06
   Zhou HX, 2006, J VIROL, V80, P2506, DOI 10.1128/JVI.80.5.2506-2514.2006
NR 56
TC 1
Z9 1
U1 33
U2 33
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2020
VL 94
IS 3
AR e01743-19
DI 10.1128/JVI.01743-19
PG 17
WC Virology
SC Virology
GA KD6WN
UT WOS:000508005900023
PM 31694960
OA Bronze
DA 2020-04-03
ER

PT J
AU Pinana, JL
   Perez, A
   Montoro, J
   Hernani, R
   Lorenzo, I
   Gimenez, E
   Gomez, MD
   Guerreiro, M
   Gonzalez-Barbera, EM
   Carretero, C
   Salavert, M
   Balaguer-Rosello, A
   Sanz, G
   Hernandez-Boluda, JC
   Solano, C
   Sanz, J
   Navarro, D
AF Luis Pinana, Jose
   Perez, Ariadna
   Montoro, Juan
   Hernani, Rafael
   Lorenzo, Ignacio
   Gimenez, Estela
   Dolores Gomez, Maria
   Guerreiro, Manuel
   Maria Gonzalez-Barbera, Eva
   Carretero, Carlos
   Salavert, Miguel
   Balaguer-Rosello, Aitana
   Sanz, Guillermo
   Carlos Hernandez-Boluda, Juan
   Solano, Carlos
   Sanz, Jaime
   Navarro, David
TI The effect of timing on community acquired respiratory virus infection
   mortality during the first year after allogeneic hematopoietic stem cell
   transplantation: a prospective epidemiological survey
SO BONE MARROW TRANSPLANTATION
LA English
DT Article
ID BONE-MARROW TRANSPLANTS; VERSUS-HOST-DISEASE; SYNCYTIAL VIRUS;
   PARAINFLUENZA VIRUS; RISK-FACTORS; AEROSOLIZED RIBAVIRIN; HUMAN
   METAPNEUMOVIRUS; INFLUENZA INFECTIONS; STATISTICAL-METHODS; HUMAN
   CORONAVIRUS
AB The effect of timing of community acquired respiratory virus (CARV) infection after allogeneic hematopoietic stem cell transplant (allo-HCT) is an as yet unsettled issue. We evaluate this issue by including all consecutive allo-HCT recipients with molecularly-documented CARV infection during the first year after transplant. The study cohort was drawn from a prospective longitudinal survey of CARV in allo-HCT recipient having respiratory symptoms conducted from December 2013 to December 2018 at two Spanish transplant centers. Respiratory viruses in upper and/or lower respiratory specimens were tested using multiplex PCR panel assays. The study cohort comprised 233 allo-HCT recipients with 376 CARV infection episodes diagnosed during the first year after allo-HCT. Overall, 60% of CARV episodes occurred within the first 6 months (227 out of 376). Thirty patients (13%) had died at 3 months after CARV detection, of which 25 (83%) were recipients developing CARV within the first 6 months after transplant. Multivariate analysis identified four risk factors for mortality: ATG used as part of conditioning regimen [odds ratio (OR) 2.8, 95% confidence interval (C.I.) 1.21-6.4, p = 0.01], CARV lower respiratory tract disease (OR 3.4, 95% C.I. 1.4-8.4, p = 0.007), CARV infection within the first 6 months of transplant (OR 3.04, 95% C.I. 1.1-8.7, p = 0.03), and absolute lymphocyte count <0.2 x 109/L (OR 2.4, 95% C.I. 1-5.3, p = 0.04). Developing CARV infection within the first 6 months was associated with higher mortality. Our data supports that the timing of CARV development after allo-HCT could be of major interest.
C1 [Luis Pinana, Jose; Montoro, Juan; Lorenzo, Ignacio; Guerreiro, Manuel; Carretero, Carlos; Balaguer-Rosello, Aitana; Sanz, Guillermo; Sanz, Jaime] Hosp Univ & Politecn La Fe, Hematol Dept, Valencia, Spain.
   [Luis Pinana, Jose; Sanz, Guillermo; Sanz, Jaime] Inst Carlos III, CIBERONC, Madrid, Spain.
   [Perez, Ariadna; Hernani, Rafael; Carlos Hernandez-Boluda, Juan; Solano, Carlos] Hosp Clin Univ, INCLIVA Res Inst, Hematol Dept, Valencia, Spain.
   [Gimenez, Estela; Navarro, David] Hosp Clin Univ, INCLIVA Res Inst, Microbiol Dept, Valencia, Spain.
   [Dolores Gomez, Maria; Maria Gonzalez-Barbera, Eva] Hosp Univ & Politecn La Fe, Microbiol Dept, Valencia, Spain.
   [Salavert, Miguel] Hosp Univ & Politecn La Fe, Dept Infect Dis, Valencia, Spain.
   [Carlos Hernandez-Boluda, Juan; Solano, Carlos] Univ Valencia, Sch Med, Dept Med, Valencia, Spain.
   [Navarro, David] Univ Valencia, Sch Med, Dept Microbiol, Valencia, Spain.
RP Pinana, JL (reprint author), Hosp Univ & Politecn La Fe, Hematol Dept, Valencia, Spain.; Pinana, JL (reprint author), Inst Carlos III, CIBERONC, Madrid, Spain.
EM jlpinana@gmail.com
RI ; Sanz, Jaime/F-8566-2018
OI Direito de Morais Guerreiro, Manuel Nuno/0000-0001-5978-2578; Pinana,
   Jose Luis/0000-0001-8533-2562; Sanz, Jaime/0000-0001-6934-4619; Balaguer
   Rosello, Aitana/0000-0003-1633-2918
CR Brendish NJ, 2017, CURR OPIN INFECT DIS, V30, P573, DOI [10.1097/QCO.0000000000000410, 10.1097/qco.0000000000000410]
   Campbell AP, 2015, CLIN INFECT DIS, V61, P192, DOI 10.1093/cid/civ272
   Chien JW, 2003, AM J RESP CRIT CARE, V168, P208, DOI 10.1164/rccm.200212-1468OC
   Erard V, 2006, J INFECT DIS, V193, P1619, DOI 10.1086/504268
   Hirsch HH, 2013, CLIN INFECT DIS, V56, P258, DOI 10.1093/cid/cis844
   Jacobs SE, 2013, TRANSPL INFECT DIS, V15, P474, DOI 10.1111/tid.12111
   Jiang LL, 2019, INFECT CONT HOSP EP, V40, P889, DOI 10.1017/ice.2019.141
   Khanna N, 2009, TRANSPL INFECT DIS, V11, P100, DOI 10.1111/j.1399-3062.2008.00362.x
   Kim YJ, 2014, J INFECT DIS, V209, P1195, DOI 10.1093/infdis/jit832
   Klein JP, 2001, BONE MARROW TRANSPL, V28, P909, DOI 10.1038/sj.bmt.1703260
   Klein JP, 2001, BONE MARROW TRANSPL, V28, P1001, DOI 10.1038/sj.bmt.1703271
   Kmeid J, 2016, BIOL BLOOD MARROW TR, V22, P542, DOI 10.1016/j.bbmt.2015.11.015
   Lehners N, 2013, BONE MARROW TRANSPL, V48, P1548, DOI 10.1038/bmt.2013.94
   Pinana JL, 2019, CLIN INFECT DIS, V68, P1894, DOI 10.1093/cid/ciy792
   Pinana JL, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12926
   Pinana JL, 2018, BIOL BLOOD MARROW TR, V24, P563, DOI 10.1016/j.bbmt.2017.11.001
   Martino R, 2005, BIOL BLOOD MARROW TR, V11, P781, DOI 10.1016/j.bbmt.2005.07.007
   Mohty M, 2003, BLOOD, V102, P470, DOI 10.1182/blood-2002-12-3629
   Ogimi C, 2017, J INFECT DIS, V216, P203, DOI 10.1093/infdis/jix264
   Ogimi C, 2017, CLIN INFECT DIS, V64, P1532, DOI 10.1093/cid/cix160
   Pinana JL, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12729
   Renaud C, 2013, BIOL BLOOD MARROW TR, V19, P1220, DOI 10.1016/j.bbmt.2013.05.005
   Seo S, 2017, HAEMATOLOGICA, V102, P1120, DOI 10.3324/haematol.2016.153767
   Seo S, 2014, CLIN INFECT DIS, V58, P1357, DOI 10.1093/cid/ciu134
   Seo S, 2013, BIOL BLOOD MARROW TR, V19, P589, DOI 10.1016/j.bbmt.2012.12.019
   Shah DP, 2014, BLOOD, V123, P3263, DOI 10.1182/blood-2013-12-541359
   Shah DP, 2013, J ANTIMICROB CHEMOTH, V68, P1872, DOI 10.1093/jac/dkt111
   Sheshadri A, 2019, BIOL BLOOD MARROW TR, V25, P800, DOI 10.1016/j.bbmt.2018.11.022
   Spahr Y, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy077
   Thomson BG, 2000, BLOOD, V96, P2703
   Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019
   Ustun C, 2012, BIOL BLOOD MARROW TR, V18, P1580, DOI 10.1016/j.bbmt.2012.04.012
   Vakil E, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12994
   Waghmare A, 2018, BIOL BLOOD MARROW TR, V1083-8791, P30804
   Waghmare A, 2016, BLOOD, V127, P2682, DOI [10.1182/blood-2016-01634873, 10.1182/blood-2016-01-634873]
   Williams JV, 2005, J INFECT DIS, V192, P1061, DOI 10.1086/432732
NR 36
TC 1
Z9 1
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0268-3369
EI 1476-5365
J9 BONE MARROW TRANSPL
JI Bone Marrow Transplant.
PD FEB
PY 2020
VL 55
IS 2
BP 431
EP 440
DI 10.1038/s41409-019-0698-7
PG 10
WC Biophysics; Oncology; Hematology; Immunology; Transplantation
SC Biophysics; Oncology; Hematology; Immunology; Transplantation
GA KI2KH
UT WOS:000511176900020
PM 31551521
DA 2020-04-03
ER

PT J
AU Thompson, RN
AF Thompson, Robin N.
TI Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance
   Is Vital for Preventing Sustained Transmission in New Locations
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE 2019-nCoV; mathematical modelling; infectious disease epidemiology;
   major outbreak; forecasting; coronavirus; Wuhan; SARS
ID ACUTE RESPIRATORY SYNDROME; DISEASE; SARS; VIRUS
AB The outbreak of pneumonia originating in Wuhan, China, has generated 24,500 confirmed cases, including 492 deaths, as of 5 February 2020. The virus (2019-nCoV) has spread elsewhere in China and to 24 countries, including South Korea, Thailand, Japan and USA. Fortunately, there has only been limited human-to-human transmission outside of China. Here, we assess the risk of sustained transmission whenever the coronavirus arrives in other countries. Data describing the times from symptom onset to hospitalisation for 47 patients infected early in the current outbreak are used to generate an estimate for the probability that an imported case is followed by sustained human-to-human transmission. Under the assumptions that the imported case is representative of the patients in China, and that the 2019-nCoV is similarly transmissible to the SARS coronavirus, the probability that an imported case is followed by sustained human-to-human transmission is 0.41 (credible interval [0.27, 0.55]). However, if the mean time from symptom onset to hospitalisation can be halved by intense surveillance, then the probability that an imported case leads to sustained transmission is only 0.012 (credible interval [0, 0.099]). This emphasises the importance of current surveillance efforts in countries around the world, to ensure that the ongoing outbreak will not become a global pandemic.
C1 [Thompson, Robin N.] Univ Oxford, Math Inst, Woodstock Rd, Oxford OX2 6GG, England.
   [Thompson, Robin N.] Univ Oxford, Christ Church, Oxford OX1 1DP, England.
RP Thompson, RN (reprint author), Univ Oxford, Math Inst, Woodstock Rd, Oxford OX2 6GG, England.; Thompson, RN (reprint author), Univ Oxford, Christ Church, Oxford OX1 1DP, England.
EM robin.thompson@chch.ox.ac.uk
OI Thompson, Robin/0000-0001-8545-5212
FU Christ Church, Oxford, via a Junior Research Fellowship
FX This research was funded by Christ Church, Oxford, via a Junior Research
   Fellowship.
CR Allen LJS, 2012, J BIOL DYNAM, V6, P590, DOI 10.1080/17513758.2012.665502
   [Anonymous], 2011, BBC
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Feng D, 2009, TROP MED INT HEALTH, V14, P28, DOI 10.1111/j.1365-3156.2008.02188.x
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Imai N., 2020, REPORT 1 ESTIMATING
   Imai N, 2020, REPORT 3 TRANSMISSIB
   Kraemer M., 2020, EPIDEMIOLOGICAL DATA
   Kupferschmidt K., STUDY CLAIMING NEW C
   Lipsitch M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003846
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Parry J, 2003, BRIT MED J, V326, P897, DOI 10.1136/bmj.326.7395.897
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356
   Thompson RN, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0274
   Thompson R, 2020, LANCET INFECT DIS, V20, P280, DOI 10.1016/S1473-3099(20)30068-2
   Thompson RN, 2019, LANCET INFECT DIS, V19, P1058, DOI 10.1016/S1473-3099(19)30483-9
   Thompson RN, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004836
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044
NR 29
TC 1
Z9 1
U1 5
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 498
DI 10.3390/jcm9020498
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000210
PM 32054124
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Wang, LS
   Shi, Y
   Xiao, TT
   Fu, JH
   Feng, X
   Mu, DZ
   Feng, Q
   Hei, MY
   Hu, XJ
   Li, ZK
   Lu, GP
   Tang, ZZ
   Wang, YJ
   Wang, CQ
   Xia, SW
   Xu, JQ
   Yang, YJ
   Yang, J
   Zeng, M
   Zheng, J
   Zhou, W
   Zhou, XY
   Zhou, XG
   Du, LZ
   Lee, SK
   Zhou, WH
AF Wang, Laishuan
   Shi, Yuan
   Xiao, Tiantian
   Fu, Jianhua
   Feng, Xing
   Mu, Dezhi
   Feng, Qi
   Hei, Mingyan
   Hu, Xiaojing
   Li, Zhankui
   Lu, Guoping
   Tang, Zezhong
   Wang, Yajuan
   Wang, Chuanqing
   Xia, Shiwen
   Xu, Jianqing
   Yang, Yujia
   Yang, Jie
   Zeng, Mei
   Zheng, Jun
   Zhou, Wei
   Zhou, Xiaoyu
   Zhou, Xiaoguang
   Du, Lizhong
   Lee, Shoo K.
   Zhou, Wenhao
CA Working Comm Perinatal Neona
TI Chinese expert consensus on the perinatal and neonatal management for
   the prevention and control of the 2019 novel coronavirus infection
   (First edition)
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Novel coronavirus; perinatology; neonate
AB Since December 2019, there has been an outbreak of novel coronavirus (2019-nCoV) infection in China. Two cases of neonates with positive 2019-nCoV tests have been reported. Due to the immature immune system and the possibility of vertical transmission from mother to infant, neonates have become a high-risk group susceptible to 2019-nCoV, which emphasize a close cooperation from both perinatal and neonatal pediatrics. In neonatal intensive care unit (NICU), to prevent and control infection, there should be practical measures to ensure the optimal management of children potentially to be infected. According to the latest 2019-nCoV national management plan and the actual situation, the Chinese Neonatal 2019-nCoV expert working Group has put forward measures on the prevention and control of neonatal 2019-nCoV infection.
C1 [Wang, Laishuan; Hu, Xiaojing; Lu, Guoping; Wang, Chuanqing; Zeng, Mei; Zhou, Wenhao] Fudan Univ, Dept Pediat, Childrens Hosp, Shanghai 201102, Peoples R China.
   [Shi, Yuan] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 401122, Peoples R China.
   [Xiao, Tiantian] Univ Elect Sci & Technol China, Sch Med, Chengdu Womens & Childrens Cent Hosp, Dept Neonatol, Chengdu 611731, Peoples R China.
   [Fu, Jianhua] China Med Univ, Shengjing Hosp, Dept Neonatol, Shenyang 110004, Peoples R China.
   [Feng, Xing] Soochow Univ, Childrens Hosp, Dept Neonatol, Suzhou 215025, Peoples R China.
   [Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China.
   [Feng, Qi; Tang, Zezhong] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   [Hei, Mingyan; Wang, Yajuan] Capital Med Univ, Beijing Childrens Hosp, Neonatal Ctr, Beijing 100045, Peoples R China.
   [Li, Zhankui] Northwest Women & Childrens Hosp, Dept Neonatol, Xian 610113, Peoples R China.
   [Xia, Shiwen] Hubei Maternal & Child Hlth Hosp, Dept Neonatol, Wuhan 430070, Peoples R China.
   [Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr & Inst Biomed Sci, Shanghai 200000, Peoples R China.
   [Yang, Yujia] Cent S Univ, Xiangya Hosp, Dept Pediat, Changsha 410008, Peoples R China.
   [Yang, Jie] Guangzhou Med Univ, Guangdong Maternal & Childrens Hosp, Dept Neonatol, Guangzhou 511400, Peoples R China.
   [Zheng, Jun] Tianjin Cent Hosp Gynecol Obstet, Dept Neonatol, Tianjin 300052, Peoples R China.
   [Zhou, Wei] Guangzhou Med Univ Guangzhou, Guangzhou Women & Childrens Med Ctr, Dept Neonatol, Guangzhou, Peoples R China.
   [Zhou, Xiaoyu; Zhou, Xiaoguang] Nanjing Med Univ, Childrens Hosp, Neonatal Med Ctr, Nanjing 210008, Peoples R China.
   [Du, Lizhong] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neonatol, Hangzhou 310052, Peoples R China.
   [Lee, Shoo K.] Mt Sinai Hosp, Maternal Infant Care Res Ctr, Toronto, ON, Canada.
   [Lee, Shoo K.] Mt Sinai Hosp, Dept Pediat, Toronto, ON, Canada.
   [Lee, Shoo K.] Univ Toronto, Dept Obstet & Gynecol, Dept Pediat, Toronto, ON, Canada.
   [Lee, Shoo K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
RP Zhou, WH (reprint author), Fudan Univ, Dept Pediat, Childrens Hosp, Shanghai 201102, Peoples R China.; Lee, SK (reprint author), Mt Sinai Hosp, Maternal Infant Care Res Ctr MiCARE, Toronto, ON, Canada.; Lee, SK (reprint author), Univ Toronto, Pediat Obstet & Gynecol, Toronto, ON, Canada.; Zhou, WH (reprint author), Fudan Univ, Childrens Hosp, Dept Neonatol, 399 Wanyuan Rd, Shanghai 201102, Peoples R China.
EM shoo.lee@sinaihealthsystem.ca; zhouwenhao@fudan.edu.cn
CR [Anonymous], 2020, DIAGN MAN PLAN PNEUM
   Azhar EI, 2019, INFECT DIS CLIN N AM, V33, P891, DOI 10.1016/j.idc.2019.08.001
   Cai JH, 2020, CHIN J PEDIAT, V58, pE002
   Fang F, 2020, Zhonghua Er Ke Za Zhi, V58, P81, DOI 10.3760/cma.j.issn.0578-1310.2020.02.001
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Li AM, 2005, ARCH DIS CHILD-FETAL, V90, pF461, DOI 10.1136/adc.2005.075309
   Maternal and Fetal Experts Committee Chinese Physician Society of Obstetrics and Gynecology Chinese Medical Doctor Association; Obstetric Subgroup Society of Obstetrics and Gynecology Chinese Medical Association; Society of Perinatal Medicine Chinese Medical Association; Editorial Board of Chinese Journal of Perinatal Medicine, 2020, CHIN J PERINAT MED, V23, P73
   Shek CC, 2003, PEDIATRICS, V112, pE254, DOI 10.1542/peds.112.4.e254
   World Health Organization, 2019, SARS SEV AC RESP SYN
   World Health Organization, 2020, LAB TEST 2019 NOV CO
   World Health OrganizationWHO, INT CLIN GUID MAN PA
   Zhang H, 2020, DIGESTIVE SYSTEM IS
   Zhang NR, 2020, J MED VIROL, V92, P408, DOI 10.1002/jmv.25674
   Zhu N, 2019, N ENGL J MED, V2020
NR 14
TC 1
Z9 1
U1 25
U2 25
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD FEB
PY 2020
VL 8
IS 3
AR 47
DI 10.21037/atm.2020.02.20
PG 8
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA KN0RI
UT WOS:000514545800011
PM 32154287
OA Other Gold, Green Published
DA 2020-04-03
ER

PT J
AU Bassetti, M
   Vena, A
   Giacobbe, DR
AF Bassetti, Matteo
   Vena, Antonio
   Giacobbe, Daniele Roberto
TI The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for
   fighting the storm
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
C1 [Bassetti, Matteo; Vena, Antonio; Giacobbe, Daniele Roberto] Univ Genoa, Dept Hlth Sci, Genoa, Italy.
   [Bassetti, Matteo; Vena, Antonio; Giacobbe, Daniele Roberto] Osped Policlinico San Martino IRCCS, Clin Malattie Infett, Lgo R Benzi 10, I-16132 Genoa, Italy.
RP Bassetti, M (reprint author), Osped Policlinico San Martino IRCCS, Clin Malattie Infett, Lgo R Benzi 10, I-16132 Genoa, Italy.
EM matteo.bassetti@unige.it
RI Ribeiro, Nuno/AAH-2299-2020
OI Giacobbe, Daniele Roberto/0000-0003-2385-1759
CR Callaway E, 2020, NATURE, DOI [10.1038/d41586-020-00180-8, DOI 10.1038/D41586-020-00180-8]
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Heymann DL, 2020, LANCET
   Huang C, 2020, LANCET
   Ji W, 2020, J MED VIROL
   Mo Y, 2016, J ANTIMICROB CHEMOTH, V71, P3340, DOI 10.1093/jac/dkw338
   Munster VJ, 2020, NEW ENGLAND J MED
   Paules CI, 2020, JAMA
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867
   Zhu N, 2019, N ENGL J MED, V2020
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 13
TC 1
Z9 1
U1 82
U2 82
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2972
EI 1365-2362
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD MAR
PY 2020
VL 50
IS 3
DI 10.1111/eci.13209
EA JAN 2020
PG 4
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA KS9EZ
UT WOS:000510768300001
PM 32003000
OA Bronze
DA 2020-04-03
ER

PT J
AU Chen, R
   Fu, JY
   Hu, JF
   Li, C
   Zhao, YJ
   Qu, H
   Wen, XT
   Cao, SJ
   Wen, YP
   Wu, R
   Zhao, Q
   Yan, QG
   Huang, Y
   Ma, XP
   Han, XF
   Huang, XB
AF Chen, Rui
   Fu, Jiayu
   Hu, Jingfei
   Li, Cheng
   Zhao, Yujia
   Qu, Huan
   Wen, Xintian
   Cao, Sanjie
   Wen, Yiping
   Wu, Rui
   Zhao, Qin
   Yan, Qigui
   Huang, Yong
   Ma, Xiaoping
   Han, Xinfeng
   Huang, Xiaobo
TI Identification of the immunodominant neutralizing regions in the spike
   glycoprotein of porcine deltacoronavirus
SO VIRUS RESEARCH
LA English
DT Article
DE Porcine deltacoronavirus (PDCoV); Spike glycoprotein; Epitope region;
   Neutralizing antibody
ID RECEPTOR-BINDING DOMAIN; RESPIRATORY SYNDROME CORONAVIRUS;
   GENETIC-CHARACTERIZATION; CRYSTAL-STRUCTURE; PROTEIN; DIARRHEA; VIRUS;
   PIGS; PATHOGENICITY; PREVALENCE
AB Porcine deltacoronavirus (PDCoV), is an emerging enteropathogenic coronavirus in pigs, that poses a novel threat to swine husbandry worldwide. Crucial to halting PDCoV transmission and infection is the development of effective therapies and vaccines. The spike (S) protein of coronavirus is the major target of host neutralizing antibodies, however the immunodominant neutralizing region in the S protein of PDCoV has not been defined. Here, three truncations of the PDCoV S protein were generated, the N-terminal domain of the S1 subunit (NTD, amino acids (aa) 50-286), the C-terminal domain of the S1 subunit (CTD, aa 278-616), and S2 subunit (aa 601-1087). The proteins were expressed using an E. coli expression system. Polyclonal antisera against the three recombinant proteins were produced in rabbits and mice. All three antisera were able to inhibit PDCoV infection in vitro, as determined by virus neutralization assay, fluorescent focus neutralization assay, and plaque-reduction neutralization. The CTD-specific antisera had the most potent PDCoV-neutralizing effect, indicating that the CTD region may contain the major neutralizing epitope(s) in the PDCoV S protein. Based on these findings, CTD may be a promising target for development of an effective vaccine against PDCoV infection in pigs.
C1 [Chen, Rui; Fu, Jiayu; Hu, Jingfei; Li, Cheng; Zhao, Yujia; Qu, Huan; Wen, Xintian; Cao, Sanjie; Wen, Yiping; Wu, Rui; Zhao, Qin; Huang, Xiaobo] Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu 611130, Peoples R China.
   [Cao, Sanjie; Yan, Qigui; Huang, Yong; Ma, Xiaoping; Han, Xinfeng; Huang, Xiaobo] Minist Agr, Sichuan Sci Observat Expt Stn Vet Drugs & Vet Dia, Chengdu 611130, Peoples R China.
   [Cao, Sanjie; Huang, Xiaobo] Sichuan Agr Univ, Natl Anim Expt Teaching Demonstrat Ctr, Chengdu 611130, Peoples R China.
RP Huang, XB (reprint author), Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu 611130, Peoples R China.
EM 18102341339@163.com; 673446390@qq.com; 14074887@qq.com;
   1247695208@qq.com; zhaoyujia2015@163.com; 1157759897@qq.com;
   xintian3211@126.com; csanjie@sicau.edu.cn; yueliang5189@163.com;
   wurui1977@163.com; 601416670@qq.com; yanqigui@126.com; hyong601@163.com;
   mxp886@sina.com.cn; hanxinf@163.com; rsghb110@126.com
FU National Key Research and Development Program of China [2016YFD0500700]
FX This study was supported by the National Key Research and Development
   Program of China (award 2016YFD0500700). We thank Dr. Kwonil Jung from
   the Ohio State University for critical reading and editing of the
   manuscript.
CR Chen YZ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.50
   Cruz DJM, 2008, VIRUS RES, V132, P192, DOI 10.1016/j.virusres.2007.10.015
   Deng F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030055
   Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587
   Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13
   Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777
   Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757
   GODET M, 1994, J VIROL, V68, P8008, DOI 10.1128/JVI.68.12.8008-8016.1994
   Hain KS, 2016, J GEN VIROL, V97, P2719, DOI 10.1099/jgv.0.000586
   He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908
   He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106
   Hou XY, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030106
   Hu H, 2016, ARCH VIROL, V161, P3421, DOI 10.1007/s00705-016-3056-8
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Lee S., 2014, GENOME ANNOUNC, V2
   Lee S, 2015, VIRUS RES, V208, P136, DOI 10.1016/j.virusres.2015.06.013
   Li C, 2017, J VIROL, V91, DOI 10.1128/JVI.01830-16
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li G., 2014, GENOME ANNOUNCEMENTS, V2
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114
   Liu C, 2016, J BIOL CHEM, V291, P24779, DOI 10.1074/jbc.M116.740746
   Luo SX, 2017, J VIROL METHODS, V249, P76, DOI 10.1016/j.jviromet.2017.08.020
   Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15
   Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63
   Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13
   Okda F, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0500-z
   Okda FA, 2017, VIROLOGY, V509, P185, DOI 10.1016/j.virol.2017.06.013
   Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210
   Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108
   Quan KJ, 2018, J MICROBIOL BIOTECHN, V28, P2095, DOI 10.4014/jmb.1809.09004
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585
   Shang J., 2017, J VIROL, V92
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Song QY, 2016, VIRUS RES, V226, P85, DOI 10.1016/j.virusres.2016.06.002
   SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939
   Suzuki T, 2018, INFECT GENET EVOL, V61, P176, DOI 10.1016/j.meegid.2018.03.030
   Tai W, 2017, J VIROL, V91, P1
   Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005
   Wang B., 2018, J VIROL, V92
   Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Xiong XL, 2018, J VIROL, V92
   Yoo DW, 2001, CLIN DIAGN LAB IMMUN, V8, P297, DOI 10.1128/CDLI.8.2.297-302.2001
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
   Zhu XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0068-3
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 50
TC 1
Z9 1
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 15
PY 2020
VL 276
AR 197834
DI 10.1016/j.virusres.2019.197834
PG 9
WC Virology
SC Virology
GA KG2NC
UT WOS:000509778600022
PM 31816342
OA Bronze
DA 2020-04-03
ER

PT J
AU Checovich, MM
   Barlow, S
   Shult, P
   Reisdorf, E
   Temte, JL
AF Checovich, Mary M.
   Barlow, Shari
   Shult, Peter
   Reisdorf, Erik
   Temte, Jonathan L.
TI Evaluation of Viruses Associated With Acute Respiratory Infections in
   Long-Term Care Facilities Using a Novel Method: Wisconsin, 2016-2019
SO JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
LA English
DT Article
DE Long-term care; acute respiratory infection; rapid influenza diagnostic
   testing; influenza
ID INFLUENZA-LIKE ILLNESS; NURSING-HOME; RESIDENTS; OUTBREAKS
AB Residents of long-term care facilities (LCTFs) have high morbidity and mortality associated with acute respiratory infections (ARIs). Limited information exists on the virology of ARI in LTCFs, where virological testing is reactive. We report on findings of a surveillance feasibility substudy from a larger prospective trial of introducing rapid influenza diagnostic testing (RIDT) at 10 Wisconsin LTCFs. Any resident with symptoms consistent with ARI had a nasal swab specimen collected for RIDT by staff. Following RIDT, the residual swab was placed into viral transport medium and tested for influenza using Reverse transcription polymerase chain reaction, and for 20 pathogens using a multiplex polymerase chain reaction respiratory pathogen panel. Numbers of viruses in each of 7 categories (influenza A, influenza B, coro-naviruses, human metapneumovirus, parainfluenza, respiratory syncytial virus, and rhinovirus/enterovirus) across the 3 years were compared using chi(2). Totals of 160, 215, and 122 specimens were collected during 2016-2017, 2017-2018, and 2018-2019, respectively. Respiratory pathogen panel identified viruses in 54.8% of tested specimens. Influenza A (19.2%), influenza B (12.6%), respiratory syncytial virus (15.9%), and human metapneumovirus (20.9%) accounted for 69% of all detections, whereas coronaviruses (17.2%), rhinovirus/enterovirus (10.5%) and parainfluenza (3.8%) were less common. The distribution of viruses varied significantly across the 3 years (chi(2) = 71.663; df = 12; P < .001). Surveillance in LTCFs using nasal swabs collected for RIDT is highly feasible and yields high virus identification rates. Significant differences in virus composition occurred across the 3 study years. Simple approaches to surveillance may provide a more comprehensive assessment of respiratory viruses in LTCF settings. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
C1 [Checovich, Mary M.; Barlow, Shari; Temte, Jonathan L.] Univ Wisconsin, Dept Family Med & Community Hlth, Sch Med & Publ Hlth, 1100 Delaplaine Court, Madison, WI 53715 USA.
   [Shult, Peter; Reisdorf, Erik] Wisconsin State Lab Hyg, Madison, WI USA.
RP Checovich, MM (reprint author), Univ Wisconsin, Dept Family Med & Community Hlth, Sch Med & Publ Hlth, 1100 Delaplaine Court, Madison, WI 53715 USA.
EM mary.checovich@fammed.wisc.edu
FU Wisconsin Partnership Program at the UW School of Medicine and Public
   Health
FX Funding for this project was provided by the Wisconsin Partnership
   Program at the UW School of Medicine and Public Health. Quidel
   Corporation provided in-kind support.
CR Affifi RM, 2012, INFECT DIS REP, V4, P84, DOI 10.4081/idr.2012.e23
   CDC, 2014, CDC HUM INFL VIR REA
   Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P909
   Chasqueira MJ, 2018, INT J INFECT DIS, V69, P1, DOI 10.1016/j.ijid.2018.01.012
   Dowson L, 2019, AM J INFECT CONTROL, V47, P911, DOI 10.1016/j.ajic.2019.02.001
   Fowlkes A, 2013, INFLUENZA OTHER RESP, V7, P694, DOI 10.1111/irv.12014
   Gravenstein S, 2002, CLIN INFECT DIS, V35, P729, DOI 10.1086/341246
   Hartman L, 2018, J AM GERIATR SOC, V66, P467, DOI 10.1111/jgs.15298
   Kodama F, 2017, INFECT DIS CLIN N AM, V31, P767, DOI 10.1016/j.idc.2017.07.006
   Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x
   Luminex, NXTAG RESP PATH PAN
   Mahmud SM, 2013, INFLUENZA OTHER RESP, V7, P1055, DOI 10.1111/irv.12052
   Masse S, 2017, BIOMED RES INT, DOI 10.1155/2017/1423718
   Millership S, 2015, J HOSP INFECT, V90, P299, DOI 10.1016/j.jhin.2015.04.019
   Ursic T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1962-8
   Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI 10.1093/cid/ciy866
   Win MK, 2010, ANN ACAD MED SINGAP, V39, P448
   Wisconsin Department of Health Service, DEM AG WISC
   Wisconsin State Legislature, COMM DIS
NR 19
TC 1
Z9 1
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-8610
EI 1538-9375
J9 J AM MED DIR ASSOC
JI J. Am. Med. Dir. Assoc.
PD JAN
PY 2020
VL 21
IS 1
BP 29
EP 33
DI 10.1016/j.jamda.2019.09.003
PG 5
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA JY8VG
UT WOS:000504685400006
PM 31636034
OA Bronze
DA 2020-04-03
ER

PT J
AU Lee, CC
   Chang, JCY
   Mao, XW
   Hsu, WT
   Chen, SY
   Chen, YC
   How, CK
AF Lee, Chien-Chang
   Chang, Julia Chia-Yu
   Mao, Xiao-Wei
   Hsu, Wan-Ting
   Chen, Shey-Ying
   Chen, Yee-Chun
   How, Chorng-Kuang
TI Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing
   for Antibiotic Stewardship in Older Adult Patients With Severe Acute
   Respiratory Infection
SO JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
LA English
DT Article
DE Older adults; severe acute respiratory infections; coronavirus;
   influenza; human rhinovirus; point-of-care test; rapid PCR respiratory
   panel; viral panel; procalcitonin; antibiotic stewardship
ID POLYMERASE-CHAIN-REACTION; ANTIMICROBIAL STEWARDSHIP;
   DIAGNOSTIC-ACCURACY; CLINICAL-OUTCOMES; PCR ASSAY; INFLUENZA; IMPACT;
   PANEL
AB Objectives: Virus infection is underevaluated in older adults with severe acute respiratory infections (SARIs). We aimed to evaluate the clinical impact of combining point-of-care molecular viral test and serum procalcitonin (PCT) level for antibiotic stewardship in the emergency department (ED).
   Design: A prospective twin-center cohort study was conducted between January 2017 and March 2018.
   Setting and Participants: Older adult patients who presented to the ED with SARIs received a rapid molecular test for 17 respiratory viruses and a PCT test.
   Measures: To evaluate the clinical impact, we compared the outcomes of SARI patients between the experimental cohort and a propensity score-matched historical cohort. The primary outcome was the proportion of antibiotics discontinuation or de-escalation in the ED. The secondary outcomes included duration of intravenous antibiotics, length of hospital stay, and mortality.
   Results: A total of 676 patients were included, of which 169 patients were in the experimental group and 507 patients were in the control group. More than one-fourth (27.9%) of the patients in the experimental group tested positive for virus. Compared with controls, the experimental group had a significantly higher proportion of antibiotics discontinuation or de-escalation in the ED (26.0% vs 16.1%, P = .007), neuraminidase inhibitor uses (8.9% vs 0.6%, P < .001), and shorter duration of intravenous antibiotics (10.0 vs 14.5 days, P < .001).
   Conclusions and Implications: Combining rapid viral surveillance and PCT test is a useful strategy for early detection of potential viral epidemics and antibiotic stewardship. Clustered viral respiratory infections in a nursing home is common. Patients transferred from nursing homes to ED may benefit from this approach. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
C1 [Lee, Chien-Chang; Chen, Shey-Ying] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.
   [Chang, Julia Chia-Yu; How, Chorng-Kuang] Natl Yang Ming Univ, Dept Emergency Med, Taipei Vet Gen Hosp, Taipei, Taiwan.
   [Chang, Julia Chia-Yu; How, Chorng-Kuang] Natl Yang Ming Univ, Dept Emergency Med, Sch Med, Taipei, Taiwan.
   [Mao, Xiao-Wei] Natl Taiwan Univ Hosp, Dept Med Technol, Taipei, Taiwan.
   [Hsu, Wan-Ting] TH Chan Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Chen, Yee-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan.
RP How, CK (reprint author), Taipei Vet Gen Hosp, Dept Emergency Med, 201,Sec 2,Shipai Rd, Taipei 112, Taiwan.
EM ckhow@vghtpe.gov.tw
OI LEE, CHIEN-CHANG/0000-0002-1243-2463; CHEN,
   SHEY-YING/0000-0002-5855-6170; Hsu, Wan-Ting/0000-0002-6677-0951
FU BioFire Diagnostics, LLC, Salt Lake City, UT; BioFire
FX BioFire Diagnostics, LLC, Salt Lake City, UT sponsored the FilmArray RP
   kits for this study. BioFire has no role in the interpretation of the
   results and writing of the manuscript.
CR Babady NE, 2013, EXPERT REV MOL DIAGN, V13, P779, DOI 10.1586/14737159.2013.848794
   Bhavnani D, 2007, INT J INFECT DIS, V11, P355, DOI 10.1016/j.ijid.2006.09.009
   Brendish NJ, 2017, LANCET RESP MED, V5, P401, DOI [10.1016/S2213-2600(17)30120-0, 10.1016/s2213-2600(17)30120-0]
   Brown K, 2015, JAMA INTERN MED, V175, P626, DOI 10.1001/jamainternmed.2014.8273
   Burk M, 2016, EUR RESPIR REV, V25, P178, DOI 10.1183/16000617.0076-2015
   Chartrand C, 2015, J CLIN MICROBIOL, V53, P3738, DOI 10.1128/JCM.01816-15
   Chen CCH, 2017, JAMA SURG, V152, P827, DOI 10.1001/jamasurg.2017.1083
   Chen HZ, 2017, BIOMED RES INT, DOI 10.1155/2017/7320859
   Childs A, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1236-6
   Del Mar C, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4170
   Dugas AF, 2015, AM J EMERG MED, V33, P770, DOI 10.1016/j.ajem.2015.03.008
   Gelfer G, 2015, DIAGN MICR INFEC DIS, V83, P400, DOI 10.1016/j.diagmicrobio.2015.08.001
   Hartman L, 2018, J AM GERIATR SOC, V66, P467, DOI 10.1111/jgs.15298
   Huang HS, 2018, CLIN MICROBIOL INFEC, V24, P1055, DOI 10.1016/j.cmi.2017.11.018
   Hung CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183612
   Jeong HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110978
   Keske S, 2018, EUR J CLIN MICROBIOL, V37, P779, DOI 10.1007/s10096-017-3174-6
   Lansbury LE, 2017, INFLUENZA OTHER RESP, V11, P356, DOI 10.1111/irv.12464
   Le Bel J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1083-6
   Leber AL, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01945-17, 10.1128/jcm.01945-17]
   Llewelyn MJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3418
   Mengelle C, 2014, J CLIN VIROL, V61, P411, DOI 10.1016/j.jcv.2014.08.023
   Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848
   Nelson RE, 2015, PEDIATR INFECT DIS J, V34, P577, DOI 10.1097/INF.0000000000000703
   Nicholson KG, 2014, HLTH TECHNOL ASSESS, V18, P1
   Pulia M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0364-7
   Rappo U, 2016, J CLIN MICROBIOL, V54, P2096, DOI 10.1128/JCM.00549-16
   Rhee C, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw249
   Rogan DT, 2017, J MOL DIAGN, V19, P460, DOI 10.1016/j.jmoldx.2017.01.009
   Rogers BB, 2015, ARCH PATHOL LAB MED, V139, P636, DOI 10.5858/arpa.2014-0257-OA
   Schuetz P, 2017, EXPERT REV MOL DIAGN, V17, P593, DOI 10.1080/14737159.2017.1324299
   Semret M, 2017, J INFECT DIS, V216, P936, DOI 10.1093/infdis/jix288
   Seynaeve D, 2019, J AM MED DIR ASS
   Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9
NR 34
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-8610
EI 1538-9375
J9 J AM MED DIR ASSOC
JI J. Am. Med. Dir. Assoc.
PD JAN
PY 2020
VL 21
IS 1
BP 62
EP 67
DI 10.1016/j.jamda.2019.09.020
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA JY8VG
UT WOS:000504685400011
PM 31791902
OA Bronze
DA 2020-04-03
ER

PT J
AU Lewandowski, K
   Xu, YF
   Pullan, ST
   Lumley, SF
   Foster, D
   Sanderson, N
   Vaughan, A
   Morgan, M
   Bright, N
   Kavanagh, J
   Vipond, R
   Carroll, MW
   Marriott, AC
   Gooch, KE
   Andersson, M
   Jeffery, K
   Peto, TEA
   Crook, DW
   Walker, AS
   Matthews, PC
AF Lewandowski, Kuiama
   Xu, Yifei
   Pullan, Steven T.
   Lumley, Sheila F.
   Foster, Dona
   Sanderson, Nicholas
   Vaughan, Alison
   Morgan, Marcus
   Bright, Nicole
   Kavanagh, James
   Vipond, Richard
   Carroll, Miles W.
   Marriott, Anthony C.
   Gooch, Karen E.
   Andersson, Monique
   Jeffery, Katie
   Peto, Timothy E. A.
   Crook, Derrick W.
   Walker, A. Sarah
   Matthews, Philippa C.
TI Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical
   Respiratory Samples
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE influenza; Nanopore; metagenomic; diagnosis; epidemiology; sequencing;
   DNA sequencing; diagnostics; metagenomics; molecular epidemiology
ID TRANSMISSION; ALIGNMENT; MINION
AB Influenza is a major global public health threat as a result of its highly pathogenic variants, large zoonotic reservoir, and pandemic potential. Metagenomic viral sequencing offers the potential for a diagnostic test for influenza virus which also provides insights on transmission, evolution, and drug resistance and simultaneously detects other viruses. We therefore set out to apply the Oxford Nanopore Technologies sequencing method to metagenomic sequencing of respiratory samples. We generated influenza virus reads down to a limit of detection of 10(2) to 10(3) genome copies/ml in pooled samples, observing a strong relationship between the viral titer and the proportion of influenza virus reads (P = 4.7 x 10(-5)). Applying our methods to clinical throat swabs, we generated influenza virus reads for 27/27 samples with mid-to-high viral titers (cycle threshold [C-T] values, <30) and 6/13 samples with low viral titers (C-T values, 30 to 40). No false-positive reads were generated from 10 influenza virus-negative samples. Thus, Nanopore sequencing operated with 83% sensitivity (95% confidence interval [CI], 67 to 93%) and 100% specificity (95% CI, 69 to 100%) compared to the current diagnostic standard. Coverage of full-length virus was dependent on sample composition, being negatively influenced by increased host and bacterial reads. However, at high influenza virus titers, we were able to reconstruct >99% complete sequences for all eight gene segments. We also detected a human coronavirus coinfection in one clinical sample. While further optimization is required to improve sensitivity, this approach shows promise for the Nanopore platform to be used in the diagnosis and genetic analysis of influenza virus and other respiratory viruses.
C1 [Lewandowski, Kuiama; Pullan, Steven T.; Vipond, Richard; Carroll, Miles W.; Marriott, Anthony C.; Gooch, Karen E.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Xu, Yifei; Foster, Dona; Sanderson, Nicholas; Vaughan, Alison; Bright, Nicole; Kavanagh, James; Peto, Timothy E. A.; Crook, Derrick W.; Walker, A. Sarah] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford, England.
   [Lumley, Sheila F.; Morgan, Marcus; Andersson, Monique; Jeffery, Katie; Peto, Timothy E. A.; Crook, Derrick W.; Matthews, Philippa C.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Infect Dis & Microbiol, Oxford, England.
   [Matthews, Philippa C.] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.
   [Xu, Yifei; Foster, Dona; Sanderson, Nicholas; Vaughan, Alison; Peto, Timothy E. A.; Crook, Derrick W.; Matthews, Philippa C.] John Radcliffe Hosp, Oxford NIHR BRC, Oxford, England.
RP Pullan, ST (reprint author), Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
EM steven.pullan@phe.gov.uk
OI Lumley, Sheila/0000-0001-6825-9324
FU NIHR Oxford Biomedical Research CentreNational Institute for Health
   Research (NIHR)
FX The study was funded by the NIHR Oxford Biomedical Research Centre.
   Computation used the Oxford Biomedical Research Computing (BMRC)
   facility, a joint development between the Wellcome Centre for Human
   Genetics and the Big Data Institute supported by Health Data Research UK
   and the NIHR Oxford Biomedical Research Centre.
CR Benirschke RC, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.01281-18, 10.1128/JCM.01281-18]
   Blanco N, 2016, AM J EPIDEMIOL, V183, P1045, DOI 10.1093/aje/kwv293
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   CDC, 2019, INFL FLU INCL SEAS A
   Dudas G, 2019, BIORXIV
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Gooch KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38885-0
   Green DA, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00711-18
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381
   Humphreys M, 2018, EVOL MED PUBLIC HLTH, P219, DOI 10.1093/emph/eoy024
   Imai K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02748
   Ito Y, 2018, METHODS MOL BIOL, V1836, P23, DOI 10.1007/978-1-4939-8678-1_2
   Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2
   Joseph U, 2017, INFLUENZA OTHER RESP, V11, P74, DOI 10.1111/irv.12412
   Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343
   Kafetzopoulou LE, 2018, EUROSURVEILLANCE, V23, P18, DOI 10.2807/1560-7917.ES.2018.23.50.1800228
   Karamitros T, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4949-6
   Keller MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32615-8
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y
   Lewandowski K, 2017, J MOL DIAGN, V19, P303, DOI 10.1016/j.jmoldx.2016.10.005
   LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]
   Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090
   McNaughton AL, 2018, BIORXIV
   Meinel DM, 2018, INFECTION, V46, P69, DOI 10.1007/s15010-017-1091-3
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118
   Morris DH, 2018, TRENDS MICROBIOL, V26, P102, DOI 10.1016/j.tim.2017.09.004
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Rambo-Martin BL, 2019, BIORXIV, DOI [10.1101/585588v1, DOI 10.1101/585588V1]
   Sansone M, 2019, J HOSP INFECT, V101, P30, DOI 10.1016/j.jhin.2018.06.004
   Schmidt RLJ, 2019, CLIN MICROBIOL INFEC, V25, P1032, DOI 10.1016/j.cmi.2018.12.017
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Sutton TC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090461
   Thompson CP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06228-8
   Uyeki TM, 2018, CLIN INFECT DIS, V48, P1003, DOI [10.1086/598513, DOI 10.1086/598513]
   Votintseva AA, 2017, J CLIN MICROBIOL, V55, P1285, DOI 10.1128/JCM.02483-16
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   World Health Organization, 2018, BURD DIS
   World Health Organization (WHO), 2019, 10 THREATS GLOB HLTH
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Xiang D, 2018, J INFECTION, V77, P205, DOI 10.1016/j.jinf.2018.05.006
   Xu Y, 2018, BIORXIV
   Xu YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02225
   Yan Y, 2016, J VIROL METHODS, V234, P22, DOI 10.1016/j.jviromet.2016.04.001
NR 55
TC 1
Z9 1
U1 13
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2020
VL 58
IS 1
AR e00963-19
DI 10.1128/JCM.00963-19
PG 15
WC Microbiology
SC Microbiology
GA KA0EE
UT WOS:000505473500008
PM 31666364
OA Other Gold, Green Published
DA 2020-04-03
ER

PT J
AU Niu, JW
   Shen, L
   Huang, BY
   Ye, F
   Zhao, L
   Wang, HJ
   Deng, Y
   Tan, WJ
AF Niu, Junwei
   Shen, Liang
   Huang, Baoying
   Ye, Fei
   Zhao, Li
   Wang, Huijuan
   Deng, Yao
   Tan, Wenjie
TI Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy
   in the central nervous system of live mice
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Coronavirus; Bioluminescence imaging; Mouse; Chloroquine; Therapy
ID CORONAVIRUS OC43 INFECTION; GAUSSIA LUCIFERASE; VIRAL-INFECTIONS;
   GENE-EXPRESSION; ENCEPHALITIS; REPLICATION; VIRUSES; DISEASE
AB Human coronaviruses (HCoVs) are important pathogens that cause upper respiratory tract infections and have neuroinvasive abilities; however, little is known about the dynamic infection process of CoVs in vivo, and there are currently no specific antiviral drugs to prevent or treat HCoV infection. Here, we verified the replication ability and pathogenicity of a reporter HCoV-OC43 strain expressing Renilla luciferase (Rluc; rOC43-ns2DelRluc) in mice with different genetic backgrounds (C57BL/6 and BALB/c). Additionally, we monitored the spatial and temporal progression of HCoV-OC43 through the central nervous system (CNS) of live BALB/c mice after intranasal or intracerebral inoculation with rOC43-ns2DelRluc. We found that rOC43-ns2DelRluc was fatal to suckling mice after intranasal inoculation, and that viral titers and Rluc expression were detected in the brains and spinal cords of mice infected with rOC43-ns2DelRluc. Moreover, viral replication was initially observed in the brain by non-invasive bioluminescence imaging before the infection spread to the spinal cord of BALB/c mice, consistent with its tropism in the CNS. Furthermore, the Rluc readout correlated with the HCoV replication ability and protein expression, which allowed quantification of antiviral activity in live mice. Additionally, we validated that chloroquine strongly inhibited rOC43-ns2DelRluc replication in vivo. These results provide new insights into the temporal and spatial dissemination of HCoV-OC43 in the CNS, and our methods provide an extremely sensitive platform for evaluating the efficacy of antiviral therapies to treat neuroinvasive HCoVs in live mice.
C1 [Niu, Junwei; Huang, Baoying; Ye, Fei; Zhao, Li; Wang, Huijuan; Deng, Yao; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Natl Hlth Commiss, Key Lab Biosafety, Beijing 102206, Peoples R China.
   [Shen, Liang] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Dept Clin Lab, Xiangyang 441021, Hubei, Peoples R China.
   [Shen, Liang] Hubei Univ Arts & Sci, Med Coll, Key Lab Mol Med, Xiangyang 441053, Peoples R China.
   [Tan, Wenjie] Chinese Acad Sci, Ctr Biosafety Megasci, 155 Changbai Rd, Beijing 102206, Peoples R China.
RP Tan, WJ (reprint author), Chinese Acad Sci, Ctr Biosafety Megasci, 155 Changbai Rd, Beijing 102206, Peoples R China.; Tan, WJ (reprint author), China CDC, Natl Inst Viral Dis Control & Prevent, MHC Key Lab Biosafety, Beijing 102206, Peoples R China.
EM tanwj28@163.com
FU National Key Research and Development Program of China [2016YFD0500301,
   2016YFC1200901, 2018YFC1200602]; National Major Project for Control and
   Prevention of Infectious Disease in China from the Ministry of Science
   and Technology of China [2016ZX10004001-003]; National Major Project for
   Control and Prevention of Infectious Disease in China from National
   Health Commissions of China [2016ZX10004001-003]
FX We thank Dr. Talbot (INRS-Institute Armand-Frappier, Universite du
   Quebec, Laval, Quebec, Canada) for providing infectious clone of
   HCoV-OC43 (WT). This research was funded by the National Key Research
   and Development Program of China (2016YFD0500301, 2016YFC1200901, and
   2018YFC1200602) and the National Major Project for Control and
   Prevention of Infectious Disease in China (2016ZX10004001-003) from the
   Ministry of Science and Technology of China and National Health
   Commissions of China. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. We also thank the staff at the Animal Center affiliated with
   the Chinese CDC.
CR Adams MJ, 2016, ARCH VIROL, V161, P2921, DOI 10.1007/s00705-016-2977-6
   Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y
   Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000
   Arden KE, 2005, J MED VIROL, V75, P455, DOI 10.1002/jmv.20288
   Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099
   BURKS JS, 1980, SCIENCE, V209, P933, DOI 10.1126/science.7403860
   Butler N, 2006, VIROLOGY, V347, P410, DOI 10.1016/j.virol.2005.11.044
   CAVALLARO JJ, 1966, P SOC EXP BIOL MED, V121, P37, DOI 10.3181/00379727-121-30691
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   Dahm T, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/8562805
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Dube M, 2018, J VIROL, V92, DOI 10.1128/JVI.00404-18
   Fan CF, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090448
   Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101
   Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454
   Hung ECW, 2003, CLIN CHEM, V49, P2108, DOI 10.1373/clinchem.2003.025437
   Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x
   Jacomy H, 2003, VIROLOGY, V315, P20, DOI 10.1016/S0042-6822(03)00323-4
   Jacomy H, 2006, VIROLOGY, V349, P335, DOI 10.1016/j.virol.2006.01.049
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   LARSON HE, 1980, J MED VIROL, V5, P221, DOI 10.1002/jmv.1890050306
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   Li XF, 2017, THERANOSTICS, V7, P912, DOI 10.7150/thno.16615
   Liu YR, 2009, J VIROL, V83, P6837, DOI 10.1128/JVI.00379-09
   Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.3.CO;2-D
   Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799
   MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P5217, DOI 10.1021/bi00643a009
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268
   Milne-Price S, 2014, PATHOG DIS, V71, P119, DOI 10.1111/2049-632X.12166
   Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Niu PH, 2016, VIROL SIN, V31, P85, DOI 10.1007/s12250-015-3653-9
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101
   Raaben M, 2009, CELL MICROBIOL, V11, P825, DOI 10.1111/j.1462-5822.2009.01298.x
   Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104
   Reed L.J., 1938, AM J HYG, V37
   Savarino A., 2003, ANTIVIRAL EFFECTS CH
   Shen L, 2016, ANTIMICROB AGENTS CH, V60, P5492, DOI 10.1128/AAC.00814-16
   St-Jean JR, 2004, J VIROL, V78, P8824, DOI 10.1128/JVI.78.16.8824-8834.2004
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016
   Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8
   Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   Yu JE, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-63
NR 55
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2020
VL 173
AR UNSP 104646
DI 10.1016/j.antiviral.2019.104646
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KH6JO
UT WOS:000510757900002
PM 31705922
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, YQ
   Li, X
   Liu, WK
   Gan, M
   Zhang, L
   Wang, J
   Zhang, ZY
   Zhu, AR
   Li, F
   Sun, J
   Zhang, GX
   Zhuang, Z
   Luo, JY
   Chen, DH
   Qiu, SY
   Zhang, L
   Xu, D
   Mok, CKP
   Zhang, FC
   Zhao, JX
   Zhou, R
   Zhao, JC
AF Wang, Yanqun
   Li, Xin
   Liu, Wenkuan
   Gan, Mian
   Zhang, Lu
   Wang, Jin
   Zhang, Zhaoyong
   Zhu, Airu
   Li, Fang
   Sun, Jing
   Zhang, Guoxian
   Zhuang, Zhen
   Luo, Jiaying
   Chen, Dehui
   Qiu, Shuyan
   Zhang, Li
   Xu, Duo
   Mok, Chris Ka Pun
   Zhang, Fuchun
   Zhao, Jingxian
   Zhou, Rong
   Zhao, Jincun
TI Discovery of a subgenotype of human coronavirus NL63 associated with
   severe lower respiratory tract infection in China, 2018
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE human coronavirus NL63; new subgenotype; pneumonia; whole-genome
   sequencing; phylogenetic analysis; viral entry
ID COMPLETE GENOME SEQUENCE; RECEPTOR-BINDING; CRYSTAL-STRUCTURE; DOMAIN;
   VIRUS; CHILDREN; 229E; HKU1
AB Human coronavirus NL63 (HCoV-NL63) is primarily associated with common cold in children, elderly and immunocompromised individuals. Outbreaks caused by HCoV-NL63 are rare. Here we report a cluster of HCoV-NL63 cases with severe lower respiratory tract infection that arose in Guangzhou, China, in 2018. Twenty-three hospitalized children were confirmed to be HCoV-NL63 positive, and most of whom were hospitalized with severe pneumonia or acute bronchitis. Whole genomes of HCoV-NL63 were obtained using next-generation sequencing. Phylogenetic and single amino acid polymorphism analyses showed that this outbreak was associated with two subgenotypes (C3 and B) of HCoV-NL63. Half of patients were identified to be related to a new subgenotype C3. One unique amino acid mutation at I507 L in spike protein receptor binding domain (RBD) was detected, which segregated this subgenotype C3 from other known subgenotypes. Pseudotyped virus bearing the I507 L mutation in RBD showed enhanced entry into host cells as compared to the prototype virus. This study proved that HCoV-NL63 was undergoing continuous mutation and has the potential to cause severe lower respiratory disease in humans.
C1 [Wang, Yanqun; Li, Xin; Liu, Wenkuan; Gan, Mian; Wang, Jin; Zhang, Zhaoyong; Zhu, Airu; Li, Fang; Sun, Jing; Zhang, Guoxian; Zhuang, Zhen; Luo, Jiaying; Chen, Dehui; Qiu, Shuyan; Zhang, Li; Xu, Duo; Mok, Chris Ka Pun; Zhao, Jingxian; Zhou, Rong; Zhao, Jincun] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou 510120, Peoples R China.
   [Zhang, Lu; Zhang, Fuchun; Zhao, Jincun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Inst Infect Dis, Guangzhou, Peoples R China.
   [Mok, Chris Ka Pun] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China.
RP Zhao, JX; Zhou, R; Zhao, JC (reprint author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou 510120, Peoples R China.; Zhao, JC (reprint author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Inst Infect Dis, Guangzhou, Peoples R China.
EM zhaojingxian@gird.cn; zhourong@gird.cn; zhaojincun@gird.cn
FU National Key Research and Development Program of China [2018YFC1200100,
   2016YFC1202701]; National Science and Technology Major Project
   [2018ZX10301403-001-003, 2018ZX10101002]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81702047, 81772191, 91842106, 8181101118]; Guangdong Provincial
   Department of Science and Technology [2018B020207013]; Thousand Talents
   Plan Award of China 2015 [SKLRD-QN-201715, SKLRD-QN201912]; State Key
   Laboratory of Respiratory Disease [SKLRD-QN-201715, SKLRD-QN201912];
   China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2019T120722]; PhD Start-up Fund of Natural Science
   Foundation of Guangdong Province, ChinaNational Natural Science
   Foundation of China; Nanshan Medical Development Foundation of Guangdong
   Province; National Key Technology RD ProgramNational Key Technology R&D
   Program [2018YFC1311900]; Guangdong Science and Technology Foundation
   [2019B030316028]
FX This research was supported by grants from National Key Research and
   Development Program of China (2018YFC1200100 and 2016YFC1202701),
   National Science and Technology Major Project (2018ZX10301403-001-003
   and 2018ZX10101002), National Natural Science Foundation of China
   (81702047, 81772191, 91842106 and 8181101118), Guangdong Provincial
   Department of Science and Technology (2018B020207013), the Thousand
   Talents Plan Award of China 2015 and State Key Laboratory of Respiratory
   Disease (SKLRD-QN-201715 and SKLRD-QN201912), China Postdoctoral Science
   Foundation (2019T120722) and the PhD Start-up Fund of Natural Science
   Foundation of Guangdong Province, China, grants from the Nanshan Medical
   Development Foundation of Guangdong Province, National Key Technology
   R&D Program (2018YFC1311900), Guangdong Science and Technology
   Foundation (2019B030316028).
CR Abdul-Rasool Sahar, 2010, Open Virol J, V4, P76, DOI 10.2174/1874357901004010076
   Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Chiu SS, 2005, CLIN INFECT DIS, V40, P1721, DOI 10.1086/430301
   CUI LJ, 2011, ADV VIROL, V2011, P129, DOI DOI 10.1155/2011/129134
   Dominguez SR, 2012, J GEN VIROL, V93, P2387, DOI 10.1099/vir.0.044628-0
   Feng YJ, 2007, COMP IMMUNOL MICROB, V30, P309, DOI 10.1016/j.cimid.2007.05.009
   Fielding BC, 2011, FUTURE MICROBIOL, V6, P153, DOI [10.2217/fmb.10.166, 10.2217/FMB.10.166]
   Geng HY, 2012, J VIROL, V86, P9546, DOI 10.1128/JVI.01457-12
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hand J, 2018, EMERG INFECT DIS, V24, P1964, DOI 10.3201/eid2410.180862
   Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102
   KAPIKIAN AZ, 1969, J INFECT DIS, V119, P282, DOI 10.1093/infdis/119.3.282
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kiyuka PK, 2018, J INFECT DIS, V217, P1728, DOI 10.1093/infdis/jiy098
   Konca C, 2017, PEDIATR INFECT DIS J, V36, P231, DOI 10.1097/INF.0000000000001390
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lin HX, 2011, VIRUS RES, V160, P283, DOI 10.1016/j.virusres.2011.06.029
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Lu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038638
   Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108
   Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Wang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.006
   Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006
   Woo PCY, 2009, VIRUSES-BASEL, V1, P57, DOI 10.3390/v1010057
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng ZQ, 2018, EUR J CLIN MICROBIOL, V37, P363, DOI 10.1007/s10096-017-3144-z
NR 33
TC 1
Z9 1
U1 10
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 246
EP 255
DI 10.1080/22221751.2020.1717999
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KG8YR
UT WOS:000510237900001
PM 31996093
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Rosa, GM
   Santos, N
   Grondahl-Rosado, R
   Fonseca, FP
   Tavares, L
   Neto, I
   Cartaxeiro, C
   Duarte, A
AF Rosa, Goncalo M.
   Santos, Nuno
   Grondahl-Rosado, Ricardo
   Fonseca, Francisco Petrucci
   Tavares, Luis
   Neto, Isabel
   Cartaxeiro, Clara
   Duarte, Ana
TI Unveiling patterns of viral pathogen infection in free-ranging
   carnivores of northern Portugal using a complementary methodological
   approach
SO COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
DE Canine parvovirus; Canine distemper virus; Coronavirus; Real-time PCR;
   Iberian wild carnivores; Serology
ID CANINE-DISTEMPER VIRUS; PARVOVIRUS INFECTIONS; CORONAVIRUS INFECTION;
   DOMESTIC DOGS; EVOLUTION; WOLVES; EMERGENCE; DISEASE; SURVEILLANCE;
   FOXES
AB Pathogen surveillance in free-ranging carnivores presents challenges due to their low densitie and secretive nature. We combined molecular and serological assays to investigate infections by viral pathogens (Canine parvovirus (CPV), Canine distemper virus (CDV) and Canine coronavirus (CCoV)) in Portuguese carnivores (Canis lupus, Vulpes vulpes, Lutra lutra, Martes foina, M. martes, Meles meles, and Genetta genetta) over a period of 16 years. Additionally we explored spatio-temporal patterns of virus occurrence in Canis lupus. Our study identified CPV DNA in all carnivore species with an overall prevalence of 91.9 %. CPV was detected in all sampled years and seasons in Canis lupus, supporting its enzootic nature. CDV RNA was mainly detected in the Canidae family, with viral nucleic acid recorded between 2005 and 2008 with a peak prevalence of 67 % among the wolf population, followed by a sharp decline, suggesting an epizootic behaviour of the virus. Antibodies show that mustelids and viverrids were often exposed to CDV. CCoV was first recorded by molecular methods in wolf samples in 2002, remaining in the wolf populations with marked fluctuations over time. The dual serological and molecular approach provided important epidemiological data on pathogens of wild carnivores in Portugal. These programmes should also include monitoring of other potential reservoir hosts such as domestic cats and dogs.
C1 [Rosa, Goncalo M.] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.
   [Rosa, Goncalo M.; Fonseca, Francisco Petrucci] Univ Lisbon, Fac Ciencias, CE3C, P-1749016 Lisbon, Portugal.
   [Santos, Nuno] Univ Porto, CIBIO InBIO Res Network Biodivers & Evolutionary, Campus Vairao,Rua Padre Armando Quintas 7, P-4485661 Vairao, Portugal.
   [Grondahl-Rosado, Ricardo] Thermo Fisher Sci, Life Sci Solut, POB 114, N-0309 Oslo, Norway.
   [Tavares, Luis; Neto, Isabel; Cartaxeiro, Clara; Duarte, Ana] Univ Lisbon, Fac Med Vet, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, P-1300477 Lisbon, Portugal.
RP Duarte, A (reprint author), Univ Lisbon, Fac Med Vet, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, P-1300477 Lisbon, Portugal.
EM goncalo.m.rosa@gmail.com; nuno.santos@cibio.up.pt; rcrosado@gmail.com;
   fpfonseca@fc.ul.pt; ltavares@fmv.ulisboa.pt; isaneto@fmv.ulisboa.pt;
   cartaxeiro@fmv.ulisboa.pt; anaduarte@fmv.ulisboa.pt
RI Santos, Nuno/D-6742-2016; Grondahl-Rosado, Ricardo/AAH-6838-2020; Rosa,
   Goncalo M./C-6028-2012
OI Santos, Nuno/0000-0002-1676-107X; Grondahl-Rosado,
   Ricardo/0000-0001-7829-4625; Rosa, Goncalo M./0000-0002-8658-8436;
   Fonseca, Maria Isabel Ferreira Neto da Cunha/0000-0001-5838-9395;
   Duarte, Ana/0000-0003-4001-0871
FU FCT - Fundacao para a Ciencia e TecnologiaPortuguese Foundation for
   Science and Technology [UID/BIA/00329/2013, UID/CVT/00276/2013CIISA -
   CIISA]; Centre for Interdisciplinary Research in Animal Health, Faculty
   of Veterinary Medicine, University of Lisbon; Fundacao para a Ciencia e
   TecnologiaPortuguese Foundation for Science and Technology
   [SFRH/BPD/116596/2016];  [PEst-OE/AGR/UI0276/2014]
FX We acknowledge the financial support by Portuguese National Funds,
   through FCT - Fundacao para a Ciencia e Tecnologia, within the project
   UID/BIA/00329/2013, UID/CVT/00276/2013CIISA - CIISA, Centre for
   Interdisciplinary Research in Animal Health, Faculty of Veterinary
   Medicine, University of Lisbon and PEst-OE/AGR/UI0276/2014, which
   enabled this work. N. Santos was supported by the postdoctoral
   fellowship (SFRH/BPD/; 116596/2016) from Fundacao para a Ciencia e
   Tecnologia. For the biological samples we acknowledge BTVS (Banco de
   Tecidos de Vida Selvagem) and SMLM (Sistema de Monitorizacao de Lobos
   Mortos) of ICNF (Instituto de Conservacao da Natureza e das Florestas,
   Portugal). We would also like to acknowledge all the colleagues and
   collaborators who collected the samples in the field.
CR Aguirre AA, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S7
   Almberg ES, 2012, PHILOS T R SOC B, V367, P2840, DOI 10.1098/rstb.2011.0369
   Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1
   Almberg ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007042
   Battilani M, 2006, VET RES COMMUN, V30, P223, DOI 10.1007/s11259-006-0046-4
   Bronson E, 2008, J ZOO WILDLIFE MED, V39, P28, DOI 10.1638/2006-0046.1
   Buonavoglia C, 2006, EMERG INFECT DIS, V12, P492, DOI 10.3201/eid1203.050839
   Castanheira P, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-91
   Decaro N, 2006, J VET MED B, V53, P468, DOI 10.1111/j.1439-0450.2006.00974.x
   Decaro N, 2004, MICROBIOLOGICA, V27, P177
   Decaro N.C.E. Greene, 2012, CANINE VIRAL ENTERIT, P67
   Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007
   Decaro N, 2007, EMERG INFECT DIS, V13, P1222, DOI 10.3201/eid1308.070505
   Decaro N, 2013, J CLIN MICROBIOL, V51, P83, DOI 10.1128/JCM.02466-12
   Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007
   Decaro N, 2011, VET CLIN N AM-SMALL, V41, P1121, DOI 10.1016/j.cvsm.2011.07.005
   Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2
   Di Sabatino D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082356
   Duarte MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059399
   EUGSTER AK, 1977, SOUTHWEST VET, V30, P59
   Ferroglio E, 2000, PREV VET MED, V43, P117, DOI 10.1016/S0167-5877(99)00090-2
   Filipov C., 2014, TRANSBOUND EMERG DIS, P1
   Frolich K, 2005, J WILDLIFE DIS, V41, P231, DOI 10.7589/0090-3558-41.1.231
   Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9
   Gil S, 2013, RES VET SCI, V94, P753, DOI 10.1016/j.rvsc.2012.09.025
   Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018
   GORDON JC, 1986, AM J VET RES, V47, P1464
   Greene C.E., 2020, INFECT DIS DOG CAT, P25
   Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005
   LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7
   Lopez-Pena M, 2001, J COMP PATHOL, V124, P207, DOI 10.1053/jcpa.2000.0432
   Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x
   Martella V, 2010, EMERG INFECT DIS, V16, P2007, DOI 10.3201/eid1612.100579
   Martinello F, 1997, J WILDLIFE DIS, V33, P628, DOI 10.7589/0090-3558-33.3.628
   McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884
   Mech L. D., 2011, Journal of Veterinary Medicine and Animal Health, V3, P27
   MECH LD, 1993, J WILDLIFE DIS, V29, P330, DOI 10.7589/0090-3558-29.2.330
   Meli ML, 2010, VET MICROBIOL, V146, P132, DOI 10.1016/j.vetmic.2010.04.024
   MILLAN J, 2009, EUR J WILDLIFE RES, V55, P285, DOI DOI 10.1007/S10344-008-0246-Z
   Miranda C, 2016, J GEN VIROL, V97, P2043, DOI 10.1099/jgv.0.000540
   MOLNAR B, 2014, EUR J WILDLIFE RES, V60, P613, DOI DOI 10.1007/S10344-014-0825-0
   Muller A, 2011, J WILDLIFE DIS, V47, P725, DOI 10.7589/0090-3558-47.3.725
   Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x
   Packard Jane M., 2003, P35
   Pena L, 2006, COMP IMMUNOL MICROB, V29, P114, DOI 10.1016/j.cimid.2006.01.003
   Pratelli A, 2006, VET RES, V37, P191, DOI 10.1051/vetres:2005053
   Pratelli A, 1999, J VIROL METHODS, V80, P11, DOI 10.1016/S0166-0934(99)00017-8
   Pratelli A, 2000, J VIROL METHODS, V84, P91, DOI 10.1016/S0166-0934(99)00134-2
   Queiroz A.I., 2005, LIVRO VERMELHO VERTE
   Randall DA, 2004, EMERG INFECT DIS, V10, P2214, DOI 10.3201/eid1012.040080
   ROELKE ME, 2008, EUR J WILDLIFE RES, V54, P171, DOI [DOI 10.1007/s10344-007-0122-2, DOI 10.1007/S10344-007-0122-2]
   RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0
   Santos N, 2009, J WILDLIFE DIS, V45, P221, DOI 10.7589/0090-3558-45.1.221
   Schultz RD, 2010, J COMP PATHOL, V141, pS102, DOI 10.1016/j.jcpa.2009.10.009
   Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029
   Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102
   Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x
   Sobrino R, 2008, VET MICROBIOL, V126, P251, DOI 10.1016/j.vetmic.2007.06.014
   Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594
   Temple HJ, 2007, STATUS DISTRIBUTION
NR 60
TC 0
Z9 0
U1 17
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0147-9571
EI 1878-1667
J9 COMP IMMUNOL MICROB
JI Comp. Immunol. Microbiol. Infect. Dis.
PD APR
PY 2020
VL 69
AR 101432
DI 10.1016/j.cimid.2020.101432
PG 8
WC Immunology; Microbiology; Veterinary Sciences
SC Immunology; Microbiology; Veterinary Sciences
GA KO4KR
UT WOS:000515519800020
PM 32062189
DA 2020-04-03
ER

PT J
AU Phan, T
AF Tung Phan
TI Novel coronavirus: From discovery to clinical diagnostics
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE China; coronavirus; Bat; Pneumonia
AB A novel coronavirus designated as 2019-nCoV first appeared in Wuhan, China in late December 2019. Dozens of people died in China, and thousands of people infected as 2019-nCoV continues to spread around the world. We have described the discovery, emergence, genomic characteristics, and clinical diagnostics of 2019-nCoV.
C1 [Tung Phan] Univ Pittsburgh, Div Clin Microbiol, Pittsburgh, PA 15260 USA.
   [Tung Phan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.
RP Phan, T (reprint author), Univ Pittsburgh, Div Clin Microbiol, Pittsburgh, PA 15260 USA.; Phan, T (reprint author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.
EM phantg@upmc.edu
FU Division of Clinical Microbiology, University of Pittsburgh Medical
   Center
FX We acknowledge support from Division of Clinical Microbiology,
   University of Pittsburgh Medical Center.
CR Babady NE, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01658-17
   Beckmann C, 2016, J MED VIROL, V88, P1319, DOI 10.1002/jmv.24492
   Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759
   Huang HS, 2018, CLIN MICROBIOL INFEC, V24, P1055, DOI 10.1016/j.cmi.2017.11.018
   Luk HKH, 2019, INFECT GENET EVOL, V71, P21, DOI 10.1016/j.meegid.2019.03.001
   Ramadan Nour, 2019, Germs, V9, P35, DOI 10.18683/germs.2019.1155
   Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 8
TC 0
Z9 0
U1 522
U2 522
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2020
VL 79
AR 104211
DI 10.1016/j.meegid.2020.104211
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA KH7YP
UT WOS:000510866400017
PM 32007627
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhang, HW
   Yu, J
   Xu, HJ
   Lei, Y
   Pu, ZH
   Dai, WC
   Lin, F
   Wang, YL
   Wu, XL
   Liu, LH
   Li, M
   Mo, YQ
   Zhang, H
   Luo, SP
   Chen, H
   Lyu, GW
   Zhou, ZG
   Liu, WM
   Liu, XL
   Song, HY
   Chen, FZ
   Zeng, L
   Zhong, H
   Guo, TT
   Hu, YQ
   Yang, XX
   Liu, PN
   Li, DF
AF Zhang, Han-Wen
   Yu, Juan
   Xu, Hua-Jian
   Lei, Yi
   Pu, Zu-Hui
   Dai, Wei-Cai
   Lin, Fan
   Wang, Yu-Li
   Wu, Xiao-Liu
   Liu, Li-Hong
   Li, Min
   Mo, Yong-Qian
   Zhang, Hong
   Luo, Si-Ping
   Chen, Huan
   Lyu, Gui-Wen
   Zhou, Zhao-Guang
   Liu, Wei-Min
   Liu, Xiao-Lei
   Song, Hai-Yan
   Chen, Fu-Zhen
   Zeng, Liang
   Zhong, Hua
   Guo, Ting-Ting
   Hu, Ya-Qiong
   Yang, Xin-Xin
   Liu, Pin-Ni
   Li, Ding-Fu
TI Corona Virus International Public Health Emergencies: Implications for
   Radiology Management
SO ACADEMIC RADIOLOGY
LA English
DT Article
DE 2019-nCoV; COVID-19; WHO; PHEIC; radiology management
AB The outbreak of 2019 novel coronavirus (2019-nCoV) pneumonia was reported in Wuhan, Hubei Province, China in December 2019 and has spread internationally. This article discusses how radiology departments can most effectively respond to this public health emergency.
C1 [Zhang, Han-Wen; Yu, Juan; Xu, Hua-Jian; Lei, Yi; Pu, Zu-Hui; Dai, Wei-Cai; Lin, Fan; Wang, Yu-Li; Wu, Xiao-Liu; Liu, Li-Hong; Li, Min; Mo, Yong-Qian; Zhang, Hong; Luo, Si-Ping; Chen, Huan; Lyu, Gui-Wen; Zhou, Zhao-Guang; Liu, Wei-Min; Liu, Xiao-Lei; Song, Hai-Yan; Chen, Fu-Zhen; Zeng, Liang; Zhong, Hua; Guo, Ting-Ting; Hu, Ya-Qiong; Yang, Xin-Xin; Liu, Pin-Ni; Li, Ding-Fu] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Radiol,Affiliated Hosp 1, 3002 SunGangXi Rd, Shenzhen 518035, Peoples R China.
RP Lei, Y (reprint author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Radiol,Affiliated Hosp 1, 3002 SunGangXi Rd, Shenzhen 518035, Peoples R China.
EM 13602658583@163.com
OI dai, wei cai/0000-0001-7657-4594; Zhang, Hanwen/0000-0001-5731-7429
CR Bassetti M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13209
   Corman VM, 2020, EURO SURVEILL, V25
   Lu H, 2020, J MED VIROL
   Wan Y, 2020, J VIROL
   Wang W, 2020, CHINA J MED VIROL
   Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e56
   Zhao S, 2020, INT J INFECT DIS
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 8
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1076-6332
EI 1878-4046
J9 ACAD RADIOL
JI Acad. Radiol.
PD APR
PY 2020
VL 27
IS 4
BP 463
EP 467
DI 10.1016/j.acra.2020.02.003
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KW0WJ
UT WOS:000520893600004
PM 32113880
OA Bronze
DA 2020-04-03
ER

PT J
AU Pan, XB
AF Pan, Xiao-Ben
TI Application of personal-oriented digital technology in preventing
   transmission of COVID-19, China
SO IRISH JOURNAL OF MEDICAL SCIENCE
LA English
DT Article; Early Access
DE Coronavirus; Information technology; Prevention
AB We reported several personal-oriented and mobile phone-based information technologies which were recently developed and widely used during the outbreak of COVID-19 in China. These technologies help reduce the transmission of COVID-19 and maintain normal social order.
C1 [Pan, Xiao-Ben] Hangzhou Normal Univ, Dept Basic Med Sci, Key Lab Aging & Canc Biol Zhejiang Prov, Key Lab Inflammat & Immunoregulat Hangzhou,Sch Me, 2318 Yuhangtang Rd, Hangzhou 311121, Zhejiang, Peoples R China.
RP Pan, XB (reprint author), Hangzhou Normal Univ, Dept Basic Med Sci, Key Lab Aging & Canc Biol Zhejiang Prov, Key Lab Inflammat & Immunoregulat Hangzhou,Sch Me, 2318 Yuhangtang Rd, Hangzhou 311121, Zhejiang, Peoples R China.
EM panxiaoben@hznu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81670530]; Hangzhou Normal University [2018QDL035]
FX This study was supported by grants from the National Natural Science
   Foundation of China (81670530), the Start-up Foundation (2018QDL035),
   and Pandeng Project of Hangzhou Normal University.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0021-1265
EI 1863-4362
J9 IRISH J MED SCI
JI Irish J. Med. Sci.
DI 10.1007/s11845-020-02215-5
EA MAR 2020
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA KX4YD
UT WOS:000521884600001
PM 32219674
DA 2020-04-03
ER

PT J
AU Cardenas-Conejo, Y
   Linan-Rico, A
   Garcia-Rodriguez, DA
   Centeno-Leija, S
   Serrano-Posada, H
AF Cardenas-Conejo, Yair
   Linan-Rico, Andromeda
   Garcia-Rodriguez, Daniel Alejandro
   Centeno-Leija, Sara
   Serrano-Posada, Hugo
TI An exclusive 42 amino acid signature in pp1ab protein provides insights
   into the evolutive history of the 2019 novel human-pathogenic
   coronavirus (SARS-CoV-2)
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE coronavirus; pp1ab protein; SARS; SARS-CoV-2; virus; Wuhan
AB The city of Wuhan, Hubei province, China, was the origin of a severe pneumonia outbreak in December 2019, attributed to a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), causing a total of 2761 deaths and 81109 cases (25 February 2020). SARS-CoV-2 belongs to genus Betacoronavirus, subgenus Sarbecovirus. The polyprotein 1ab (pp1ab) remains unstudied thoroughly since it is similar to other sarbecoviruses. In this short communication, we performed phylogenetic-structural sequence analysis of pp1ab protein of SARS-CoV-2. The analysis showed that the viral pp1ab has not changed in most isolates throughout the outbreak time, but interestingly a deletion of 8 aa in the virulence factor nonstructural protein 1 was found in a virus isolated from a Japanese patient that did not display critical symptoms. While comparing pp1ab protein with other betacoronaviruses, we found a 42 amino acid signature that is only present in SARS-CoV-2 (AS-SCoV2). Members from clade 2 of sarbecoviruses have traces of this signature. The AS-SCoV2 located in the acidic-domain of papain-like protein of SARS-CoV-2 and bat-SL-CoV-RatG13 guided us to suggest that the novel 2019 coronavirus probably emerged by genetic drift from bat-SL-CoV-RaTG13. The implication of this amino acid signature in papain-like protein structure arrangement and function is something worth to be explored.
C1 [Cardenas-Conejo, Yair; Centeno-Leija, Sara; Serrano-Posada, Hugo] Univ Colima, Natl Council Sci & Technol CONACYT, Lab Agrobiotechnol, Colima, Mexico.
   [Linan-Rico, Andromeda] Univ Colima, Natl Council Sci & Technol CONACYT, Univ Ctr Biomed Res, Colima, Mexico.
   [Garcia-Rodriguez, Daniel Alejandro] Univ Colima, Lab Agrobiotechnol, Colima, Mexico.
RP Cardenas-Conejo, Y (reprint author), Carretera Los Limones Loma Juarez, Colima 28629, Mexico.
EM ycardenasco@conacyt.mx
OI Cardenas-Conejo, Yair/0000-0002-0190-244X
FU Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [APN-2015-01-741]
FX Consejo Nacional de Ciencia y Tecnologia, Grant/Award Number:
   APN-2015-01-741 to Yair Cardenas-Conejo
CR Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525
   Baez-Santos YM, 2015, ANTIVIR RES, V115, P21, DOI 10.1016/j.antiviral.2014.12.015
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Hagemeijer MC, 2012, VIRUSES-BASEL, V4, P3245, DOI 10.3390/v4113245
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Serrano P, 2007, J VIROL, V81, P12049, DOI 10.1128/JVI.00969-07
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109
NR 11
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25758
EA MAR 2020
PG 5
WC Virology
SC Virology
GA KV8KZ
UT WOS:000520727900001
PM 32167166
OA Bronze
DA 2020-04-03
ER

PT J
AU Poon, LC
   Yang, H
   Lee, JCS
   Copel, JA
   Leung, TY
   Zhang, Y
   Chen, D
   Prefumo, F
AF Poon, L. C.
   Yang, H.
   Lee, J. C. S.
   Copel, J. A.
   Leung, T. Y.
   Zhang, Y.
   Chen, D.
   Prefumo, F.
TI ISUOG Interim Guidance on 2019 novel coronavirus infection during
   pregnancy and puerperium: information for healthcare professionals
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article; Early Access
ID MEDICATION USE; RISK-FACTORS; PNEUMONIA; ILLNESS; MOTHERS; SEPSIS;
   WOMEN; BORN
C1 [Poon, L. C.; Leung, T. Y.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China.
   [Yang, H.] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China.
   [Lee, J. C. S.] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore.
   [Copel, J. A.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
   [Zhang, Y.] Wuhan Univ, Zhongnan Hosp, Dept Obstet & Gynaecol, Wuhan, Peoples R China.
   [Chen, D.] Guangzhou Med Univ, Affiliated Hosp 3, Dept Obstet & Gynaecol, Guangzhou, Peoples R China.
   [Prefumo, F.] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy.
RP Poon, LC (reprint author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China.
OI Lee, Jill Cheng Sim/0000-0003-1803-7058
CR Abe K, 2003, BIRTH DEFECTS RES A, V67, P911, DOI 10.1002/bdra.10130
   Ai Tao, 2020, Radiology, P200642, DOI 10.1148/radiol.2020200642
   Alfaraj SH, 2019, J MICROBIOL IMMUNOL, V52, P501, DOI 10.1016/j.jmii.2018.04.005
   American College of Obstetricians and Gynecologists, PRACT ADV NOV COR 20
   [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   [Anonymous], 2020, NIH CLIN TRIAL REMDE
   [Anonymous], 2020, REPORT WHO CHINA JOI
   BASSEAL JM, 2017, AUSTRALAS J ULTRASOU, V20, P30
   Bhatia Pradeep Kumar, 2016, J Anaesthesiol Clin Pharmacol, V32, P431, DOI 10.4103/0970-9185.194779
   Boseley S, GUARDIAN
   Centers for Disease Control, INT COND INF PREV CO
   Centers for Disease Control, INT CLIN GUID MAN PA
   Centers for Disease Control and Prevention, 2020, INT INF PREV CONTR R
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023
   Chua MSQ, 2020, BJOG
   Copel J, 2017, OBSTET GYNECOL, V130, pE210, DOI [10.1097/AOG.0000000000002355, 10.1097/AOG.0000000000002237]
   European Centre for Disease Prevention and Control, 2020, DAIL RISK ASS COVID
   Favre Guillaume, 2020, Lancet Infect Dis, DOI 10.1016/S1473-3099(20)30157-2
   Guan Wei-Jie, 2020, N Engl J Med, DOI 10.1056/NEJMoa2002032
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Li Yan, 2020, AJR Am J Roentgenol, P1, DOI 10.2214/AJR.20.22954
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   MADINGER NE, 1989, AM J OBSTET GYNECOL, V161, P657, DOI 10.1016/0002-9378(89)90373-6
   Maternal and Fetal Experts Committee Chinese Physician Society of Obstetrics and Gynecology Chinese Medical Doctor Association; Obstetric Subgroup Society of Obstetrics and Gynecology Chinese Medical Association; Society of Perinatal Medicine Chinese Medical Association; Editorial Board of Chinese Journal of Perinatal Medicine, 2020, CHIN J PERINAT MED, V23, P73
   Maxwell C, 2017, J OBSTET GYNAECOL CA, V39, pE130, DOI 10.1016/j.jogc.2017.04.024
   Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST
   Miller RW, 1999, TERATOLOGY, V59, P234, DOI 10.1002/(SICI)1096-9926(199904)59:4<234::AID-TERA8>3.0.CO;2-B
   Mullins E, 2020, CORONAVIRUS PREGNANC, DOI [10.1101/2020.03.06.20032144, DOI 10.1101/2020.03.06.20032144]
   National Library of Medicine, DRUGS LACT DAT LACTM
   Oster ME, 2011, J PEDIATR-US, V158, P990, DOI 10.1016/j.jpeds.2010.11.058
   Patel SJ, 2007, RADIOGRAPHICS, V27, P1705, DOI 10.1148/rg.276075002
   Plante LA, 2019, AM J OBSTET GYNECOL, V220, pB2, DOI 10.1016/j.ajog.2019.01.216
   Qi H, 2020, CHIN J OBSTET GYNECO, V55
   Rasmussen Sonja A, 2020, Am J Obstet Gynecol, DOI 10.1016/j.ajog.2020.02.017
   Rodrigo C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub2
   Rosjo H, 2011, INTENS CARE MED, V37, P77, DOI 10.1007/s00134-010-2051-x
   Sass L, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1585-0
   Schultz MJ, 2017, INTENS CARE MED, V43, P612, DOI 10.1007/s00134-017-4750-z
   Shaw GM, 1998, TERATOLOGY, V57, P1
   Shek CC, 2003, PEDIATRICS, V112, pE254, DOI 10.1542/peds.112.4.e254
   Siegel JD, 2007, GUIDELINE ISOLATION
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   WHO, 2020, RAT US PROT EQ COR D
   WHO, 2020, GLOB SURV COVID 19 D
   WHO, 2020, CLIN MAN SEV AC RESP
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, EM PREP RESP SUMM PR
   World Health Organization, NOV COR CHIN
   World Health Organization, INF PREV CONTR HLTH
   Yang H, 2020, ULTRASOUND OBSTET GY, DOI 10.1002/uog.22013
   Yin ZH, 2011, CHILD NERV SYST, V27, P149, DOI 10.1007/s00381-010-1198-7
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao Wei, 2020, AJR Am J Roentgenol, P1, DOI 10.2214/AJR.20.22976
   Zhu Huaping, 2020, Transl Pediatr, V9, P51, DOI 10.21037/tp.2020.02.06
NR 60
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
DI 10.1002/uog.22013
EA MAR 2020
PG 9
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA KV8UT
UT WOS:000520753300001
PM 32160345
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, CT
   Liu, ZP
   Chen, ZX
   Huang, X
   Xu, MY
   He, TF
   Zhang, ZH
AF Wang, Changtai
   Liu, Zhongping
   Chen, Zixiang
   Huang, Xin
   Xu, Mengyuan
   He, Tengfei
   Zhang, Zhenhua
TI The establishment of reference sequence for SARS-CoV-2 and variation
   analysis
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE homology; nucleotide; reference sequence; SARS-CoV-2; variation
ID RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA
AB Starting around December 2019, an epidemic of pneumonia, which was named COVID-19 by the World Health Organization, broke out in Wuhan, China, and is spreading throughout the world. A new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses was soon found to be the cause. At present, the sensitivity of clinical nucleic acid detection is limited, and it is still unclear whether it is related to genetic variation. In this study, we retrieved 95 full-length genomic sequences of SARAS-CoV-2 strains from the National Center for Biotechnology Information and GISAID databases, established the reference sequence by conducting multiple sequence alignment and phylogenetic analyses, and analyzed sequence variations along the SARS-CoV-2 genome. The homology among all viral strains was generally high, among them, 99.99% (99.91%-100%) at the nucleotide level and 99.99% (99.79%-100%) at the amino acid level. Although overall variation in open-reading frame (ORF) regions is low, 13 variation sites in 1a, 1b, S, 3a, M, 8, and N regions were identified, among which positions nt28144 in ORF 8 and nt8782 in ORF 1a showed mutation rate of 30.53% (29/95) and 29.47% (28/95), respectively. These findings suggested that there may be selective mutations in SARS-COV-2, and it is necessary to avoid certain regions when designing primers and probes. Establishment of the reference sequence for SARS-CoV-2 could benefit not only biological study of this virus but also diagnosis, clinical monitoring and intervention of SARS-CoV-2 infection in the future.
C1 [Wang, Changtai; Liu, Zhongping; Xu, Mengyuan; He, Tengfei; Zhang, Zhenhua] Anhui Med Univ, Dept Infect Dis, Hosp 2, Furong Rd 678, Hefei 230601, Anhui, Peoples R China.
   [Wang, Changtai; Liu, Zhongping; Chen, Zixiang; Huang, Xin; Xu, Mengyuan; He, Tengfei; Zhang, Zhenhua] Anhui Med Univ, Inst Clin Virol, Hosp 2, Hefei, Peoples R China.
   [Wang, Changtai] Anhui Med Univ, Dept Infect Dis, Affiliated Anqing Hosp, Anqing, Peoples R China.
   [Zhang, Zhenhua] Anhui Med Univ, Anhui Prov Lab Inflammatory & Immun Dis, Hefei, Peoples R China.
RP Zhang, ZH (reprint author), Anhui Med Univ, Dept Infect Dis, Hosp 2, Furong Rd 678, Hefei 230601, Anhui, Peoples R China.
EM zzh1974cn@163.com
FU Emergency Science and Technology Plan for Novel Coronavirus Infection of
   Anqing [2020Z1001]; Anhui Provincial Natural Science Foundation of
   ChinaNatural Science Foundation of Anhui Province [1608085MH162]
FX Emergency Science and Technology Plan for Novel Coronavirus Infection of
   Anqing, Grant/Award Number: 2020Z1001; Anhui Provincial Natural Science
   Foundation of China, Grant/Award Number: 1608085MH162
CR Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen L, 2018, MED SCI MONITOR, V24, P6781, DOI 10.12659/MSM.910049
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Chu D, 2020, CLIN CHEM
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lam T, 2020, 945485 BIORXIV, DOI [10.1101/2020.02.13.945485, DOI 10.1101/2020.02.13.945485]
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Wang S, 2020, DEEP LEARNING ALGORI, DOI [10.1101/2020.02.14.20023028, DOI 10.1101/2020.02.14.20023028]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xiao KP, 2020, 951335 BIORXIV, DOI [10.1101/2020.02.17.951335, DOI 10.1101/2020.02.17.951335]
   Zhang NR, 2020, J MED VIROL, V92, P408, DOI 10.1002/jmv.25674
   Zhang ZH, 2015, J VIROL METHODS, V213, P57, DOI 10.1016/j.jviromet.2014.11.007
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 22
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25762
EA MAR 2020
PG 8
WC Virology
SC Virology
GA KV9UD
UT WOS:000520819300001
PM 32167180
OA Bronze
DA 2020-04-03
ER

PT J
AU Connolly, J
AF Connolly, John
TI Global Crisis Leadership for Disease-Induced Threats: One Health and
   Urbanisation
SO GLOBAL POLICY
LA English
DT Article; Early Access
ID KNOWLEDGE INTEGRATION; POLICY; WILDLIFE; DECADE
AB The concept of 'One Health' (OH) has gathered momentum among the public health and animal health communities as an important global policy agenda for drawing together these disciplines to inform urban planning and health security policies. OH research, from a risk governance perspective, is generally concerned with identifying preventative programmes that can minimise the threats posed by diseases at the animal-human interface (e.g. Corona virus, Ebola, avian influenza, the Q virus, for example). This article, by drawing on examples of disease threats, discusses the multi-level challenges of establishing OH with a particular focus on urban change. It considers the risks posed by the increasing urbanisation of animal habitats and what this means for achieving OH. The article concludes by discussing why social scientists need to pay greater attention to the concept of OH.
C1 [Connolly, John] Univ West Scotland, Publ Policy, Paisley, Renfrew, Scotland.
RP Connolly, J (reprint author), Univ West Scotland, Publ Policy, Paisley, Renfrew, Scotland.
EM john.connolly@uws.ac.uk
CR Boin A., 2016, POLITICS CRISIS MANA
   Cairney P., 2017, COMPLEXITY GOVERNANC, V3, P1, DOI [10.20377/cgn-56, DOI 10.20377/CGN-56]
   Connolly J., 2016, POLITICS CRISIS MANA
   Connolly J., 2019, POLICY BRIEFING BREX
   Connolly J, 2017, GLOB POLICY, V8, P483, DOI 10.1111/1758-5899.12505
   Coronavirus latest: WHO officially names disease COVID-19, 2020, NATURE, DOI 10.1038/s41586-020-1969-6
   Council of the European Union, 2012, EMPL SOC POL HLTH CO
   Davidson K, 2019, GLOB POLICY, V10, P697, DOI 10.1111/1758-5899.12740
   Dhont K, 2019, GROUP PROCESS INTERG, V22, P769, DOI 10.1177/1368430219864455
   Essack S, 2018, LANCET GLOB HEALTH, V6, pS27, DOI 10.1016/S2214-109X(18)30156-6
   European Medicines Agency, 2018, EMA BREX PREP BUS CO
   Firth C., 2014, CONVERSATION
   Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143
   HAAS PM, 1992, INT ORGAN, V46, P1, DOI 10.1017/S0020818300001442
   Hasler B, 2014, REV SCI TECH OIE, V33, P453, DOI 10.20506/rst.33.2.2294
   Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012
   Heymann DL, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0011-2012
   Hitziger M, 2018, B WORLD HEALTH ORGAN, V96, P211, DOI [10.2471/BLT.17.202705, 10.2471/blt.17.202705]
   Hogwood B. W., 1984, POLICY ANAL REAL WOR
   Hood C, 2002, GOV OPPOS, V37, P15, DOI 10.1111/1477-7053.00085
   Houle K. L. F., 2015, ONE HLTH THEORY PRAC
   Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kock R., 2018, INTEGRATED APPROACHE, P22
   Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707
   Kung NY, 2015, ONE HEALTH, V1, P24, DOI 10.1016/j.onehlt.2015.07.002
   Kynge J., 2020, CORONAVIRUS COST CHI
   Leboeuf A., 2011, IFRI HLTH ENV REPORT, V7
   Lee K, 2013, HEALTH POLICY PLANN, V28, P778, DOI 10.1093/heapol/czs127
   Lipsky M, 2010, STREET-LEVEL BUREAUCRACY: DILEMMAS OF THE INDIVIDUAL IN PUBLIC SERVICES, 30TH EDITION, P1
   Liverman DM, 2018, DIALOGUES HUM GEOGR, V8, P168, DOI 10.1177/2043820618780787
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Luke J. S., 1998, CATALYTIC LEADERSHIP
   Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006
   Marmot M., 2005, SOCIAL DETERMINANTS
   McGee ZA, 2019, POLICY STUD J, V47, pS138, DOI 10.1111/psj.12319
   Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837
   Moore M, 2003, INT J HYG ENVIR HEAL, V206, P269, DOI 10.1078/1438-4639-00223
   Moore M. H., 1995, CREATING PUBLIC VALU
   Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060
   OIE, 2019, ONE WORLD ONE HLTH
   Oliver K, 2019, PALGR COMMUN, V5, DOI 10.1057/s41599-019-0266-1
   Peters B. G., 2013, STRATEGIES COMP RES
   Queenan K., 2017, CAB Reviews, V12, P1, DOI 10.1079/PAVSNNR201712014
   Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867
   Ruegg SR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00020
   Rushton J, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.461
   Salson M, 2010, J DISCRET ALGORITHMS, V8, P241, DOI 10.1016/j.jda.2009.02.007
   Schelling E, 2005, BRIT MED J, V331, P1264, DOI 10.1136/bmj.331.7527.1264
   Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69
   Siebert H., 2001, KOBRA EFFEKT WIE MAN
   Singh N, 2016, LANCET GLOB HEALTH, V4, pE237, DOI 10.1016/S2214-109X(16)00002-4
   Stoker G, 2006, AM REV PUBLIC ADM, V36, P41, DOI 10.1177/0275074005282583
   Thorson A., 2005, J CONTING CRISIS MAN, V13, P21
   Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572
   UN, 2019, UN SUST DEV GOALS
   UN, 2019, GOAL 3 ENS HLTH LIV
   US Centers for Disease Control and Prevention, 2019, Q FEV
   US Centers for Disease Control and Prevention, 2016, 2014 2016 EB OUTBR W
   US Centers for Disease Control and Prevention, 2020, 2019 NOV COR 2019 NC
   Van Mead M., 2016, GUARDIAN
   Vann Michael G., 2003, FRENCH COLONIAL HIST, V4, P191
   Waage J., 2015, THINKING SECTORS SUS, P79
   WHO, 2019, FAQS H5N1 INFL
   WHO, 2015, FACT CONTR UND SPREA
   WHO, 2005, INT HLTH REG
   WHO, 2019, AV INFL WEEKL UPD NU
   Williams P, 2012, J INTEGR CARE, V20, P164, DOI 10.1108/14769011211237500
   Winarso H, 2011, CSUR UT SER LIB SUST, V10, P163
   World Bank, 2018, ON HLTH OP FRAM STRE
   Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206
   Zinsstag J., 2015, ONE HLTH THEORY PRAC
NR 72
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1758-5880
EI 1758-5899
J9 GLOB POLICY
JI Glob. Policy
DI 10.1111/1758-5899.12806
EA MAR 2020
PG 10
WC International Relations; Political Science
SC International Relations; Government & Law
GA KV5MV
UT WOS:000520528000001
OA Bronze
DA 2020-04-03
ER

PT J
AU Tai, WB
   He, L
   Zhang, XJ
   Pu, J
   Voronin, D
   Jiang, SB
   Zhou, YS
   Du, LY
AF Tai, Wanbo
   He, Lei
   Zhang, Xiujuan
   Pu, Jing
   Voronin, Denis
   Jiang, Shibo
   Zhou, Yusen
   Du, Lanying
TI Characterization of the receptor-binding domain (RBD) of 2019 novel
   coronavirus: implication for development of RBD protein as a viral
   attachment inhibitor and vaccine
SO CELLULAR & MOLECULAR IMMUNOLOGY
LA English
DT Article; Early Access
DE 2019 novel coronavirus; SARS-CoV-2; spike protein; receptor-binding
   domain; viral inhibitor; cross-neutralization
ID RESPIRATORY SYNDROME CORONAVIRUS; DIPEPTIDYL PEPTIDASE 4; SPIKE PROTEIN;
   MERS-COV; FUNCTIONAL RECEPTOR; S PROTEIN; SARS-COV; TARGET;
   IDENTIFICATION; MICE
AB The outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S protein and found that the RBD protein bound strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. SARS-CoV-2 RBD exhibited significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD and could block the binding and, hence, attachment of SARS-CoV-2 RBD and SARS-CoV RBD to ACE2-expressing cells, thus inhibiting their infection to host cells. SARS-CoV RBD-specific antibodies could cross-react with SARS-CoV-2 RBD protein, and SARS-CoV RBD-induced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.
C1 [Tai, Wanbo; Zhang, Xiujuan; Pu, Jing; Voronin, Denis; Jiang, Shibo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
   [He, Lei; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.
   [Pu, Jing; Jiang, Shibo] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
RP Jiang, SB; Du, LY (reprint author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.; Zhou, YS (reprint author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.; Jiang, SB (reprint author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
EM sjiang@nybc.org; yszhou@bmi.ac.cn; ldu@nybc.org
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI137472, R01AI139092]; New York
   Blood Center [VIM-NYB616, CFM-NYB595]
FX The authors thank Dr. Fang Li at the University of Minnesota for
   providing 293T cells stably expressing human dipeptidyl peptidase 4.
   This study was supported by the NIH grants (R01AI137472 and R01AI139092)
   and intramural funds of the New York Blood Center (VIM-NYB616 and
   CFM-NYB595).
CR Chen WH, 2014, HUM VACC IMMUNOTHER, V10, P648, DOI 10.4161/hv.27464
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, 2020, Nat Microbiol, V5, P536, DOI 10.1038/s41564-020-0695-z
   Du LY, 2017, EXPERT OPIN THER TAR, V21, P131, DOI 10.1080/14728222.2017.1271415
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Du LY, 2016, EXPERT REV VACCINES, V15, P1123, DOI 10.1586/14760584.2016.1167603
   Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14
   Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13
   Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090
   Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06
   Jiang Shibo, 2020, Lancet, V395, P949, DOI 10.1016/S0140-6736(20)30419-0
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Tai WB, 2017, J VIROL, V91, DOI 10.1128/JVI.01651-16
   Tai WB, 2016, VIROLOGY, V499, P375, DOI 10.1016/j.virol.2016.10.005
   Wang N, 2020, FRONT MICROBIOL, DOI [10.3389/fmicb.2020.00298, DOI 10.3389/FMICB.2020.00298]
   Wang QH, 2016, ANTIVIR RES, V133, P165, DOI 10.1016/j.antiviral.2016.07.015
   WHO, 2020, COR DIS 2019 COVID 1
   World Health Organization, 2020, NAM COR DIS COVID 19
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou YS, 2018, EXPERT REV VACCINES, V17, P677, DOI 10.1080/14760584.2018.1506702
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 35
TC 0
Z9 0
U1 9
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1672-7681
EI 2042-0226
J9 CELL MOL IMMUNOL
JI Cell. Mol. Immunol.
DI 10.1038/s41423-020-0400-4
EA MAR 2020
PG 8
WC Immunology
SC Immunology
GA KV6TI
UT WOS:000520614400003
PM 32203189
OA Other Gold
DA 2020-04-03
ER

PT J
AU Wu, JT
   Leung, K
   Bushman, M
   Kishore, N
   Niehus, R
   de Salazar, PM
   Cowling, BJ
   Lipsitch, M
   Leung, GM
AF Wu, Joseph T.
   Leung, Kathy
   Bushman, Mary
   Kishore, Nishant
   Niehus, Rene
   de Salazar, Pablo M.
   Cowling, Benjamin J.
   Lipsitch, Marc
   Leung, Gabriel M.
TI Estimating clinical severity of COVID-19 from the transmission dynamics
   in Wuhan, China
SO NATURE MEDICINE
LA English
DT Article; Early Access
ID ACUTE RESPIRATORY SYNDROME; FATALITY RISK; INFECTION; VIRUS
AB As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter, Wuhan. A key public health priority during the emergence of a novel pathogen is estimating clinical severity, which requires properly adjusting for the case ascertainment rate and the delay between symptoms onset and death. Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9-2.1%), which is substantially lower than both the corresponding crude or naive confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator(1) of deaths/deaths + recoveries (2,169/2,169 + 17,572 = 11%) as of 29 February 2020. Compared to those aged 30-59 years, those aged below 30 and above 59 years were 0.6 (0.3-1.1) and 5.1 (4.2-6.1) times more likely to die after developing symptoms. The risk of symptomatic infection increased with age (for example, at similar to 4% per year among adults aged 30-60 years).
C1 [Wu, Joseph T.; Leung, Kathy; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, LKS Fac Med, Hong Kong, Peoples R China.
   [Bushman, Mary; Kishore, Nishant; Niehus, Rene; de Salazar, Pablo M.; Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA USA.
RP Wu, JT (reprint author), Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, LKS Fac Med, Hong Kong, Peoples R China.
EM joewu@hku.hk
OI Leung, Gabriel/0000-0002-2503-6283
FU Health and Medical Research Fund from the Government of the Hong Kong
   Special Administrative Region; US National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U54GM088558]; Fellowship Foundation Ramon
   Areces
FX We thank D. Liu, M. Wong and C.K. Lam from the School of Public Health
   at the University of Hong Kong for technical support. This research was
   supported by a commissioned grant from the Health and Medical Research
   Fund from the Government of the Hong Kong Special Administrative Region
   and award no. U54GM088558 from the US National Institute of General
   Medical Sciences. P.M.d.S. was supported by the Fellowship Foundation
   Ramon Areces. The content is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Institute of General Medical Sciences or the National Institutes of
   Health. The funding bodies had no role in study design, data collection
   and analysis, preparation of the manuscript, or the decision to publish.
   All authors have seen and approved the manuscript. All authors
   contributed significantly to the work.
CR Abbad A, 2019, EUROSURVEILLANCE, V24, P43, DOI 10.2807/1560-7917.ES.2019.24.48.1900244
   Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Callaway E, 2020, NATURE
   Chinese Center for Disease Control and Prevention, 2020, DASHB REP 2019 NCOV
   Collins Selwyn D., 1944, PUBL HEALTH REPTS, V59, P1483, DOI 10.2307/4585095
   Data Platform of Shanghai Observer, 2020, LIN LIST 2019 NCOV C
   Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Hubei Municipal Health Commission, 2020, HUB MUN HLTH COMM BR
   Hubei Municipal Health Commission, 2020, SIT EP PNEUM CAUS NO, V12
   Jia N, 2009, TROP MED INT HEALTH, V14, P21, DOI 10.1111/j.1365-3156.2008.02147.x
   Lau EHY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-50
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1
   National Health Commission of People's Republic of China, 2020, NOT GEN OFF NAT HLTH
   Niehus R., 2020, QUANTIFYING BIAS COV, DOI [10.1101/2020.02.13.20022707, DOI 10.1101/2020.02.13.20022707]
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Pan Yang, 2020, Lancet Infect Dis, V20, P411, DOI 10.1016/S1473-3099(20)30113-4
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   The State Council of The People's Republic of China, 2020, PRESS C JOINT PREV C
   Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054
   Wong JY, 2013, EPIDEMIOLOGY, V24, P830, DOI 10.1097/EDE.0b013e3182a67448
   Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314
   World Health Organization, 2020, REP WHO CHIN JOINT M
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wuhan Municipal Health Commission, 2020, WUH MUN HLTH COMM BR
   Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6
   Zou Lirong, 2020, N Engl J Med, V382, P1177, DOI 10.1056/NEJMc2001737
NR 32
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
DI 10.1038/s41591-020-0822-7
EA MAR 2020
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA KV6SM
UT WOS:000520612200001
OA Bronze
DA 2020-04-03
ER

PT J
AU Khachfe, HH
   Chahrour, M
   Sammouri, J
   Salhab, HA
   Makki, BE
   Fares, MY
AF Khachfe, Hussein H.
   Chahrour, Mohamad
   Sammouri, Julie
   Salhab, Hamza A.
   Makki, Bassel Eldeen
   Fares, Mohamad Y.
TI An Epidemiological Study on COVID-19: A Rapidly Spreading Disease
SO CUREUS
LA English
DT Article
DE coronavirus; novel coronavirus; covid-19; infectious disease;
   epidemiology
AB Background
   The outbreak of the novel coronavirus disease in 2019 (COVID-19) caused a major public health crisis worldwide and challenged healthcare systems across the six continents. The high infectivity of the disease led many governments to adopt strict regulations and measures with the aim of containing its spread. The purpose of this study is to assess the incidence, severity, and territorial expansion of COVID-19.
   Methods
   Data from the World Health Organization was screened, and COVID-19 situation reports were extracted from January 21 up till March 14 (inclusive). Our data included the total number of cases, total number of new cases, total number of cured cases, and total number of related deaths. Percentage change of cases over the days of our study were calculated using the Joinpoint regression, with a significance level set at greater than 0.05.
   Results
   The total number of COVID-19 cases reached 156,622, with 5,845 subsequent deaths. China, Italy, and Iran have the highest number of cases worldwide. During the first 22 days, the incidence rate of COVID-19 increased significantly to reach 1.81 cases per million persons (p<0.001). That was followed by a significant decrease over the next 11 days (p<0.001) to reach 0.071 cases per million persons. A steady rise then followed, which saw a significant increase in incidence rate to 1.429 cases per million persons (p<0.001). Percentages of death and cured cases varied across the different countries; nevertheless, death percentages have generally been decreasing since the start of the crisis.
   Conclusion
   Adopting precautionary regulations such as social isolation, increasing sanitation, and employing strict quarantine measures have proved to be beneficial in containing the virus. Further research needs to be conducted to help discover therapeutic modalities and improve outcomes.
C1 [Khachfe, Hussein H.] Amer Univ Beirut, Gen Surg, Med Ctr, Beirut, Lebanon.
   [Chahrour, Mohamad; Sammouri, Julie; Salhab, Hamza A.; Fares, Mohamad Y.] Amer Univ Beirut, Med, Med Ctr, Beirut, Lebanon.
   [Makki, Bassel Eldeen] Univ Tehran Med Sci, Med, Tehran, Iran.
RP Khachfe, HH (reprint author), Amer Univ Beirut, Gen Surg, Med Ctr, Beirut, Lebanon.
EM hhk15@mail.aub.edu
RI Khachfe, Hussein H./AAC-3520-2020
OI Khachfe, Hussein H./0000-0001-7537-9033
CR [Anonymous], 2020, IRAN ELECTIONS RECOR
   [Anonymous], 2020, CORONAVIRUS DIS COVI
   [Anonymous], 2020, WUHAN CLOSES LAST MA
   Cascella M, 2020, FEATURES EVALUATION
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Fares J, 2019, HDB HEALTHCARE ARAB, P1, DOI [10.1007/978-3-319-74365-3_166-1, DOI 10.1007/978-3-319-74365-3_166-1]
   Fares J, 2019, HDB HEALTHCARE ARAB, V1, P20, DOI [10.1007/978-3-319-74365-3_167-1, DOI 10.1007/978-3-319-74365-3_167-1]
   Fares MY, 2019, HDB HEALTHCARE ARAB, P1, DOI [10.1007/978-3-319-74365-3_165-1, DOI 10.1007/978-3-319-74365-3_165-1]
   Ferre Francesca, 2014, Health Syst Transit, V16, P1
   Guan WJ, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2002032, DOI 10.1056/NEJM0A2002032]
   Guo Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P643, DOI 10.3760/cma.j.cn112338-20200301-00222
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Mooketsane KS, 2015, GLOB SOC POLICY, V15, P345, DOI 10.1177/1468018115600123d
   Purcell Laura N, 2020, Int J Surg, V76, P111, DOI 10.1016/j.ijsu.2020.03.002
   Remuzzi Andrea, 2020, Lancet, DOI 10.1016/S0140-6736(20)30627-9
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rothan Hussin A, 2020, J Autoimmun, P102433, DOI 10.1016/j.jaut.2020.102433
   Sohrabi Catrin, 2020, Int J Surg, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Wang Yixuan, 2020, J Med Virol, DOI 10.1002/jmv.25748
   Xiong Z, 2020, Zhonghua Yi Xue Za Zhi, V100, pE019, DOI 10.3760/cma.j.cn112137-20200228-00499
   Yang Yongshi, 2020, J Autoimmun, P102434, DOI 10.1016/j.jaut.2020.102434
   Zhou Fei, 2020, Lancet, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 22
TC 0
Z9 0
U1 0
U2 0
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD MAR 18
PY 2020
VL 12
IS 3
AR e7313
DI 10.7759/cureus.7313
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU9DU
UT WOS:000520024400012
OA Other Gold, Bronze
DA 2020-04-03
ER

PT J
AU Li, YZ
   Guo, FF
   Cao, Y
   Li, LF
   Guo, YJ
AF Li, Yuanzhe
   Guo, FeiFei
   Cao, Yang
   Li, LiFeng
   Guo, YanJun
TI Insight into COVID-2019 for pediatricians
SO PEDIATRIC PULMONOLOGY
LA English
DT Article; Early Access
DE COVID-2019; pediatric infection; SARSCoV-2
AB Since December 2019, patients with unexplained pneumonia have been found in Wuhan City, Hubei Province, China. The pathogen in these cases is a new type of coronavirus. The World Health Organization confirmed this diagnosis and named the pathogen SARSCoV-2. The disease caused by SARSCoV-2 is called Corona Virus Disease (COVID-2019). The virus is highly infectious and pathogenic, causing human-to-human transmission. At present, SARSCoV-2 is still rampant in the world. Zhengzhou City in Henan Province serves as an example, 102 people have been confirmed to be infected with SARSCoV-2 (at 24:00 on February 5th, 2020), including three children, the youngest is 4 years old. From the perspective of clinical pediatricians as the first line fighting the epidemic, this paper will discuss the clinical characteristics, prevention and control measures, outcomes, diagnosis, and treatment of pediatric cases.
C1 [Li, Yuanzhe; Guo, YanJun] Zhengzhou Univ, Dept Pediat, Childrens Hosp, 33 Long Hu Wai Huan East Rd, Zhengzhou 450018, Henan, Peoples R China.
   [Guo, FeiFei] First Peoples Hosp Yunnan Prov, Dept Pediat, Kunming, Yunnan, Peoples R China.
   [Cao, Yang] Zhengzhou Gen Hosp, Dept Pediat, Zhengzhou, Peoples R China.
   [Li, LiFeng] Zhengzhou Univ, Natl Engn Lab, Affiliated Hosp 1, Zhengzhou, Peoples R China.
RP Guo, YJ (reprint author), Zhengzhou Univ, Dept Pediat, Childrens Hosp, 33 Long Hu Wai Huan East Rd, Zhengzhou 450018, Henan, Peoples R China.
EM 289679861@qq.com
FU Henan Provincial associated Co-construction Project [2018020599]; Henan
   Provincial Ministry Co-construction Project [2018010040]
FX Henan Provincial associated Co-construction Project, Grant/Award Number:
   2018020599; Henan Provincial Ministry Co-construction Project,
   Grant/Award Number: 2018010040
CR Cai JH, 2020, CHIN J PEDIAT, V58, P86, DOI [10.3760/cma.j.issn.0578-1310.2020.0002, DOI 10.3760/CMA.J.ISSN.0578-1310.2020.0002]
   Chai X, 2020, SPECIFIC ACE2 EXPRES, DOI [10.1101/2020.02.03.931766, DOI 10.1101/2020.02.03.931766]
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Deng H, 2020, CHIN PEDIAT EMERG ME, V27, P81
   Fang F, 2020, Zhonghua Er Ke Za Zhi, V58, P81, DOI 10.3760/cma.j.issn.0578-1310.2020.02.001
   Health and Health Commission of the people's Republic of China, EP SIT NOV COR PNEUM
   Henan Province Health Committee of the people's Republic of China, EP SIT NOV COR PNEUM
   Jiang Y, 2020, CHIN J APPL CLIN PED, V35, P81, DOI [10.3760/cma.j.issn.2095-428X.2020.02.001, DOI 10.3760/CMA.J.ISSN.2095-428X.2020.02.001]
   Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Zhao Y, 2020, SINGLE CELL RNA EXPR, DOI [10.1101/2020.01.26.919985, DOI 10.1101/2020.01.26.919985]
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 13
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8755-6863
EI 1099-0496
J9 PEDIATR PULM
JI Pediatr. Pulmonol.
DI 10.1002/ppul.24734
EA MAR 2020
PG 4
WC Pediatrics; Respiratory System
SC Pediatrics; Respiratory System
GA KV2HV
UT WOS:000520271200001
PM 32187887
OA Bronze
DA 2020-04-03
ER

PT J
AU Lung, JH
   Lin, YS
   Yang, YH
   Chou, YL
   Shu, LH
   Cheng, YC
   Liu, HT
   Wu, CY
AF Lung, Jrhau
   Lin, Yu-Shih
   Yang, Yao-Hsu
   Chou, Yu-Lun
   Shu, Li-Hsin
   Cheng, Yu-Ching
   Liu, Hung Te
   Wu, Ching-Yuan
TI The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA
   polymerase
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE RNA-dependent RNA polymerase; SARS-CoV-2; theaflavin; traditional
   Chinese medicinal compounds
ID SARS
AB An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan and it has rapidly spread to almost all parts of the world. For coronaviruses, RNA-dependent RNA polymerase (RdRp) is an important protease that catalyzes the replication of RNA from RNA template and is an attractive therapeutic target. In this study, we screened these chemical structures from traditional Chinese medicinal compounds proven to show antiviral activity in severe acute respiratory syndrome coronavirus (SARS-CoV) and the similar chemical structures through a molecular docking study to target RdRp of SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV). We found that theaflavin has a lower idock score in the catalytic pocket of RdRp in SARS-CoV-2 (-9.11 kcal/mol), SARS-CoV (-8.03 kcal/mol), and MERS-CoV (-8.26 kcal/mol) from idock. To confirm the result, we discovered that theaflavin has lower binding energy of -8.8 kcal/mol when it docks in the catalytic pocket of SARS-CoV-2 RdRp by using the Blind Docking server. Regarding contact modes, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and RdRp. Moreover, one pi-cation interaction was formed between theaflavin and Arg553 from the Blind Docking server. Our results suggest that theaflavin could be a potential SARS-CoV-2 RdRp inhibitor for further study.
C1 [Lung, Jrhau] Chiayi Chang Gung Mem Hosp, Dept Res & Dev, Chiayi Branch, Putzu, Taiwan.
   [Lin, Yu-Shih] Chiayi Chang Gung Mem Hosp, Dept Pharm, Chiayi Branch, Putzu, Taiwan.
   [Yang, Yao-Hsu; Shu, Li-Hsin; Cheng, Yu-Ching; Liu, Hung Te; Wu, Ching-Yuan] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Putzu 61363, Taiwan.
   [Yang, Yao-Hsu] Chang Gung Mem Hosp, Chiayi Branch, Hlth Informat & Epidemiol Lab, Putzu, Taiwan.
   [Yang, Yao-Hsu; Wu, Ching-Yuan] Chang Gung Univ, Sch Chinese Med, Taoyuan, Taiwan.
   [Chou, Yu-Lun] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan.
RP Wu, CY (reprint author), Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Putzu 61363, Taiwan.; Wu, CY (reprint author), Chang Gung Univ, Coll Med, Sch Chinese Med, 6 W Sec,Jiapu Rd, Taoyuan 333, Taiwan.
EM smbepigwu77@gmail.com
FU Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG6H0162];
   Ministry of Science and Technology [MOST 108-2320-B-182-021]
FX Chang Gung Memorial Hospital, Grant/Award Number: CMRPG6H0162; Ministry
   of Science and Technology, Grant/Award Number: MOST 108-2320-B-182-021
CR Chen CN, 2005, EVID-BASED COMPL ALT, V2, P209, DOI 10.1093/ecam/neh081
   Chowdhury P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198226
   Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X
   Dey SK, 2020, J MED VIROL, DOI 10.1002/jmv.25743
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Gordon Calvin J, 2020, J Biol Chem, DOI 10.1074/jbc.AC120.013056
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Park JY, 2012, BIOORGAN MED CHEM, V20, P5928, DOI 10.1016/j.bmc.2012.07.038
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ryu YB, 2010, BIOORGAN MED CHEM, V18, P7940, DOI 10.1016/j.bmc.2010.09.035
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011
   Yi L, 2004, J VIROL, V78, P11334, DOI 10.1128/JVI.78.20.11334-11339.2004
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhang MM, 2004, WORLD J GASTROENTERO, V10, P3500
NR 17
TC 0
Z9 0
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25761
EA MAR 2020
PG 5
WC Virology
SC Virology
GA KV1XU
UT WOS:000520244300001
PM 32167173
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhang, XM
   Song, W
   Liu, XL
   Lyu, L
AF Zhang, Xiangmin
   Song, Wei
   Liu, Xingli
   Lyu, Liang
TI CT image of novel coronavirus pneumonia: a case report
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Article; Early Access
DE COVID-19 pneumonia; Ground-glass opacities; CT
AB Objective Knowledge of CT characteristics of COVID-19 pneumonia might be helpful to the early diagnosis and treatment of patients, and to control the spread of infection. Methods The chest CT images of the patient were collected to describe the CT manifestations and characteristics, and they were compared with the previous studies. Results Multiple patchy ground-glass opacities (GGOs) were seen in bilateral lung, mostly in subpleural areas. They progressed within 3 days, and nodular GGOs were also seen together with subpleural patchy GGOs. Conclusion Our case of COVID-19 pneumonia showed multiple subpleural GGOs in bilateral lung, rapid progression, and it also accompanied nodular GGOs on chest CT. These findings were consistent with the previous reports, and they might be useful for early detection and evaluation of severity of COVID-19 pneumonia.
C1 [Zhang, Xiangmin; Song, Wei; Liu, Xingli; Lyu, Liang] First Peoples Hosp Yunnan Prov, Dept Radiol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China.
   [Zhang, Xiangmin; Song, Wei; Liu, Xingli; Lyu, Liang] Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Yunnan, Peoples R China.
RP Lyu, L (reprint author), First Peoples Hosp Yunnan Prov, Dept Radiol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China.; Lyu, L (reprint author), Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Yunnan, Peoples R China.
EM lyuliang0720@hotmail.com
CR Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Pan YY, 2020, EUR RADIOL, DOI 10.1007/s00330-020-06731-x
NR 5
TC 0
Z9 0
U1 21
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
DI 10.1007/s11604-020-00945-1
EA MAR 2020
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KV9VP
UT WOS:000520823100001
PM 32189175
OA Bronze
DA 2020-04-03
ER

PT J
AU Nakajima, K
   Kato, H
   Yamashiro, T
   Izumi, T
   Takeuchi, I
   Nakajima, H
   Utsunomiya, D
AF Nakajima, Kento
   Kato, Hideaki
   Yamashiro, Tsuneo
   Izumi, Toshiharu
   Takeuchi, Ichiro
   Nakajima, Hideaki
   Utsunomiya, Daisuke
TI COVID-19 pneumonia: infection control protocol inside computed
   tomography suites
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Article; Early Access
DE COVID-19; Pneumonia; Computed tomography; Infection
AB A novel coronavirus (severe acute respiratory syndrome coronavirus 2) causes a cluster of pneumonia cases in Wuhan, China. It spread rapidly and globally. CT imaging is helpful for the evaluation of the novel coronavirus disease 2019 (COVID-19) pneumonia. Infection control inside the CT suites is also important to prevent hospital-related transmission of COVID-19. We present our experience with infection control protocol for COVID-19 inside the CT suites.
C1 [Nakajima, Kento; Takeuchi, Ichiro] Yokohama City Univ Med, Adv Crit Care Med, Yokohama, Kanagawa, Japan.
   [Kato, Hideaki] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Kanagawa, Japan.
   [Yamashiro, Tsuneo; Utsunomiya, Daisuke] Yokohama City Univ Med, Diagnost Radiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.
   [Izumi, Toshiharu; Utsunomiya, Daisuke] Yokohama City Univ Med, Cent Radiol, Yokohama, Kanagawa, Japan.
   [Nakajima, Hideaki] Yokohama City Univ Med, Hematol & Clin Immunol, Yokohama, Kanagawa, Japan.
   [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa, Japan.
RP Utsunomiya, D (reprint author), Yokohama City Univ Med, Diagnost Radiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.; Utsunomiya, D (reprint author), Yokohama City Univ Med, Cent Radiol, Yokohama, Kanagawa, Japan.
EM d.utsunomiya@gmail.com
CR Japanese College of Radiology, INTR INF PROT CT SCA
   Pan Feng, 2020, Radiology, P200370, DOI 10.1148/radiol.2020200370
   Pan YY, 2020, EUR RADIOL, DOI 10.1007/s00330-020-06731-x
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
NR 4
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
DI 10.1007/s11604-020-00948-y
EA MAR 2020
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA KV8AN
UT WOS:000520700700002
PM 32185669
OA Bronze
DA 2020-04-03
ER

PT J
AU Chen, R
   Zhang, Y
   Huang, L
   Cheng, BH
   Xia, ZY
   Meng, QT
AF Chen, Rong
   Zhang, Yuan
   Huang, Lei
   Cheng, Bi-heng
   Xia, Zhong-yuan
   Meng, Qing-tao
TI Safety and efficacy of different anesthetic regimens for parturients
   with COVID-19 undergoing Cesarean delivery: a case series of 17 patients
SO CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE
LA English
DT Article; Early Access
ID RESPIRATORY SYNDROME; CORONAVIRUS
AB Purpose To assess the management and safety of epidural or general anesthesia for Cesarean delivery in parturients with coronavirus disease (COVID-19) and their newborns, and to evaluate the standardized procedures for protecting medical staff. Methods We retrospectively reviewed the cases of parturients diagnosed with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection disease (COVID-19). Their epidemiologic history, chest computed tomography scans, laboratory measurements, and SARS-CoV-2 nucleic acid positivity were evaluated. We also recorded the patients' demographic and clinical characteristics, anesthesia and surgery-related data, maternal and neonatal complications, as well as the health status of the involved medical staff. Results The clinical characteristics of 17 pregnant women infected with SARS-CoV-2 were similar to those previously reported in non-pregnant adult patients. All of the 17 patients underwent Cesarean delivery with anesthesia performed according to standardized anesthesia/surgery procedures. Fourteen of the patients underwent continuous epidural anesthesia with 12 experiencing significant intraoperative hypotension. Three patients received general anesthesia with tracheal intubation because emergency surgery was needed. Three of the parturients are still recovering from their Cesarean delivery and are receiving in-hospital treatment for COVID-19. Three neonates were born prematurely. There were no deaths or serious neonatal asphyxia events. All neonatal SARS-CoV-2 nucleic acid tests were negative. No medical staff were infected throughout the patient care period. Conclusions Both epidural and general anesthesia were safely used for Cesarean delivery in the parturients with COVID-19. Nevertheless, the incidence of hypotension during epidural anesthesia appeared excessive. Proper patient transfer, medical staff access procedures, and effective biosafety precautions are important to protect medical staff from COVID-19.
C1 [Chen, Rong; Zhang, Yuan; Xia, Zhong-yuan; Meng, Qing-tao] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China.
   [Chen, Rong; Zhang, Yuan; Huang, Lei; Xia, Zhong-yuan; Meng, Qing-tao] Wuhan Univ, East Hosp, Renmin Hosp, Dept Anesthesiol, Wuhan, Peoples R China.
   [Cheng, Bi-heng] Wuhan Univ, East Hosp, Renmin Hosp, Dept Obstet, Wuhan, Peoples R China.
RP Meng, QT (reprint author), Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China.; Meng, QT (reprint author), Wuhan Univ, East Hosp, Renmin Hosp, Dept Anesthesiol, Wuhan, Peoples R China.
EM mengqingtao2018@126.com
CR Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Birnbach DJ, 2019, OBSTET GYN CLIN N AM, V46, P329, DOI 10.1016/j.ogc.2019.01.015
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen R, 2020, CAN J ANESTH, DOI 10.1007/s12630-020-01625-4
   Fan C, 2020, UROLOGY, DOI [10.1101/2020.02.12.20022418, DOI 10.1101/2020.02.12.20022418]
   Gagneur A, 2007, PATHOL BIOL, V55, P525, DOI 10.1016/j.patbio.2007.07.013
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   Wax RS, 2020, CAN J ANESTH, DOI 10.1007/s12630-020-01591-x
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m606
   Yang Xiaobo, 2020, Lancet Respir Med, DOI 10.1016/S2213-2600(20)30079-5
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 14
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0832-610X
EI 1496-8975
J9 CAN J ANESTH
JI Can. J. Anesth.
DI 10.1007/s12630-020-01630-7
EA MAR 2020
PG 9
WC Anesthesiology
SC Anesthesiology
GA KV7EH
UT WOS:000520642900002
PM 32180175
OA Bronze
DA 2020-04-03
ER

PT J
AU Ji, LN
   Chao, S
   Wang, YJ
   Li, XJ
   Mu, XD
   Lin, MG
   Jiang, RM
AF Ji, Li-Na
   Chao, Shuang
   Wang, Yue-Jiao
   Li, Xue-Jun
   Mu, Xiang-Dong
   Lin, Ming-Gui
   Jiang, Rong-Meng
TI Clinical features of pediatric patients with COVID-19: a report of two
   family cluster cases
SO WORLD JOURNAL OF PEDIATRICS
LA English
DT Article; Early Access
DE Children; Coronavirus; COVID-19; Wuhan
AB Background Coronovirus disease 2019 (COVID-19) has spread rapidly across the globe. People of all ages are susceptible to COVID-19. However, literature reports on pediatric patients are limited. Methods To improve the recognition of COVID-19 infection in children, we retrospectively reviewed two confirmed pediatric cases from two family clusters. Both clinical features and laboratory examination results of the children and their family members were described. Results The two confirmed children only presented with mild respiratory or gastrointestinal symptoms. Both of them had normal chest CT images. After general and symptomatic treatments, both children recovered quickly. Both families had travel histories to Hubei Province. Conclusions Pediatric patients with COVID-19 are mostly owing to family cluster or with a close contact history. Infected children have relatively milder clinical symptoms than infected adults. We should attach importance to early recognition, early diagnosis, and early treatment of infected children.
C1 [Ji, Li-Na; Chao, Shuang; Wang, Yue-Jiao; Li, Xue-Jun] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Pediat, Litang Rd 168, Beijing 102218, Peoples R China.
   [Mu, Xiang-Dong] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Resp Med, Litang Rd 168, Beijing 102218, Peoples R China.
   [Lin, Ming-Gui] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Infect Dis, Litang Rd 168, Beijing 102218, Peoples R China.
   [Jiang, Rong-Meng] Capital Med Univ, Dept Infect Dis, Beijing Ditan Hosp, Jingshun East St 8, Beijing 100011, Peoples R China.
RP Ji, LN (reprint author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Pediat, Litang Rd 168, Beijing 102218, Peoples R China.
EM jlna01103@btch.edu.cn
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen F, 2020, Zhonghua Er Ke Za Zhi, V58, pE005, DOI 10.3760/cma.j.issn.0578-1310.2020.0005
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen ZM, 2020, WORLD J PEDIATR, DOI 10.1007/s12519-020-00345-5
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Coronavirus latest: WHO officially names disease COVID-19, 2020, NATURE, DOI 10.1038/s41586-020-1969-6
   Epidemiology Working Group for NCIP Epidemic Response, 2020, CHIN J EPIDEMIOL, V41, P145
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Real-time reporting of 2019-nCoV outbreak, 2020, XINHUA NEWS NETWORK
   Shen KL, 2020, WORLD J PEDIATR, DOI 10.1007/s12519-020-00344-6
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 11
TC 0
Z9 0
U1 1
U2 1
PU ZHEJIANG UNIV SCH MEDICINE
PI HANGZHOU
PA CHILDRENS HOSPITAL, 57 ZHUGAN XIANG, HANGZHOU, 310003, PEOPLES R CHINA
SN 1708-8569
EI 1867-0687
J9 WORLD J PEDIATR
JI World Journal of Pediatrics
DI 10.1007/s12519-020-00356-2
EA MAR 2020
PG 4
WC Pediatrics
SC Pediatrics
GA KV6XS
UT WOS:000520625800001
PM 32180140
OA Bronze
DA 2020-04-03
ER

PT J
CA Korean Soc Infect Dis
   Korean Soc Infect Dis
   Korean Soc Pediat Infect Dis
   Korean Soc Epidemiology
   Korean Soc Antimicrobial Therapy
   Korean Soc Healthcare-Associated
   Korea Ctr Dis Control Prevention
TI Report on the Epidemiological Features of Coronavirus Disease 2019
   (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2,
   2020
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Coronavirus; SARS-CoV-2; COVID-19; Korea; Epidemiology
AB Since the first case of coronavirus disease19 (COVID-19) was reported in Wuhan, China, as of March 2, 2020, the total number of confirmed cases of COVID-19 was 89,069 cases in 67 countries and regions. As of 0 AM, March 2, 2020, the Republic of Korea had the second-largest number of confirmed cases (n = 4,212) after China (n = 80,026). This report summarizes the epidemiologic features and the snapshots of the outbreak in the Republic of Korea from January 19 and March 2, 2020.
RP 23 Seocho Daero,74 Gil, Seoul 06621, South Korea.
CR Gyeongsangnamdo, UPD COVID 19 GYEON U
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Korea Centers for Disease Control and Prevention, UPD COVID 19 KOR 30
   Korea Centers for Disease Control and Prevention, UPD COVID 19 KOR MAR
   Korea Centers for Disease Control and Prevention, UPD COVID 19 KOR FEB
   Korea Centers for Disease Control and Prevention, UPD COVID 19 KOR 19
   Korean Statistical Information Service, 2019, 2018 POP CENS UPD KO
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Wu Z, 2020, JAMA
   Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e56
NR 10
TC 0
Z9 0
U1 1
U2 1
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD MAR 16
PY 2020
VL 35
IS 10
AR e112
DI 10.3346/jkms.2020.35.e112
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU9BH
UT WOS:000520016200008
PM 32174069
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Zhou, YD
   Hou, Y
   Shen, JY
   Huang, Y
   Martin, W
   Cheng, FX
AF Zhou, Yadi
   Hou, Yuan
   Shen, Jiayu
   Huang, Yin
   Martin, William
   Cheng, Feixiong
TI Network-based drug repurposing for novel coronavirus
   2019-nCoV/SARS-CoV-2
SO CELL DISCOVERY
LA English
DT Article
ID EAST RESPIRATORY SYNDROME; SMALL-MOLECULE INHIBITORS; PAPAIN-LIKE
   PROTEASE; CONVERTING-ENZYME; POTENT INHIBITOR; VIRUS; IDENTIFICATION;
   MELATONIN; SARS; INTERACTS
AB Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. Drug repurposing, representing as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery. In this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV-host interactome and drug targets in the human protein-protein interaction network. Phylogenetic analyses of 15 HCoV whole genomes reveal that 2019-nCoV/SARS-CoV-2 shares the highest nucleotide sequence identity with SARS-CoV (79.7%). Specifically, the envelope and nucleocapsid proteins of 2019-nCoV/SARS-CoV-2 are two evolutionarily conserved regions, having the sequence identities of 96% and 89.6%, respectively, compared to SARS-CoV. Using network proximity analyses of drug targets and HCoV-host interactions in the human interactome, we prioritize 16 potential anti-HCoV repurposable drugs (e.g., melatonin, mercaptopurine, and sirolimus) that are further validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in human cell lines. We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the "Complementary Exposure" pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network. In summary, this study offers powerful network-based methodologies for rapid identification of candidate repurposable drugs and potential drug combinations targeting 2019-nCoV/SARS-CoV-2.
C1 [Zhou, Yadi; Hou, Yuan; Shen, Jiayu; Huang, Yin; Martin, William; Cheng, Feixiong] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA.
   [Cheng, Feixiong] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.
   [Cheng, Feixiong] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.
RP Cheng, FX (reprint author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA.; Cheng, FX (reprint author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.
EM chengf@ccf.org
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [K99 HL138272, R00 HL138272]
FX This work was supported by the National Heart, Lung, and Blood Institute
   of the National Institutes of Health (NIH) under Award Number K99
   HL138272 and R00 HL138272 to F.C. The content of this publication does
   not necessarily reflect the views of the Cleveland Clinic.
CR Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bedi O, 2016, N-S ARCH PHARMACOL, V389, P695, DOI 10.1007/s00210-016-1252-4
   Biedenkopf N, 2017, ANTIVIR RES, V137, P76, DOI 10.1016/j.antiviral.2016.11.011
   Chang CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065045
   Chen HY, 2002, J VIROL, V76, P5233, DOI 10.1128/JVI.76.10.5233-5250.2002
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Xin, 2009, Antivir Chem Chemother, V19, P151
   Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10744-6
   Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09186-x
   Cheng Feixiong, 2019, Methods Mol Biol, V1878, P243, DOI 10.1007/978-1-4939-8868-6_15
   Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Cheng FX, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005074
   Cheng FX, 2017, BRIEF BIOINFORM, V18, P682, DOI 10.1093/bib/bbw051
   Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503
   Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011
   Chiang CW, 2018, CLIN PHARMACOL THER, V103, P287, DOI 10.1002/cpt.914
   Cong Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194868
   Dai J, 2002, J PINEAL RES, V32, P112, DOI 10.1034/j.1600-079x.2002.1844.x
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dyall J, 2017, DRUGS, V77, P1935, DOI 10.1007/s40265-017-0830-1
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Emmott E, 2013, J VIROL, V87, P9486, DOI 10.1128/JVI.00321-13
   Erlandson KM, 2017, CLIN INFECT DIS, V65, P2042, DOI 10.1093/cid/cix645
   Fang J., 2020, NETWORK BASED TRANSL, DOI [10.1101/2020.01.15.20017160, DOI 10.1101/2020.01.15.20017160]
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Fung TS, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0053-0
   Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010
   Garcia CC, 2010, DISCOV MED, V10, P479
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Gebre M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020055
   Greene JA, 2017, NEW ENGL J MED, V377, P2493, DOI 10.1056/NEJMms1706744
   Gupta A, 2017, RESPIR MED CASE REP, V21, P116, DOI 10.1016/j.rmcr.2017.04.010
   Halder AK, 2018, BRIEF FUNCT GENOMICS, V17, P381, DOI 10.1093/bfgp/elx026
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Ho TY, 2007, ANTIVIR RES, V74, P92, DOI 10.1016/j.antiviral.2006.04.014
   Hong M, 2008, VIRAL IMMUNOL, V21, P153, DOI 10.1089/vim.2007.0108
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13
   Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292
   Kim JH, 2013, ASIA PAC ALLERGY, V3, P136, DOI 10.5415/apallergy.2013.3.2.136
   Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14
   Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3
   Ko C, 2015, ANTIVIR THER, V20, P835, DOI 10.3851/IMP2965
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085
   Lasso G, 2019, CELL, V178, P1526, DOI 10.1016/j.cell.2019.08.005
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   LEWIS EL, 1992, J GEN VIROL, V73, P3285, DOI 10.1099/0022-1317-73-12-3285
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu Chuang, 2020, PHYS REP, V846, P1, DOI [10.1016/j.physrep.2019.12.004, DOI 10.1016/J.PHYSREP.2019.12.004]
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12
   Moskowitz DW, 2004, CURR TOP MED CHEM, V4, P1433
   Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143
   Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5
   Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2
   Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230
   Schwarz S, 2011, ANTIVIR RES, V90, P64, DOI 10.1016/j.antiviral.2011.02.008
   Seko Y, 2006, CLIN SCI, V110, P379, DOI 10.1042/CS20050299
   Silvestri M, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-61
   Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318
   Smith IN, 2019, AM J HUM GENET, V104, P861, DOI 10.1016/j.ajhg.2019.03.009
   Srinivasan V, 2012, RECENT PATENTS ENDOC, V6, P30, DOI 10.2174/187221412799015317
   Stohr S, 2016, GUT, V65, P2017, DOI 10.1136/gutjnl-2014-308971
   Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x
   Tan DX, 2014, J PINEAL RES, V57, P381, DOI 10.1111/jpi.12186
   Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391
   V'kovski P, 2019, ELIFE, V8, DOI 10.7554/eLife.42037
   Wang CH, 2014, CRIT CARE MED, V42, P313, DOI 10.1097/CCM.0b013e3182a2727d
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang XJ, 2015, ANTIVIR RES, V120, P140, DOI 10.1016/j.antiviral.2015.06.007
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI 10.1126/science.abb2507
   Xiao J, 2009, EUR J HEART FAIL, V11, P349, DOI 10.1093/eurjhf/hfp023
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230
   Yang SP, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00303-18
   Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x
   Zeng XX, 2020, CHEM SCI, V11, P1775, DOI 10.1039/c9sc04336e
   Zeng Xiangxiang, 2020, Bioinformatics, DOI 10.1093/bioinformatics/btaa010
   Zeng XX, 2019, BIOINFORMATICS, V35, P5191, DOI 10.1093/bioinformatics/btz418
   Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou WB, 2011, BREAST CANCER RES TR, V128, P625, DOI 10.1007/s10549-011-1556-5
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 97
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD MAR 16
PY 2020
VL 6
IS 1
AR 14
DI 10.1038/s41421-020-0153-3
PG 18
WC Cell Biology
SC Cell Biology
GA KU4SS
UT WOS:000519701100001
PM 32194980
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Graham, JB
   Swarts, JL
   Menachery, VD
   Gralinski, LE
   Schafer, A
   Plante, KS
   Morrison, CR
   Voss, KM
   Green, R
   Choonoo, G
   Jeng, S
   Miller, DR
   Mooney, MA
   McWeeney, SK
   Ferris, MT
   de Villena, FPM
   Gale, M
   Heise, MT
   Baric, RS
   Lund, JM
AF Graham, Jessica B.
   Swarts, Jessica L.
   Menachery, Vineet D.
   Gralinski, Lisa E.
   Schafer, Alexandra
   Plante, Kenneth S.
   Morrison, Clayton R.
   Voss, Kathleen M.
   Green, Richard
   Choonoo, Gabrielle
   Jeng, Sophia
   Miller, Darla R.
   Mooney, Michael A.
   McWeeney, Shannon K.
   Ferris, Martin T.
   de Villena, Fernando Pardo-Manuel
   Gale, Michael, Jr.
   Heise, Mark T.
   Baric, Ralph S.
   Lund, Jennifer M.
TI Immune Predictors of Mortality After Ribonucleic Acid Virus Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Collaborative Cross; immune correlates of mortality; RNA virus infection
ID REGULATORY T-CELLS; COLLABORATIVE CROSS; MEMORY PHENOTYPE; NEONATAL
   MICE; ARCHITECTURE; HOMEOSTASIS; INNATE; ICOS
AB Background. Virus infections result in a range of clinical outcomes for the host, from asymptomatic to severe or even lethal disease. Despite global efforts to prevent and treat virus infections to limit morbidity and mortality, the continued emergence and re-emergence of new outbreaks as well as common infections such as influenza persist as a health threat. Challenges to the prevention of severe disease after virus infection include both a paucity of protective vaccines as well as the early identification of individuals with the highest risk that may require supportive treatment.
   Methods. We completed a screen of mice from the Collaborative Cross (CC) that we infected with influenza, severe acute respiratory syndrome-coronavirus, and West Nile virus.
   Results. The CC mice exhibited a range of disease manifestations upon infections, and we used this natural variation to identify strains with mortality after infection and strains exhibiting no mortality. We then used comprehensive preinfection immunophenotyping to identify global baseline immune correlates of protection from mortality to virus infection.
   Conclusions. These data suggest that immune phenotypes might be leveraged to identify humans at highest risk of adverse clinical outcomes upon infection, who may most benefit from intensive clinical interventions, in addition to providing insight for rational vaccine design.
C1 [Graham, Jessica B.; Swarts, Jessica L.; Lund, Jennifer M.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Menachery, Vineet D.; Gralinski, Lisa E.; Schafer, Alexandra; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Menachery, Vineet D.] Univ Texas Med Ctr, Dept Microbiol & Immunol, Galveston, TX USA.
   [Plante, Kenneth S.; Morrison, Clayton R.; Miller, Darla R.; Ferris, Martin T.; de Villena, Fernando Pardo-Manuel; Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.
   [Voss, Kathleen M.; Green, Richard; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Dept Immunol, Sch Med, Seattle, WA 98195 USA.
   [Choonoo, Gabrielle; Jeng, Sophia; Mooney, Michael A.; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.
   [Mooney, Michael A.; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA.
   [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA.
   [de Villena, Fernando Pardo-Manuel; Heise, Mark T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.
   [Lund, Jennifer M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
RP Lund, JM (reprint author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,E5-110, Seattle, WA 98109 USA.
EM jlund@fredhutch.org
OI Lund, Jennifer/0000-0003-3284-979X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI100625]
FX Funding for this study was provided by National Institutes of Health
   Grant U19AI100625.
CR Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723
   Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y
   Brinkmeyer-Langford CL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12477-2
   Cai CW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005902
   Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916
   Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020
   Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133
   Das Shibali, 2017, F1000Res, V6, P741, DOI 10.12688/f1000research.10862.1
   Elbahesh H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26437
   Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196
   Graham JB, 2019, J INFECT DIS, V219, P1162, DOI 10.1093/infdis/jiy623
   Graham Jessica B, 2017, Curr Protoc Mouse Biol, V7, P221, DOI 10.1002/cpmo.33
   Graham JB, 2017, CELL REP, V21, P2313, DOI 10.1016/j.celrep.2017.10.093
   Graham JB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005996
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829
   Humphreys IR, 2006, EUR J IMMUNOL, V36, P2928, DOI 10.1002/eji.200636155
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260
   Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003
   Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
   Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413
   Kollmus H, 2018, MAMM GENOME, V29, P446, DOI 10.1007/s00335-018-9750-y
   Lanzer KG, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-018-0122-y
   Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536
   Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699
   Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110
   Leist SR, 2018, TRENDS GENET, V34, P777, DOI 10.1016/j.tig.2018.07.005
   Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209
   McDermott JE, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0336-6
   Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3
   Pattacini L, 2016, JAIDS-J ACQ IMM DEF, V72, P119, DOI 10.1097/QAI.0000000000000919
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Richert-Spuhler LE, 2015, PROG MOL BIOL TRANSL, V136, P217, DOI 10.1016/bs.pmbts.2015.07.015
   Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1
   Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09
   Schuler T, 2004, J IMMUNOL, V172, P15, DOI 10.4049/jimmunol.172.1.15
   Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170
   Soerens AG, 2016, MUCOSAL IMMUNOL, V9, P1395, DOI 10.1038/mi.2016.19
   Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149
   Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6
NR 45
TC 0
Z9 0
U1 12
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 15
PY 2020
VL 221
IS 6
BP 882
EP 889
DI 10.1093/infdis/jiz531
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KS8JI
UT WOS:000518552500006
PM 31621854
DA 2020-04-03
ER

PT J
AU Chen, X
   Chughtai, AA
   MacIntyre, CR
AF Chen, Xin
   Chughtai, Abrar A.
   MacIntyre, Chandini R.
TI Application of a Risk Analysis Tool to Middle East Respiratory Syndrome
   Coronavirus (MERS-CoV) Outbreak in Saudi Arabia
SO RISK ANALYSIS
LA English
DT Article; Early Access
DE Algorithm; bioterrorism; MERS-CoV; outbreak investigation; risk
   analysis; scoring system; unnatural epidemic
ID CONTAMINATION; TRANSMISSION; DISEASE
AB The Grunow-Finke assessment tool (GFT) is an accepted scoring system for determining likelihood of an outbreak being unnatural in origin. Considering its high specificity but low sensitivity, a modified Grunow-Finke tool (mGFT) has been developed with improved sensitivity. The mGFT has been validated against some past disease outbreaks, but it has not been applied to ongoing outbreaks. This study is aimed to score the outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia using both the original GFT and mGFT. The publicly available data on human cases of MERS-CoV infections reported in Saudi Arabia (2012-2018) were sourced from the FluTrackers, World Health Organization, Saudi Ministry of Health, and published literature associated with MERS outbreaks investigations. The risk assessment of MERS-CoV in Saudi Arabia was analyzed using the original GFT and mGFT criteria, algorithms, and thresholds. The scoring points for each criterion were determined by three researchers to minimize the subjectivity. The results showed 40 points of total possible 54 points using the original GFT (likelihood: 74%), and 40 points of a total possible 60 points (likelihood: 67%) using the mGFT, both tools indicating a high likelihood that human MERS-CoV in Saudi Arabia is unnatural in origin. The findings simply flag unusual patterns in this outbreak, but do not prove unnatural etiology. Proof of bioattacks can only be obtained by law enforcement and intelligence agencies. This study demonstrated the value and flexibility of the mGFT in assessing and predicting the risk for an ongoing outbreak with simple criteria.
C1 [Chen, Xin; MacIntyre, Chandini R.] Univ New South Wales, Kirby Inst, Fac Med, Biosecur Program, Sydney, NSW 2052, Australia.
   [Chughtai, Abrar A.] Univ New South Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.
   [MacIntyre, Chandini R.] Arizona State Univ, Coll Publ Serv & Community Solut, Tempe, AZ USA.
   [MacIntyre, Chandini R.] Arizona State Univ, Coll Hlth Solut, Tempe, AZ USA.
RP Chen, X (reprint author), UNSW Sydney, Kirby Inst, Biosecur Program, Level 6,Wallace Wurth Bldg, Sydney, NSW 2052, Australia.
EM xinjessiechen@protonmail.com
OI Chen, Xin/0000-0002-9905-2307
FU Australian National Health and Medical Research Council (NHMRC)-Centre
   for Research Excellence (CRE), Integrated systems for epidemic response
   (ISER)National Health and Medical Research Council of Australia
   [APP1107393]
FX This research was supported by the Australian National Health and
   Medical Research Council (NHMRC)-Centre for Research Excellence (CRE),
   Integrated systems for epidemic response (ISER) grant (APP1107393).
CR Ajisegiri WS, 2018, RISK ANAL, V38, P429, DOI 10.1111/risa.12876
   Arms Control Association, 2018, BIOL WEAP CONV SIGN
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2018, BIOT AG DIS
   Chen X, 2018, J HOUS ECON, V39, P1, DOI 10.1016/j.jhe.2017.12.005
   Chen X, 2017, MIL MED, V182, pE1827, DOI 10.7205/MILMED-D-17-00090
   Chen X, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.40
   Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057
   Cui J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-304
   Dembek Z. F., 2007, EPIDEMIOLOGY BIOWARF, P39
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/eLife.31257, 10.7554/elife.37324]
   European Centre for Disease Prevention and Control, 2017, OUTBR PLAG MAD 2017
   FluTrackers, 2012, JORD CLUST APPR 12 P
   FluTrackers, 2018, 2012 2018 CAS LIST M
   Gardner LM, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw063
   Gardner LM, 2014, RISK ANAL, V34, P1391, DOI 10.1111/risa.12253
   Gardner Lauren M, 2014, BMC Res Notes, V7, P358, DOI 10.1186/1756-0500-7-358
   Global Engage, 2017, BIG LIST SYNTH BIOL
   Global Research, 2017, BIOL WARF US SAUD US
   Grunow R, 2002, CLIN MICROBIOL INFEC, V8, P510, DOI 10.1046/j.1469-0691.2002.00524.x
   Hemida MG, 2015, EMERG INFECT DIS, V21, P699, DOI 10.3201/eid2104.141949
   Hummel S, 2016, CTC SENTINEL, V9, P18
   Johnston W. R., 2017, SUMMARY HIST ATTACKS
   Kim JI, 2019, J VET SCI, V20, DOI 10.4142/jvs.2019.20.e1
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Koblentz GD, 2017, HEALTH SECUR, V15, P1
   Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003
   MacIntyre C. R., 2017, ENV SYSTEMS DECISION, V38, P198
   MacIntyre CR, 2015, MIL MED, V180, P943, DOI 10.7205/MILMED-D-14-00482
   MacIntyre C. Raina, 2015, Environment Systems & Decisions, V35, P129, DOI 10.1007/s10669-015-9534-9
   MacIntyre C. Raina, 2014, Environment Systems & Decisions, V34, P383, DOI 10.1007/s10669-014-9506-5
   MacIntyre CR, 2016, LAW ENFORC EXEC FORU, V16, P25
   Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X
   Modjarrad K, 2016, VACCINE, V34, P2982, DOI 10.1016/j.vaccine.2016.03.104
   Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Public Health Emergency, 2014, US GOV GAIN OF FUNCT
   Saudi MoH, 2015, NO NEW COR CAS REC
   The Washington Post, 2017, WASHINGTON POST
   Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389
   Treadwell TA, 2003, PUBLIC HEALTH REP, V118, P92, DOI 10.1016/S0033-3549(04)50224-8
   US Army, 1977, US ARM ACT US BIOL W
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   WHEAT RP, 1951, ARCH INTERN MED, V88, P461, DOI 10.1001/archinte.1951.03810100045004
   WHO, 2017, MIDDL E RESP SYNDR C
   WHO, 2018, MERS SIT UPD DEC 201
   WHO, 2018, SARS SEV AC RESP SYN
   WHO, 2019, SMALLPOX
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 52
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
DI 10.1111/risa.13472
EA MAR 2020
PG 11
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA KU0DV
UT WOS:000519383500001
PM 32170774
OA Bronze
DA 2020-04-03
ER

PT J
AU He, ZJ
AF He, Zhenjian
TI What further should be done to control COVID-19 outbreaks in addition to
   cases isolation and contact tracing measures?
SO BMC MEDICINE
LA English
DT Article
C1 [He, Zhenjian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.
   [He, Zhenjian] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Peoples R China.
RP He, ZJ (reprint author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.; He, ZJ (reprint author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Peoples R China.
EM hezhenj3@mail.sysu.edu.cn
CR Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Hellewell J, 2020, FEASIBILITY CONTROLL, DOI [10.1101/2020.02.08.20021162, DOI 10.1101/2020.02.08.20021162]
   Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012
   World Health Organization (WHO), 2020, 39 WHO
NR 5
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAR 13
PY 2020
VL 18
IS 1
AR 80
DI 10.1186/s12916-020-01551-8
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU8CH
UT WOS:000519939000001
PM 32164708
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Kouzy, R
   Jaoude, JA
   Kraitem, A
   El Alam, MB
   Karam, B
   Adib, E
   Zarka, J
   Traboulsi, C
   Akl, EW
   Baddour, K
AF Kouzy, Ramez
   Jaoude, Joseph Abi
   Kraitem, Afif
   El Alam, Molly B.
   Karam, Basil
   Adib, Elio
   Zarka, Jabra
   Traboulsi, Cindy
   Akl, Elie W.
   Baddour, Khalil
TI Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic
   on Twitter
SO CUREUS
LA English
DT Article
DE coronavirus; twitter; social media; epidemic; public health; pandemic;
   infodemic; covid-19
AB Background
   Since the beginning of the coronavirus disease 2019 (COVID-19) epidemic, misinformation has been spreading uninhibited over traditional and social media at a rapid pace. We sought to analyze the magnitude of misinformation that is being spread on Twitter (Twitter, Inc., San Francisco, CA) regarding the coronavirus epidemic.
   Materials and methods
   We conducted a search on Twitter using 14 different trending hashtags and keywords related to the COVID-19 epidemic. We then summarized and assessed individual tweets for misinformation in comparison to verified and peer-reviewed resources. Descriptive statistics were used to compare terms and hashtags, and to identify individual tweets and account characteristics.
   Results
   The study included 673 tweets. Most tweets were posted by informal individuals/groups (66%), and 129 (19.2%) belonged to verified Twitter accounts. The majority of included tweets contained serious content (91.2%); 548 tweets (81.4%) included genuine information pertaining to the COVID-19 epidemic. Around 70% of the tweets tackled medical/public health information, while the others were pertaining to sociopolitical and financial factors. In total, 153 tweets (24.8%) included misinformation, and 107 (17.4%) included unverifiable information regarding the COVID-19 epidemic. The rate of misinformation was higher among informal individual/group accounts (33.8%, p: <0.001). Tweets from unverified Twitter accounts contained more misinformation (31.0% vs 12.6% for verified accounts, p: <0.001). Tweets from healthcare/public health accounts had the lowest rate of unverifiable information (12.3%, p: 0.04). The number of likes and retweets per tweet was not associated with a difference in either false or unverifiable content. The keyword "COVID-19" had the lowest rate of misinformation and unverifiable information, while the keywords "#2019_ncov" and "Corona" were associated with the highest amount of misinformation and unverifiable content respectively.
   Conclusions
   Medical misinformation and unverifiable content pertaining to the global COVID-19 epidemic are being propagated at an alarming rate on social media. We provide an early quantification of the magnitude of misinformation spread and highlight the importance of early interventions in order to curb this phenomenon that endangers public safety at a time when awareness and appropriate preventive actions are paramount.
C1 [Kouzy, Ramez; Jaoude, Joseph Abi; Kraitem, Afif; Karam, Basil; Adib, Elio; Zarka, Jabra; Traboulsi, Cindy; Akl, Elie W.; Baddour, Khalil] Amer Univ Beirut, Fac Med, Beirut, Lebanon.
   [El Alam, Molly B.] Amer Univ Beirut, Publ Hlth, Beirut, Lebanon.
RP Kouzy, R (reprint author), Amer Univ Beirut, Fac Med, Beirut, Lebanon.
EM rtk10@mail.aub.edu
OI Abi Jaoude, Joseph/0000-0002-2283-4765
CR Armstrong PW, 2019, JAMA-J AM MED ASSOC, V321, P1863, DOI 10.1001/jama.2019.5168
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865
   European Centre for Disease Prevention and Control, 2020, COVID 19
   Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4
   Merchant RM, 2018, JAMA-J AM MED ASSOC, V320, P2415, DOI 10.1001/jama.2018.18416
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Ortiz-Martinez Y, 2017, AM J INFECT CONTROL, V45, P816, DOI 10.1016/j.ajic.2017.02.027
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   WHO, 2020, COR DIS COVID 2019 S
   WHO, 2020, Q A COR COVID 19
   Wu Zunyou, 2020, JAMA, DOI 10.1001/jama.2020.2648
   Zarocostas J, 2020, LANCET, V395, P401, DOI 10.1016/S0140-6736(20)30292-0
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 14
TC 0
Z9 0
U1 9
U2 9
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD MAR 13
PY 2020
VL 12
IS 3
AR e7255
DI 10.7759/cureus.7255
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU3QD
UT WOS:000519625400002
OA Bronze, Other Gold
DA 2020-04-03
ER

PT J
AU Ni, L
   Zhou, L
   Zhou, M
   Zhao, JP
   Wang, DW
AF Ni, Li
   Zhou, Ling
   Zhou, Min
   Zhao, Jianping
   Wang, Dao Wen
TI Combination of western medicine and Chinese traditional patent medicine
   in treating a family case of COVID-19 in Wuhan
SO FRONTIERS OF MEDICINE
LA English
DT Article; Early Access
DE novel coronavirus (2019-nCoV); COVID-19; Chinese traditional patent
   medicine; Shuanghuanglian oral liquid
AB In December 2019, an outbreak of novel Coronavirus (2019-nCoV) occurred in Wuhan, Hubei Province, China. By February 14, 2020, it has led to 66 492 confirmed patients in China and high mortality up to similar to 2.96% (1123/37 914) in Wuhan. Here we report the first family case of coronavirus disease 2019 (COVID-19) confirmed in Wuhan and treated using the combination of western medicine and Chinese traditional patent medicine Shuanghuanglian oral liquid (SHL). This report describes the identification, diagnosis, clinical course, and management of three cases from a family, suggests the expected therapeutic effects of SHL on COVID-19, and warrants further clinical trials.
C1 [Ni, Li; Zhou, Ling; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan 430030, Peoples R China.
   [Zhou, Min; Zhao, Jianping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Respirat,Dept Internal Med, Wuhan 430030, Peoples R China.
   [Zhou, Min; Zhao, Jianping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan 430030, Peoples R China.
RP Wang, DW (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan 430030, Peoples R China.
EM dwwang@tjh.tjmu.edu.cn
FU Tongji Hospital Clinical Research Flagship Program [2019CR207]
FX This work was supported by Tongji Hospital Clinical Research Flagship
   Program (No. 2019CR207).
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Li Q, 2020, NEW ENGL J MED, DOI [10.1056/NEJ-Moa2001316, DOI 10.1056/NEJ-M0A2001316]
   National Health Commission of the People's Republic of China, 2020, LAT UPD NOV COR PNEU
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 5
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2095-0217
EI 2095-0225
J9 FRONT MED-PRC
JI Front. Med.
DI 10.1007/s11684-020-0757-x
EA MAR 2020
PG 5
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA KV7RL
UT WOS:000520677100001
PM 32170559
OA Bronze, Green Accepted
DA 2020-04-03
ER

PT J
AU Tang, N
   Li, DJ
   Wang, X
   Sun, ZY
AF Tang, Ning
   Li, Dengju
   Wang, Xiong
   Sun, Ziyong
TI Abnormal coagulation parameters are associated with poor prognosis in
   patients with novel coronavirus pneumonia
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article; Early Access
DE coagulation parameter; D-dimer; disseminated intravascular coagulation;
   fibrin degradation product; novel coronavirus pneumonia
AB Background In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
   Objectives To describe the coagulation feature of patients with NCP.
   Methods Conventional coagulation results and outcomes of 183 consecutive patients with confirmed NCP in Tongji hospital were retrospectively analyzed.
   Results The overall mortality was 11.5%, the non-survivors revealed significantly higher D-dimer and fibrin degradation product (FDP) levels, longer prothrombin time and activated partial thromboplastin time compared to survivors on admission (P < .05); 71.4% of non-survivors and 0.6% survivors met the criteria of disseminated intravascular coagulation during their hospital stay.
   Conclusions The present study shows that abnormal coagulation results, especially markedly elevated D-dimer and FDP are common in deaths with NCP.
C1 [Tang, Ning; Wang, Xiong; Sun, Ziyong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Clin Lab, Wuhan, Peoples R China.
   [Li, Dengju] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China.
RP Sun, ZY (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Lab, Wuhan, Hubei, Peoples R China.
EM 499388475@qq.com
CR Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P812, DOI 10.1160/TH03-09-0577
   Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kitchens Craig S, 2009, Hematology Am Soc Hematol Educ Program, P240, DOI 10.1182/asheducation-2009.1.240
   Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   WHO, 2020, CLIN MAN SEV AC RESP
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 10
TC 0
Z9 0
U1 15
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
DI 10.1111/jth.14768
EA MAR 2020
PG 4
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA KU0EH
UT WOS:000519384700001
PM 32073213
OA Bronze
DA 2020-04-03
ER

PT J
AU Xu, Y
   Li, XF
   Zhu, B
   Liang, HY
   Fang, CX
   Gong, Y
   Guo, QZ
   Sun, X
   Zhao, DY
   Shen, J
   Zhang, HY
   Liu, HS
   Xia, HM
   Tang, JL
   Zhang, K
   Gong, ST
AF Xu, Yi
   Li, Xufang
   Zhu, Bing
   Liang, Huiying
   Fang, Chunxiao
   Gong, Yu
   Guo, Qiaozhi
   Sun, Xin
   Zhao, Danyang
   Shen, Jun
   Zhang, Huayan
   Liu, Hongsheng
   Xia, Huimin
   Tang, Jinling
   Zhang, Kang
   Gong, Sitang
TI Characteristics of pediatric SARS-CoV-2 infection and potential evidence
   for persistent fecal viral shedding
SO NATURE MEDICINE
LA English
DT Article; Early Access
ID CHINA
AB We report epidemiological and clinical investigations on ten pediatric SARS-CoV-2 infection cases confirmed by real-time reverse transcription PCR assay of SARS-CoV-2 RNA. Symptoms in these cases were nonspecific and no children required respiratory support or intensive care. Chest X-rays lacked definite signs of pneumonia, a defining feature of the infection in adult cases. Notably, eight children persistently tested positive on rectal swabs even after nasopharyngeal testing was negative, raising the possibility of fecal-oral transmission.
   Children infected with the COVID-19 outbreak coronavirus, SARS-CoV-2, show mild symptoms but prolonged shedding of viral RNA in feces, suggesting that the fecal-oral route might play a role in virus transmission.
C1 [Xu, Yi; Li, Xufang; Fang, Chunxiao; Gong, Yu; Shen, Jun; Zhang, Huayan; Gong, Sitang] Guangzhou Med Univ, Dept Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
   [Li, Xufang] Guangzhou Med Univ, Dept Ctr Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
   [Zhu, Bing; Xia, Huimin; Tang, Jinling] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Clin Data Ctr, Guangzhou, Peoples R China.
   [Liang, Huiying; Zhang, Huayan; Xia, Huimin; Tang, Jinling; Gong, Sitang] Guangzhou Med Univ, Guangdong Prov Childrens Med Res Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
   [Guo, Qiaozhi; Sun, Xin; Zhao, Danyang] Guangzhou Med Univ, Dept Med Adm, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
   [Zhang, Huayan] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.
   [Zhang, Huayan] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.
   [Zhang, Huayan] Univ Penn, Philadelphia, PA 19104 USA.
   [Liu, Hongsheng] Guangzhou Med Univ, Dept Radiol, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
   [Xia, Huimin; Zhang, Kang] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Key Lab Res Struct Birth Defect Di, Guangzhou, Peoples R China.
   [Zhang, Kang] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.
   [Zhang, Kang] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.
RP Gong, ST (reprint author), Guangzhou Med Univ, Dept Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.; Xia, HM; Tang, JL (reprint author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Clin Data Ctr, Guangzhou, Peoples R China.; Xia, HM; Tang, JL; Gong, ST (reprint author), Guangzhou Med Univ, Guangdong Prov Childrens Med Res Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.; Xia, HM; Zhang, K (reprint author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Key Lab Res Struct Birth Defect Di, Guangzhou, Peoples R China.; Zhang, K (reprint author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.; Zhang, K (reprint author), Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.
EM huiminxia@hotmail.com; jltang@cuhk.edu.hk; kang.zhang@gmail.com;
   sitangg@126.com
FU National Key Research and Development Program of China [2019YFB1404803];
   Guangzhou Regenerative Medicine Guangdong Laboratory [2020GZR110306001];
   CDCs of Guangzhou CityUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX This work was funded by the National Key Research and Development
   Program of China (2019YFB1404803) and Guangzhou Regenerative Medicine
   Guangdong Laboratory (2020GZR110306001). We thank the CDCs of Guangzhou
   City and Guangdong Province for helping with confirmation of the
   diagnosis of the viral infection.
CR [Anonymous], 2020, 36 WHO, P2020
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Guan Wei-Jie, 2020, N Engl J Med, DOI 10.1056/NEJMoa2002032
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zhu ZQ, 2015, J CLIN VIROL, V69, P30, DOI 10.1016/j.jcv.2015.05.013
NR 10
TC 0
Z9 0
U1 118
U2 118
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
DI 10.1038/s41591-020-0817-4
EA MAR 2020
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA KU0SW
UT WOS:000519422600001
OA Bronze
DA 2020-04-03
ER

PT J
AU Li, CL
   Chen, LJ
   Chen, XY
   Zhang, MZ
   Pang, CP
   Chen, HY
AF Li, Cuilian
   Chen, Li Jia
   Chen, Xueyu
   Zhang, Mingzhi
   Pang, Chi Pui
   Chen, Haoyu
TI Retrospective analysis of the possibility of predicting the COVID-19
   outbreak from Internet searches and social media data, China, 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB The peak of Internet searches and social media data about the coronavirus disease 2019 (COVID-19) outbreak occurred 10-14 days earlier than the peak of daily incidences in China. Internet searches and social media data had high correlation with daily incidences, with the maximum r> 0.89 in all correlations. The lag correlations also showed a maximum correlation at 8-12 days for laboratory-confirmed cases and 6-8 days for suspected cases.
C1 [Li, Cuilian; Chen, Xueyu; Zhang, Mingzhi; Pang, Chi Pui; Chen, Haoyu] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China.
   [Li, Cuilian; Chen, Xueyu; Zhang, Mingzhi; Pang, Chi Pui; Chen, Haoyu] Chinese Univ Hong Kong, Shantou, Peoples R China.
   [Chen, Li Jia; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China.
RP Chen, HY (reprint author), Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China.; Chen, HY (reprint author), Chinese Univ Hong Kong, Shantou, Peoples R China.
EM drchenhaoyu@gmail.com
FU Grant for Key Disciplinary Project of Clinical Medicine under the
   Guangdong High-level University Development Program [002-18119101]
FX Funding statement: This study was supported by the Grant for Key
   Disciplinary Project of Clinical Medicine under the Guangdong High-level
   University Development Program (002-18119101). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Marques-Toledo CD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005729
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Santangelo OE, 2019, ANN IG MED PREV COMU, V31, P385, DOI 10.7416/ai.2019.2300
   Shin SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32920
   Wilson N, 2009, EUROSURVEILLANCE, V14, P19
   World Health Organization, 2020, WHO DIR GEN STAT IHR
   World Health Organization ( WHO), NOV COR COVID 19 SIT
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 10
TC 0
Z9 0
U1 3
U2 3
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 12
PY 2020
VL 25
IS 10
BP 7
EP 11
AR 2000199
DI 10.2807/1560-7917.ES.2020.25.10.2000199
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KU8UV
UT WOS:000519988300002
PM 32183935
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Mizumoto, K
   Kagaya, K
   Zarebski, A
   Chowell, G
AF Mizumoto, Kenji
   Kagaya, Katsushi
   Zarebski, Alexander
   Chowell, Gerardo
TI Estimating the asymptomatic proportion of coronavirus disease 2019
   (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama,
   Japan, 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB On 5 February 2020, in Yokohama, Japan, a cruise ship hosting 3,711 people underwent a 2-week quarantine after a former passenger was found with COVID-19 post-disembarking. As at 20 February, 634 persons on board tested positive for the causative virus. We conducted statistical modelling to derive the delay-adjusted asymptomatic proportion of infections, along with the infections' timeline. The estimated asymptomatic proportion was 17.9% (95% credible interval (CrI): 15.5-20.2%). Most infections occurred before the quarantine start.
C1 [Mizumoto, Kenji] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Yoshida Nakaadachi Cho, Kyoto, Japan.
   [Mizumoto, Kenji; Kagaya, Katsushi] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan.
   [Mizumoto, Kenji; Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Dept Populat Hlth Sci, Atlanta, GA 30303 USA.
   [Kagaya, Katsushi] Kyoto Univ, Educ & Reseach Ctr, Field Sci, Seto Marine Biol Lab, Shirahama Cho, Wakayama, Japan.
   [Zarebski, Alexander] Univ Oxford, Dept Zool, Oxford, England.
RP Mizumoto, K (reprint author), Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Yoshida Nakaadachi Cho, Kyoto, Japan.; Mizumoto, K (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan.; Mizumoto, K (reprint author), Georgia State Univ, Sch Publ Hlth, Dept Populat Hlth Sci, Atlanta, GA 30303 USA.
EM mizumoto.kenji.5a@kyoto-u.ac.jp
OI Kagaya, Katsushi/0000-0003-3001-7690
FU Japan Society for the Promotion of Science (JSPS) KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [18K17368]; Leading Initiative for Excellent Young
   Researchers from the Ministry of Education, Culture, Sport, Science &
   Technology of Japan; JSPS KAKENHIMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K19336,
   19H05330]; Oxford Martin School Programme on Pandemic Genomics; NSF as
   part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious
   Diseases program [1414374]
FX KM acknowledges support from the Japan Society for the Promotion of
   Science (JSPS) KAKENHI Grant Number 18K17368 and from the Leading
   Initiative for Excellent Young Researchers from the Ministry of
   Education, Culture, Sport, Science & Technology of Japan. KK
   acknowledges support from the JSPS KAKENHI Grant Number 18K19336 and
   19H05330. AZ acknowledges supports from the Oxford Martin School
   Programme on Pandemic Genomics. GC acknowledges support from NSF grant
   1414374 as part of the joint NSF-NIH-USDA Ecology and Evolution of
   Infectious Diseases program.
CR Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Centers for Disease Control and Prevention (CDC), INT US GUID RISK ASS
   Hoehl S, 2020, NEW ENGL J MED, V41, DOI 10.1056/
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   KROON FP, 1995, CLIN INFECT DIS, V20, P454, DOI 10.1093/clinids/20.2.454
   Linton NM, 2020, EPIDEMIOLOGICAL CHAR, DOI [10.1101/2020.01.26.20018754, DOI 10.1101/2020.01.26.20018754]
   Mbabazi WB, 2009, HEALTH POLICY PLANN, V24, P261, DOI 10.1093/heapol/czp008
   Ministry of Health. Labour and Welfare Japan, COR DIS COVID 19 SIT
   Miura F, 2018, J EPIDEMIOL, V28, P382, DOI 10.2188/jea.JE20170040
   Mizumoto K, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.24.1800239
   Nishiura H, 2020, ESTIMATION ASYMPTOMA, P5, DOI DOI 10.1101/2020.02.03.20020248
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Smallman-Raynor MR, 2006, POLIOMYELITIS EMERGE, P32
   World Health Organization, COR DIS COVID 2019 S
   Zou Lirong, 2020, N Engl J Med, V382, P1177, DOI 10.1056/NEJMc2001737
NR 15
TC 0
Z9 0
U1 0
U2 0
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 12
PY 2020
VL 25
IS 10
BP 2
EP 6
AR 2000180
DI 10.2807/1560-7917.ES.2020.25.10.2000180
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KU8UV
UT WOS:000519988300001
PM 32183930
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Sun, WC
   Wang, L
   Huang, HX
   Wang, W
   Cao, L
   Zhang, JY
   Zheng, M
   Lu, HJ
AF Sun, Wenchao
   Wang, Li
   Huang, Haixin
   Wang, Wei
   Cao, Liang
   Zhang, Jinyong
   Zheng, Min
   Lu, Huijun
TI Genetic characterization and phylogenetic analysis of porcine
   deltacoronavirus (PDCoV) in Shandong Province, China
SO VIRUS RESEARCH
LA English
DT Article
DE Porcine deltacoronavirus (PDCoV); Spike protein; Nucleocapsid protein;
   ORF1a; Deletion
ID EPIDEMIC DIARRHEA VIRUS; TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS;
   LENGTH GENOME SEQUENCE; NUCLEOCAPSID PROTEIN; NONSTRUCTURAL PROTEINS;
   RNA-BINDING; KAPPA-B; INTERFERON; IDENTIFICATION; PATHOGENICITY
AB Porcine deltacoronavirus (PDCoV) is the etiological agent of acute diarrhoea and vomiting in pigs, threatening the swine industry worldwide. Although several PDCoV studies have been conducted in China, more sequence information is needed to understand the molecular characterization of PDCoV. In this study, the partial ORF1a, spike protein (S) and nucleocapsid protein (N) were sequenced from Shandong Province between 2017 and 2018. The sequencing results for the S protein from 10 PDCoV strains showed 96.7 %-99.7 % nucleotide sequence identity with the China lineage strains, while sharing a lower level of nucleotide sequence identity, ranging from 95.7 to 96.8%, with the Vietnam/Laos/Thailand lineage strains. N protein sequencing analysis showed that these strains showed nucleotide homologies of 97.3%-99.3% with the reference strains. Phylogenetic analyses based on S protein sequences showed that these PDCoV strains were classified into the China lineage. The discontinuous 2 + 3 as deletions at 400-401 and 758-760 were found in the Nsp2 and Nsp3 coding region in five strains, respectively, with similar deletions having been identified in Vietnam, Thailand, and Laos. Three novel patterns of deletion were observed for the first time in the Nsp2 and Nsp3 regions. Importantly, those findings suggest that PDCoV may have undergone a high degree of variation since PDCoV was first detected in China.
C1 [Sun, Wenchao; Huang, Haixin; Lu, Huijun] Wenzhou Univ, Inst Virol, Wenzhou 325035, Peoples R China.
   [Wang, Li] Shandong New Hope Liuhe Grp Co, Qingdao 266100, Peoples R China.
   [Wang, Wei; Cao, Liang; Zhang, Jinyong] Acad Mil Med Sci, Inst Mil Vet Med, Changchun 130122, Peoples R China.
   [Zheng, Min] Guangxi Ctr Anim Dis Control & Prevent, Nanning 530001, Peoples R China.
RP Lu, HJ (reprint author), Wenzhou Univ, Inst Virol, Wenzhou 325035, Peoples R China.
EM huijun_lu@126.com
FU Wenzhou Basic Agricultural Science and Technology Project [N20180010,
   N20190005]
FX This work was supported by the Wenzhou Basic Agricultural Science and
   Technology Project (Grant Numbers N20180010 and N20190005).
CR Alfuwaires M, 2017, BIOL PHARM BULL, V40, P345, DOI 10.1248/bpb.b16-00870
   Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009
   Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069
   Chen CJ, 2004, J VIROL, V78, P5658, DOI 10.1128/JVI.78.11.5658-5669.2004
   Chen J, 2019, VIRUS GENES, V55, P520, DOI 10.1007/s11262-019-01673-z
   Chen PF, 2019, INFECT GENET EVOL, V69, P153, DOI 10.1016/j.meegid.2019.01.022
   Chiou HY, 2017, TRANSBOUND EMERG DIS, V64, P157, DOI 10.1111/tbed.12357
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   Dong N, 2015, EMERG INFECT DIS, V21, P2254, DOI 10.3201/eid2112.150283
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Fang PX, 2016, VIROLOGY, V499, P170, DOI 10.1016/j.virol.2016.09.015
   Forni D, 2016, J VIROL, V90, P3627, DOI 10.1128/JVI.02988-15
   Fu XL, 2018, INFECT GENET EVOL, V62, P179, DOI 10.1016/j.meegid.2018.04.031
   Hsu TH, 2018, ARCH VIROL, V163, P3113, DOI 10.1007/s00705-018-3964-x
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852
   Jang G, 2017, TRANSBOUND EMERG DIS, V64, P1364, DOI 10.1111/tbed.12690
   Ji LK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01024
   Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219
   Lee S, 2015, VIRUS RES, V208, P136, DOI 10.1016/j.virusres.2015.06.013
   Li DL, 2018, RES VET SCI, V120, P63, DOI 10.1016/j.rvsc.2018.06.001
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Li ZL, 2012, VIRUS GENES, V45, P181, DOI 10.1007/s11262-012-0735-8
   Liang Q., 2019, MICROBIOL RESOUR ANN, V8
   Liao QJ, 2005, ACTA BIOCH BIOPH SIN, V37, P607, DOI 10.1111/j.1745-7270.2005.00082.x
   Lin CM, 2016, VIRUS RES, V226, P20, DOI 10.1016/j.virusres.2016.05.023
   Liu BJ, 2018, TRANSBOUND EMERG DIS, V65, P874, DOI 10.1111/tbed.12821
   Lorsirigool A, 2017, VIRUS GENES, V53, P240, DOI 10.1007/s11262-016-1413-z
   Lorsirigool A, 2016, ARCH VIROL, V161, P2909, DOI 10.1007/s00705-016-2983-8
   Luo JY, 2016, VIROLOGY, V495, P10, DOI 10.1016/j.virol.2016.04.025
   Mai K, 2018, TRANSBOUND EMERG DIS, V65, P166, DOI 10.1111/tbed.12644
   Mai KaiJie, 2018, Genome Announcements, V6, pe01545, DOI 10.1128/genomea.01545-17
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   Nelson SW, 2019, J WILDLIFE DIS, V55, P223, DOI 10.7589/2018-03-074
   Neuman BW, 2016, ANTIVIR RES, V135, P97, DOI 10.1016/j.antiviral.2016.10.005
   Niederwerder MC, 2018, TRANSBOUND EMERG DIS, V65, P660, DOI 10.1111/tbed.12823
   Nogales A, 2012, J VIROL, V86, P1261, DOI 10.1128/JVI.06428-11
   Perez-Rivera C, 2019, TRANSBOUND EMERG DIS, V66, P1436, DOI 10.1111/tbed.13193
   Phan MVT, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey035
   Qing Y, 2016, VIRUS GENES, V52, P218, DOI 10.1007/s11262-016-1296-z
   Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585
   SHAN Y, 2018, J ZHEJIANG UNIV SC B, V19, P570, DOI DOI 10.1631/JZUS.B1700283
   Shang J., 2018, J VIROL, V92
   Shi D, 2017, SCI REP-UK, V7, DOI 10.1038/srep39700
   Shokri S, 2019, J CELL PHYSIOL, V234, P2143, DOI 10.1002/jcp.27155
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Su MJ, 2016, J VET MED SCI, V78, P601, DOI 10.1292/jvms.15-0533
   Suzuki T, 2018, INFECT GENET EVOL, V61, P176, DOI 10.1016/j.meegid.2018.03.030
   Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650
   Le VP, 2018, ARCH VIROL, V163, P203, DOI 10.1007/s00705-017-3594-8
   Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756
   Wang L, 2018, TRENDS MICROBIOL, V26, P466, DOI 10.1016/j.tim.2018.03.001
   Wang M, 2018, TRANSBOUND EMERG DIS, V65, P363, DOI 10.1111/tbed.12819
   Wang XY, 2018, INFECT GENET EVOL, V62, P34, DOI 10.1016/j.meegid.2018.04.001
   Wang Y.W., 2015, GENOME ANNOUNC, V3
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803
   Xia L, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1012-9
   Xu ZC, 2018, VIROL SIN, V33, P131, DOI 10.1007/s12250-018-0003-8
   Yuan L, 2015, J BIOL CHEM, V290, P3172, DOI 10.1074/jbc.M114.619890
   Zeng SL, 2015, PROTEOMICS, V15, P1819, DOI 10.1002/pmic.201400458
   Zhang HL, 2019, PREV VET MED, V166, P8, DOI 10.1016/j.prevetmed.2019.02.017
   Zhang JL, 2019, J BIOL CHEM, V294, P9830, DOI 10.1074/jbc.RA119.007779
   Zhang MJ, 2019, ARCH VIROL, V164, P413, DOI 10.1007/s00705-018-4081-6
   Zhang Q, 2017, CHIN CONT DECIS CONF, P2013, DOI 10.1109/CCDC.2017.7978847
   Zhang X, 2015, VIRUS RES, V200, P56, DOI 10.1016/j.virusres.2014.12.013
   Zhang X, 2014, VET MICROBIOL, V172, P443, DOI 10.1016/j.vetmic.2014.05.034
   Zhang YT, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGY FOR EDUCATION (ICTE 2016), P20
   Zhou L, 2019, TRANSBOUND EMERG DIS, V66, P687, DOI 10.1111/tbed.13008
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
NR 72
TC 0
Z9 0
U1 13
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAR 12
PY 2020
VL 278
AR 197869
DI 10.1016/j.virusres.2020.197869
PG 9
WC Virology
SC Virology
GA KO3DZ
UT WOS:000515429400008
PM 31962065
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, Y
   Zhu, LQ
AF Wang, Yan
   Zhu, Li-Qin
TI Pharmaceutical care recommendations for antiviral treatments in children
   with coronavirus disease 2019
SO WORLD JOURNAL OF PEDIATRICS
LA English
DT Article; Early Access
ID INTERFERON-ALPHA-2B
C1 [Wang, Yan] Tianjin Childrens Hosp, Dept Pharm, Tianjin 300134, Peoples R China.
   [Zhu, Li-Qin] Tianjin First Cent Hosp, Dept Pharm, Tianjin 300192, Peoples R China.
RP Zhu, LQ (reprint author), Tianjin First Cent Hosp, Dept Pharm, Tianjin 300192, Peoples R China.
EM zlq0713@aliyun.com
CR Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen ZM, 2020, J ZHEJIANG U MED SCI, DOI [10.3785/j.issn.1008-9292.2020.02.01, DOI 10.3785/J.ISSN.1008-9292.2020.02.01]
   Chong YP, 2015, INFECT CHEMOTHER, V47, P212, DOI 10.3947/ic.2015.47.3.212
   Cui LD, 2018, CHIN J HOSP PHARM, V38, P403
   DailyMed, KAL LOP RIT TABL FIL
   DailyMed, REB IB CAPS LIQ
   DailyMed, LOP IT SOL
   De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Lai CZ, 2014, CHIN J CLIN RATIO DR, V7, P49
   Lin HL, 2016, ARCH VIROL, V161, P3073, DOI 10.1007/s00705-016-3012-7
   Lin Y, 2017, J PEDIAT PHARM, V23, P9
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia, 2020, CHIN J TUBERE RESP D, V43, pE019
   National Health Commission of the People's Republic of China, NOT PRINT DIST ADJ D
   National Health Commission of the People's Republic of China, NOT PINT DIST DIAGN
   Rao YH, 2007, EVA ANA DRUG USE HOS, V4, P52
   RIOU B, 1988, NEW ENGL J MED, V318, P1, DOI 10.1056/NEJM198801073180101
   [尚云晓 Shang Yunxiao], 2014, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V29, P840
   Shen KL, 2018, ZHONGHUA SHIYONG ERK, V33, P1301
   Shen KL, 2020, WORLD J PEDIATR, DOI 10.1007/s12519-020-00343-7
   UpToDate, LOP RIT
   [张国成 Zhang Guocheng], 2015, [中华实用儿科临床杂志, Chinese Journal of Applied Clinical Pediatrics], V30, P1220
   Zhong QL, 2017, CHIN MED PHARM, V7, P80
   张菊, 2011, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V6, P308
NR 27
TC 0
Z9 0
U1 1
U2 1
PU ZHEJIANG UNIV SCH MEDICINE
PI HANGZHOU
PA CHILDRENS HOSPITAL, 57 ZHUGAN XIANG, HANGZHOU, 310003, PEOPLES R CHINA
SN 1708-8569
EI 1867-0687
J9 WORLD J PEDIATR
JI World Journal of Pediatrics
DI 10.1007/s12519-020-00353-5
EA MAR 2020
PG 4
WC Pediatrics
SC Pediatrics
GA KV7PN
UT WOS:000520672100001
PM 32166483
OA Bronze
DA 2020-04-03
ER

PT J
AU Xing, YY
   Mo, PZ
   Xiao, Y
   Zhao, O
   Zhang, YX
   Wang, F
AF Xing, Yuanyuan
   Mo, Pingzheng
   Xiao, Yu
   Zhao, Oiu
   Zhang, Yongxi
   Wang, Fan
TI Post-discharge surveillance and positive virus detection in two medical
   staff recovered from coronavirus disease 2019 (COVID-19), China, January
   to February 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB Since December 2019, 62 medical staff of Zhongnan Hospital in Wuhan, China have been hospitalised with coronavirus disease 2019. During the post-discharge surveillance after clinical recovery, swabs were positive in two asymptomatic cases (3.23%). Case 1 had presented typical clinical and radiological manifestations on admission, while manifestation in Case 2 was very mild. In conclusion, a small proportion of recovered patients may test positive after discharge, and post-discharge surveillance and isolation need to be strengthened.
C1 [Xing, Yuanyuan; Xiao, Yu] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan, Peoples R China.
   [Mo, Pingzheng; Zhang, Yongxi] Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan, Peoples R China.
   [Zhao, Oiu; Wang, Fan] Zhongnan Hosp Wuhan Univ, Dept Gastroenterol, Zhongnan Hosp, Wuhan, Peoples R China.
RP Wang, F (reprint author), Zhongnan Hosp Wuhan Univ, Dept Gastroenterol, Zhongnan Hosp, Wuhan, Peoples R China.
EM fanndywang@foxmail.com
CR China Daily Website, 2020, CHINA DAILY WEBSITE
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   He WJ, 2020, NEURORADIOLOGY, DOI 10.1007/s00234-020-02361-8
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   National Health Commission of Changde (China), 2020, UPD EP SIT NOV COR P
   National Health Commission of the People's Republic of China, 2020, DIAGN TREATM PROT NO
   National Health Commission of the People's Republic of China, 2020, UPD EP SIT NOV COR P
   National Institute for Viral Disease Control and Prevention ( China), 2020, SPEC PRIM PROB DET 2
   World Health Organization ( WHO), 2020, WORLD EXP FUND SET P
   Xie Xingzhi, 2020, Radiology, P200343, DOI 10.1148/radiol.2020200343
   Zhang Wei, 2020, Emerg Microbes Infect, V9, P386, DOI 10.1080/22221751.2020.1729071
NR 12
TC 0
Z9 0
U1 3
U2 3
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 12
PY 2020
VL 25
IS 10
BP 12
EP 15
AR 200191
DI 10.2807/1560-7917.ES.2020.25.10.2000191
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KU8UV
UT WOS:000519988300003
PM 32183934
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Zhou, ZH
   Sun, Y
   Yan, XL
   Tang, XY
   Li, QN
   Tan, YR
   Lan, T
   Ma, JY
AF Zhou, Zhihai
   Sun, Yuan
   Yan, Xiaoling
   Tang, Xiaoyu
   Li, Qianniu
   Tan, Yaorong
   Lan, Tian
   Ma, Jingyun
TI Swine acute diarrhea syndrome coronavirus (SADS-CoV) antagonizes
   interferon-beta production via blocking IPS-1 and RIG-I
SO VIRUS RESEARCH
LA English
DT Article
DE Swine acute diarrhea syndrome coronavirus; IPS-1; RIG-I; Interferon beta
ID NF-KAPPA-B; ENTERIC ALPHACORONAVIRUS; VIRUS; INHIBITION; RECOGNITION;
   INDUCTION; ACTIVATION; INFECTION; CHINA; IFN
AB Swine acute diarrhea syndrome coronavirus (SADS-CoV), a newly emerging enteric coronavirus, is considered to be associated with swine acute diarrhea syndrome (SADS) which has caused significantly economic losses to the porcine industry. Interactions between SADS-CoV and the host innate immune response is unclear yet. In this study, we used IPEC-J2 cells as a model to explore potential evasion strategies employed by SADS-CoV. Our results showed that SADS-CoV infection failed to induce IFN-beta production, and inhibited poly (I:C) and Sendai virus (SeV)-triggered IFN-beta expression. SADS-CoV also blocked poly (I:C)-induced phosphorylation and nuclear translocation of IRF-3 and NF-kappa B. Furthermore, SADS-CoV did not interfere with the activity of IFN-beta promoter stimulated by IRF3, TBK1 and IKK epsilon, but counteracted its activation induced by IPS-1 and RIG-I. Collectively, this study is the first investigation that shows interactions between SADS-CoV and the host innate immunity, which provides information of the molecular mechanisms underlying SASD-CoV infection.
C1 [Zhou, Zhihai; Sun, Yuan; Yan, Xiaoling; Tang, Xiaoyu; Li, Qianniu; Tan, Yaorong; Lan, Tian; Ma, Jingyun] South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China.
   [Zhou, Zhihai; Sun, Yuan; Yan, Xiaoling; Tang, Xiaoyu; Li, Qianniu; Tan, Yaorong; Lan, Tian; Ma, Jingyun] Key Lab Anim Hlth Aquaculture & Environm Control, Guangzhou, Guangdong, Peoples R China.
RP Lan, T; Ma, JY (reprint author), South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China.
EM lantian2016@scau.edu.cn; majy2400@scau.edu.cn
FU Research and Extension of Major Animal Epidemic Prevention and Control
   Technologies in the Strategic Project of Rural Revitalization of
   Guangdong Agricultural Department of China (Building Modern Agricultural
   System) (2018-2020); Science and Technology Program of Guangzhou City of
   China [201904010433]; China Scholarship CouncilChina Scholarship Council
   [201807630021]
FX This work was supported by the Research and Extension of Major Animal
   Epidemic Prevention and Control Technologies in the Strategic Project of
   Rural Revitalization of Guangdong Agricultural Department of China
   (Building Modern Agricultural System) (2018-2020), the Science and
   Technology Program of Guangzhou City of China (No. 201904010433), and
   China Scholarship Council (201807630021).
CR Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101
   Cao LY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0345-x
   Carlos TS, 2007, VIROLOGY, V363, P166, DOI 10.1016/j.virol.2007.01.014
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   Ding Z, 2017, ONCOTARGET, V8, P49655, DOI 10.18632/oncotarget.17912
   Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]
   Fu XL, 2018, INFECT GENET EVOL, V62, P179, DOI 10.1016/j.meegid.2018.04.031
   Fung TS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070184
   Gong L, 2017, EMERG INFECT DIS, V23, P1607, DOI 10.3201/eid2309.170915
   Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13
   Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x
   Ji LK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01024
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Koonpaew S, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00034
   Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10
   Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33
   Luo JY, 2016, VIROLOGY, V495, P10, DOI 10.1016/j.virol.2016.04.025
   Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028
   Pan YF, 2017, VET MICROBIOL, V211, P15, DOI 10.1016/j.vetmic.2017.09.020
   Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07
   Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005
   Temeeyasen G, 2018, VIROLOGY, V517, P188, DOI 10.1016/j.virol.2017.11.024
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Xu ZC, 2019, TRANSBOUND EMERG DIS, V66, P119, DOI 10.1111/tbed.12992
   Zhang QZ, 2017, VIROLOGY, V510, P111, DOI 10.1016/j.virol.2017.07.009
   Zhou L, 2018, J VIROL METHODS, V255, P66, DOI 10.1016/j.jviromet.2018.02.002
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zhu LQ, 2017, VET MICROBIOL, V199, P128, DOI 10.1016/j.vetmic.2016.12.031
   Zhu XY, 2017, VIROLOGY, V502, P33, DOI 10.1016/j.virol.2016.12.005
NR 29
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAR 12
PY 2020
VL 278
AR 197843
DI 10.1016/j.virusres.2019.197843
PG 8
WC Virology
SC Virology
GA KO3DZ
UT WOS:000515429400002
PM 31884203
OA Bronze
DA 2020-04-03
ER

PT J
AU Li, W
   Cui, HQ
   Li, KW
   Fang, YJ
   Li, SL
AF Li, Wei
   Cui, Huaqian
   Li, Kunwei
   Fang, Yijie
   Li, Shaolin
TI Chest computed tomography in children with COVID-19 respiratory
   infection
SO PEDIATRIC RADIOLOGY
LA English
DT Article; Early Access
DE Child; Computed tomography; Coronavirus; COVID-19; Pneumonia; Viral
AB Background Infection with COVID-19 is currently rare in children. Objective To describe chest CT findings in children with COVID-19. Materials and methods We studied children at a large tertiary-care hospital in China, during the period from 28 January 2019 to 8 February 2020, who had positive reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19. We recorded findings at any chest CT performed in the included children, along with core clinical observations. Results We included five children from 10 months to 6 years of age (mean 3.4 years). All had had at least one CT scan after admission. Three of these five had CT abnormality on the first CT scan (at 2 days, 4 days and 9 days, respectively, after onset of symptoms) in the form of patchy ground-glass opacities; all normalised during treatment. Conclusion Compared to reports in adults, we found similar but more modest lung abnormalities at CT in our small paediatric cohort.
C1 [Li, Wei; Li, Kunwei; Fang, Yijie; Li, Shaolin] Sun Yat Sen Univ, Guangdong Prov Key Lab Biomed Imaging, Dept Radiol, Affiliated Hosp 5, 52 East Meihua Rd, Zhuhai, Guangdong, Peoples R China.
   [Cui, Huaqian] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Med Affairs, 52 East Meihua Rd, Zhuhai, Guangdong, Peoples R China.
RP Li, SL (reprint author), Sun Yat Sen Univ, Guangdong Prov Key Lab Biomed Imaging, Dept Radiol, Affiliated Hosp 5, 52 East Meihua Rd, Zhuhai, Guangdong, Peoples R China.
EM lishlin5@mail.sysu.edu.cn
CR Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   International Committee on Taxonomy Viruses, 2020, NAM 2019 COR
   Pan YY, 2020, EUR RADIOL, DOI 10.1007/s00330-020-06731-x
   WHO, 2020, 22 WHO
   World Health Organization, 2020, COR DIS COVID 19 OUT
   World Health Organization, 2020, NOV COR COVID 19 SIT
   World Health Organization, 2020, NOV COR CHIN
   Xie XZ, 2020, RADIOLOGY, DOI [10.1148/radiol.2020200343, DOI 10.1148/RADI0L.2020200343]
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0301-0449
EI 1432-1998
J9 PEDIATR RADIOL
JI Pediatr. Radiol.
DI 10.1007/s00247-020-04656-7
EA MAR 2020
PG 4
WC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
SC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
GA KV7ZP
UT WOS:000520698300001
PM 32162081
OA Bronze, Green Accepted
DA 2020-04-03
ER

PT J
AU Kaplan, EH
AF Kaplan, Edward H.
TI Containing 2019-nCoV (Wuhan) coronavirus
SO HEALTH CARE MANAGEMENT SCIENCE
LA English
DT Article; Early Access
DE Coronavirus; Containment; Isolation; Quarantine; Probability modeling
AB The novel coronavirus 2019-nCoV first appeared in December 2019 in Wuhan, China. While most of the initial cases were linked to the Huanan Seafood Wholesale Market, person-to-person transmission has been verified. Given that a vaccine cannot be developed and deployed for at least a year, preventing further transmission relies upon standard principles of containment, two of which are the isolation of known cases and the quarantine of persons believed at high risk of exposure. This note presents probability models for assessing the effectiveness of case isolation and quarantine within a community during the initial phase of an outbreak with illustrations based on early observations from Wuhan.
C1 [Kaplan, Edward H.] Yale Sch Management, Operat Res, 165 Whitney Ave, New Haven, CT 06511 USA.
   [Kaplan, Edward H.] Yale Sch Management, Publ Hlth, 165 Whitney Ave, New Haven, CT 06511 USA.
   [Kaplan, Edward H.] Yale Sch Management, Engn, 165 Whitney Ave, New Haven, CT 06511 USA.
RP Kaplan, EH (reprint author), Yale Sch Management, Operat Res, 165 Whitney Ave, New Haven, CT 06511 USA.; Kaplan, EH (reprint author), Yale Sch Management, Publ Hlth, 165 Whitney Ave, New Haven, CT 06511 USA.; Kaplan, EH (reprint author), Yale Sch Management, Engn, 165 Whitney Ave, New Haven, CT 06511 USA.
EM edward.kaplan@yale.edu
OI Kaplan, Edward/0000-0002-8722-7667
CR Anderson R. M., 1991, INFECT DIS HUMANS DY
   Becker NG, 2015, MODELING INFORM INFE
   Borio L, 2020, WALL STREET J
   Britton T, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0670
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Imai N, 2020, 3 LOND IMP COLL
   Kaplan EH, 2003, MATH BIOSCI, V185, P33, DOI 10.1016/S0025-5564(03)00090-7
   Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697
   Kupferschmidt K, 2020, SCIENCE
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Miller SL, 2017, AM J INFECT CONTROL, V45, P652, DOI 10.1016/j.ajic.2017.01.029
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 14
TC 0
Z9 0
U1 11
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1386-9620
EI 1572-9389
J9 HEALTH CARE MANAG SC
JI Health Care Manag. Sci.
DI 10.1007/s10729-020-09504-6
EA MAR 2020
PG 4
WC Health Policy & Services
SC Health Care Sciences & Services
GA KV7JM
UT WOS:000520656400001
PM 32146554
OA Green Accepted, Bronze
DA 2020-04-03
ER

PT J
AU Shang, WL
   Yang, Y
   Rao, YF
   Rao, XC
AF Shang, Weilong
   Yang, Yi
   Rao, Yifan
   Rao, Xiancai
TI The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
SO NPJ VACCINES
LA English
DT Article
ID SPIKE PROTEIN; SARS-COV; NEUTRALIZATION; IMMUNIZATION
AB The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.
C1 [Shang, Weilong; Yang, Yi; Rao, Yifan; Rao, Xiancai] Third Mil Med Univ, Army Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing 400038, Peoples R China.
RP Rao, XC (reprint author), Third Mil Med Univ, Army Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing 400038, Peoples R China.
EM raoxiancai@126.com
FU National Key Biosafety Technology Research and Development Program of
   China [2017YFC1200404-4]; Biosafety Research Program of PLA [17SAZ08]
FX This work was supported by the National Key Biosafety Technology
   Research and Development Program of China (2017YFC1200404-4), and the
   Biosafety Research Program of PLA (17SAZ08).
CR Bukreyev A, 2004, LANCET, V363, P2122, DOI 10.1016/S0140-6736(04)16501-X
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Duan YN, 2020, RADIOLOGY, V295, P21, DOI 10.1148/radiol.2020200323
   Eyigun CP, 1998, J VIRAL HEPATITIS, V5, P265, DOI 10.1046/j.1365-2893.1998.00106.x
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   He WQ, 2015, METHODS, V90, P95, DOI 10.1016/j.ymeth.2015.04.037
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang SB, 2005, EMERG INFECT DIS, V11, P1016, DOI 10.3201/1107.050219
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   National Health Commission of the People's Republic of China, EP PREV CONTR DYN
   Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963
   Regla-Nava JA, 2015, J VIROL, V89, P3870, DOI 10.1128/JVI.03566-14
   Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI 10.1586/ERV.09.43
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Shi SQ, 2006, MOL IMMUNOL, V43, P1791, DOI 10.1016/j.molimm.2005.11.005
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463
   Yuan JZ, 2018, NANO LETT, V18, P725, DOI 10.1021/acs.nanolett.7b03893
NR 25
TC 0
Z9 0
U1 51
U2 51
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD MAR 6
PY 2020
VL 5
IS 1
AR 18
DI 10.1038/s41541-020-0170-0
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KS5SB
UT WOS:000518367000001
PM 32194995
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Johnson, HC
   Gossner, CM
   Colzani, E
   Kinsman, J
   Alexakis, L
   Beaut, J
   Wurz, A
   Tsolova, S
   Bundle, N
   Ekdahl, K
AF Johnson, Helen C.
   Gossner, Celine M.
   Colzani, Edoardo
   Kinsman, John
   Alexakis, Leonidas
   Beaut, Julien
   Wurz, Andrea
   Tsolova, Svetla
   Bundle, Nick
   Ekdahl, Karl
TI Potential scenarios for the progression of a COVID-19 epidemic in the
   European Union and the European Economic Area, March 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area ( EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.
C1 [Johnson, Helen C.; Gossner, Celine M.; Colzani, Edoardo; Kinsman, John; Alexakis, Leonidas; Beaut, Julien; Wurz, Andrea; Tsolova, Svetla; Bundle, Nick; Ekdahl, Karl] European Ctr Dis Prevent & Control, Solna, Sweden.
RP Gossner, CM (reprint author), European Ctr Dis Prevent & Control, Solna, Sweden.
EM Celine.Gossner@ecdc.europa.eu
CR DeSalazar PM, 2020, USING PREDICTED IMPO, DOI DOI 10.1101/2020.02.04.20020495V2
   European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 SIT UPD WOR
   European Centre for Disease Prevention and Control (ECDC), 2020, COMM DIS THREATS REP
   European Centre for Disease Prevention and Control (ECDC), 2020, PUBL HLTH MAN PERS H
   Reusken CBEM, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.6.2000082
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 8
TC 0
Z9 0
U1 15
U2 15
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 5
PY 2020
VL 25
IS 9
BP 8
EP 12
AR 2000202
DI 10.2807/1560-7917.ES.2020.25.9.2000202
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KT7LC
UT WOS:000519193900002
PM 32156332
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Konrad, R
   Eberle, U
   Dangel, A
   Treis, B
   Berger, A
   Bengs, K
   Fingerle, V
   Liebl, B
   Ackermann, N
   Sing, A
AF Konrad, Regina
   Eberle, Ute
   Dangel, Alexandra
   Treis, Bianca
   Berger, Anja
   Bengs, Katja
   Fingerle, Volker
   Liebl, Bernhard
   Ackermann, Nikolaus
   Sing, Andreas
TI Rapid establishment of laboratory diagnostics for the novel coronavirus
   SARS-CoV-2 in Bavaria, Germany, February 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB The need for timely establishment of diagnostic assays arose when Germany was confronted with the first travel-associated outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe. We describe our laboratory experiences during a large contact tracing investigation, comparing previously published real-time RT-PCR assays in different PCR systems and a commercial kit. We found that assay performance using the same primers and probes with different PCR systems varied and the commercial kit performed well.
C1 [Konrad, Regina; Dangel, Alexandra; Berger, Anja; Bengs, Katja; Sing, Andreas] Bavarian Hlth & Food Safety Author, Publ Hlth Microbiol Unit, Oberschleissheim, Germany.
   [Eberle, Ute; Treis, Bianca; Fingerle, Volker; Ackermann, Nikolaus] Bavarian Hlth & Food Safety Author, Unit Virol, Oberschleissheim, Germany.
   [Liebl, Bernhard] Bavarian Hlth & Food Safety Author, State Inst Hlth, Oberschleissheim, Germany.
   [Liebl, Bernhard; Sing, Andreas] Ludwig Maximilians Univ Munchen, Munich, Germany.
RP Dangel, A (reprint author), Bavarian Hlth & Food Safety Author, Publ Hlth Microbiol Unit, Oberschleissheim, Germany.
EM alexandra.dangel@lgl.bayern.de
CR Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006
   Ren Li-Li, 2020, Chin Med J (Engl), DOI 10.1097/CM9.0000000000000722
   Reusken CBEM, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.6.2000082
   Romette JL, 2018, ANTIVIR RES, V158, P127, DOI 10.1016/j.antiviral.2018.07.017
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   World Health Organization (WHO), 2020, LAB BIOS GUID REL NO
   World Health Organization (WHO), 2020, DIS OUTBR NEWS NOV C
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
NR 9
TC 0
Z9 0
U1 10
U2 10
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 5
PY 2020
VL 25
IS 9
BP 13
EP 17
AR 2000173
DI 10.2807/1560-7917.ES.2020.25.9.2000173
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KT7LC
UT WOS:000519193900003
PM 32156330
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Pfefferle, S
   Reucher, S
   Norz, D
   Lutgehetmann, M
AF Pfefferle, Susanne
   Reucher, Svenja
   Noerz, Dominic
   Luetgehetmann, Marc
TI Evaluation of a quantitative RT-PCR assay for the detection of the
   emerging coronavirus SARS-CoV-2 using a high throughput system
SO EUROSURVEILLANCE
LA English
DT Article
ID AUTOMATION
AB Facing the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), high-volume respiratory testing is demanded in laboratories worldwide. We evaluated the performance of a molecular assay for the detection of SARS-CoV-2 on a high-throughput platform, the cobas 6800, using the 'open channel' for integration of a laboratory-developed assay. We observed good analytical performance in clinical specimens. The fully automated workflow enables high-throughput testing with minimal hands-on time, while offering fast and reliable results.
C1 [Pfefferle, Susanne; Reucher, Svenja; Noerz, Dominic; Luetgehetmann, Marc] Univ Med Ctr Hamburg Eppendorf UKE, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.
RP Pfefferle, S (reprint author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.
EM s.pfefferle@uke.de
CR Boujnan M, 2018, TRANSFUSION, V58, P641, DOI 10.1111/trf.14460
   Centers for Disease Control and Prevention (CDC), 2020, RES US ONL 2019 NOV
   Cobb B, 2017, EXPERT REV MOL DIAGN, V17, P167, DOI 10.1080/14737159.2017.1275962
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Eigner U, 2019, J VIROL METHODS, V269, P49, DOI 10.1016/j.jviromet.2019.03.015
   Enserink M, 2013, SCIENCE, V339, P1264, DOI 10.1126/science.339.6125.1266
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Greub G, 2016, FUTURE MICROBIOL, V11, P403, DOI 10.2217/fmb.15.152
   MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M408
   Marlowe EM, 2017, EUR J MICROBIOL IMMU, V7, P176, DOI 10.1556/1886.2017.00018
   Romette JL, 2018, ANTIVIR RES, V158, P127, DOI 10.1016/j.antiviral.2018.07.017
   Saville M, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01239-18
   Van Der Pol B, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01996-18
   Vermehren J, 2017, J CLIN MICROBIOL, V55, P1131, DOI 10.1128/JCM.02193-16
   Yao JD, 2018, J CLIN VIROL, V102, P63, DOI 10.1016/j.jcv.2018.02.017
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 0
Z9 0
U1 14
U2 14
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 5
PY 2020
VL 25
IS 9
BP 18
EP 22
AR 2000152
DI 10.2807/1560-7917.ES.2020.25.9.2000152
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KT7LC
UT WOS:000519193900004
PM 32156329
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Spiteri, G
   Fielding, J
   Diercke, M
   Campese, C
   Enouf, V
   Gaymard, A
   Bella, A
   Sognamiglios, P
   Moros, MJS
   Riutort, AN
   Demina, YV
   Mahieu, R
   Broas, M
   Bengner, M
   Buda, S
   Schilling, J
   Filleul, L
   Lepoutre, A
   Saura, C
   Mailles, A
   Levy-Bruhl, D
   Coignard, B
   Bernard-Stoecklin, S
   Behillil, S
   van der Werf, S
   Valette, M
   Lina, B
   Riccardo, F
   Nicastri, E
   Casas, I
   Larrauri, A
   Castell, MS
   Pozo, F
   Maksyutov, RA
   Martin, C
   Van Ranst, M
   Bossuyt, N
   Siira, L
   Sane, J
   Tegmark-Wisell, K
   Palmerus, M
   Broberg, EK
   Beaute, J
   Jorgensen, P
   Bundle, N
   Pereyaslov, D
   Adlhoch, C
   Pukkila, J
   Pebody, R
   Olsen, S
   Ciancio, BC
AF Spiteri, Gianfranco
   Fielding, James
   Diercke, Michaela
   Campese, Christine
   Enouf, Vincent
   Gaymard, Alexandre
   Bella, Antonino
   Sognamiglios, Paola
   Sierra Moros, Maria Jose
   Nicolau Riutort, Antonio
   Demina, Yulia, V
   Mahieu, Romain
   Broas, Markku
   Bengner, Malin
   Buda, Silke
   Schilling, Julia
   Filleul, Laurent
   Lepoutre, Agnes
   Saura, Christine
   Mailles, Alexandra
   Levy-Bruhl, Daniel
   Coignard, Bruno
   Bernard-Stoecklin, Sibylle
   Behillil, Sylvie
   van der Werf, Sylvie
   Valette, Martine
   Lina, Bruno
   Riccardo, Flavia
   Nicastri, Emanuele
   Casas, Inmaculada
   Larrauri, Amparo
   Salom Castell, Magdalena
   Pozo, Francisco
   Maksyutov, Rinat A.
   Martin, Charlotte
   Van Ranst, Marc
   Bossuyt, Nathalie
   Siira, Lotta
   Sane, Jussi
   Tegmark-Wisell, Karin
   Palmerus, Maria
   Broberg, Eeva K.
   Beaute, Julien
   Jorgensen, Pernille
   Bundle, Nick
   Pereyaslov, Dmitriy
   Adlhoch, Cornelia
   Pukkila, Jukka
   Pebody, Richard
   Olsen, Sonja
   Ciancio, Bruno Christian
TI First cases of coronavirus disease 2019 (COVID-19) in the WHO European
   Region, 24 January to 21 February 2020
SO EUROSURVEILLANCE
LA English
DT Article
AB In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases.
C1 [Spiteri, Gianfranco; Broberg, Eeva K.; Beaute, Julien; Bundle, Nick; Adlhoch, Cornelia; Ciancio, Bruno Christian] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Fielding, James; Jorgensen, Pernille; Pereyaslov, Dmitriy; Pukkila, Jukka; Pebody, Richard; Olsen, Sonja] WHO, Reg Off Europe, Copenhagen, Denmark.
   [Diercke, Michaela; Buda, Silke; Schilling, Julia] Robert Koch Inst, Berlin, Germany.
   [Campese, Christine; Mailles, Alexandra; Levy-Bruhl, Daniel; Coignard, Bruno; Bernard-Stoecklin, Sibylle] Sante Publ France Direct Malad Infect, St Maurice, France.
   [Enouf, Vincent; Behillil, Sylvie; van der Werf, Sylvie] Inst Pasteur, Ctr Natl Reference Virus Infect Resp, Paris, France.
   [Gaymard, Alexandre; Valette, Martine; Lina, Bruno] Hosp Civils Lyon, Ctr Natl Reference Virus Infect Resp, Lyon, France.
   [Bella, Antonino; Riccardo, Flavia] Ist Super Sanita, Rome, Italy.
   [Sognamiglios, Paola; Nicastri, Emanuele] Ist Nazl Malattie Infett Lazzaro Spallanzani, Rome, Italy.
   [Sierra Moros, Maria Jose] Spanish Minist Hlth, Coordinat Ctr Hlth Alerts & Emergencies, Madrid, Spain.
   [Nicolau Riutort, Antonio] Direcc Gen Salut Publ, Serv Epidemiol, Islas Baleares, Spain.
   [Demina, Yulia, V] Fed Serv Surveillance Consumer Rights Protect & H, Moscow, Russia.
   [Mahieu, Romain] Common Community Commiss, Dept Infect Dis Prevent & Control, Brussels, Brussels Capita, Belgium.
   [Broas, Markku] Lapland Hosp Dist, Infect Control Unit, Rovaniemi, Finland.
   [Filleul, Laurent] Cellule Reg Nouvelle Aquitaine, Sante Publ France Direct Reg, Bordeaux, France.
   [Lepoutre, Agnes] Cellule Reg Ile de France, Sante Publ France Direct Reg, Paris, France.
   [Saura, Christine] Cellule Reg Auvergne Rhone Alpes, Sante Publ France Direct Reg, Lyon, France.
   [Casas, Inmaculada; Pozo, Francisco] Inst Hlth Carlos III, WHO Natl Influenza Ctr, Natl Ctr Microbiol, Madrid, Spain.
   [Larrauri, Amparo] Inst Hlth Carlos III, Natl Ctr Epidemiol, CIBERESP, Madrid, Spain.
   [Salom Castell, Magdalena] Direcc Gen Salut Publ, Islas Baleares, Spain.
   [Maksyutov, Rinat A.] Rospotrebnadzor, State Res Ctr Virol & Biotechnol Vector, Moscow, Russia.
   [Martin, Charlotte] St Pierre Hosp, Brussels, Belgium.
   [Van Ranst, Marc] KU Leuven Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Clin Virol, Leuven, Belgium.
   [Bossuyt, Nathalie] Sciensano, Epidemiol Infect Dis, Brussels, Belgium.
   [Siira, Lotta] Finnish Inst Hlth & Welf THL, Dept Hlth Secur, Expert Microbiol Unit, Helsinki, Finland.
   [Sane, Jussi] Finnish Inst Hlth & Welf THL, Dept Hlth Secur, Infect Dis Control & Vaccinat Unit, Helsinki, Finland.
   [Tegmark-Wisell, Karin] Publ Hlth Agcy Sweden, Solna, Sweden.
RP Spiteri, G (reprint author), European Ctr Dis Prevent & Control, Stockholm, Sweden.
EM Marco.Cavaleri@ema.europa.eu
CR Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bayerische Gesundheitsministerium, 2020, LUNG DURCH NEUART CO
   Corman V, 2020, DIAGNOSTIC DETECTION
   Department of Health and Social Care, 2020, CHIEF MED OFF ENGL A
   ECDC, 2020, GEOGR DISTR 2019 NCO
   European Centre for Disease Prevention and Control (ECDC), 2020, RAP RISK ASS OUTBR A
   European Centre for Disease Prevention and Control (ECDC), 2020, OUTBR AC RESP SYNDR
   European Centre for Disease Prevention and Control (ECDC), EUR SURV HUM INF NOV
   European Centre for Disease Prevention and Control (ECDC), 2020, 2019 NOV COR NCOV DI
   European Centre for Disease Prevention and Control (ECDC), 2020, OUTBR NOV COR DIS 20
   Lebensmittelsicherheit BLfGu Robert Koch Institute, 2020, EPIDEMIOLOGISCHES B, V7, P3
   Reusken CBEM, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.6.2000082
   Sante publique France, 2020, EP COR 2019 NCOV DEP
   Sante publique France, 2020, COVID 19 SIT CAS GRO
   Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, EP CHAR OUTBR 2019 N
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   World Health Organization Regional Office for Europe, COUNTR 2020
   World Health Organization Regional Office for Europe ( WHO/ Europe), COVID 19 SIT WHO EUR
   World Health Organization (WHO), 2020, COR DIS COVID 19 TEC
   World Health Organization ( WHO), 2020, GLOB SURV COVID 19 D
   Wuhan City Health Committee (WCHC), 2019, WUH MUN HLTH HLTH CO
NR 22
TC 0
Z9 0
U1 18
U2 18
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 5
PY 2020
VL 25
IS 9
BP 2
EP 7
AR 2000178
DI 10.2807/1560-7917.ES.2020.25.9.2000178
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KT7LC
UT WOS:000519193900001
PM 32156327
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Xiao, H
   Zhang, Y
   Kong, DS
   Li, SY
   Yang, NX
AF Xiao, Han
   Zhang, Yan
   Kong, Desheng
   Li, Shiyue
   Yang, Ningxi
TI The Effects of Social Support on Sleep Quality of Medical Staff Treating
   Patients with Coronavirus Disease 2019 (COVID-19) in January and
   February 2020 in China
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Anxiety; SARS Virus; Social Support; Stress, Psychological
ID SELF-EFFICACY; PSYCHOMETRIC PROPERTIES; POSTTRAUMATIC STRESS;
   MENTAL-HEALTH; ANXIETY; EMPATHY; ASSOCIATION; DEPRESSION; INSOMNIA
AB Background: Coronavirus disease 2019 (COVID-19), formerly known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 2019 novel coronavirus (2019-nCoV), was first identified in December 2019 in Wuhan City, China. Structural equation modeling (SEM) is a multivariate analysis method to determine the structural relationship between measured variables. This observational study aimed to use SEM to determine the effects of social support on sleep quality and function of medical staff who treated patients with COVID-19 in January and February 2020 in Wuhan, China.
   Material/Methods: A one-month cross-sectional observational study included 180 medical staff who treated patients with COVID-19 infection. Levels of anxiety, self-efficacy, stress, sleep quality, and social support were measured using the and the Self-Rating Anxiety Scale (SAS), the General Self-Efficacy Scale (GSES), the Stanford Acute Stress Reaction (SASR) questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Social Support Rate Scale (SSRS), respectively. Pearson's correlation analysis and SEM identified the interactions between these factors.
   Results: Levels of social support for medical staff were significantly associated with self-efficacy and sleep quality and negatively associated with the degree of anxiety and stress. Levels of anxiety were significantly associated with the levels of stress, which negatively impacted self-efficacy and sleep quality. Anxiety, stress, and self-efficacy were mediating variables associated with social support and sleep quality.
   Conclusions: SEM showed that medical staff in China who were treating patients with COVID-19 infection during January and February 2020 had levels of anxiety, stress, and self-efficacy that were dependent on sleep quality and social support.
C1 [Xiao, Han] Capital Med Univ, Dept Respirat, Xuanwu Hosp, Beijing, Peoples R China.
   [Zhang, Yan; Kong, Desheng; Yang, Ningxi] Harbin Engn Univ, Coll Humanities & Social Sci, Harbin, Heilongjiang, Peoples R China.
   [Li, Shiyue] Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China.
RP Yang, NX (reprint author), Harbin Engn Univ, Coll Humanities & Social Sci, Harbin, Heilongjiang, Peoples R China.
EM yangningxi@bjmu.edu.cn
FU Basic Research Project of Coronavirus Disease 2019 Epidemic of
   Fundamental Research Funds for the Central Universities (Harbin
   Engineering University)
FX This study was funded by the Basic Research Project of Coronavirus
   Disease 2019 Epidemic of Fundamental Research Funds for the Central
   Universities (Harbin Engineering University)
CR Adamczyk K, 2015, CURR PSYCHOL, V34, P82, DOI 10.1007/s12144-014-9242-5
   Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bandura A., 1977, COGNITIVE THERAPY RE, V1, P287, DOI DOI 10.1007/BF01663995
   Bihlmaier I, 2016, SOMNOLOGIE, V20, P275, DOI 10.1007/s11818-016-0085-1
   Brugha TS, 1990, CURRENT OPINION PSYC, V3, P264
   Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186
   Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5
   Centers for Disease Control and Prevention, 2019, NOV COR
   Chen XF, 2019, MED SCI MONITOR, V25, P7889, DOI 10.12659/MSM.917552
   Dahlgren A, 2005, SCAND J WORK ENV HEA, V31, P277, DOI 10.5271/sjweh.883
   de Grey RGK, 2018, HEALTH PSYCHOL, V37, P787, DOI [10.1037/hea0000628, 10.1037/hea0000628.supp]
   Glozah FN, 2015, INT J QUAL STUD HEAL, V10, DOI 10.3402/qhw.v10.26370
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Jarrin DC, 2014, J SLEEP RES, V23, P681, DOI 10.1111/jsr.12172
   Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008
   Kolahkaj B, 2015, NURS MIDWIFERY STUD, V4, DOI 10.17795/nmsjournal29655
   Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x
   Luby JL, 2003, ARCH GEN PSYCHIAT, V60, P1248, DOI 10.1001/archpsyc.60.12.1248
   Miller RL, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-12
   Olatunji BO, 2006, J ANXIETY DISORD, V20, P543, DOI 10.1016/j.janxdis.2005.08.002
   Peng EYC, 2010, J FORMOS MED ASSOC, V109, P524, DOI 10.1016/S0929-6646(10)60087-3
   Poznanski B, 2018, CHILD PSYCHIAT HUM D, V49, P352, DOI 10.1007/s10578-017-0769-1
   Prati G, 2010, J COMMUNITY PSYCHOL, V38, P403, DOI 10.1002/jcop.20371
   Przepiorka A, 2019, CHRONOBIOL INT, V36, P1025, DOI 10.1080/07420528.2019.1607370
   Rutledge CM, 2013, J CLIN NURS, V22, P1254, DOI 10.1111/jocn.12005
   Segrin C, 2010, HEALTH COMMUN, V25, P312, DOI 10.1080/10410231003773334
   Van Reeth O, 2000, SLEEP MED REV, V4, P201, DOI 10.1053/smrv.1999.0097
   World Health Organisation, 2020, 29 WHO
   World Health Organization, NOV COR 2019 NCOV TE
   Wu KK, 2005, EMERG INFECT DIS, V11, P1297, DOI 10.3201/eid1108.041083
   Wu KK, 2005, J TRAUMA STRESS, V18, P39, DOI 10.1002/jts.20004
   Yang NX, 2018, PSYCHOL RES BEHAV MA, V11, P279, DOI 10.2147/PRBM.S168649
   Yang NX, 2018, PATIENT PREFER ADHER, V12, P1305, DOI 10.2147/PPA.S166460
   Yao Ke-Wu, 2008, J Nurs Res, V16, P131
   Zhang WJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0053-0
   [朱美侠 Zhu Meixia], 2016, [心理科学, Journal of Psychological Science], V39, P371
   Zhang XL, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0872-4
NR 38
TC 0
Z9 0
U1 61
U2 61
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAR 5
PY 2020
VL 26
AR e923549
DI 10.12659/MSM.923549
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KS8XY
UT WOS:000518593100001
PM 32132521
DA 2020-04-03
ER

PT J
AU Hu, ZL
   Song, C
   Xu, CJ
   Jin, GF
   Chen, YL
   Xu, X
   Ma, HX
   Chen, W
   Lin, Y
   Zheng, YS
   Wang, JM
   Hu, ZB
   Yi, YX
   Shen, HB
AF Hu, Zhiliang
   Song, Ci
   Xu, Chuanjun
   Jin, Guangfu
   Chen, Yaling
   Xu, Xin
   Ma, Hongxia
   Chen, Wei
   Lin, Yuan
   Zheng, Yishan
   Wang, Jianming
   Hu, Zhibin
   Yi, Yongxiang
   Shen, Hongbing
TI Clinical characteristics of 24 asymptomatic infections with COVID-19
   screened among close contacts in Nanjing, China
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Article; Early Access
DE COVID-19; asymptomatic infections; close contact; China
AB Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.
C1 [Hu, Zhiliang; Chen, Yaling; Yi, Yongxiang] Nanjing Univ Chinese Med, Hosp Nanjing 2, Nanjing Infect Dis Ctr, Nanjing 210003, Peoples R China.
   [Hu, Zhiliang; Song, Ci; Jin, Guangfu; Xu, Xin; Ma, Hongxia; Wang, Jianming; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Global Hlth, Nanjing 211166, Peoples R China.
   [Song, Ci; Jin, Guangfu; Ma, Hongxia; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.
   [Xu, Chuanjun] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Radiol, Nanjing 210003, Peoples R China.
   [Chen, Wei] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Clin Res Ctr, Nanjing 210003, Peoples R China.
   [Lin, Yuan] Nanjing Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Nanjing 211166, Peoples R China.
   [Zheng, Yishan] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Crit Med, Nanjing 210003, Peoples R China.
RP Yi, YX (reprint author), Nanjing Univ Chinese Med, Hosp Nanjing 2, Nanjing Infect Dis Ctr, Nanjing 210003, Peoples R China.
EM zhibin_hu@njmu.edu.cn; ian0126@126.com
FU project of Jiangsu province medical youth talent [QNRC2016059]; Nanjing
   medical science and technique development foundation [ZKX17040,
   YKK18153]; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81903382]; Cheung Kong Scholars Program of
   China
FX The authors would like to thank the patients and the supporting staff in
   this study. This work was supported by the project of Jiangsu province
   medical youth talent (QNRC2016059), Nanjing medical science and
   technique development foundation (ZKX17040 and YKK18153), the National
   Natural Science Foundation of China (81903382), Cheung Kong Scholars
   Program of China.
CR [Anonymous], 2020, NEW CORONAVIRUS PNEU
   [Anonymous], 2020, DIAM PRINC SHIP
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang D, 2020, JAMA
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Ding L., 2020, SCI SIN VITAE, V50, DOI [10.1360/SSV-2020-0044, DOI 10.1360/SSV-2020-0044]
   Guan WJ, 2020, N ENGL J MED
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yang HN, 2020, CLIN CARDIOL, DOI 10.1002/clc.23341
   Zhang Z, 2020, VIROL SIN, DOI 10.1007/s12250-020-00203-8
   Zou L, 2020, N ENGL J MED
NR 15
TC 0
Z9 0
U1 37
U2 37
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
DI 10.1007/s11427-020-1661-4
EA MAR 2020
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KS7IA
UT WOS:000518479200001
PM 32146694
OA Green Accepted, Bronze
DA 2020-04-03
ER

PT J
AU Jiang, F
   Deng, LH
   Zhang, LQ
   Cai, Y
   Cheung, CW
   Xia, ZY
AF Jiang, Fang
   Deng, Liehua
   Zhang, Liangqing
   Cai, Yin
   Cheung, Chi Wai
   Xia, Zhengyuan
TI Review of the Clinical Characteristics of Coronavirus Disease 2019
   (COVID-19)
SO JOURNAL OF GENERAL INTERNAL MEDICINE
LA English
DT Article; Early Access
DE COVID-19; SARS-CoV-2; coronavirus; pneumonia; Wuhan; review
AB In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-CoV-2) in Wuhan, China, aroused worldwide concern. Previous studies have reported epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19). The purpose of this brief review is to summarize those published studies as of late February 2020 on the clinical features, symptoms, complications, and treatments of COVID-19 and help provide guidance for frontline medical staff in the clinical management of this outbreak.
C1 [Jiang, Fang; Cai, Yin; Cheung, Chi Wai; Xia, Zhengyuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anesthesiol, Hong Kong, Peoples R China.
   [Deng, Liehua] Guangdong Med Univ, Affiliated Hosp, Dept Crit Care Med, Zhanjiang, Peoples R China.
   [Zhang, Liangqing; Xia, Zhengyuan] Guangdong Med Univ, Affiliated Hosp, Dept Anesthesiol, Zhanjiang, Peoples R China.
RP Xia, ZY (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anesthesiol, Hong Kong, Peoples R China.; Xia, ZY (reprint author), Guangdong Med Univ, Affiliated Hosp, Dept Anesthesiol, Zhanjiang, Peoples R China.
EM zyxia@hku.hk
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [81970247]
FX The authors' work was supported by the National Natural Science
   Foundation of China (NSFC, 81970247).
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen H, CLIN CHARACTERISTICS, DOI [10.1016/S0140-6736(20)30360-3, DOI 10.1016/S0140-6736(20)30360-3]
   Chen L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE005, DOI 10.3760/cma.j.issn.1001-0939.2020.0005
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Hoehl Sebastian, 2020, N Engl J Med, V382, P1278, DOI 10.1056/NEJMc2001899
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huaxia, 2020, XINHUANET       0213
   Huaxia, 2020, XINHUANET       0212
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu Kui, 2020, Chin Med J (Engl), DOI 10.1097/CM9.0000000000000744
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Song FX, 2020, RADIOLOGY, V295, P210, DOI 10.1148/radiol.2020200274
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   World Health Organization, 36 WHO
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 23
TC 0
Z9 0
U1 8
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0884-8734
EI 1525-1497
J9 J GEN INTERN MED
JI J. Gen. Intern. Med.
DI 10.1007/s11606-020-05762-w
EA MAR 2020
PG 5
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA KV7KR
UT WOS:000520659500001
PM 32133578
OA Bronze
DA 2020-04-03
ER

PT J
AU Baruah, V
   Bose, S
AF Baruah, Vargab
   Bose, Sujoy
TI Immunoinformatics-aided identification of T cell and B cell epitopes in
   the surface glycoprotein of 2019-nCoV
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE 2019-nCoV; coronavirus; COVID-19; epitope prediction; immunoinformatics;
   SARS-CoV-2
ID PREDICTION; PROTEIN; EVOLUTION
AB The 2019 novel coronavirus (2019-nCoV) outbreak has caused a large number of deaths with thousands of confirmed cases worldwide, especially in East Asia. This study took an immunoinformatics approach to identify significant cytotoxic T lymphocyte (CTL) and B cell epitopes in the 2019-nCoV surface glycoprotein. Also, interactions between identified CTL epitopes and their corresponding major histocompatibility complex (MHC) class I supertype representatives prevalent in China were studied by molecular dynamics simulations. We identified five CTL epitopes, three sequential B cell epitopes and five discontinuous B cell epitopes in the viral surface glycoprotein. Also, during simulations, the CTL epitopes were observed to be binding MHC class I peptide-binding grooves via multiple contacts, with continuous hydrogen bonds and salt bridge anchors, indicating their potential in generating immune responses. Some of these identified epitopes can be potential candidates for the development of 2019-nCoV vaccines.
C1 [Baruah, Vargab; Bose, Sujoy] Gauhati Univ, Dept Biotechnol, Gauhati 781014, Assam, India.
RP Baruah, V (reprint author), Gauhati Univ, Dept Biotechnol, Gauhati 781014, Assam, India.
EM vargabbarua@gauhati.ac.in
OI Baruah, Vargab/0000-0002-2882-7785
CR Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Fernando BG, 2016, BIOMED RES INT, V2016, P1
   Francisco RD, 2015, IMMUNOGENETICS, V67, P651, DOI 10.1007/s00251-015-0875-9
   Guest JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01117
   Huang J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-50
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Ji W, 2019, MOL IMMUNOL, V112, P274, DOI 10.1016/j.molimm.2019.06.005
   Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   ROGNAN D, 1992, EUR J BIOCHEM, V208, P101, DOI 10.1111/j.1432-1033.1992.tb17163.x
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004
   Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   Ul Qamar MT, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2116-8
   Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292
   World Health Organization, 2020 WHO
   Zhou YS, 2018, EXPERT REV VACCINES, V17, P677, DOI 10.1080/14760584.2018.1506702
NR 26
TC 0
Z9 0
U1 65
U2 65
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 495
EP 500
DI 10.1002/jmv.25698
EA MAR 2020
PG 6
WC Virology
SC Virology
GA KU3AY
UT WOS:000517679900001
PM 32022276
OA Bronze
DA 2020-04-03
ER

PT J
AU Gorse, GJ
   Donovan, MM
   Patel, GB
AF Gorse, Geoffrey J.
   Donovan, Mary M.
   Patel, Gira B.
TI Antibodies to coronaviruses are higher in older compared with younger
   adults and binding antibodies are more sensitive than neutralizing
   antibodies in identifying coronavirus-associated illnesses
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE antibody; coronavirus; immunity; neutralization; respiratory illness
ID RESPIRATORY ILLNESS; INFECTION; OC43; 229E; INACTIVATION; VIRUSES; NL63
AB Human coronaviruses (HCoV) are common causes of respiratory illnesses (RI) despite preexisting humoral immunity. Sera were obtained near the onset of RI and 3 to 4 weeks later as part of a prospective study of 200 subjects evaluated for RI from 2009 to 2013. Antibodies against common HCoV strains were measured by enzyme-linked immunosorbent assay and neutralization assay comparing older adults with cardiopulmonary diseases (99 subjects) to younger, healthy adults (101 subjects). Virus shedding was detected in respiratory secretions by polymerase chain reaction. Of 43 HCoV-associated illnesses, 15 (35%) occurred in 14 older adults (aged >= 60 years) and 28 (65%) in 28 younger adults (aged 21-40 years). Binding and neutralizing antibodies were higher in older adults. Only 16 (35.7%) of RI with increases in binding antibodies also had increases in neutralizing antibodies to HCoV. Increases in binding antibodies with RI were more frequent than increased neutralizing antibodies and virus shedding, and more frequent in younger compared to older adults. Functional neutralizing antibodies were not stimulated as often as binding antibodies, explaining in part a susceptibility to reinfection with HCoV. Monitoring binding antibodies may be more sensitive for the serologic detection of HCoV infections.
C1 [Gorse, Geoffrey J.; Donovan, Mary M.; Patel, Gira B.] VA St Louis Hlth Care Syst, Infect Dis Sect & Res & Dev Serv, St Louis, MO USA.
   [Gorse, Geoffrey J.; Patel, Gira B.] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, 1100 South Grand Blvd DRC 8th Floor, St Louis, MO 63104 USA.
RP Gorse, GJ (reprint author), St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, 1100 South Grand Blvd DRC 8th Floor, St Louis, MO 63104 USA.
EM gorsegj@slu.edu
FU Veterans Affairs Research, Department of Veterans Affairs Office of
   Research and Development
FX Veterans Affairs Research, Department of Veterans Affairs Office of
   Research and Development
CR Chan CM, 2009, J CLIN VIROL, V45, P54, DOI 10.1016/j.jcv.2009.02.011
   Chan KH, 2005, CLIN DIAGN LAB IMMUN, V12, P1317, DOI 10.1128/CDLI.12.11.1317-1321.2005
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   CORAPI WV, 1992, J VIROL, V66, P6695, DOI 10.1128/JVI.66.11.6695-6705.1992
   Dijkman R, 2008, J CLIN MICROBIOL, V46, P2368, DOI 10.1128/JCM.00533-08
   GILL EP, 1994, J CLIN MICROBIOL, V32, P2372, DOI 10.1128/JCM.32.10.2372-2376.1994
   Gorse GJ, 2017, J MED VIROL, V89, P1330, DOI 10.1002/jmv.24780
   Gorse GJ, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.05.034
   Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10
   Gorse GJ, 2009, J INFECT DIS, V199, P847, DOI 10.1086/597122
   HADDAD EE, 1994, AVIAN DIS, V38, P755, DOI 10.2307/1592111
   HANSON CV, 1978, J GEN VIROL, V40, P345, DOI 10.1099/0022-1317-40-2-345
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lim Y.X., 2016, DISEASES, V4, P26, DOI DOI 10.3390/DISEASES4030026
   Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14
   MONTO AS, 1974, J INFECT DIS, V129, P271, DOI 10.1093/infdis/129.3.271
   Myint SH, 1995, DIAGNOSTIC PROCEDURE, P245
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   REDFIELD DC, 1981, INFECT IMMUN, V32, P1216, DOI 10.1128/IAI.32.3.1216-1226.1981
   REIZENSTEIN E, 1995, J IMMUNOL METHODS, V183, P279, DOI 10.1016/0022-1759(95)00067-K
   Shirato K, 2012, J GEN VIROL, V93, P1908, DOI 10.1099/vir.0.043117-0
   Walsh EE, 2013, J INFECT DIS, V208, P1634, DOI 10.1093/infdis/jit393
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090
   Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102
   Yip M S, 2016, Hong Kong Med J, V22, P25
   Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393
NR 26
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 512
EP 517
DI 10.1002/jmv.25715
EA MAR 2020
PG 6
WC Virology
SC Virology
GA KU3AY
UT WOS:000517679800001
PM 32073157
OA Bronze
DA 2020-04-03
ER

PT J
AU Lai, AL
   Bergna, A
   Acciarri, C
   Galli, M
   Zehender, G
AF Lai, Alessia
   Bergna, Annalisa
   Acciarri, Carla
   Galli, Massimo
   Zehender, Gianguglielmo
TI Early phylogenetic estimate of the effective reproduction number of
   SARS-CoV-2
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE evolutionary dynamics; reproductive number; SARS-CoV-2
AB To reconstruct the evolutionary dynamics of the 2019 novel-coronavirus recently causing an outbreak in Wuhan, China, 52 SARS-CoV-2 genomes available on 4 February 2020 at Global Initiative on Sharing All Influenza Data were analyzed. The two models used to estimate the reproduction number (coalescent-based exponential growth and a birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 x 10(-4) subs/site/year (range, 1.1 x 10(-4)-15 x 10(-4)) and a mean tMRCA of the tree root of 73 days. The estimated R value was 2.6 (range, 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The estimated mean doubling time of the epidemic was between 3.6 and 4.1 days. This study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections even as the epidemic is growing.
C1 [Lai, Alessia; Bergna, Annalisa; Acciarri, Carla; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.
   [Lai, Alessia; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Coordinated Res Ctr EpiSoMI, Milan, Italy.
   [Zehender, Gianguglielmo] Univ Milan, Romeo & Enrica Invernizzi Pediat Res Ctr, Milan, Italy.
RP Zehender, G (reprint author), Via GB Grassi 74, I-20157 Milan, Italy.
EM gianguglielmo.zehender@unimi.it
CR Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Liu T, 2020, TRANSMISSION DYNAMIC, V2020, P2025
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Towers Sherry, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.9e4c4294ec8ce1adad283172b16bc908
   Veo C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090814
   Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011
   Zhao S, 2020, J CLIN MED, V9, P388
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 18
TC 0
Z9 0
U1 9
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25723
EA MAR 2020
PG 5
WC Virology
SC Virology
GA KR5TI
UT WOS:000517680300001
PM 32096566
OA Bronze
DA 2020-04-03
ER

PT J
AU Lai, THT
   Tang, EWH
   Chau, SKY
   Fung, KSC
   Li, KKW
AF Lai, Tracy H. T.
   Tang, Emily W. H.
   Chau, Sandy K. Y.
   Fung, Kitty S. C.
   Li, Kenneth K. W.
TI Stepping up infection control measures in ophthalmology during the novel
   coronavirus outbreak: an experience from Hong Kong
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article; Early Access
DE Coronavirus; COVID-19; Hong Kong; Infection control; Ophthalmology;
   SARS-CoV-2
AB Purpose Coronavirus disease (COVID-19) has rapidly emerged as a global health threat. The purpose of this article is to share our local experience of stepping up infection control measures in ophthalmology to minimise COVID-19 infection of both healthcare workers and patients. Methods Infection control measures implemented in our ophthalmology clinic are discussed. The measures are based on detailed risk assessment by both local ophthalmologists and infection control experts. Results A three-level hierarchy of control measures was adopted. First, for administrative control, in order to lower patient attendance, text messages with an enquiry phone number were sent to patients to reschedule appointments or arrange drug refill. In order to minimise cross-infection of COVID-19, a triage system was set up to identify patients with fever, respiratory symptoms, acute conjunctivitis or recent travel to outbreak areas and to encourage these individuals to postpone their appointments for at least 14 days. Micro-aerosol generating procedures, such as non-contact tonometry and operations under general anaesthesia were avoided. Nasal endoscopy was avoided as it may provoke sneezing and cause generation of droplets. All elective clinical services were suspended. Infection control training was provided to all clinical staff. Second, for environmental control, to reduce droplet transmission of COVID-19, installation of protective shields on slit lamps, frequent disinfection of equipment, and provision of eye protection to staff were implemented. All staff were advised to measure their own body temperatures before work and promptly report any symptoms of upper respiratory tract infection, vomiting or diarrhoea. Third, universal masking, hand hygiene, and appropriate use of personal protective equipment (PPE) were promoted. Conclusion We hope our initial experience in stepping up infection control measures for COVID-19 infection in ophthalmology can help ophthalmologists globally to prepare for the potential community outbreak or pandemic. In order to minimise transmission of COVID-19, ophthalmologists should work closely with local infection control teams to implement infection control measures that are appropriate for their own clinical settings.
C1 [Lai, Tracy H. T.; Tang, Emily W. H.; Li, Kenneth K. W.] United Christian Hosp, Dept Ophthalmol, Kwun Tong, Kowloon, 130 Hip Wo St, Hong Kong, Peoples R China.
   [Lai, Tracy H. T.; Tang, Emily W. H.; Li, Kenneth K. W.] Tseung Kwan O Hosp, Dept Ophthalmol, Tseung Kwan O, 2 Po Ning Path, Hong Kong, Peoples R China.
   [Chau, Sandy K. Y.] Tseung Kwan O Hosp, Dept Pathol, Tseung Kwan O, 2 Po Ning Path, Hong Kong, Peoples R China.
   [Fung, Kitty S. C.] United Christian Hosp, Dept Pathol, Kwun Tong, Kowloon, 130 Hip Wo St, Hong Kong, Peoples R China.
RP Li, KKW (reprint author), United Christian Hosp, Dept Ophthalmol, Kwun Tong, Kowloon, 130 Hip Wo St, Hong Kong, Peoples R China.; Li, KKW (reprint author), Tseung Kwan O Hosp, Dept Ophthalmol, Tseung Kwan O, 2 Po Ning Path, Hong Kong, Peoples R China.
EM kennethli@rcsed.ac.uk
RI ; Li, Kenneth/M-4140-2017
OI Lai, Tracy/0000-0002-0420-9456; Li, Kenneth/0000-0001-9440-8063
CR [Anonymous], 2020, 25 WHO
   [Anonymous], WHAT HAPP EYE EX
   [Anonymous], 2020, SYMPT COR DIS 2019
   [Anonymous], 2020, AL IMP COR CONT OPHT
   [Anonymous], 2020, SHANGHAI OFFICIALS R
   [Anonymous], 2020, COVID 19
   [Anonymous], 2020, HOSP AUTHORITY ACTIV
   [Anonymous], 2020, CDC TESTS COVID 19
   [Anonymous], 2020, COR KILLS CHIN WHIST
   [Anonymous], 2020, HOW FLU SPREADS
   BRITT JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P225, DOI 10.1001/archopht.1991.01080020071046
   Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Latest Situation of Coronavirus Disease (COVID-19) in Hong Kong, 2020, LAT SIT COR DIS COVI
   Leung G M, 2009, Hong Kong Med J, V15 Suppl 9, P12
   Loon SC, 2004, BRIT J OPHTHALMOL, V88, P1229, DOI 10.1136/bjo.2003.035931.corr1
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Team TNCPERE, 2020, EP CHAR OUTBR 2019 N, V2020
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   WHO, 2020, 38 WHO
   WHO, 2020, WHO DIR GEN REM MED
   Zhou Y, 2020, OPHTHALMOLOGIC EVIDE, DOI [10.1101/2020.02.11.20021956, DOI 10.1101/2020.02.11.20021956]
NR 25
TC 0
Z9 0
U1 32
U2 32
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
DI 10.1007/s00417-020-04641-8
EA MAR 2020
PG 7
WC Ophthalmology
SC Ophthalmology
GA KR6AD
UT WOS:000517698000001
PM 32124000
OA Bronze
DA 2020-04-03
ER

PT J
AU Henwood, AF
AF Henwood, Anthony F.
TI Coronavirus disinfection in histopathology
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article; Early Access
DE Coronavirus; SARS-CoV-2; histotechnology; biosafety; histopathology
   laboratory; disinfection
AB The 2019 Coronavirus epidemic, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. There is an international push to contain the virus and prevent its spread. It is feasible that potentially infectious samples may be received in histopathology laboratories for diagnosis. This technical note presents disinfection procedures and histotechnology processes that should alleviate the risk of infection to laboratory staff. Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus. Formalin fixation and heating samples to 56oC, as used in routine tissue processing, were found to inactivate several coronaviruses and it is believed that 2019-nCoV would be similarly affected.
C1 [Henwood, Anthony F.] Childrens Hosp Westmead, Dept Histopathol, Sydney, NSW, Australia.
   [Henwood, Anthony F.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia.
RP Henwood, AF (reprint author), Childrens Hosp Westmead, Dept Histopathol, Sydney, NSW, Australia.
EM tony.henwood@health.nsw.gov.au
OI Henwood, Anthony/0000-0001-5499-060X
CR Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006
   Duan SM, 2003, BIOMED ENVIRON SCI, V16, P246
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY
   Guarner J., 2020, EDITORIAL AM J CLIN, DOI [10.1093/AJCP/AQAA029, DOI 10.1093/AJCP/AQAA029]
   Henwood A, 2019, SURVIVAL GUIDE LAB P, P149
   Henwood AF, 2018, J HISTOTECHNOL, V41, P71, DOI 10.1080/01478885.2018.1449791
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   World Health Organization, 2020, INF PREV CONTR HLTH, P1
   Xu Zhe, 2020, Lancet Respir Med, DOI 10.1016/S2213-2600(20)30076-X
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 12
TC 0
Z9 0
U1 18
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0147-8885
EI 2046-0236
J9 J HISTOTECHNOL
JI J. Histotechnol.
DI 10.1080/01478885.2020.1734718
EA MAR 2020
PG 3
WC Cell Biology
SC Cell Biology
GA KS3ZZ
UT WOS:000518252400001
PM 32116147
OA Bronze
DA 2020-04-03
ER

PT J
AU Catton, H
AF Catton, H.
TI Global challenges in health and health care for nurses and midwives
   everywhere
SO INTERNATIONAL NURSING REVIEW
LA English
DT Article
DE climate change; coronavirus; COVID-19 recruitment and retention; Year of
   the Nurse and Midwife
AB The next decade is likely to produce any number of global challenges that will affect health and health care, including pan-national infections such as the new coronavirus COVID-19 and others that will be related to global warming. Nurses will be required to react to these events, even though they will also be affected as ordinary citizens. The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges.
C1 [Catton, H.] Int Council Nurses, Geneva, Switzerland.
RP Catton, H (reprint author), Int Council Nurses, Geneva, Switzerland.
EM catton@icn.ch
RI Ribeiro, Nuno/AAH-2299-2020
CR International Council of Nurses, 2018, NURS CLIM CHANG HLTH
   International Council of Nurses, 2019, COR COMP DIS NURS VE
   International Council of Nurses, 2020, POP ACKN INT YEAR NU
   Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6
   WHO, 2020, 2 M INT HLTH REG 200
   World Health Organization, 2020, YEAR NURS MIDW 2020
NR 6
TC 0
Z9 0
U1 73
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-8132
EI 1466-7657
J9 INT NURS REV
JI Int. Nurs. Rev.
PD MAR
PY 2020
VL 67
IS 1
BP 4
EP 6
DI 10.1111/inr.12578
PG 3
WC Nursing
SC Nursing
GA KN3QG
UT WOS:000514754800002
PM 32083728
OA Bronze
DA 2020-04-03
ER

PT J
AU Dear, JD
AF Dear, Jonathan D.
TI Bacterial Pneumonia in Dogs and Cats: An Update
SO VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
LA English
DT Article
DE Bacterial pneumonia; Lower respiratory tract infection; Canine; Feline;
   Lower airway disease
ID CANINE RESPIRATORY CORONAVIRUS; BRONCHOALVEOLAR LAVAGE FLUID; EQUI SUBSP
   ZOOEPIDEMICUS; ASPIRATION PNEUMONIA; GASTROESOPHAGEAL-REFLUX;
   INFLUENZA-VIRUS; TRACT DISEASE; INFECTION; OUTBREAK; TRACHEOBRONCHITIS
AB Bacterial pneumonia is a common clinical diagnosis in dogs but seems to occur less often in cats. Underlying causes include viral infection, aspiration injury, foreign body inhalation, and defects in clearance of respiratory secretions. Identification of the specific organisms involved in disease, appropriate use of antibiotics and adjunct therapy, and control of risk factors for pneumonia improve management.
C1 [Dear, Jonathan D.] Univ Calif Davis, Dept Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
RP Dear, JD (reprint author), Univ Calif Davis, Dept Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
EM jddear@ucdavis.edu
CR An DJ, 2010, J VET MED SCI, V72, P1217, DOI 10.1292/jvms.10-0067
   Bedu AS, 2012, VET RADIOL ULTRASOUN, V53, P492, DOI 10.1111/j.1740-8261.2012.01948.x
   Brownlie J, 2013, J VET INT MED SEATTL
   Chalker VJ, 2012, J CLIN MICROBIOL, V50, P2134, DOI 10.1128/JCM.00719-12
   Chalker VJ, 2004, MICROBIOL-SGM, V150, P3491, DOI 10.1099/mic.0.26848-0
   Chalker VJ, 2003, VET MICROBIOL, V95, P149, DOI 10.1016/S0378-1135(03)00155-X
   Cohn LA, 2010, TXB VET INTERNAL MED, V2
   Craven DE, 2010, CLIN INFECT DIS, V51, pS59, DOI 10.1086/653051
   Egberink H, 2009, J FELINE MED SURG, V11, P610, DOI 10.1016/j.jfms.2009.05.010
   Epstein SE, 2010, J VET EMERG CRIT CAR, V20, P587, DOI 10.1111/j.1476-4431.2010.00587.x
   Foley JE, 2002, PREV VET MED, V54, P141, DOI 10.1016/S0167-5877(02)00022-3
   Foster SF, 2004, J FELINE MED SURG, V6, P167, DOI 10.1016/j.jfms.2003.11.006
   Foster SF, 2004, J FELINE MED SURG, V6, P189, DOI 10.1016/j.jfms.2003.12.001
   Garcia RS, 2017, J VET INTERN MED, V31, P734, DOI 10.1111/jvim.14704
   HAWKINS EC, 1995, J VET INTERN MED, V9, P386, DOI 10.1111/j.1939-1676.1995.tb03298.x
   JEZYK PF, 1989, CLIN IMMUNOL IMMUNOP, V52, P173, DOI 10.1016/0090-1229(89)90170-0
   Johnson LR, 2013, J VET INTERN MED, V27, P259, DOI 10.1111/jvim.12037
   Kawakami K, 2010, J CLIN MICROBIOL, V48, P1176, DOI 10.1128/JCM.02128-09
   Keil DJ, 2000, RECENT ADV CANINE IN
   Knesl O, 2009, NEW ZEAL VET J, V57, P295, DOI 10.1080/00480169.2009.58624
   Kogan DA, 2008, JAVMA-J AM VET MED A, V233, P1748, DOI 10.2460/javma.233.11.1748
   Kogan DA, 2008, JAVMA-J AM VET MED A, V233, P1742, DOI 10.2460/javma.233.11.1742
   Kuzi S, 2016, J SMALL ANIM PRACT, V57, P617, DOI 10.1111/jsap.12555
   Lappin MR, 2017, J VET INTERN MED, V31, P279, DOI 10.1111/jvim.14627
   Leroy O, 1997, AM J RESP CRIT CARE, V156, P1922, DOI 10.1164/ajrccm.156.6.9702069
   Levy N, 2019, J SMALL ANIM PRACT, V60, P356, DOI 10.1111/jsap.12990
   McBrearty AR, 2011, JAVMA-J AM VET MED A, V238, P1622, DOI 10.2460/javma.238.12.1622
   MCKIERNAN BC, 1984, J AM ANIM HOSP ASSOC, V20, P139
   Mellema M., 2004, TXB RESP DIS DOGS CA, V1, P431
   Mitchell JA, 2013, VET MICROBIOL, V162, P582, DOI 10.1016/j.vetmic.2012.11.025
   Mitsushima H, 2002, MICROB PATHOGENESIS, V33, P203, DOI 10.1006/mpat.2002.0529
   Ogden J, 2019, J SMALL ANIM PRACT, V60, P183, DOI 10.1111/jsap.12940
   Ovbey DH, 2014, VET ANAESTH ANALG, V41, P127, DOI 10.1111/vaa.12110
   Peeters DE, 2000, J VET INTERN MED, V14, P534, DOI 10.1892/0891-6640(2000)014&lt;0534:QBCACE&gt;2.3.CO;2
   Pesavento PA, 2008, VET PATHOL, V45, P51, DOI 10.1354/vp.45-1-51
   Priestnall S, 2011, VET J, V188, P142, DOI 10.1016/j.tvjl.2010.04.028
   Proulx A, 2014, J VET EMERG CRIT CAR, V24, P194, DOI 10.1111/vec.12128
   Radhakrishnan A, 2007, JAVMA-J AM VET MED A, V230, P1493, DOI 10.2460/javma.230.10.1493
   Schultz RM, 2008, VET RADIOL ULTRASOUN, V49, P249, DOI 10.1111/j.1740-8261.2008.00360.x
   Taha-Abdelaziz K, 2016, J VET DIAGN INVEST, V28, P369, DOI 10.1177/1040638716646806
   Tart KM, 2010, J VET EMERG CRIT CAR, V20, P319, DOI 10.1111/j.1476-4431.2010.00542.x
   Tenwolde AC, 2010, J VET INTERN MED, V24, P1063, DOI 10.1111/j.1939-1676.2010.0580.x
   Viitanen SJ, 2017, J VET INTERN MED, V31, P124, DOI 10.1111/jvim.14631
   Viitanen SJ, 2019, J VET INTERN MED, V33, P846, DOI 10.1111/jvim.15413
   Watson PJ, 1999, VET REC, V144, P718, DOI 10.1136/vr.144.26.718
   Watson PJ, 2006, J VET INTERN MED, V20, P523, DOI 10.1892/0891-6640(2006)20[523:IDICKC]2.0.CO;2
   Wayne A, 2017, CAN VET J, V58, P610
   Wood PR, 2013, ANN ALLERG ASTHMA IM, V110, P328, DOI 10.1016/j.anai.2013.01.022
   Workman HC, 2008, J CLIN MICROBIOL, V46, P4099, DOI 10.1128/JCM.00173-08
   Ybarra WL, 2012, J VET INTERN MED, V26, P1281, DOI 10.1111/j.1939-1676.2012.01016.x
   Zacuto AC, 2012, J VET INTERN MED, V26, P518, DOI 10.1111/j.1939-1676.2012.00929.x
NR 51
TC 0
Z9 0
U1 7
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0195-5616
EI 1878-1306
J9 VET CLIN N AM-SMALL
JI Vet. Clin. N. Am.-Small Anim. Pract.
PD MAR
PY 2020
VL 50
IS 2
BP 447
EP +
DI 10.1016/j.cvsm.2019.10.007
PG 20
WC Veterinary Sciences
SC Veterinary Sciences
GA KR0YQ
UT WOS:000517346700012
PM 31813555
OA Bronze, Green Published
DA 2020-04-03
ER

PT J
AU Fong, SJ
   Li, G
   Dey, N
   Crespo, RG
   Herrera-Viedma, E
AF Fong, Simon James
   Li, Gloria
   Dey, Nilanjan
   Gonzalez Crespo, Ruben
   Herrera-Viedma, Enrique
TI Finding an Accurate Early Forecasting Model from Small Dataset: A Case
   of 2019-nCoV Novel Coronavirus Outbreak
SO INTERNATIONAL JOURNAL OF INTERACTIVE MULTIMEDIA AND ARTIFICIAL
   INTELLIGENCE
LA English
DT Article
DE Forecasting; Machine Learning; Method; Prediction; Data Mining; Epidemic
ID NEURAL-NETWORKS; SELECTION
AB Epidemic is a rapid and wide spread of infectious disease threatening many lives and economy damages. It is important to fore-tell the epidemic lifetime so to decide on timely and remedic actions. These measures include closing borders, schools, suspending community services and commuters. Resuming such curfews depends on the momentum of the outbreak and its rate of decay. Being able to accurately forecast the fate of an epidemic is an extremely important but difficult task. Due to limited knowledge of the novel disease, the high uncertainty involved and the complex societal-political factors that influence the widespread of the new virus, any forecast is anything but reliable. Another factor is the insufficient amount of available data. Data samples are often scarce when an epidemic just started. With only few training samples on hand, finding a forecasting model which offers forecast at the best efforts is a big challenge in machine learning. In the past, three popular methods have been proposed, they include 1) augmenting the existing little data, 2) using a panel selection to pick the best forecasting model from several models, and 3) fine-tuning the parameters of an individual forecasting model for the highest possible accuracy. In this paper, a methodology that embraces these three virtues of data mining from a small dataset is proposed. An experiment that is based on the recent coronavirus outbreak originated from Wuhan is conducted by applying this methodology. It is shown that an optimized forecasting model that is constructed from a new algorithm, namely polynomial neural network with corrective feedback (PNN+cf) is able to make a forecast that has relatively the lowest prediction error. The results showcase that the newly proposed methodology and PNN+cf are useful in generating acceptable forecast upon the critical time of disease outbreak when the samples are far from abundant.
C1 [Fong, Simon James] Univ Macau, Dept Comp & Informat Sci, Macau, Peoples R China.
   [Fong, Simon James; Li, Gloria] Chinese Acad Sci, Zhuhai Inst Adv Technol, DACC Lab, Beijing, Peoples R China.
   [Dey, Nilanjan] Techno India Coll Technol, Dept Informat Technol, Kolkata, W Bengal, India.
   [Gonzalez Crespo, Ruben] Univ Int La Rioja, Logrono, Spain.
   [Herrera-Viedma, Enrique] Univ Granada, Granada, Spain.
RP Fong, SJ (reprint author), Univ Macau, Dept Comp & Informat Sci, Macau, Peoples R China.; Fong, SJ (reprint author), Chinese Acad Sci, Zhuhai Inst Adv Technol, DACC Lab, Beijing, Peoples R China.; Dey, N (reprint author), Techno India Coll Technol, Dept Informat Technol, Kolkata, W Bengal, India.
EM ccfong@um.edu.mo; nilanjan.dey@tict.edu.in
CR Adhikari R., 2013, ARXIV13026613
   Andoni A., 2014, P 31 INT C MACH LEAR, V32
   Andonie R, 2010, INT J COMPUT COMMUN, V5, P280, DOI 10.15837/ijccc.2010.3.2481
   Arun V, 2018, INT J INTERACT MULTI, V5, P61, DOI 10.9781/ijimai.2018.10.001
   Croda RMC, 2019, INT J INTERACT MULTI, V5, P35, DOI 10.9781/ijimai.2018.04.003
   Cohen Jon, 2020, SCIENCE, DOI [10.1126/science.abb0611, DOI 10.1126/SCIENCE.ABB0611]
   Dey N., 2018, COMMUNICATIONS COMPU, V876
   Fong S, 2012, INT CONF DAT MIN WOR, P464, DOI 10.1109/ICDMW.2012.67
   Hyndman R.J., 2007, INT J APPL FORECAST, V6, P12
   Ingrassia S, 2005, TECHNOMETRICS, V47, P297, DOI 10.1198/004017005000000058
   Ivakhnenko A. G., 1992, Journal of Automation and Information Science, V25, P25
   IVAKHNENKO AG, 1970, AUTOMATICA, V6, P207, DOI 10.1016/0005-1098(70)90092-0
   Lateh M. A., J PHYS C SERIES, V892
   Oh SK, 2003, COMPUT ELECTR ENG, V29, P703, DOI 10.1016/S0045-7906(02)00045-9
   Pasini A, 2015, J THORAC DIS, V7, P953, DOI 10.3978/j.issn.2072-1439.2015.04.61
   Shaikhina T, 2017, ARTIF INTELL MED, V75, P51, DOI 10.1016/j.artmed.2016.12.003
   Shevade S. K., 1999, IEEE T NEURAL NETWOR
   Singh A., 2015, STAT TRANSITION, V16, P83
   SLIFKER JF, 1980, TECHNOMETRICS, V22, P239, DOI 10.2307/1268463
   Sparrow Annie, FOREIGN POLICY
   Su J., 2006, P 21 NAT C ART INT A, V1, P500
   Waheeb W, 2019, INT J INTERACT MULTI, V5, P126, DOI 10.9781/ijimai.2019.04.004
   Wang Y., 1997, 9 EUR C MACH LEARN
   WHO, WHO NOV COR CHIN
NR 24
TC 0
Z9 0
U1 82
U2 82
PU UNIV INT RIOJA-UNIR
PI LOGRONO
PA RECTORADO, AVENIDA DE LA PAZ, 137, LOGRONO, 26006, SPAIN
SN 1989-1660
J9 INT J INTERACT MULTI
JI Int. J. Interact. Multimed. Artif. Intell.
PD MAR
PY 2020
VL 6
IS 1
BP 132
EP 140
DI 10.9781/ijimai.2020.02.002
PG 9
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications
SC Computer Science
GA KN4XF
UT WOS:000514841200016
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Lee, JY
   Kang, SJ
AF Lee, Jiyeon
   Kang, Sook Jung
TI Factors influencing nurses' intention to care for patients with emerging
   infectious diseases: Application of the theory of planned behavior
SO NURSING & HEALTH SCIENCES
LA English
DT Article
DE emerging infectious disease; intention; Korea; nursing; theory of
   planned behavior
ID RESPIRATORY SYNDROME-CORONAVIRUS; HEALTH-CARE; OUTBREAK; WORKERS;
   WILLINGNESS; EXPERIENCES
AB Emerging infectious diseases have caused many health problems and have been identified as a major health issue worldwide. The aim of this descriptive, cross-sectional survey study was to investigate nursing intention among nurses caring for emerging infectious disease patients in Korea and to describe factors influencing nurses' intention to care by applying the theory of planned behavior. A total of 147 Korean nurses were included and data accrued using an online questionnaire. Among the independent variables, perceived behavioral control, attitudes toward the behavior, and sex significantly influenced nursing intention. These variables explained 55.1% of nursing intention to care for patients with emerging infectious diseases, and perceived behavioral control (confidence or self-efficacy in caring for patients) was the strongest predictor. These findings showed the usefulness of the theory of planned behavior in predicting nurses' intention to care for patients with emerging infectious diseases. Providing an educational program on caring for patients with pandemic diseases would also increase self-confidence and reduce concerns. In addition, institutional support, such as compensation payments and recognition from administrators, would also strengthen positive attitudes among nurses.
C1 [Lee, Jiyeon; Kang, Sook Jung] Ewha Womans Univ, Coll Nursing, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
RP Kang, SJ (reprint author), Ewha Womans Univ, Coll Nursing, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
EM sookjungkang@ewha.ac.kr
OI Kang, Sook Jung/0000-0002-1668-0392
FU Hanmaeum Scholarship from the Seoul Nurse Association
CR Ajzen I., 2005, ATTITUDES PERSONALIT
   Ajzen I, 2002, CONSTRUCTING TPB QUE
   Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939
   *CDCP, 2014, EID J BACKGR GOALS
   Chen CS, 2005, PSYCHIAT SERV, V56, P76, DOI 10.1176/appi.ps.56.1.76
   Cowden J, 2010, INFLUENZA OTHER RESP, V4, P213, DOI 10.1111/j.1750-2659.2010.00145.x
   Damery S, 2010, J MED ETHICS, V36, P12, DOI 10.1136/jme.2009.032821
   Dyess SM, 2009, J CONTIN EDUC NURS, V40, P403, DOI 10.3928/00220124-20090824-03
   Ferencz-Kaddari M, 2016, PSYCHOL REP, V118, P691, DOI 10.1177/0033294116647691
   Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840
   Grimes DE, 2010, NURS OUTLOOK, V58, P10, DOI 10.1016/j.outlook.2009.07.002
   Jeong Sun-Young, 2015, [Journal of Korean Academic Society of Home Health Care Nursing, 가정간호학회지], V22, P78
   Johnstone MJ, 2014, NURS HEALTH SCI, V16, P67, DOI 10.1111/nhs.12130
   June Kyung Ja, 2016, [Korean Journal of Occupational Health Nursing, 한국직업건강간호학회지], V25, P1
   Kang HS, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12664
   Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303
   Kim Cho-Ja, 2006, Taehan Kanho Hakhoe Chi, V36, P596
   Kim JS, 2016, NURS HEALTH SCI, V18, P299, DOI 10.1111/nhs.12269
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466
   Kim Y, 2018, AM J INFECT CONTROL, V46, P781, DOI 10.1016/j.ajic.2018.01.012
   Ko Nai-Ying, 2004, Kaohsiung Journal of Medical Sciences, V20, P389, DOI 10.1016/S1607-551X(09)70175-5
   Korea Health Industry Development Institute, 2014, KHIDI PUBL, V11-1352000-001476-01
   Lee J. K., 2017, J KOREAN ACAD NURS, V31, P292
   Lemmens KPH, 2005, TRANSFUSION, V45, P945, DOI 10.1111/j.1537-2995.2005.04379.x
   LYNN MR, 1986, NURS RES, V35, P382
   Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036
   Maunder RG, 2006, EMERG INFECT DIS, V12, P1924
   Moon S, 2014, NURS EDUC TODAY, V34, P325, DOI 10.1016/j.nedt.2013.06.014
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Palamidessi Dominguez J., 2015, INTENSIVE CARE ME S1, V3, pA732
   Rassin M, 2008, NURS ETHICS, V15, P614, DOI 10.1177/0969733008092870
   Shiao JSC, 2007, NURS ETHICS, V14, P5, DOI 10.1177/0969733007071350
   WEBER D, 2016, AM J INFECT CONTROL, V44
   Weis D, 2000, J NURS SCHOLARSHIP, V32, P201, DOI 10.1111/j.1547-5069.2000.00201.x
   World Health Organization, 2015, WHO PUBL LIST TOP EM
   Wu CC, 2012, INT J HUM RESOUR MAN, V23, P2698, DOI 10.1080/09585192.2011.637056
   Yeun Eun-Ja, 2005, Taehan Kanho Hakhoe Chi, V35, P1091
   Yoo Hye Ra, 2005, Taehan Kanho Hakhoe Chi, V35, P1063
NR 39
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1441-0745
EI 1442-2018
J9 NURS HEALTH SCI
JI Nurs. Health Sci.
PD MAR
PY 2020
VL 22
IS 1
BP 82
EP 90
DI 10.1111/nhs.12652
PG 9
WC Nursing
SC Nursing
GA KQ7KJ
UT WOS:000517098200011
PM 31670456
DA 2020-04-03
ER

PT J
AU Li, JY
   You, Z
   Wang, Q
   Zhou, ZJ
   Qiu, Y
   Luo, R
   Ge, XY
AF Li, Jin-Yan
   You, Zhi
   Wang, Qiong
   Zhou, Zhi-Jian
   Qiu, Ye
   Luo, Rui
   Ge, Xing-Yi
TI The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and
   insights for emerging infectious diseases in the future
SO MICROBES AND INFECTION
LA English
DT Article
DE 2019-nCoV; Pneumonia; ACE2; Spike; SARS-CoV; Bat
ID EAST RESPIRATORY SYNDROME; SARS; CORONAVIRUS; TRANSMISSION; LOPINAVIR;
   CHINA
AB At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world. To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections. Intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures. Herein, we describe the epidemic and etiological characteristics of 2019-nCoV, discuss its essential biological features, including tropism and receptor usage, summarize approaches for disease prevention and treatment, and speculate on the transmission route of 2019-nCoV. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Li, Jin-Yan; You, Zhi; Wang, Qiong; Zhou, Zhi-Jian; Qiu, Ye; Ge, Xing-Yi] Hunan Univ, Coll Biol, Inst Pathogen Biol & Immunol, Hunan Prov Key Lab Med Virol, Changsha 410082, Hunan, Peoples R China.
   [Luo, Rui] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Luo, Rui] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
RP Ge, XY (reprint author), Hunan Univ, Coll Biol, Inst Pathogen Biol & Immunol, Hunan Prov Key Lab Med Virol, Changsha 410082, Hunan, Peoples R China.
EM lijinyan@hnu.edu.cn; YOUZHI@hnu.edu.cn; qw@hnu.edu.cn;
   zjzhou@hnu.edu.cn; qiuye@hnu.edu.cn; luorui@mail.hzau.edu.cn;
   xyge@hnu.edu.cn
FU National Key Research and Development Program of China [2017YFD0500104];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470260]; Science Fund for Distinguished Young
   Scholars of Hunan ProvinceNational Natural Science Foundation of
   ChinaNational Science Fund for Distinguished Young Scholars
   [2019JJ20004]
FX This work was jointly funded by the National Key Research and
   Development Program of China (grant number 2017YFD0500104), National
   Natural Science Foundation of China (31470260), and the Science Fund for
   Distinguished Young Scholars of Hunan Province (grant number
   2019JJ20004).
CR [Anonymous], 2020, 1 CHIN NAT HLTH COMM
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan KH, 2011, ADV VIROL, DOI 10.1155/2011/734690
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chong YP, 2015, INFECT CHEMOTHER, V47, P212, DOI 10.3947/ic.2015.47.3.212
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kupferschmidt K, 2014, SCIENCE, V343, P1422, DOI 10.1126/science.343.6178.1422
   Letko MMV, 2020, FUNCTIONAL ASSESSMEN
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   M Hoffmann, 2020, NOVEL CORONAVIRUS 20
   Nukoolkarn V, 2008, J THEOR BIOL, V254, P861, DOI 10.1016/j.jtbi.2008.07.030
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tai DYH, 2007, ANN ACAD MED SINGAP, V36, P438
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xu ZJ, 2020, NELFINAVIR WAS PREDI
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang H, 2020, DIGESTIVE SYSTEM IS
   Zhao Y, 2020, SINGLE CELL RNA EXPR
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 41
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2020
VL 22
IS 2
SI SI
BP 80
EP 85
DI 10.1016/j.micinf.2020.02.002
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KU8UJ
UT WOS:000519987000004
PM 32087334
OA Bronze
DA 2020-04-03
ER

PT J
AU Li, YM
   Hu, LB
   Chen, T
   Chang, M
   Deng, F
   Hu, ZH
   Wang, HL
   Wang, ML
AF Li, Yimeng
   Hu, Liangbo
   Chen, Tong
   Chang, Meng
   Deng, Fei
   Hu, Zhihong
   Wang, Hualin
   Wang, Manli
TI Host AAA plus ATPase TER94 Plays Critical Roles in Building the
   Baculovirus Viral Replication Factory and Virion Morphogenesis
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE baculovirus; AAA plus ATPase; TER94; BV production; ODV morphogenesis;
   virogenic stroma; DNA replication; LEF3; helicase
ID NUCLEAR POLYHEDROSIS-VIRUS; CONTAINING PROTEIN VCP/P97; FACTOR-BINDING;
   BUDDED VIRUS; P97; INFECTION; COMPLEX; P143; FUSION; CELLS
AB TER94 is a multifunctional AAA+ ATPase crucial for diverse cellular processes, especially protein quality control and chromatin dynamics in eukaryotic organisms. Many viruses, including coronavirus, herpesvirus, and retrovirus, coopt host cellular TER94 for optimal viral invasion and replication. Previous proteomics analysis identified the association of TER94 with the budded virions (BVs) of baculovirus, an enveloped insect large DNA virus. Here, the role of TER94 in the prototypic baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) life cycle was investigated. In virus-infected cells, TER94 accumulated in virogenic stroma (VS) at the early stage of infection and subsequently partially rearranged in the ring zone region. In the virions, TER94 was associated with the nucleocapsids of both BV and occlusion-derived virus (ODV). Inhibition of TER94 ATPase activity significantly reduced viral DNA replication and BV production. Electron/immunoelectron microscopy revealed that inhibition of TER94 resulted in the trapping of nucleocapsids within cytoplasmic vacuoles at the nuclear periphery for BV formation and blockage of ODV envelopment at a premature stage within infected nuclei, which appeared highly consistent with its pivotal function in membrane biogenesis. Further analyses showed that TER94 was recruited to the VS or subnuclear structures through interaction with viral early proteins LEF3 and helicase, whereas inhibition of TER94 activity blocked the proper localization of replication-related viral proteins and morphogenesis of VS, providing an explanation for its role in viral DNA replication. Taken together, these data indicated the crucial functions of TER94 at multiple steps of the baculovirus life cycle, including genome replication, BV formation, and ODV morphogenesis.
   IMPORTANCE TER94 constitutes an important AAA+ ATPase that associates with diverse cellular processes, including protein quality control, membrane fusion of the Golgi apparatus and endoplasmic reticulum network, nuclear envelope reformation, and DNA replication. To date, little is known regarding the role(s) of TER94 in the baculovirus life cycle. In this study, TER94 was found to play a crucial role in multiple steps of baculovirus infection, including viral DNA replication and BV and ODV formation. Further evidence showed that the membrane fission/fusion function of TER94 is likely to be exploited by baculovirus for virion morphogenesis. Moreover, TER94 could interact with the viral early proteins LEF3 and helicase to transport and further recruit viral replication-related proteins to establish viral replication factories. This study highlights the critical roles of TER94 as an energy-supplying chaperon in the baculovirus life cycle and enriches our knowledge regarding the biological function of this important host factor.
C1 [Li, Yimeng; Hu, Liangbo; Chen, Tong; Chang, Meng; Deng, Fei; Hu, Zhihong; Wang, Hualin; Wang, Manli] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.
   [Chen, Tong; Chang, Meng] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Wang, HL; Wang, ML (reprint author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.
EM h.wang@wh.iov.cn; wangml@wh.iov.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31621061, 31572334]
FX This work was supported by grants from the National Natural Science
   Foundation of China (grant no. 31621061 and 31572334).
CR Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002
   Arita M, 2012, J VIROL, V86, P5541, DOI 10.1128/JVI.00114-12
   Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104
   Au S, 2016, J CELL SCI, V129, P2905, DOI 10.1242/jcs.191668
   Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181
   Bhowmick S, 2017, ARCH VIROL, V162, P919, DOI 10.1007/s00705-016-3153-8
   Brahms A, 2017, J VIROL, V91, DOI 10.1128/JVI.00968-17
   Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028
   Byun H, 2017, MBIO, V8, DOI 10.1128/mBio.00328-17
   CHARLTON CA, 1993, VIROLOGY, V197, P245, DOI 10.1006/viro.1993.1585
   Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108
   Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07
   Dong ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46187
   Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933
   Fang MG, 2009, VIROLOGY, V385, P496, DOI 10.1016/j.virol.2008.12.023
   FRASER MJ, 1986, J ULTRA MOL STRUCT R, V95, P189, DOI 10.1016/0889-1605(86)90040-6
   Fu YJ, 2016, CYTOTECHNOLOGY, V68, P381, DOI 10.1007/s10616-014-9789-x
   Guo Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01111-17
   Hanzelmann P, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00021
   Hansen JC, 2018, BIOCHEM SOC T, V46, P67, DOI 10.1042/BST20170101
   Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758
   Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086
   Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12
   Hu LB, 2019, VIROL SIN, V34, P454, DOI 10.1007/s12250-019-00133-0
   Hu LB, 2019, J VIROL, V93, DOI 10.1128/JVI.00709-19
   Huang N, 2011, J VIROL, V85, P12547, DOI 10.1128/JVI.05766-11
   Ito E, 2004, VIROLOGY, V329, P337, DOI 10.1016/j.virol.2004.08.035
   Jiang ZY, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00456
   Kawasaki Y, 2004, J GEN VIROL, V85, P3575, DOI 10.1099/vir.0.80418-0
   KOGAN PH, 1994, J VIROL, V68, P813, DOI 10.1128/JVI.68.2.813-822.1994
   KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212
   KRAPPA R, 1992, J VIROL, V66, P3494, DOI 10.1128/JVI.66.6.3494-3503.1992
   Laufs S, 1997, VIROLOGY, V228, P98, DOI 10.1006/viro.1996.8361
   Leisy DJ, 2000, VIROLOGY, V274, P196, DOI 10.1006/viro.2000.0452
   Li YM, 2018, J VIROL, V92, DOI 10.1128/JVI.02083-17
   Li ZF, 2012, J VIROL, V86, P459, DOI 10.1128/JVI.06049-11
   Lin YC, 2016, MATER DESIGN, V97, P13, DOI 10.1016/j.matdes.2016.02.052
   Lyupina YV, 2018, VIRUS RES, V253, P68, DOI 10.1016/j.virusres.2018.06.001
   Maric M, 2017, CELL REP, V18, P3033, DOI 10.1016/j.celrep.2017.03.020
   Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596
   McDougal VV, 2000, J VIROL, V74, P5273, DOI 10.1128/JVI.74.11.5273-5279.2000
   Meyer Hemmo H, 2005, Biochim Biophys Acta, V1744, P481
   Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181
   Mikhailov VS, 2002, J VIROL, V76, P2287, DOI 10.1128/JVI.76.5.2287-2297.2002
   Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585
   Nagamine T, 2006, VIROLOGY, V352, P400, DOI 10.1016/j.virol.2006.04.034
   Okano K, 1999, J VIROL, V73, P110, DOI 10.1128/JVI.73.1.110-119.1999
   Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503
   Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025
   Patmanidi AL, 2003, VIROLOGY, V317, P308, DOI 10.1016/j.virol.2003.08.035
   PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x
   PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F
   Phongphaew W, 2017, VIRUS RES, V228, P114, DOI 10.1016/j.virusres.2016.11.029
   Qin FJ, 2019, J VIROL, V93, DOI [10.1128/JVI.00033-19, 10.1128/jvi.00033-19]
   Ramadan K, 2017, CHROMOSOMA, V126, P17, DOI 10.1007/s00412-016-0587-4
   Ren XS, 2017, PESTIC BIOCHEM PHYS, V140, P97, DOI 10.1016/j.pestbp.2017.07.003
   Rohrmann G.F., 2013, BACULOVIRUS MOL BIOL
   Shang Y, 2017, ACS SYNTH BIOL, V6, P1393, DOI 10.1021/acssynbio.7b00028
   Shi Y, 2015, VIROLOGY, V476, P298, DOI 10.1016/j.virol.2014.11.030
   Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783
   SUMMERS MD, 1971, J ULTRA MOL STRUCT R, V35, P606, DOI 10.1016/S0022-5320(71)80014-X
   Sundquist WI, 2015, SCIENCE, V348, P1314, DOI 10.1126/science.aac7083
   Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079
   Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028
   Vanarsdall AL, 2005, VIROLOGY, V331, P175, DOI 10.1016/j.virol.2004.10.024
   Vekaria PH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00181
   VOLKMAN LE, 1977, J INVERTEBR PATHOL, V30, P102, DOI 10.1016/0022-2011(77)90045-3
   Wang ML, 2008, J VIROL, V82, P9800, DOI 10.1128/JVI.00759-08
   Wang T, 2016, J BIOL CHEM, V291, P14373, DOI 10.1074/jbc.M116.729343
   Wang TS, 2017, LINER SHIP FLEET PLANNING: MODELS AND ALGORITHMS, P3, DOI 10.1016/B978-0-12-811502-2.00001-6
   Wong HH, 2015, J VIROL, V89, P11116, DOI 10.1128/JVI.01360-15
   Wu CP, 2010, J VIROL, V84, P5015, DOI 10.1128/JVI.02423-09
   Wu YT, 1998, VIROLOGY, V247, P32, DOI 10.1006/viro.1998.9235
   Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042
   Xue L, 2016, MOL CELL PROTEOMICS, V15, P2970, DOI 10.1074/mcp.M116.061036
   Yi ZG, 2017, J GEN VIROL, V98, P1667, DOI 10.1099/jgv.0.000828
   Yi ZG, 2016, J VIROL, V90, P9953, DOI 10.1128/JVI.01140-16
   Yue Q, 2018, J VIROL, V92, DOI 10.1128/JVI.01636-17
NR 78
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 6
AR e01674-19
DI 10.1128/JVI.01674-19
PG 20
WC Virology
SC Virology
GA KS5ZP
UT WOS:000518387200013
PM 31896597
OA Bronze
DA 2020-04-03
ER

PT J
AU MacIntyre, CR
AF MacIntyre, C. Raina
TI On a knife's edge of a COVID-19 pandemic: is containment still possible?
SO PUBLIC HEALTH RESEARCH & PRACTICE
LA English
DT Article
C1 [MacIntyre, C. Raina] UNSW Sydney, Kirby Inst, Fac Med, Biosecur Res Program, Sydney, NSW, Australia.
RP MacIntyre, CR (reprint author), UNSW Sydney, Kirby Inst, Fac Med, Biosecur Res Program, Sydney, NSW, Australia.
EM r.macintyre@unsw.edu.au
CR Bai Y, 2020, JAMA
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Gates B, 2020, N ENGL J MED
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   MacIntyre C, 2019, GLOBAL BIOSECURITY, V1, P91
   MacIntyre C, 2019, GLOBAL BIOSECURITY, V1, P74
   MacIntyre CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217704
   MacIntyre R., 2019, GLOBAL BIOSECURITY, V1, P85
   McCallum L, 2010, WEST PAC SURVEILL RE, V1, P5, DOI [10.5365/WPSAR.2010.1.1.008, 10.5365/wpsar.2010.1.1.008]
   McKinney KR, 2006, J ENVIRON HEALTH, V68, P26
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114
   Regan H., 2020, CNN
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Wang D, 2020, JAMA
   Wei M, 2020, JAMA
   WHO, 2020, 38 WHO
   World Health Organisation, 2020, 29 WHO
   Wu Z, 2020, CHARACTERISTICS IMPO
   Xia H, 2020, XINHUA NEWS AGENCY
   Xie Xingzhi, 2020, Radiology, P200343, DOI 10.1148/radiol.2020200343
   Xu X, 2020, SCI CHINA LIFE SCI, P1
   Zou L, 2020, N ENGL J MED
NR 23
TC 0
Z9 0
U1 1
U2 1
PU SAX INST
PI ULTIMO
PA LEVEL 13, BUILDING 10, 235 JONES ST, ULTIMO, NSW 2007, AUSTRALIA
SN 2204-2091
J9 PUBLIC HEALTH RES PR
JI Public Health Res. Pract.
PD MAR
PY 2020
VL 30
IS 1
AR 3012000
DI 10.17061/phrp3012000
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KU4ZI
UT WOS:000519719100005
PM 32152612
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Pan, XC
   Ojcius, DM
   Gao, TY
   Li, ZS
   Pan, CH
   Pan, CG
AF Pan, Xingchen
   Ojcius, David M.
   Gao, Tianyue
   Li, Zhongsheng
   Pan, Chunhua
   Pan, Chungen
TI Lessons learned from the 2019-nCoV epidemic on prevention of future
   infectious diseases
SO MICROBES AND INFECTION
LA English
DT Article
DE 2019-nCoV; Traffic restriction; Government; Public health emergency
ID ACUTE RESPIRATORY SYNDROME; SARS CORONAVIRUS; DIAGNOSIS; INFLUENZA;
   IMPACT; BATS
AB Only a month after the outbreak of pneumonia caused by 2019-nCoV, more than forty-thousand people were infected. This put enormous pressure on the Chinese government, medical healthcare provider, and the general public, but also made the international community deeply nervous. On the 25th day after the outbreak, the Chinese government implemented strict traffic restrictions on the area where the 2019-nCoV had originated-Hubei province, whose capital city is Wuhan. Ten days later, the rate of increase of cases in Hubei showed a significant difference (p = 0.0001) compared with the total rate of increase in other provinces of China. These preliminary data suggest the effectiveness of a traffic restriction policy for this pandemic thus far. At the same time, solid financial support and improved research ability, along with network communication technology, also greatly facilitated the application of epidemic prevention measures. These measures were motivated by the need to provide effective treatment of patients, and involved consultation with three major groups in policy formulation-public health experts, the government, and the general public. It was also aided by media and information technology, as well as international cooperation. This experience will provide China and other countries with valuable lessons for quickly coordinating and coping with future public health emergencies. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Pan, Xingchen] Shanghai Univ Finance & Econ, Dept Human Resources, Shanghai, Peoples R China.
   [Ojcius, David M.] Univ Pacific, Sch Dent, Dept Biomed Sci, San Francisco, CA 94115 USA.
   [Gao, Tianyue] Earl Haig Secondary Sch, N York, ON, Canada.
   [Li, Zhongsheng; Pan, Chungen] Guangdong Haid Grp Co Ltd, Haid Res Inst, Guangdong Prov Key Lab Res Technol Pig Breeding &, Guangdong Haid Inst Anim Husb & Vet, Guangzhou, Peoples R China.
   [Pan, Chunhua] Guangzhou Med Univ, Med Dept, Affiliated Canc Hosp & Inst, 1st Ward,78 Heng Zhi Gang Rd, Guangzhou 510000, Peoples R China.
RP Pan, CH (reprint author), Guangzhou Med Univ, Med Dept, Affiliated Canc Hosp & Inst, 1st Ward,78 Heng Zhi Gang Rd, Guangzhou 510000, Peoples R China.; Pan, CG (reprint author), Guangdong Haid Grp Co Ltd, Haid Res Inst, 5 Eighth St,Fu Ping Rd, Guangzhou 511400, Peoples R China.
EM chhpan@163.com; chungenp@163.com
FU Panyu Innovation and Entrepreneurship Leading Team Project [2017-R02-4]
FX Chungen Pan was supported by a grant from the Panyu Innovation and
   Entrepreneurship Leading Team Project (2017-R02-4).
CR Ahmad A, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02146.x
   Al-Surimi K, 2017, ADV EXP MED BIOL, V972, P131, DOI 10.1007/5584_2016_132
   Ayittey FK, 2020, J MED VIROL, V92, P403, DOI 10.1002/jmv.25695
   Chu Daniel K W, 2020, Clin Chem, V66, P549, DOI 10.1093/clinchem/hvaa029
   Corman VM, 2020, EURO SURVEILL, V25
   Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232
   Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   [谢晓非 Nie Xiaofei], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P628
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Pang XH, 2003, JAMA-J AM MED ASSOC, V290, P3215, DOI 10.1001/jama.290.24.3215
   Parashar UD, 2004, INT J EPIDEMIOL, V33, P628, DOI 10.1093/ije/dyh198
   Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Shi YL, 2003, J CLIN MICROBIOL, V41, P5781, DOI 10.1128/JCM.41.12.5781-5782.2003
   Taubenberger JK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5485
   Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   Wang LF, 2006, EMERG INFECT DIS, V12, P1834
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 26
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2020
VL 22
IS 2
SI SI
BP 86
EP 91
DI 10.1016/j.micinf.2020.02.004
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KU8UJ
UT WOS:000519987000005
PM 32088333
OA Bronze
DA 2020-04-03
ER

PT J
AU Pardon, B
   Callens, J
   Maris, J
   Allais, L
   Van Praet, W
   Deprez, P
   Ribbens, S
AF Pardon, B.
   Callens, J.
   Maris, J.
   Allais, L.
   Van Praet, W.
   Deprez, P.
   Ribbens, S.
TI Pathogen-specific risk factors in acute outbreaks of respiratory disease
   in calves
SO JOURNAL OF DAIRY SCIENCE
LA English
DT Article
DE bovine respiratory disease; PCR; bronchoalveolar lavage; coronavirus
ID HEALTHY FEEDLOT CATTLE; SYNCYTIAL VIRUS; BOVINE CORONAVIRUS; BACTERIAL
   PATHOGENS; MYCOPLASMA-BOVIS; INFECTION; PREVALENCE; AGREEMENT;
   DIAGNOSIS; MASTITIS
AB Respiratory tract infections (bovine respiratory disease) are a major concern in calf rearing. The objective of this study was to identify pathogen-specific risk factors associated with epidemic respiratory disease in calves. A cross-sectional study was conducted, involving 128 outbreaks (29 dairy, 58 dairy-mixed, and 41 beef) in Belgium (2016-2018). A semiquantitative PCR for 7 respiratory pathogens was done on a pooled nonendoscopic bronchoalveolar lavage sample for each herd. Potential risk factors were collected by questionnaire arid derived from the national cattle registration databank. Most outbreaks occurred between October and March, and single and multiple viral infections were detected in 58.6% (75/128) and 13.3% (17/128), respectively. Bovine coronavirus (BCV) was the most frequently isolated virus (38.4%), followed by bovine respiratory syncytial virus (bRSV; 29.4%) and parainfluenzavirus type 3 (PI-3; 8.1%). Mycoplasma bovis, Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni were detected in 33.3, 41.2, 89.1, and 36.4% of the herds, respectively. Specific risk factors for BCV detection were detection of M. haemolytica [odds ratio (OR) = 2.8 (95% confidence interval = 1.1-7.5)], increasing herd size [OR = 1.3 (1.0-1.8) for each increase with 100 animals] arid detection of BCV by antigen ELISA on feces in calves in the last year [OR = 3.6 (1.2-11.1)]. A seasonal effect was shown for bRSV only {more in winter compared with autumn [OR = 10.3 (2.8-37.5)]}. Other factors associated with bRSV were PI-3 detection [OR = 13.4 (2.1-86.0)], prevalence of calves with respiratory disease [OR = 1.02 (1.00-1.04) per 1% increase], and number of days with respiratory signs before sampling [OR = 0.99 (0.98-0.99) per increase]. Next to its association with BCV, M. haemolytica was more frequently detected in herds with 5 to 10 animals per pen [OR = 8.0 (1.4-46.9)] compared with <5 animals, and in herds with sawdust as bedding [OR = 18.3 (1.8-191.6)]. Also, for H. somni, housing on sawdust was a risk factor [OR = 5.2 (1.2-23.0)]. Purchase of cattle [OR = 2.9 (1.0-8.0)] and housing of recently purchased animals in the same airspace [OR = 5.0 (1.5-16.5)] were risk factors for M. bovis. This study identified pathogen-specific risk factors that might be useful for the development of customized control and prevention arid for the design of decision support tools to justify antimicrobial use by predicting the most likely pathogen before sampling results are available.
C1 [Pardon, B.; Deprez, P.] Univ Ghent, Dept Large Anim Internal Med, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   [Callens, J.; Allais, L.; Van Praet, W.; Ribbens, S.] Anim Hlth Serv Flanders DGZ Vlaanderen, Ind Laan 29, B-8820 Torhout, Belgium.
   [Maris, J.] Boehringer Ingelheim Belgium, Arianelaan 16, B-1200 Sint Lambrechts Wolume, Belgium.
RP Pardon, B (reprint author), Univ Ghent, Dept Large Anim Internal Med, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.
EM bart.pardon@ugent.be
OI Pardon, Bart/0000-0003-1026-8433; Allais, Liesbeth/0000-0003-2663-8566;
   Ribbens, Stefaan/0000-0002-4075-999X
FU (Federal Agency for Safety of the Food Chain); Boehringer Ingelheim
   BelgiumBoehringer Ingelheim; Dechra, Northwich, UK; Merial, Brussels,
   Belgium; (Elanco, Antwerp, Belgium)
FX The authors thank the financial and technical support of 'veepeiler
   rund' (Animal Health Service Flanders; Federal Agency for Safety of the
   Food Chain) and Boehringer Ingelheim Belgium, which made the
   Griepbarometer initiative (Griepbarometer), which sourced the data of
   this study, possible. All collaborating farmers and veterinarians are
   greatly acknowledged for their active cooperation. BP has received
   honoraria for acting as speaker or consultant for pharmaceutical
   (Zoetis, Zaventem, Belgium; MSD, Brussels, Belgium; Vetoquinol,
   Aartselaar, Belgium; Dopharma, Raamdonskveer, the Netherlands;
   Boehringer Ingelheim, Brussels, Belgium; Dechra, Northwich, UK; Hipra,
   Amer, Spain; Ceva, Brussels, Belgium; Merial, Brussels, Belgium; and
   Elanco, Antwerp, Belgium) and agricultural (Boerenbond, Leuven, Belgium;
   Algoet Nutrition, Zulte, Belgium) companies. JM is an employee of
   Boehringer Ingelheim. JC has received speaker or consultant honoraria
   from pharmaceutical (Boehringer Ingelheim, Hipra, and Elanco) and
   agricultural (Algoet Nutrition) companies. All authors declare that
   these relationships have not influenced the independent analysis of the
   current study.
CR AMCRA, 2019, CLASS ANT METH
   Autio T, 2007, VET MICROBIOL, V119, P256, DOI 10.1016/j.vetmic.2006.10.001
   Buczinski S, 2018, J DAIRY SCI, V101, P2423, DOI 10.3168/jds.2017-13459
   Buczinski S, 2016, NEW ZEAL VET J, V64, P243, DOI 10.1080/00480169.2016.1153439
   Buczinski S, 2014, J VET INTERN MED, V28, P234, DOI 10.1111/jvim.12251
   Calcutt MJ, 2018, TRANSBOUND EMERG DIS, V65, P91, DOI 10.1111/tbed.12860
   CALDOW GL, 1988, VET REC, V122, P529, DOI 10.1136/vr.122.22.529
   Decaro N, 2008, VET MICROBIOL, V126, P30, DOI 10.1016/j.vetmic.2007.06.024
   DGZ, 2016, GRIEPB
   Dohoo I. R., 2009, VET EPIDEMIOLOGICAL, P865
   Doyle D, 2017, J VET INTERN MED, V31, P954, DOI 10.1111/jvim.14683
   Ellis J, 2019, CAN VET J, V60, P147
   EMA/EFSA, 2017, EMA EFSA JOINT SCI O
   Fulton RW, 2012, CAN VET J, V53, P754
   Gille L, 2018, J DAIRY SCI, V101, P8284, DOI 10.3168/jds.2018-14940
   Giusti AM, 1998, DEUT TIERARZTL WOCH, V105, P142
   Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004
   Karle BM, 2019, J DAIRY SCI, V102, P7583, DOI 10.3168/jds.2018-14775
   KIMMAN TG, 1986, AM J VET RES, V47, P143
   KNMVD, 2015, PROC DEV FORM RESP A
   Leecaster M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-105
   Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x
   Murray GM, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1372-9
   O'Neill R, 2014, VET REC, V175, DOI 10.1136/vr.102574
   Ohlson A, 2010, VET REC, V167, P201, DOI 10.1136/vr.c4119
   Pardon B, 2011, VET REC, V169, P278, DOI 10.1136/vr.d4406
   Pardon B, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-26
   Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570
   Parker AM, 2018, J VET INTERN MED, V32, P1241, DOI 10.1111/jvim.15135
   Passchyn P, 2014, J DAIRY SCI, V97, P6260, DOI 10.3168/jds.2014-8119
   Reiten M, 2018, PREV VET MED, V155, P21, DOI 10.1016/j.prevetmed.2018.04.007
   Saif LJ, 2010, VET CLIN N AM-FOOD A, V26, P349, DOI 10.1016/j.cvfa.2010.04.005
   Schibrowski ML, 2018, PREV VET MED, V157, P152, DOI 10.1016/j.prevetmed.2018.06.005
   Schukken Y, 2012, VET CLIN N AM-FOOD A, V28, P239, DOI 10.1016/j.cvfa.2012.04.001
   Soehnlen MK, 2012, J DAIRY SCI, V95, P247, DOI 10.3168/jds.2011-4309
   Theurer ME, 2015, JAVMA-J AM VET MED A, V246, P126, DOI 10.2460/javma.246.1.126
   Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567
   Timsit E, 2009, VET REC, V165, P230
   Timsit E, 2018, VET MICROBIOL, V221, P105, DOI 10.1016/j.vetmic.2018.06.007
   Timsit E, 2017, VET MICROBIOL, V208, P118, DOI 10.1016/j.vetmic.2017.07.013
   Toftaker Ingrid, 2018, Prev Vet Med, DOI 10.1016/j.prevetmed.2018.07.002
   Toftaker I, 2016, PREV VET MED, V133, P73, DOI 10.1016/j.prevetmed.2016.09.003
   Toiosa T, 2015, PREV VET MED, V120, P306, DOI 10.1016/j.prevetmed.2015.05.001
   Van Driessche L, 2017, J VET INTERN MED, V31, P946, DOI 10.1111/jvim.14668
   van Leenen K, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1921-x
   Workman AM, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1887-8
NR 46
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-0302
EI 1525-3198
J9 J DAIRY SCI
JI J. Dairy Sci.
PD MAR
PY 2020
VL 103
IS 3
BP 2556
EP 2566
DI 10.3168/jds.2019-17486
PG 11
WC Agriculture, Dairy & Animal Science; Food Science & Technology
SC Agriculture; Food Science & Technology
GA KN4OE
UT WOS:000514817200041
PM 31954585
OA Bronze
DA 2020-04-03
ER

PT J
AU Premraj, A
   Aleyas, AG
   Nautiyal, B
   Rasool, TJ
AF Premraj, Avinash
   Aleyas, Abi George
   Nautiyal, Binita
   Rasool, Thaha Jamal
TI Camelid type I interferons: Identification and functional
   characterization of interferon alpha from the dromedary camel (Camelus
   dromedarius)
SO MOLECULAR IMMUNOLOGY
LA English
DT Article
DE Antiviral; IFN; Virus; Infection; Interferon-stimulated genes;
   Recombinant protein purification; Inclusion body; Protein refolding;
   Rare codons; Column chromatography; Real-time PCR; RACE; Gene walking;
   Camel cell line; Zoonotic; MERS; Coronavirus; Poxvirus
ID ESCHERICHIA-COLI; EXPRESSION; CLONING; GENES; CORONAVIRUS; EVOLUTION;
   VIRUS
AB Investigations into the molecular immune response of dromedary camel, a key livestock species of the arid, have been limited due to the lack of species-specific reagents. Here we describe for the first time, the identification and characterization of type I IFNs of dromedary camel, which are the most important cytokines in the innate host immune response against viruses. We cloned camel IFN-alpha coding sequences and identified a total of eleven subtypes. The canonical IFN-alpha subtype designated as IFN-alpha 1 contained a 555-bp Open Reading Frame encoding a protein of 184 amino acids. Recombinant IFN-alpha 1 protein was produced in E. coli and purified from inclusion bodies. Recombinant camel IFN-alpha 1 induced the mRNA expression of interferon-stimulated genes (ISGs) in camel kidney cells. The purified protein also showed potent in-vitro antiviral activity against Camelpox Virus in kidney cells. The identified camel IFN-alpha protein and the subtypes will facilitate a better understanding of the host immune response to viral infections in camel and the development of potential antiviral biologicals for zoonotic diseases for which camel act as a reservoir.
C1 [Premraj, Avinash; Aleyas, Abi George; Nautiyal, Binita; Rasool, Thaha Jamal] Camel Biotechnol Ctr, Presidential Camels & Camel Racing Affairs Ctr, Dept Presidents Affairs, POB 17292, Al Ain, U Arab Emirates.
RP Rasool, TJ (reprint author), Camel Biotechnol Ctr, Presidential Camels & Camel Racing Affairs Ctr, Dept Presidents Affairs, POB 17292, Al Ain, U Arab Emirates.
EM tjrasool@gmail.com
FU Department of President's Affairs
FX The authors wish to acknowledge the vision and support of His Highness
   Sheikh Khalifa bin Zayed Al Nahyan, the honorable president of UAE for
   establishing the Camel Biotechnology Center under the auspices of the
   Department of President's Affairs. His Highness Sheikh Sultan bin Hamdan
   Al Nahyan, Private advisor to the President is gratefully acknowledged
   for the motivation and providing all resources for this research. We
   also acknowledge Ms Sreelakshmi Puthirikattil Raveendranathan and Ms.
   Shamma Juma Al Ketbi, for the excellent technical assistance provided
   for the research support.
CR Antonelli G, 2015, CYTOKINE GROWTH F R, V26, P121, DOI 10.1016/j.cytogfr.2014.12.006
   Babu KR, 2000, APPL MICROBIOL BIOT, V53, P655, DOI 10.1007/s002530000318
   BEILHARZ MW, 1986, J INTERFERON RES, V6, P677, DOI 10.1089/jir.1986.6.677
   Bera BC, 2011, VET MICROBIOL, V152, P29, DOI 10.1016/j.vetmic.2011.04.010
   CAPON DJ, 1985, MOL CELL BIOL, V5, P768, DOI 10.1128/MCB.5.4.768
   Cheng G, 2006, GENE, V382, P28, DOI 10.1016/j.gene.2006.06.013
   de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9
   DIAZ MO, 1994, GENOMICS, V22, P540, DOI 10.1006/geno.1994.1427
   Duraffour S, 2011, ANTIVIR RES, V92, P167, DOI 10.1016/j.antiviral.2011.09.003
   Duraffour S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021561
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   GILLESPIE D, 1983, J INTERFERON RES, V3, P83, DOI 10.1089/jir.1983.3.83
   GOEDDEL DV, 1981, NATURE, V290, P20, DOI 10.1038/290020a0
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   HIMMLER A, 1986, DNA-J MOLEC CELL BIO, V5, P345, DOI 10.1089/dna.1986.5.345
   KERRY JA, 1988, BIOCHEM BIOPH RES CO, V155, P714, DOI 10.1016/S0006-291X(88)80553-9
   Khalafalla AI, 2017, VECTOR-BORNE ZOONOT, V17, P281, DOI 10.1089/vbz.2016.2070
   Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396
   Kuruganti S, 2014, PROTEIN EXPRES PURIF, V103, P75, DOI 10.1016/j.pep.2014.08.010
   Li SY, 2010, RES VET SCI, V88, P148, DOI 10.1016/j.rvsc.2009.06.010
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Premraj A, 2013, INT J IMMUNOGENET, V40, P377, DOI 10.1111/iji.12040
   Premraj A, 2015, MOL IMMUNOL, V67, P357, DOI 10.1016/j.molimm.2015.06.022
   Roberts RM, 1998, J INTERF CYTOK RES, V18, P805, DOI 10.1089/jir.1998.18.805
   Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069
   Steinbach F, 2002, VET IMMUNOL IMMUNOP, V84, P83, DOI 10.1016/S0165-2427(01)00396-8
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tan XM, 2007, MOL IMMUNOL, V44, P3061, DOI 10.1016/j.molimm.2006.12.017
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wernery U, 2017, VET J, V220, P75, DOI 10.1016/j.tvjl.2016.12.020
   Yanagida K, 2004, ANTIVIR RES, V64, P195, DOI 10.1016/S0166-3542(04)00202-5
   Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342
   Zhang HL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0359-z
NR 36
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD MAR
PY 2020
VL 119
BP 132
EP 143
DI 10.1016/j.molimm.2020.01.020
PG 12
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA KR5KS
UT WOS:000517657900016
PM 32014632
OA Bronze
DA 2020-04-03
ER

PT J
AU Sah, R
   Rodriguez-Morales, AJ
   Jha, R
   Chu, DKW
   Gu, HG
   Peiris, M
   Bastola, A
   Lal, BK
   Ojha, HC
   Rabaan, AA
   Zambrano, LI
   Costello, A
   Morita, K
   Pandey, BD
   Poon, LLM
AF Sah, Ranjit
   Rodriguez-Morales, Alfonso J.
   Jha, Runa
   Chu, Daniel K. W.
   Gu, Haogao
   Peiris, Malik
   Bastola, Anup
   Lal, Bibek Kumar
   Ojha, Hemant Chanda
   Rabaan, Ali A.
   Zambrano, Lysien, I
   Costello, Anthony
   Morita, Kouichi
   Pandey, Basu Dev
   Poon, Leo L. M.
TI Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain
   Isolated in Nepal
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19), who had returned to Nepal after traveling to Wuhan, China.
C1 [Sah, Ranjit; Jha, Runa] Natl Publ Hlth Lab, Kathmandu, Nepal.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia.
   [Chu, Daniel K. W.; Gu, Haogao; Peiris, Malik; Poon, Leo L. M.] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China.
   [Bastola, Anup; Pandey, Basu Dev] Sukraraj Trop & Infect Dis Hosp, Kathmandu, Nepal.
   [Lal, Bibek Kumar; Ojha, Hemant Chanda] Govt Nepal, Epidemiol & Dis Control Div, Kathmandu, Nepal.
   [Rabaan, Ali A.] Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
   [Zambrano, Lysien, I] Univ Nacl Autonoma Honduras, Sch Med Sci, Dept Physiol, Tegucigalpa, Honduras.
   [Zambrano, Lysien, I] Univ Nacl Autonoma Honduras, Sch Med Sci, Dept Morphol Sci, Tegucigalpa, Honduras.
   [Costello, Anthony] UCL, Global Hlth & Sustainable Dev, London, England.
   [Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.
RP Sah, R (reprint author), Natl Publ Hlth Lab, Kathmandu, Nepal.
EM ranjitsah@iom.edu.np
RI sah, Ranjit/T-5865-2018
OI sah, Ranjit/0000-0002-2695-8714
FU UNAH [CU-0-041-05-2014/03-2014]
FX The Facultad de Ciencias Medicas (FCM) (2-03-01-01), National Autonomous
   University of Honduras, Tegucigalpa, MDC, Honduras, supported the
   publication fees of this article. L.I.Z. was the recipient of the UNAH
   CU-0-041-05-2014/03-2014 scholarship.
CR Bastola A, 2020, LANCET INFECT DIS, V20, P279, DOI 10.1016/S1473-3099(20)30067-0
   Chu Daniel K W, 2020, Clin Chem, V66, P549, DOI 10.1093/clinchem/hvaa029
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101578
   Rodriguez-Morales Alfonso J, 2020, Infez Med, V28, P3
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wisecaver JH, 2014, MOL PHYLOGENET EVOL, V71, P184, DOI 10.1016/j.ympev.2013.11.016
NR 7
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAR
PY 2020
VL 9
IS 11
AR e00169-20
DI 10.1128/MRA.00169-20
PG 3
WC Microbiology
SC Microbiology
GA KU8YJ
UT WOS:000520001100014
PM 32165386
OA Other Gold, Bronze, Green Published
DA 2020-04-03
ER

PT J
AU Sheikh, A
   Al-Taher, A
   Al-Nazawi, M
   Al-Mubarak, AI
   Kandeel, M
AF Sheikh, Abdullah
   Al-Taher, Abdulla
   Al-Nazawi, Mohammed
   Al-Mubarak, Abdullah, I
   Kandeel, Mahmoud
TI Analysis of preferred codon usage in the coronavirus N genes and their
   implications for genome evolution and vaccine design
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Coronavirus; Nucleocapsid protein; Preferred nucleotides; Amino acid;
   Codon bias
ID SARS-ASSOCIATED CORONAVIRUS; NUCLEOCAPSID PROTEIN; MONOCLONAL-ANTIBODY;
   BACTERIAL GENES; SPIKE PROTEIN; PATTERNS; VIRUS; BIAS; PRESSURE;
   PURIFICATION
AB The nucleocapsid (N) protein of a coronavirus plays a crucial role in virus assembly and in its RNA transcription. It is important to characterize a virus at the nucleotide level to discover the virus's genomic sequence variations and similarities relative to other viruses that could have an impact on the functions of its genes and proteins. This entails a comprehensive and comparative analysis of the viral genomes of interest for preferred nucleotides, codon bias, nucleotide changes at the 3rd position (NT3s), synonymous codon usage and relative synonymous codon usage. In this study, the variations in the N proteins among 13 different coronaviruses (CoVs) were analysed at the nucleotide and amino acid levels in an attempt to reveal how these viruses adapt to their hosts relative to their preferred codon usage in the N genes. The results revealed that, overall, eighteen amino acids had different preferred codons and eight of these were over-biased. The N genes had a higher AT% over GC% and the values of their effective number of codons ranged from 40.43 to 53.85, indicating a slight codon bias. Neutrality plots and correlation analyses showed a very high level of GC3s/GC correlation in porcine epidemic diarrhea CoV (pedCoV), followed by Middle East respiratory syndrome-CoV (MERS CoV), porcine delta CoV (dCoV), bat CoV (bCoV) and feline CoV (fCoV) with r values 0.81, 0.68, -0.47, 0.98 and 0.58, respectively. These data implied a high rate of evolution of the CoV genomes and a strong influence of mutation on evolutionary selection in the CoV N genes. This type of genetic analysis would be useful for evaluating a virus's host adaptation, evolution and is thus of value to vaccine design strategies.
C1 [Sheikh, Abdullah] King Faisal Univ, Camel Res Ctr, Alhofuf 31982, Alahsa, Saudi Arabia.
   [Al-Taher, Abdulla; Al-Nazawi, Mohammed; Kandeel, Mahmoud] King Faisal Univ, Coll Vet Med, Dept Biomed Sci, Alhofuf 31982, Alahsa, Saudi Arabia.
   [Al-Mubarak, Abdullah, I] King Faisal Univ, Coll Vet Med, Dept Microbiol, Alhofuf 31982, Alahsa, Saudi Arabia.
   [Kandeel, Mahmoud] Kafrelsheikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelsheikh 33516, Egypt.
RP Sheikh, A (reprint author), King Faisal Univ, Camel Res Ctr, Alhofuf 31982, Alahsa, Saudi Arabia.
RI Al-Taher, Abdulla/P-6246-2016; Sheikh, Abdullah/X-7065-2018; Kandeel,
   Mahmoud/G-3636-2016
OI Al-Taher, Abdulla/0000-0002-0831-6486; Sheikh,
   Abdullah/0000-0002-0482-503X; Kandeel, Mahmoud/0000-0003-3668-5147
FU Deanship of Scientific Research at King Faisal University [171001]
FX The authors acknowledge the Deanship of Scientific Research at King
   Faisal University for the financial support under strategic projects
   track [grant number 171001].
CR Ahn I, 2009, EXP MOL MED, V41, P746, DOI 10.3858/emm.2009.41.10.081
   Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71
   Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x
   Berry M., 2012, AFR J BIOTECHNOL, V11, P13962
   Blanchard EG, 2011, J VIROL METHODS, V177, P100, DOI 10.1016/j.jviromet.2011.07.005
   Cavanagh D., 1995, CORONAVIRIDAE, P73
   Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333
   Chantawannakul P, 2008, J INVERTEBR PATHOL, V98, P206, DOI 10.1016/j.jip.2008.02.016
   Che XY, 2004, EMERG INFECT DIS, V10, P1947, DOI 10.3201/eid1011.040516
   Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100
   Chen Y, 2014, INFECT GENET EVOL, V28, P95, DOI 10.1016/j.meegid.2014.09.004
   Chen Youhua, 2014, VirusDisease, V25, P285, DOI 10.1007/s13337-014-0191-2
   Cheng XF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-113
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   D'Andrea L, 2011, VIRUS RES, V157, P19, DOI 10.1016/j.virusres.2011.01.012
   Di B, 2005, CLIN DIAGN LAB IMMUN, V12, P135, DOI 10.1128/CDLI.12.1.135-140.2005
   Doolittle WE, 1998, TRENDS GENET, V14, P307
   Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001
   Dutta NK, 2008, IMMUNOL LETT, V118, P65, DOI 10.1016/j.imlet.2008.03.003
   Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298
   Gao J, 2013, J VIROL, V87, P13134, DOI 10.1128/JVI.02433-13
   Greenacre M. J, 1984, THEORY APPL CORRES A
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   He QG, 2005, J VIROL METHODS, V127, P46, DOI 10.1016/j.jviromet.2005.03.004
   IKEMURA T, 1985, MOL BIOL EVOL, V2, P13
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Johnson R.F., 2019, U.S. Patent Application, Patent No. [16/091,005, 16091005]
   Kanaya S, 2001, GENE, V276, P89, DOI 10.1016/S0378-1119(01)00673-4
   Kandeel M, 2017, BIOL PHARM BULL, V40, P1086, DOI 10.1248/bpb.b17-00168
   Kandeel Mahmoud, 2009, Nucleic Acids Symp Ser (Oxf), P39, DOI 10.1093/nass/nrp020
   Kandeel Mahmoud, 2009, Nucleic Acids Symp Ser (Oxf), P283, DOI 10.1093/nass/nrp142
   Kandeel M, 2009, BIOL PHARM BULL, V32, P1321, DOI 10.1248/bpb.32.1321
   Karniychuk UU, 2016, VIRUS RES, V223, P73, DOI 10.1016/j.virusres.2016.06.015
   Kattoor JJ, 2015, INFECT GENET EVOL, V34, P17, DOI 10.1016/j.meegid.2015.06.018
   Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376
   Lee HK, 2008, J MICROBIOL BIOTECHN, V18, P1717
   Liang FY, 2013, J VIROL METHODS, V187, P413, DOI 10.1016/j.jviromet.2012.11.009
   LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289
   Loa CC, 2004, J VIROL METHODS, V116, P161, DOI 10.1016/j.jviromet.2003.11.006
   Ma YP, 2015, J FISH DIS, V38, P665, DOI 10.1111/jfd.12316
   Maache M, 2006, CLIN VACCINE IMMUNOL, V13, P409, DOI 10.1128/CVI.13.3.409-414.2006
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Peden J.F., 2000, ANAL CODON USAGE, P2000
   Perriere G, 2002, NUCLEIC ACIDS RES, V30, P4548, DOI 10.1093/nar/gkf565
   Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996
   Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363
   SHARP PM, 1987, MOL BIOL EVOL, V4, P222
   SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835
   Shi SL, 2016, INFECT GENET EVOL, V44, P412, DOI 10.1016/j.meegid.2016.07.042
   Shi SL, 2013, VIRUS GENES, V46, P10, DOI 10.1007/s11262-012-0818-6
   Siddell S.G., 2005, TOPLEY WILSONS MICRO
   SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653
   Sui JH, 2014, J VIROL, V88, P13769, DOI 10.1128/JVI.02232-14
   Supek F, 2016, J MOL EVOL, V82, P65, DOI 10.1007/s00239-015-9714-8
   Suzuki H, 2008, DNA RES, V15, P357, DOI 10.1093/dnares/dsn028
   Timani KA, 2004, J CLIN VIROL, V30, P309, DOI 10.1016/j.jcv.2004.01.001
   van Hemert F, 2016, J GEN VIROL, V97, P2608, DOI 10.1099/jgv.0.000579
   Wasmoen T L, 1995, Adv Exp Med Biol, V380, P221
   Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999
   Wu G, 2005, J MOL MODEL, V11, P8, DOI 10.1007/s00894-004-0210-0
   Wu HS, 2004, J BIOMED SCI, V11, P117, DOI [10.1007/BF02256554, 10.1159/000075294]
   Wu XD, 2004, CELL RES, V14, P400, DOI 10.1038/sj.cr.7290240
   Yu M, 2008, J IMMUNOL METHODS, V331, P1, DOI 10.1016/j.jim.2007.11.009
   Zhou H, 2015, INFECT GENET EVOL, V35, P27, DOI 10.1016/j.meegid.2015.07.024
   Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002
NR 69
TC 0
Z9 0
U1 37
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAR
PY 2020
VL 277
AR 113806
DI 10.1016/j.jviromet.2019.113806
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA KM6NT
UT WOS:000514255500007
PM 31911390
OA Bronze
DA 2020-04-03
ER

PT J
AU Shi, ZH
   Wang, WJ
   Xu, ZX
   Zhao, MM
   Lan, YL
AF Shi, Zhihai
   Wang, Wenjia
   Xu, Zhaoxue
   Zhao, Mengmeng
   Lan, Yali
TI Detection and Molecular Characterization of BCoVs Circulating in Central
   China Based on the Full-length Spike Gene
SO KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
LA English
DT Article
DE BCoV; Spike gene; Phylogenetic analysis; China
ID BOVINE CORONAVIRUS; DAIRY-CATTLE; DIARRHEA
AB Bovine coronavirus (BCoV) is prevalent throughout the world and is an important aetiological agent of diarrhoea in new-born calves. However, little is known about the genetic diversity and molecular epidemiology of BCoV in China. In this study, a total of 127 faecal samples from diarrhoeic dairy calves from nine cities in Henan Province, Central China, were collected between 2017 and 2018 and evaluated by RTPCR for the N gene. BCoV was detected in 15% (19/127) of calves. In addition, the full-length sequence of the S gene from 13 representative BCoV strains was obtained and analysed. Sequencing results for the full-length S gene showed 97.3-97.5% nucleotide (nt) identity and 96.3-96.8% amino acid (aa) identity with the classical Mebus strain. Phylogenetic analysis based on the full-length S gene showed that the BCoV strains in this study clustered with Vietnamese and Cuban BCoV strains on a large branch of the tree. These results enrich the molecular characterization of the Chinese BCoV strains and provide the first large-scale epidemiological examination of the prevalence of BCoV in diarrhoeic calves in Henan Province, Central China.
C1 [Shi, Zhihai; Xu, Zhaoxue; Lan, Yali] Henan Acad Agr Sci, Inst Anim Husb & Vet, Zhengzhou 450002, Henan, Peoples R China.
   [Wang, Wenjia] Henan Univ Anim Husb & Econ, Coll Pharmaceut Engn, Zhengzhou 450046, Henan, Peoples R China.
   [Shi, Zhihai; Xu, Zhaoxue; Lan, Yali] Henan Key Lab Farm Anim Breeding & Nutr Regulat, Zhengzhou 450002, Henan, Peoples R China.
   [Zhao, Mengmeng] Foshan Univ, Sch Life Sci & Engn, Foshan 528225, Guangdong, Peoples R China.
RP Lan, YL (reprint author), Henan Acad Agr Sci, Inst Anim Husb & Vet, Zhengzhou 450002, Henan, Peoples R China.; Lan, YL (reprint author), Henan Key Lab Farm Anim Breeding & Nutr Regulat, Zhengzhou 450002, Henan, Peoples R China.; Zhao, MM (reprint author), Foshan Univ, Sch Life Sci & Engn, Foshan 528225, Guangdong, Peoples R China.
EM mzhao8@tulane.edu; yali2005haonan@sina.com
FU Key Program for Science and Technology Development of Henan
   [192102110074]; National Key Research and Development Program of China
   [2018YFD0501700]; National beef cattle industrial technology system
   [CARS-37]; Open Program for Buffalo research of Guangxi [SNKF-2015-03];
   National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [31902279]
FX This work was funded by the Key Program for Science and Technology
   Development of Henan (192102110074), the National Key Research and
   Development Program of China 2018YFD0501700), the National beef cattle
   industrial technology system (CARS-37), the Open Program for Buffalo
   research of Guangxi (SNKF-2015-03), as well as the National Natural
   Science Foundation of China (NSFC) (grants 31902279).
CR Aleanizy FS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2137-3
   Castells M, 2019, ARCH VIROL, V164, P2715, DOI 10.1007/s00705-019-04384-w
   Dennis AF, 2014, J VIROL, V88, P3789, DOI 10.1128/JVI.03516-13
   Fernandes AD, 2018, VET MED SCI, V4, P183, DOI 10.1002/vms3.102
   Forni D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14480
   Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757
   Gao FL, 2019, ECOL EVOL, V9, P3891, DOI 10.1002/ece3.5015
   Giannitti F, 2015, VET PATHOL, V52, P1148, DOI 10.1177/0300985814568683
   Gomez DE, 2017, J VET INTERN MED, V31, P1884, DOI 10.1111/jvim.14811
   Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09
   Gunn L, 2015, IRISH VET J, V68, DOI 10.1186/s13620-015-0060-3
   Keha A, 2019, TRANSBOUND EMERG DIS, V66, P1971, DOI 10.1111/tbed.13228
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Lojkic I, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0511-9
   LU CP, 1991, J VET MED B, V38, P473, DOI 10.1111/j.1439-0450.1991.tb00898.x
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Park SJ, 2006, J CLIN MICROBIOL, V44, P3178, DOI 10.1128/JCM.02667-05
   Rambaut A, 2009, FIGTREE V1 4 3
   Ribeiro J, 2016, TROP ANIM HEALTH PRO, V48, P649, DOI 10.1007/s11250-015-0975-4
   Singasa K, 2017, TROP ANIM HEALTH PRO, V49, P1523, DOI 10.1007/s11250-017-1358-9
   YOO DW, 1991, VIROLOGY, V183, P91, DOI 10.1016/0042-6822(91)90121-Q
   Yoo DW, 2001, CLIN DIAGN LAB IMMUN, V8, P297, DOI 10.1128/CDLI.8.2.297-302.2001
NR 22
TC 0
Z9 0
U1 52
U2 52
PU KAFKAS UNIV, VETERINER FAKULTESI DERGISI
PI KARS
PA KAFKAS UNIV, VETERINER FAKULTESI DERGISI, KARS, 36040, TURKEY
SN 1300-6045
J9 KAFKAS UNIV VET FAK
JI Kafkas Univ. Vet. Fak. Derg.
PD MAR-APR
PY 2020
VL 26
IS 2
BP 181
EP 186
DI 10.9775/kvfd.2019.22678
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA KF0UR
UT WOS:000508967700004
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Tetro, JA
AF Tetro, Jason A.
TI Is COVID-19 receiving ADE from other coronaviruses?
SO MICROBES AND INFECTION
LA English
DT Article
DE COVID-19; Coronavirus; Antibody dependent enhancement
ID SARS-CORONAVIRUS; ANTIBODIES; MACROPHAGES; INFECTION; PNEUMONIA;
   RESPONSES
AB One of the most perplexing questions regarding the current COVID-19 coronavirus epidemic is the discrepancy between the severity of cases observed in the Hubei province of China and those occurring elsewhere in the world. One possible answer is antibody dependent enhancement (ADE) of SARS-CoV-2 due to prior exposure to other coronaviruses. ADE modulates the immune response and can elicit sustained inflammation, lymphopenia, and/or cytokine storm, one or all of which have been documented in severe cases and deaths. ADE also requires prior exposure to similar antigenic epitopes, presumably circulating in local viruses, making it a possible explanation for the observed geographic limitation of severe cases and deaths. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Tetro, Jason A.] Univ Guelph, Coll Biol Sci, Guelph, ON N1G 2W1, Canada.
RP Tetro, JA (reprint author), Univ Guelph, Coll Biol Sci, Guelph, ON N1G 2W1, Canada.
EM jason@jasontetro.com
CR [Anonymous], 2020, NATL POST
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005
   Donnelly CA, 2004, LANCET INFECT DIS, V4, P672, DOI 10.1016/S1473-3099(04)01173-9
   Gorbalenya AE, 2020, BIORXIV, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659
   Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11
   Leung GM, 2006, EPIDEMIOL INFECT, V134, P211, DOI 10.1017/S0950268805004826
   Lu R, 2020, LANCET, P30251
   Wang Dawei, 2020, JAMA, DOI 10.1001/jama.2020.1585
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090
   Wu ZQ, 2016, ISME J, V10, P609, DOI 10.1038/ismej.2015.138
   Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102
   Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82
   Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08
NR 18
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2020
VL 22
IS 2
SI SI
BP 72
EP 73
DI 10.1016/j.micinf.2020.02.006
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KU8UJ
UT WOS:000519987000002
PM 32092539
OA Bronze
DA 2020-04-03
ER

PT J
AU Wan, YS
   Shang, J
   Sun, SH
   Tai, WB
   Chen, J
   Geng, QB
   He, L
   Chen, YH
   Wu, JM
   Shi, ZL
   Zhou, YS
   Du, LY
   Li, F
AF Wan, Yushun
   Shang, Jian
   Sun, Shihui
   Tai, Wanbo
   Chen, Jing
   Geng, Qibin
   He, Lei
   Chen, Yuehong
   Wu, Jianming
   Shi, Zhengli
   Zhou, Yusen
   Du, Lanying
   Li, Fang
TI Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus
   Entry
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE antibody-dependent enhancement of viral entry; MERS coronavirus; SARS
   coronavirus; spike protein; neutralizing antibody; viral receptor; IgG
   Fc receptor; antibody-dependent enhancement of viral entry
ID RESPIRATORY SYNDROME CORONAVIRUS; RECEPTOR-BINDING DOMAIN; SPIKE
   PROTEIN; CELL ENTRY; MERS-COV; VIRUS-INFECTION; ENHANCING ANTIBODIES;
   FUNCTIONAL RECEPTOR; GLYCOPROTEIN; IMMUNOGENICITY
AB Antibody-dependent enhancement (ADE) of viral entry has been a major concern for epidemiology, vaccine development, and antibody-based drug therapy. However, the molecular mechanism behind ADE is still elusive. Coronavirus spike protein mediates viral entry into cells by first binding to a receptor on the host cell surface and then fusing viral and host membranes. In this study, we investigated how a neutralizing monoclonal antibody (MAb), which targets the receptor-binding domain (RBD) of Middle East respiratory syndrome (MERS) coronavirus spike, mediates viral entry using pseudovirus entry and biochemical assays. Our results showed that MAb binds to the virus surface spike, allowing it to undergo conformational changes and become prone to proteolytic activation. Meanwhile, MAb binds to cell surface IgG Fc receptor, guiding viral entry through canonical viral-receptordependent pathways. Our data suggest that the antibody/Fc-receptor complex functionally mimics viral receptor in mediating viral entry. Moreover, we characterized MAb dosages in viral-receptor-dependent, Fc-receptor-dependent, and both-receptorsdependent viral entry pathways, delineating guidelines on MAb usages in treating viral infections. Our study reveals a novel molecular mechanism for antibody-enhanced viral entry and can guide future vaccination and antiviral strategies.
   IMPORTANCE Antibody-dependent enhancement (ADE) of viral entry has been observed for many viruses. It was shown that antibodies target one serotype of viruses but only subneutralize another, leading to ADE of the latter viruses. Here we identify a novel mechanism for ADE: a neutralizing antibody binds to the surface spike protein of coronaviruses like a viral receptor, triggers a conformational change of the spike, and mediates viral entry into IgG Fc receptor-expressing cells through canonical viral-receptor-dependent pathways. We further evaluated how antibody dosages impacted viral entry into cells expressing viral receptor, Fc receptor, or both receptors. This study reveals complex roles of antibodies in viral entry and can guide future vaccine design and antibody-based drug therapy.
C1 [Wan, Yushun; Shang, Jian; Geng, Qibin; Wu, Jianming; Li, Fang] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Sun, Shihui; He, Lei; Chen, Yuehong; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, Lab Infect & Immun, Beijing, Peoples R China.
   [Tai, Wanbo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
   [Chen, Jing; Shi, Zhengli] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China.
RP Li, F (reprint author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.; Du, LY (reprint author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
EM LDu@nybc.org; lifang@umn.edu
RI ?, ??/A-1013-2013
OI ?, ??/0000-0001-8089-163X; Shang, Jian/0000-0003-2600-6059
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI089728, R01AI110700, R01AI139092]
FX This work was supported by NIH grants R01AI089728 (to F.L), R01AI110700
   (to F.L.), and R01AI139092 (to L.D. and F.L.).
CR Beck Z, 2008, VACCINE, V26, P3078, DOI 10.1016/j.vaccine.2007.12.028
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11
   Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13
   CORAPI WV, 1992, J VIROL, V66, P6695, DOI 10.1128/JVI.66.11.6695-6705.1992
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14
   Du LY, 2009, BIOCHEM BIOPH RES CO, V384, P486, DOI 10.1016/j.bbrc.2009.05.003
   Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157
   Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9
   Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407
   Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908
   Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557
   Hohdatsu T, 1998, J VET MED SCI, V60, P49, DOI 10.1292/jvms.60.49
   Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11
   Jing YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121788
   Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011
   Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu C, 2016, J BIOL CHEM, V291, P24779, DOI 10.1074/jbc.M116.740746
   Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Qiu HJ, 2016, ANTIVIR RES, V132, P141, DOI 10.1016/j.antiviral.2016.06.003
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Shang J, 2018, J VIROL, V92, DOI 10.1128/JVI.01556-17
   Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009
   Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13
   Snyder KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02873
   Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236
   Su KH, 2004, J IMMUNOL, V172, P7192, DOI 10.4049/jimmunol.172.11.7192
   Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405
   Takada A, 2003, J VIROL, V77, P7539, DOI 10.1128/JVI.77.13.7539-7544.2003
   Takada A, 2001, J VIROL, V75, P2324, DOI 10.1128/JVI.75.5.2324-2330.2001
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   VENNEMA H, 1990, J VIROL, V64, P1407, DOI 10.1128/JVI.64.3.1407-1409.1990
   Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028
   Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114
   Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293
   Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18
NR 64
TC 0
Z9 0
U1 7
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e02015-19
DI 10.1128/JVI.02015-19
PG 15
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000032
PM 31826992
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, Y
   Cui, XJ
   Chen, X
   Yang, SX
   Ling, Y
   Song, QB
   Zhu, S
   Sun, LY
   Li, C
   Li, Y
   Deng, XT
   Delwart, E
   Zhang, W
AF Wang, Yan
   Cui, Xuejiao
   Chen, Xu
   Yang, Shixing
   Ling, Yu
   Song, Qianben
   Zhu, Su
   Sun, Luying
   Li, Chuang
   Li, Yu
   Deng, Xutao
   Delwart, Eric
   Zhang, Wen
TI A recombinant infectious bronchitis virus from a chicken with a spike
   gene closely related to that of a turkey coronavirus
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Viral metagenomics; Coronavirus; Infectious bronchitis virus; Genome
   recombination
ID SEQUENCE
AB Using viral metagenomics, the complete genome sequence of an infectious bronchitis virus (IBV) strain (named ahysx-1) from a fecal sample from a healthy chicken in Anhui province, China, was determined. The genome sequence of ahysx-1 was found to be very similar to that of IBV strain ck/CH/LLN/131040 (KX252787), except for the spike gene region, which is similar to that of a turkey coronavirus strain (EU022526), suggesting that ahysx-1 is a recombinant. Recombination analysis and phylogenetic analysis based on the genomic sequences of ahysx-1 and other related strains confirmed that ahysx-1 appears to be a recombinant resulting from a recombination event that occurred between a chicken coronavirus and a turkey coronavirus. Further studies need to be performed to determine whether this recombinant IBV strain is pathogenic and whether it is transmitted between chickens and turkeys.
C1 [Wang, Yan; Cui, Xuejiao; Li, Yu] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei 230036, Peoples R China.
   [Wang, Yan; Chen, Xu; Yang, Shixing; Ling, Yu; Song, Qianben; Zhu, Su; Sun, Luying; Li, Chuang; Zhang, Wen] Jiangsu Univ, Sch Med, 310 Xuefu Rd, Zhenjiang 202103, Jiangsu, Peoples R China.
   [Deng, Xutao; Delwart, Eric] Vitalant Res Inst, 270 Masonic Ave, San Francisco, CA USA.
   [Deng, Xutao; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
RP Li, Y (reprint author), Anhui Agr Univ, Coll Anim Sci & Technol, Hefei 230036, Peoples R China.; Zhang, W (reprint author), Jiangsu Univ, Sch Med, 310 Xuefu Rd, Zhenjiang 202103, Jiangsu, Peoples R China.
EM liyu@ahau.edu.cn; z0216wen@yahoo.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81741062]; Student's Platform for Innovation and
   Entrepreneurship Training Program [201810299587W]; National Key Research
   and Development Programs of China [2017YFC1200201]; Jiangsu social
   development project [BE2016663]; Jiangsu Provincial Key Research and
   Development Projects [BE2017693]; Blood Systems Research Institute [No]
CR Bickerton E, 2018, J VIROL, V92, DOI 10.1128/JVI.01044-18
   Cao J, 2008, VIRUS RES, V136, P43, DOI 10.1016/j.virusres.2008.04.015
   Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
   Eddy Sean R, 2009, Genome Inform, V23, P205
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367
   Goebel SJ, 2004, J VIROL, V78, P669, DOI 10.1128/JVI.78.2.669-682.2004
   Jackwood MW, 2010, VIROLOGY, V398, P98, DOI 10.1016/j.virol.2009.11.044
   Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lin SY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102030
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Shan D, 2018, VIRUS RES, V250, P104, DOI 10.1016/j.virusres.2018.04.013
   Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Zhang W, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0308-0
   Zhang W, 2016, TRANSFUSION, V56, P2248, DOI 10.1111/trf.13692
   Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200
NR 20
TC 0
Z9 0
U1 30
U2 30
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAR
PY 2020
VL 165
IS 3
BP 703
EP 707
DI 10.1007/s00705-019-04488-3
PG 5
WC Virology
SC Virology
GA KL5GP
UT WOS:000513451500014
PM 31982944
OA Bronze
DA 2020-04-03
ER

PT J
AU Xie, CY
   Lau, EHY
   Yoshida, T
   Yu, H
   Wang, X
   Wu, HT
   Wei, JJ
   Cowling, B
   Peiris, M
   Li, YG
   Yen, HL
AF Xie, Chenyi
   Lau, Eric H. Y.
   Yoshida, Tomoyo
   Yu, Han
   Wang, Xin
   Wu, Huitao
   Wei, Jianjian
   Cowling, Ben
   Peiris, Malik
   Li, Yuguo
   Yen, Hui-Ling
TI Detection of Influenza and Other Respiratory Viruses in Air Sampled From
   a University Campus: A Longitudinal Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE influenza and respiratory viruses; airborne particles; human density;
   temporal pattern; surveillance
ID REAL-TIME PCR; CLINICAL SPECIMENS; TRANSMISSION; MORTALITY
AB Background. Respiratory virus-laden particles are commonly detected in the exhaled breath of symptomatic patients or in air sampled from healthcare settings. However, the temporal relationship of detecting virus-laden particles at nonhealthcare locations vs surveillance data obtained by conventional means has not been fully assessed.
   Methods. From October 2016 to June 2018, air was sampled weekly from a university campus in Hong Kong. Viral genomes were detected and quantified by real-time reverse-transcription polymerase chain reaction. Logistic regression models were fitted to examine the adjusted odds ratios (aORs) of ecological and environmental factors associated with the detection of virus-laden airborne particles.
   Results. Influenza A (16.9% [117/694]) and influenza B (4.5% [31/694]) viruses were detected at higher frequencies in air than rhinovirus (2.2% [6/270]), respiratory syncytial virus (0.4% [1/270]), or human coronaviruses (0% [0/270]). Multivariate analyses showed that increased crowdedness (aOR, 2.3 [95% confidence interval {CI}, 1.5-3.8]; P < .001) and higher indoor temperature (aOR, 1.2 [95% CI, 1.1-1.3]; P < .001) were associated with detection of influenza airborne particles, but absolute humidity was not (aOR, 0.9 [95% CI,.7-1.1]; P = .213). Higher copies of influenza viral genome were detected from airborne particles >4 mu m in spring and <1 mu m in autumn. Influenza A(H3N2) and influenza B viruses that caused epidemics during the study period were detected in air prior to observing increased influenza activities in the community.
   Conclusions. Air sampling as a surveillance tool for monitoring influenza activity at public locations may provide early detection signals on influenza viruses that circulate in the community.
C1 [Xie, Chenyi; Lau, Eric H. Y.; Yoshida, Tomoyo; Wang, Xin; Wu, Huitao; Cowling, Ben; Peiris, Malik; Yen, Hui-Ling] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China.
   [Yu, Han; Wei, Jianjian; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China.
RP Yen, HL (reprint author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China.
EM hyen@hku.hk
RI Peiris, Joseph Sriyal Malik/C-4380-2009; Yen, Hui-Ling/C-4501-2009
OI Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Xie,
   Chenyi/0000-0001-7399-6425; Yen, Hui-Ling/0000-0003-2493-3609
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400006C]; Research
   Grants Council, Hong Kong Special Administrative Region, ChinaHong Kong
   Research Grants Council [T11-705/14N, C7025-16G]
FX This study was supported by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health (contract
   number HHSN272201400006C) and the Theme-Based Research Scheme
   (T11-705/14N) and Collaborative Research Fund (C7025-16G) from the
   Research Grants Council, Hong Kong Special Administrative Region, China.
CR Ackerson B, 2019, CLIN INFECT DIS, V69, P197, DOI 10.1093/cid/ciy991
   Bi JN, 2019, INSUR MATH ECON, V85, P1, DOI 10.1016/j.insmatheco.2018.11.007
   Birger R, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00249-18
   Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773
   Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478
   Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4
   Center for Health Protection, FLU EXPR
   Chen Y, 2011, J CLIN MICROBIOL, V49, P1653, DOI 10.1128/JCM.02184-10
   Hong S, 2018, IEEE INT CONF ELECTR, P21
   Ip DKM, 2016, CLIN INFECT DIS, V62, P431, DOI 10.1093/cid/civ909
   Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2
   Kutter JS, 2018, CURR OPIN VIROL, V28, P142, DOI 10.1016/j.coviro.2018.01.001
   Leung NHL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148669
   Lindsley WG, 2017, NIOSH MANUAL ANAL ME
   Lindsley WG, 2016, INFLUENZA OTHER RESP, V10, P404, DOI 10.1111/irv.12390
   Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457
   Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205
   Munro SB, 2013, J CLIN MICROBIOL, V51, P1124, DOI 10.1128/JCM.03113-12
   Osterback R, 2013, J CLIN MICROBIOL, V51, P3960, DOI 10.1128/JCM.01646-13
   Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8
   Pan MH, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00251-17
   Prussin AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151004
   Shaman J, 2018, J INFECT DIS, V217, P1074, DOI 10.1093/infdis/jix685
   Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316
   Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/S0140-6736(17)30938-8, 10.1016/s0140-6736(17)30938-8]
   Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426
   Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus
   The American Society of Heating, 2016, 6222016 ASHRAE
   Triado-Margarit X, 2017, INDOOR AIR, V27, P564, DOI 10.1111/ina.12343
   Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1
   van Elden LJR, 2004, J INFECT DIS, V189, P652, DOI 10.1086/381207
   Venables W. N., 2002, MODERN APPL STAT S
   Wallace JM, 2006, ATMOSPHERIC SCI INTR
   World Health Organization, CDC PROT REALT RT PC
   Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628
   Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115
   Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686
   Zhou J, 2016, EURO SURVEILL, V21
NR 39
TC 0
Z9 0
U1 4
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2020
VL 70
IS 5
BP 850
EP 858
DI 10.1093/cid/ciz296
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KV5VW
UT WOS:000520551800022
PM 30963180
DA 2020-04-03
ER

PT J
AU Yang, D
   Su, MJ
   Li, CQ
   Zhang, B
   Qi, SS
   Sun, DB
   Yin, BS
AF Yang, Dan
   Su, Mingjun
   Li, Chunqiu
   Zhang, Bei
   Qi, Shanshan
   Sun, Dongbo
   Yin, Baishuang
TI Isolation and characterization of a variant subgroup GII-a porcine
   epidemic diarrhea virus strain in China
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Porcine epidemic diarrhea virus; Variant strain; Pathogenicity; Vaccine
ID SWINE ENTERIC CORONAVIRUS; S-INDEL STRAIN; UNITED-STATES; PATHOGENICITY;
   DELTACORONAVIRUS
AB Background: Highly virulent variants of porcine epidemic diarrhea virus (PEDV) have been closely associated with recent outbreaks of porcine epidemic diarrhea (PED) in China, which have resulted in severe economic losses to the pork industry.
   Methods: In the current study, the variant PEDV strain HM2017 was isolated and purified and a viral growth curve was constructed according to the median tissue culture infective dose (TCID50). HM2017 were amplify with RT-PCR and analyzed by phylogeny analysis. Animal pathogenicity experiment was carried to evaluate the HM2017 clinical assessment.
   Results: Genome-based phylogenetic analysis revealed that PEDV strain HM2017 was clustered into the variant subgroup GII-a that is currently circulating in pig populations in China. The highest median tissue culture infectious dose of strain HM2017 after 15 passages in Vero cells was 1.33 x 10(7) viral particles/mL. Strain HM2017 was highly virulent to suckling piglets, which exhibited clinical symptoms at 12 h post-infection (hpi) (i.e., weight loss at 12-84 hpi, increased body temperatures at 24-48 hpi, high viral loads in the jejunum and ileum, and 100% mortality by 84 hpi).
   Conclusion: The present study reports a variant subgroup GII-a PEDV HM2017 strain in China and characterize its pathogenicity. PEDV strain HM2017 of subgroup GII-a presents a promising vaccine candidate for the control of PED outbreaks in China.
C1 [Yang, Dan; Su, Mingjun; Li, Chunqiu; Zhang, Bei; Qi, Shanshan; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Lab Prevent & Control Swine Infect Dis, Daqing, Peoples R China.
   [Sun, Dongbo; Yin, Baishuang] Jilin Agr Sci & Technol Univ, Coll Anim Sci & Technol, Jilin, Jilin, Peoples R China.
RP Sun, DB (reprint author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Lab Prevent & Control Swine Infect Dis, Daqing, Peoples R China.; Yin, BS (reprint author), Jilin Agr Sci & Technol Univ, Coll Anim Sci & Technol, Jilin, Jilin, Peoples R China.
EM dongbosun@126.com; ybs3421@126.com
FU National Key Research and Development Program of China
   [2017YFD0501604-5]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31873011]; Outstanding Youth
   Science Foundation of Heilongjiang province [JC2017007]; Heilongjiang
   Province Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [LBH-Q16188]; Graduate innovative research projects in
   Heilongjiang Bayi Agricultural University [YJSCX2018-Z02/YJSCX2017-Z02]
FX This work was supported by the National Key Research and Development
   Program of China (grant no. 2017YFD0501604-5), the National Natural
   Science Foundation of China (grant no. 31873011), the Outstanding Youth
   Science Foundation of Heilongjiang province (grant no. JC2017007), the
   Heilongjiang Province Postdoctoral Science Foundation (grant no.
   LBH-Q16188), and Graduate innovative research projects in Heilongjiang
   Bayi Agricultural University (YJSCX2018-Z02/YJSCX2017-Z02).
CR Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544
   Chen JF, 2012, J VIROL, V86, P3408, DOI 10.1128/JVI.07150-11
   Chen PF, 2019, INFECT GENET EVOL, V69, P153, DOI 10.1016/j.meegid.2019.01.022
   Chen Q, 2016, J GEN VIROL, V97, P1107, DOI 10.1099/jgv.0.000419
   Chen XL, 2019, MICROB PATHOGENESIS, V129, P43, DOI 10.1016/j.micpath.2019.01.017
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   Fan BC, 2017, VIROLOGY, V500, P50, DOI 10.1016/j.virol.2016.10.011
   Gallien S, 2019, VET MICROBIOL, V228, P20, DOI 10.1016/j.vetmic.2018.09.025
   Gallien S, 2018, VET MICROBIOL, V226, P9, DOI 10.1016/j.vetmic.2018.09.023
   Guo JH, 2019, TRANSBOUND EMERG DIS, V66, P111, DOI 10.1111/tbed.12991
   Hanke D, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070177
   Hou YX, 2017, J VIROL, V91, DOI 10.1128/JVI.00227-17
   Jiang N, 2018, J VET MED SCI, V80, P590, DOI 10.1292/jvms.17-0581
   Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685
   Lee S, 2015, VIRUS RES, V208, P215, DOI 10.1016/j.virusres.2015.07.010
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002
   Lin CM, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1756-x
   Lin CM, 2017, VET MICROBIOL, V201, P62, DOI 10.1016/j.vetmic.2017.01.015
   Lin CM, 2016, VIRUS RES, V226, P20, DOI 10.1016/j.virusres.2016.05.023
   Liu XS, 2019, VET MICROBIOL, V230, P278, DOI 10.1016/j.vetmic.2019.02.018
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Niederwerder MC, 2018, TRANSBOUND EMERG DIS, V65, P660, DOI 10.1111/tbed.12823
   Park JE, 2018, VET MICROBIOL, V221, P19, DOI 10.1016/j.vetmic.2018.05.012
   PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   SHI W, 2017, VIRUSES-BASEL, V9, P10019, DOI DOI 10.3390/V9010019
   Sun DB, 2016, J VET MED SCI, V78, P355, DOI 10.1292/jvms.15-0446
   Sun YK, 2019, INFECT GENET EVOL, V70, P24, DOI 10.1016/j.meegid.2019.02.013
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wang DC, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5063603
   Wang EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160561
   Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195
   Wang YH, 2015, VIRUS RES, V208, P82, DOI 10.1016/j.virusres.2015.06.009
   Yamamoto R, 2015, RES VET SCI, V103, P103, DOI 10.1016/j.rvsc.2015.09.024
   Yang DK, 2018, J VET SCI, V19, P71, DOI 10.4142/jvs.2018.19.1.71
   Zhang LP, 2019, ARCH VIROL, V164, P1287, DOI 10.1007/s00705-019-04167-3
   Zhu TJ, 2019, INFECT GENET EVOL, V71, P82, DOI 10.1016/j.meegid.2019.03.015
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD MAR
PY 2020
VL 140
AR 103922
DI 10.1016/j.micpath.2019.103922
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KR5NL
UT WOS:000517665000011
PM 31838173
OA Bronze
DA 2020-04-03
ER

PT J
AU Yuan, Y
   Qi, JX
   Peng, RC
   Li, CR
   Lu, GW
   Yan, JH
   Wang, QH
   Gao, GF
AF Yuan, Yuan
   Qi, Jianxun
   Peng, Ruchao
   Li, Chunrui
   Lu, Guangwen
   Yan, Jinghua
   Wang, Qihui
   Gao, George Fu
TI Molecular Basis of Binding between Middle East Respiratory Syndrome
   Coronavirus and CD26 from Seven Bat Species
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE interspecies transmission; MERS-RBD; evolution; bat CD26; receptor;
   MERS-CoV
ID MERS-COV; SPIKE PROTEIN; SARS-COV; RECEPTOR; BETACORONAVIRUS;
   TRANSMISSION; REPLICATION; INFECTION; EVOLUTION
AB Continued reports of Middle East respiratory syndrome coronavirus (MERS-CoV) infecting humans have occurred since the identification of this virus in 2012. MERS-CoV is prone to cause endemic disease in the Middle East, with several dozen spillover infections to other continents. It is hypothesized that MERS-CoV originated from bat coronaviruses and that dromedary camels are its natural reservoir. Although gene segments identical to MERS-CoV were sequenced from certain species of bats and one species experimentally shed the virus, it is still unknown whether other bats can transmit the virus. Here, at the molecular level, we found that all purified bat CD26s (bCD26s) from a diverse range of species interact with the receptor binding domain (RBD) of MERS-CoV, with equilibrium dissociation constant values ranging from several to hundreds at the micromolar level. Moreover, all bCD26s expressed in this study mediated the entry of pseudotyped MERS-CoV to receptor-expressing cells, indicating the broad potential engagement of bCD26s as MERS-CoV receptors. Further structural analysis indicated that in the bat receptor, compared to the human receptor, substitutions of key residues and their adjacent amino acids leads to decreased binding affinity to the MERS-RBD. These results add more evidence to the existing belief that bats are the original source of MERS-CoV and suggest that bCD26s in many species can mediate the entry of the virus, which has significant implications for the surveillance and control of MERS-CoV infection.
   IMPORTANCE In this study, we found that bat CD26s (bCD26s) from different species exhibit large diversities, especially in the region responsible for binding to the receptor binding domain (RBD) of Middle East respiratory syndrome coronavirus (MERS-CoV). However, they maintain the interaction with MERS-RBD at varied affinities and support the entry of pseudotyped MERS-CoV. These bat receptors polymorphisms seem to confer evolutionary pressure for the adaptation of CD26-binding virus, such as the ancestor of MERS-CoV, and led to the generation of diversified CD26-engaging CoV strains. Thus, our data add more evidence to support that bats are the reservoir of MERS-CoV and similar viruses, as well as further emphasize the necessity to survey MERS-CoV and other CoVs among bats.
C1 [Yuan, Yuan; Qi, Jianxun; Peng, Ruchao; Li, Chunrui; Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Lu, Guangwen] Sichuan Univ, West China Hosp, Emergency Dept, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Lu, Guangwen] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China.
   [Lu, Guangwen] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Yan, Jinghua; Wang, Qihui] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.
   [Yan, Jinghua; Wang, Qihui; Gao, George Fu] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Gao, George Fu] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George Fu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Gao, GF (reprint author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Wang, QH (reprint author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.; Wang, QH; Gao, GF (reprint author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Gao, GF (reprint author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF (reprint author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM wangqihui@im.ac.cn; gaof@im.ac.cn
FU National Key Plan for Scientific Research and Development of China
   [2016YFD0500305]; NSFCNational Natural Science Foundation of China
   [81922044, 81973228, 31570157]; Youth Innovation Promotion Association
   CAS [2018119]; Foundation of the NSFC Innovative Research Group
   [81621091]
FX This study was supported by the National Key Plan for Scientific
   Research and Development of China (grant 2016YFD0500305). G.L. is
   supported by NSFC (grant 31570157). Q.W. is supported by the Youth
   Innovation Promotion Association CAS (grant 2018119) and NSFC (grants
   81922044 and 81973228). J.Y and G.F.G. are supported by the Foundation
   of the NSFC Innovative Research Group (grant 81621091).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Adney DR, 2016, EMERG INFECT DIS, V22, P1031, DOI [10.3201/eid2206.160192, 10.3201/2206.160192]
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Cai YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112060
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Dingle H, 1996, MIGRATION BIOL LIFE
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946
   Knipe DM, 2013, FIELDS VIROLOGY
   Letko M, 2018, CELL REP, V24, P1730, DOI 10.1016/j.celrep.2018.07.045
   Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   Munster VJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21878
   Peck KM, 2017, J VIROL, V91, DOI 10.1128/JVI.00534-17
   Peck KM, 2015, J VIROL, V89, P4696, DOI 10.1128/JVI.03445-14
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   Reusken CBEM, 2016, EMERG INFECT DIS, V22, P1129, DOI 10.3201/eid2206.152113
   Wang QH, 2016, ANTIVIR RES, V133, P165, DOI 10.1016/j.antiviral.2016.07.015
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhu JQ, 2004, BIOCHEM BIOPH RES CO, V319, P283, DOI 10.1016/j.bbrc.2004.04.141
NR 32
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01387-19
DI 10.1128/JVI.01387-19
PG 13
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000006
PM 31776269
OA Bronze
DA 2020-04-03
ER

PT J
AU Al-Ahmadi, K
   Alahmadi, M
   Al-Zahrani, A
AF Al-Ahmadi, Khalid
   Alahmadi, Mohammed
   Al-Zahrani, Ali
TI Spatial association between primary Middle East respiratory syndrome
   coronavirus infection and exposure to dromedary camels in Saudi Arabia
SO ZOONOSES AND PUBLIC HEALTH
LA English
DT Article; Early Access
DE dromedary camels; epidemiology; geographic information system; MERS-CoV;
   Saudi Arabia; zoonosis
ID MERS-COV; RISK; EPIDEMIOLOGY; TRANSMISSION; ANTIBODIES
AB Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic disease. Exposure to dromedary camels (Camelus dromedaries) has been consistently considered the main source of primary human infection. Although Saudi Arabia reports the highest rate of human MERS-CoV infection and has one of the largest populations of dromedary camels worldwide, their spatial association has not yet been investigated. Thus, this study aimed to examine the correlation between the spatial distribution of primary MERS-CoV cases with or without a history of camel exposure reported between 2012 and 2019 and dromedary camels at the provincial level in Saudi Arabia. In most provinces, a high proportion of older men develop infections after exposure to camels. Primary human infections during spring and winter were highest in provinces characterized by seasonal breeding and calving, increased camel mobilization and camel-human interactions. A strong and significant association was found between the total number of dromedary camels and the numbers of primary camel-exposed and non-exposed MERS-CoV cases. Furthermore, spatial correlations between MERS-CoV cases and camel sex, age and dairy status were significant. Via a cluster analysis, we identified Riyadh, Makkah and Eastern provinces as having the most primary MERS-CoV cases and the highest number of camels. Transmission of MERS-CoV from camels to humans occurs in most primary cases, but there is still a high proportion of primary infections with an ambiguous link to camels. The results from this study include significant correlations between primary MERS-CoV cases and camel populations in all provinces, regardless of camel exposure history. This supports the hypothesis of the role of an asymptomatic human carrier or, less likely, an unknown animal host that has direct contact with both infected camels and humans. In this study, we performed a preliminary risk assessment of prioritization measures to control the transmission of infection from camels to humans.
C1 [Al-Ahmadi, Khalid; Alahmadi, Mohammed] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia.
   [Al-Zahrani, Ali] King Faisal Specialist Hosp & Res Ctr, POB 3354, Riyadh 11211, Saudi Arabia.
RP Al-Zahrani, A (reprint author), King Faisal Specialist Hosp & Res Ctr, POB 3354, Riyadh 11211, Saudi Arabia.
EM alisaz@kfshrc.edu.sa
OI Al-Zahrani, Ali/0000-0001-9183-6150
FU King Abdulaziz City for Science and Technology and King Faisal
   Specialist Hospital and Research Centre
FX The authors wish to express their gratitude to King Abdulaziz City for
   Science and Technology and King Faisal Specialist Hospital and Research
   Centre for supporting this study and the Saudi Ministry of Health and
   the World Health Organization for providing the data.
CR Abbas B., 2000, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V53, P293
   Abdallah HR, 2013, EMIR J FOOD AGR, V25, P250, DOI 10.9755/ejfa.v25i4.15491
   Al-Tawfiq JA, 2014, INFECT DRUG RESIST, V7, P281, DOI 10.2147/IDR.S51283
   Alagaili AN, 2014, MBIO, V5, DOI 10.1128/mBio.00884-14
   Ali M, 2017, EUROSURVEILLANCE, V22, P19, DOI 10.2807/1560-7917.ES.2017.22.11.30487
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340
   Alshukairi AN, 2018, MBIO, V9, DOI [10.1128/mBio.01985-18, 10.1128/mbio.01985-18]
   Auty R.M., 2001, RESOURCE ABUNDANCE E
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Corman VM, 2012, EUROSURVEILLANCE, V17, P2
   Dudas G, 2018, ELIFE, V7, DOI 10.7554/eLife.37324
   Duque JC, 2007, INT REGIONAL SCI REV, V30, P195, DOI 10.1177/0160017607301605
   Elfadil AAM, 2018, REV SCI TECH OIE, V37, P985, DOI 10.20506/rst.37.3.2901
   Faye B, 2014, EMIR J FOOD AGR, V26, P359, DOI 10.9755/ejfa.v26i4.17278
   Faye B, 2013, CAMEL MEAT AND MEAT PRODUCTS, P7, DOI 10.1079/9781780641010.0007
   General Authority for Statistics, 2010, GEN POP HOUS CENS
   General Authority for Statistics, 2015, DET RES AGR CENS 201
   GeoDa<(TM)>v1.12, 2018, SOFTWARE EXPLORATORY
   Gikonyo S, 2018, ECOHEALTH, V15, P372, DOI 10.1007/s10393-018-1317-6
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P2093, DOI 10.1111/tbed.12630
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401
   Hemida MG, 2013, EUROSURVEILLANCE, V18, P21, DOI 10.2807/1560-7917.ES2013.18.50.20659
   Kandeil A, 2019, EMERG MICROBES INFEC, V8, P103, DOI 10.1080/22221751.2018.1560235
   Kasem S, 2018, J INFECT PUBLIC HEAL, V11, P331, DOI [10.1016/j.jiph.2017.00.022, 10.1016/j.jiph.2017.09.022]
   Kayali G, 2015, LANCET INFECT DIS, V15, P495, DOI 10.1016/S1473-3099(15)70128-3
   Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070
   Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402
   Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746
   Ministry of Environment Water and Agriculture, 2019, ENV EN VET EST DIG C
   Ministry of Health in Saudi Arabia, 2019, COMM CONTR CTR
   Ministry of Health in Saudi Arabia, 2018, MIDDL E RESP SYNDR C
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Padalino B, 2015, EMIR J FOOD AGR, V27, P338, DOI 10.9755/ejfa.v27i4.19909
   Pimpler E., 2017, SPATIAL ANAL ARCGIS
   Reeves Tarian, 2015, BMC Res Notes, V8, P801, DOI 10.1186/s13104-015-1789-1
   Reusken CB, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.23.20829
   Reusken CB, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.50.20662
   Sikkema RS, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800345X, 10.1017/s0950268819000669]
   Uerpmann Hans-Peter, 2002, J OMAN STUDIES, V12, P235
   World Health Organization, 2019, EM PREP RESP DIS OUT
   World Health Organization, 2019, EM MIDDL E RESP SYND
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 44
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1863-1959
EI 1863-2378
J9 ZOONOSES PUBLIC HLTH
JI Zoonoses Public Health
DI 10.1111/zph.12697
EA FEB 2020
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
GA KQ5SE
UT WOS:000516981100001
PM 32112508
OA Bronze
DA 2020-04-03
ER

PT J
AU Chen, TM
   Rui, J
   Wang, QP
   Zhao, ZY
   Cui, JA
   Yin, L
AF Chen, Tian-Mu
   Rui, Jia
   Wang, Qiu-Peng
   Zhao, Ze-Yu
   Cui, Jing-An
   Yin, Ling
TI A mathematical model for simulating the phase-based transmissibility of
   a novel coronavirus
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Novel coronavirus; Mathematical model; Basic reproduction number; Next
   generation matrix; Transmissibility
ID RESPIRATORY SYNDROME CORONAVIRUS; INFLUENZA; EPIDEMIC; DISEASE; SARS
AB Background As reported by the World Health Organization, a novel coronavirus (2019-nCoV) was identified as the causative virus of Wuhan pneumonia of unknown etiology by Chinese authorities on 7 January, 2020. The virus was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by International Committee on Taxonomy of Viruses on 11 February, 2020. This study aimed to develop a mathematical model for calculating the transmissibility of the virus. Methods In this study, we developed a Bats-Hosts-Reservoir-People transmission network model for simulating the potential transmission from the infection source (probably be bats) to the human infection. Since the Bats-Hosts-Reservoir network was hard to explore clearly and public concerns were focusing on the transmission from Huanan Seafood Wholesale Market (reservoir) to people, we simplified the model as Reservoir-People (RP) transmission network model. The next generation matrix approach was adopted to calculate the basic reproduction number (R-0) from the RP model to assess the transmissibility of the SARS-CoV-2. Results The value of R-0 was estimated of 2.30 from reservoir to person and 3.58 from person to person which means that the expected number of secondary infections that result from introducing a single infected individual into an otherwise susceptible population was 3.58. Conclusions Our model showed that the transmissibility of SARS-CoV-2 was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than MERS in the Republic of Korea.
C1 [Chen, Tian-Mu; Rui, Jia; Wang, Qiu-Peng; Zhao, Ze-Yu] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, 4221-117 South Xiangan Rd, Xiamen, Fujian, Peoples R China.
   [Cui, Jing-An] Beijing Univ Civil Engn & Architecture, Sch Sci, Dept Math, Beijing, Peoples R China.
   [Yin, Ling] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.
RP Chen, TM (reprint author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, 4221-117 South Xiangan Rd, Xiamen, Fujian, Peoples R China.
EM 13698665@qq.com
OI Chen, Tianmu/0000-0003-0710-5086
FU Xiamen New Coronavirus Prevention and Control Emergency Tackling Special
   Topic Program [3502Z2020YJ03]
FX This study was supported by Xiamen New Coronavirus Prevention and
   Control Emergency Tackling Special Topic Program (No: 3502Z2020YJ03).
CR Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa008
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen SL, 2019, PUBLIC HEALTH, V174, P42, DOI 10.1016/j.puhe.2019.05.032
   Chen T, 2020, MATH MODEL SIMULATIN
   Chen TM, 2017, EPIDEMIOL INFECT, V145, P424, DOI [10.1017/s0950268816002508, 10.1017/S0950268816002508]
   Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015
   Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006
   China Business Network, WUH CIT HAS PERM FLO
   Cui JA, 2020, APPL MATH LETT, V103, DOI 10.1016/j.aml.2019.106203
   Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Japan MoH, DEV PAT PNEUM ASS NE
   Li Q, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2001316, DOI 10.1056/NEJM0A2001316]
   Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717
   Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   TAKEFOTO.CN, WUH CIT SET TEMP DET
   World Health Organization, NOV COR JAP EXCH
   World Health Organization, NOV COR THAIL EXCH
   World Health Organization, NOV COR CHIN
   World Health Organization (WHO), COR
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wuhan Government, POPULATION DISTRIBUT
   Xia ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144778
   Yi B, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007659
   Zhang Siyu, 2020, Sci Rep, V10, P119, DOI 10.1038/s41598-019-56850-9
   Zhang XS, 2017, INFLUENZA OTHER RESP, V11, P434, DOI 10.1111/irv.12467
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zhou GF, 2003, EMERG INFECT DIS, V9, P1608
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 34
TC 0
Z9 0
U1 23
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD FEB 28
PY 2020
VL 9
IS 1
AR 24
DI 10.1186/s40249-020-00640-3
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KR4BT
UT WOS:000517564300001
PM 32111262
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Fisher, D
   Heymann, D
AF Fisher, Dale
   Heymann, David
TI Q&A: The novel coronavirus outbreak causing COVID-19
SO BMC MEDICINE
LA English
DT Article
C1 [Fisher, Dale] Natl Univ Hlth Syst, Univ Med Cluster, Div Infect Dis, Singapore, Singapore.
   [Fisher, Dale] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Heymann, David] London Sch Hyg & Trop Med, London, England.
RP Fisher, D (reprint author), Natl Univ Hlth Syst, Univ Med Cluster, Div Infect Dis, Singapore, Singapore.; Fisher, D (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
EM mdcfda@nus.edu.sg
CR Anita Patel, 2020, MMWR MORBIDITY MORTA, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 6
TC 0
Z9 0
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD FEB 28
PY 2020
VL 18
IS 1
AR 57
DI 10.1186/s12916-020-01533-w
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU8CQ
UT WOS:000519939900001
PM 32106852
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Bordi, L
   Nicastri, E
   Scorzolini, L
   Di Caro, A
   Capobianchi, MR
   Castilletti, C
   Lalle, E
AF Bordi, Licia
   Nicastri, Emanuele
   Scorzolini, Laura
   Di Caro, Antonino
   Capobianchi, Maria R.
   Castilletti, Concetta
   Lalle, Eleonora
CA INMI COVID-19 Study Grp
TI Differential diagnosis of illness in patients under investigation for
   the novel coronavirus (SARS-CoV-2), Italy, February 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID INFLUENZA
AB A novel coronavirus (SARS- CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.
C1 [Bordi, Licia; Nicastri, Emanuele; Scorzolini, Laura; Di Caro, Antonino; Capobianchi, Maria R.; Castilletti, Concetta; Lalle, Eleonora] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy.
RP Castilletti, C (reprint author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy.
EM concetta.castilletti@inmi.it
FU Ministero della SaluteMinistry of Health, Italy
FX This research was supported by funds to National Institute for
   Infectious Diseases `Lazzaro Spallanzani' IRCCS from: Ministero della
   Salute, Ricerca Corrente, linea1.
CR Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   European Centre for Disease Prevention and Control (ECDC), COVID 19 SIT UPD WOR
   Follin P, 2009, EUROSURVEILLANCE, V14, P1
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869
   Puro V, 2005, CLIN INFECT DIS, V40, P1068, DOI 10.1086/428359
   Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057
   WHO, 2019, GLOB SURV HUM INF CO
   WHO, 2020, WHO DIR GEN REM MED
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   World Health Organization (WHO), 2020, NOV COR
   Wu Yi-Chi, 2020, J Chin Med Assoc, DOI 10.1097/JCMA.0000000000000270
NR 14
TC 0
Z9 0
U1 17
U2 17
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 27
PY 2020
VL 25
IS 8
BP 2
EP 5
AR 2000170
DI 10.2807/1560-7917.ES.2020.25.8.2000170
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KS0UK
UT WOS:000518026900001
PM 32127123
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Chen, Y
   Cheng, J
   Jiang, Y
   Liu, KJ
AF Chen, Yu
   Cheng, Jin
   Jiang, Yu
   Liu, Keji
TI A time delay dynamic system with external source for the local outbreak
   of 2019-nCoV
SO APPLICABLE ANALYSIS
LA English
DT Article; Early Access
DE Y; S; Xu; Dynamic system; external source; prediction; 2019-nCoV
AB How to model the 2019 CoronaVirus (2019-nCov) spread in China is one of the most urgent and interesting problems in applied mathematics. In this paper, we propose a novel time delay dynamic system with external source to describe the trend of local outbreak for the 2019-nCoV. The external source is introduced in the newly proposed dynamic system, which can be considered as the suspected people travel to different areas. The numerical simulations exhibit the dynamic system with the external source is more reliable than the one without it, and the rate of isolation is extremely important for controlling the increase of cumulative confirmed people of 2019-nCoV. Based on our numerical simulation results with the public data, we suggest that the local government should have some more strict measures to maintain the rate of isolation. Otherwise the local cumulative confirmed people of 2019-nCoV might be out of control.
C1 [Chen, Yu; Jiang, Yu] Shanghai Univ Finance & Econ, Sch Math, Shanghai, Peoples R China.
   [Cheng, Jin] Fudan Univ, Sch Math Sci, Shanghai, Peoples R China.
   [Cheng, Jin] Fudan Univ, SKLCAM, Shanghai, Peoples R China.
   [Liu, Keji] Shanghai Univ Finance & Econ, Sch Math, Shanghai Key Lab Financial Informat Technol, Shanghai, Peoples R China.
RP Cheng, J (reprint author), Fudan Univ, Sch Math Sci, Shanghai, Peoples R China.; Cheng, J (reprint author), Fudan Univ, SKLCAM, Shanghai, Peoples R China.
EM jcheng@fudan.edu.cn
FU National Science Foundation of China [NSFC]National Natural Science
   Foundation of China [11971121]; Science and Technology Commission of
   Shanghai Municipality under the 'Shanghai Rising-Star Program'
   [19QA1403400]
FX Y This work of Jin Cheng was supported in part by the National Science
   Foundation of China [NSFC: No. 11971121], and the work of Keji Liu was
   substantially supported by the Science and Technology Commission of
   Shanghai Municipality under the `Shanghai Rising-Star Program' No.
   19QA1403400.
CR Canto B, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1078-5
   Chen Y, 2020, ARXIV200200418
   Kaipio J, 2005, STAT COMPUTATIONAL I
   Kaltenbacher B, 2008, RADON SER COMPUT APP, V6, P1, DOI 10.1515/9783110208276
   Ma E, 2004, MATH MODELS DYNAMICS
   Yan Y, 2020, SCI SIN MATH, V50, P1, DOI [10.1360/SSM-2020-0026, DOI 10.1360/SSM-2020-0026]
   刘畅, 2004, [科学通报, Chinese science bulletin], V49, P2245
NR 7
TC 0
Z9 0
U1 14
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0003-6811
EI 1563-504X
J9 APPL ANAL
JI Appl. Anal.
DI 10.1080/00036811.2020.1732357
EA FEB 2020
PG 12
WC Mathematics, Applied
SC Mathematics
GA KQ2EE
UT WOS:000516741100001
OA Bronze
DA 2020-04-03
ER

PT J
AU Emma, BH
AF Emma, Hodcroft B.
TI Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and
   Spain
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE COVID-19; SARS-CoV-2; coronavirus; cluster description; case description
AB Almost half of the confirmed COVID-19 cases detected so far in the United Kingdom are part of a large cluster of 13 British nationals who tested positive for SARS-CoV-2 in the UK, Spain, and France. Transmissions among this cluster occurred at a ski resort in France, and originated from a single infected traveller returning from a conference in Singapore where he acquired the virus. At least 21 individuals were exposed to the virus, tested, and quarantined, with 13 of those testing positive between the period of 6th February and 15th February. Here, all publicly available information about the primarily UK/France cluster is consolidated, providing a complete and accessible summary of the cases and their connections. Notable in this cluster are the number of individuals infected, the apparent absence of any severe illness among those infected, and a case of a "delayed positive" test during isolation after initially testing negative, at least 7 days after last possible contact.
C1 [Emma, Hodcroft B.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Emma, Hodcroft B.] Swiss Inst Bioinformat, Basel, Switzerland.
RP Emma, BH (reprint author), Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM croft@unibas.ch
CR [Anonymous], ARG
   [Anonymous], BBC NEWS
   [Anonymous], LOCAL
   [Anonymous], SUDDEUTSCHE ZEITUNG
   [Anonymous], STARS STRIPES
   [Anonymous], SUN
   [Anonymous], FIGARO
   [Anonymous], CHANNEL NEWS ASIA
   [Anonymous], SUDOUEST
   [Anonymous], MAJORCA DLY B
   [Anonymous], THE LOCAL
   Bal A, 2020, TECHNICAL REPORT
   Baldacchino J., FRANCE INTER
   Bazaraa D., MIRROR
   Bernard Stoecklin S, 2020, EUROSURVEILLANCE, V25, DOI [10.2807/1560-7917.ES.2020.25.6.2000094, DOI 10.2807/1560-7917.ES.2020.25.6.2000094]
   Bourgine B., FRANCE BLEU
   Bullmore H., ARG
   Campbell D, 2020, GUARD
   Charlton A., BUS INSID
   Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399
   CHURCHMAN L, ARG
   Coronavirus VG, LEPARISIEN
   Couzens G, MIRROR
   Couzens G., SUN
   Department of Health and Social Care, CMO CONF 4 CAS COR E
   Department of Health and Social Care, CHIEF MED OFF ENGL A
   Department of Health and Social Care, CMO CONF 3 CAS COR E
   DohertyCove J., ARG
   Donnelly L, TELEGR
   Elbe S, GLOB CHALLENGES, V1, P33
   Fagge N, MAIL ONLINE
   Fourgeaud G., FRANCE BLEU
   Guan Wj, 2020, CLIN CHARACTERISTICS, DOI DOI 10.1101/2020.02.06.20020974V1
   HartleyParkinson R., METRO
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ikonen C., ARG
   Jones J., REUTERS
   Koh A., SINGAPORE COVID 19 C
   La Conselleria de Salut i Consum, ELS RES CONF QUE HOM
   La Conselleria de Salut i Consum, MOSTR HOM INGR SON E
   La Conselleria de Salut i Consum, CONS SAL CONS ILL BA
   LC de Salut i Consum, 1 VEG MOSTR HOM ING
   LC de Salut i Consum, AN MOSTR 4 CAS INV C
   leDuc F, BRIGHT HOVE NEWS
   Merrifield N, PULSE TODAY
   Merrifield R., MIRROR
   Ministere des Solidarites et de la Sante, COR COVIN 19 DOUZ CA
   Ministry of Health, 2019, SING UPD COVID 19 CO
   Mullin G, SUN
   Murray J, GUARD
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Pennetier M., GLOB NEWS
   Perraudin F, GUARD
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Seedat J, 2020, 72020 R KOCH I
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Siddique H, GUARD
   Staff agencies, GUARD
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WKLY, V2, P1
   UK coronavirus, SKY NEWS
   Vaswani K., BBC NEWS
   Wadsworth J., BRIGHT HOVE NEWS
   Walker E., ARG
   Ward V, TELEGR
   Wee SL, NY TIMES
   WHO Emergency Committee, NOV COR 2019 NCOV SI
   Yu Ping, 2020, J Infect Dis, DOI 10.1093/infdis/jiaa077
   Zhang WJ, 2019, ANAL LETT, DOI 10.1080/00032719.2019.1702669
NR 68
TC 0
Z9 0
U1 15
U2 15
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD FEB 27
PY 2020
VL 150
AR w20212
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA KS3IS
UT WOS:000518204500001
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Okada, P
   Buathong, R
   Phuygun, S
   Thanadachakul, T
   Parnmen, S
   Wongboot, W
   Waicharoen, S
   Wacharapluesadee, S
   Uttayamakul, S
   Vachlraphan, A
   Chittaganpitch, M
   Mekha, N
   Janejai, N
   Iamsirithaworn, S
   Lee, RTC
   Maurer-Stroh, S
AF Okada, Pilailuk
   Buathong, Rome
   Phuygun, Siripaporn
   Thanadachakul, Thanutsapa
   Parnmen, Sittiporn
   Wongboot, Warawan
   Waicharoen, Sunthareeya
   Wacharapluesadee, Supaporn
   Uttayamakul, Sumonmal
   Vachlraphan, Apichart
   Chittaganpitch, Malinee
   Mekha, Nanthawan
   Janejai, Noppavan
   Iamsirithaworn, Sopon
   Lee, Raphael T. C.
   Maurer-Stroh, Sebastian
TI Early transmission patterns of coronavirus disease 2019 (COVID-19) in
   travellers from Wuhan to Thailand, January 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID OUTBREAK
AB We report two cases of coronavirus disease 2019 (COVID-19) in travellers from Wuhan, China to Thailand. Both were independent introductions on separate flights, discovered with thermoscanners and confirmed with RT-PCR and genome sequencing. Both cases do not seem directly linked to the Huanan Seafood Market in Hubei but the viral genomes are identical to four other sequences from Wuhan, suggesting early spread within the city already in the first week of January.
C1 [Okada, Pilailuk; Phuygun, Siripaporn; Thanadachakul, Thanutsapa; Parnmen, Sittiporn; Wongboot, Warawan; Waicharoen, Sunthareeya; Chittaganpitch, Malinee; Mekha, Nanthawan; Janejai, Noppavan] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand.
   [Buathong, Rome; Uttayamakul, Sumonmal; Vachlraphan, Apichart; Iamsirithaworn, Sopon] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand.
   [Wacharapluesadee, Supaporn] Chulalongkorn Univ, Hlth Sci Ctr, Thai Red Cross Emerging Infect Dis, Bangkok, Thailand.
   [Lee, Raphael T. C.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.
   [Maurer-Stroh, Sebastian] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
RP Okada, P (reprint author), Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand.
EM pilailuk.o@dmsc.mail.go.th
CR Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Crossley G., 2020, REUTERS
   Department of Medical Sciences Ministry of Public Health Thailand, 2020, DIAGN DET NOV COR 20
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Du Toit A, 2020, NAT REV MICROBIOL, V18, P123, DOI 10.1038/s41579-020-0332-0
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M308
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Naess A, 2017, INFECTION, V45, P299, DOI 10.1007/s15010-016-0972-1
   Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 20
TC 0
Z9 0
U1 11
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 27
PY 2020
VL 25
IS 8
BP 6
EP 10
AR 2000097
DI 10.2807/1560-7917.ES.2020.25.8.2000097
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KS0UK
UT WOS:000518026900002
PM 32127124
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Vichier-Guerre, S
   Ku, TRC
   Pochet, S
   Seley-Radtke, KL
AF Vichier-Guerre, Sophie
   Ku, Therese C.
   Pochet, Sylvie
   Seley-Radtke, Katherine L.
TI An Expedient Synthesis of Flexible Nucleosides through Enzymatic
   Glycosylation of Proximal and Distal Fleximer Bases
SO CHEMBIOCHEM
LA English
DT Article; Early Access
DE biocatalysis; deoxyribosyltransferase; fleximers; nucleosides; purine
   nucleoside phosphorylase
ID LACTOBACILLUS-HELVETICUS; ANTIVIRAL ACTIVITY; DESIGN; SERIES;
   RECOGNITION; NUCLEOBASES; PYRIMIDINE
AB The structurally unique "fleximer" nucleosides were originally designed to investigate how flexibility in a nucleobase could potentially affect receptor-ligand recognition and function. Recently they have been shown to have low-to-sub-micromolar levels of activity against a number of viruses, including coronaviruses, filoviruses, and flaviviruses. However, the synthesis of distal fleximers in particular has thus far been quite tedious and low yielding. As a potential solution to this issue, a series of proximal fleximer bases (flex-bases) has been successfully coupled to both ribose and 2 '-deoxyribose sugars by using the N-deoxyribosyltransferase II of Lactobacillus leichmannii (LlNDT) and Escherichia coli purine nucleoside phosphorylase (PNP). To explore the range of this facile approach, transglycosylation experiments on a thieno-expanded tricyclic heterocyclic base, as well as several distal and proximal flex-bases were performed to determine whether the corresponding fleximer nucleosides could be obtained in this fashion, thus potentially significantly shortening the route to these biologically significant compounds. The results of those studies are reported herein.
C1 [Vichier-Guerre, Sophie; Pochet, Sylvie] Inst Pasteur, CNRS, UMR3523, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75015 Paris, France.
   [Ku, Therese C.; Seley-Radtke, Katherine L.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
RP Pochet, S (reprint author), Inst Pasteur, CNRS, UMR3523, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75015 Paris, France.; Seley-Radtke, KL (reprint author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
EM sylvie.pochet@pasteur.fr; kseley@umbc.edu
RI Seley-Radtke, Katherine/E-5362-2010
OI Seley-Radtke, Katherine/0000-0002-0154-3459; Ku,
   Therese/0000-0002-8353-4985
FU Institut Pasteur; Centre National de la Recherche Scientifique
   (CNRS)Centre National de la Recherche Scientifique (CNRS); National
   Institutes of Health/NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21 AI118470-01, T32 GM066706]
FX The authors from the IP would like to thank Frederic Bonhomme (UMR3523)
   for assisting with HRMS analysis and Drs. Bruno Vitorge and Inaki
   Guijarro (BioNMR platform) for providing access to Avance 600 and Avance
   Neo 800 spectrometers. This work was funded by the Institut Pasteur and
   the Centre National de la Recherche Scientifique (CNRS; S.V.-G. and
   S.P.) and the National Institutes of Health/NIAID R21 AI118470-01
   (K.S.-R.) and T32 GM066706 (K.S.-R. and T.K.).
CR BETBEDER D, 1990, NUCLEOS NUCLEOT, V9, P569, DOI 10.1080/07328319008045188
   CARDINAUD R, 1979, BIOCHIM BIOPHYS ACTA, V568, P339, DOI 10.1016/0005-2744(79)90301-2
   CARSON DA, 1988, BIOCHEM BIOPH RES CO, V155, P829, DOI 10.1016/S0006-291X(88)80570-9
   Chen Z, 2015, ACS INFECT DIS, V1, P357, DOI 10.1021/acsinfecdis.5b00029
   Condezo L. A., 2006, BIOCATALYSIS PHARM B
   DANZIN C, 1976, EUR J BIOCHEM, V62, P365, DOI 10.1111/j.1432-1033.1976.tb10168.x
   del Arco J, 2019, ORG BIOMOL CHEM, V17, P7891, DOI 10.1039/c9ob01315f
   Downey AM, 2017, CHEM-EUR J, V23, P3910, DOI 10.1002/chem.201604955
   Fateev IV, 2015, CHEM-EUR J, V21, P13401, DOI 10.1002/chem.201501334
   Fateev IV, 2014, BEILSTEIN J ORG CHEM, V10, P1657, DOI 10.3762/bjoc.10.173
   Fernandez-Lucas J., 2018, ENZYMATIC CHEM SYNTH
   Fresco-Taboada A, 2013, APPL MICROBIOL BIOT, V97, P3773, DOI 10.1007/s00253-013-4816-y
   HENNEN WJ, 1989, J ORG CHEM, V54, P4692, DOI 10.1021/jo00280a046
   Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200
   KRENITSKY TA, 1981, BIOCHEMISTRY-US, V20, P3615, DOI 10.1021/bi00515a048
   Ku C. T., 2019, ENZYMATIC CHEM SYNTH, P195
   Ku T, 2019, BIOORGAN MED CHEM, V27, P2883, DOI 10.1016/j.bmc.2019.05.019
   Merino P., 2013, CHEM SYNTHESIS NUCLE
   Mikhailopulo IA, 2010, ACTA NATURAE, V2, P36, DOI 10.32607/20758251-2010-2-2-36-58
   Mikhailopulo IA, 2007, CURR ORG CHEM, V11, P317, DOI 10.2174/138527207780059330
   Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661
   Perez E, 2018, CHEMCATCHEM, V10, P4406, DOI 10.1002/cctc.201800775
   Peters HL, 2015, CURR MED CHEM, V22, P3910, DOI 10.2174/0929867322666150818103624
   POCHET S, 1995, BIOORG MED CHEM LETT, V5, P1679, DOI 10.1016/0960-894X(95)00280-7
   Polak M, 2004, J AM CHEM SOC, V126, P8159, DOI 10.1021/ja0498078
   Quirk S, 2005, BIOCHEMISTRY-US, V44, P13172, DOI 10.1021/bi051288d
   Quirk S, 2005, BIOCHEMISTRY-US, V44, P10854, DOI 10.1021/bi0503605
   Seley KL, 2005, ORG LETT, V7, P63, DOI 10.1021/ol047895v
   Seley KL, 2003, BIOORG MED CHEM LETT, V13, P1985, DOI 10.1016/S0960-894X(03)00331-7
   Seley KL, 2002, J ORG CHEM, V67, P3365, DOI 10.1021/jo0255476
   Seley KL, 2000, J MED CHEM, V43, P4877, DOI 10.1021/jm000326i
   Seley KL, 2001, ORG LETT, V3, P3209, DOI 10.1021/ol0165443
   Slater MJ, 1996, BIOORG MED CHEM LETT, V6, P2787, DOI 10.1016/S0960-894X(96)00514-8
   Stachelska-Wierzchowska A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081493
   Tomney M, 2010, ANTIVIR RES, V86, pA68, DOI 10.1016/j.antiviral.2010.02.472
   Townsend L. B., 1978, NUCLEIC ACID CHEM IM
   VanDraanen NA, 1996, J MED CHEM, V39, P538, DOI 10.1021/jm950701k
   Vichier-Guerre S, 2017, ORG BIOMOL CHEM, V15, P8193, DOI 10.1039/c7ob01850a
   Vichier-Guerre S, 2016, ORG BIOMOL CHEM, V14, P3638, DOI 10.1039/c6ob00405a
   Vichier-Guerre S, 2014, TETRAHEDRON LETT, V55, P6347, DOI 10.1016/j.tetlet.2014.09.104
   Vorbruggen H., 2001, HDB NUCLEOSIDE SYNTH
   Wauchope OR, 2012, SYNTHESIS-STUTTGART, V44, P3496, DOI 10.1055/s-0032-1316791
   Wauchope OR, 2010, ORG LETT, V12, P4466, DOI 10.1021/ol101482h
   Ye WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097358
   Zhang ZB, 2008, TETRAHEDRON, V64, P10791, DOI 10.1016/j.tet.2008.09.011
   Zucman-Rossi J, 2009, B CANCER, V96, P45, DOI 10.1684/bdc.2009.0792
NR 46
TC 0
Z9 0
U1 4
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
DI 10.1002/cbic.201900714
EA FEB 2020
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA KQ1BB
UT WOS:000516664100001
PM 31899839
OA Bronze
DA 2020-04-03
ER

PT J
AU Gao, PC
   Zhang, H
   Wu, ZW
   Wang, JC
AF Gao, Peichao
   Zhang, Hong
   Wu, Zhiwei
   Wang, Jicheng
TI Visualising the expansion and spread of coronavirus disease 2019 by
   cartograms
SO ENVIRONMENT AND PLANNING A-ECONOMY AND SPACE
LA English
DT Article; Early Access
DE Cartogram; visualisation; graphic
AB Coronavirus disease 2019 (COVID-19) has emerged as a growing focus of global attention and a critical factor in public-health decision making. Towards fighting the COVID-19 outbreak, countries worldwide and international organisations have taken various actions, including promoting the transparency of and public access to disease data. In such public communications, maps have played an important role in that a map is worth a thousand words. Most of these have taken the form of a choropleth map. Here, we propose employing cartograms to visualise both the expansion and spread of COVID-19. We designed a combination of six circular cartograms containing the data of confirmed cases every 48 hours from 24 January to 3 February 2020. Such a design conveys both spatial and temporal information more intuitively and efficiently, so it can be expected to facilitate better public participation in the fight against COVID-19.
C1 [Gao, Peichao] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China.
   [Gao, Peichao] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China.
   [Zhang, Hong; Wu, Zhiwei; Wang, Jicheng] Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu 611756, Sichuan, Peoples R China.
   [Wang, Jicheng] Hong Kong Polytech Univ, Geoinformat, Hong Kong, Peoples R China.
   [Wang, Jicheng] Dept Land Surveying, Chengdu, Sichuan, Peoples R China.
RP Zhang, H (reprint author), Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu 611756, Sichuan, Peoples R China.
EM zhangh2011@swjtu.edu.cn
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2019NTST02]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: This
   research was supported by the Fundamental Research Funds for the Central
   Universities (Grant No. 2019NTST02).
CR [Anonymous], 2020, NOV COR 2019 NCOV
   Dorling D, 1996, AREA CARTOGRAMS THEI
   Gao PC, 2019, J SPAT SCI, V64, P239, DOI 10.1080/14498596.2018.1440649
   Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042
NR 4
TC 0
Z9 0
U1 43
U2 43
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0308-518X
EI 1472-3409
J9 ENVIRON PLANN A
JI Environ. Plan. A
AR 0308518X20910162
DI 10.1177/0308518X20910162
EA FEB 2020
PG 4
WC Environmental Studies; Geography
SC Environmental Sciences & Ecology; Geography
GA KQ4LZ
UT WOS:000516897400001
OA Bronze
DA 2020-04-03
ER

PT J
AU Gostic, K
   Gomez, ACR
   Mummah, RO
   Kucharski, AJ
   Lloyd-Smith, JO
AF Gostic, Katelyn
   Gomez, Ana C. R.
   Mummah, Riley O.
   Kucharski, Adam J.
   Lloyd-Smith, James O.
TI Estimated effectiveness of symptom and risk screening to prevent the
   spread of COVID-19
SO ELIFE
LA English
DT Article
ID SYSTEMS; WUHAN
AB Traveller screening is being used to limit further spread of COVID-19 following its recent emergence, and symptom screening has become a ubiquitous tool in the global response. Previously, we developed a mathematical model to understand factors governing the effectiveness of traveller screening to prevent spread of emerging pathogens (Gostic et al., 2015). Here, we estimate the impact of different screening programs given current knowledge of key COVID-19 life history and epidemiological parameters. Even under best-case assumptions, we estimate that screening will miss more than half of infected people. Breaking down the factors leading to screening successes and failures, we find that most cases missed by screening are fundamentally undetectable, because they have not yet developed symptoms and are unaware they were exposed. Our work underscores the need for measures to limit transmission by individuals who become ill after being missed by a screening program. These findings can support evidence-based policy to combat the spread of COVID-19, and prospective planning to mitigate future emerging pathogens.
C1 [Gostic, Katelyn] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.
   [Gomez, Ana C. R.; Mummah, Riley O.; Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.
   [Kucharski, Adam J.] London Sch Trop Hyg & Med, Dept Infect Dis Epidemiol, London, England.
   [Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Gostic, K (reprint author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.; Lloyd-Smith, JO (reprint author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.; Lloyd-Smith, JO (reprint author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
EM kgostic@uchicago.edu; jlloydsmith@ucla.edu
FU James S. McDonnell Foundation Postdoctoral fellowship in dynamic and
   multiscale systems; Wellcome [206250/Z/17/Z]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; National Science
   FoundationNational Science Foundation (NSF) [DEB-1557022]; Defense
   Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA) [PREEMPT
   D18AC00031]; Strategic Environmental Research and Development Program
   [RC-2635]
FX James S. McDonnell Foundation Postdoctoral fellowship in dynamic and
   multiscale systems Katelyn Gostic; Wellcome 206250/Z/17/Z Adam J
   Kucharski; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   Science without borders fellowship Ana CR Gomez; National Science
   Foundation DEB-1557022 James O Lloyd-Smith; Defense Advanced Research
   Projects Agency PREEMPT D18AC00031 James O Lloyd-Smith; Strategic
   Environmental Research and Development Program RC-2635 Ana C R Gomez
   Riley O Mummah James O Lloyd-Smith; The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR [Anonymous], 2020, BBC NEWS
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Biomeme, 2020, FAST DET IS CRIT CON
   Bitar D, 2009, EUROSURVEILLANCE, V14
   Cao Z, 2020, ESTIMATING EFFECTIVE, DOI [10.1101/2020.01.27.20018952, DOI 10.1101/2020.01.27.20018952]
   Cellan-Jones R., 2020, BBC NEWS
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang W, 2019, SHINY WEB APPL FRAME
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chinazzi M, 2020, EFFECT TRAVEL RESTRI, DOI [10.1101/ 2020.02.09.20021261, DOI 10.1101/2020.02.09.20021261, 10.1101/2020.02.09.20021261]
   Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82
   de Salazar PM, 2020, USING PREDICTED IMPO, DOI [10.1101/2020.02.04.20020495, DOI 10.1101/2020.02.04.20020495]
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Gostic K., 2020, ELIFE
   Gostic KM, 2015, ELIFE, V4, DOI 10.7554/eLife.05564
   Guan WJ, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2002032, DOI 10.1056/NEJM0A2002032]
   Guardian reporting team, 2020, GUARDIAN
   Hoehl Sebastian, 2020, N Engl J Med, V382, P1278, DOI 10.1056/NEJMc2001899
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   I Dorigatti, 2020, 4 IMP COLL
   Imai N, 2020, REPORT 3 TRANSMISSIB
   Jankowicz M., 2020, BUSINESS INSIDER
   Japan Ministry of Health Labor and Welfare, 2020, NEW COR INF DIS CONF
   Jiang Shibo, 2020, Lancet, V395, P949, DOI 10.1016/S0140-6736(20)30419-0
   Kucharski AJ, 2020, EARLY DYNAMICS TRANS, DOI [10.1101/2020.01.31.20019901, DOI 10.1101/2020.01.31.20019901]
   Lauer SA, 2020, INCUBATION PERIOD 20, DOI [10.1101/2020.02.02.20020016, DOI 10.1101/2020.02.02.20020016]
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Ma J, 2020, S CHINA MORNING POST
   Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202
   Mahbubani R., 2020, BUSINESS INSIDER
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Mizumoto K, 2020, ESTIMATING ASYMPTOMA, DOI [10.1101/2020.02.20. 20025866, DOI 10.1101/2020.02.20.20025866]
   Niehus R., 2020, QUANTIFYING BIAS COV, DOI [10.1101/2020.02.13.20022707, DOI 10.1101/2020.02.13.20022707]
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020419
   Priest PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014490
   Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [DOI 10.1101/2020.01.23.20018549, 10.1101/2020.01.23.20018549]
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   S Bhatia, 2020, 6 IMP COLL
   Sanche S, 2020, NOVEL CORONAVIRUS 20
   Sang-Hun C., 2020, NY TIMES
   Schengen Visa Info, 2020, SCHENGEN VISA INFO
   Schnirring L, 2020, CHINAS COVID 19 DEAT
   Schnirring L, 2020, CRUISE SHIP COVID 19
   Schnirring L, 2020, CHINA COVID 19 CASES
   T Liu, 2020, BIORXIV, DOI [https://doi.org/10.1101/2020.01.25.919787, 10.1101/2020.01.25.919787, DOI 10.1101/2020.01.25.919787]
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   Tay MR, 2015, PUBLIC HEALTH, V129, P1471, DOI 10.1016/j.puhe.2015.07.023
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, ZHONGHUA LIU XING BI, V41, P145, DOI [10.3760/cma.j.issn.0254-6450.2020.02.003, DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003]
   World Health Organization, 2020, MAN ILL TRAV POINTS
   World Health Organization, 2020, 37 WHO
   World Health Organization, 2020, UPD WHO ADV INT TRAF
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yu Ping, 2020, J Infect Dis, DOI 10.1093/infdis/jiaa077
   Z Hu, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.20.20025619, DOI 10.1101/2020.02.20.20025619]
NR 56
TC 0
Z9 0
U1 12
U2 12
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD FEB 24
PY 2020
VL 9
AR e55570
DI 10.7554/eLife.55570
PG 18
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KS8HN
UT WOS:000518547600001
PM 32091395
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Jiang, X
   Rayner, SM
   Luo, MH
AF Jiang, Xuan
   Rayner, Simon
   Luo, Min-Hua
TI Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE coronavirus; incubation; local infection; replication; spread; pandemic;
   virulence
AB The outbreak of a novel coronavirus (SARS-CoV-2) since December 2019 in Wuhan, the major transportation hub in central China, became an emergency of major international concern. While several etiological studies have begun to reveal the specific biological features of this virus, the epidemic characteristics need to be elucidated. Notably, a long incubation time was reported to be associated with SARS-CoV-2 infection, leading to adjustments in screening and control policies. To avoid the risk of virus spread, all potentially exposed subjects are required to be isolated for 14 days, which is the longest predicted incubation time. However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and middle east respiratory syndrome coronavirus (MERS-CoV), highlighting the need for larger and well-annotated datasets.
C1 [Jiang, Xuan; Luo, Min-Hua] Guangzhou Women & Children Med Ctr, Guangzhou Inst Pediat, Joint Ctr Translat Precis Med, Guangzhou, Peoples R China.
   [Jiang, Xuan; Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, Joint Ctr Translat Precis Med, Wuhan, Peoples R China.
   [Rayner, Simon] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.
   [Rayner, Simon] Univ Oslo, Oslo, Norway.
   [Rayner, Simon] Univ Oslo, Inst Basic Med Sci, Hybrid Technol Hub Ctr Excellence, Oslo, Norway.
   [Rayner, Simon; Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China.
   [Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Wuhan, Peoples R China.
   [Luo, Min-Hua] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Luo, MH (reprint author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China.
EM luomh@wh.iov.cn
RI rayner, simon/N-7715-2013
OI rayner, simon/0000-0001-8703-9140; luo, min hua/0000-0001-9352-0643
CR Backer J.A., 2020, INCUBATION PERIOD 20, DOI [10.1101/2020.01.27.20018986, DOI 10.1101/2020.01.27.20018986]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Li Q, N ENGL J MED
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   PARK J, 2018, SENSORS BASEL, V18, P1
   Sun K, 2020, ONLINE REPOSITORY
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2019, N ENGL J MED, V2020
NR 9
TC 0
Z9 0
U1 17
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 476
EP 478
DI 10.1002/jmv.25708
EA FEB 2020
PG 3
WC Virology
SC Virology
GA KU3AY
UT WOS:000515227800001
PM 32056235
OA Bronze
DA 2020-04-03
ER

PT J
AU Kim, JY
   Ko, JH
   Kim, Y
   Kim, YJ
   Kim, JM
   Chung, YS
   Kim, HM
   Han, MG
   Kim, SY
   Chin, BS
AF Kim, Jin Yong
   Ko, Jae-Hoon
   Kim, Yeonjae
   Kim, Yae-Jean
   Kim, Jeong-Min
   Chung, Yoon-Seok
   Kim, Heui Man
   Han, Myung-Guk
   Kim, So Yeon
   Chin, Bum Sik
TI Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in
   Korea
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Coronavirus; SARS-CoV-2; 2019-nCoV; COVID-19; Viral Load Kinetics
AB As of February 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started in China in December 2019 has been spreading in many countries in the world. With the numbers of confirmed cases are increasing, information on the epidemiologic investigation and clinical manifestation have been accumulated. However, data on viral load kinetics in confirmed cases are lacking. Here, we present the viral load kinetics of the first two confirmed patients with mild to moderate illnesses in Korea in whom distinct viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 may be different from that of previously reported other coronavirus infections such as SARS-CoV.
C1 [Kim, Jin Yong] Incheon Med Ctr, Dept Internal Med, Div Infect Dis, Incheon, South Korea.
   [Ko, Jae-Hoon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Infect Dis,Sch Med, Seoul, South Korea.
   [Kim, Yeonjae; Chin, Bum Sik] Natl Med Ctr, Dept Internal Med, 245 Eulji Ro, Seoul 04564, South Korea.
   [Kim, Yae-Jean] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea.
   [Kim, Jeong-Min; Chung, Yoon-Seok; Kim, Heui Man; Han, Myung-Guk] Korea Ctr Dis Control & Prevent, Ctr Lab Control Infect Dis, Div Viral Dis, Cheongju, South Korea.
   [Kim, So Yeon] Natl Med Ctr, Dept Lab Med, Seoul, South Korea.
RP Chin, BS (reprint author), Natl Med Ctr, Dept Internal Med, 245 Eulji Ro, Seoul 04564, South Korea.
EM moberrer@nmc.or.kr
OI Ko, Jae-Hoon/0000-0002-9490-6609; Chung, Yoon-Seok/0000-0003-4562-5533;
   Kim, Jin Yong/0000-0002-4306-1597
CR Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY
   Huh HJ, 2017, ANN LAB MED, V37, P81, DOI 10.3343/alm.2017.37.1.81
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   World Health Organization, LAB TEST 2019 NOV CO
   World Health Organization, 2005, 2 M INT HLTH REG 200
   Zhu N, 2019, N ENGL J MED
NR 9
TC 0
Z9 0
U1 29
U2 29
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD FEB 24
PY 2020
VL 35
IS 7
AR e86
DI 10.3346/jkms.2020.35.e86
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ3RJ
UT WOS:000516843700007
PM 32080991
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Park, WB
   Kwon, NJ
   Choi, SJ
   Kang, CK
   Choe, PG
   Kim, JY
   Yun, J
   Lee, GW
   Seong, MW
   Kim, NJ
   Seo, JS
   Oh, MD
AF Park, Wan Beom
   Kwon, Nak-Jung
   Choi, Su-Jin
   Kang, Chang Kyung
   Choe, Pyoeng Gyun
   Kim, Jin Yong
   Yun, Jiyoung
   Lee, Gir-Won
   Seong, Moon-Woo
   Kim, Nam Joong
   Seo, Jeong-Sun
   Oh, Myoung-don
TI Virus Isolation from the First Patient with SARS-CoV-2 in Korea
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE 2019 Novel Coronavirus; Culture; Microscopy; Electron; Phylogeny; Korea
ID CORONAVIRUS; ALIGNMENT
AB Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARSCoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan.
C1 [Park, Wan Beom; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Oh, Myoung-don] Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Park, Wan Beom; Choi, Su-Jin; Kim, Nam Joong; Oh, Myoung-don] Seoul Natl Univ Hosp, Lab Infect & Immun, Biomed Res Inst, Seoul, South Korea.
   [Kwon, Nak-Jung; Yun, Jiyoung; Lee, Gir-Won; Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea.
   [Kim, Jin Yong] Incheon Med Ctr, Dept Internal Med, Incheon, South Korea.
   [Seong, Moon-Woo] Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul, South Korea.
   [Seo, Jeong-Sun] Seoul Natl Univ, Precis Med Ctr, Bundang Hosp, Seongnam, South Korea.
RP Oh, MD (reprint author), Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM mdohmd@snu.ac.kr
OI Kim, Jin Yong/0000-0002-4306-1597; Seong, Moon-Woo/0000-0003-2954-3677;
   Kang, Chang Kyung/0000-0003-1952-072X; Choe, Pyoeng
   Gyun/0000-0001-6794-7918
CR Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Park WB, 2016, J KOREAN MED SCI, V31, P315, DOI 10.3346/jkms.2016.31.2.315
   Rutvisuttinunt W, 2015, J CLIN VIROL, V68, P16, DOI 10.1016/j.jcv.2015.04.010
   Rutvisuttinunt W, 2017, J CLIN VIROL, V94, P91, DOI 10.1016/j.jcv.2017.07.004
   Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001
   TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467
   World Health Organization, 2019, COR DIS
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 14
TC 0
Z9 0
U1 12
U2 12
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD FEB 24
PY 2020
VL 35
IS 7
AR e84
DI 10.3346/jkms.2020.35.e84
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ3RJ
UT WOS:000516843700006
PM 32080990
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Wang, HW
   Wang, ZZ
   Dong, YQ
   Chang, RJ
   Xu, C
   Yu, XY
   Zhang, SX
   Tsamlag, L
   Shang, ML
   Huang, JY
   Wang, Y
   Xu, G
   Shen, T
   Zhang, XX
   Cai, Y
AF Wang, Huwen
   Wang, Zezhou
   Dong, Yinqiao
   Chang, Ruijie
   Xu, Chen
   Yu, Xiaoyue
   Zhang, Shuxian
   Tsamlag, Lhakpa
   Shang, Meili
   Huang, Jinyan
   Wang, Ying
   Xu, Gang
   Shen, Tian
   Zhang, Xinxin
   Cai, Yong
TI Phase-adjusted estimation of the number of Coronavirus Disease 2019
   cases in Wuhan, China
SO CELL DISCOVERY
LA English
DT Article
ID CONTROL STRATEGIES; EPIDEMIC; HEALTH; INFLUENZA; SARS
AB An outbreak of clusters of viral pneumonia due to a novel coronavirus (2019-nCoV/SARS-CoV-2) happened in Wuhan, Hubei Province in China in December 2019. Since the outbreak, several groups reported estimated R-0 of Coronavirus Disease 2019 (COVID-19) and generated valuable prediction for the early phase of this outbreak. After implementation of strict prevention and control measures in China, new estimation is needed. An infectious disease dynamics SEIR (Susceptible, Exposed, Infectious, and Removed) model was applied to estimate the epidemic trend in Wuhan, China under two assumptions of R-t. In the first assumption, R-t was assumed to maintain over 1. The estimated number of infections would continue to increase throughout February without any indication of dropping with R-t = 1.9, 2.6, or 3.1. The number of infections would reach 11,044, 70,258, and 227,989, respectively, by 29 February 2020. In the second assumption, R-t was assumed to gradually decrease at different phases from high level of transmission (R-t = 3.1, 2.6, and 1.9) to below 1 (R-t = 0.9 or 0.5) owing to increasingly implemented public health intervention. Several phases were divided by the dates when various levels of prevention and control measures were taken in effect in Wuhan. The estimated number of infections would reach the peak in late February, which is 58,077-84,520 or 55,869-81,393. Whether or not the peak of the number of infections would occur in February 2020 may be an important index for evaluating the sufficiency of the current measures taken in China. Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases, in order to reduce R-t to an ideal level and control the infection.
C1 [Wang, Huwen; Chang, Ruijie; Xu, Chen; Yu, Xiaoyue; Zhang, Shuxian; Tsamlag, Lhakpa; Wang, Ying; Xu, Gang; Shen, Tian; Cai, Yong] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China.
   [Wang, Zezhou] Fudan Univ, Shanghai Canc Ctr, Dept Canc Prevent, Shanghai 200032, Peoples R China.
   [Wang, Zezhou] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.
   [Dong, Yinqiao] China Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shenyang 110122, Peoples R China.
   [Shang, Meili] Sanlin Community Hlth Serv Ctr, Shanghai 200124, Peoples R China.
   [Huang, Jinyan] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, Shanghai Inst Hematol, State Key Lab Med Genom,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China.
   [Zhang, Xinxin] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, Res Lab Clin Virol, Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China.
   [Zhang, Xinxin] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp North, Shanghai 200025, Peoples R China.
RP Cai, Y (reprint author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China.; Zhang, XX (reprint author), Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, Res Lab Clin Virol, Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China.; Zhang, XX (reprint author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp North, Shanghai 200025, Peoples R China.
EM zhangx@shsmu.edu.cn; caiyong202028@hotmail.com
FU Medicine and Engineering Interdisciplinary Research Fund of Shanghai
   Jiao Tong University [YG2020YQ06]; National Key Research and Development
   Project [2018YFC1705100, 2018YFC1705103]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [71673187]; National Health Commission of the People's Republic of China
FX This work is funded by Medicine and Engineering Interdisciplinary
   Research Fund of Shanghai Jiao Tong University (YG2020YQ06), the
   National Key Research and Development Project (2018YFC1705100,
   2018YFC1705103), and the National Natural Science Foundation of China
   (71673187), which had no role in study design, data collection, data
   analysis, data interpretation, or writing of the report. We acknowledge
   all health-care workers involved in the diagnosis and treatment of
   patients all around China. We thank National Health Commission of the
   People's Republic of China for coordinating data collection for patients
   with COVID-19 infection.
CR [Anonymous], 2020, CHINA CDC WEEKLY, V2, P79
   CDC; C, 2020, 2019 NOV COR 2019 NC
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen SC, 2006, INDOOR AIR, V16, P469, DOI 10.1111/j.1600-0668.2006.00443.x
   Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006
   Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161
   Commission; CNH, 2020, PREV CONTR PLAN NEW
   Commission; CNH, 2020, UPD INC PNEUM NOV CO
   Fang HP, 2005, P ANN INT IEEE EMBS, P7470
   Feng ZL, 2009, J THEOR BIOL, V259, P165, DOI 10.1016/j.jtbi.2009.03.006
   Getz WM, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0282
   Guan WJ, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Imai N, 2020, REPORT 3 TRANSMISSIB
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Nishiura H, 2006, J EPIDEMIOL COMMUN H, V60, P640, DOI 10.1136/jech.2005.042424
   Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114
   Read J. M., 2020, NOVEL CORONAVIRUS 20, DOI DOI 10.1101/2020.01.23.20018549V1.FULL.PDF
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Saito MM, 2013, MATH BIOSCI, V246, P47, DOI 10.1016/j.mbs.2013.08.009
   Smirnova A, 2019, B MATH BIOL, V81, P4343, DOI 10.1007/s11538-017-0284-3
   Tang B, 2020, ESTIMATION TRANSMISS
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   WHO, 22 WHO
   World Health Organization, 2005, 2 M INT HLTH REG 200
   World Health Organization, NOV COR CHIN
   World Health Organization, PNEUM UNKN CAUS CHIN
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xu B, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071223
   Yang Y, 2020, EPIDEMIOLOGICAL CLIN, DOI [10.1101/2020.02.10.20021675, DOI 10.1101/2020.02.10.20021675]
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 33
TC 0
Z9 0
U1 6
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD FEB 24
PY 2020
VL 6
IS 1
AR 10
DI 10.1038/s41421-020-0148-0
PG 8
WC Cell Biology
SC Cell Biology
GA KV5GM
UT WOS:000520511100001
PM 32133152
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Satheesan, MK
   Mui, KW
   Wong, LT
AF Satheesan, Manoj Kumar
   Mui, Kwok Wai
   Wong, Ling Tim
TI A numerical study of ventilation strategies for infection risk
   mitigation in general inpatient wards
SO BUILDING SIMULATION
LA English
DT Article; Early Access
DE ventilation; bioaerosol dispersion; indoor air quality (IAQ); infection
   risk; hospital general ward; computational fluid dynamics (CFD)
ID EAST RESPIRATORY SYNDROME; AIRBORNE TRANSMISSION; AIR-FLOW; EXPIRATORY
   DROPLETS; PARTICLE-TRANSPORT; HOSPITAL WARD; DEPOSITION; OUTBREAK; CFD;
   ENVIRONMENTS
AB Aerial dispersion of human exhaled microbial contaminants and subsequent contamination of surfaces is a potential route for infection transmission in hospitals. Most general hospital wards have ventilation systems that drive air and thus contaminants from the patient areas towards the corridors. This study investigates the transport mechanism and deposition patterns of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) within a typical six bedded general inpatient ward cubicle through numerical simulation. It demonstrates that both air change and exhaust airflow rates have significant effects on not only the airflow but also the particle distribution within a mechanically ventilated space. Moreover, the location of an infected patient within the ward cubicle is crucial in determining the extent of infection risk to other ward occupants. Hence, it is recommended to provide exhaust grilles in close proximity to a patient, preferably above each patient's bed. To achieve infection prevention and control, high exhaust airflow rate is also suggested. Regardless of the ventilation design, all patients and any surfaces within a ward cubicle should be regularly and thoroughly cleaned and disinfected to remove microbial contamination. The outcome of this study can serve as a source of reference for hospital management to better ventilation design strategies for mitigating the risk of infection.
C1 [Satheesan, Manoj Kumar; Mui, Kwok Wai; Wong, Ling Tim] Hong Kong Polytech Univ, Dept Bldg Serv Engn, Hong Kong, Peoples R China.
RP Wong, LT (reprint author), Hong Kong Polytech Univ, Dept Bldg Serv Engn, Hong Kong, Peoples R China.
EM beltw@polyu.edu.hk
FU Research Grants Council of HKSARHong Kong Research Grants Council; Hong
   Kong Polytechnic UniversityHong Kong Polytechnic University [15208817E]
FX This work was partially supported by the Research Grants Council of
   HKSAR and The Hong Kong Polytechnic University (Project No. 15208817E).
CR ANSYS, 2010, ANS FLUENT 13 0 DOC
   ASHRAE, 2013, ASHRAE FUND SI HDB
   ASHRAE, 2013, ASHRAE STAND VENT HL
   Beggs CB, 2008, AM J INFECT CONTROL, V36, P250, DOI 10.1016/j.ajic.2007.07.012
   Blocken B, 2018, BUILD SIMUL-CHINA, V11, P821, DOI 10.1007/s12273-018-0459-3
   Bolashikov ZD, 2012, HVAC&R RES, V18, P602, DOI 10.1080/10789669.2012.682692
   Chao CYH, 2008, AEROSOL SCI TECH, V42, P377, DOI 10.1080/02786820802104973
   Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658
   Chen C, 2011, J R SOC INTERFACE, V8, P699, DOI 10.1098/rsif.2010.0486
   CHEN Q, 1995, NUMER HEAT TR B-FUND, V28, P353, DOI 10.1080/10407799508928838
   DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288
   Gao NP, 2005, INDOOR BUILT ENVIRON, V14, P5, DOI 10.1177/1420326X05050132
   Ghia U, 2012, ASHRAE TRAN, V118, P442
   Giannini MA, 2009, AM J INFECT CONTROL, V37, P505, DOI 10.1016/j.ajic.2008.11.005
   Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010
   Hang J, 2014, BUILD ENVIRON, V77, P119, DOI 10.1016/j.buildenv.2014.03.029
   Humphreys Hilary, 2006, Ir Med J, V99, P102
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Lai ACK, 2012, BUILD ENVIRON, V56, P118, DOI 10.1016/j.buildenv.2012.02.027
   Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x
   Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x
   Li YG, 2015, SCI TECHNOL BUILT EN, V21, P25, DOI 10.1080/10789669.2014.965557
   Licina D, 2015, INDOOR AIR, V25, P672, DOI 10.1111/ina.12177
   Memarzadeh F, 2012, BUILD SIMUL-CHINA, V5, P15, DOI 10.1007/s12273-011-0053-4
   Nicas M, 2004, APPL BIOSAFETY, V9, P118, DOI DOI 10.1177/153567600400900302
   Nielsen PV, 2015, BUILD ENVIRON, V91, P78, DOI 10.1016/j.buildenv.2015.02.035
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Pantelic J., 2013, HVAC&R RES, V19, P947, DOI DOI 10.1080/10789669.2013.842447
   Qian H, 2010, INDOOR AIR, V20, P284, DOI 10.1111/j.1600-0668.2010.00653.x
   Roache PJ, 1998, AIAA J, V36, P696, DOI 10.2514/2.457
   Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051
   Shen C, 2013, BUILD ENVIRON, V63, P69, DOI 10.1016/j.buildenv.2013.02.003
   Tang Julian W, 2015, Curr Treat Options Infect Dis, V7, P176, DOI 10.1007/s40506-015-0057-1
   Tian L, 2009, INDOOR BUILT ENVIRON, V18, P360, DOI 10.1177/1420326X09337335
   van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590
   Wan MP, 2007, AEROSOL SCI TECH, V41, P244, DOI 10.1080/02786820601146985
   Wells W. F., 1955, AIRBORNE CONTAGION A
   Wong LT, 2015, INDOOR BUILT ENVIRON, V24, P401, DOI 10.1177/1420326X13515897
   Wong LT, 2010, AEROSOL SCI TECH, V44, P117, DOI 10.1080/02786820903426226
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x
   Yu HC, 2017, INDOOR BUILT ENVIRON, V26, P514, DOI 10.1177/1420326X16631596
   Zeytounian RK, 2003, CR MECANIQUE, V331, P575, DOI 10.1016/S1631-0721(03)00120-7
   Zhang Z, 2007, ATMOS ENVIRON, V41, P5236, DOI 10.1016/j.atmosenv.2006.05.086
   Zhang Z, 2006, ATMOS ENVIRON, V40, P3396, DOI 10.1016/j.atmosenv.2006.01.014
   Zhang Z, 2007, HVAC&R RES, V13, P871, DOI 10.1080/10789669.2007.10391460
   Zhao B, 2004, BUILD ENVIRON, V39, P1, DOI 10.1016/j.buildenv.2003.08.002
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 48
TC 0
Z9 0
U1 2
U2 2
PU TSINGHUA UNIV PRESS
PI BEIJING
PA B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA
SN 1996-3599
EI 1996-8744
J9 BUILD SIMUL-CHINA
JI Build. Simul.
DI 10.1007/s12273-020-0623-4
EA FEB 2020
PG 10
WC Thermodynamics; Construction & Building Technology
SC Thermodynamics; Construction & Building Technology
GA KP8SI
UT WOS:000516499400001
PM 32211123
OA Bronze
DA 2020-04-03
ER

PT J
AU Hu, SY
   Li, Z
   Lan, YG
   Guan, JY
   Zhao, K
   Chu, DF
   Fan, GH
   Guo, YG
   Gao, F
   He, WQ
AF Hu, Shiyu
   Li, Zi
   Lan, Yungang
   Guan, Jiyu
   Zhao, Kui
   Chu, Dianfeng
   Fan, Gencheng
   Guo, Yuguang
   Gao, Feng
   He, Wenqi
TI MiR-10a-5p-Mediated Syndecan 1 Suppression Restricts Porcine
   Hemagglutinating Encephalomyelitis Virus Replication
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE porcine hemagglutinating encephalomyelitis virus; miR-10a-5p; Syndecan
   1; virus replication; antiviral mechanism
ID MICRORNAS; EXPRESSION
AB Porcine hemagglutinating encephalomyelitis virus (PHEV) is a single-stranded RNA coronavirus that causes nervous dysfunction in the infected hosts and leads to widespread alterations in the host transcriptome by modulating specific microRNA (miRNA) levels. MiRNAs contribute to RNA virus pathogenesis by promoting antiviral immune response, enhancing viral replication, or altering miRNA-mediated host gene regulation. Thus, exploration of the virus-miRNA interactions occurring in PHEV-infected host may lead to the identification of novel mechanisms combating the virus life cycle or pathogenesis. Here, we discovered that the expression of miR-10a-5p was constitutively up-regulated by PHEV in both the N2a cells in vitro and mice brain in vivo. Treatment with miR-10a-5p mimics allowed miR-10a-5p enrichment and resulted in a significant restriction in PHEV replication, suggesting widespread negative regulation of the RNA virus infection by miR-10a-5p. The outcomes were also evidenced by miR-10a-5p inhibitor over-expression. Luciferase reporter, quantitative real-time PCR (qRT-PCR), and western blotting analysis further showed that Syndecan 1 (SDC1), a cell surface proteoglycan associated with host defense mechanisms, acts as a target gene of miR-10a-5p during PHEV infection. Naturally, siRNA-mediated knockdown of SDC1 leads to a reduction in viral replication, implying that SDC1 expression is likely a favorable condition for viral replication. Together, the findings demonstrated that the abundant miR-10a-5p leads to downstream suppression of SDC1, and it functions as an antiviral mechanism in the PHEV-induced disease, providing a potential strategy for the prevention and treatment of PHEV infection in the future work.
C1 [Hu, Shiyu; Li, Zi; Lan, Yungang; Guan, Jiyu; Zhao, Kui; Gao, Feng; He, Wenqi] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China.
   [Chu, Dianfeng; Fan, Gencheng; Guo, Yuguang] Yebio Bioengn Co Ltd Qingdao, State Key Lab Genet Engn Vet Vaccines, Qingdao, Peoples R China.
RP He, WQ (reprint author), Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China.
EM hewq@jlu.edu.cn
FU National Key Research and Development Program of China [2016YFD0500102];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31902262, 31872446, 31772704, 31672519]; Scientific
   and Technological Project of Jilin Province [20180101270JC]; China
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [2018M640285]; State Key Laboratory of Genetically Engineered Veterinary
   Vaccines [AGVSKL-ZD-201808]
FX This study was supported by the National Key Research and Development
   Program of China (Grant No. 2016YFD0500102), the National Natural
   Science Foundation of China (Grant Nos. 31902262, 31872446, 31772704,
   and 31672519), the State Key Laboratory of Genetically Engineered
   Veterinary Vaccines No. AGVSKL-ZD-201808, the Scientific and
   Technological Project of Jilin Province (Grant No. 20180101270JC), and
   the China Postdoctoral Science Foundation (Grant 2018M640285). The
   funders had no role in the study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Balasubramaniam M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030110
   Deng J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050118
   Dong B, 2014, ARCH VIROL, V159, P2329, DOI 10.1007/s00705-014-2070-y
   Ellis-Connell AL, 2010, J VIROL, V84, P10329, DOI 10.1128/JVI.00923-10
   Fan HX, 2018, LIFE SCI, V213, P9, DOI 10.1016/j.lfs.2018.10.016
   Gao W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-130
   Haasnoot J., 2011, METHODS MOL BIOL MET, V721
   Huang JY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01084
   Jia XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10651
   Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222
   Li Z, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00155
   Li Z, 2016, PEERJ, V4, DOI 10.7717/peerj.2443
   Lv XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00304
   Panoutsopoulou K, 2018, EXPERT REV MOL DIAGN, V18, P963, DOI 10.1080/14737159.2018.1538794
   Peng SX, 2018, MOL THER-NUCL ACIDS, V10, P361, DOI 10.1016/j.omtn.2017.12.016
   Rho S, 2011, VIRUS GENES, V42, P90, DOI 10.1007/s11262-010-0551-y
   Scheel TKH, 2016, CELL HOST MICROBE, V19, P409, DOI 10.1016/j.chom.2016.02.007
   Sun W, 2018, J INT MED RES, V46, P4693, DOI 10.1177/0300060518792780
   Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001
   Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05
   Wang YJ, 2018, BIOMED PHARMACOTHER, V99, P576, DOI 10.1016/j.biopha.2018.01.097
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 22
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 20
PY 2020
VL 11
AR 105
DI 10.3389/fmicb.2020.00105
PG 10
WC Microbiology
SC Microbiology
GA KT8ZD
UT WOS:000519299900001
PM 32153518
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Altamimi, A
   Abu-Saris, R
   El-Metwally, A
   Alaifan, T
   Alamri, A
AF Altamimi, Asmaa
   Abu-Saris, Raghib
   El-Metwally, Ashraf
   Alaifan, Taghreed
   Alamri, Aref
TI Demographic Variations of MERS-CoV Infection among Suspected and
   Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data
   from Riyadh Regional Laboratory
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION;
   CRITICALLY-ILL PATIENTS; SAUDI-ARABIA; RISK-FACTORS; PREDICTORS; DISEASE
AB Introduction. Middle East respiratory syndrome coronavirus was first recognized in September 2012 in Saudi Arabia. The clinical presentations of MERS and non-MERS SARI are often similar. Therefore, the identification of suspected cases that may have higher chances of being diagnosed as cases of MERS-CoV is essential. However, the real challenge is to flag these patients through some demographic markers. The nature of these markers has not previously been investigated in Saudi Arabia, and hence, this study aims to identify them. Methods. It was a surveillance system-based study, for which data from a total of 23,646 suspected patients in Riyadh and Al Qassim regions were analyzed from January 2017 until December 2017 to estimate the prevalence of MERS-CoV among suspected cases and to determine potential demographic risk factors related to the confirmation of the diagnosis. Results. Of 23,646 suspected cases, 119 (0.5%) were confirmed by laboratory results. These confirmed cases (67.2% of which were males) had a mean age of 43.23 years (SD +/- 22.8). Around 42.2% of the confirmed cases were aged between 41 and 60 years and about 47% of confirmed cases had their suspected specimen tested in the summer. The study identified three significant and independent predictors for confirmation of the disease: an age between 41 and 60 years, male gender, and summer season admission. Conclusion. The study provides evidence that the MERS-CoV epidemic in the subject regions has specific characteristics that might help future plans for the prevention and management of such a contagious disease. Future studies should aim to confirm such findings in other regions of Saudi Arabia as well and explore potential preventable risk factors.
C1 [Altamimi, Asmaa; Abu-Saris, Raghib; El-Metwally, Ashraf] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia.
   [Altamimi, Asmaa; Alaifan, Taghreed] Saudi Ctr Dis Prevent & Control Saudi CDC, Natl Hlth Lab, Riyadh, Saudi Arabia.
   [Abu-Saris, Raghib; El-Metwally, Ashraf] King Abdullah Int Med Res Ctr KAIMARC, Riyadh, Saudi Arabia.
   [Alamri, Aref] Riyadh Reg Lab, Dept Virol & Cytogenet, Riyadh, Saudi Arabia.
RP Altamimi, A (reprint author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia.; Altamimi, A (reprint author), Saudi Ctr Dis Prevent & Control Saudi CDC, Natl Hlth Lab, Riyadh, Saudi Arabia.
EM altamimi.asmaa@outlook.com; rabusaris@yahoo.com;
   ashraf.elmetwally@gmail.com; talaifan@moh.gov.sa; arefamri@gmail.com
CR Ahmed AE, 2018, HEMODIAL INT, V22, P474, DOI 10.1111/hdi.12661
   Ahmed AE, 2018, EPIDEMIOL INFECT, V146, P489, DOI [10.1017/S095026881700293X, 10.1017/s095026881700293x]
   Ahmed AE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2712-2
   Ahmed AE, 2017, INT J INFECT DIS, V62, P47, DOI 10.1016/j.ijid.2017.07.008
   Al Johani S, 2016, J INFECT PUBLIC HEAL, V9, P216, DOI 10.1016/j.jiph.2016.04.005
   Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226
   Alghamdi IG, 2014, INT J GEN MED, V7, P417, DOI 10.2147/IJGM.S67061
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P1915, DOI 10.3201/eid2211.160920
   Aly M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183850
   Arabi YM, 2017, CRIT CARE MED, V45, P1683, DOI 10.1097/CCM.0000000000002621
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Centers for Disease Control and Prevention, 2015, MIDDL E RESP SYNDR M
   Da'ar OB, 2018, EPIDEMIOL INFECT, V146, P1343, DOI 10.1017/S0950268818001541
   European Centre for Disease Prevention and Control, 2015, COMM DIS THREATS REP
   Fagbo SF, 2017, J MED VIROL, V89, P195, DOI 10.1002/jmv.24632
   Faridi U, 2018, SAUDI J BIOL SCI, V25, P1402, DOI 10.1016/j.sjbs.2016.09.020
   Garbati MA, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0165978, 10.1371/journal.Pone.0165978]
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Mohamed DH, 2017, DIAGN MICR INFEC DIS, V87, P320, DOI 10.1016/j.diagmicrobio.2017.01.003
   Mohd HA, 2016, TRAVEL MED INFECT DI, V14, P464, DOI 10.1016/j.tmaid.2016.09.008
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Qattan I., 2016, BIOL MED, V8, P1
   Thabet F, 2015, SAUDI MED J, V36, P484, DOI 10.15537/smj.2015.4.10243
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, 2015, MERS COV OUTBR LARG
   World Health Organization, 2019, MERS SIT UPD
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 29
TC 0
Z9 0
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD FEB 19
PY 2020
VL 2020
AR 9629747
DI 10.1155/2020/9629747
PG 6
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA KS9LH
UT WOS:000518629700002
PM 32149148
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Ceraolo, C
   Giorgi, FM
AF Ceraolo, Carmine
   Giorgi, Federico M.
TI Genomic variance of the 2019-nCoV coronavirus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE biostatistics & bioinformatics; CLUSTAL analysis; coronavirus; data
   visualization; virus classification
ID MULTIPLE SEQUENCE ALIGNMENT
AB There is a rising global concern for the recently emerged novel coronavirus (2019-nCoV). Full genomic sequences have been released by the worldwide scientific community in the last few weeks to understand the evolutionary origin and molecular characteristics of this virus. Taking advantage of all the genomic information currently available, we constructed a phylogenetic tree including also representatives of other coronaviridae, such as Bat coronavirus (BCoV) and severe acute respiratory syndrome. We confirm high sequence similarity (>99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence sharing 96.2% sequence identity, confirming the notion of a zoonotic origin of 2019-nCoV. Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hypervariable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein. Finally, we perform a full proteomic comparison with other coronaviridae, identifying key aminoacidic differences to be considered for antiviral strategies deriving from previous anti-coronavirus approaches.
C1 [Ceraolo, Carmine; Giorgi, Federico M.] Univ Bologna, Dept Pharm & Biotechnol, Via Selmi 3, I-40126 Bologna, Italy.
RP Giorgi, FM (reprint author), Univ Bologna, Dept Pharm & Biotechnol, Via Selmi 3, I-40126 Bologna, Italy.
EM federico.giorgi@unibo.it
RI Giorgi, Federico M./AAE-4281-2020; Ribeiro, Nuno/AAH-2299-2020
OI Giorgi, Federico M./0000-0002-7325-9908; 
FU Ministero dell'Istruzione, dell' Universita e della RicercaMinistero
   dell' Istruzione, dell' Universita e della Ricerca (MIUR)
FX Ministero dell'Istruzione, dell' Universita e della Ricerca, Grant/Award
   Number: Montalcini 2016
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   Benvenuto D, 2020, J MED VIROL, V92, P455, DOI 10.1002/jmv.25688
   Burley Stephen K, 2017, Methods Mol Biol, V1607, P627, DOI 10.1007/978-1-4939-7000-1_26
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Hu B, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0422-1
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Manaresi E, 2017, VIROLOGY, V508, P54, DOI 10.1016/j.virol.2017.05.006
   Narayanan K, 2008, VIRUS RES, V133, P113, DOI 10.1016/j.virusres.2007.10.009
   Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
NR 20
TC 0
Z9 0
U1 48
U2 48
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 522
EP 528
DI 10.1002/jmv.25700
EA FEB 2020
PG 7
WC Virology
SC Virology
GA KU3AY
UT WOS:000517439500001
PM 32027036
OA Bronze
DA 2020-04-03
ER

PT J
AU Nilsson, A
   Edner, N
   Albert, J
   Ternhag, A
AF Nilsson, Anna
   Edner, Niklas
   Albert, Jan
   Ternhag, Anders
TI Fatal encephalitis associated with coronavirus OC43 in an
   immunocompromised child
SO INFECTIOUS DISEASES
LA English
DT Article; Early Access
DE Coronavirus; encephalitis; next generation sequencing; brain biopsy
AB A child with pre-B acute lymphoblastic leukaemia (ALL) developed fatal encephalitis associated with human coronavirus OC43 (HCoV-OC43). During chemotherapy the child had a persistent HCoV-OC43 respiratory infection and later developed progressive encephalitis. Cerebrospinal fluid was negative for pathogens including HCoV-OC43, but a brain biopsy was HCoV-OC43-positive by metagenomic next-generation sequencing.
C1 [Nilsson, Anna] Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.
   [Edner, Niklas] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden.
   [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
   [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.
   [Ternhag, Anders] Karolinska Inst, Dept Med Solna, Unit Infect Dis, S-17177 Stockholm, Sweden.
RP Ternhag, A (reprint author), Karolinska Inst, Dept Med Solna, Unit Infect Dis, S-17177 Stockholm, Sweden.
EM anders.ternhag@sll.se
CR Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Brown JR, 2018, J INFECTION, V76, P225, DOI 10.1016/j.jinf.2017.12.014
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Dhawan S, 2019, WORLD NEUROSURG, V127, P607, DOI 10.1016/j.wneu.2019.04.016
   Lee J, 2014, PEDIATR INFECT DIS J, V33, P814, DOI 10.1097/INF.0000000000000292
   Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458
   Riche Maximilien, 2020, Neurosurg Rev, DOI 10.1007/s10143-019-01234-w
   SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939
   Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368
   Toft N, 2018, LEUKEMIA, V32, P606, DOI 10.1038/leu.2017.265
   Wickstrom R, 2017, ACTA PAEDIATR, V106, P463, DOI 10.1111/apa.13682
NR 11
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2374-4235
EI 2374-4243
J9 INFECT DIS-NOR
JI Infect. Dis.
DI 10.1080/23744235.2020.1729403
EA FEB 2020
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KN3FT
UT WOS:000514727300001
PM 32067542
OA Bronze, Other Gold
DA 2020-04-03
ER

PT J
AU Wang, SQ
   Wu, JY
   Wang, F
   Wang, HF
   Wu, ZC
   Wu, SL
   Bao, WB
AF Wang, Shiqin
   Wu, Jiayun
   Wang, Fang
   Wang, Haifei
   Wu, Zhengchang
   Wu, Shenglong
   Bao, Wenbin
TI Expression Pattern Analysis of Antiviral Genes and Inflammatory
   Cytokines in PEDV-Infected Porcine Intestinal Epithelial Cells
SO FRONTIERS IN VETERINARY SCIENCE
LA English
DT Article
DE pigs; PEDV; innate immune response; antiviral genes; inflammatory
   cytokines
ID EPIDEMIC-DIARRHEA-VIRUS; I INTERFERON; RIG-I; CORONAVIRUS; PROTEIN;
   PATHOGENESIS
AB Porcine diarrhea disease in newborn and suckling piglets due to infection with porcine epidemic diarrhea virus (PEDV) is a leading cause of economic loss in the pig industry globally. In this study, we investigated the molecular mechanism of the host innate immune response to PEDV infection. The expression dynamics of antiviral genes (e.g., RIG-1, PKR, OAS1, Mx1, and Mx2) and inflammatory cytokines (e.g., IFN-alpha, IFN-beta, TNF-alpha, IL-6, IL-8, and IL-12) in porcine small intestinal epithelial (IPEC-J2) cells were analyzed following PEDV stimulation. The results showed that the expression of antiviral genes (e.g., PKR, OAS1, and Mx2) and inflammatory cytokines (e.g., IFN-alpha and TNF-alpha) were significantly reduced within 0-4 h post-infection (P < 0.05). However, all antiviral genes and inflammatory cytokines were up-regulated from 12 to 24 h (P < 0.05), and cytopathic changes were observed during this time. The expression of RIG-1, PKR, OAS1, Mx1, and Mx2 were significantly and positively correlated to each other during the entire infection (P < 0.01). The results suggested that the RIG-1, PKR, OAS1, Mx1, and Mx2 genes may play an important role in PEDV infection in piglets. Initially, PEDV displayed cellular invasion by inhibiting IFN-alpha transcription and interfering with the antiviral function of PKR, OAS1, and Mx2, ultimately induced an intense inflammatory response. The relationship between antiviral genes and inflammatory cytokines with PEDV infection at the cellular level provides a reference for studying the mechanism of resistance to PEDV infection in piglets.
C1 [Wang, Shiqin; Wu, Jiayun; Wang, Fang; Wang, Haifei; Wu, Zhengchang; Wu, Shenglong; Bao, Wenbin] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.
   [Wang, Haifei; Wu, Zhengchang; Wu, Shenglong; Bao, Wenbin] Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou, Jiangsu, Peoples R China.
RP Bao, WB (reprint author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.; Bao, WB (reprint author), Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou, Jiangsu, Peoples R China.
EM wbbao@yzu.edu.cn
FU National Natural Science FundsNational Natural Science Foundation of
   China [31972535, 31772560]; Natural Science Foundation of Jiangsu
   province, ChinaNatural Science Foundation of Jiangsu Province
   [BK20180899]; Qingnan Project of Yangzhou University; Priority Academic
   Program Development of Jiangsu Higher Education Institutions
FX This study was supported by grants from the National Natural Science
   Funds (Grant Nos. 31972535, 31772560), the Natural Science Foundation of
   Jiangsu province, China (Grant No. BK20180899), and Qingnan Project of
   Yangzhou University and the Priority Academic Program Development of
   Jiangsu Higher Education Institutions.
CR Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1
   Cao LY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0345-x
   Chen JF, 2008, VIRUS GENES, V36, P355, DOI 10.1007/s11262-007-0196-7
   DEBOUCK P, 1980, AM J VET RES, V41, P219
   Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S
   Fribourg M, 2014, J THEOR BIOL, V351, P47, DOI 10.1016/j.jtbi.2014.02.029
   Gan ZL, 2010, SWINE SCI, V27, P24
   Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06
   HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0
   Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017
   Kindler E, 2014, CURR OPIN MICROBIOL, V20, P69, DOI 10.1016/j.mib.2014.05.005
   Lee C, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0465-y
   Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10
   Liu WT, 2013, STUDY CHARACTERISTIC
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001
   Oh Jin Sik, 2003, J Vet Sci, V4, P269
   Oldham J, 1972, PIG FARMING, V10, P72
   PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606
   Song Q. Y., 2005, CHINESE J VET MED, V41, P33
   Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675
   Sun M, 2017, VET MICROBIOL, V205, P6, DOI 10.1016/j.vetmic.2017.04.031
   TAKAHASHI K, 1983, JPN J VET SCI, V45, P829
   Xing YL, 2013, J GEN VIROL, V94, P1554, DOI 10.1099/vir.0.051169-0
   Zhang Bai-Ling, 2011, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V27, P516
   Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010
NR 27
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-1769
J9 FRONT VET SCI
JI Front. Vet. Sci.
PD FEB 18
PY 2020
VL 7
AR 75
DI 10.3389/fvets.2020.00075
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA KT0IX
UT WOS:000518695300001
PM 32133381
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Wen, J
   Aston, J
   Liu, XY
   Ying, TY
AF Wen, Jun
   Aston, Joshua
   Liu, Xinyi
   Ying, Tianyu
TI Effects of misleading media coverage on public health crisis: a case of
   the 2019 novel coronavirus outbreak in China
SO ANATOLIA-INTERNATIONAL JOURNAL OF TOURISM AND HOSPITALITY RESEARCH
LA English
DT Article; Early Access
DE Misleading media coverage; public health crisis; racial discrimination;
   mental disorders; country image; destination image
ID RACIAL-DISCRIMINATION; DESTINATION IMAGE; COUNTRY
AB The coronavirus outbreak in Wuhan, China has sparked a global epidemic, which the World Health Organization declared a public health emergency of international concern on 31st January 2020 (Beijing time). This crisis has attracted intense media attention. Recently, some media outlets inappropriately labelled the coronavirus by race, using such headlines as "Chinese virus pandemonium" and even suggesting "China kids stay home." The biased and misleading coverage presented via Western media channels has incited anger throughout the Chinese community and has placed undue stress upon Chinese individuals living outside China. This post-published review takes a tourism-focused perspective to examine findings from a quantitative study (Rodriguez-Seijas, Stohl, Hasin, & Eaton, 2015) published in 2015 in JAMA Psychiatry. The current paper highlights the potential impacts of misleading and biased media coverage on Chinese individuals' mental health. Specifically, this work considers perceived racial discrimination stemming from coronavirus as a public health crisis and the effects of such discrimination on individuals of Chinese heritage. Similarly imperative are pertinent effects on country image and destination image with respect to tourism marketing and tourist behaviour during times of crisis. By considering racism in the context of the coronavirus outbreak, this paper identifies potential avenues for relevant research in tourism and hospitality.
C1 [Wen, Jun; Aston, Joshua] Edith Cowan Univ, Sch Business & Law, Perth, WA, Australia.
   [Liu, Xinyi] Sichuan Univ, Coll Tourism, Chengdu, Peoples R China.
   [Ying, Tianyu] Zhejiang Univ, Dept Tourism & Hotel Management, Sch Management, Hangzhou, Peoples R China.
RP Wen, J (reprint author), Edith Cowan Univ, Sch Business & Law, Perth, WA, Australia.
EM j.wen@ecu.edu.au
RI Wen, Jun/V-2706-2018
OI Wen, Jun/0000-0002-1110-824X
CR ABC News, 2020, ABC NEWS
   Aguilera J., 2020, TIME
   Allport G.W., 1954, NATURE PREJUDICE
   Amnesty International, 2020, EXPL 7 WAYS COR AFF
   [Anonymous], 2020, 8 WHO
   [Anonymous], NOT NAT HLTH COMM PR
   [Anonymous], 2020, XINHUA NEWS
   Brewster ZW, 2014, SOCIOL INQ, V84, P545, DOI 10.1111/soin.12056
   Brewster ZW, 2012, CORNELL HOSP Q, V53, P274, DOI 10.1177/1938965512458178
   Martinez SC, 2010, J TRAVEL TOUR MARK, V27, P748, DOI 10.1080/10548408.2010.519680
   Carter RT, 2017, J MULTICULT COUNS D, V45, P232, DOI 10.1002/jmcd.12076
   CGTN, 2020, CHINA DAILY
   De Nisco A, 2015, J VACAT MARK, V21, P305, DOI 10.1177/1356766715577502
   Dirks Danielle, 2004, CORNELL HOTEL REST A, V45, P30
   Gill A, 2010, INT J CONTEMP HOSP M, V22, P263, DOI 10.1108/09596111011018223
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Mossberg L, 2005, SERV IND J, V25, P493, DOI 10.1080/02642060500092147
   Ontario Human Rights Commission [OHRC], 2020, OHRC URG RESP HUM RI
   Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740
   Peffley M, 2017, AM POLIT RES, V45, P1032, DOI 10.1177/1532673X17692326
   Rich M., 2020, NY TIMES
   Rodriguez-Seijas C, 2015, JAMA PSYCHIAT, V72, P706, DOI 10.1001/jamapsychiatry.2015.0148
   Schultz F, 2011, PUBLIC RELAT REV, V37, P20, DOI 10.1016/j.pubrev.2010.12.001
   Sellers RM, 2003, J PERS SOC PSYCHOL, V84, P1079, DOI 10.1037/0022-3514.84.5.1079
   Triana MD, 2015, J ORGAN BEHAV, V36, P491, DOI 10.1002/job.1988
   Tribe J, 1997, ANN TOURISM RES, V24, P638, DOI 10.1016/S0160-7383(97)00020-0
   Unnever JD, 2017, RACE JUSTICE, V7, P350, DOI 10.1177/2153368716658768
   Wintemute R, 2017, KINGS LAW J, V28, P89
NR 29
TC 0
Z9 0
U1 21
U2 21
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1303-2917
EI 2156-6909
J9 ANATOLIA
JI Anatolia
DI 10.1080/13032917.2020.1730621
EA FEB 2020
PG 6
WC Hospitality, Leisure, Sport & Tourism
SC Social Sciences - Other Topics
GA KO3FH
UT WOS:000515432800001
OA Bronze
DA 2020-04-03
ER

PT J
AU Yoshizawa, S
   Hattori, Y
   Kobayashi, K
   Akaji, K
AF Yoshizawa, Shin-ichiro
   Hattori, Yasunao
   Kobayashi, Kazuya
   Akaji, Kenichi
TI Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL
   protease inhibitor
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE SARS 3CL protease; Inhibitor; Fused ring scaffold; Octahydroisochromene
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; DIHYDROXYLATION
AB An octahydroisochromene scaffold has been introduced into a known SARS 3CL protease inhibitor as a novel hydrophobic core to interact with the S2 pocket of the protease. An alkyl or aryl substituent was also introduced at the 1-position of the octahydroisochromene scaffold and expected to introduce additional interactions with the protease. Sharpless-Katsuki asymmetric epoxidation and Sharpless asymmetric dihydroxylation were employed to construct the octahydroisochromene scaffold. The introductions of the P1 site His-al and the substituent at 1-position was achieved using successive reductive amination reactions. Our initial evaluations of the diastereo-isomeric mixtures (16a-d) revealed that the octahydroisochromene moiety functions as a core hydrophobic scaffold for the S2 pocket of the protease and the substituent at the 1-position may form additional interactions with the protease. The inhibitory activities of the diastereoisomerically-pure inhibitors (3a-d) strongly suggest that a specific stereo-isomer of the octahydroisochromene scaffold, (1S, 3S) 3b, directs the P1 site imidazole, the warhead aldehyde, and substituent at the 1-position of the fused ring to their appropriate pockets in the protease.
C1 [Yoshizawa, Shin-ichiro; Kobayashi, Kazuya; Akaji, Kenichi] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan.
   [Hattori, Yasunao] Kyoto Pharmaceut Univ, Ctr Instrumental Anal, Yamashina Ku, Kyoto 6078412, Japan.
RP Akaji, K (reprint author), Kyoto Pharmaceut Univ, Dept Med Chem, Kyoto 6078412, Japan.
EM akaji@mb.kyoto-phu.ac.jp
FU Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [16H05104]
FX This work was supported, in part, by a Grant-in-aid for Scientific
   Research 16H05104 given to KA from the Japan Society for the Promotion
   of Science.
CR Akaji K., 2018, AMINO ACIDS PEPT PRO, V42, P228
   Akaji K, 2008, BIOORGAN MED CHEM, V16, P9400, DOI 10.1016/j.bmc.2008.09.057
   Akaji K, 2011, J MED CHEM, V54, P7962, DOI 10.1021/jm200870n
   BASHA A, 1977, TETRAHEDRON LETT, P4171
   Bredikhina ZA, 2014, TETRAHEDRON-ASYMMETR, V25, P1015, DOI 10.1016/j.tetasy.2014.05.008
   Corey EJ, 2001, ORG LETT, V3, P3211, DOI 10.1021/ol016577i
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   HENTGES SG, 1980, J AM CHEM SOC, V102, P4263, DOI 10.1021/ja00532a050
   KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Moitessier N, 2002, J ORG CHEM, V67, P7275, DOI 10.1021/jo0258148
   Ohnishi K, 2019, BIOORGAN MED CHEM, V27, P425, DOI 10.1016/j.bmc.2018.12.019
   Pillaiyar T, 2016, J MED CHEM, V59, P6595, DOI 10.1021/acs.jmedchem.5b01461
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Shimamoto Y, 2015, BIOORGAN MED CHEM, V23, P876, DOI 10.1016/j.bmc.2014.12.028
   Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0
NR 18
TC 0
Z9 0
U1 66
U2 66
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD FEB 15
PY 2020
VL 28
IS 4
AR 115273
DI 10.1016/j.bmc.2019.115273
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA KF8CA
UT WOS:000509463700004
PM 31926775
DA 2020-04-03
ER

PT J
AU Zhao, XY
   Chu, H
   Wong, BHY
   Chiu, MC
   Wang, D
   Li, C
   Liu, XJ
   Yang, D
   Poon, VKM
   Cai, JP
   Chan, JFW
   To, KKW
   Zhou, J
   Yuen, KY
AF Zhao, Xiaoyu
   Chu, Hin
   Wong, Bosco Ho-Yin
   Chiu, Man Chun
   Wang, Dong
   Li, Cun
   Liu, Xiaojuan
   Yang, Dong
   Poon, Vincent Kwok-Man
   Cai, Jianpiao
   Chan, Jasper Fuk-Woo
   To, Kelvin Kai-Wang
   Zhou, Jie
   Yuen, Kwok-Yung
TI Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors
   Contributes to Proinflammatory Response in Middle East Respiratory
   Syndrome Coronavirus-Infected Macrophages
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE CLR; MERS-CoV; Mincle; proinflammatory response; RLR
ID I INTERFERON; RIG-I; NLRP3 INFLAMMASOME; CYTOKINE STORM; IKK-EPSILON;
   PROTEIN; REPLICATION; RECOGNITION; MDA5; PNEUMONIA
AB Background: Human infection with Middle East respiratory syndrome coronavirus (MERS-CoV) poses an ongoing threat to public health worldwide. The studies of MERS patients with severe disease and experimentally infected animals showed that robust viral replication and intensive proinflammatory response in lung tissues contribute to high pathogenicity of MERS-CoV. We sought to identify pattern recognition receptor (PRR) signaling pathway(s) that mediates the inflammatory cascade in human macrophages upon MERS-CoV infection.
   Methods: The potential signaling pathways were manipulated individually by pharmacological inhibition, small interfering ribonucleic acid (siRNA) depletion, and antibody blocking. The MERS-CoV-induced proinflammatory response was evaluated by measuring the expression levels of key cytokines and/or chemokines. Reverse transcription-quantitative polymerase chain reaction assay, flow cytometry analysis, and Western blotting were applied to evaluate the activation of related PRRs and engagement of adaptors.
   Results: MERS-CoV replication significantly upregulated C-type lectin receptor (CLR) macrophage-inducible Ca2+-dependent lectin receptor (Mincle). The role of Mincle for MERS-CoV-triggered cytokine/chemokine induction was established based on the results of antibody blockage, siRNA depletion of Mincle and its adaptor spleen tyrosine kinase (Syk), and Syk pharmacological inhibition. The cytokine and/or chemokine induction was significantly attenuated by siRNA depletion of retinoic acid-inducible-I-like receptors (RLR) or adaptor, indicating that RLR signaling also contributed to MERS-CoV-induced proinflammatory response.
   Conclusions: The CLR and RLR pathways are activated and contribute to the proinflammatory response in MERS-CoV-infected macrophages.
C1 [Zhao, Xiaoyu; Chu, Hin; Wong, Bosco Ho-Yin; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Zhou, Jie; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Zhao, Xiaoyu; Chu, Hin; Chiu, Man Chun; Wang, Dong; Li, Cun; Liu, Xiaojuan; Yang, Dong; Poon, Vincent Kwok-Man; Cai, Jianpiao; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Zhou, Jie; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Zhou, J (reprint author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Dept Microbiol, Queen Mary Hosp,Pokfulam, Hong Kong, Peoples R China.
EM jiezhou@hku.hk
OI Chiu, Man Chun/0000-0001-9503-6396
FU Health and Medical Research Fund [14131392, 17161272]; Food and Health
   Bureau of the Hong Kong Special Administrative Region (HKSAR)
   Government; Themebased Research Scheme [T11-707/15-R]; Research Grants
   CouncilHong Kong Research Grants Council; HKSAR Government; Shaw
   Foundation Hong Kong; Respiratory Viral Research Foundation Limited;
   Chow Sin Lan Charity Fund Limited, and Chan Yin Chuen Memorial
   Charitable Foundation
FX This work was partly supported by funding from Health and Medical
   Research Fund (Project Nos. 14131392 and 17161272) of the Food and
   Health Bureau of the Hong Kong Special Administrative Region (HKSAR)
   Government; Themebased Research Scheme (T11-707/15-R) of the Research
   Grants Council, the HKSAR Government; the High Level HospitalSummit
   Program in Guangdong, The University of Hong KongShenzhen Hospital; and
   the donations by the Shaw Foundation Hong Kong, Richard Yu and Carol Yu,
   Michael Seak-Kan Tong, Respiratory Viral Research Foundation Limited,
   Hui Ming, Hui Hoy & Chow Sin Lan Charity Fund Limited, and Chan Yin
   Chuen Memorial Charitable Foundation.
CR Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Baseler LJ, 2016, AM J PATHOL, V186, P630, DOI 10.1016/j.ajpath.2015.10.025
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Chu H, 2012, CELL HOST MICROBE, V12, P360, DOI 10.1016/j.chom.2012.07.011
   Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480
   Ding Z, 2017, VIROLOGY, V507, P170, DOI 10.1016/j.virol.2017.04.024
   Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940
   Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067
   Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147
   Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4
   Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kock G, 2011, BLOOD, V117, P3569, DOI 10.1182/blood-2010-08-302224
   Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10
   Lian H, 2018, IMMUNITY, V49, P438, DOI 10.1016/j.immuni.2018.08.014
   Masumoto M, 1999, J IMMUNOL, V163, P5039
   Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359
   Monteiro JT, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030059
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Niederberger E, 2013, CURR MOL MED, V13, P1089
   Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13
   Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227
   Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178
   Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Vijayan D, 2012, IMMUNOL CELL BIOL, V90, P889, DOI 10.1038/icb.2012.24
   Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015
   Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zalinger ZB, 2015, J VIROL, V89, P12330, DOI 10.1128/JVI.01470-15
   Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011
   Zhou J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809528
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   Zhou J, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0446-6
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
   Zhou J, 2012, J INFECT DIS, V206, P495, DOI 10.1093/infdis/jis378
NR 46
TC 0
Z9 0
U1 8
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB 15
PY 2020
VL 221
IS 4
BP 647
EP 659
DI 10.1093/infdis/jiz483
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KS8CO
UT WOS:000518533500021
PM 31562757
OA Bronze
DA 2020-04-03
ER

PT J
AU Li, XG
   Wang, W
   Zhao, XF
   Zai, JJ
   Zhao, Q
   Li, Y
   Chaillon, A
AF Li, Xingguang
   Wang, Wei
   Zhao, Xiaofang
   Zai, Junjie
   Zhao, Qiang
   Li, Yi
   Chaillon, Antoine
TI Transmission dynamics and evolutionary history of 2019-nCoV
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE 2019-nCoV; evolutionary rate; phylogenetic cluster; time to most recent
   common ancestor; TMRCA; transmission cluster
ID RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; RECOMBINATION;
   EPIDEMIOLOGY; PERFORMANCE; ALGORITHMS; INFECTION; CAMELS; GENOME; CHINA
AB To investigate the time origin, genetic diversity, and transmission dynamics of the recent 2019-nCoV outbreak in China and beyond, a total of 32 genomes of virus strains sampled from China, Thailand, and the USA with sampling dates between 24 December 2019 and 23 January 2020 were analyzed. Phylogenetic, transmission network, and likelihood-mapping analyses of the genome sequences were performed. On the basis of the likelihood-mapping analysis, the increasing tree-like signals (from 0% to 8.2%, 18.2%, and 25.4%) over time may be indicative of increasing genetic diversity of 2019-nCoV in human hosts. We identified three phylogenetic clusters using the Bayesian inference framework and three transmission clusters using transmission network analysis, with only one cluster identified by both methods using the above genome sequences of 2019-nCoV strains. The estimated mean evolutionary rate for 2019-nCoV ranged from 1.7926 x 10(-3) to 1.8266 x 10(-3) substitutions per site per year. On the basis of our study, undertaking epidemiological investigations and genomic data surveillance could positively impact public health in terms of guiding prevention efforts to reduce 2019-nCOV transmission in real-time.
C1 [Li, Xingguang; Li, Yi] Wuhan Univ Bioengn, Hubei Engn Res Ctr Viral Vector, Wuhan 430415, Peoples R China.
   [Wang, Wei] Guangxi Univ Chinese Med, Dept Spleen & Stomach Dis, Affiliated Hosp 1, Nanning, Peoples R China.
   [Zhao, Xiaofang] Guangxi Univ Chinese Med, Dept Sci & Technol, Ruikang Hosp, Nanning, Peoples R China.
   [Zai, Junjie] Ningbo Univ, Sch Med, Immunol Innovat Team, Ningbo, Peoples R China.
   [Zhao, Qiang] Tianjin Canc Hosp, Precis Canc Ctr, Airport Ctr, Airport Hosp, Tianjin, Peoples R China.
   [Chaillon, Antoine] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Li, XG; Li, Y (reprint author), Wuhan Univ Bioengn, Hubei Engn Res Ctr Viral Vector, Wuhan 430415, Peoples R China.; Chaillon, A (reprint author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM xingguanglee@hotmail.com; liyi@whsw.edu.cn; achaillon@health.ucsd.edu
RI Ribeiro, Nuno/AAH-2299-2020
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470268]; Project of Guangxi Health Committee
   [Z20191111]; Natural Science Foundation of Guangxi Province of
   ChinaNational Natural Science Foundation of Guangxi Province
   [2017GXNSFAA198080]
FX National Natural Science Foundation of China, Grant/Award Number:
   31470268; Project of Guangxi Health Committee, Grant/Award Number:
   Z20191111; Natural Science Foundation of Guangxi Province of China,
   Grant/Award Number: 2017GXNSFAA198080
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   CHINESE SME, 2004, SCIENCE, V303, P1666, DOI DOI 10.1126/SCIENCE.1092002
   Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299
   Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Li Q, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2001316, DOI 10.1056/NEJM0A2001316]
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li XG, 2020, J MED VIROL, V92, P448, DOI 10.1002/jmv.25693
   Lu R, 2020, LANCET
   Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026
   Muth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33487-8
   Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Schmidt HA, 2007, CURR PROTOC BIOINFOR, V1, P661
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao ZM, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-21
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhou P, 2020, DISCOVERY NOVEL CORO, DOI 10.1101/2020.01.22.914952
NR 37
TC 0
Z9 0
U1 51
U2 51
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 501
EP 511
DI 10.1002/jmv.25701
EA FEB 2020
PG 11
WC Virology
SC Virology
GA KU3AY
UT WOS:000513293400001
PM 32027035
OA Bronze
DA 2020-04-03
ER

PT J
AU Zhang, PX
   Li, J
   Liu, HX
   Han, N
   Ju, JB
   Kou, YH
   Chen, L
   Jiang, MX
   Pan, F
   Zheng, YL
   Gao, ZC
   Jiang, BG
AF Zhang, Peixun
   Li, Jia
   Liu, Huixin
   Han, Na
   Ju, Jiabao
   Kou, Yuhui
   Chen, Lei
   Jiang, Mengxi
   Pan, Feng
   Zheng, Yali
   Gao, Zhancheng
   Jiang, Baoguo
TI Long-term bone and lung consequences associated with hospital-acquired
   severe acute respiratory syndrome: a 15-year follow-up from a
   prospective cohort study
SO BONE RESEARCH
LA English
DT Article
ID STEROID-INDUCED OSTEONECROSIS; AVASCULAR NECROSIS; CORONAVIRUS;
   PNEUMONIA; OUTBREAK; SARS; HIP
AB The most severe sequelae after rehabilitation from SARS are femoral head necrosis and pulmonary fibrosis. We performed a 15-year follow-up on the lung and bone conditions of SARS patients. We evaluated the recovery from lung damage and femoral head necrosis in an observational cohort study of SARS patients using pulmonary CT scans, hip joint MRI examinations, pulmonary function tests and hip joint function questionnaires. Eighty medical staff contracted SARS in 2003. Two patients died of SARS, and 78 were enrolled in this study from August 2003 to March 2018. Seventy-one patients completed the 15-year follow-up. The percentage of pulmonary lesions on CT scans diminished from 2003 (9.40 +/- 7.83)% to 2004 (3.20 +/- 4.78)% (P < 0.001) and remained stable thereafter until 2018 (4.60 +/- 6.37)%. Between 2006 and 2018, the proportion of patients with interstitial changes who had improved pulmonary function was lower than that of patients without lesions, as demonstrated by the one-second ratio (FEV1/FVC%, t = 2.21, P = 0.04) and mid-flow of maximum expiration (FEF25%-75%, t = 2.76, P = 0.01). The volume of femoral head necrosis decreased significantly from 2003 (38.83 +/- 21.01)% to 2005 (30.38 +/- 20.23)% (P = 0.000 2), then declined slowly from 2005 to 2013 (28.99 +/- 20.59)% and plateaued until 2018 (25.52 +/- 15.51)%. Pulmonary interstitial damage and functional decline caused by SARS mostly recovered, with a greater extent of recovery within 2 years after rehabilitation. Femoral head necrosis induced by large doses of steroid pulse therapy in SARS patients was not progressive and was partially reversible.
C1 [Zhang, Peixun; Kou, Yuhui; Jiang, Baoguo] Peking Univ, Dept Orthoped & Trauma, Peoples Hosp, Beijing, Peoples R China.
   [Li, Jia; Zheng, Yali; Gao, Zhancheng] Peking Univ, Dept Resp Med, Peoples Hosp, Beijing, Peoples R China.
   [Liu, Huixin] Peking Univ, Dept Clin Epidemiol & Biostat, Peoples Hosp, Beijing, Peoples R China.
   [Han, Na] Peking Univ, Dept Cent Lab, Peoples Hosp, Beijing, Peoples R China.
   [Ju, Jiabao] Peking Univ, Dept Educ, Peoples Hosp, Beijing, Peoples R China.
   [Chen, Lei; Jiang, Mengxi; Pan, Feng] Peking Univ, Dept Radiol, Peoples Hosp, Beijing, Peoples R China.
RP Jiang, BG (reprint author), Peking Univ, Dept Orthoped & Trauma, Peoples Hosp, Beijing, Peoples R China.; Gao, ZC (reprint author), Peking Univ, Dept Resp Med, Peoples Hosp, Beijing, Peoples R China.
EM zcgao@bjmu.edu.cn; jiangbaoguo@vip.sina.com
FU Innovation Team of the Ministry of Education [IRT1601]; National Key
   Research and Development Programme of China [2016YFC0903800]; National
   Natural Science FoundationNational Natural Science Foundation of China
   [31771322, 31571235]; Fostering Young Scholars of Peking University
   Health Science Center [BMU2017PY013]; Beijing Science & Technology New
   Star Cross Project [201819]
FX We thank all the SARS patients for their commitment to this study and
   all other staff members for their contributions, especially the
   Department of Human Resources of Peking University People's Hospital. We
   thank Clare Cox, PhD, from Liwen Bianji, Edanz Editing China
   (www.liwenbianji.cn/ac) for editing the English text of a draft of this
   manuscript. This work was supported by Innovation Team of the Ministry
   of Education (IRT1601), the National Key Research and Development
   Programme of China (2016YFC0903800), the National Natural Science
   Foundation (31771322, 31571235), Fostering Young Scholars of Peking
   University Health Science Center (BMU2017PY013), and Beijing Science &
   Technology New Star Cross Project (201819).
CR [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P73
   Chan MHM, 2006, PATHOLOGY, V38, P229, DOI 10.1080/00313020600696231
   Chen JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17497-6
   Das KM, 2015, AM J ROENTGENOL, V205, pW267, DOI 10.2214/AJR.15.14445
   Dundamadappa S., 2004, SCI ASS M
   Griffith JF, 2005, RADIOLOGY, V235, P168, DOI 10.1148/radiol.2351040100
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Hongyu W., 2009, THESIS
   J G, 1992, ARCO NEWS, V4, P41
   Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Liu B Y, 2017, Zhonghua Yi Xue Za Zhi, V97, P3213, DOI 10.3760/cma.j.issn.0376-2491.2017.41.004
   Liu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133698
   MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473
   Mont MA, 2015, J BONE JOINT SURG AM, V97A, P1604, DOI 10.2106/JBJS.O.00071
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   OHZONO K, 1991, J BONE JOINT SURG BR, V73, P68
   Ong KC, 2005, CHEST, V128, P1393, DOI 10.1378/chest.128.3.1393
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   SHIMIZU K, 1994, J BONE JOINT SURG AM, V76A, P215, DOI 10.2106/00004623-199402000-00007
   Wu XH, 2016, MED SCI MONITOR, V22, P2793, DOI 10.12659/MSM.896985
   Zhang NF, 2008, J BONE JOINT SURG BR, V90B, P1239, DOI 10.1302/0301-620X.90B9.20056
   Zhao Feng-Chao, 2013, Eur J Orthop Surg Traumatol, V23, P671, DOI 10.1007/s00590-012-1054-4
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
NR 27
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-4700
EI 2095-6231
J9 BONE RES
JI Bone Res.
PD FEB 14
PY 2020
VL 8
IS 1
AR 8
DI 10.1038/s41413-020-0084-5
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA KL1BP
UT WOS:000513166800001
PM 32128276
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Benezit, F
   Loubet, P
   Galtier, F
   Pronier, C
   Lenzi, N
   Lesieur, Z
   Jouneau, S
   Lagathu, G
   L'Honneur, AS
   Foulongne, V
   Vallejo, C
   Alain, S
   Duval, X
   Houhou, N
   Costa, Y
   Vanhems, P
   Amour, S
   Carrat, F
   Lina, B
   Launay, O
   Tattevin, P
AF Benezit, Francois
   Loubet, Paul
   Galtier, Florence
   Pronier, Charlotte
   Lenzi, Nezha
   Lesieur, Zineb
   Jouneau, Stephane
   Lagathu, Gisele
   L'Honneur, Anne-Sophie
   Foulongne, Vincent
   Vallejo, Christine
   Alain, Sophie
   Duval, Xavier
   Houhou, Nawal
   Costa, Yolande
   Vanhems, Philippe
   Amour, Selilah
   Carrat, Fabrice
   Lina, Bruno
   Launay, Odile
   Tattevin, Pierre
CA FLUVAC Study Grp
TI Non-influenza respiratory viruses in adult patients admitted with
   influenza-like illness: a 3-year prospective multicenter study
SO INFECTION
LA English
DT Article; Early Access
DE Influenza-like illness; Influenza; Picornavirus; Respiratory syncytial
   virus; Coronavirus; Human metapneumovirus
ID COMMUNITY-ACQUIRED PNEUMONIA; EXPERIMENTAL RHINOVIRUS INFECTION;
   VIRAL-INFECTIONS; RISK; RELEVANCE
AB Purpose To describe the burden, and characteristics, of influenza-like illness (ILI) associated with non-influenza respiratory viruses (NIRV). Methods We performed a prospective, multicenter, observational study of adults admitted with ILI during three influenza seasons (2012-2015). Patients were screened for picornavirus, respiratory syncytial virus (RSV), coronavirus, human metapneumovirus, adenovirus, bocavirus, parainfluenza virus, and influenza, by PCR on nasopharyngeal samples. We excluded patients coinfected with NIRV and influenza. Results Among 1421 patients enrolled, influenza virus was detected in 535 (38%), and NIRV in 215 (15%), mostly picornavirus (n = 61), RSV (n = 53), coronavirus 229E (n = 48), and human metapneumovirus (n = 40). In-hospital mortality was 5% (NIRV), 4% (influenza), and 5% (no respiratory virus). As compared to influenza, NIRV were associated with age (median, 73 years vs. 68, P = 0.026), chronic respiratory diseases (53% vs. 45%, P = 0.034), cancer (14% vs. 9%, P = 0.029), and immunosuppressive drugs (21% vs. 14%, P = 0.028), and inversely associated with diabetes (18% vs. 25%, P = 0.038). On multivariable analysis, only chronic respiratory diseases (OR 1.5 [1.1-2.0], P = 0.008), and diabetes (OR 0.5 [0.4-0.8], P = 0.01) were associated with NIRV detection. Conclusions NIRV are common in adults admitted with ILI during influenza seasons. Outcomes are similar in patients with NIRV, influenza, or no respiratory virus.
C1 [Benezit, Francois; Tattevin, Pierre] Univ Rennes 1, CHU Pontchaillou, Hop Pontchaillou, Serv Malad Infect & Reanimat Med, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.
   [Loubet, Paul; Lenzi, Nezha; Lesieur, Zineb; Launay, Odile] Univ Paris 05, AP HP, Hop Cochin, CIC Cochin Pasteur,Inserm,Sorbonne Paris Cite,Inn, Paris, France.
   [Galtier, Florence] INSERM, F CRIN, Innovat Clin Res Network VACcinol I REIVAC, Paris, France.
   [Galtier, Florence] CHU Montpellier, Hop St Eloi, CIC1411, F-34295 Montpellier, France.
   [Lagathu, Gisele] Univ Rennes 1, Hop Pontchaillou, Virol, Rennes, France.
   [Jouneau, Stephane] Univ Rennes 1, Hop Pontchaillou, Pneumol, Rennes, France.
   [Jouneau, Stephane; Tattevin, Pierre] Univ Rennes 1, Hop Pontchaillou, INSERM, CIC 1414, Rennes, France.
   [L'Honneur, Anne-Sophie] AHU, Hop Cochin, Serv Virol, Paris, France.
   [Foulongne, Vincent] CHU Montpellier, Hop St Eloi, Serv Virol, F-34295 Montpellier, France.
   [Vallejo, Christine] CHU Dupuytren, INSERM CIC 1435, Limoges, France.
   [Alain, Sophie] Univ Limoges, CHU Limoges, INSERM, RESINFIT,U1092, F-87000 Limoges, France.
   [Duval, Xavier; Costa, Yolande] Hop Bichat Claude Bernard, AP HP, INSERM,CIC1125, F CRIN,Innovat Clin Res Network Vaccinol I REIVAC, Paris, France.
   [Houhou, Nawal] Hop Bichat Claude Bernard, Lab Virol, Paris, France.
   [Vanhems, Philippe; Amour, Selilah] Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, F-69437 Lyon, France.
   [Vanhems, Philippe] Univ Claude Bernard Lyon, Ecole Normale Super Lyon, Ctr Int Rech Infectiol,UMR5308,U1111, CNRS,INSERM,Lab Pathogenes Emergents Fdn Merieux, Lyon, France.
   [Carrat, Fabrice] Sorbonne Univ, Hop St Antoine, AP HP, INSERM,IPLESP, F-75013 Paris, France.
   [Lina, Bruno] Hosp Civils Lyon, Ctr Natl Reference Virus Resp France Sud, IAI, Lab Virol, F-69317 Lyon 04, France.
RP Tattevin, P (reprint author), Univ Rennes 1, CHU Pontchaillou, Hop Pontchaillou, Serv Malad Infect & Reanimat Med, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.; Tattevin, P (reprint author), Univ Rennes 1, Hop Pontchaillou, INSERM, CIC 1414, Rennes, France.
EM pierre.tattevin@chu-rennes.fr
FU Sanofi Pasteur; Sanofi Pasteur MSD
FX The current work received no funding. However, the study sites received
   funding from Sanofi Pasteur and Sanofi Pasteur MSD for the FLUVAC study.
   Vaccine producers had no role in the study design, data analysis,
   decision to publish or preparation of the manuscript. The FLUVAC Study
   group. Hopital Cochin, Paris: P. Loulergue, S. Momcilovic, JP Mira, N.
   Marin, A. Regent, Kanaan, F. Dumas, B. Doumenc. Hopital Bichat Claude
   Bernard, Paris: J.F. Alexandra, H. Becheur, K. Belghalem, J. Bernard, A.
   Bleitreu, M. Boisseau, R. Bories, O. Brugiere, F. Brunet, C. Burdet, E.
   Casalino, M. Caseris, Chansiaux, M. Chauchard, P. Chavance, C. Choquet,
   Cloppet-Fontaine, L. Colosi, B. Couset, B. Crestani, F. Crocket, A.
   Debit, Delanoe, V. Descamps, P. Dieude, A. Dossier, N. Douron, E.
   Dupeyrat, N. Emeyrat, Fernet, T. Goulenok, S. Harent, Jouenne, A.
   Justet, M. Lachatre, A. Leleu, I. Lerat, M. Lilamand, H. Mal, A.
   Marceau, A-C Metivier, K. Oplelatora, T. Papo, A-L. Pelletier, L.
   Pereira, P. Pradere, Prommier, P. Ralainnazava, M. Ranaivoision, A.
   RaynaudSimon, C. Rioux, K. Sacre, V. Verry, V. Vuong, Y. Yazdapanah. CHU
   de Montpellier: P. Geraud, V. Driss, V. Maugueret, M. Ray, F. Letois, T.
   Mura, C. Merle, A. Bourdin, A. Konate, X. Capdevilla, G. Du Cailar, A.
   Terminet, H. Blain, M.-S. Leglise, A. Le Quellec, P. Corne, L. Landreau,
   K. Klouche, A. Bourgeois, M. Sebbane, G. Mourad, H. Leray, M. Maarouf.
   CHU Dupuytren, Limoges: D. Postil, S. Alcolea, E. Couve Deacon, S.
   Rogez. Hopital Edouard Herriot, Lyon: L. Argaud, K. Tazarourte, R.
   Hernu, M. Cour, M. Simon, T. Baudry, L. Jacquin. CHU Pontchaillou,
   Rennes: F. Laine, B. Laviolle, J.-S. Allain, N. Belhomme, V. Thibault,
   S. Rochas, S. Cochennec, E. Ouamara-Digue, C. Lepape, M. Revest, S.
   Simon, J. Fouchard, C. Gautier, N. Nouredine, E. Thebault.
CR Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102
   Ambrosioni J, 2014, CLIN MICROBIOL INFEC, V20, pO578, DOI 10.1111/1469-0691.12525
   Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x
   European Centre for Disease Prevention and Control, 2019, INFL CAS DEF
   Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951
   Gunawardana N, 2014, ANTIVIR RES, V102, P95, DOI 10.1016/j.antiviral.2013.12.006
   Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245
   Loubet P, 2017, CLIN MICROBIOL INFEC, V23, P253, DOI 10.1016/j.cmi.2016.11.014
   Loubet P, 2016, J CLIN VIROL, V79, P68, DOI 10.1016/j.jcv.2016.04.005
   Luchsinger V, 2013, THORAX, V68, P1000, DOI 10.1136/thoraxjnl-2013-203551
   Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC
   Galvan JM, 2015, ARCH BRONCONEUMOL, V51, P590, DOI 10.1016/j.arbres.2015.02.015
   Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587
   Pavia AT, 2013, INFECT DIS CLIN N AM, V27, P157, DOI 10.1016/j.idc.2012.11.007
   Pearson-Stuttard J, 2016, LANCET DIABETES ENDO, V4, P148, DOI 10.1016/S2213-8587(15)00379-4
   Rondy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059681
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510
   Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3
   van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098
   Zwaans WAR, 2014, J CLIN VIROL, V61, P181, DOI 10.1016/j.jcv.2014.06.025
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
DI 10.1007/s15010-019-01388-1
EA FEB 2020
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA KP3CJ
UT WOS:000516117500001
PM 32056143
OA Bronze
DA 2020-04-03
ER

PT J
AU Nazareth, R
   Chasqueira, MJ
   Rodrigues, ML
   Paulino, C
   Conceicao, C
   Ledo, L
   Segura, U
   Santos, M
   Messias, A
   Povoa, P
   Paixao, P
AF Nazareth, Raquel
   Chasqueira, Maria-Jesus
   Rodrigues, Maria-Lucia
   Paulino, Carolina
   Conceicao, Catarina
   Ledo, Lia
   Segura, Ursula
   Santos, Madalena
   Messias, Antonio
   Povoa, Pedro
   Paixao, Paulo
TI Respiratory viruses in mechanically ventilated patients: a pilot study
SO BMC PULMONARY MEDICINE
LA English
DT Article
DE Human microbiome; Respiratory virome; Respiratory viruses; Real-time PCR
ID MICROBIOME; PNEUMONIA
AB Background Respiratory virome is an integral part of the human microbiome and its characterization may contribute to a better understanding of the changes that arise in the disease and, consequently, influence the approach and treatment of patients with acute lower respiratory infections. The aim of this study was to evaluate the presence of respiratory viruses in the lower airways of individuals undergoing invasive mechanical ventilation, with and without acute lower respiratory infection (respectively WRI and WORI groups). Methods We studied 44 mini-bronchoalveolar lavage samples (collected with a double catheter, Combicath (R) kit) from patients with mean age in the seventh decade, 20 from WORI group and 24 from WRI group, who were hospitalized for acute respiratory failure in Intensive Care Units of two hospitals in the Lisbon area. Real-time PCR was applied to verify analyse the presence of 15 common respiratory viruses (adenovirus, human bocavirus, influenza virus A and B, repiratory syncytial virus, human parainfluenza virus types 1, 2, 3 and 4, human enterovirus, human rhinovirus, human metapneumovirus, human coronavirus group 1 (229E, NL63) and 2 (OC43, HKU1). Results Respiratory viruses were detected in six of the 20 patients in the WORI group: influenza AH3 (n = 2), parainfluenza virus 1/3 (n = 2), human rhinovirus (n = 2), respiratory syncytial virus (n = 1) and human metapneumovirus (n = 1). In the WRI group, respiratory viruses were detected in 12 of the 24 patients: influenza AH3 (n = 3), human rhinovirus (n = 3), respiratory syncytial virus (n = 3), human metapneumovirus (n = 3), human bocavirus (n = 2) and human enterovirus (n = 1). Simultaneous detection of two viruses was recorded in two samples in both groups. Conclusions The results of this study suggest the presence of common respiratory viruses in the lower respiratory tract without causing symptomatic infection, even in carefully collected lower samples. This may have important implications on the interpretation of the results on the diagnostic setting.
C1 [Nazareth, Raquel; Segura, Ursula; Messias, Antonio] Hosp Beatriz Angelo, Ave Carlos Teixeira 3, P-2674514 Loures, Portugal.
   [Nazareth, Raquel; Chasqueira, Maria-Jesus; Rodrigues, Maria-Lucia; Povoa, Pedro; Paixao, Paulo] NOVA Med Sch, Fac Ciencias Med, Ctr Estudos Doencas Cron, CEDOC, Campo Martires da Patria 130, P-1169056 Lisbon, Portugal.
   [Paulino, Carolina; Conceicao, Catarina; Ledo, Lia; Povoa, Pedro] Hosp Sao Francisco Xavier, Estr Forte Alto Duque, P-1449005 Lisbon, Portugal.
   [Santos, Madalena] Hosp Curry Cabral, Ctr Hosp Lisboa Cent, Rua Beneficiencia 8, P-1069166 Lisbon, Portugal.
   [Povoa, Pedro] OUH, Ctr Clin Epidemiol, Odense, Denmark.
   [Povoa, Pedro] OUH, Res Unit Clin Epidemiol, Odense, Denmark.
   [Paixao, Paulo] Hosp Luz, Clin Pathol Lab Synlab, Av Lusiada 100, P-1500650 Lisbon, Portugal.
RP Nazareth, R (reprint author), Hosp Beatriz Angelo, Ave Carlos Teixeira 3, P-2674514 Loures, Portugal.; Nazareth, R (reprint author), NOVA Med Sch, Fac Ciencias Med, Ctr Estudos Doencas Cron, CEDOC, Campo Martires da Patria 130, P-1169056 Lisbon, Portugal.
EM raquelnazareth@gmail.com
FU Infection unit of the NOVA Medical School; academic unit of the NOVA
   University of Lisbon
FX The work was funded by the Infection unit of the NOVA Medical School, an
   academic unit of the NOVA University of Lisbon.
CR Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC
   Chasqueira MJ, 2018, INT J INFECT DIS, V69, P1, DOI 10.1016/j.ijid.2018.01.012
   Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC
   Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004
   Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923
   Faner R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02086-2016
   Forel JM, 2014, INTENS CARE MED, V40, P1945, DOI 10.1007/s00134-014-3445-y
   Luyt CE, 2008, CURR OPIN CRIT CARE, V14, P605, DOI 10.1097/MCC.0b013e32830f1e12
   Luyt CE, 2012, AM J RESP CRIT CARE, V186, P301, DOI 10.1164/rccm.201206-1119ED
   Luyt Charles-Edouard, 2011, Presse Med, V40, pe561, DOI 10.1016/j.lpm.2011.05.027
   Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875
   Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5
   O'Dwyer DN, 2016, J IMMUNOL, V196, P4839, DOI 10.4049/jimmunol.1600279
   Romero-Espinoza JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192878
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855
   Wang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.006
   Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC
   Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370
   Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735
   Xu LL, 2017, J MED VIROL, V89, P2098, DOI 10.1002/jmv.24895
   Zou SM, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0177-y
NR 22
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2466
J9 BMC PULM MED
JI BMC Pulm. Med.
PD FEB 13
PY 2020
VL 20
IS 1
AR 39
DI 10.1186/s12890-020-1082-5
PG 6
WC Respiratory System
SC Respiratory System
GA KN6BP
UT WOS:000514921200001
PM 32054471
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Nooh, HZ
   Alshammary, RH
   Alenezy, JM
   Alrowaili, NH
   Alsharari, AJ
   Alenzi, NM
   Sabaa, HE
AF Nooh, Hanaa Zakaria
   Alshammary, Rawan Humaidy
   Alenezy, Jomanh Mohammed
   Alrowaili, Njood Hial
   Alsharari, Amani Jaded
   Alenzi, Njood Menwer
   Sabaa, Hanan E.
TI Public awareness of coronavirus in Al-Jouf region, Saudi Arabia
SO JOURNAL OF PUBLIC HEALTH-HEIDELBERG
LA English
DT Article; Early Access
DE Awareness; Coronavirus; Population; Jouf; Camels
ID EAST RESPIRATORY SYNDROME; STUDENTS
AB Aim Since 2012 and to date, outbreak/new cases of Middle East respiratory syndrome-related coronavirus (MERS-CoV) were always reported in Saudi Arabia. Al-Jouf region is considered as one of the most vulnerable areas to the disease outbreak. This research aimed to assess (to the best of our knowledge), for the first time, the current level of awareness towards MERS-CoV among the Al-Jouf region population through a well-designed multistage questionnaire. Subjects and methods A cross-sectional study of 384 participants recruited from various places in Al-Jouf government was conducted through a valid and reliable questionnaire including sociodemographic and MERS-CoV knowledge data. Results The majority of the participants showed generally moderate knowledge about MERS-CoV. Age, education, and occupation were the only significant predictors of the level of low awareness concern. Also, the public awareness about the nature, communicability, and lethal effect of the disease was good overall; however, knowledge about incubation period, clinical picture, and epidemiology of the disease needs more governmental concern. The Ministry of Health was the main source of information. Conclusion Empowering public information regarding the incubation period and epidemiology of the disease is needed. Frequent communication between healthcare providers and both school students and non-educated individuals is recommended to help the Saudi government in controlling the disease outbreak.
C1 [Nooh, Hanaa Zakaria; Alshammary, Rawan Humaidy; Alenezy, Jomanh Mohammed; Alrowaili, Njood Hial; Alsharari, Amani Jaded; Alenzi, Njood Menwer; Sabaa, Hanan E.] Jouf Univ, Fac Med, Sakaka, Saudi Arabia.
RP Nooh, HZ (reprint author), Jouf Univ, Fac Med, Sakaka, Saudi Arabia.
EM hznooh@ju.edu.sa; rawanalhumaidy@gmail.com; Jomanh-alenezy@hotmail.com;
   Nj68140@gmail.com; Amaniii07@hotmail.com; Exbt2017@gmail.com;
   Hanan123967@gmail.com
CR Aguanno R, 2018, ANTIVIR RES, V159, P35, DOI 10.1016/j.antiviral.2018.09.002
   Al-Abdullah N, 2016, INTERNET J INFECT DI, V15, P1, DOI [10.5580/IJPH.46719, DOI 10.5580/IJPH.46719]
   Al-Mohrej A, 2017, J INFECT PUBLIC HEAL, V10, P388, DOI 10.1016/j.jiph.2016.06.013
   Al-Osail AM, 2017, MULTIDISCIP RESP MED, V12, DOI 10.1186/s40248-017-0101-8
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Alqahtani SH, 2015, CLIN RES TRIALS, V1, P55, DOI [10.15761/CRT.1000114, DOI 10.15761/CRT.1000114]
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Andualem Y, 2017, J VET MED ANIMAL HLT, V9, P39, DOI [10.5897/JVMAH2016.0519, DOI 10.5897/JVMAH2016.0519]
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Center for International Communication (CIC), 2018, 2000 YEAR OLD CAM SC
   Elbur A, 2016, IOSR J PHARM, V6, P33, DOI [10.9790/3021-068023340, DOI 10.9790/3021-068023340]
   General Authority for Statistics (GAS), 2010, AR ALJ POP GEND GOV
   Joshi RM, 2013, J CLIN MICROBIOL, V2, pe113, DOI DOI 10.4172/2327-5073.1000e113
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Kharma MY, 2015, J INT SOC PREV COMMU, V5, P163, DOI 10.4103/2231-0762.159951
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Memish ZA, 2014, INT J INFECT DIS, V24, P51, DOI 10.1016/j.ijid.2014.05.001
   Seto WH, 2013, E MEDITERR HEALTH J, V19, pS39
   Tahir M, 2013, EUROSURVEILLANCE, V18, P4
   World Health Organization, 2014, MIDDL E RESP SYNDR C
   World Health Organization (WHO), 2019, MIDDLE E RESP SYNDR
NR 22
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2198-1833
EI 1613-2238
J9 J PUBLIC HEALTH-HEID
JI J. Public Health-Heidelberg
DI 10.1007/s10389-020-01209-y
EA FEB 2020
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KS2LI
UT WOS:000518141500002
PM 32206545
OA Bronze, Green Accepted
DA 2020-04-03
ER

PT J
AU Benvenuto, D
   Giovanetti, M
   Salemi, M
   Prosperi, M
   De Flora, C
   Alcantara, LC
   Angeletti, S
   Ciccozzi, M
AF Benvenuto, Domenico
   Giovanetti, Marta
   Salemi, Marco
   Prosperi, Mattia
   De Flora, Cecilia
   Junior Alcantara, Luiz Carlos
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The global spread of 2019-nCoV: a molecular evolutionary analysis
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article; Early Access
DE 2019-nCoV; molecular Epidemiology; phylogeny; SARS
ID CORONAVIRUS
AB The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary phylodynamic and phylogeographic analysis of this new virus. A Maximum Clade Credibility tree has been built using the 29 available whole genome sequences of 2019-nCoV and two whole genome sequences that are highly similar sequences from Bat SARS-like Coronavirus available in GeneBank. We are able to clarify the mechanism of transmission among the countries which have provided the 2019-nCoV sequence isolates from their patients. The Bayesian phylogeographic reconstruction shows that the 2019-2020 nCoV most probably originated from the Bat SARS-like Coronavirus circulating in the Rhinolophus bat family. In agreement with epidemiological observations, the most likely geographic origin of the new outbreak was the city of Wuhan, China, where 2019-nCoV time of the most recent common ancestor emerged, according to molecular clock analysis, around November 25(th), 2019. These results, together with previously recorded epidemics, suggest a recurring pattern of periodical epizootic outbreaks due to Betacoronavirus. Moreover, our study describes the same population genetic dynamic underlying the SARS 2003 epidemic, and suggests the urgent need for the development of effective molecular surveillance strategies of Betacoronavirus among animals and Rhinolophus of the bat family.
C1 [Benvenuto, Domenico; De Flora, Cecilia] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos; Ciccozzi, Massimo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
RP Angeletti, S (reprint author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
EM s.angeletti@unicampus.it
RI Ribeiro, Nuno/AAH-2299-2020
OI Benvenuto, Domenico/0000-0003-3833-2927
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 0
Z9 0
U1 29
U2 29
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
DI 10.1080/20477724.2020.1725339
EA FEB 2020
PG 4
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA KL7QL
UT WOS:000513613400001
PM 32048560
OA Bronze
DA 2020-04-03
ER

PT J
AU Lu, MM
   Liu, QG
   Wang, XB
   Zhang, JL
   Zhang, X
   Shi, D
   Liu, JB
   Shi, HY
   Chen, JF
   Feng, L
AF Lu, Manman
   Liu, Qiuge
   Wang, Xiaobo
   Zhang, Jialin
   Zhang, Xin
   Shi, Da
   Liu, Jianbo
   Shi, Hongyan
   Chen, Jianfei
   Feng, Li
TI Development of an indirect ELISA for detecting porcine deltacoronavirus
   IgA antibodies
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Early Access
ID TRANSMISSIBLE GASTROENTERITIS VIRUS; RESPIRATORY CORONAVIRUS INFECTIONS;
   EPIDEMIC DIARRHEA VIRUS; LENGTH GENOME SEQUENCE; SPIKE PROTEIN;
   IDENTIFICATION; PIGS; IMMUNITY; SWINE; PREVALENCE
AB Porcine deltacoronavirus (PDCoV) is a novel coronavirus that can cause vomiting and watery diarrhea in pigs and death in piglets. Since PDCoV was first detected in 2009 in Hong Kong, the prevalence of PDCoV has increased in recent years, resulting in serious economic losses to the swine industry. The coronavirus spike (S) protein is an antigen that has been demonstrated to contain epitopes that induce neutralizing antibodies. The presence of serum and milk IgA antibodies against pathogens that replicate primarily on mucosal surfaces is important for mucosal immunity. Here, an indirect anti-PDCoV IgA antibody enzyme-linked immunosorbent assay (PDCoV S1 IgA ELISA) using the purified S1 portion of S protein as the coating antigen was developed to detect PDCoV IgA antibodies in serum and sow's milk. A receiver operating characteristic (ROC) curve analysis showed high specificity and sensitivity of the PDCoV-S1-IgA-ELISA based on samples confirmed by IFA. Anti-PDCoV IgA antibodies in 152 serum samples and 65 milk samples collected from six farms that had experienced diarrhea outbreaks within previous last two years were detected by this assay, and 62.5% of the serum samples and 100% of the milk samples were positive for PDCoV. The indirect ELISA method established in this study will provide a convenient tool for measurement of serum and milk IgA levels against PDCoV in pig herds, rapid detection of PDCoV infection in pigs, and evaluation of the immunogenicity of vaccines.
C1 [Lu, Manman; Liu, Qiuge; Wang, Xiaobo; Zhang, Jialin; Zhang, Xin; Shi, Da; Liu, Jianbo; Shi, Hongyan; Chen, Jianfei; Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Swine Digest Syst Infect Dis, State Key Lab Vet Biotechnol, Harbin 150069, Peoples R China.
RP Chen, JF; Feng, L (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Swine Digest Syst Infect Dis, State Key Lab Vet Biotechnol, Harbin 150069, Peoples R China.
EM chenjianfei@caas.cn; fengli@caas.cn
RI Ribeiro, Nuno/AAH-2299-2020
FU National Key Research and Development Program of China [2016YFD0500705];
   Heilongjiang Province Natural Science Foundation of ChinaNatural Science
   Foundation of Heilongjiang Province [C2016065]
FX This study was funded by the National Key Research and Development
   Program of China (2016YFD0500705) and the Heilongjiang Province Natural
   Science Foundation of China (C2016065).
CR ABRAHAM S, 1990, VIROLOGY, V176, P296, DOI 10.1016/0042-6822(90)90257-R
   Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123
   Chen FZ, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01284-15
   [陈建飞 Chen Jianfei], 2016, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V38, P171
   Chiou HY, 2017, TRANSBOUND EMERG DIS, V64, P157, DOI 10.1111/tbed.12357
   de Arriba ML, 2002, VET IMMUNOL IMMUNOP, V85, P85, DOI 10.1016/S0165-2427(01)00417-2
   DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990
   Elia G, 2010, J VIROL METHODS, V163, P309, DOI 10.1016/j.jviromet.2009.10.015
   Hu H, 2016, ARCH VIROL, V161, P3421, DOI 10.1007/s00705-016-3056-8
   Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852
   KNUCHEL M, 1992, VET MICROBIOL, V32, P117, DOI 10.1016/0378-1135(92)90100-8
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Li GW, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00278-14
   Lorsirigool A, 2016, ARCH VIROL, V161, P2909, DOI 10.1007/s00705-016-2983-8
   LUYTJES W, 1987, VIROLOGY, V161, P479, DOI 10.1016/0042-6822(87)90142-5
   Ma YM, 2016, VET MICROBIOL, V186, P90, DOI 10.1016/j.vetmic.2016.02.004
   Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15
   Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.140526, 10.3201/eid2008.14-0526]
   Saif LJ, 1996, VET IMMUNOL IMMUNOP, V54, P163, DOI 10.1016/S0165-2427(96)05702-9
   SAIF LJ, 1994, VET IMMUNOL IMMUNOP, V43, P89, DOI 10.1016/0165-2427(94)90124-4
   Salmon H, 2000, ADV EXP MED BIOL, V480, P279
   SIMKINS RA, 1993, AM J VET RES, V54, P254
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Su MJ, 2016, J VET MED SCI, V78, P601, DOI 10.1292/jvms.15-0533
   Thachil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124363
   To TL, 1998, J GEN VIROL, V79, P2661
   Wang YW, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00945-15
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Zhai SL, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0591-6
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
NR 30
TC 0
Z9 0
U1 10
U2 10
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
DI 10.1007/s00705-020-04541-6
EA FEB 2020
PG 7
WC Virology
SC Virology
GA KK9HH
UT WOS:000513045100003
PM 32052195
OA Bronze, Green Accepted
DA 2020-04-03
ER

PT J
AU Wei, XN
   She, GL
   Wu, TT
   Xue, CY
   Cao, YC
AF Wei, Xiaona
   She, Gaoli
   Wu, Tingting
   Xue, Chunyi
   Cao, Yongchang
TI PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated
   endocytosis and traffics via the endo-/lysosome pathway
SO VETERINARY RESEARCH
LA English
DT Article
ID PORCINE EPIDEMIC DIARRHEA; RESPIRATORY SYNDROME-CORONAVIRUS; MURINE
   CORONAVIRUS; SARS CORONAVIRUS; EARLY-STAGE; VIRUS; DYNAMIN; ENTRY;
   CHOLESTEROL; INFECTION
AB With the emergence of highly pathogenic variant strains, porcine epidemic diarrhea virus (PEDV) has led to significant economic loss in the global swine industry. Many studies have described how coronaviruses enter cells, but information on PEDV invasion strategies remains insufficient. Given that the differences in gene sequences and pathogenicity between classical and mutant strains of PEDV may lead to diverse invasion mechanisms, this study focused on the cellular entry pathways and cellular transport of the PEDV GI and GII subtype strains in Vero cells and IPEC-J2 cells. We first characterized the kinetics of PEDV entry into cells and found that the highest invasion rate of PEDV was approximately 33% in the IPEC-J2 cells and approximately 100% in the Vero cells. To clarify the specific endocytic pathways, systematic research methods were used and showed that PEDV enters cells via the clathrin- and caveolae-mediated endocytosis pathways, in which dynamin II, clathrin heavy chain, Eps15, cholesterol, and caveolin-1 were indispensably involved. In addition, lipid raft extraction assay showed that PEDV can also enter cells through lipid raft-mediated endocytosis. To investigate the trafficking of internalized PEDV, we found that PEDV entry into cells relied on low pH and internalized virions reached lysosomes through the early endosome-late endosome-lysosome pathway. The results concretely revealed the entry mechanisms of PEDV and provided an insightful theoretical basis for the further understanding of PEDV pathogenesis and guidance for new targets of antiviral drugs.
C1 [Wei, Xiaona; She, Gaoli; Wu, Tingting; Xue, Chunyi; Cao, Yongchang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Peoples R China.
RP Xue, CY; Cao, YC (reprint author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Peoples R China.
EM xuecy@mail.sysu.edu.cn; caoych@mail.sysu.edu.cn
FU National Key Research and Development Program of China [2016YFD0500101]
FX This study was supported by the National Key Research and Development
   Program of China (No. 2016YFD0500101).
CR Abdulkarim AS, 2003, J HEPATOL, V38, P76, DOI 10.1016/S0168-8278(02)00326-4
   Benmerah A, 1999, J CELL SCI, V112, P1303
   Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055
   Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502
   Callera GE, 2017, METHODS MOL BIOL, V1527, P251, DOI 10.1007/978-1-4939-6625-7_20
   CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1
   Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004
   Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540
   Eifart P, 2007, J VIROL, V81, P10758, DOI 10.1128/JVI.00725-07
   Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7
   Freeman MC, 2014, MBIO, V5, DOI 10.1128/mBio.01340-14
   Gong L, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1042-3
   Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85
   Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200
   Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468
   Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018
   Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07
   Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017
   Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132
   Kalia M, 2011, AMINO ACIDS, V41, P1147, DOI 10.1007/s00726-009-0363-3
   Krause MR, 2014, ACCOUNTS CHEM RES, V47, P3512, DOI 10.1021/ar500260t
   Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x
   Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2
   Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015
   Li L, 2019, J VIROL, V93, DOI 10.1128/JVI.01682-18
   Li L, 2017, ANTIVIR RES, V140, P76, DOI 10.1016/j.antiviral.2017.01.012
   Li QN, 2018, VACCINE, V36, P4228, DOI 10.1016/j.vaccine.2018.05.124
   Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002
   Li Z, 2017, J VIROL, V91, DOI [10.1128/JVI.01083-17, 10.1128/jvi.01083-17]
   Liu C, 2016, J BIOL CHEM, V291, P24779, DOI 10.1074/jbc.M116.740746
   Luo XL, 2017, J VIROL, V91, DOI [10.1128/jvi.00202-17, 10.1128/JVI.00202-17]
   Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002
   Marquardt D, 2016, SOFT MATTER, V12, P9417, DOI 10.1039/c6sm01777k
   Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17
   Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07
   Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109
   Nicola AV, 2013, ADV VIROL, DOI 10.1155/2013/469538
   Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004
   OCHIAI H, 1995, ANTIVIR RES, V27, P425, DOI 10.1016/0166-3542(95)00040-S
   Park JE, 2014, VIRUS RES, V191, P21, DOI 10.1016/j.virusres.2014.07.022
   Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x
   Podinovskaia M, 2018, PROG MOL SUBCELL BIO, V57, P1, DOI 10.1007/978-3-319-96704-2_1
   Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06
   Rituper BT, 2013, BBA-MOL CELL BIOL L, V1831, P1228, DOI 10.1016/j.bbalip.2013.04.007
   SCARMATO P, 1990, J BIOL CHEM, V265, P3661
   Shi BJ, 2016, J VIROL, V90, P9194, DOI 10.1128/JVI.00688-16
   Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166
   Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1
   STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985
   Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259
   Tachikawa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08259-5
   Temeeyasen G, 2018, VIROLOGY, V517, P188, DOI 10.1016/j.virol.2017.11.024
   VALLEE RB, 1993, CIBA F SYMP, V176, P185
   Van Leeuwen MR, 2009, J APPL MICROBIOL, V106, P1908, DOI 10.1111/j.1365-2672.2009.04165.x
   Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491
   Walker WA, 2016, J MATER CHEM B, V4, P1254, DOI 10.1039/c5tb02079d
   Wang D, 2016, VIRUS RES, V226, P7, DOI 10.1016/j.virusres.2016.05.026
   Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15
   Wang JB, 2013, EMERG INFECT DIS, V19, P2048, DOI 10.3201/eid1912.121088
   Wang Peng, 2019, VirusDisease, V30, P294, DOI 10.1007/s13337-019-00513-w
   Wang QC, 2015, J REPROD DEVELOP, V61, P49, DOI 10.1262/jrd.2014-079
   Wen Z, 2018, TRANSBOUND EMERG DIS, V65, P883, DOI 10.1111/tbed.12825
   Wen ZF, 2018, VACCINE, V36, P6803, DOI 10.1016/j.vaccine.2018.09.014
   Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14
   Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685
   Zhu YZ, 2015, CELL PHYSIOL BIOCHEM, V35, P1347, DOI 10.1159/000373956
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
NR 67
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0928-4249
EI 1297-9716
J9 VET RES
JI Vet. Res.
PD FEB 10
PY 2020
VL 51
IS 1
AR 10
DI 10.1186/s13567-020-0739-7
PG 18
WC Veterinary Sciences
SC Veterinary Sciences
GA KU7UU
UT WOS:000519918900001
PM 32041637
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Kemp, V
   Laconi, A
   Cocciolo, G
   Berends, AJ
   Breit, TM
   Verheije, MH
AF Kemp, Vera
   Laconi, Andrea
   Cocciolo, Giulio
   Berends, Alinda J.
   Breit, Timo M.
   Verheije, M. Helene
TI miRNA repertoire and host immune factor regulation upon avian
   coronavirus infection in eggs
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Early Access
ID BRONCHITIS VIRUS; MICRORNAS; PROLIFERATION; INFLAMMATION; TISSUE
AB Avian infectious bronchitis virus (IBV) is a coronavirus with great economic impact on the poultry industry, causing an acute and highly contagious disease in chickens that primarily affects the respiratory and reproductive systems. The cellular regulation of IBV pathogenesis and the host immune responses involved remain to be fully elucidated. MicroRNAs (miRNAs) have emerged as a class of crucial regulators of numerous cellular processes, including responses to viral infections. Here, we employed a high-throughput sequencing approach to analyze the miRNA composition of the spleen and the lungs of chicken embryos upon IBV infection. Compared to healthy chicken embryos, 13 and six miRNAs were upregulated in the spleen and the lungs, respectively, all predicted to influence viral transcription, cytokine production, and lymphocyte functioning. Subsequent downregulation of NFATC3, NFAT5, SPPL3, and TGFB2 genes in particular was observed only in the spleen, demonstrating the biological functionality of the miRNAs in this lymphoid organ. This is the first study that describes the modulation of miRNAs and the related host immune factors by IBV in chicken embryos. Our data provide novel insight into complex virus-host interactions and specifically highlight components that could affect the host's immune response to IBV infection.
C1 [Kemp, Vera; Laconi, Andrea; Berends, Alinda J.; Verheije, M. Helene] Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Div Pathol, Utrecht, Netherlands.
   [Cocciolo, Giulio] Univ Bari, Dept Vet Med, Valenzano, Italy.
   [Breit, Timo M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands.
   [Laconi, Andrea] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy.
RP Verheije, MH (reprint author), Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Div Pathol, Utrecht, Netherlands.
EM m.h.verheije@uu.nl
OI Verheije, Helene/0000-0003-1274-2987
CR Amaral AJ, 2017, EMBO J, V36, P346, DOI 10.15252/embj.201694335
   Castillo JA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1364-y
   Bakre A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066796
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chen QL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00704
   Chhabra R, 2016, VIROLOGY, V488, P232, DOI 10.1016/j.virol.2015.11.011
   Dickey LL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0699-z
   Dinh H, 2014, VET IMMUNOL IMMUNOP, V159, P74, DOI 10.1016/j.vetimm.2014.02.003
   Ellis-Connell AL, 2010, J VIROL, V84, P10329, DOI 10.1128/JVI.00923-10
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Gutkoska J, 2017, VIROLOGY, V504, P52, DOI 10.1016/j.virol.2017.01.019
   Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154
   Inchley CS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0878-z
   Jia YQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051291
   Kamada K, 2012, MICROBES INFECT, V14, P69, DOI 10.1016/j.micinf.2011.08.009
   Li ZH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00017
   Liang JQ, 2019, VIROLOGY, V531, P48, DOI 10.1016/j.virol.2019.02.017
   Liu DJ, 2015, BIOCHEM BIOPH RES CO, V464, P1215, DOI 10.1016/j.bbrc.2015.07.107
   Lv XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00304
   Ma XL, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5128-5
   Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837
   Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14
   Peng F, 2016, INT J MED SCI, V13, P77, DOI 10.7150/ijms.13301
   Peng XX, 2011, MBIO, V2, DOI 10.1128/mBio.00198-11
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Shi TY, 2017, PATHOL RES PRACT, V213, P1464, DOI 10.1016/j.prp.2017.10.020
   Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278
   Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512
   Wu AR, 2016, EXP CELL RES, V349, P191, DOI 10.1016/j.yexcr.2016.10.016
   Wu GX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3413-8
   Yang X, 2017, ARCH VIROL, V162, P3397, DOI 10.1007/s00705-017-3502-2
   Zheng Y, 2018, MICROB PATHOGENESIS, V121, P252, DOI 10.1016/j.micpath.2018.05.015
NR 34
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
DI 10.1007/s00705-020-04527-4
EA FEB 2020
PG 9
WC Virology
SC Virology
GA KO9SJ
UT WOS:000515886200001
PM 32025807
OA Green Accepted, Other Gold
DA 2020-04-03
ER

PT J
AU Laconi, A
   Weerts, EAWS
   Bloodgood, JCG
   Marrero, JPD
   Berends, AJ
   Cocciolo, G
   de Wit, JJ
   Verheije, MH
AF Laconi, A.
   Weerts, E. A. W. S.
   Bloodgood, J. C. G.
   Marrero, J. P. Deniz
   Berends, A. J.
   Cocciolo, G.
   de Wit, J. J.
   Verheije, M. H.
TI Attenuated live infectious bronchitis virus QX vaccine disseminates
   slowly to target organs distant from the site of inoculation
SO VACCINE
LA English
DT Article
DE Infectious bronchitis virus; Nephropathogenicity; Broilers; Attenuation;
   Vaccine; Virulence
ID SEROTYPE; STRAIN; PROTECTION; CHALLENGE; GENOTYPES; BROILERS; EFFICACY;
   SAFETY
AB Infectious bronchitis (IB) is a highly contagious respiratory disease of poultry, caused by the avian coronavirus infectious bronchitis virus (IBV). Currently, one of the most relevant genotypes circulating worldwide is IBV-QX (GI-19), for which vaccines have been developed by passaging virulent QX strains in embryonated chicken eggs. Here we explored the attenuated phenotype of a commercially available QX live vaccine, IB Primo QX, in specific pathogens free broilers. At hatch, birds were inoculated with QX vaccine or its virulent progenitor IBV-D388, and postmortem swabs and tissues were collected each day up to eight days post infection to assess viral replication and morphological changes. In the trachea, viral RNA replication and protein expression were comparable in both groups. Both viruses induced morphologically comparable lesions in the trachea, albeit with a short delay in the vaccinated birds. In contrast, in the kidney, QX vaccine viral RNA was nearly absent, which coincided with the lack of any morphological changes in this organ. This was in contrast to high viral RNA titers and abundant lesions in the kidney after IBV D388 infection. Furthermore, QX vaccine showed reduced ability to reach and replicate in conjunctivae and intestines including cloaca, resulting in significantly lower titers and delayed protein expression, respectively. Nephropathogenic IBVs might reach the kidney also via an ascending route from the cloaca, based on our observation that viral RNA was detected in the cloaca one day before detection in the kidney. In the kidney distal tubular segments, collecting ducts and ureter were positive for viral antigen. Taken together, the attenuated phenotype of QX vaccine seems to rely on slower dissemination and lower replication in target tissues other than the site of inoculation. (C) 2019 The Author(s). Published by Elsevier Ltd.
C1 [Laconi, A.; Weerts, E. A. W. S.; Bloodgood, J. C. G.; Marrero, J. P. Deniz; Berends, A. J.; Verheije, M. H.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.
   [Cocciolo, G.] Univ Bari, Dept Vet Med, Valenzano, Italy.
   [de Wit, J. J.] GD Anim Hlth, Deventer, Netherlands.
   [Laconi, A.] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.
RP Verheije, MH (reprint author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.
EM m.h.verheije@uu.nl
OI Bloodgood, Jennifer/0000-0002-9044-8591; Laconi,
   Andrea/0000-0003-0102-7021; Verheije, Helene/0000-0003-1274-2987
FU Utrecht University (Utrecht, The Netherlands)Netherlands Government; GD
   Animal Health (Deventer, The Netherlands)
FX Utrecht University (Utrecht, The Netherlands) and GD Animal Health
   (Deventer, The Netherlands) financially supported this research. The
   authors have no competing interests to declare.
CR Abro SH, 2012, ARCH VIROL, V157, P1211, DOI 10.1007/s00705-012-1284-0
   Amarasinghe A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181801
   Benyeda Z, 2010, J COMP PATHOL, V143, P276, DOI 10.1016/j.jcpa.2010.04.007
   Bijlenga G, 2004, AVIAN PATHOL, V33, P550, DOI 10.1080/03079450400013154
   Brand JMA, 2011, EFFICACY VACCINATION, V85, P2851, DOI [10.1128/N1.01939-10, DOI 10.1128/N1.01939-10]
   Cavanagh D, 2005, BIRK ADV INFECT DIS, P1
   Chen B, 2007, ANAL LETT, V40, P2465, DOI 10.1080/00032710701583466
   Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432
   de Wit JJ, 2018, AVIAN PATHOL, V47, P140, DOI 10.1080/03079457.2017.1387231
   de Wit JJ, 2011, AVIAN PATHOL, V40, P463, DOI 10.1080/03079457.2011.599060
   de Wit JJ, 2014, AVIAN PATHOL, V43, P485, DOI 10.1080/03079457.2014.974504
   Dolz R, 2012, VET MICROBIOL, V156, P256, DOI 10.1016/j.vetmic.2011.11.001
   Ganapathy K, 2012, VET REC, V171, P597, DOI 10.1136/vr.101005
   Geerligs HJ, 2011, AVIAN PATHOL, V40, P93, DOI 10.1080/03079457.2010.542742
   Gelb JJ, 1983, AVIAN DIS, V27, P240
   HOFSTAD MS, 1966, AVIAN DIS, V10, P230, DOI 10.2307/1588355
   Jackwood MW, 2003, AVIAN DIS, V47, P627, DOI 10.1637/6094
   Krapei U, 2011, AVIAN DIS DIG, V6, pe60, DOI [10.1637/9662-953317-digest.1, DOI 10.1637/9662-953317-DIGEST.1]
   Laconi A, 2020, J VIROL METHODS, V275, DOI 10.1016/j.jviromet.2019.113771
   Reddy VRAP, 2016, VET RES, V47, P1, DOI [10.1186/s13567-016-0154-9, DOI 10.1186/S13567-016-0154-9]
   Terregino C, 2008, AVIAN PATHOL, V37, P487, DOI 10.1080/03079450802356938
   Valastro V, 2010, VET REC, V167, P865, DOI 10.1136/vr.c6001
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
   van Beurden SJ, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0775-8
   van der Sluis HJ, 2009, POULTRY SCI, V88, P1242, DOI 10.3382/ps.2008-00155
   Worthington KJ, 2008, AVIAN PATHOL, V37, P247, DOI 10.1080/03079450801986529
   YuDong W, 1998, CHINESE J ANIM Q, V15, P1998
NR 27
TC 0
Z9 0
U1 17
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 5
PY 2020
VL 38
IS 6
BP 1486
EP 1493
DI 10.1016/j.vaccine.2019.11.064
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KO3JY
UT WOS:000515445900027
PM 31822427
OA Other Gold
DA 2020-04-03
ER

PT J
AU Wang, J
   Li, YY
   Wang, SY
   Liu, F
AF Wang, Jian
   Li, Yangyang
   Wang, Shouyu
   Liu, Fei
TI Dynamics of transmissible gastroenteritis virus internalization
   unraveled by single-virus tracking in live cells
SO FASEB JOURNAL
LA English
DT Article
DE actin; caveolae; clathrin; dynamin 2; TGEV
ID GROWTH-FACTOR RECEPTOR; MEDIATED ENDOCYTOSIS; DEPENDENT FUSION;
   CLATHRIN; ENTRY; CHOLESTEROL; INFECTION; CAVEOLAE
AB Transmissible gastroenteritis virus (TGEV) is a swine enteropathogenic coronavirus that causes significant economic losses in swine industry. Current studies on TGEV internalization mainly focus on viral receptors, but the internalization mechanism is still unclear. In this study, we used single-virus tracking to obtain the detailed insights into the dynamic events of the TGEV internalization and depict the whole sequential process. We observed that TGEVs could be internalized through clathrin- and caveolae-mediated endocytosis, and the internalization of TGEVs was almost completed within similar to 2 minutes after TGEVs attached to the cell membrane. Furthermore, the interactions of TGEVs with actin and dynamin 2 in real time during the TGEV internalization were visualized. To our knowledge, this is the first report that single-virus tracking technique is used to visualize the entire dynamic process of the TGEV internalization: before the TGEV internalization, with the assistance of actin, clathrin, and caveolin 1 would gather around the virus to form the vesicle containing the TGEV, and after similar to 60 seconds, dynamin 2 would be recruited to promote membrane fission. These results demonstrate that TGEVs enter ST cells via clathrin- and caveolae-mediated endocytic, actin-dependent, and dynamin 2-dependent pathways.
C1 [Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China.
   [Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China.
   [Wang, Shouyu] Jiangnan Univ, Computat Opt Lab, Sch Sci, Wuxi, Jiangsu, Peoples R China.
RP Liu, F (reprint author), Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China.; Liu, F (reprint author), Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China.
EM feiliu24@njau.edu.cn
FU National Key Research and Development Program [2018YFD0500100]; National
   Natural Science Foundation of China (NSFC)National Natural Science
   Foundation of China [31870154, 31522056, 61705092]; Natural Science
   Foundation of Jiangsu Province of ChinaNatural Science Foundation of
   Jiangsu Province [BK20170194]; Jiangsu Key Research and Development
   Program [BE2018709]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions
FX National Key Research and Development Program, Grant/Award Number:
   2018YFD0500100; National Natural Science Foundation of China (NSFC),
   Grant/Award Number: 31870154, 31522056 and 61705092; Natural Science
   Foundation of Jiangsu Province of China, Grant/Award Number: BK20170194;
   Jiangsu Key Research and Development Program, Grant/Award Number:
   BE2018709; Priority Academic Program Development of Jiangsu Higher
   Education Institutions
CR Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307
   Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615
   Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394
   DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915
   Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004
   DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0
   Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799
   Hansen GH, 1998, J VIROL, V72, P527, DOI 10.1128/JVI.72.1.527-534.1998
   Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09
   Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483
   Holla P, 2015, TRAFFIC, V16, P398, DOI 10.1111/tra.12260
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Hu WW, 2018, VIROLOGY, V521, P33, DOI 10.1016/j.virol.2018.05.009
   Hu WW, 2016, ONCOTARGET, V7, P12206, DOI 10.18632/oncotarget.7723
   Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9
   Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100
   LAUDE H, 1990, VET MICROBIOL, V23, P147, DOI 10.1016/0378-1135(90)90144-K
   Li Q, 2017, ACS NANO, V11, P3890, DOI 10.1021/acsnano.7b00275
   Li Z, 2017, J VIROL, V91, DOI [10.1128/JVI.01083-17, 10.1128/jvi.01083-17]
   Liu HB, 2011, J VIROL, V85, P6252, DOI 10.1128/JVI.00109-11
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151
   Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046
   Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416
   PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   Ren XF, 2008, VIRUS RES, V137, P220, DOI 10.1016/j.virusres.2008.07.023
   ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931
   Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769
   Rust MJ, 2011, COLD SPRING HARB PRO, V2011, P065623, DOI DOI 10.1101/PDB.T0P065623
   Salanueva IJ, 1999, J VIROL, V73, P7952, DOI 10.1128/JVI.73.10.7952-7964.1999
   SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034
   Schwegmann-Wessels C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-435
   Sun E, 2013, CURR OPIN VIROL, V3, P34, DOI 10.1016/j.coviro.2013.01.005
   Sun EZ, 2017, ACS NANO, V11, P4395, DOI 10.1021/acsnano.6b07853
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774
   Zhang FX, 2018, VIROLOGY, V513, P195, DOI 10.1016/j.virol.2017.09.019
   ZHANG S, 2018, SCI CHINA INFORM SCI, V16
   Zhao TT, 2019, VIROLOGY, V529, P160, DOI 10.1016/j.virol.2019.01.009
NR 43
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR
PY 2020
VL 34
IS 3
BP 4653
EP 4669
DI 10.1096/fj.201902455R
EA FEB 2020
PG 17
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA KT7UL
UT WOS:000511115000001
PM 32017270
OA Bronze
DA 2020-04-03
ER

PT J
AU Ahmed, HG
   Alquwaiay, FK
   Al-Dhamadi, HF
   Alzamil, AF
   Alshammari, IHE
   Altayep, KM
AF Ahmed, Hussain Gadelkarim
   Alquwaiay, Fahad Khalid
   Al-Dhamadi, Hamoud Fahad
   Alzamil, Abdullah Fahad
   Alshammari, Ibrahim Homoud Essa
   Altayep, Kheder Mohamed
TI ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN HAIL REGION, SAUDI ARABIA
SO INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
LA English
DT Article
DE Acute respiratory distress syndrome; Pneumonia; H1N1; Coronavirus; Saudi
   Arabia
ID PNEUMONIA; RISK
AB Background: Acute respiratory distress syndrome (ARDS) is a medical condition occurring in critically ill patients characterized by extensive inflammation in the lungs and associated with several complications. Therefore, the present study aimed to identify the common risk factors associated with ARDS in Hail Region, Northern Saudi Arabia. Methodology: This study investigated retrospectively 68 patients with ARDS clinical presentations during the period from January 2015 to January 2016 in King Khalid Hospital, Hail, Saudi Arabia. Results: Out of 68 patients with ARDS clinical presentations. ARDS was verified in 38/68 (55.9%). Out of 38 ARDS patients, 21/38(55.3%) were males and 17/38 (44.7%) of the 68 studied patients, pneumonia, trauma. H1N1 infection and fibrosis were identified in 50(73.5%), 3(4.4%). 13(19.1%) and 12 (17.6%), respectively. Out of the 38 ARDS patients, 29/38 (76.3%) died. Conclusion: ARDS is common in Hail Region and a common cause of patients to be admitted to specialized intensive care units. Inhalation injuries associated with pneumonia. HIN1 infection and fibrosis were an independent risk factor for ARDS. The mortality rate observed in the study patients was high and associated with ARDS diagnosis.
C1 [Ahmed, Hussain Gadelkarim; Alquwaiay, Fahad Khalid; Al-Dhamadi, Hamoud Fahad; Alzamil, Abdullah Fahad; Alshammari, Ibrahim Homoud Essa] Univ Hail, Coll Med, Hail 2440, Saudi Arabia.
   [Ahmed, Hussain Gadelkarim; Altayep, Kheder Mohamed] Univ Khartoum, Dept Histopathol & Cytol, FMLS, Khartoum, Sudan.
   King Salman Hosp, Dept Med, Hail, Saudi Arabia.
RP Ahmed, HG (reprint author), Univ Hail, Coll Med, Hail 2440, Saudi Arabia.
EM hussaingad5@gmail.com
CR Al-Hameed F, 2016, J INTENSIVE CARE MED, V31, P344, DOI 10.1177/0885066615579858
   Al-Qahtani AA, 2017, ONCOTARGET, V8, P9053, DOI 10.18632/oncotarget.14754
   Caires ND, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2222-7
   Cobbin JCA, 2017, J VIROL, V91, DOI 10.1128/JVI.00096-17
   Monreal MF, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA316
   Herath HMLY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3631-6
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Kao KC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31811-w
   Khalid I, 2016, RESP CARE, V61, P340, DOI 10.4187/respcare.04325
   Killien EY, 2019, J TRAUMA ACUTE CARE, V86, P844, DOI 10.1097/TA.0000000000002202
   Mahmoud ES, 2016, SAUDI MED J, V37, P973, DOI 10.15537/smj.2016.9.15183
   Hernandez-Cardenas CM, 2016, REV INVEST CLIN, V68, P235
   McNicholas BA, 2018, CURR OPIN CRIT CARE, V24, P41, DOI 10.1097/MCC.0000000000000473
   Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC
   Neto AS, 2016, LANCET RESP MED, V4, P882, DOI 10.1016/S2213-2600(16)30305-8
   Sharma BS, 2015, INDIAN J PEDIATR, V82, P629, DOI 10.1007/s12098-014-1559-4
   Shinno Y, 2018, RESPIROLOGY, V23, P55, DOI 10.1111/resp.13192
   Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zatorski P, 2018, ANN TRANSPL, V23, P218, DOI 10.12659/AOT.907083
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 21
TC 0
Z9 0
U1 2
U2 2
PU INT JOURNAL PHARMACEUTICAL SCIENCES & RESEARCH
PI HARYANA
PA 1117, SECTOR 12 A, PANCHKULA, HARYANA, 00000, INDIA
SN 0975-8232
J9 INT J PHARM SCI RES
JI Int. J. Pharm.l Sci. Res.
PD FEB
PY 2020
VL 11
IS 2
BP 987
EP 992
DI 10.13040/IJPSR.0975-8232.11(2).987-92
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KI1XY
UT WOS:000511142200060
DA 2020-04-03
ER

PT J
AU Alburikan, KA
   Abuelizz, HA
AF Alburikan, Khalid A.
   Abuelizz, Hatem A.
TI Identifying factors and target preventive therapies for Middle East
   Respiratory Syndrome sucsibtable patients
SO SAUDI PHARMACEUTICAL JOURNAL
LA English
DT Article
DE Middle East Respiratory Syndrome; MERS-CoV; Diabetes
ID SYNDROME CORONAVIRUS
AB Background: Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia. It is associated with significant mortality and morbidity. We identified factors associated with the Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus. We also looked at the impact of medication history on virus transmission.
   Method: We included subjects with suspected MERS-CoV infection and confirmed cases of MERS infection. Subjects were excluded if there were any missing data that prevent the final analysis. Descriptive statistics were used to report demographic data. Percentages and frequencies were used to summarize the categorical variables, while means and standard deviations were calculated for continuous variables. Logistic regression was used to assess the risk of MERS-CoV infection among the suspected cases. A value of p < 0.05 was considered statistically significant.
   Results: A total of 16,189 suspected cases were identified, complete data were analyzed for 3154 to assess factors that are independently associated with MERS-CoV infection. MERS-CoV infection was associated with age (adjusted odds ratio [AOR] = 1.06; 95% CI [1.02-1.098], P-value = 0.004), male gender (AOR = 1.617; 95% CI [1.365-1.77], P-value < 0.001) and diabetes (AOR = 1.68; 95% CI [1.346-1.848], P-value = 0.002. There was no significant association with the other comorbidities. Medication history was not associated with an increase or decrease the likelihood of the infection.
   Conclusions: MERS-Cov infection is more common in male, advanced age and diabetes. No medications were associated with an increase or decrease the likelihood of the infection. This is important to focus on screening and detection to this patient population. (C) 2019 Published by Elsevier B.V. on behalf of King Saud University.
C1 [Alburikan, Khalid A.] King Saud Univ, Coll Pharm, Dept Clincal Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
   [Abuelizz, Hatem A.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia.
RP Abuelizz, HA (reprint author), King Saud Univ, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
EM habuelizz@ksu.edu.sa
FU King Abdulaziz City for Science and Technology (KACST), Target Research
   Program, Middle East Respiratory Syndrome-Corona Virus (MERS-CoV RGP)
   [17-01]
FX This work was supported by King Abdulaziz City for Science and
   Technology (KACST), Target Research Program, Middle East Respiratory
   Syndrome-Corona Virus (MERS-CoV RGP) grant no. 17-01.
CR Aleanizy FS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2137-3
   [Anonymous], 2019, MIDDLE E RESP SYNDRO
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chen X, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.40
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Rivers CM, 2016, AM J EPIDEMIOL, V184, P460, DOI 10.1093/aje/kww013
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 11
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-0164
EI 2213-7475
J9 SAUDI PHARM J
JI Saudi Pharm. J.
PD FEB
PY 2020
VL 28
IS 2
BP 161
EP 164
DI 10.1016/j.jsps.2019.11.016
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KH4RD
UT WOS:000510635800002
PM 32042254
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Alosaimi, B
   Hamed, ME
   Naeem, A
   Alsharef, AA
   AlQahtani, SY
   AlDosari, KM
   Alamri, AA
   Al-Eisa, K
   Khojah, T
   Assiri, AM
   Enani, MA
AF Alosaimi, Bandar
   Hamed, Maaweya E.
   Naeem, Asif
   Alsharef, Ali A.
   AlQahtani, Saeed Y.
   AlDosari, Kamel M.
   Alamri, Aref A.
   Al-Eisa, Kholoud
   Khojah, Taghreed
   Assiri, Abdullah M.
   Enani, Mushira A.
TI MERS-CoV infection is associated with downregulation of genes encoding
   Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune
   response in the lower respiratory tract
SO CYTOKINE
LA English
DT Article
DE Cytokines; Chemokines; MERS-CoV; Th1/Th2; Gene expression
ID SYNDROME CORONAVIRUS; DISEASE SEVERITY; CYTOKINES; INDUCTION;
   PATHOGENESIS; INTERFERON; EXPRESSION; SARS; IMMUNOPATHOGENESIS;
   SUPPRESSION
AB MERS-CoV, a highly pathogenic virus in humans, is associated with high morbidity and case fatality. Inflammatory responses have a significant impact on MERS-CoV pathogenesis and disease outcome. However, CD4 T-cell induced immune responses during acute MERS-CoV infection are barely detectable, with potent inhibition of effector T cells and downregulation of antigen presentation. The local pulmonary immune response, particularly the Th1 and Th2-related immune response during acute severe MERS-CoV infection is not fully understood. In this study, we offer the first insights into the pulmonary gene expression profile of Th1 and Th2-related cytokines/chemokines (Th1 & Th2 responses) during acute MERS-CoV infection using RT2 Profiler PCR Arrays. We also quantified the expression level of primary inflammatory cytokines/chemokines. Our results showed a downregulation of Th2, inadequate (partial) Th1 immune response and high expression levels of inflammatory cytokines IL-1 alpha and IL-1 beta and the neutrophil chemoattractant chemokine IL-8 (CXCL8) in the lower respiratory tract of MERS-CoV infected patients. Moreover, we identified a high viral load in all included patients. We also observed a correlation between inflammatory cytokines, Th1, and Th2 downregulation and the case fatality rate. Th1 and Th2 response downregulation, high expression of inflammatory cytokines, and high viral load may contribute to lung inflammation, severe infection, the evolution of pneumonia and ARDS, and a higher case fatality rate. Further study of the molecular mechanisms underlying the Th1 and Th2 regulatory pathways will be vital for active vaccine development and the identification of novel therapeutic strategies.
C1 [Alosaimi, Bandar; Naeem, Asif] King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia.
   [Alosaimi, Bandar] King Fahad Med City, Coll Med, Riyadh, Saudi Arabia.
   [Hamed, Maaweya E.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia.
   [Alsharef, Ali A.; AlQahtani, Saeed Y.] Minist Hlth, Gen Directorate Labs & Blood Banks, Riyadh, Saudi Arabia.
   [AlDosari, Kamel M.; Alamri, Aref A.; Al-Eisa, Kholoud; Khojah, Taghreed] Minist Hlth, Riyadh Reg Lab, Riyadh, Saudi Arabia.
   [Assiri, Abdullah M.] Minist Hlth, Prevent Med Assistant Deputyship, Riyadh, Saudi Arabia.
   [Enani, Mushira A.] King Fahad Med City, Sect Infect Dis, Med Specialties Dept, Riyadh, Saudi Arabia.
RP Alosaimi, B (reprint author), King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia.
EM balosaimi@kfmc.med.sa
RI AWADALLA, MAAWEYA/AAE-1542-2020
OI Assiri, Abdullah/0000-0002-5605-2876
FU Research Center at King Fahad Medical City [017-066]
FX The authors thank the Research Center at King Fahad Medical City for
   funding this study (Grant No 017-066). We also thank the Deanship of
   Scientific Research and RSSU at King Saud University for their technical
   support.
CR Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062
   Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10
   Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x
   Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389
   Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004
   Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014
   Canton J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006838
   Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604
   Comar CE, 2019, MBIO, V10, DOI 10.1128/mBio.00319-19
   Davidson S, 2015, J INTERF CYTOK RES, V35, P252, DOI 10.1089/jir.2014.0227
   de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477
   Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503
   Duan QL, 2013, MOL MED REP, V7, P332, DOI 10.3892/mmr.2012.1142
   Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716
   Fitch PM, 2012, INNATE IMMUN-LONDON, V18, P179, DOI 10.1177/1753425910391826
   Frey KG, 2009, J IMMUNOL, V183, P1253, DOI 10.4049/jimmunol.0900570
   Frota OP, 2014, REV ESC ENFERM USP, V48, P618, DOI 10.1590/S0080-623420140000400007
   Gao H, 2018, J RADIAT RES, V59, P395, DOI 10.1093/jrr/rry011
   Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155
   Giannella M, 2012, CRIT CARE, V16, DOI 10.1186/cc11387
   Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454
   Guo XZJ, 2017, SEMIN IMMUNOPATHOL, V39, P541, DOI 10.1007/s00281-017-0636-y
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Hamad ME, 2018, ACTA VIROL, V62, P137, DOI 10.4149/av_2018_203
   Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09
   Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026
   Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306
   Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC
   Jordan JA, 2001, J IMMUNOL, V167, P7060, DOI 10.4049/jimmunol.167.12.7060
   Jutel M, 2011, CURR ALLERGY ASTHM R, V11, P139, DOI 10.1007/s11882-011-0178-7
   Kedzierski L, 2017, ELIFE, V6, DOI 10.7554/eLife.20444
   Kidd Parris, 2003, Altern Med Rev, V8, P223
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Kim KS, 2015, J MED VIROL, V87, P1104, DOI 10.1002/jmv.24138
   Kindler E, 2016, ADV VIRUS RES, V96, P219, DOI 10.1016/bs.aivir.2016.08.006
   Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022
   Kong H., 2004, CLIN EXP IMMUNOL, V136, P1, DOI [10.1111/j.1365-2249.2004.02415.x, DOI 10.1111/J.1365-2249.2004.02415.X]
   Lamacchia C, 2013, CYTOKINE, V63, P135, DOI 10.1016/j.cyto.2013.04.010
   Lau SKP, 2013, J GEN VIROL, V94, P2679, DOI 10.1099/vir.0.055533-0
   Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855
   MEDURI GU, 1995, CHEST, V108, P1315, DOI 10.1378/chest.108.5.1315
   Mella C, 2013, J INFECT DIS, V207, P564, DOI 10.1093/infdis/jis721
   Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17
   Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359
   Morrison PT, 2008, CLIN IMMUNOL, V128, P85, DOI 10.1016/j.clim.2008.03.460
   Morrow B, 2004, PEDIATR PULM, V38, P217, DOI 10.1002/ppul.20082
   Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024
   Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732
   Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2
   Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x
   Rossingol JF, 2016, J INFECT PUBLIC HEAL, V9, P227, DOI 10.1016/j.jiph.2016.04.001
   Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366
   Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595
   Shokri S, 2019, J CELL PHYSIOL, V234, P2143, DOI 10.1002/jcp.27155
   Sprenger M., 2014, EUROSURVEILLANCE, V19, P1, DOI [10.2807/15607917.es2014.19.16.20783, DOI 10.2807/15607917.ES2014.19.16.20783]
   Stolz D, 2004, THORAX, V59, P773, DOI 10.1136/thx.2003.019836
   Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912
   Teijaro JR, 2017, SEMIN IMMUNOPATHOL, V39, P501, DOI 10.1007/s00281-017-0640-2
   Tsang K.W., 2016, INT ENCY PUBL HEAL, V290, P477, DOI [10.1016/13978-0-12-803678-5.00401-X, DOI 10.1016/13978-0-12-803678-5.00401-X]
   Tynell J, 2016, J GEN VIROL, V97, P344, DOI 10.1099/jgv.0.000351
   van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Ward SE, 2005, ANTIVIR THER, V10, P263
   Welsh RM, 2013, VIROLOGY, V435, P37, DOI 10.1016/j.virol.2012.10.005
   Wong R.S.M., 2003, BMJ, V326
   Xiang LB, 2014, MOL IMMUNOL, V60, P129, DOI 10.1016/j.molimm.2014.03.004
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
NR 80
TC 0
Z9 0
U1 16
U2 16
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD FEB
PY 2020
VL 126
AR 154895
DI 10.1016/j.cyto.2019.154895
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA KG0DR
UT WOS:000509612400027
PM 31706200
OA Bronze
DA 2020-04-03
ER

PT J
AU Andreeva, A
   Nikolaeva, O
   Altynbekov, O
   Galieva, C
   Ilina, K
AF Andreeva, Alfia
   Nikolaeva, Oksana
   Altynbekov, Oleg
   Galieva, Chulpan
   Ilina, Kseniia
TI Influence of interferon-based drugs on immunological indices in specific
   prevention
SO VETERINARY WORLD
LA English
DT Article
DE antibody titer; coronavirus; immunoglobulins A, M, and G; interferon;
   Rotavirus; vaccinations
AB Aim: The research aimed to study the effect of interferon (IFN)-based drugs on the behavior of immunological parameters in calves during the specific prevention of associative infections.
   Materials and Methods: The object of research was 45 black motley cows and their calves from birth to 2 months of life. Serum and colostnun samples were screened for antibodies against Rotavirus, diarrhea, and coronavirus using serological methods. The testing was performed before vaccination, 40 days before calving, 20 days before calving, and before calving. Colostrum samples were taken during the first milk yield. Serum samples from calves were drawn before colostrum feeding as well as at 7, 14, and 21 days, and 1 and 2 months of age. To measure the level of immunoglobulins A, M, and G, additional serum samples were collected from calves at 25, 35, 65, and 75 days after birth.
   Results: Giving pregnant cows, an IFN-based drug at a dose of 1 ml/kg 48 h before vaccination results in the development and accumulation of antibodies to Rotavirus, coronavirus, and viral diarrhea (VD) in the colostrum, with a titer of 7.61-0.3 log(2), 5.81 +/- 0.34 log(2), and 4.41 +/- 0.18 log(2), respectively. It indicates an increase in the antigenic activity of the multivalent vaccine.
   Conclusion: IFN-based drugs enhance the protective effect of vaccination against associative infections in the newborn calves. They stimulate a rise in the titer of antibodies to Rotavirus, coronavirus, VD, and mucosal disease complex as well as an increase in irrununoglobulins A, M, and G.
C1 [Andreeva, Alfia; Nikolaeva, Oksana; Altynbekov, Oleg; Galieva, Chulpan; Ilina, Kseniia] Bashkir State Agr Univ, Dept Infect Dis Zoohyg & Vet Sanit Inspect, Fed State Budget Educ Inst Higher Educ, Ufa 450001, Republic Bashko, Russia.
RP Andreeva, A (reprint author), Bashkir State Agr Univ, Dept Infect Dis Zoohyg & Vet Sanit Inspect, Fed State Budget Educ Inst Higher Educ, Ufa 450001, Republic Bashko, Russia.
EM alandreeva98@yahoo.com; oksananik83@mail.ru; oleg030291@mail.ru;
   chulpanochka801@mail.ru; kseniiailina1994@gmail.com
CR Abuelo A, 2019, J DAIRY SCI, V102, P8352, DOI 10.3168/jds.2019-16578
   Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069
   An D, 2017, RES VET SCI, V115, P125, DOI 10.1016/j.rvsc.2017.01.028
   Andersen SH, 2017, VET IMMUNOL IMMUNOP, V193, P18, DOI 10.1016/j.vetimm.2017.10.001
   BUKHOLM G, 1990, J INTERFERON RES, V10, P83, DOI 10.1089/jir.1990.10.83
   Dec M, 2008, POL J VET SCI, V11, P175
   Floris S, 2002, J NEUROIMMUNOL, V127, P69, DOI 10.1016/S0165-5728(02)00098-X
   Joklik V.K., 1989, VIROLOGY, P35
   Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10
   KHAZIAHMETOV F, 2018, J ENG APPL SCI, V13, P6541
   Kim Y, 2011, ANTIVIR RES, V89, P165, DOI 10.1016/j.antiviral.2010.11.016
   Krylov V.P., 2006, VET PATOL, V1, P31
   Li SF, 2017, INT IMMUNOPHARMACOL, V52, P253, DOI 10.1016/j.intimp.2017.08.028
   Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200
   Pirozhkov M.K., 2011, VETERINARIJA, V1, P24
   Safonov VA, 2018, GEOCHEM INT+, V56, P1046, DOI 10.1134/S0016702918100105
   Yang J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-156
NR 17
TC 0
Z9 0
U1 0
U2 0
PU VETERINARY WORLD
PI GUJARAT
PA STAR, GULSHAN PARK, NH-8A, CHANDRAPUR RD, WANKANER, GUJARAT, 363 621,
   INDIA
SN 0972-8988
EI 2231-0916
J9 VET WORLD
JI Vet. World
PD FEB
PY 2020
VL 13
IS 2
BP 238
EP 244
DI 10.14202/vetworld.2020.238-244
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA KT2MC
UT WOS:000518849100003
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Anzai, A
   Kobayashi, T
   Linton, NM
   Kinoshita, R
   Hayashi, K
   Suzuki, A
   Yang, YC
   Jung, S
   Miyama, T
   Akhmetzhanov, AR
   Nishiura, H
AF Anzai, Asami
   Kobayashi, Tetsuro
   Linton, Natalie M.
   Kinoshita, Ryo
   Hayashi, Katsuma
   Suzuki, Ayako
   Yang, Yichi
   Jung, Sung-mok
   Miyama, Takeshi
   Akhmetzhanov, Andrei R.
   Nishiura, Hiroshi
TI Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel
   Coronavirus Infection (COVID-19)
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE migration; quarantine; travel; imported case; emerging infectious
   diseases
ID SARS; QUARANTINE
AB The impact of the drastic reduction in travel volume within mainland China in January and February 2020 was quantified with respect to reports of novel coronavirus (COVID-19) infections outside China. Data on confirmed cases diagnosed outside China were analyzed using statistical models to estimate the impact of travel reduction on three epidemiological outcome measures: (i) the number of exported cases, (ii) the probability of a major epidemic, and (iii) the time delay to a major epidemic. From 28 January to 7 February 2020, we estimated that 226 exported cases (95% confidence interval: 86,449) were prevented, corresponding to a 70.4% reduction in incidence compared to the counterfactual scenario. The reduced probability of a major epidemic ranged from 7% to 20% in Japan, which resulted in a median time delay to a major epidemic of two days. Depending on the scenario, the estimated delay may be less than one day. As the delay is small, the decision to control travel volume through restrictions on freedom of movement should be balanced between the resulting estimated epidemiological impact and predicted economic fallout.
C1 [Anzai, Asami; Kobayashi, Tetsuro; Linton, Natalie M.; Kinoshita, Ryo; Hayashi, Katsuma; Suzuki, Ayako; Yang, Yichi; Jung, Sung-mok; Akhmetzhanov, Andrei R.; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Miyama, Takeshi] Osaka Inst Publ Hlth, Higashinari Ku, Nakamichi 1-3-69, Osaka 5370025, Japan.
   [Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
RP Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
EM aanzai@eis.hokudai.ac.jp; tootsieroll2910@gmail.com; nlinton@gmail.com;
   kinoshitaryo@gmail.com; katsuma_hayashi@eis.hokudai.ac.jp;
   akmskorokoro@gmail.com; lukeyang1993@eis.hokudai.ac.jp;
   seductmd@med.hokudai.ac.jp; takeshi.j.miyama@gmail.com;
   akhmetzhanov@med.hokudai.ac.jp; nishiurah@med.hokudai.ac.jp
RI Akhmetzhanov, Andrei R./B-5530-2013; Ribeiro, Nuno/AAH-2299-2020
OI Akhmetzhanov, Andrei R./0000-0003-3269-7351; Jung,
   Sung-mok/0000-0002-0787-4515; Kinoshita, Ryo/0000-0002-0116-4598;
   Linton, Natalie/0000-0002-5464-0076
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108050]; Japan Society
   for the Promotion of Science (JSPS) KAKENHIMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [17H04701, 17H05808, 18H04895, 19H01074, 18J21587, 19K24159]; Inamori
   Foundation; Japan Science and Technology Agency (JST) CREST program
   [JPMJCR1413]; Ministry of Education, Culture, Sports, Science and
   Technology, JapanMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)
FX H.N. received funding from the Japan Agency for Medical Research and
   Development (AMED) [grant number: JP18fk0108050]; the Japan Society for
   the Promotion of Science (JSPS) KAKENHI [grant numbers, H.N.: 17H04701,
   17H05808, 18H04895 and 19H01074; R.K.: 18J21587; AS.: 19K24159], the
   Inamori Foundation, and the Japan Science and Technology Agency (JST)
   CREST program [grant number: JPMJCR1413]. SMJ and NML receive graduate
   study scholarships from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan.
CR [Anonymous], 2020, BBC NEWS
   Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711
   Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38
   Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006
   Center for Disease Central and Prevention, 2020, 2019 NOV COR WUH CHI
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chinazzi M., 2020, EFFECT TRAVEL RESTRI
   Hsieh YH, 2007, J THEOR BIOL, V244, P729, DOI 10.1016/j.jtbi.2006.09.015
   John RKS, 2005, EMERG INFECT DIS, V11, P6, DOI 10.3201/eid1101.040835
   Jung S., 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Nishiura H., 2020, ESTIMATION ASYMPTOMA, DOI DOI 10.1101/2020.02.03.20020248V1
   Nishiura H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-27
   Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A
   Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Samaan G, 2004, MED J AUSTRALIA, V180, P220, DOI 10.5694/j.1326-5377.2004.tb05889.x
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   Thompson RN, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020498
   Tian H., 2020, EARLY EVALUATION WUH, DOI DOI 10.1101/2020.01.30.20019844V1
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   World Health Organization, 2020, NOV COR CHIN
   World Health Organization Statement on the Second Meeting of the International Health Regulations, 2005, STAT 2 M INT HLTH RE
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 25
TC 0
Z9 0
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 601
DI 10.3390/jcm9020601
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000313
PM 32102279
OA DOAJ Gold, Green Accepted
DA 2020-04-03
ER

PT J
AU Boley, PA
   Alhamo, MA
   Lossie, G
   Yadav, KK
   Vasquez-Lee, M
   Saif, LJ
   Kenney, SP
AF Boley, Patricia A.
   Alhamo, Moyasar A.
   Lossie, Geoffrey
   Yadav, Kush Kumar
   Vasquez-Lee, Marcia
   Saif, Linda J.
   Kenney, Scott P.
TI Porcine Deltacoronavirus Infection and Transmission in Poultry, United
   States
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID EPIDEMIC DIARRHEA VIRUS; AMINOPEPTIDASE-N; GNOTOBIOTIC PIGS;
   CORONAVIRUS; PATHOGENICITY; PREVALENCE; STRAINS
AB Coronaviruses cause respiratory and gastrointestinal diseases in diverse host species. Deltacoronaviruses (DCoVs) have been identified in various songbird species and in leopard cats in China. In 2009, porcine deltacoronavirus (PDCoV) was detected in fecal samples from pigs in Asia, but its etiologic role was not identified until 2014, when it caused major diarrhea outbreaks in swine in the United States. Studies have shown that PDCoV uses a conserved region of the aminopeptidase N protein to infect cell lines derived from multiple species, including humans, pigs, and chickens. Because PDCoV is a potential zoonotic pathogen, investigations of its prevalence in humans and its contribution to human disease continue. We report experimental PDCoV infection and subsequent transmission among poultry. In PDCoV-inoculated chicks and turkey poults, we observed diarrhea, persistent viral RNA titers from cloaca) and tracheal samples, PDCoV-specific serum IgY antibody responses, and antigen-positive cells from intestines.
C1 [Boley, Patricia A.] Ohio State Univ, OARDC, Wooster, OH USA.
   [Boley, Patricia A.; Alhamo, Moyasar A.; Yadav, Kush Kumar; Vasquez-Lee, Marcia; Saif, Linda J.; Kenney, Scott P.] Ohio State Univ, Wooster, OH USA.
   [Lossie, Geoffrey] Ohio State Univ, Columbus, OH 43210 USA.
RP Kenney, SP (reprint author), Ohio State Univ, Food Anim Hlth Res Program, 1680 Madison Ave,Hayden Hall, Wooster, OH 44691 USA.
EM kenney.157@osu.edu
FU National Institute of Food and Agriculture through the Food Animal
   Health Research Program [OHO00005-AH]
FX The National Institute of Food and Agriculture provided funding through
   the Food Animal Health Research Program (project number OHO00005-AH).
CR Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chen Q, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0108-z
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dijkman R, 2013, J VIROL, V87, P6081, DOI 10.1128/JVI.03368-12
   Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215
   Hu H, 2018, J VIROL METHODS, V256, P116, DOI 10.1016/j.jviromet.2018.02.021
   Hu H, 2016, ARCH VIROL, V161, P3421, DOI 10.1007/s00705-016-3056-8
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13
   Ismail MM, 2003, AVIAN DIS, V47, P515, DOI 10.1637/5917
   Ismail MM, 2001, AVIAN DIS, V45, P157, DOI 10.2307/1593023
   Jean A, 2013, PEDIATR INFECT DIS J, V32, P325, DOI 10.1097/INF.0b013e3182812787
   Ji CM, 2018, VIROLOGY, V517, P16, DOI 10.1016/j.virol.2018.02.019
   Jung K, 2006, VET J, V171, P445, DOI 10.1016/j.tvjl.2005.02.016
   Jung K, 2018, VET MICROBIOL, V221, P49, DOI 10.1016/j.vetmic.2018.05.019
   Jung K, 2017, ARCH VIROL, V162, P2357, DOI 10.1007/s00705-017-3351-z
   Jung K, 2015, EMERG INFECT DIS, V21, P650, DOI 10.3201/eid2104.141859
   Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685
   KENNY AJ, 1982, PHYSIOL REV, V62, P91
   Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05
   Li GW, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00278-14
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Liang QQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060573
   Marthaler D., 2014, GENOME ANNOUNC, V2014, P2, DOI DOI 10.1128/GEN0MEA.00218-14
   Masters P.S., 2013, FIELDS VIROLOGY, P825
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003
   Okda F, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0716-6
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schwegmann-Wessels C, 2006, DEUT TIERARZTL WOCH, V113, P157
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Van der Velden VHJ, 1998, CLIN EXP ALLERGY, V28, P110
   Vitosh-Sillman S, 2016, J VET DIAGN INVEST, V28, P486, DOI 10.1177/1040638716654200
   Vlasova AN, 2013, VIRAL INFECT GLOBAL, P393
   Wang B, 2018, J VIROL, V92, DOI [10.1128/JVI.00318-18, 10.1128/jvi.00318-18]
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
NR 41
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2020
VL 26
IS 2
BP 255
EP 264
DI 10.3201/eid2602.190346
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA KH1WI
UT WOS:000510436500009
PM 31961296
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Burimuah, V
   Sylverken, A
   Owusu, M
   El-Duah, P
   Yeboah, R
   Lamptey, J
   Frimpong, YO
   Agbenyega, O
   Folitse, R
   Tasiame, W
   Emikpe, B
   Owiredu, EW
   Oppong, S
   Adu-Sarkodie, Y
   Drosten, C
AF Burimuah, Vitus
   Sylverken, Augustina
   Owusu, Michael
   El-Duah, Philip
   Yeboah, Richmond
   Lamptey, Jones
   Frimpong, Yaw Oppong
   Agbenyega, Olivia
   Folitse, Raphael
   Tasiame, William
   Emikpe, Benjamin
   Owiredu, Eddie-Williams
   Oppong, Samuel
   Adu-Sarkodie, Yaw
   Drosten, Christian
TI Sero-prevalence, cross-species infection and serological determinants of
   prevalence of Bovine Coronavirus in Cattle, Sheep and Goats in Ghana
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Bovine Coronavirus; Africa; Ghana; Global health
ID VIRUS-INFECTIONS; RESPIRATORY-DISEASE; ANTIBODIES; ROTAVIRUS; DIARRHEA;
   TRACT
AB Cattle, goats and sheep are dominant livestock species in sub-Saharan Africa, with sometimes limited information on the prevalence of major infectious diseases. Restrictions due to notifiable epizootics complicate the exchange of samples in surveillance studies and suggest that laboratory capacities should be established domestically. Bovine Coronavirus (BCoV) causes mainly enteric disease in cattle. Spillover to small ruminants is possible. Here we established BCoV serology based on a recombinant immunofluorescence assay for cattle, goats and sheep, and studied the seroprevalence of BCoV in these species in four different locations in the Greater Accra, Volta, Upper East, and Northern provinces of Ghana. The whole sampling and testing was organized and conducted by a veterinary school in Kumasi, Ashanti Region of Ghana. Among sampled sheep (n = 102), goats (n = 66), and cattle (n = 1495), the seroprevalence rates were 25.8 %, 43.1 % and 55.8 %. For cattle, seroprevalence was significantly higher on larger farms (82.2 % vs 17.8 %, comparing farms with > 50 or < 50 animals; p = 0.027). Highest prevalence was seen in the Northern province with dry climate, but no significant trend following the north-south gradient of sampling sites was detected. Our study identifies a considerable seroprevalence for BCoV in Ghana and provides further support for the spillover of BCoV to small ruminants in settings with mixed husbandry and limited separation between species.
C1 [Burimuah, Vitus; El-Duah, Philip; Yeboah, Richmond; Lamptey, Jones; Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana.
   [Burimuah, Vitus; Folitse, Raphael; Tasiame, William; Emikpe, Benjamin] Kwame Nkrumah Univ Sci & Technol, Sch Vet Med, Kumasi, Ghana.
   [Sylverken, Augustina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana.
   [Sylverken, Augustina; Owusu, Michael; El-Duah, Philip; Yeboah, Richmond; Lamptey, Jones; Frimpong, Yaw Oppong] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.
   [Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana.
   [El-Duah, Philip; Tasiame, William; Drosten, Christian] Univ Med Berlin, Inst Virol, Charite, Charitepl 1, D-10117 Berlin, Germany.
   [Frimpong, Yaw Oppong] Kwame Nkrumah Univ Sci & Technol, Dept Anim Sci, Kumasi, Ghana.
   [Agbenyega, Olivia] Kwame Nkrumah Univ Sci & Technol, Dept Agroforestry, Kumasi, Ghana.
   [Owiredu, Eddie-Williams] Kwame Nkrumah Univ Sci & Technol, Dept Mol Med, Kumasi, Ghana.
   [Oppong, Samuel] Kwame Nkrumah Univ Sci & Technol, Dept Wildlife & Range Management, Kumasi, Ghana.
RP Drosten, C (reprint author), Univ Med Berlin, Inst Virol, Charite, Charitepl 1, D-10117 Berlin, Germany.
EM vitus7uk@yahoo.co.uk; annan@kccr.de; owusumichael-gh@hotmail.com;
   elduahphilip9@gmail.com; Yeboahrichmond82@yahoo.com;
   jlamptey80@gmail.com; oppongfrimpong1@gmail.com;
   olivia_agbenyega@yahoo.com; raphfolitse@yahoo.com;
   drwilly2002@gmail.com; banabis2001@yahoo.com;
   eddiewilliams.owiredu@gmail.com; kobbyoppong@yahoo.com;
   yasax@hotmail.co.uk; Christian.drosten@charite.de
OI Owiredu, Eddie-Williams/0000-0003-4499-0678; Emikpe,
   Benjamin/0000-0003-2458-6504
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DR
   772/12-1]
FX This work was supported by Deutsche Forschungsgemeinschaft under a Grant
   to Y. A. S. and C. D. (DR 772/12-1).
CR Alkan F., 2003, Ankara Universitesi Veteriner Fakultesi Dergisi, V50, P59
   Beaudeau F, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-33
   Bidokhti MRM, 2009, VET J, V182, P436, DOI 10.1016/j.tvjl.2008.08.010
   Boileau MJ, 2010, VET CLIN N AM-FOOD A, V26, P123, DOI 10.1016/j.cvfa.2009.10.003
   CLARK MA, 1993, BRIT VET J, V149, P51, DOI 10.1016/S0007-1935(05)80210-6
   DURHAM PJK, 1979, NEW ZEAL VET J, V27, P30, DOI 10.1080/00480169.1979.34595
   Eisa M. I., 2004, Veterinary Medical Journal Giza, V52, P41
   El-Duah P., 2019, TROP MED INFECT DIS, V4, P34
   ELGHORR AA, 1989, ARCH VIROL, V104, P241, DOI 10.1007/BF01315546
   Gumusova Okur S., 2007, Veterinarski Glasnik, V61, P75
   Hagglund S, 2006, VET J, V172, P320, DOI 10.1016/j.tvjl.2005.04.029
   Hasoksuz M, 2005, ACTA VET HUNG, V53, P137, DOI 10.1556/AVet.53.2005.1.13
   Hasoksuz M, 2002, J VET DIAGN INVEST, V14, P308, DOI 10.1177/104063870201400406
   Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589
   KAPIL S, 1990, ARCH VIROL, V115, P127, DOI 10.1007/BF01310629
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lathrop SL, 2000, AM J VET RES, V61, P1057, DOI 10.2460/ajvr.2000.61.1057
   Lathrop SL, 2000, AM J VET RES, V61, P1062, DOI 10.2460/ajvr.2000.61.1062
   Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746
   O'Connor A, 2001, CAN J VET RES, V65, P137
   Ohlson A, 2010, VET REC, V167, P201, DOI 10.1136/vr.c4119
   Oma VS, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0555-x
   Park SJ, 2007, ARCH VIROL, V152, P1885, DOI 10.1007/s00705-007-1005-2
   PASS DA, 1982, VET REC, V111, P106, DOI 10.1136/vr.111.5.106
   Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224
   Reinhardt G, 1995, ARCH MED VET, V27, P129
   Reusken C., 2013, MIDDLE E RESP SYNDRO
   Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6
   SNODGRASS DR, 1980, VET REC, V106, P193, DOI 10.1136/vr.106.9.193
   Traven M, 1999, ACTA VET SCAND, V40, P69
   Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05
   Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025
   Yavru S, 2016, ACTA SCI VET, V44
   Yildirim Y, 2008, J ANIM VET ADV, V7, P1320
NR 34
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD FEB
PY 2020
VL 241
AR 108544
DI 10.1016/j.vetmic.2019.108544
PG 6
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA KL2YK
UT WOS:000513294300002
PM 31928696
OA Bronze
DA 2020-04-03
ER

PT J
AU Dong, LY
   Hu, SS
   Gao, JJ
AF Dong, Liying
   Hu, Shasha
   Gao, Jianjun
TI Discovering drugs to treat coronavirus disease 2019 (COVID-19)
SO DRUG DISCOVERIES AND THERAPEUTICS
LA English
DT Article
DE novel coronavirus; pneumonia; COVID-19; 2019-nCoV; SARS-CoV-2
ID SARS
AB The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
C1 [Dong, Liying; Gao, Jianjun] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Shandong, Peoples R China.
   [Hu, Shasha] Qingdao Univ, Affiliated Hosp, Dept Pathol, Qingdao, Shandong, Peoples R China.
RP Gao, JJ (reprint author), Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Shandong, Peoples R China.
EM gaojj@qdu.edu.cn
CR Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16
   Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Hoffmann M, 2020, BIORXIV
   Holshue ML, 2020, N ENGL J MED
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Shanghai Institute of Materia Medica website Chinese Academy of Sciences, JOINT RES TEAM SHANG
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Su B, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01472
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
NR 12
TC 0
Z9 0
U1 49
U2 49
PU INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
PI TOKYO
PA INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT,
   TOKYO, 00000, JAPAN
SN 1881-7831
EI 1881-784X
J9 DRUG DISCOV THER
JI Drug Discov. Ther.
PD FEB
PY 2020
VL 14
IS 1
BP 58
EP 60
DI 10.5582/ddt.2020.01012
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KS7AJ
UT WOS:000518458200010
PM 32147628
OA Bronze
DA 2020-04-03
ER

PT J
AU Fan, P
   Guan, JY
   He, WQ
   Lv, XL
   Hu, SY
   Lan, YG
   Zhao, K
   Gao, F
   Li, F
   Fan, GC
   He, HB
   Li, Z
AF Fan, Peng
   Guan, Jiyu
   He, Wenqi
   Lv, Xiaoling
   Hu, Shiyu
   Lan, Yungang
   Zhao, Kui
   Gao, Feng
   Li, Fang
   Fan, Gencheng
   He, Hongbin
   Li, Zi
TI miR-142a-3p promotes the proliferation of porcine hemagglutinating
   encephalomyelitis virus by targeting Rab3a
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID CORONAVIRUS INFECTION; DISEASE; SWINE; MICRORNAS
AB Porcine hemagglutinating encephalomyelitis virus (PHEV) is a typical neurotropic coronavirus that mainly invades the central nervous system (CNS) in piglets and causes vomiting and wasting disease. Emerging evidence suggests that PHEV alters microRNA (miRNA) expression profiles, and miRNA has also been postulated to be involved in its pathogenesis, but the mechanisms underlying this process have not been fully explored. In this study, we found that PHEV infection upregulates miR-142a-3p RNA expression in N2a cells and in the CNS of mice. Downregulation of miR-142a-3p by an miRNA inhibitor led to a significant repression of viral proliferation, implying that it acts as a positive regulator of PHEV proliferation. Using a dual-luciferase reporter assay, miR-142a-3p was found to bind directly bound to the 3' untranslated region (3'UTR) of Rab3a mRNA and downregulate its expression. Knockdown of Rab3a expression by transfection with an miR-142a-3p mimic or Rab3a siRNA significantly increased PHEV replication in N2a cells. Conversely, the use of an miR-142a-3p inhibitor or overexpression of Rab3a resulted in a marked restriction of viral production at both the mRNA and protein level. Our data demonstrate that miR-142a-3p promotes PHEV proliferation by directly targeting Rab3a mRNA, and this provides new insights into the mechanisms of PHEV-related pathogenesis and virus-host interactions.
C1 [Fan, Peng; Guan, Jiyu; He, Wenqi; Lv, Xiaoling; Hu, Shiyu; Lan, Yungang; Zhao, Kui; Gao, Feng; Li, Zi] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China.
   [Li, Fang; Fan, Gencheng; Li, Zi] Yebio Bioengn Co Ltd Qingdao, State Key Lab Genetically Engn Vet Vaccines, Qingdao, Peoples R China.
   [He, Hongbin] Shandong Normal Univ, Coll Life Sci, Ruminant Dis Res Ctr, Key Lab Anim Resistant Biol Shandong, Jinan, Peoples R China.
RP Li, Z (reprint author), Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China.; Li, Z (reprint author), Yebio Bioengn Co Ltd Qingdao, State Key Lab Genetically Engn Vet Vaccines, Qingdao, Peoples R China.
EM lizi@jlu.edu.cn
FU National Key Research and Development Program of China [2016YFD0500102];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31902262, 31872446, 31772704, 31672519, 31602018];
   State Key Laboratory of Genetically Engineered Veterinary Vaccines
   [AGVSKLZD-201808]; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2018M640285]
FX This study was supported by the National Key Research and Development
   Program of China (Grant 2016YFD0500102), the National Natural Science
   Foundation of China (Grants 31902262, 31872446, 31772704, 31672519, and
   31602018), the State Key Laboratory of Genetically Engineered Veterinary
   Vaccines (no. AGVSKLZD-201808), the China Postdoctoral Science
   Foundation (Grant 2018M640285).
CR Alsop JE, 2006, J SWINE HEALTH PROD, V14, P97
   Ambros Victor, 2004, Methods Mol Biol, V265, P131
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Coleman WL, 2007, NEUROSCIENCE, V148, P1, DOI 10.1016/j.neuroscience.2007.06.011
   Dong B, 2014, ARCH VIROL, V159, P2329, DOI 10.1007/s00705-014-2070-y
   Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gao W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-130
   GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0
   Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954
   GREIG AS, 1962, CAN J COMP MED VET S, V26, P49
   Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173
   Hirano N, 2004, J COMP PATHOL, V130, P58, DOI 10.1016/S0021-9975(03)00083-5
   Khanna M, 2019, DATA BRIEF, V24, DOI 10.1016/j.dib.2019.103945
   Lai FW, 2014, J VIROL, V88, P54, DOI 10.1128/JVI.02678-13
   Lan YG, 2014, J GEN VIROL, V95, P2192, DOI 10.1099/vir.0.066845-0
   Lan YG, 2013, VIRUS RES, V176, P292, DOI 10.1016/j.virusres.2013.05.019
   Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171
   Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021
   Li Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep42742
   Li Z, 2016, PEERJ, V4, DOI 10.7717/peerj.2443
   Lorbach JN, 2017, EMERG INFECT DIS, V23, P1168, DOI 10.3201/eid2307.170019
   Lv XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00304
   Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837
   Powdrill MH, 2016, CURR OPIN VIROL, V19, P71, DOI 10.1016/j.coviro.2016.07.005
   Quiroga MA, 2008, EMERG INFECT DIS, V14, P484, DOI 10.3201/eid1403.070825
   ROE C. K., 1958, CANADIAN JOUR COMP MED AND VET SCI, V22, P305
   Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03
   Shrestha A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136913
   Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869
   Zhao XM, 2016, PEERJ, V4, DOI 10.7717/peerj.1635
   Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2020
VL 165
IS 2
BP 345
EP 354
DI 10.1007/s00705-019-04470-z
PG 10
WC Virology
SC Virology
GA KT0LE
UT WOS:000518701200004
OA Bronze
DA 2020-04-03
ER

PT J
AU Fan, P
   Guan, JY
   He, WQ
   Lv, XL
   Hu, SY
   Lan, YG
   Zhao, K
   Gao, F
   Li, F
   Fan, GC
   He, HB
   Li, Z
AF Fan, Peng
   Guan, Jiyu
   He, Wenqi
   Lv, Xiaoling
   Hu, Shiyu
   Lan, Yungang
   Zhao, Kui
   Gao, Feng
   Li, Fang
   Fan, Gencheng
   He, Hongbin
   Li, Zi
TI miR-142a-3p promotes the proliferation of porcine hemagglutinating
   encephalomyelitis virus by targeting Rab3a
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID CORONAVIRUS INFECTION; WASTING DISEASE; SWINE; MICRORNAS; PIGLETS
AB Porcine hemagglutinating encephalomyelitis virus (PHEV) is a typical neurotropic coronavirus that mainly invades the central nervous system (CNS) in piglets and causes vomiting and wasting disease. Emerging evidence suggests that PHEV alters microRNA (miRNA) expression profiles, and miRNA has also been postulated to be involved in its pathogenesis, but the mechanisms underlying this process have not been fully explored. In this study, we found that PHEV infection upregulates miR-142a-3p RNA expression in N2a cells and in the CNS of mice. Downregulation of miR-142a-3p by an miRNA inhibitor led to a significant repression of viral proliferation, implying that it acts as a positive regulator of PHEV proliferation. Using a dual-luciferase reporter assay, miR-142a-3p was found to bind directly bound to the 3' untranslated region (3'UTR) of Rab3a mRNA and downregulate its expression. Knockdown of Rab3a expression by transfection with an miR-142a-3p mimic or Rab3a siRNA significantly increased PHEV replication in N2a cells. Conversely, the use of an miR-142a-3p inhibitor or overexpression of Rab3a resulted in a marked restriction of viral production at both the mRNA and protein level. Our data demonstrate that miR-142a-3p promotes PHEV proliferation by directly targeting Rab3a mRNA, and this provides new insights into the mechanisms of PHEV-related pathogenesis and virus-host interactions.
C1 [Fan, Peng; Guan, Jiyu; He, Wenqi; Lv, Xiaoling; Hu, Shiyu; Lan, Yungang; Zhao, Kui; Gao, Feng; Li, Zi] Jilin Univ, Coll Vet Med, Key Lab Zoonosis Res, Minist Educ, Changchun, Peoples R China.
   [Li, Fang; Fan, Gencheng; Li, Zi] Yebio Bioengn Co Ltd Qingdao, State Key Lab Genetically Engn Vet Vaccines, Qingdao, Peoples R China.
   [He, Hongbin] Shandong Normal Univ, Coll Life Sci, Ruminant Dis Res Ctr, Key Lab Anim Resistant Biol Shandong, Jinan, Peoples R China.
RP Li, Z (reprint author), Jilin Univ, Coll Vet Med, Key Lab Zoonosis Res, Minist Educ, Changchun, Peoples R China.; Li, Z (reprint author), Yebio Bioengn Co Ltd Qingdao, State Key Lab Genetically Engn Vet Vaccines, Qingdao, Peoples R China.
EM lizi@jlu.edu.cn
FU National Key Research and Development Program of China [2016YFD0500102];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31902262, 31872446, 31772704, 31672519, 31602018];
   State Key Laboratory of Genetically Engineered Veterinary Vaccines
   [AGVSKL-ZD-201808]; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2018M640285]
FX This study was supported by the National Key Research and Development
   Program of China (Grant 2016YFD0500102), the National Natural Science
   Foundation of China (Grants 31902262, 31872446, 31772704, 31672519, and
   31602018), the State Key Laboratory of Genetically Engineered Veterinary
   Vaccines (no. AGVSKL-ZD-201808), the China Postdoctoral Science
   Foundation (Grant 2018M640285).
CR Alsop JE, 2006, J SWINE HEALTH PROD, V14, P97
   Ambros Victor, 2004, Methods Mol Biol, V265, P131
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Coleman WL, 2007, NEUROSCIENCE, V148, P1, DOI 10.1016/j.neuroscience.2007.06.011
   Dong B, 2014, ARCH VIROL, V159, P2329, DOI 10.1007/s00705-014-2070-y
   Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gao W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-130
   GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0
   Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954
   GREIG AS, 1962, CAN J COMP MED VET S, V26, P49
   Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173
   Hirano N, 2004, J COMP PATHOL, V130, P58, DOI 10.1016/S0021-9975(03)00083-5
   Khanna M, 2019, DATA BRIEF, V24, DOI 10.1016/j.dib.2019.103945
   Lai FW, 2014, J VIROL, V88, P54, DOI 10.1128/JVI.02678-13
   Lan YG, 2014, J GEN VIROL, V95, P2192, DOI 10.1099/vir.0.066845-0
   Lan YG, 2013, VIRUS RES, V176, P292, DOI 10.1016/j.virusres.2013.05.019
   Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171
   Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021
   Li Z, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00155
   Li Z, 2016, PEERJ, V4, DOI 10.7717/peerj.2443
   Lorbach JN, 2017, EMERG INFECT DIS, V23, P1168, DOI 10.3201/eid2307.170019
   Lv XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00304
   Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837
   Powdrill MH, 2016, CURR OPIN VIROL, V19, P71, DOI 10.1016/j.coviro.2016.07.005
   Quiroga MA, 2008, EMERG INFECT DIS, V14, P484, DOI 10.3201/eid1403.070825
   ROE C. K., 1958, CANADIAN JOUR COMP MED AND VET SCI, V22, P305
   Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03
   Shrestha A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136913
   Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869
   Zhao XM, 2016, PEERJ, V4, DOI 10.7717/peerj.1635
   Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2020
VL 165
IS 2
BP 345
EP 354
DI 10.1007/s00705-019-04470-z
PG 10
WC Virology
SC Virology
GA KV2AX
UT WOS:000520252700001
OA Bronze
DA 2020-04-03
ER

PT J
AU Goraichuk, IV
   Davis, JF
   Kulkarni, AB
   Afonso, CL
   Suarez, DL
AF Goraichuk, Iryna, V
   Davis, James F.
   Kulkarni, Arun B.
   Afonso, Claudio L.
   Suarez, David L.
TI A 25-Year-Old Sample Contributes the Complete Genome Sequence of Avian
   Coronavirus Vaccine Strain ArkDPI, Reisolated from Commercial Broilers
   in the United States
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID INFECTIOUS-BRONCHITIS VIRUS; SELECTION; SUBPOPULATIONS; PERSISTENCE
AB Here, we report the complete genome sequence of Avian coronavirus strain ArkDPI of the GI-9 lineage, isolated from broiler chickens in North Georgia in 1994. This is the complete genome sequence of this vaccine strain, reisolated from broilers in the United States.
C1 [Goraichuk, Iryna, V; Afonso, Claudio L.; Suarez, David L.] ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA.
   [Davis, James F.; Kulkarni, Arun B.] Georgia Poultry Lab Network, Gainesville, GA USA.
RP Suarez, DL (reprint author), ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA.
EM david.suarez@usda.gov
OI Afonso, Claudio/0000-0001-5699-4743
FU USDA CRIS project [6040-32000-072]
FX The mention of trade names or commercial products in this publication is
   solely for the purpose of providing specific information and does not
   imply recommendation or endorsement by the U.S. Department of
   Agriculture.; This study was supported by USDA CRIS project
   6040-32000-072.
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Ammayappan A, 2009, ARCH VIROL, V154, P495, DOI 10.1007/s00705-009-0325-9
   Ammayappan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-157
   Andrews S., 2020, FASTQC QUALITY CONTR
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465
   Chrzastek K, 2017, VIROLOGY, V509, P159, DOI 10.1016/j.virol.2017.06.019
   Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1
   Davis JF, 1996, AVIAN DIS, V40, P158, DOI 10.2307/1592385
   Dimitrov KM, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0741-5
   Goraichuk IV, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00840-19
   Jackwood MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176709
   Jackwood MW, 2009, AVIAN DIS, V53, P175, DOI 10.1637/8465-090308-Reg.1
   Jackwood MW, 2005, AVIAN DIS, V49, P614, DOI 10.1637/7389-052905R.1
   Jackwood MW, 2013, DIS POULTRY, P139
   King AMQ, 2018, ARCH VIROL, V163, P2601, DOI 10.1007/s00705-018-3847-1
   Leyson C, 2016, VIROLOGY, V498, P218, DOI 10.1016/j.virol.2016.08.030
   Leyson CM, 2017, AVIAN DIS, V61, P123, DOI [10.1637/11474-072216-resnote, 10.1637/11474-072216-ResNote]
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   McKinley ET, 2008, VACCINE, V26, P1274, DOI 10.1016/j.vaccine.2008.01.006
   Naqi S, 2003, AVIAN DIS, V47, P594, DOI 10.1637/6087
   Ndegwa EN, 2014, AVIAN DIS, V58, P102, DOI 10.1637/10609-070613-Reg.1
   Nix WA, 2000, AVIAN DIS, V44, P568, DOI 10.2307/1593096
   Toro H, 2012, AVIAN DIS, V56, P449, DOI 10.1637/10072-020212-Review.1
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
   van Santen VL, 2008, AVIAN PATHOL, V37, P293, DOI 10.1080/03079450802043783
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 28
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD FEB
PY 2020
VL 9
IS 9
AR e00067-20
DI 10.1128/MRA.00067-20
PG 4
WC Microbiology
SC Microbiology
GA KS3NC
UT WOS:000518217700004
PM 32107295
OA Bronze, Green Published
DA 2020-04-03
ER

PT J
AU Goraichuk, IV
   Davis, JF
   Kulkarni, AB
   Afonso, CL
   Suarez, DL
AF Goraichuk, Iryna, V
   Davis, James F.
   Kulkarni, Arun B.
   Afonso, Claudio L.
   Suarez, David L.
TI Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27
   Lineage)
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID INFECTIOUS-BRONCHITIS VIRUS
AB Avian coronavirus, also known as infectious bronchitis virus, is a highly contagious respiratory pathogen of chickens that is responsible for major economic losses to the poultry industry around the globe. Here, we report the complete genome sequence of strain GA08 of the GI-27 lineage, isolated from a fecal sample from a broiler chicken collected in Georgia in 2015.
C1 [Goraichuk, Iryna, V; Afonso, Claudio L.; Suarez, David L.] ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA.
   [Davis, James F.; Kulkarni, Arun B.] Georgia Poultry Lab Network, Gainesville, GA USA.
RP Suarez, DL (reprint author), ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA.
EM david.suarez@usda.gov
OI Afonso, Claudio/0000-0001-5699-4743
FU USDA CRIS project [6040-32000-072]
FX The mention of trade names or commercial products in this publication is
   solely for the purpose of providing specific information and does not
   imply recommendation or endorsement by the U.S. Department of
   Agriculture.; This study was supported by USDA CRIS project
   6040-32000-072.
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Ammayappan A, 2009, ARCH VIROL, V154, P495, DOI 10.1007/s00705-009-0325-9
   Ammayappan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-157
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465
   Chrzastek K, 2017, VIROLOGY, V509, P159, DOI 10.1016/j.virol.2017.06.019
   Dimitrov KM, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0741-5
   Goraichuk IV, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00840-19
   Jackwood M. W., 2013, DIS POULTRY, P139, DOI DOI 10.1002/9781119421481
   Jackwood MW, 2010, AVIAN PATHOL, V39, P227, DOI 10.1080/03079451003801516
   King AMQ, 2018, ARCH VIROL, V163, P2601, DOI 10.1007/s00705-018-3847-1
   Kulkarni AB, 2010, AVIAN DIS, V54, P1144, DOI 10.1637/9358-040510-Reg.1
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu SW, 2006, AVIAN PATHOL, V35, P394, DOI 10.1080/03079450600920984
   Roh HJ, 2013, J VET DIAGN INVEST, V25, P458, DOI 10.1177/1040638713493906
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
NR 16
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD FEB
PY 2020
VL 9
IS 9
AR e00068-20
DI 10.1128/MRA.00068-20
PG 3
WC Microbiology
SC Microbiology
GA KS3NC
UT WOS:000518217700005
PM 32107296
OA Bronze, Green Published
DA 2020-04-03
ER

PT J
AU Guan, XT
   Li, H
   Han, MJ
   Jia, S
   Feng, BH
   Gao, XW
   Wang, Z
   Jiang, YP
   Cui, W
   Wang, L
   Xu, YG
AF Guan, Xueting
   Li, Hua
   Han, Meijing
   Jia, Shuo
   Feng, Baohua
   Gao, Xuwen
   Wang, Zhuo
   Jiang, Yanping
   Cui, Wen
   Wang, Li
   Xu, Yigang
TI Epidemiological investigation of feline infectious peritonitis in cats
   living in Harbin, Northeast China from 2017 to 2019 using a combination
   of an EvaGreen-based real-time RT-PCR and serum chemistry assays
SO MOLECULAR AND CELLULAR PROBES
LA English
DT Article
DE Feline infectious peritonitis virus; N gene; EvaGreen-based real-time
   12T-PCR; Hyperglobulinemia; Epidemiological survey
ID VIRUS; CORONAVIRUS; STRAINS; TISSUES; UPDATE
AB Feline infectious peritonitis (FIP) is caused by the FIP virus (FIPV), a highly virulent mutant form of feline coronavirus (FCoV). This disease is one of the most important infectious diseases in cats, and it is associated with high mortality, particularly among younger cats. In this study, we isolated a wild-type FIPV HRB-17 epidemic strain from the blood sample of household pet cat exhibiting the characteristic wet-form FIP symptoms, which has been confirmed further by animal infection. Further, we developed an EvaGreen-based real-time RT-PCR assay for the accurate detection of FCoV based on the amplification of the highly conserved FIPV N gene. Then, using a combination of the real-time RT-PCR approach and a serum chemistry assay, we performed an epidemiological survey of FIPV infection in cats living in Harbin City, Northeast China. The results indicated that the EvaGreen-based real-time RT-PCR assay can be used for screening FCoV infection in the affected cats at an analytical detection limit of 8.2 x 10(1) viral genome copies/A, but could not effectively distinguish FIPVs from FECVs. Additionally, the results of the epidemiological survey investigating feline blood samples (n = 1523) collected between July 2017 to July 2019 revealed an FIPV prevalence of approximately 12% (189/1523). Maybe, the prevalence would be less than 12% due to the real-time RT-PCR assay could not accurately differentiate FIPV and FECV. Nevertheless, it still highlighted the severity of the FIP epidemic in cats and reiterated the urgent need to develop effective anti-FIP therapeutic agents and anti-FIPV vaccines. As pet cats are household animals, risk communication and continuous region-extended surveillance cat programs are recommended.
C1 [Guan, Xueting; Li, Hua; Han, Meijing; Jia, Shuo; Feng, Baohua; Gao, Xuwen; Wang, Zhuo; Jiang, Yanping; Cui, Wen; Wang, Li; Xu, Yigang] Northeast Agr Univ, Heilongjiang Key Lab Anim Dis Control & Pharmaceu, Harbin, Peoples R China.
   [Wang, Li; Xu, Yigang] Minist Agr China, Key Lab Anim Pathogen Biol, Northeast Sci Inspect Stn, Harbin, Peoples R China.
RP Xu, YG (reprint author), Northeast Agr Univ, Heilongjiang Key Lab Anim Dis Control & Pharmaceu, Harbin, Peoples R China.
EM yigangxu@neau.edu.cn
FU National Key Research and Development Program of China [2016YFD0501003,
   2016YFD0500704]; Heilongjiang Province Postdoctoral Science Fund
   [LBH-Z15015]
FX This work was supported by the National Key Research and Development
   Program of China (grant 2016YFD0501003, 2016YFD0500704) and Heilongjiang
   Province Postdoctoral Science Fund (grant LBH-Z15015).
CR Addie DD, 2001, VET REC, V148, P649, DOI 10.1136/vr.148.21.649
   Dye C, 2008, J FELINE MED SURG, V10, P167, DOI 10.1016/j.jfms.2007.10.010
   Gao XW, 2019, VIRULENCE, V10, P166, DOI 10.1080/21505594.2019.1582975
   HOLZWORTH J, 1963, CORNELL VET, V53, P157
   Hornyak A, 2012, J VIROL METHODS, V181, P155, DOI 10.1016/j.jviromet.2012.01.022
   Kipar A, 2014, VET PATHOL, V51, P505, DOI 10.1177/0300985814522077
   Li CQ, 2019, TRANSBOUND EMERG DIS, V66, P763, DOI 10.1111/tbed.13081
   LI XT, 1994, VET MICROBIOL, V42, P65, DOI 10.1016/0378-1135(94)90078-7
   Macneill A.L., 2016, ADV SMALL ANIM MED S, V29, P1
   MONTALI RJ, 1972, VET PATHOL, V9, P109, DOI 10.1177/030098587200900204
   Norris JM, 2005, AUST VET J, V83, P666, DOI 10.1111/j.1751-0813.2005.tb13044.x
   OLSEN CW, 1993, VET MICROBIOL, V36, P1, DOI 10.1016/0378-1135(93)90126-R
   PEDERSEN NC, 1981, AM J VET RES, V42, P368
   PEDERSEN NC, 1985, COMP CONT EDUC PRACT, V7, P1001
   PEDERSEN NC, 1981, AM J VET RES, V42, P363
   Pedersen NC, 2014, VET J, V201, P123, DOI 10.1016/j.tvjl.2014.04.017
   Pedersen NC, 2009, VIRUSES-BASEL, V1, P166, DOI 10.3390/v1020166
   Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008
   Poland AM, 1996, J CLIN MICROBIOL, V34, P3180, DOI 10.1128/JCM.34.12.3180-3184.1996
   Riemer F, 2016, J FELINE MED SURG, V18, P348, DOI 10.1177/1098612X15586209
   Soma T, 2013, J VET MED SCI, V75, P1389, DOI 10.1292/jvms.13-0094
   Tasker S, 2018, J FELINE MED SURG, V20, P228, DOI 10.1177/1098612X18758592
   Tsai HY, 2011, J FELINE MED SURG, V13, P74, DOI 10.1016/j.jfms.2010.09.014
   Vennema H, 1998, VIROLOGY, V243, P150, DOI 10.1006/viro.1998.9045
   Wang YX, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060575
   WARD JM, 1970, VIROLOGY, V41, P191, DOI 10.1016/0042-6822(70)90070-X
NR 26
TC 0
Z9 0
U1 21
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0890-8508
J9 MOL CELL PROBE
JI Mol. Cell. Probes
PD FEB
PY 2020
VL 49
AR 101495
DI 10.1016/j.mcp.2019.101495
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology; Cell Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Cell Biology
GA KG7EB
UT WOS:000510110100016
PM 31846702
OA Bronze
DA 2020-04-03
ER

PT J
AU Jung, SM
   Akhmetzhanov, AR
   Hayashi, K
   Linton, NM
   Yang, YC
   Yuan, BY
   Kobayashi, T
   Kinoshita, R
   Nishiura, H
AF Jung, Sung-mok
   Akhmetzhanov, Andrei R.
   Hayashi, Katsuma
   Linton, Natalie M.
   Yang, Yichi
   Yuan, Baoyin
   Kobayashi, Tetsuro
   Kinoshita, Ryo
   Nishiura, Hiroshi
TI Real-Time Estimation of the Risk of Death from Novel Coronavirus
   (COVID-19) Infection: Inference Using Exported Cases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mortality; censoring; travel; migration; importation; emerging
   infectious diseases
ID RESPIRATORY SYNDROME MERS; REPUBLIC-OF-KOREA; OUTBREAK
AB The exported cases of 2019 novel coronavirus (COVID-19) infection that were confirmed outside China provide an opportunity to estimate the cumulative incidence and confirmed case fatality risk (cCFR) in mainland China. Knowledge of the cCFR is critical to characterize the severity and understand the pandemic potential of COVID-19 in the early stage of the epidemic. Using the exponential growth rate of the incidence, the present study statistically estimated the cCFR and the basic reproduction number-the average number of secondary cases generated by a single primary case in a naive population. We modeled epidemic growth either from a single index case with illness onset on 8 December 2019 (Scenario 1), or using the growth rate fitted along with the other parameters (Scenario 2) based on data from 20 exported cases reported by 24 January 2020. The cumulative incidence in China by 24 January was estimated at 6924 cases (95% confidence interval [CI]: 4885, 9211) and 19,289 cases (95% CI: 10,901, 30,158), respectively. The latest estimated values of the cCFR were 5.3% (95% CI: 3.5%, 7.5%) for Scenario 1 and 8.4% (95% CI: 5.3%, 12.3%) for Scenario 2. The basic reproduction number was estimated to be 2.1 (95% CI: 2.0, 2.2) and 3.2 (95% CI: 2.7, 3.7) for Scenarios 1 and 2, respectively. Based on these results, we argued that the current COVID-19 epidemic has a substantial potential for causing a pandemic. The proposed approach provides insights in early risk assessment using publicly available data.
C1 [Jung, Sung-mok; Akhmetzhanov, Andrei R.; Hayashi, Katsuma; Linton, Natalie M.; Yang, Yichi; Yuan, Baoyin; Kobayashi, Tetsuro; Kinoshita, Ryo; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo,Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
RP Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo,Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
EM seductmd@med.hokudai.ac.jp; akhmetzhanov@gmail.com;
   katsuma5miffy@gmail.com; nlinton@gmail.com;
   lukeyang1993@eis.hokudai.ac.jp; baoyinyuan@gmail.com;
   tootsieroll2910@gmail.com; kinoshitaryo@gmail.com;
   nishiurah@med.hokudai.ac.jp
RI Akhmetzhanov, Andrei R./B-5530-2013
OI Akhmetzhanov, Andrei R./0000-0003-3269-7351; Jung,
   Sung-mok/0000-0002-0787-4515
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108050]; Japan Society
   for the Promotion of Science (JSPS) KAKENHIMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [17H04701, 17H05808, 18H04895, 19H01074, 18J21587]; Inamori Foundation;
   Japan Science and Technology Agency (JST) CREST program [JPMJCR1413];
   Ministry of Education, Culture, Sports, Science and Technology,
   JapanMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); China Scholarship CouncilChina Scholarship Council
FX H.N. received funding from the Japan Agency for Medical Research and
   Development (AMED) [grant number: JP18fk0108050]; the Japan Society for
   the Promotion of Science (JSPS) KAKENHI [grant numbers, H.N.: 17H04701,
   17H05808, 18H04895 and 19H01074; R.K.: 18J21587], the Inamori
   Foundation, and the Japan Science and Technology Agency (JST) CREST
   program [grant number: JPMJCR1413]. S.M.J. and N.M.L. receive graduate
   study scholarships from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan. B.Y. wishes to thank China Scholarship
   Council.
CR Boldog P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020571
   Centers for Disease Control and Prevention, 2019, NOV COR
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kucharski A.J, 2020, CMMID NCOV WORKING G, DOI [10.1101/2020.01.31.20019901, DOI 10.1101/2020.01.31.20019901]
   Li M, 2018, STAT METHODS MED RES, V27, P1956, DOI 10.1177/0962280217747054
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Majumder MS, 2015, EMERG INFECT DIS, V21, P2088, DOI 10.3201/eid2111.151231
   Mizumoto K, 2015, INT J INFECT DIS, V39, P7, DOI 10.1016/j.ijid.2015.08.005
   Mizumoto K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0468-3
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020419
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [10.1101/2020.01.23.20018549v2, DOI 10.1101/2020.01.23.20018549V2]
   Thompson R.N., DOES MINOR OUTBREAK
   Thompson R.N., 2020, BIORXIV, DOI [10.1101/2020.01.24.919159, DOI 10.1101/2020.01.24.919159]
   Thompson RN, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004836
   World Health Organization, NOV COR CHIN DIS OUT
   World Health Organization, 3 WHO
   Zhao S., PRELIMINARY ESTIMATI
NR 26
TC 0
Z9 0
U1 15
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 523
DI 10.3390/jcm9020523
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000235
PM 32075152
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Kannan, S
   Ali, PSS
   Sheeza, A
   Hemalatha, K
AF Kannan, S.
   Ali, P. Shaik Syed
   Sheeza, A.
   Hemalatha, K.
TI COVID-19 (Novel Coronavirus 2019) - recent trends
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Coronavirus; Pneumona; Novel coronavirus 2019; 2019-nCoV; COVID-19;
   SARS; MERS
ID RNA INTERFERENCE; 2019-NCOV; WUHAN
AB The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it should be contained to prevent the global spread. The COVID-19 virus was known earlier as 2019-nCoV. As of 12 February 2020, WHO reported 45,171 cases and 1115 deaths related to COVID-19. COVID-19 is similar to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) virus in its pathogenicity, clinical spectrum, and epidemiology. Comparison of the genome sequences of COVID-19, SARS-CoV, and Middle East Respiratory Syndrome coronavirus (MERS-CoV) showed that COVID-19 has a better sequence identity with SARS-CoV compared to MERS CoV. However, the amino acid sequence of COVID-19 differs from other coronaviruses specifically in the regions of lab polyprotein and surface glycoprotein or S-protein. Although several animals have been speculated to be a reservoir for COVID-19, no animal reservoir has been already confirmed. COVID-19 causes COVID-19 disease that has similar symptoms as SARSCoV. Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARS-CoV. The nucleocapsid (N) protein of COVID-19 has nearly 90% amino acid sequence identity with SARS-CoV. The N protein antibodies of SARS-CoV may cross react with COVID-19 but may not provide cross-immunity. In a similar fashion to SARS-CoV, the N protein of COVID-19 may play an important role in suppressing the RNA interference (RNAi) to overcome the host defense. This mini-review aims at investigating the most recent trend of COVID-19.
C1 [Kannan, S.; Ali, P. Shaik Syed; Sheeza, A.] Maldives Natl Univ, Sch Med, Male, Maldives.
   [Hemalatha, K.] Jimma Univ, Dept Lab Sci & Pathol, Jimma, Ethiopia.
RP Kannan, S (reprint author), Maldives Natl Univ, Sch Med, Male, Maldives.
EM Kannan.subbaram@mnu.edu.mv
CR Ali PSS, 2015, MICROBIOL IMMUNOL, V59, P299, DOI 10.1111/1348-0421.12253
   Callaway E, 2020, NATURE, V577, P605, DOI 10.1038/d41586-020-00166-6
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen TM, 2020, BIORXIV, DOI [10.1101/2020.01.19.911669, DOI 10.1101/2020.01.19.911669]
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Cui L, 2015, J VIROL, V89, P9029, DOI 10.1128/JVI.01331-15
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Dong N, 2020, BIORXIV, DOI [10.1101/2020.01.20.913368., DOI 10.1101/2020.01.20.913368]
   Fraire AE, 2014, VIRUSES LUNG INFECTI, pXIV
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Guo Q, 2020, BIORXIV, DOI [10.1101/2020.01.21.914044., DOI 10.1101/2020.01.21.914044]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Letko M, 2020, BIORXIV, DOI [10.1101/2020.01.22.915660., DOI 10.1101/2020.01.22.915660]
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI 10.1002/jmv.25678
   MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M308
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Read JM, 2020, NOVEL CORONAVIRUS 20, DOI [DOI 10.1101/2020.01.23.20018549, 10.1101/2020.01.23.20018549]
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005
   World Health Organization, 2020, WHO NOV COR 2019 NCO
   Wu F, 2020, BIORXIV, DOI [10.1101/2020.01.24.919183., DOI 10.1101/2020.01.24.919183]
   Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044
   Zhao Y, 2020, BIORXIV, DOI [10.1101/2020.01.26.919985., DOI 10.1101/2020.01.26.919985]
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 30
TC 0
Z9 0
U1 18
U2 18
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD FEB
PY 2020
VL 24
IS 4
BP 2006
EP 2011
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KT1IP
UT WOS:000518765300047
PM 32141569
DA 2020-04-03
ER

PT J
AU Linton, NM
   Kobayashi, T
   Yang, YC
   Hayashi, K
   Akhmetzhanov, AR
   Jung, SM
   Yuan, BY
   Kinoshita, R
   Nishiura, H
AF Linton, Natalie M.
   Kobayashi, Tetsuro
   Yang, Yichi
   Hayashi, Katsuma
   Akhmetzhanov, Andrei R.
   Jung, Sung-mok
   Yuan, Baoyin
   Kinoshita, Ryo
   Nishiura, Hiroshi
TI Incubation Period and Other Epidemiological Characteristics of 2019
   Novel Coronavirus Infections with Right Truncation: A Statistical
   Analysis of Publicly Available Case Data
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE epidemiology; incubation period; virus; distribution; emerging
   infectious diseases
ID INFLUENZA-A H1N1
AB The geographic spread of 2019 novel coronavirus (COVID-19) infections from the epicenter of Wuhan, China, has provided an opportunity to study the natural history of the recently emerged virus. Using publicly available event-date data from the ongoing epidemic, the present study investigated the incubation period and other time intervals that govern the epidemiological dynamics of COVID-19 infections. Our results show that the incubation period falls within the range of 2-14 days with 95% confidence and has a mean of around 5 days when approximated using the best-fit lognormal distribution. The mean time from illness onset to hospital admission (for treatment and/or isolation) was estimated at 3-4 days without truncation and at 5-9 days when right truncated. Based on the 95th percentile estimate of the incubation period, we recommend that the length of quarantine should be at least 14 days. The median time delay of 13 days from illness onset to death (17 days with right truncation) should be considered when estimating the COVID-19 case fatality risk.
C1 [Linton, Natalie M.; Kobayashi, Tetsuro; Yang, Yichi; Hayashi, Katsuma; Akhmetzhanov, Andrei R.; Jung, Sung-mok; Yuan, Baoyin; Kinoshita, Ryo; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
RP Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
EM natalie.linton@med.hokudai.ac.jp; tootsieroll2910@gmail.com;
   lukeyang1993@eis.hokudai.ac.jp; katsuma5miffy@eis.hokudai.ac.jp;
   akhmetzhanov@gmail.com; seductmd@med.hokudai.ac.jp;
   baoyinyuan@outlook.com; ryokinoshita@med.hokudai.ac.jp;
   nishiurah@med.hokudai.ac.jp
RI Akhmetzhanov, Andrei R./B-5530-2013; Ribeiro, Nuno/AAH-2299-2020
OI Akhmetzhanov, Andrei R./0000-0003-3269-7351; Linton,
   Natalie/0000-0002-5464-0076; Jung, Sung-mok/0000-0002-0787-4515;
   Kinoshita, Ryo/0000-0002-0116-4598
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108050]; Japan Society
   for the Promotion of Science (JSPS) KAKENHIMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [17H04701, 17H05808, 18H04895, 19H01074, 18J21587]; Inamori Foundation;
   Japan Science and Technology Agency (JST) CREST program [JPMJCR1413];
   Ministry of Education, Culture, Sports, Science and Technology,
   JapanMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); China Scholarship CouncilChina Scholarship Council
FX H.N. received funding from the Japan Agency for Medical Research and
   Development (AMED) [grant number: JP18fk0108050]; the Japan Society for
   the Promotion of Science (JSPS) KAKENHI [grant numbers, H.N.: 17H04701,
   17H05808, 18H04895 and 19H01074; R.K.: 18J21587], the Inamori
   Foundation, and the Japan Science and Technology Agency (JST) CREST
   program [grant number: JPMJCR1413]. S.J. and N.M.L. receive graduate
   study scholarships from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan. B.Y. wishes to thank the China
   Scholarship Council.
CR Backer J.A., 2020, INCUBATION PERIOD 20, DOI [10.1101/2020.01.27.20018986, DOI 10.1101/2020.01.27.20018986]
   Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   European Centre for Disease Prevention and Control data, GEOGR DISTR 2019 NCO
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jung S., 2020, REAL TIME ESTIMATION, DOI [10.1101/2020.01.29.20019547v1, DOI 10.1101/2020.01.29.20019547V1]
   Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   National Health Commission of the People's Republic of China, UPD PNEUM NEW COR IN
   Nishiura H, 2007, T ROY SOC TROP MED H, V101, P338, DOI 10.1016/j.trstmh.2006.11.002
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Nishiura H, 2009, INT J HYG ENVIR HEAL, V212, P97, DOI 10.1016/j.ijheh.2007.10.003
   R Core Team, R LANG ENV STAT COMP
   Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659
   Stan Development Team, STAN MOD LANG US GUI
   Virlogeux V, 2016, EMERG INFECT DIS, V22, P526, DOI 10.3201/eid2203.151437
NR 19
TC 0
Z9 0
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 538
DI 10.3390/jcm9020538
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000250
PM 32079150
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Mattiuzzi, C
   Lippi, G
AF Mattiuzzi, Camilla
   Lippi, Giuseppe
TI Which lessons shall we learn from the 2019 novel coronavirus outbreak?
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article
C1 [Mattiuzzi, Camilla] Prov Agcy Social & Sanit Serv, Serv Clin Governance, Trento, Italy.
   [Lippi, Giuseppe] Univ Verona, Clin Biochem Sect, Piazzale LA Scuro, I-37134 Verona, Italy.
RP Lippi, G (reprint author), Univ Verona, Clin Biochem Sect, Piazzale LA Scuro, I-37134 Verona, Italy.
EM giuseppe.lippi@univr.it
CR Centers for Disease Control and Prevention (CDC), 2019, NOV COR REAL TIM RT
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Huang C, 2020, LANCET
   Ji W, 2020, J MED VIROL
   Li Q, 2020, N ENGL J MED
   Lippi G, 2020, DIAGNOSIS BERL
   Lippi G, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.11.55
   Munster V.J, 2020, N ENGL J MED
   Perlman S, 2020, N ENGL J MED
   Phan LT, 2020, N ENGL J MED
   Plebani M, 2019, CLIN CHIM ACTA, V489, P49, DOI 10.1016/j.cca.2018.11.021
   Ventola C Lee, 2014, P T, V39, P491
   Wang W, 2020, J MED VIROL, V2020
   World Health Organization, NOV COR 2019 NCOV SI
   World Health Organization, LAB TEST 2019 NOV CO
   World Health Organization, PROJ MORT CAUS DEATH
   World Health Organization, ANT RES
   Zhu N, 2019, N ENGL J MED, V2020
NR 19
TC 0
Z9 0
U1 23
U2 23
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD FEB
PY 2020
VL 8
IS 3
AR 48
DI 10.21037/atm.2020.02.06
PG 4
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA KN0RI
UT WOS:000514545800012
PM 32154288
OA Other Gold, Green Published
DA 2020-04-03
ER

PT J
AU Meo, SA
   Alhowikan, AM
   Al-Khlaiwi, T
   Meo, IM
   Halepoto, DM
   Iqbal, M
   Usmani, AM
   Hajjar, W
   Ahmed, N
AF Meo, S. A.
   Alhowikan, A. M.
   Al-Khlaiwi, T.
   Meo, I. M.
   Halepoto, D. M.
   Iqbal, M.
   Usmani, A. M.
   Hajjar, W.
   Ahmed, N.
TI Novel coronavirus 2019-nCoV: prevalence, biological and clinical
   characteristics comparison with SARS-CoV and MERS-CoV
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Coronavirus; SARS-CoV; MERS-CoV; 2019-nCoV; Prevalence; Outbreak
ID EPIDEMIOLOGY; INFECTION
AB OBJECTIVE: Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study aimed at investigating the global prevalence, biological and clinical characteristics of novel coronavirus, Wuhan China (2019-nCoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection outbreaks.
   MATERIALS AND METHODS: The data on the global outbreak of "2019-nCoV, SARS-CoV, and MERS-CoV" were obtained from World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), concerned ministries and research institutes. We also recorded the information from research documents published in global scientific journals indexed in ISI Web of Science and research centers on the prevalence, biological and clinical characteristics of 2019-nCoV, SARS-CoV, and MERS-CoV.
   RESULTS: Worldwide, SARS-CoV involved 32 countries, with 8422 confirmed cases and 916 (10.87%) casualties from November 2002 to August 2003. MERS-CoV spread over 27 states, causing 2496 cases and 868 (34.77%) fatalities during the period April 2012 to December 2019. However, the novel coronavirus 2019-nCoV spread swiftly the global borders of 27 countries. It infected 34799 people and resulted in 724 (2.08%) casualties during the period December 29, 2019 to February 7. 2020. The fatality rate of coronavirus MERS-CoV was (34.77%) higher than SARS-CoV (10.87%) and 2019-nCoV (2.08%); however, the 2019-nCoV transmitted rapidly in comparison to SARS-CoV and MERS-CoV.
   CONCLUSIONS: The novel coronavirus 2019-nCoV has diverse epidemiological and biological characteristics, making it more contagious than SARS-CoV and MERS-CoV. It has affected more people in a short time period compared to SARS-CoV and MERS-CoV, although the fatality rate of MERS-CoV was higher than SARS-CoV and 2019-nCoV. The major clinical manifestations in coronavirus infections 2019-nCoV, MERS-CoV, and SARS CoV are fever, chills. cough. shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and pneumonia. Global health authorities should take immediate measures to prevent the outbreaks of such emerging and reemerging pathogens across the globe to minimize the disease burden locally and globally.
C1 [Meo, S. A.; Alhowikan, A. M.; Al-Khlaiwi, T.; Meo, I. M.; Halepoto, D. M.; Iqbal, M.] King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia.
   [Usmani, A. M.] King Saud Univ, Coll Med, Strateg Ctr Diabet Res, Riyadh, Saudi Arabia.
   [Hajjar, W.] King Saud Univ, Coll Med, Thorac Surg, Riyadh, Saudi Arabia.
   [Ahmed, N.] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.
RP Meo, SA (reprint author), King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia.
EM sultanmeo@hotmail.com
FU King Saud University, Riyadh, Saudi ArabiaDeanship of Scientific
   Research at King Saud University [RSP-2019/47]
FX Researchers Supporting Project Number (RSP-2019/47), King Saud
   University, Riyadh, Saudi Arabia.
CR Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379
   Aly M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183850
   Callaway E, 2020, NATURE, V577, P605, DOI 10.1038/d41586-020-00166-6
   Lee JY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2576-5
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Nassar MS, 2018, EUR REV MED PHARMACO, V22, P4956, DOI 10.26355/eurrev_201808_15635
   Nassar MS, 2018, EUR REV MED PHARMACO, V22, P3913, DOI 10.26355/eurrev_201806_15276
   Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010
   Raj VS, 2014, J VIROL, V88, P1834, DOI 10.1128/JVI.02935-13
   REBECCA LAI KK, CORONAVIRUS MAP TRAC
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
NR 12
TC 0
Z9 0
U1 10
U2 10
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD FEB
PY 2020
VL 24
IS 4
BP 2012
EP 2019
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KT1IP
UT WOS:000518765300048
PM 32141570
DA 2020-04-03
ER

PT J
AU Ok, M
   Yildiz, R
   Hatipoglu, F
   Baspinar, N
   Ider, M
   Uney, K
   Erturk, A
   Durgut, MK
   Terzi, F
AF Ok, Mahmut
   Yildiz, Ramazan
   Hatipoglu, Fatih
   Baspinar, Nuri
   Ider, Merve
   Uney, Kamil
   Erturk, Alper
   Durgut, Murat K.
   Terzi, Funda
TI Use of intestine-related biomarkers for detecting intestinal epithelial
   damage in neonatal calves with diarrhea
SO AMERICAN JOURNAL OF VETERINARY RESEARCH
LA English
DT Article
ID PLATELET-ACTIVATING-FACTOR; GUT-ASSOCIATED BIOMARKERS; NECROTIZING
   ENTEROCOLITIS; ALKALINE-PHOSPHATASE; CALF DIARRHEA; COLONIC
   INFLAMMATION; ISCHEMIA-REPERFUSION; LEPTIN LEVELS; EXPRESSION;
   INTERLEUKIN-8
AB OBJECTIVE
   To evaluate the usefulness of intestinal biomarkers in determining the presence of intestinal epithelial damage in neonatal calves with diarrhea caused by 4 etiologic agents.
   ANIMALS
   40 neonatal calves that were healthy (n = 10) or had diarrhea (30).
   PROCEDURES
   The study was a cross-sectional study. Results of hematologic analyses and serum concentrations of intestinal fatty acid-binding protein (I-FABP), liver fatty acid-binding protein (L-FABP), trefoil factor 3 (TFF-3), Claudin-3 (CLDN-3), gamma-enteric smooth muscle actin (ACTG2), intestinal alkaline phosphatase (IAP), interleukin-8 (IL-8), platelet-activating factor (PAF), and leptin (LP) were compared among calves grouped according to whether they were healthy (control group; G-1) or had diarrhea caused by K99 Escherichia coli (G-2; n = 10), bovine rota-or coronavirus (G-3; 5 each), or Cryptosporidium spp (G-4; 10).
   RESULTS
   Across the 3 time points at which blood samples were obtained and evaluated, the groups of calves with diarrhea generally had markedly higher mean serum concentrations of L-FABP, TFF-3, IAP, IL-8, and LP, compared with the control group. In addition, G-2 also consistently had markedly higher mean serum concentrations of I-FAB and ACTG2 and lower mean serum concentrations of CLDN-3, compared with the control group.
   CONCLUSIONS AND CLINICAL RELEVANCE
   Results indicated that degree of intestinal epithelial damage differed among calves grouped by the etiologic agent of diarrhea and that such damage might have been more severe in calves with diarrhea caused by K99 E coli. Additionally, our results indicated that serum concentrations of I-FABP, L-FABP, TFF-3, IAP, IL-8, ACTG2, LP, and CLDN-3 were useful biomarkers of intestinal epithelial damage in calves of the present study.
C1 [Ok, Mahmut; Ider, Merve; Durgut, Murat K.] Selcuk Univ, Fac Vet Med, Dept Internal Med, TR-42031 Konya, Turkey.
   [Hatipoglu, Fatih] Selcuk Univ, Fac Vet Med, Dept Pathol, TR-42031 Konya, Turkey.
   [Baspinar, Nuri] Selcuk Univ, Fac Vet Med, Dept Biochem, TR-42031 Konya, Turkey.
   [Uney, Kamil] Selcuk Univ, Fac Vet Med, Dept Pharmacol & Toxicol, TR-42031 Konya, Turkey.
   [Yildiz, Ramazan] Univ Mehmet Akif Ersoy, Fac Vet Med, Dept Internal Med, TR-15030 Burdur, Turkey.
   [Erturk, Alper] Univ Mustafa Kemal, Fac Vet Med, Dept Internal Med, TR-31000 Antakya, Turkey.
   [Terzi, Funda] Univ Kastamonu, Fac Vet Med, Dept Pathol, TR-37200 Kastamonu, Turkey.
RP Ok, M (reprint author), Selcuk Univ, Fac Vet Med, Dept Internal Med, TR-42031 Konya, Turkey.
EM mok@selcuk.edu.tr
FU Scientific and Technological Research Council of Turkey (TUBITAK)Turkiye
   Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [1160456]
FX Funded by The Scientific and Technological Research Council of Turkey
   (TUBITAK; project No. 1160456).
CR Al Mawly J, 2015, VET J, V203, P155, DOI 10.1016/j.tvjl.2015.01.010
   Benkoe TM, 2014, J PEDIATR SURG, V49, P1446, DOI 10.1016/j.jpedsurg.2014.03.012
   Bjorkman C, 2003, ACTA VET SCAND, V44, P145, DOI 10.1186/1751-0147-44-145
   CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4
   Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216
   Derikx JPM, 2010, CRIT CARE MED, V38, P133, DOI 10.1097/CCM.0b013e3181b4a5ed
   Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1
   Evennett N, 2014, J SURG RES, V191, P323, DOI 10.1016/j.jss.2014.04.020
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Gaige S, 2003, J PHYSIOL-LONDON, V546, P267, DOI 10.1113/jphysiol.2002.029462
   Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105
   Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058
   Hacioglu A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-37
   Ivanov AI, 2004, NOVART FDN SYMP, V263, P124
   Ivanov AI, 2004, NOVART FDN SYMP, V263, p[115, 211]
   Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115
   Jasim SM, 2015, MINTAGE J PHARM MED, V4, P9
   Kalkanov I, 2018, KAFKAS UNIV VET FAK, V24, P791, DOI 10.9775/kvfd.2018.19827
   Kampanatkosol R, 2014, J PEDIATR SURG, V49, P273, DOI 10.1016/j.jpedsurg.2013.11.037
   Koca YS, 2018, ANN ITAL CHIR, V89, P66
   Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082
   Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x
   Liu DR, 2018, WORLD J GASTROENTERO, V24, P46, DOI 10.3748/wjg.v24.i1.46
   Luna L.G., 1968, MANUAL HISTOLOGIC ST, P32
   MACKENDRICK W, 1993, BIOL NEONATE, V64, P89, DOI 10.1159/000243976
   Madan R, 2014, INFECT IMMUN, V82, P341, DOI 10.1128/IAI.00972-13
   Martin CR, 2006, SEMIN FETAL NEONAT M, V11, P369, DOI 10.1016/j.siny.2006.03.002
   Martinez-Moya P, 2012, PHARMACOL RES, V66, P144, DOI 10.1016/j.phrs.2012.04.006
   Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008
   Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637
   Ng EWY, 2013, ANN SURG, V258, P1111, DOI 10.1097/SLA.0b013e318288ea96
   Ok M, 2009, ZOONOSES PUBLIC HLTH, V56, P94, DOI 10.1111/j.1863-2378.2008.01156.x
   Rondelli ALH, 2018, PESQUI VET BRASIL, V38, P1890, DOI [10.1590/1678-5150-PVB-5617, 10.1590/1678-5150-pvb-5617]
   Semnani S, 2009, J CLIN GASTROENTEROL, V43, P826, DOI 10.1097/MCG.0b013e3181986900
   Sen I, 2009, JAVMA-J AM VET MED A, V234, P926, DOI 10.2460/javma.234.7.926
   Smith GW, 2009, VET CLIN N AM-FOOD A, V25, P55, DOI 10.1016/j.cvfa.2008.10.006
   Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4
   Tuglu B, 2011, TURK J BIOCHEM, V9, P31
   Volynets V, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1208468
   Wolinski J, 2003, J ENDOCRINOL, V177, P215, DOI 10.1677/joe.0.1770215
   Yildiz R, 2018, J VET RES, V62, P379, DOI 10.2478/jvetres-2018-0054
   Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375
   Zhang BH, 2003, REGUL PEPTIDES, V116, P53, DOI 10.1016/S0167-0115(03)00177-0
NR 43
TC 0
Z9 0
U1 5
U2 5
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0002-9645
EI 1943-5681
J9 AM J VET RES
JI Am. J. Vet. Res.
PD FEB
PY 2020
VL 81
IS 2
BP 139
EP 146
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA KG1ZJ
UT WOS:000509740400015
PM 31985285
DA 2020-04-03
ER

PT J
AU Peng, Q
   Fang, LR
   Ding, Z
   Wang, D
   Peng, GQ
   Xiao, SB
AF Peng, Qi
   Fang, Liurong
   Ding, Zhen
   Wang, Dang
   Peng, Guiqing
   Xiao, Shaobo
TI Rapid manipulation of the porcine epidemic diarrhea virus genome by
   CRISPR/Cas9 technology
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Porcine epidemic diarrhea virus; Reverse genetics system; CRISPR/Cas9
ID PROTEIN; CORONAVIRUSES
AB Porcine epidemic diarrhea virus (PEDV) is a highly pathogenic enteric coronavirus causing lethal watery diarrhea in suckling piglets. Reverse genetics is a valuable tool to study the functions of viral genes and to generate vaccine candidates. In this study, a full-length infectious cDNA clone of the highly virulent PEDV strain AJ1102 was assembled in a bacterial artificial chromosome (BAC). The rescued virus (rAJ1102) exhibited similar proliferation characteristics in vitro to the wildtype AJ1102. Using CRISPR/Cas9 technology, a recombinant virus rAJ1102-Delta ORF3-EGFP in which the ORF3 gene was replaced with an EGFP gene, was successfully generated, and its proliferation characteristics were compared with the parental rAJ1102. Importantly, it just took one week to construct the recombinant PEDV rAJ1102-Delta ORF3-EGFP using this method, providing a more efficient platform for PEDV genome manipulation, which could also be applied to other RNA viruses.
C1 [Peng, Qi; Fang, Liurong; Ding, Zhen; Wang, Dang; Peng, Guiqing; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.
   [Peng, Qi; Fang, Liurong; Ding, Zhen; Wang, Dang; Peng, Guiqing; Xiao, Shaobo] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Peoples R China.
   [Ding, Zhen] Jiangxi Agr Univ, Coll Anim Sci & Technol, Jiangxi Prov Key Lab Anim Sci & Technol, Nanchang 330045, Jiangxi, Peoples R China.
RP Xiao, SB (reprint author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.
EM vet@mail.hzau.edu.cn
FU National Key RD Plan of China [2016YFD0500103]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31730095, 31672569]; Major S&T Project of Hubei Province [2017ABA138]
FX We thank Dr. Gang Wang for technical assistance. This work was supported
   by the National Key R&D Plan of China (2016YFD0500103), the National
   Natural Science Foundation of China (31730095; 31672569), and the Major
   S&T Project of Hubei Province (2017ABA138).
CR Beall A, 2016, MBIO, V7, DOI 10.1128/mBio.01451-15
   Bi J, 2012, J VIROL, V86, P10910, DOI 10.1128/JVI.01919-12
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   DUARTE M, 1993, ADV EXP MED BIOL, V342, P55
   Fan BC, 2017, VIROLOGY, V500, P50, DOI 10.1016/j.virol.2016.10.011
   Hou Yixuan, 2019, J Virol, V93, DOI 10.1128/JVI.01758-18
   Hou YX, 2017, J VIROL, V91, DOI 10.1128/JVI.00227-17
   Jengarn J, 2015, J GEN VIROL, V96, P2206, DOI 10.1099/vir.0.000184
   Jiang WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9101
   Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017
   Kaewborisuth C, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080399
   Kao CF, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100543
   Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2
   Li CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069997
   Li J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173998
   Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Moradpour Mahdi, 2020, Plant Biotechnol J, V18, P32, DOI 10.1111/pbi.13232
   Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166
   Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1
   Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675
   Sun DB, 2016, J VET MED SCI, V78, P355, DOI 10.1292/jvms.15-0446
   Teeravechyan S, 2016, VIRUS RES, V226, P152, DOI 10.1016/j.virusres.2016.05.003
   VANREETH K, 1994, VET REC, V135, P594
   Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491
   Wang DC, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5063603
   Wang JW, 2015, BIOTECHNIQUES, V58, P161, DOI 10.2144/000114261
   Wang K, 2012, FEBS LETT, V586, P384, DOI 10.1016/j.febslet.2012.01.005
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Wongthida P, 2017, ARCH VIROL, V162, P2553, DOI 10.1007/s00705-017-3390-5
   WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243
   Zhang QZ, 2016, VIRUS RES, V226, P128, DOI 10.1016/j.virusres.2016.05.015
NR 32
TC 0
Z9 0
U1 36
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD FEB
PY 2020
VL 276
AR 113772
DI 10.1016/j.jviromet.2019.113772
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA KE7RX
UT WOS:000508749900002
PM 31712093
OA Bronze
DA 2020-04-03
ER

PT J
AU Persky, ME
   Jafarey, YS
   Christoff, SE
   Maddox, DD
   Stowell, SA
   Norton, TM
AF Persky, Meredith E.
   Jafarey, Yousuf S.
   Christoff, Sarah E.
   Maddox, Dewey D.
   Stowell, Stephanie A.
   Norton, Terry M.
TI Tick paralysis in a free-ranging bobcat (Lynx rufus)
SO JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
LA English
DT Article
AB CASE DESCRIPTION
   A free-ranging male bobcat (Lynx rufus) was evaluated because of signs of pelvic limb paralysis.
   CLINICAL FINDINGS
   Physical examination of the anesthetized animal revealed tick infestation, normal mentation, and a lack of evidence of traumatic injuries. Radiography revealed no clinically relevant abnormalities. Hematologic analysis results were generally unremarkable, and serologic tests for exposure to feline coronavirus, FeLV, FIV, and Toxoplasma gondii were negative. Results of PCR assays for flea- and common tick-borne organisms other than Bartonella clarridgeiae were negative.
   TREATMENT AND OUTCOME
   Ticks were manually removed, and the patient received supportive care and fipronil treatment. The bobcat made a full recovery within 72 hours after treatment for ticks, and a presumptive diagnosis of tick paralysis was made. Identified tick species included Dermacenter variabilis, Amblyomma americanum, and Ixodes scapularis.
   CLINICAL RELEVANCE
   To the authors' knowledge, tick paralysis has not previously been reported in felids outside Australia. This disease should be considered a differential diagnosis in felids, including exotic cats, with signs of neuromuscular disease of unknown etiopathogenesis.
C1 [Persky, Meredith E.; Jafarey, Yousuf S.; Christoff, Sarah E.; Maddox, Dewey D.] Jacksonville Zoo & Gardens, Dept Anim Hlth, 370 Zoo Pkwy, Jacksonville, FL 32218 USA.
   [Stowell, Stephanie A.; Norton, Terry M.] Georgia Sea Turtle Ctr, 214 Stable Rd, Jekyll Isl, GA 31527 USA.
   [Norton, Terry M.] Jekyll Isl Author, 100 James Rd, Jekyll Isl, GA 31527 USA.
RP Persky, ME (reprint author), Jacksonville Zoo & Gardens, Dept Anim Hlth, 370 Zoo Pkwy, Jacksonville, FL 32218 USA.
EM perskym@jacksonvillezoo.org
CR Atwell R., MERCK VET MANUAL OVE
   Beyer AB, 1997, J WILDLIFE DIS, V33, P900, DOI 10.7589/0090-3558-33.4.900
   BOTZLER RG, 1980, J WILDLIFE DIS, V16, P223, DOI 10.7589/0090-3558-16.2.223
   Bowman DD, 2003, GEORGIS PARASITOLOGY, P1
   Chomel BB, 2010, J APPL MICROBIOL, V109, P743, DOI 10.1111/j.1365-2672.2010.04679.x
   JESSUP DA, 1979, J WILDLIFE DIS, V15, P271, DOI 10.7589/0090-3558-15.2.271
   Konjevic D, 2007, J ZOO WILDLIFE MED, V38, P585, DOI 10.1638/2007-0022R.1
   Luttrell MP, 1996, J WILDLIFE DIS, V32, P133, DOI 10.7589/0090-3558-32.1.133
   Nagamori Y., 2015, Today's Veterinary Practice, V5, P69
   Schull DN, 2007, J FELINE MED SURG, V9, P487, DOI 10.1016/j.jfms.2007.06.006
   Shaw SE, 2003, P WORLD SMALL AN VET, P118
NR 11
TC 0
Z9 0
U1 4
U2 4
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0003-1488
EI 1943-569X
J9 JAVMA-J AM VET MED A
JI JAVMA-J. Am. Vet. Med. Assoc.
PD FEB 1
PY 2020
VL 256
IS 3
BP 362
EP 364
PG 3
WC Veterinary Sciences
SC Veterinary Sciences
GA KG2OE
UT WOS:000509781400015
PM 31961273
DA 2020-04-03
ER

PT J
AU Porcheddu, R
   Serra, C
   Kelvin, D
   Kelvin, N
   Rubino, S
AF Porcheddu, Rossella
   Serra, Caterina
   Kelvin, David
   Kelvin, Nikki
   Rubino, Salvatore
TI Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy
   and China
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Novel coronavirus COVID-19; outbreak; Italy; Case Fatality Rates
   SARS-CoV-19
AB As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.
C1 [Porcheddu, Rossella] JIDC Italy, Sassari, Italy.
   [Serra, Caterina; Rubino, Salvatore] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy.
   [Kelvin, David] JIDC Canada, Toronto, ON, Canada.
   [Kelvin, David] Dalhousie Univ, Canadian Ctr Vaccinol, Dept Microbiol & Immunol, Halifax, NS, Peoples R China.
   [Kelvin, David] Int Inst Infect & Immun, Shantou, Peoples R China.
   [Kelvin, Nikki] Dalhousie Univ, Dept Microbiol & Immunol, JIDC Canada, Halifax, NS, Canada.
RP Kelvin, D (reprint author), Dalhousie Univ, Fac Med, Dept Microbiol & Immunol, Halifax, NS, Canada.
EM dkelvin@jidc.org
FU Li-Ka Shing Foundation, Shantou University Medical College; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR); Rapid Response award for COVID-1
FX We are grateful to Emanuela Sias, Gabriele Carenti, and Esmeralda Ughi
   for their valuable assistance. This work was supported by the Li-Ka
   Shing Foundation, Shantou University Medical College and a Rapid
   Response award for COVID-19, Canadian Institutes of Health Research (DJK
   and SR). DJK holds the Canada Research Chair in Translational
   Vaccinology and Inflammation.
CR [Anonymous], 2020, DAILY HERALD
   En24, 2020, CORONAVIRUS 1 INFECT
   Istituto Nazionale per le Malattie Infettive, 2020, MED B
   Istituto Nazionale per le Malattie Infettive, 2020, MED B
   Istituto Nazionale per le Malattie Infettive, 2020, MED B
   Italian Ministry of Health, 2020, COVID 19 CURR SIT IT
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   World Health Organization (WHO), 2020, NAM COR DIS COV 2019
   World Health Organization (WHO), 2020, CORN DIS 2019 COVID
NR 9
TC 0
Z9 0
U1 3
U2 3
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD FEB
PY 2020
VL 14
IS 2
BP 125
EP 128
DI 10.3855/jidc.12600
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KU2PN
UT WOS:000519550500002
PM 32146445
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Raibhandari, B
   Phuyal, N
   Shrestha, B
   Thapa, M
AF Raibhandari, Bibek
   Phuyal, Naveen
   Shrestha, Bikal
   Thapa, Moon
TI Air Medical Evacuation of Nepalese Citizen During Epidemic of COVID-19
   from Wuhan to Nepal
SO JOURNAL OF NEPAL MEDICAL ASSOCIATION
LA English
DT Article
DE Novel Corona virus; evacuation; Wuhan; Nepal
AB In December 2019, the world was disrupted by the news of a new strain of virus known as Novel Corona virus, taking lives of many in China. Wuhan, the capital of Central China's Hubei province is said to be the place where the outbreak started. The city went on lockdown as the disease spread rapidly. After the lockdown, most countries like India and Bangladesh airlifted their citizens who were studying in Wuhan. Similarly, Nepal also has many youth studying medicine in Wuhan. Pleas for help from the students reached the government. This was the first encounter of such experience for Nepal government. With the help of Ministry of Health, Ministry of foreign affair, Health Emergency Organizing committee, Epidemiology and Disease Control Division, Nepal Army Hospital, Nepal Police Hospital, Waste Management team, Nepal Ambulance service, Tribhuwan international Airport Authorities and Royal Airlines the government of Nepal planned, organized and successfully brought back all the 175 students on 15 th February 2019 from Wuhan, China. The present article aims to share the experience, the challenges faced and recommendations for future similar cases.
C1 [Raibhandari, Bibek] Nepal Police Hosp, Kathmandu, Nepal.
   [Phuyal, Naveen; Shrestha, Bikal; Thapa, Moon] Nepalese Army Inst Hlth Sci, Kathmandu, Nepal.
RP Raibhandari, B (reprint author), Nepal Police Hosp, Dept Emergency & Gen Practice, Kathmandu, Nepal.
EM brbhandari@nepalpolice.gov.np
CR Aerospace Medical Association Task Force, 2004, AVIAT SPACE ENV MED, V75, P85
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Gibbs Shawn G, 2019, Air Med J, V38, P359, DOI 10.1016/j.amj.2019.06.006
   Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777
   Klaus J, 2016, BUNDESGESUNDHEITSBLA, V59, P1544, DOI 10.1007/s00103-016-2460-2
   Vogt TM, 2006, J TRAVEL MED, V13, P268, DOI 10.1111/j.1708-8305.2006.00048.x
   WISE Airbus SAS, 2020, WUH COR VIR MIDDL E
NR 7
TC 0
Z9 0
U1 5
U2 5
PU NEPAL MEDICAL ASSOC
PI KATHMANDU
PA NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU,
   00000, NEPAL
SN 0028-2715
EI 1815-672X
J9 J NEPAL MED ASSOC
JI J. Nepal Med. Assoc.
PD FEB
PY 2020
VL 58
IS 222
BP 125
EP +
DI 10.31729/jnma.4857
PG 9
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA KT7KY
UT WOS:000519193500014
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Roosa, K
   Lee, Y
   Luo, R
   Kirpich, A
   Rothenberg, R
   Hyman, JM
   Yan, P
   Chowell, G
AF Roosa, Kimberlyn
   Lee, Yiseul
   Luo, Ruiyan
   Kirpich, Alexander
   Rothenberg, Richard
   Hyman, James M.
   Yan, Ping
   Chowell, Gerardo
TI Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang,
   China: February 13-23, 2020
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE COVID-19; coronavirus; China; real-time forecasts; phenomenological
   models; sub-epidemic model
ID MODEL
AB The ongoing COVID-19 epidemic continues to spread within and outside of China, despite several social distancing measures implemented by the Chinese government. Limited epidemiological data are available, and recent changes in case definition and reporting further complicate our understanding of the impact of the epidemic, particularly in the epidemic's epicenter. Here we use previously validated phenomenological models to generate short-term forecasts of cumulative reported cases in Guangdong and Zhejiang, China. Using daily reported cumulative case data up until 13 February 2020 from the National Health Commission of China, we report 5- and 10-day ahead forecasts of cumulative case reports. Specifically, we generate forecasts using a generalized logistic growth model, the Richards growth model, and a sub-epidemic wave model, which have each been previously used to forecast outbreaks due to different infectious diseases. Forecasts from each of the models suggest the outbreaks may be nearing extinction in both Guangdong and Zhejiang; however, the sub-epidemic model predictions also include the potential for further sustained transmission, particularly in Zhejiang. Our 10-day forecasts across the three models predict an additional 65-81 cases (upper bounds: 169-507) in Guangdong and an additional 44-354 (upper bounds: 141-875) cases in Zhejiang by February 23, 2020. In the best-case scenario, current data suggest that transmission in both provinces is slowing down.
C1 [Roosa, Kimberlyn; Lee, Yiseul; Luo, Ruiyan; Kirpich, Alexander; Rothenberg, Richard; Chowell, Gerardo] Georgia State Univ, Dept Populat Hlth Sci, Sch Publ Hlth, Atlanta, GA 30302 USA.
   [Hyman, James M.] Tulane Univ, Dept Math, Ctr Computat Sci, New Orleans, LA 70118 USA.
   [Yan, Ping] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON K1A 0K9, Canada.
RP Roosa, K (reprint author), Georgia State Univ, Dept Populat Hlth Sci, Sch Publ Hlth, Atlanta, GA 30302 USA.
EM kroosa1@student.gsu.edu; ylee97@gsu.edu; rluo@gsu.edu; akirpich@gsu.edu;
   rrothenberg@gsu.edu; mhyman@tulane.edu; ping.yan@canada.ca;
   gchowell@gsu.edu
FU NSFNational Science Foundation (NSF) [1610429, 1633381]
FX G.C. is supported by NSF grants 1610429 and 1633381.
CR [Anonymous], REP CAS 2019 NCOV
   Chowell G, 2019, Epidemics, V30, P100379, DOI 10.1016/j.epidem.2019.100379
   Chowell G., 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Chowell G, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1406-6
   Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Ganyani T, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268818002819, 10.1017/s0950268818002819]
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Mizumoto K., 2020, EARLY EPIDEMIOLOGICA, DOI [10.1101/2020.02.12.20022434, DOI 10.1101/2020.02.12.20022434]
   Pell B, 2018, EPIDEMICS-NETH, V22, P62, DOI 10.1016/j.epidem.2016.11.002
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Roosa K, 2020, Infect Dis Model, V5, P256, DOI 10.1016/j.idm.2020.02.002
   Roosa K., 2020, ROYAL SOC INTE UNPUB
   Roosa K, 2019, MATH BIOSCI ENG, V16, P4299, DOI 10.3934/mbe.2019214
   Roosa K, 2019, THEOR BIOL MED MODEL, V16, DOI 10.1186/s12976-018-0097-6
   Sanche S., 2020, POPUL EVOL, DOI [10.1101/2020.02.07.20021154, DOI 10.1101/2020.02.07.20021154]
   Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002
   Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024
   World Health Organization, NOV COR 2019 NCOV SI
NR 19
TC 0
Z9 0
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2020
VL 9
IS 2
AR 596
DI 10.3390/jcm9020596
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA KT2DG
UT WOS:000518823000308
PM 32098289
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Sardar, T
   Ghosh, I
   Rodo, X
   Chattopadhyay, J
AF Sardar, Tridip
   Ghosh, Indrajit
   Rodo, Xavier
   Chattopadhyay, Joydev
TI A realistic two-strain model for MERS-CoV infection uncovers the high
   risk for epidemic propagation
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RESPIRATORY SYNDROME CORONAVIRUS; MULTIPLE GENERATIONS; TRANSMISSION;
   OUTBREAKS; SPREAD
AB Author summary
   There is currently no way to anticipate MERS-CoV epidemic outbreaks and strategies for disease prediction and containment are largely undermined by the limited knowledge of its epidemiological cycle. Not an effective treatment nor a vaccine for MERS-CoV exist to date. Instead, using three two-strain mathematical models that incorporate human social behavior as different disease incidence functions (e.g. bilinear, non-monotone and saturated), the best model combinations successfully anticipate the occurrence of the peak week in the season and the incidence at the peak. Our results confirm there are currently 2 strains co-circulating in the most populated regions in Saudi Arabia and highlight the high risk for large epidemic outbreaks, while the role of super-spreaders appears irrelevant for disease spread.
   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe acute respiratory illness with a case fatality rate (CFR) of 35,5%. The highest number of MERS-CoV cases are from Saudi-Arabia, the major worldwide hotspot for this disease. In the absence of neither effective treatment nor a ready-to-use vaccine and with yet an incomplete understanding of its epidemiological cycle, prevention and containment measures can be derived from mathematical models of disease epidemiology. We constructed 2-strain models to predict past outbreaks in the interval 2012-2016 and derive key epidemiological information for Macca, Madina and Riyadh. We approached variability in infection through three different disease incidence functions capturing social behavior in response to an epidemic (e.g. Bilinear, BL; Non-monotone, NM; and Saturated, SAT models). The best model combination successfully anticipated the total number of MERS-CoV clinical cases for the 2015-2016 season and accurately predicted both the number of cases at the peak of seasonal incidence and the overall shape of the epidemic cycle. The evolution in the basic reproduction number (R-0) warns that MERS-CoV may easily take an epidemic form. The best model correctly captures this feature, indicating a high epidemic risk (1 <= R-0 <= 2,5) in Riyadh and Macca and confirming the alleged co-circulation of more than one strain. Accurate predictions of the future MERS-CoV peak week, as well as the number of cases at the peak are now possible. These results indicate public health agencies should be aware that measures for strict containment are urgently needed before new epidemics take off in the region.
C1 [Sardar, Tridip] Dinabandhu Andrews Coll, Dept Math, Kolkata, India.
   [Ghosh, Indrajit; Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, India.
   [Rodo, Xavier] Barcelona Inst Global Hlth, ISGlobal, ICREA, Barcelona, Spain.
   [Rodo, Xavier] Barcelona Inst Global Hlth, ISGlobal, CLIMA Climate & Hlth Program, Barcelona, Spain.
RP Rodo, X (reprint author), Barcelona Inst Global Hlth, ISGlobal, ICREA, Barcelona, Spain.; Rodo, X (reprint author), Barcelona Inst Global Hlth, ISGlobal, CLIMA Climate & Hlth Program, Barcelona, Spain.
EM xavier.rodo@isglobal.org
RI ; Rodo, Xavier/F-7663-2017
OI Ghosh, Indrajit/0000-0002-0492-2948; Rodo, Xavier/0000-0003-4843-6180
FU University Grants Commission, Government of IndiaUniversity Grants
   Commission, India; PERIS PICAT project from the Catalan Ministry of
   Health [SLT002/16/00466]
FX I.G. was supported by the research fellowship from University Grants
   Commission (https://www.ugc.ac.in/), Government of India. X. R.
   acknowledges the support of a fellowship by the PERIS PICAT project
   SLT002/16/00466 (peris@gencat.cat vertical bar
   http://canalsalut.gencat.cat) from the Catalan Ministry of Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   [Anonymous], 2016, LIFE EXPECTANCY
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5
   Biggerstaff M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1669-x
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Chan RWY, 2014, LANCET RESP MED, V2, P813, DOI 10.1016/S2213-2600(14)70158-4
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011
   Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0
   Hemida MG, 2015, EMERG INFECT DIS, V21, P699, DOI 10.3201/eid2104.141949
   Hsieh YH, 2015, PEERJ, V3, DOI 10.7717/peerj.1505
   Johnson LR, 2018, ANN APPL STAT, V12, P27, DOI 10.1214/17-AOAS1090
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Lee SS, 2015, INT J INFECT DIS, V38, P65, DOI 10.1016/j.ijid.2015.07.014
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012
   Ministry of Health (Saudi Arabia), 2017, MIDDL E RESP SYNDR C
   Mukandavire Z, 2011, P NATL ACAD SCI USA, V108, P8767, DOI 10.1073/pnas.1019712108
   Muth D, 2015, J CLIN MICROBIOL, V53, P2951, DOI 10.1128/JCM.01368-15
   Myers MF, 2000, ADV PARASIT, V47, P309, DOI 10.1016/S0065-308X(00)47013-2
   Nishiura H, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.27.21181
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5
   Poletto C, 2016, EPIDEMICS-NETH, V15, P1, DOI 10.1016/j.epidem.2015.12.001
   Ray EL, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005910
   Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608
   Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Wang WD, 2006, MATH BIOSCI ENG, V3, P267
   Waters EK, 2015, B AUST MATH SOC, V92, P522, DOI 10.1017/S0004972715000684
   World Health Organization (WHO), 2017, WHO MERS COV GLOB SU
   World Health Organization (WHO), 2018, MERS COV SIT
   World Health Organization (WHO), 2018, DIS OUTBR NEWS MERS
   World Health Organization (WHO), 2017, E RESP SYNDR COR MER
   Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025
   Yamana TK, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0410
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
   2015, CORSALUD, V6
   2016, CANC DISCOV, V6
NR 46
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0008065
DI 10.1371/journal.pntd.0008065
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700020
PM 32059047
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Sayed, ASM
   Malek, SS
   Abushahba, MFN
AF Sayed, Amal S. M.
   Malek, Safaa S.
   Abushahba, Mostafa F. N.
TI Seroprevalence of Middle East Respiratory Syndrome Corona Virus in
   dromedaries and their traders in upper Egypt
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Dromedary camels; MERS-CoV; ELISA; zoonosis
ID MERS-COV INFECTION; SAUDI-ARABIA; SLAUGHTERHOUSE WORKERS; HIGH
   PREVALENCE; CAMELS; ANTIBODIES; TRANSMISSION; RISK; CORONAVIRUSES;
   AFRICA
AB Introduction: Camel trade in Egypt depends mainly on importation. Seemingly healthy imported camels are responsible for the ingress of serious diseases into Egypt. A striking example of this concerning public health globally is the Middle East respiratory coronavirus (MERS-CoV) which causes case fatalities of over 34%. Here, we detennined the seroepidemiological situation of the MERS-CoV in imported camels and their traders in Upper Egypt.
   Methodology: Sera of sixty-three dromedaries and twenty-eight camel traders were recruited (January 2015-December 2016). The age, gender, and sampling locality of each sampled camel and human were obtained. Semi-quantitative anti-MERS-CoV IgG ELISAs which utilize the purified spike protein domain Si antigen of MERS coronavirus (MERS-CoV S1) were used to detect specific IgG antibodies against the virus.
   Results: The data showed that 58.73% of imported camels and 25% of traders had antibodies specific to MERS-CoV. Interestingly, like seroreactive camels, all seropositive humans were apparently healthy without any history of developing severe respiratory disease in the 14 days prior to sampling. Having specific antibodies among the examined camel sera was significantly different (P < 0.0001) in relation to various sampling localities, gender and age groups. In contrast, the seropositivity rate of MERS-CoV IgG in humans did not differ significantly by any of the studied factors.
   Conclusions: The current study provides the first serological evidence of occupational exposure of humans to MERS-CoV in Africa. Additionally, it reports that imported camels could be implicated in introducing MERS-CoV into Egypt. Accordingly, application of strict control measures to camel importation is a priority.
C1 [Sayed, Amal S. M.; Abushahba, Mostafa F. N.] Assiut Univ, Fac Vet Med, Dept Zoonoses, Asyut 71526, Egypt.
   [Malek, Safaa S.] Assiut Univ, Fac Vet Med, Dept Anim Med, Asyut, Egypt.
RP Abushahba, MFN (reprint author), Assiut Univ, Fac Vet Med, Dept Zoonoses, Asyut 71526, Egypt.
EM mateya@aun.edu.eg
CR Aburizaiza AS, 2014, J INFECT DIS, V209, P243, DOI 10.1093/infdis/jit589
   Al Hammadi ZM, 2015, EMERG INFECT DIS, V21, P2197, DOI 10.3201/eid2112.151132
   Alagaili AN, 2014, MBIO, V5, DOI 10.1128/mBio.00884-14
   Alghamdi IG, 2014, INT J GEN MED, V7, P417, DOI 10.2147/IJGM.S67061
   Ali M, 2017, EUROSURVEILLANCE, V22, P19, DOI 10.2807/1560-7917.ES.2017.22.11.30487
   Ali MA, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.130
   Alshukairi AN, 2018, MBIO, V9, DOI [10.1128/mBio.01985-18, 10.1128/mbio.01985-18]
   Amer H, 2018, INT J INFECT DIS, V71, P113, DOI 10.1016/j.ijid.2018.04.001
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232
   Chu DK, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES.2015.20.49.30086
   Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115
   Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299
   Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/eLife.31257, 10.7554/elife.37324]
   (EAPSG) EAPSG, 2013, PLOS CURR, V5
   Elfadil AAM, 2018, REV SCI TECH OIE, V37, P985, DOI 10.20506/rst.37.3.2901
   Falzarano D, 2017, ONE HEALTH, V3, P41, DOI 10.1016/j.onehlt.2017.03.003
   Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, DOI 10.3402/iee.v5.28305
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Gutierrez C, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.37.30019
   Hemida MG, 2015, EMERG INFECT DIS, V21, P699, DOI 10.3201/eid2104.141949
   KANDEIL A, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11080717
   Kasem S, 2018, J INFECT PUBLIC HEAL, V11, P884, DOI 10.1016/j.jiph.2018.01.004
   Kasem S, 2018, J INFECT PUBLIC HEAL, V11, P331, DOI [10.1016/j.jiph.2017.00.022, 10.1016/j.jiph.2017.09.022]
   Khudhair A, 2019, EMERG INFECT DIS, V25, P927, DOI 10.3201/eid2505.181728
   Ko JH, 2017, EUR J CLIN MICROBIOL, V36, P2179, DOI 10.1007/s10096-017-3043-3
   Memish ZA, 2015, INFLUENZA OTHER RESP, V9, P64, DOI 10.1111/irv.12287
   Memish ZA, 2014, PEDIATR INFECT DIS J, V33, P904, DOI 10.1097/INF.0000000000000325
   Memish ZA, 2014, INT J INFECT DIS, V23, P63, DOI 10.1016/j.ijid.2014.03.1372
   Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026
   Munyua P, 2017, AM J TROP MED HYG, V96, P1318, DOI 10.4269/ajtmh.16-0880
   Nowotny N, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.16.20781
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Ommeh S, 2018, VIROL SIN, V33, P484, DOI 10.1007/s12250-018-0076-4
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574
   Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663
   Reusken CBEM, 2015, EMERG INFECT DIS, V21, P1422, DOI 10.3201/eid2108.150481
   So RT, 2018, EUROSURVEILLANCE, V23
   van Doremalen N, 2017, VECTOR-BORNE ZOONOT, V17, P155, DOI 10.1089/vbz.2016.2062
   Wernery U, 2017, VET J, V220, P75, DOI 10.1016/j.tvjl.2016.12.020
   World Health Organization, 2019, MIDDL E RESP SYNDR C
NR 49
TC 0
Z9 0
U1 0
U2 0
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD FEB
PY 2020
VL 14
IS 2
BP 191
EP 198
DI 10.3855/jidc.10862
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA KU2PN
UT WOS:000519550500011
PM 32146454
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Shin, YS
   Jarhad, DB
   Jang, MH
   Kovacikova, K
   Kim, G
   Yoon, JS
   Kim, HR
   Hyun, YE
   Tipnis, AS
   Chang, TS
   van Hemert, MJ
   Jeong, LS
AF Shin, Young Sup
   Jarhad, Dnyandev B.
   Jang, Min Hwan
   Kovacikova, Kristina
   Kim, Gyudong
   Yoon, Ji-seong
   Kim, Hong-Rae
   Hyun, Young Eum
   Tipnis, Amol S.
   Chang, Tong-Shin
   van Hemert, Martijn J.
   Jeong, Lak Shin
TI Identification of 6 '-beta-fluoro-homoaristeromycin as a potent
   inhibitor of chikungunya virus replication
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE 6 '-fluorohomoaristeromycin; Anti-RNA virus; Chikungunya;
   S-adenosylhomocysteine hydrolase; Electrophilic fluorination
ID S-ADENOSYLHOMOCYSTEINE HYDROLASE; L-HOMOCYSTEINE HYDROLASE; CARBOCYCLIC
   ANALOG; NEPLANOCIN; ADENOSINE; (-)-ARISTEROMYCIN; INFECTION
AB We have reported on aristeromycin (1) and 6'-fluorinated-aristeromycin analogues (2), which are active against RNA viruses such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), and Chikungunya virus (CHIKV). However, these exhibit substantial cytotoxicity. As this cytotoxicity may be attributed to 5'-phosphorylation, we designed and synthesized one-carbon homologated 6'-fluorinated-aristeromycin analogues. This modification prevents 5'-phosphorlyation by cellular kinases, whereas the inhibitory activity towards S-adenosyk-homocysteine (SAH) hydrolase will be retained. The enantiomerically pure 6'-fluorinated-5'-homoaristeromycin analogues 3a-e were synthesized via the electrophilic fluorination of the silyl enol ether with Selectfluor, using a base-build up approach as the key steps. All synthesized compounds exhibited potent inhibitory activity towards SAH hydrolase, among which 6'-beta-fluoroadenosine analogue 3a was the most potent (IC50 = 0.36 mu M). Among the compounds tested, 6'-beta-fluoro-homoaristeromycin 3a showed potent antiviral activity (EC50 = 0.12 mu M) against the CHIKV, without noticeable cytotoxicity up to 250 mu M. Only 3a displayed anti-CHIKV activity, whereas both3a and 3b inhibited SAH hydrolase with similar IC50 values (0.36 and 0.37 mu M, respectively), which suggested that 3a's antiviral activity did not merely depend on the inhibition of SAH hydrolase. This is further supported by the fact that the antiviral effect was specific for CHIKV and some other alphaviruses and none of the homologated analogues inhibited other RNA viruses, such as SARS-CoV, MERS-CoV, and ZIKV. The potent inhibition and high selectivity index make 6'-beta-fluoro-homoaristeromycin (3a) a promising new template for the development of antivirals against CHIKV, a serious re-emerging pathogen that has infected millions of people over the past 15 years. (C) 2019 Elsevier Masson SAS. All rights reserved.
C1 [Shin, Young Sup; Jarhad, Dnyandev B.; Jang, Min Hwan; Kim, Gyudong; Yoon, Ji-seong; Kim, Hong-Rae; Hyun, Young Eum; Tipnis, Amol S.; Chang, Tong-Shin; Jeong, Lak Shin] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.
   [Kovacikova, Kristina; van Hemert, Martijn J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Albinusdreef 2, NL-2333ZA Leiden, Netherlands.
RP Jeong, LS (reprint author), Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.
EM lakjeong@snu.ac.kr
FU National Research Foundation (NRF), Korea [NRF-2016R1A2B3010164]
FX This work was supported by a grant from the Mid-career Research program
   (NRF-2016R1A2B3010164) of National Research Foundation (NRF), Korea.
CR Agumadu VC, 2018, CUREUS, V10, DOI 10.7759/cureus.3025
   ARITA M, 1983, J AM CHEM SOC, V105, P4049, DOI 10.1021/ja00350a050
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   BENNETT LL, 1986, MOL PHARMACOL, V29, P383
   BENNETT LL, 1986, BIOCHEM PHARMACOL, V35, P4106, DOI 10.1016/0006-2952(86)90036-5
   Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292
   Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Cantoni G. L., 1986, BIOL METHYLATION DRU, P227
   Chambers TJ., 2003, FLAVIVIRUSES DETECTI, P3
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   Jarhad DB, 2019, ORG CHEM FRONT, V6, P959, DOI 10.1039/c9qo00099b
   Kim G, 2017, ORG LETT, V19, P5732, DOI 10.1021/acs.orglett.7b02470
   KUSAKA T, 1968, J ANTIBIOT, V21, P255, DOI 10.7164/antibiotics.21.255
   MADHAVAN GVB, 1986, J ORG CHEM, V51, P1287, DOI 10.1021/jo00358a023
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Payne S., 2018, INTRO RNA VIRUSES, P97
   SHEALY YF, 1980, CHEM PHARM BULL, V28, P3114
   SHEALY YF, 1969, J AM CHEM SOC, V91, P3075, DOI 10.1021/ja01039a042
   SHEALY YF, 1966, J AM CHEM SOC, V88, P3885, DOI 10.1021/ja00968a055
   SNOECK R, 1993, ANTIVIR RES, V21, P197, DOI 10.1016/0166-3542(93)90028-H
   Thiel V., 2007, CORONAVIRUSES MOL CE
   TSENG CKH, 1989, J MED CHEM, V32, P1442, DOI 10.1021/jm00127a007
   Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101
   WOLFE MS, 1992, J MED CHEM, V35, P1782, DOI 10.1021/jm00088a013
   WOLFE MS, 1991, J MED CHEM, V34, P1521, DOI 10.1021/jm00109a001
   Yang MM, 2005, BIOORG MED CHEM LETT, V15, P149, DOI 10.1016/j.bmcl.2004.10.019
   Yang MM, 2004, J ORG CHEM, V69, P3993, DOI 10.1021/jo040119g
   Yoon JS, 2019, J MED CHEM, V62, P6346, DOI 10.1021/acs.jmedchem.9b00781
   YOSHIKAWA M, 1990, TETRAHEDRON, V46, P7459, DOI 10.1016/S0040-4020(01)89060-8
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 31
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 1
PY 2020
VL 187
AR UNSP 111956
DI 10.1016/j.ejmech.2019.111956
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KH3CV
UT WOS:000510525000031
PM 31841728
OA Bronze
DA 2020-04-03
ER

PT J
AU Stoian, A
   Rowland, RRR
   Petrovan, V
   Sheahan, M
   Samuel, MS
   Whitworth, KM
   Wells, KD
   Zhang, JQ
   Beaton, B
   Cigan, M
   Prather, RS
AF Stoian, Ana
   Rowland, Raymond R. R.
   Petrovan, Vlad
   Sheahan, Maureen
   Samuel, Melissa S.
   Whitworth, Kristin M.
   Wells, Kevin D.
   Zhang, Jianqiang
   Beaton, Benjamin
   Cigan, Mark
   Prather, Randall S.
TI The use of cells from ANPEP knockout pigs to evaluate the role of
   aminopeptidase N (APN) as a receptor for porcine deltacoronavirus
   (PDCoV)
SO VIROLOGY
LA English
DT Article
DE Aminopeptidase N; Porcine deltacoronavirus; APN; CRISPR; ANPEP; CD13
ID EPIDEMIC-DIARRHEA-VIRUS; FUNCTIONAL RECEPTOR; MAJOR RECEPTOR;
   DETERMINANTS; PATHOGENESIS; INFECTION; ISOLATE; DOMAIN
AB The coronaviruses, porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), and porcine deltacoronavirus (PDCoV) represent important sources of neonatal diarrhea on pig farms. The requirement for aminopeptidase N (APN) as a receptor for TGEV, but not for PEDV, is well established. In this study, the biological relevance of APN as a receptor for PDCoV was tested by using CRISPR/Cas9 to knockout the APN gene, ANPEP, in pigs. Porcine alveolar macrophages (PAMs) from ANPEP knockout (KO) pigs showed resistance to PDCoV infection. However, lung fibroblast-like cells, derived from the ANPEP KO PAM cultures, supported PDCoV infection to high levels. The results suggest that APN is a receptor for PDCoV in PAMs but is not necessary for infection of lung-derived fibroblast cells. The infection of the ANPEP KO pigs with PDCoV further confirmed that APN is dispensable as a receptor for PDCoV.
C1 [Samuel, Melissa S.; Whitworth, Kristin M.; Wells, Kevin D.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
   [Stoian, Ana; Rowland, Raymond R. R.; Petrovan, Vlad; Sheahan, Maureen] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Beaton, Benjamin; Cigan, Mark] Genus Plc, De Forest, WI USA.
   [Zhang, Jianqiang] Iowa State Univ, Vet Diagnost & Prod Anim Med, Ames, IA USA.
RP Prather, RS (reprint author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
EM PratherR@missouri.edu
FU Genus plc and Food for the 21st Century at the University of Missouri
FX The work was supported by Genus plc and Food for the 21st Century at the
   University of Missouri. The authors acknowledge many people, including
   undergraduate students who made many of the experiments possible.
CR Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024
   DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994
   DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0
   DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991
   GODET M, 1994, J VIROL, V68, P8008, DOI 10.1128/JVI.68.12.8008-8016.1994
   Jung K, 2015, VET MICROBIOL, V178, P31, DOI 10.1016/j.vetmic.2015.04.022
   Khatri M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0220-0
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saif LJ, 2012, DIS SWINE, P501
   Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675
   Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266
   Vitosh-Sillman S, 2016, J VET DIAGN INVEST, V28, P486, DOI 10.1177/1040638716654200
   Wang B, 2018, J VIROL, V92, DOI [10.1128/JVI.00318-18, 10.1128/jvi.00318-18]
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wells KD, 2017, J VIROL, V91, DOI [10.1128/JVI.01521-16, 10.1128/jvi.01521-16]
   Whitworth KM, 2019, TRANSGENIC RES, V28, P21, DOI 10.1007/s11248-018-0100-3
   Whitworth KM, 2017, TRANSGENIC RES, V26, P97, DOI 10.1007/s11248-016-9989-6
   Zhu XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0068-3
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2020
VL 541
BP 136
EP 140
DI 10.1016/j.virol.2019.12.007
PG 5
WC Virology
SC Virology
GA KM5ZX
UT WOS:000514219400013
PM 32056711
OA Other Gold
DA 2020-04-03
ER

PT J
AU Stranieri, A
   Probo, M
   Pisu, MC
   Fioletti, A
   Meazzi, S
   Gelain, ME
   Bonsembiante, F
   Lauzi, S
   Paltrinieri, S
AF Stranieri, Angelica
   Probo, Monica
   Pisu, Maria C.
   Fioletti, Alberto
   Meazzi, Sara
   Gelain, Maria E.
   Bonsembiante, Federico
   Lauzi, Stefania
   Paltrinieri, Saverio
TI Preliminary investigation on feline coronavirus presence in the
   reproductive tract of the tom cat as a potential route of viral
   transmission
SO JOURNAL OF FELINE MEDICINE AND SURGERY
LA English
DT Article
DE Feline coronavirus; feline infectious peritonitis; tom cat reproduction;
   cattery management; PCR; prevention
ID POLYMERASE-CHAIN-REACTION; INFECTIOUS-PERITONITIS; VIRUS; DIAGNOSIS;
   ORCHITIS; SAMPLES; UPDATE; LOADS; SEMEN; RNA
AB Objectives Feline infectious peritonitis (FIP) is an immune-mediated disease initiated by feline coronavirus (FCoV) infection. To date, the only proven route of transmission is the faecal-oral route, but a possible localisation of FCoV in the reproductive tract of tom cats is of concern, owing to the involvement of the male reproductive tract during FIP and to the presence of reproduction disorders in FCoV-endemic feline catteries. The aim of the study was to investigate the presence and localisation of FCoV in semen and/or in the reproductive tract of tom cats, and its possible association with seroconversion and viraemic phase. Methods Blood, serum, semen and/or testicle samples were obtained from 46 tom cats. Serology was performed on 38 serum samples, nested reverse transcriptase PCR (nRT-PCR) and reverse transcriptase quantitative PCR (RT-qPCR) were performed on 39 blood samples and on 17 semen samples, and histology, immunohistochemistry and nRT-PCR were performed on 39 testicles. Results Twenty-four of 38 serum samples were positive on serology. Semen samples were negative on RT-PCR and RT-qPCR for FCoV, while all blood samples were negative at both molecular methods, except for one sample positive at RT-qPCR with a very low viral load. All testicles were negative at immunohistochemistry, while six were positive at nRT-PCR for FCoV. Serology and blood PCR results suggest that the virus was present in the environment, stimulating transient seroconversion. FCoV seems not to localise in the semen of tom cats, making the venereal route as a way of transmission unlikely. Although viral RNA was found in some testicles, it could not be correlated with the viraemic phase. Conclusions and relevance In the light of these preliminary results, artificial insemination appears safer than natural mating as it eliminates the direct contact between animals, thus diminishing the probability of faecal-oral FCoV transmission.
C1 [Stranieri, Angelica; Probo, Monica; Fioletti, Alberto; Meazzi, Sara; Lauzi, Stefania; Paltrinieri, Saverio] Univ Milan, Dept Vet Med, Via Celoria 10, I-20133 Milan, Italy.
   [Stranieri, Angelica; Meazzi, Sara; Lauzi, Stefania; Paltrinieri, Saverio] Univ Milan, Vet Teaching Hosp, Cent Lab, Via Univ 6, I-26900 Lodi, Italy.
   [Pisu, Maria C.] Vet Reference Ctr, Turin, Italy.
   [Gelain, Maria E.; Bonsembiante, Federico] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.
RP Stranieri, A (reprint author), Univ Milan, Dept Vet Med, Via Celoria 10, I-20133 Milan, Italy.; Stranieri, A (reprint author), Univ Milan, Vet Teaching Hosp, Cent Lab, Via Univ 6, I-26900 Lodi, Italy.
EM angelica.stranieri@unimi.it
RI ; Meazzi, Sara/V-3365-2017; Paltrinieri, Saverio/L-3174-2017
OI Bonsembiante, Federico/0000-0002-2879-7117; STRANIERI,
   ANGELICA/0000-0002-8529-572X; gelain, maria elena/0000-0002-8633-0988;
   Meazzi, Sara/0000-0002-8157-7973; Paltrinieri,
   Saverio/0000-0001-7117-7987
CR ADDIE D., 2012, INFECTIONS DIS DOG C, V4, P92
   Addie DD, 2004, J FELINE MED SURG, V6, P125, DOI 10.1016/j.jfms.2003.12.009
   ADDIE DD, 1992, VET REC, V130, P133, DOI 10.1136/vr.130.7.133
   Addie DD, 2000, VET J, V159, P8, DOI 10.1053/tvjl.1999.0429
   Addie DD, 2001, VET REC, V148, P649, DOI 10.1136/vr.148.21.649
   Andrew SE, 2000, VET CLIN N AM-SMALL, V30, P987, DOI 10.1016/S0195-5616(00)05002-6
   Das PJ, 2010, THERIOGENOLOGY, V74, P1099, DOI 10.1016/j.theriogenology.2010.04.023
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Doenges SJ, 2017, J FELINE MED SURG, V19, P344, DOI 10.1177/1098612X15625354
   Doenges SJ, 2016, J FELINE MED SURG, V18, P104, DOI 10.1177/1098612X15574757
   Foley JE, 1997, J AM VET MED ASSOC, V210, P1313
   Foster RA, 1996, CAN VET J, V37, P681
   Gunn-Moore DA, 1998, VET MICROBIOL, V62, P193, DOI 10.1016/S0378-1135(98)00210-7
   Gut M, 1999, J VIROL METHODS, V77, P37, DOI 10.1016/S0166-0934(98)00129-3
   HERREWEGH AAPM, 1995, J CLIN MICROBIOL, V33, P684, DOI 10.1128/JCM.33.3.684-689.1995
   Hoffmann B, 2013, VET MICROBIOL, V167, P289, DOI 10.1016/j.vetmic.2013.09.002
   Jordan HL, 1996, J VIROL, V70, P8224, DOI 10.1128/JVI.70.11.8224-8228.1996
   Kipar A, 1998, VET IMMUNOL IMMUNOP, V65, P243, DOI 10.1016/S0165-2427(98)00158-5
   Kipar A, 2006, J FELINE MED SURG, V8, P69, DOI 10.1016/j.jfms.2005.07.002
   Kipar A, 2010, J GEN VIROL, V91, P1698, DOI 10.1099/vir.0.020214-0
   Meli M, 2004, J FELINE MED SURG, V6, P69, DOI 10.1016/j.jfms.2003.08.007
   Meli ML, 2013, J FELINE MED SURG, V15, P295, DOI 10.1177/1098612X12467995
   OSTERHAUS ADME, 1977, ZBL VET MED B, V24, P835
   Paltrinieri S, 1998, VET IMMUNOL IMMUNOP, V65, P205, DOI 10.1016/S0165-2427(98)00155-X
   Pedersen NC, 2014, VET J, V201, P123, DOI 10.1016/j.tvjl.2014.04.017
   Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008
   Pelican KM, 2006, THERIOGENOLOGY, V66, P37, DOI 10.1016/j.theriogenology.2006.03.013
   Pisu MC, 2017, J FELINE MED SURG, V19, P1087, DOI 10.1177/1098612X16679589
   Porter E, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-49
   Rota A, 2008, J FELINE MED SURG, V10, P181, DOI 10.1016/j.jfms.2007.08.006
   Siguroardottir OG, 2001, J COMP PATHOL, V124, P219, DOI 10.1053/jcpa.2000.0443
   Tasker S, 2018, J FELINE MED SURG, V20, P228, DOI 10.1177/1098612X18758592
   Vanbinst T, 2010, J VIROL METHODS, V169, P162, DOI 10.1016/j.jviromet.2010.07.019
NR 33
TC 0
Z9 0
U1 3
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1098-612X
EI 1532-2750
J9 J FELINE MED SURG
JI J. Feline Med. Surg.
PD FEB
PY 2020
VL 22
IS 2
BP 178
EP 185
DI 10.1177/1098612X19837114
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA KG6DD
UT WOS:000510040100015
PM 30900940
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, X
   Zhang, XX
   He, JJ
AF Wang, Xu
   Zhang, Xiaoxi
   He, Jiangjiang
TI Challenges to the system of reserve medical supplies for public health
   emergencies: reflections on the outbreak of the severe acute respiratory
   syndrome coronavirus 2 (SARS-CoV-2) epidemic in China
SO BIOSCIENCE TRENDS
LA English
DT Article
DE public health emergency; SARS-CoV-2; COVID-19; medical supplies
AB On December 31, 2019, the Wuhan Municipal Health Commission announced an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), China is now at a critical period in the control of the epidemic. The Chinese Government has been taking a series of rapid, comprehensive, and effective prevention and control measures. As the pandemic has developed, a fact has become apparent: there is a serious dearth of emergency medical supplies, and especially an extreme shortage of personal protective equipment such as masks and medical protective clothing. This is one of the major factors affecting the progress of epidemic prevention and control. Although China has made great efforts to strengthen the ability to quickly respond to public health emergencies since the SARS outbreak in 2003 and it has clarified requirements for emergency supplies through legislation, the emergency reserve supplies program has not been effectively implemented. and there are also deficiencies in the types. quantity, and availability of emergency medical supplies. A sound system of emergency reserve supplies is crucial to the management of public health emergencies. Based on international experiences with pandemic control. the world should emphasize improving the system of emergency reserve medical supplies in the process of establishing and improving public health emergency response systems, and it should promote the establishment of international cooperative programs to jointly deal with public health emergencies of international concern in the future.
C1 [Wang, Xu; Zhang, Xiaoxi; He, Jiangjiang] Shanghai Med Informat Ctr, Shanghai Hlth Dev Res Ctr, Dept Hlth Policy Res, Shanghai, Peoples R China.
RP He, JJ (reprint author), Shanghai Med Informat Ctr, Shanghai Hlth Dev Res Ctr, 1477 Beijing W Rd, Shanghai 200040, Peoples R China.
EM hejiangjiang@shdrc.org
CR [Anonymous], GUANGMING DAILY
   [Anonymous], LEGALWEEKLY
   Esbitt Debraelee, 2003, Disaster Manag Response, V1, P68, DOI 10.1016/S1540-2487(03)00044-0
   Government of Canada, NAT EM STRAT STOCKP
   Jiang XC, 2013, JIANGSU HLTH CARE, V15, P36
   Ministry of Industry and Information Technology of People's Republic of China, 6 DEP REP STAT KEY M
   Ministry of Industry and Information Technology of People's Republic of China, 6 MEAS MIN IND INF T
   National Health Commission of the People's Republic of China, LAT INF PREV PNEUM C
   National Health Commission of the People's Republic of China, DRAFT CAT HLTH EM PE
   National Health Commission of the People's Republic of China, ISS GUID OP ENH STAN
   National Health Commission of the People's Republic of China, REG PREP RESP EM PUB
   National Health Commission of the People's Republic of China, GUID ACC CREAT DEV P
   Rebmann T, 2009, AM J INFECT CONTROL, V37, pE5, DOI 10.1016/j.ajic.2009.09.003
   State Council of the People's Republic of China, SECR GEN SHANGH COOP
   [孙梅 Sun Mei], 2014, [中国卫生政策研究, Chinese Journal of Health Policy], V7, P24
   The Central People's Government of the People's Republic of China, NAT CONT PLAN PUBL H
   The Central People's Government of the People's Republic of China, MAST STAT PLAN RAP R
   The Central People's Government of the People's Republic of China, 2004 REV LAW PEOPL R
   The Central People's Government of the People's Republic of China, LAW PEOPL REP CHIN E
   The Department of Health of Australian Government, NAT MED STOCKP
   The State Economic and Trade Commission, PROV NAT PHARM STOCK
   U.S. Department of Health & Human Services, STRAT NAT STOCKP
   Wang LZ, 2010, SOFT SCI HLTH, V24, P402
   Wang LZ, 2010, CHINESE HLTH SERVICE, V27, P177
   Wang ZJ, 2004, CHINESE J PUBLIC HLT, V6, P502
   World Health Organization, WHO DIR GEN BRIEF EX
   [吴丹 Wu Dan], 2014, [中国卫生政策研究, Chinese Journal of Health Policy], V7, P30
NR 27
TC 0
Z9 0
U1 8
U2 8
PU IRCA-BSSA
PI TOKYO
PA PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003,
   JAPAN
SN 1881-7815
EI 1881-7823
J9 BIOSCI TRENDS
JI BioSci. Trends
PD FEB
PY 2020
VL 14
IS 1
BP 3
EP 8
DI 10.5582/bst.2020.01043
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU2OR
UT WOS:000519548300002
PM 32062645
OA Bronze
DA 2020-04-03
ER

PT J
AU Yang, S
   Cao, PH
   Du, PP
   Wu, ZT
   Zhuang, ZA
   Yang, L
   Yu, X
   Zhou, Q
   Feng, XX
   Wang, XH
   Li, WG
   Liu, EM
   Chen, J
   Chen, YL
   He, DH
AF Yang, Shu
   Cao, Peihua
   Du, Peipei
   Wu, Ziting
   Zhuang, Zian
   Yang, Lin
   Yu, Xuan
   Zhou, Qi
   Feng, Xixi
   Wang, Xiaohui
   Li, Weiguo
   Liu, Enmei
   Chen, Ju
   Chen, Yaolong
   He, Daihai
CA COVID-19 Evidence Recommendations
TI Early estimation of the case fatality rate of COVID-19 in mainland
   China: a data-driven analysis
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE 2019 novel coronavirus; severe acute respiratory syndrome coronavirus-2
   (SARS-CoV-2); COVID-19; case fatality rate (CFR)
ID ACUTE RESPIRATORY SYNDROME; QUALITY; SPREAD; SARS
AB Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date.
   Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three dusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster.
   Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan.
   Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
C1 [Yang, Shu; Chen, Ju] Chengdu Univ Tradit Chinese Med, Coll Med Informat Engn, Chengdu 611137, Peoples R China.
   [Yang, Shu] Chengdu Univ Tradit Chinese Med, Digital Inst Med, Chengdu 611137, Peoples R China.
   [Cao, Peihua] Southern Med Univ, Zhujiang Hosp, Clin Res Ctr, Guangzhou 510280, Peoples R China.
   [Du, Peipei; Feng, Xixi] Chengdu Med Coll, Sch Publ Hlth, Chengdu 610500, Peoples R China.
   [Wu, Ziting] Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China.
   [Wu, Ziting] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Zhuang, Zian; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   [Yu, Xuan; Chen, Yaolong] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
   [Zhou, Qi] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China.
   [Wang, Xiaohui] Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China.
   [Li, Weiguo; Liu, Enmei] Chongqing Med Univ, Dept Resp,Childrens Hosp, Minist Educ,China Int Sci & Technol Cooperat Base, Key Lab Child Dev & Disorders,Natl Clin Res Ctr C, Chongqing 400014, Peoples R China.
   [Li, Weiguo; Liu, Enmei] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China.
   [Chen, Yaolong] WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou 730000, Peoples R China.
   [Chen, Yaolong] GIN Guidelines Int Network Asia, Lanzhou 730000, Peoples R China.
   [Chen, Yaolong] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou 730000, Peoples R China.
RP He, DH (reprint author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.; Chen, YL (reprint author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
EM chenyaolong@lzu.edu.cn; daihai.he@polyu.edu.hk
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81903406, 81804222]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2017M620378]; 2020 Key
   R&D project of Gansu Province, China [2020001]; General Research Fund of
   the Research Grants Council (RGC) of Hong Kong, China [15205119]
FX This study was supported by National Natural Science Foundation of China
   (Grant Number 81903406, 81804222), China Postdoctoral Science Foundation
   (Grant Number 2017M620378), 2020 Key R&D project of Gansu Province,
   China (Reference Number 2020001), and General Research Fund (Grant
   Number 15205119) of the Research Grants Council (RGC) of Hong Kong,
   China.
CR Cheng DY, 2020, J CLIN LAB ANAL, DOI 10.1002/jcla.23224
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Haque M, 2012, ANN PURE APPL MATH, V1, P192
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imperial College London-MRC Centre for Global Infectious Disease Analysis, 2020, NEWS WUH COR
   Jia N, 2009, TROP MED INT HEALTH, V14, P21, DOI 10.1111/j.1365-3156.2008.02147.x
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Fisman David, 2014, PLoS Curr, V6, DOI [10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]
   Phelan AL, 2020, JAMA
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Tian JH, 2017, J CLIN EPIDEMIOL, V85, P50, DOI 10.1016/j.jclinepi.2016.12.004
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wang C, 2020, LANCET
   World Health Organization, 2020, UPD SIT REG NEW COR
   World Health Organization, 14 WHO
   World Health Organization, 2020, 16 WHO
   Wu JT, 2020, LANCET
   Yang KH, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-1
   Yao L, 2016, J CLIN EPIDEMIOL, V74, P73, DOI 10.1016/j.jclinepi.2016.01.003
NR 20
TC 0
Z9 0
U1 37
U2 37
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD FEB
PY 2020
VL 8
IS 4
AR 128
DI 10.21037/atm.2020.02.66
PG 6
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA KS6IG
UT WOS:000518410000080
PM 32175421
OA Other Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zaher, KS
   El-Dabae, WH
   El-Sebelgy, MM
   Aly, NI
   Salama, ZT
AF Zaher, Kawther Sayed
   El-Dabae, Wahid Hussein
   El-Sebelgy, Mostafa Mohamed
   Aly, Naglaa Ibrahim
   Salama, Zeinab Taha
TI Genotyping and phylogenetic analysis of canine parvovirus circulating in
   Egypt
SO VETERINARY WORLD
LA English
DT Article
DE canine parvovirus; Egypt; genotyping; phylogenetic analysis; serotyping
ID DIARRHEIC DOGS; SEQUENCES; 2B
AB Aim: This study aimed to detect and characterize current genotypes of canine parvovirus (CPV) in Egypt during 2018.
   Materials and Methods: A total of 50 fecal swabs were collected from clinically infected domestic dogs of 2-5 months of age, suspected to suffer from CPV infection, from Cairo and Giza Governorates. The samples were subjected to qualitative antigen detection using the rapid test, followed by isolation on Madin-Darby Canine Kidney (MDCK) cells, molecular characterization with partial amplification of VP2 gene using polymerase chain reaction (PCR), followed by sequencing and phylogenetic analysis.
   Results: Out of 50 fecal samples, 20 samples were positive (40%) by Rapid CPV/canine coronavirus Ag Test Kit. These positive samples were cultured successfully on MDCK cells. Nine randomly chosen samples out of 30 apparently negative samples were amplified using PCR with primers Hfor and Hrev to yield a typical 630 bp fragment. Then, six randomly chosen samples out of nine were amplified using PCR with primers Pbs and Pbas to yield a typical 427 bp fragment. Sequencing, BLAST analysis and assembly of the two fragments (630 bp and 427 bp) to produce 912 bp fragments, in the six samples, revealed two serotypes CPV-2b and CPV-2c. The obtained strains were submitted to GenBank and given accession numbers MK642272, MK642273, MK642274, MK642275, MK642276, and MK642277. Phylogenetic analysis of the Egyptian strains serotype 2b illustrated that they were closely related to Thailand strains (accession numbers KP715709, 10715694, 10715701, and 10715700); while Egyptian strains serotype 2c was closely related to Thailand strains (accession numbers MH711894 and MH711902). Taiwanese strain (KU244254). Chinese strain (MF467242). and Vietnamese strain (accession number LC216910).
   Conclusion: The current research recommends further epidemiological studies to assess the extent of the occurrence of different serotypes of CPV in Egypt and the efficiency of imported and locally produced vaccines in protection against CPV infection.
C1 [Zaher, Kawther Sayed; El-Dabae, Wahid Hussein; El-Sebelgy, Mostafa Mohamed] Natl Res Ctr, Vet Res Div, Dept Microbiol & Immunol, Giza 12622, Egypt.
   [Aly, Naglaa Ibrahim; Salama, Zeinab Taha] Vet Serum & Vaccine Res Inst, Dept Pet Anim Vaccine Res, Abbasiya, Egypt.
RP El-Dabae, WH (reprint author), Natl Res Ctr, Vet Res Div, Dept Microbiol & Immunol, Giza 12622, Egypt.
EM zaherkus@yahoo.com; dr_wahidhussein@yahoo.com; bestvet007@gmail.com;
   naglaaaly20093@yahoo.com; drzainabtaha2@gmail.com
FU NRC In-House Project [AR111209]
FX The authors would like to express their appreciation to all members of
   Microbiology and Immunology Department, Veterinary Research Division,
   National Research Centre, for their support and help during this work.
   This work was conducted at National Research Centre, Egypt and funded by
   NRC In-House Project Grant no. AR111209.
CR Ahmed N, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0958-y
   AL-Hosary A.A.T., 2016, ALEX J VET SCI, V51, P174
   Al-Hosary A. A. T. A., 2018, Journal of Advanced Veterinary Research, V8, P79
   Ali N.I., 2011, KAFRELSHEIKH VET MED, V9, P73
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Aly N.I., 2005, BENI SUEF VET MED J, V15, P208
   Amthal A.F., 2014, THESIS, P139
   Bucci T. J., 1982, Journal of the Egyptian Veterinary Medical Association, V42, P21
   Chinchkar SR, 2006, ARCH VIROL, V151, P1881, DOI 10.1007/s00705-006-0753-8
   Clark NJ, 2018, INFECT GENET EVOL, V58, P50, DOI 10.1016/j.meegid.2017.12.013
   Cotmore SF, 2019, J GEN VIROL, V100, P367, DOI 10.1099/jgv.0.001212
   El-Gallad S.B., 2007, ZAG VET J, V35, P172
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Miranda C., 2016, THESIS, P216
   Mohamed A.M., 1988, THESIS
   Nei M, 2000, MOL EVOLUTION PHYLOG
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sharma S, 2016, VET WORLD, V9, P964, DOI 10.14202/vetworld.2016.964-969
   Soliman A.F., 2011, ZAG VET J, V39, P130
   Soliman R.M., 2018, EUR J PHARM MED RES, V5, P525
   Xiong Ning, 2008, Virologica Sinica, V23, P203, DOI 10.1007/s12250-008-2928-9
   Yanni M.I., 2012, THESIS
NR 22
TC 0
Z9 0
U1 0
U2 0
PU VETERINARY WORLD
PI GUJARAT
PA STAR, GULSHAN PARK, NH-8A, CHANDRAPUR RD, WANKANER, GUJARAT, 363 621,
   INDIA
SN 0972-8988
EI 2231-0916
J9 VET WORLD
JI Vet. World
PD FEB
PY 2020
VL 13
IS 2
BP 326
EP 333
DI 10.14202/vetworld.2020.326-333
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA KT2MC
UT WOS:000518849100014
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Zhang, L
   Gan, M
   Zhang, ZY
   Li, X
   Liu, WK
   Zhu, AR
   Sun, J
   Li, F
   Wang, YQ
   Zhang, FC
   Zhao, JX
   Zhou, R
   Zhao, JC
AF Zhang, Lu
   Gan, Mian
   Zhang, Zhaoyong
   Li, Xin
   Liu, Wenkuan
   Zhu, Airu
   Sun, Jing
   Li, Fang
   Wang, Yanqun
   Zhang, Fuchun
   Zhao, Jingxian
   Zhou, Rong
   Zhao, Jincun
TI Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing
   Respiratory Illness in Hospitalized Children in China
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report the complete genome sequences of five human coronavirus NL63 (HCoV-NL63) strains obtained using next-generation sequencing. The five HCoV-NL63 strains were obtained from hospitalized children with severe acute respiratory infection detected in Guangdong, China. This study provides several complete genomes of HCoV-NL63 and improves our understanding of HCoV-NL63 evolution in China.
C1 [Zhang, Lu; Zhang, Fuchun; Zhao, Jincun] Guangzhou Med Univ, Guangzhou Eighth Peoples Hosp, Inst Infect Dis, Guangzhou, Peoples R China.
   [Gan, Mian; Zhang, Zhaoyong; Li, Xin; Liu, Wenkuan; Zhu, Airu; Sun, Jing; Li, Fang; Wang, Yanqun; Zhao, Jingxian; Zhou, Rong; Zhao, Jincun] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,State Key Lab Resp Dis, Guangzhou, Peoples R China.
RP Zhao, JC (reprint author), Guangzhou Med Univ, Guangzhou Eighth Peoples Hosp, Inst Infect Dis, Guangzhou, Peoples R China.; Zhou, R; Zhao, JC (reprint author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,State Key Lab Resp Dis, Guangzhou, Peoples R China.
EM zhourong@vip.163.com; zhaojincun@gird.cn
FU National Key Research and Development Program of China [2018YFC1200100];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [NSFC 81702047, 81772191, 91842106, 8181101118];
   State Key Laboratory of Respiratory Disease [SKLRD-QN-201715,
   SKLRD-QN-201912]; National Key Technology RD ProgramNational Key
   Technology R&D Program [2018YFC1311900]; Guangdong Science and
   Technology Foundation [2019B030316028]; 2015 Thousand Talents Plan Award
   of China; China Postdoctoral Science FoundationChina Postdoctoral
   Science Foundation; Ph.D. Start-up Fund of the Natural Science
   Foundation of Guangdong Province, China
FX This research was supported by grants from the National Key Research and
   Development Program of China (2018YFC1200100), National Natural Science
   Foundation of China (NSFC 81702047, 81772191, 91842106, and 8181101118),
   State Key Laboratory of Respiratory Disease (SKLRD-QN-201715 and
   SKLRD-QN-201912), National Key Technology R&D Program (2018YFC1311900),
   Guangdong Science and Technology Foundation (2019B030316028), 2015
   Thousand Talents Plan Award of China, China Postdoctoral Science
   Foundation, and the Ph.D. Start-up Fund of the Natural Science
   Foundation of Guangdong Province, China.
CR Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102
   Kaiser L, 2005, PEDIATR INFECT DIS J, V24, P1015, DOI 10.1097/01.inf.0000183773.80217.12
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x
   Wang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.006
NR 9
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD FEB
PY 2020
VL 9
IS 8
AR e01597-19
DI 10.1128/MRA.01597-19
PG 4
WC Microbiology
SC Microbiology
GA KN5DK
UT WOS:000514857300011
PM 32079638
OA Green Published, Bronze, Other Gold
DA 2020-04-03
ER

PT J
AU Chen, YK
   Li, Y
   Wang, XH
   Zou, P
AF Chen, Yongkang
   Li, Yuan
   Wang, Xiaohuan
   Zou, Peng
TI Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by
   Disrupting Viral Integrity
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; flavivirus; montelukast; viral inactivator; viral integrity
ID SYNDROME CORONAVIRUS REPLICATION; SMALL-MOLECULE INHIBITORS; DENGUE
   VIRUS; IDENTIFICATION; VACCINE; BRAIN
AB The association of Zika virus (ZIKV) infection and severe complications including neurological sequelae especially fetal microcephaly has aroused global attentions since its outbreak in 2015. Currently, there are no vaccines or therapeutic drugs clinically approved for treatments of ZIKV infection, however. And the drugs used for treating ZIKV in pregnant women require a higher safety profile. Here, we identified an anti-asthmatic drug, montelukast, which is of safety profile for pregnant women and exhibited antiviral efficacy against ZIKV infection in vitro and in vivo. And we showed that montelukast could disrupt the integrity of the virions to release the viral genomic RNA, hence irreversibly inhibiting viral infectivity. In consideration of the neuro-protective activity that montelukast possessed, which was previously reported, it is promising that montelukast could be used for patients with ZIKV infection, particularly for pregnant women.
C1 [Chen, Yongkang; Li, Yuan; Wang, Xiaohuan; Zou, Peng] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
RP Zou, P (reprint author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
EM zoupeng@shphc.org.cn
FU Shanghai Public Health Clinical Center [2016-27, KY-GW-2017-17]
FX This work was supported by the funding from the Shanghai Public Health
   Clinical Center (2016-27 and KY-GW-2017-17).
CR Ahmad A, 2018, TROP BIOMED, V35, P1115
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Bakhireva LN, 2007, J ALLERGY CLIN IMMUN, V119, P618, DOI 10.1016/j.jaci.2006.12.618
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cavero-Carbonell C, 2017, BIRTH DEFECTS RES, V109, P452, DOI 10.1002/bdra.23621
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Fernandes-Monteiro AG, 2015, HUM VACC IMMUNOTHER, V11, P1865, DOI 10.4161/21645515.2014.990854
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Gelosa P, 2019, PHARMACOL RES, V142, P223, DOI 10.1016/j.phrs.2019.02.025
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hoxha M, 2017, EUR J CLIN PHARMACOL, V73, P799, DOI 10.1007/s00228-017-2242-2
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lai JE, 2014, NEUROPHARMACOLOGY, V79, P707, DOI 10.1016/j.neuropharm.2014.01.011
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liu Q, 2015, ANTIMICROB AGENTS CH, V59, P742, DOI 10.1128/AAC.03977-14
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Peixoto HM, 2019, T ROY SOC TROP MED H, V113, P252, DOI 10.1093/trstmh/trz010
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Si LL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8408
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   St John AL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003783
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WANG XH, 2017, FRONT MED PRC, V11, P449, DOI DOI 10.1007/s11684-017-0589-5
   Wang XH, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111064
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu NN, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008093
   Wu WH, 2018, J MED VIROL, V90, P1681, DOI 10.1002/jmv.25253
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan MC, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0913-3
NR 57
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 30
PY 2020
VL 10
AR 3079
DI 10.3389/fmicb.2019.03079
PG 14
WC Microbiology
SC Microbiology
GA KN2GP
UT WOS:000514660100001
PM 32082265
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Liui, JL
   Wang, FF
   Du, LY
   Li, J
   Yu, TQ
   Jin, YL
   Yan, Y
   Zhou, JY
   Gu, JY
AF Liui, Junli
   Wang, Fangfang
   Du, Liuyang
   Li, Juan
   Yu, Tianqi
   Jin, Yulan
   Yan, Yan
   Zhou, Jiyong
   Gu, Jinyan
TI Comprehensive Genomic Characterization Analysis of lncRNAs in Cells With
   Porcine Delta Coronavirus Infection
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE PDCoV infection; RNA-seq; lncRNA; TNF; metabolic pathway
ID LONG NONCODING RNA; TNF-ALPHA; DELTACORONAVIRUS; EXPRESSION; DISCOVERY;
   ANNOTATION; ACTIVATION; REPRESSION; EVOLUTION
AB Porcine delta coronavirus (PDCoV) is a novel emerging enterocytetropic virus causing diarrhea, vomiting, dehydration, and mortality in suckling piglets. Long non-coding RNAs (lncRNAs) are known to be important regulators during virus infection. Here, we describe a comprehensive transcriptome profile of lncRNA in PDCoV-infected swine testicular (ST) cells. In total, 1,308 annotated and 1,190 novel lncRNA candidate sequences were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed that these lncRNAs might be involved in numerous biological processes. Clustering analysis of differentially expressed lncRNAs showed that 454 annotated and 376 novel lncRNAs were regulated after PDCoV infection. Furthermore, we constructed a lncRNA-protein-coding gene co-expression interaction network. The KEGG analysis of the co-expressed genes showed that these differentially expressed lncRNAs were enriched in pathways related to metabolism and TNF signaling. Our study provided comprehensive information about lncRNAs that would be a useful resource for studying the pathogenesis of and designing antiviral therapy for PDCoV infection.
C1 [Liui, Junli; Wang, Fangfang; Du, Liuyang; Li, Juan; Yu, Tianqi; Gu, Jinyan] Nanjing Agr Univ, Inst Immunol, MOE Int Joint Collaborat Res Lab Anim Hlth & Food, Nanjing, Peoples R China.
   [Jin, Yulan; Yan, Yan; Zhou, Jiyong] Zhejiang Univ, Dept Vet Med, MOA Key Lab Anim Urol, Hangzhou, Peoples R China.
RP Gu, JY (reprint author), Nanjing Agr Univ, Inst Immunol, MOE Int Joint Collaborat Res Lab Anim Hlth & Food, Nanjing, Peoples R China.; Zhou, JY (reprint author), Zhejiang Univ, Dept Vet Med, MOA Key Lab Anim Urol, Hangzhou, Peoples R China.
EM jyzhou@zju.edu.cn; GJY@njau.edu.cn
FU National Key Research & Development Program of China [2016YFD0500102]
FX This work was supported by the National Key Research & Development
   Program of China (2016YFD0500102).
CR Ajayi T, 2018, TRANSBOUND EMERG DIS, V65, P1197, DOI 10.1111/tbed.12858
   Betakova T, 2017, CURR PHARM DESIGN, V23, P2616, DOI 10.2174/1381612823666170316123736
   Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925
   Clark BS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00164
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275
   Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015
   Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005
   Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040
   Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009
   Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111
   Lorsirigool A, 2017, VIRUS GENES, V53, P240, DOI 10.1007/s11262-016-1413-z
   Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024
   Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15
   Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430
   Masood KI, 2018, IRAN J MICROBIOL, V10, P202
   Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942
   Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001
   Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006
   Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110
   Saeng-chuto K, 2020, TRANSBOUND EMERG DIS, V67, P183, DOI 10.1111/tbed.13339
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Wu JL, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1848-2
   Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12
   Zhu XY, 2017, J VIROL, V91, DOI [10.1128/JVI.00003-17, 10.1128/jvi.00003-17]
   Zhu XY, 2017, VIROLOGY, V502, P33, DOI 10.1016/j.virol.2016.12.005
NR 36
TC 0
Z9 0
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 28
PY 2020
VL 10
AR 3036
DI 10.3389/fmicb.2019.03036
PG 10
WC Microbiology
SC Microbiology
GA KM7JI
UT WOS:000514316100001
PM 32063887
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Li, SM
   Yuan, LX
   Dai, G
   Chen, RA
   Liu, DX
   Fung, TS
AF Li, Shumin
   Yuan, Lixia
   Dai, Guo
   Chen, Rui Ai
   Liu, Ding Xiang
   Fung, To Sing
TI Regulation of the ER Stress Response by the Ion Channel Activity of the
   Infectious Bronchitis Coronavirus Envelope Protein Modulates Virion
   Release, Apoptosis, Viral Fitness, and Pathogenesis
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE coronavirus; viroporin; ion channel activity; ER stress response;
   pro-inflammatory cytokine; pathogenesis
ID RESPIRATORY SYNDROME CORONAVIRUS; ENDOPLASMIC-RETICULUM STRESS; SPIKE
   PROTEIN; AVIAN CORONAVIRUS; FUNCTIONAL-CHARACTERIZATION; MURINE
   CORONAVIRUS; UP-REGULATION; VIRUS; CELLS; FORMS
AB Coronavirus (CoV) envelope (E) protein is a small structural protein critical for virion morphogenesis and release. The recently characterized E protein ion channel activity (EIC) has also been implicated in modulating viral pathogenesis. In this study, we used infectious bronchitis coronavirus (IBV) as a model to study EIC. Two recombinant IBVs (rIBVs) harboring EIC-inactivating mutations - rT16A and rA26F - were serially passaged, and several compensatory mutations were identified in the transmembrane domain (TMD). Two rIBVs harboring these putative EIC-reverting mutations - rT16A/A26V and rA26F/F14N - were recovered. Compared with the parental rIBV-p65 control, all four EIC mutants exhibited comparable levels of intracellular RNA synthesis, structural protein production, and virion assembly. Our results showed that the IBV EIC contributed to the induction of ER stress response, as up-regulation of ER stress-related genes was markedly reduced in cells infected with the EIC-defective mutants. EIC-defective mutants also formed smaller plaques, released significantly less infectious virions into the culture supernatant, and had lower levels of viral fitness in cell culture. Significantly, all these defective phenotypes were restored in cells infected with the putative EIC revertants. EIC mutations were also implicated in regulating IBV-induced apoptosis, induction of pro-inflammatory cytokines, and viral pathogenicity in vivo. Taken together, this study highlights the importance of CoV EIC in modulating virion release and various aspects of CoV - host interaction.
C1 [Li, Shumin; Yuan, Lixia; Dai, Guo; Liu, Ding Xiang; Fung, To Sing] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Peoples R China.
   [Li, Shumin; Yuan, Lixia; Dai, Guo; Liu, Ding Xiang; Fung, To Sing] South China Agr Univ, Integrat Microbiol Res Ctr, Guangzhou, Peoples R China.
   [Chen, Rui Ai] South China Agr Univ, Coll Vet Med, Guangzhou, Peoples R China.
   [Chen, Rui Ai] Zhaoqing DaHuaNong Biol Med Co Ltd, Zhaoqing, Peoples R China.
RP Liu, DX; Fung, TS (reprint author), South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Peoples R China.; Liu, DX; Fung, TS (reprint author), South China Agr Univ, Integrat Microbiol Res Ctr, Guangzhou, Peoples R China.
EM dxliu0001@163.com; tosingfung@qq.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31972660, 31900135]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2018A030313472]; Guangdong Province Key Laboratory of
   Microbial Signals and Disease Control grants [MSDC-2017-05,
   MSDC-2017-06]
FX This work was partially supported by the National Natural Science
   Foundation of China grants 31972660 and 31900135, the Natural Science
   Foundation of Guangdong Province grant 2018A030313472, and the Guangdong
   Province Key Laboratory of Microbial Signals and Disease Control grants
   MSDC-2017-05 and MSDC-2017-06.
CR Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165
   Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17
   Chen CC, 2011, BBA-BIOMEMBRANES, V1808, P572, DOI 10.1016/j.bbamem.2010.08.004
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000
   DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06
   DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315
   Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105
   Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020
   Fung TS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00296
   Fung TS, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0053-0
   Fung TS, 2014, VIRUS RES, V194, P110, DOI 10.1016/j.virusres.2014.09.016
   Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14
   Giorgi C, 2008, CURR MOL MED, V8, P119
   Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320
   Kuo LL, 2003, J VIROL, V77, P4597, DOI 10.1128/JVI.77.8.4597-4608.2003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Liang JQ, 2019, VIROLOGY, V531, P48, DOI 10.1016/j.virol.2019.02.017
   Liao Y, 2004, BIOCHEM BIOPH RES CO, V325, P374, DOI 10.1016/j.bbrc.2004.10.050
   Liao Y, 2006, VIROLOGY, V349, P264, DOI 10.1016/j.virol.2006.01.028
   Liao Y, 2013, J VIROL, V87, P8124, DOI 10.1128/JVI.00626-13
   Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200
   Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001
   Liu DX, 2007, CELL MOL LIFE SCI, V64, P2043, DOI 10.1007/s00018-007-7103-1
   LIU DX, 1991, VIROLOGY, V185, P911, DOI 10.1016/0042-6822(91)90572-S
   LIU DX, 1991, VIROLOGY, V184, P531, DOI 10.1016/0042-6822(91)90423-9
   Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847
   Ng LFP, 1998, VIROLOGY, V243, P388, DOI 10.1006/viro.1998.9058
   Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010
   Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ruch TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002674
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Shen S, 2004, VIROLOGY, V326, P288, DOI 10.1016/j.virol.2004.06.016
   Shen S, 2003, VIROLOGY, V311, P16, DOI 10.1016/S0042-6822(03)00117-X
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   To J, 2017, J VIROL, V91, DOI 10.1128/JVI.02158-16
   Torres J, 2005, BIOPHYS J, V88, P1283, DOI 10.1529/biophysj.104.051730
   Torres J, 2007, PROTEIN SCI, V16, P2065, DOI 10.1110/ps.062730007
   Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119
   Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x
   Verdia-Baguena C, 2012, VIROLOGY, V432, P485, DOI 10.1016/j.virol.2012.07.005
   Versteeg GA, 2007, J VIROL, V81, P10981, DOI 10.1128/JVI.01033-07
   Westerbeck JW, 2019, J VIROL, V93, DOI [10.1128/jvi.00015-19, 10.1128/JVI.00015-19]
   Westerbeck JW, 2015, J VIROL, V89, P9313, DOI 10.1128/JVI.01237-15
   Yamada Y, 2009, J VIROL, V83, P8744, DOI 10.1128/JVI.00613-09
   Yamada Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006130
   Yuan Q, 2006, FEBS LETT, V580, P3192, DOI 10.1016/j.febslet.2006.04.076
   Zheng J, 2018, VIROLOGY, V513, P65, DOI 10.1016/j.virol.2017.10.003
NR 54
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 24
PY 2020
VL 10
AR 3022
DI 10.3389/fmicb.2019.03022
PG 14
WC Microbiology
SC Microbiology
GA KK2QC
UT WOS:000512591900001
PM 32038520
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zhang, XZ
   Deng, TW
   Lu, JZ
   Zhao, PD
   Chen, LL
   Qian, MW
   Guo, YW
   Qiao, HX
   Xu, YH
   Wang, Y
   Li, XZ
   Zhang, GZ
   Wang, Z
   Bian, CZ
AF Zhang, Xiaozhan
   Deng, Tongwei
   Lu, Jianzhou
   Zhao, Pandeng
   Chen, Lulu
   Qian, Mengwei
   Guo, Yiwen
   Qiao, Hongxing
   Xu, Yaohui
   Wang, Yan
   Li, Xinzheng
   Zhang, Guizhi
   Wang, Zeng
   Bian, Chuanzhou
TI Molecular characterization of variant infectious bronchitis virus in
   China, 2019: Implications for control programmes
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article; Early Access
DE epidemiology; evolutionary; GI-19 genotype; infectious bronchitis virus
ID IDENTIFICATION; CORONAVIRUS; SEROTYPE; DIVERSITY; GENOTYPE; PROTEIN
AB Infectious bronchitis virus (IBV), an ongoing emergence enveloped virus with a single-stranded positive-sense RNA genome, belongs to the Gammacoronavirus genus in the Coronaviridae family. IBV-associated tracheitis, nephritis, salpingitis, proventriculitis and egg drop have caused devastating economic losses to poultry industry worldwide. Since the end of 2018, a remarkably increasing number of commercial broilers and layers, vaccinated or not, were infected with IBV in China. Here, we described two IB outbreaks with severe respiratory system or kidney injury in IBV-vaccinated commercial poultry farms in central China. Other possible causative viral pathogens, including avian influenza virus (AIV), Newcastle disease virus (NDV) and Kedah fatal kidney syndrome virus (KFKSV), were excluded by reverse transcription-polymerase chain reaction (RT-PCR), and three virulent IBV strains, HeN-1/China/2019, HeN-2/China/2019 and HeN-101/China/2019, were identified. Although the gross pathologic appearance of these two IB outbreaks was different, the newly identified IBV strains were all closely related to the ck/China/I0529/17 strain and grouped into GI-19 genotype clade based on the sequencing and phylogenetic analysis of the complete S1 genes. Moreover, there are still some evolutionary distance between the newly identified IBV strains, HeN-101/China/2019 in particular, and other GI-19 strains, suggesting that Chinese IBV strains constantly emerge and evolve towards different directions. In conclusion, this study provided an insight of the recently emerging IBV outbreaks in IBV-vaccinated commercial poultry farms and identified the genetic characteristics of three virulent GI-19 IBV strains, which shows the need to carry out proper preventive measures and control strategies.
C1 [Zhang, Xiaozhan; Deng, Tongwei; Lu, Jianzhou; Zhao, Pandeng; Chen, Lulu; Qian, Mengwei; Guo, Yiwen; Qiao, Hongxing; Xu, Yaohui; Wang, Yan; Bian, Chuanzhou] Henan Univ Anim Husb & Econ, Coll Vet Med, 6 Longzihu North Rd, Zhengzhou 450046, Henan, Peoples R China.
   [Li, Xinzheng; Zhang, Guizhi] Henan Univ Anim Husb & Econ, Coll Anim Sci & Technol, Henan Engn & Tech Res Ctr Avian Dis Control & Pre, Zhengzhou, Peoples R China.
   [Wang, Zeng] Henan Agr Univ, Coll Anim Sci & Vet Med, Dept Prevent Vet Med, Zhengzhou 450002, Henan, Peoples R China.
RP Bian, CZ (reprint author), Henan Univ Anim Husb & Econ, Coll Vet Med, 6 Longzihu North Rd, Zhengzhou 450046, Henan, Peoples R China.; Wang, Z (reprint author), Henan Agr Univ, Coll Anim Sci & Vet Med, Dept Prevent Vet Med, Zhengzhou 450002, Henan, Peoples R China.
EM wzzxz20140105@126.com; chuanzhou-bian@126.com
FU Scientific and Technological Project of Henan Province [192102110186];
   Youth Science Foundations of Henan University of Animal Husbandry and
   Economy [906/24030027, 906/24030090]; Veterinary Discipline Key
   Construction Project of Henan University of Animal Husbandry and Economy
   [MXK2016102]; Science and Technology Innovation Group Project of Henan
   University of Animal Husbandry and Economy [2018KYTS13]
FX Scientific and Technological Project of Henan Province, Grant/Award
   Number: 192102110186; Youth Science Foundations of Henan University of
   Animal Husbandry and Economy, Grant/Award Number: 906/24030027 and
   906/24030090; Veterinary Discipline Key Construction Project of Henan
   University of Animal Husbandry and Economy, Grant/Award Number:
   MXK2016102; Science and Technology Innovation Group Project of Henan
   University of Animal Husbandry and Economy, Grant/Award Number:
   2018KYTS13
CR Bande F, 2017, ANIM HEALTH RES REV, V18, P70, DOI 10.1017/S1466252317000044
   Chen YQ, 2017, VET MICROBIOL, V198, P108, DOI 10.1016/j.vetmic.2016.12.017
   de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260
   Fan WS, 2018, J VET MED SCI, V80, P1438, DOI 10.1292/jvms.18-0249
   Han ZX, 2018, VIRUS RES, V257, P82, DOI 10.1016/j.virusres.2018.09.009
   Han ZX, 2011, INFECT GENET EVOL, V11, P190, DOI 10.1016/j.meegid.2010.09.002
   Jackwood M. W., 2013, DIS POULTRY, P139, DOI DOI 10.1002/9781119421481
   Jiang L, 2017, INFECT GENET EVOL, V54, P437, DOI 10.1016/j.meegid.2017.08.006
   Jordan B, 2017, VET MICROBIOL, V206, P137, DOI 10.1016/j.vetmic.2017.01.002
   Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239
   Li M, 2012, ARCH VIROL, V157, P467, DOI 10.1007/s00705-011-1206-6
   Lin SY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102030
   Ma TX, 2019, VET MICROBIOL, V230, P178, DOI 10.1016/j.vetmic.2019.01.020
   Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17
   Masters P.S., 2013, FIELDS VIROLOGY, P825
   Mo ML, 2013, VIRUSES-BASEL, V5, P3007, DOI 10.3390/v5123007
   Moore KM, 1997, ARCH VIROL, V142, P2249, DOI 10.1007/s007050050239
   Moreno A, 2017, AVIAN PATHOL, V46, P28, DOI 10.1080/03079457.2016.1200011
   Palya V, 2019, EMERG INFECT DIS, V25, P1110, DOI 10.3201/eid2506.181661
   Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018
   Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009
   Nguyen TT, 2013, J VIROL METHODS, V188, P41, DOI 10.1016/j.jviromet.2012.12.004
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
   Zhang X, 2018, TRANSBOUND EMERG DIS, V65, P297, DOI 10.1111/tbed.12750
NR 24
TC 0
Z9 0
U1 28
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
DI 10.1111/tbed.13477
EA JAN 2020
PG 7
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA KF1GT
UT WOS:000508999600001
PM 31943814
OA Bronze
DA 2020-04-03
ER

PT J
AU Qian, SJ
   Gao, ZT
   Cao, R
   Yang, K
   Cui, YJ
   Li, SW
   Meng, XR
   He, QG
   Li, ZL
AF Qian, Shaoju
   Gao, Zitong
   Cao, Rui
   Yang, Kang
   Cui, Yijie
   Li, Shaowen
   Meng, Xianrong
   He, Qigai
   Li, Zili
TI Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn
   Expression via Nucleocapsid Protein and Secretion of TGF-beta in Porcine
   Intestinal Epithelial Cells
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE transmissible gastroenteritis virus; nucleocapsid protein; TGF-beta;
   neonatal Fc receptor; toll-like receptor; NF-kappa B
ID POLYMERIC IMMUNOGLOBULIN RECEPTOR; ENDOPLASMIC-RETICULUM STRESS;
   TOLL-LIKE-RECEPTORS; RIG-I-LIKE; INNATE; CORONAVIRUS; ACTIVATION; IGG;
   IDENTIFICATION; RECOGNITION
AB Transmissible gastroenteritis virus (TGEV) is a porcine intestinal coronavirus that causes fatal severe watery diarrhea in piglets. The neonatal Fc receptor (FcRn) is the only IgG transport receptor, its expression on mucosal surfaces is triggered upon viral stimulation, which significantly enhances mucosal immunity. We utilized TGEV as a model pathogen to explore the role of FcRn in resisting viral invasion in overall intestinal mucosal immunity. TGEV induced FcRn expression by activating NF-kappa B signaling in porcine small intestinal epithelial (IPEC-J2) cells, however, the underlying mechanisms are unclear. First, using small interfering RNAs, we found that TGEV up-regulated FcRn expression via TLR3, TLR9 and RIG-I. Moreover, TGEV induced IL-1 beta, IL-6, IL-8, TGF-beta, and TNF-alpha production. TGF-beta-stimulated IPEC-J2 cells highly up-regulated FcRn expression, while treatment with a JNK-specific inhibitor down-regulated the expression. TGEV nucleocapsid (N) protein also enhanced FcRn promoter activity via the NF-kappa B signaling pathway and its central region (aa 128-252) was essential for FcRn activation. Additionally, N protein-mediated FcRn up-regulation promotes IgG transcytosis. Thus, TGEV N protein and TGF-beta up-regulated FcRn expression, further clarifying the molecular mechanism of up-regulation of FcRn expression by TGEV.
C1 [Qian, Shaoju; Gao, Zitong; Cao, Rui; Yang, Kang; Cui, Yijie; Li, Shaowen; Meng, Xianrong; He, Qigai; Li, Zili] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.
   [Li, Shaowen; Meng, Xianrong; He, Qigai; Li, Zili] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China.
   [Li, Shaowen; Meng, Xianrong; He, Qigai; Li, Zili] Minist Agr Peoples Republ China, Key Lab Dev Vet Diagnost Prod, Wuhan, Peoples R China.
RP Li, ZL (reprint author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.; Li, ZL (reprint author), Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China.; Li, ZL (reprint author), Minist Agr Peoples Republ China, Key Lab Dev Vet Diagnost Prod, Wuhan, Peoples R China.
EM lizili@mail.hzau.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31572500]
FX This work was supported by the National Natural Science Foundation of
   China (31572500 to ZL).
CR An K, 2014, J PROTEOME RES, V13, P5376, DOI 10.1021/pr500173p
   Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003
   Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007
   Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862
   Burkey TE, 2009, VET IMMUNOL IMMUNOP, V130, P96, DOI 10.1016/j.vetimm.2008.12.027
   Cao LY, 2015, J GEN VIROL, V96, P1757, DOI 10.1099/vir.0.000133
   Cao LY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0345-x
   Chen X, 2017, J VIROL, V91, DOI 10.1128/JVI.00986-17
   Cruz JLG, 2013, J VIROL, V87, P9754, DOI 10.1128/JVI.01032-13
   Cruz JLG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002090
   Ding L, 2014, BIOCHEM BIOPH RES CO, V445, P497, DOI 10.1016/j.bbrc.2014.02.039
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   Escors D, 2003, J VIROL, V77, P7890, DOI 10.1128/JVI.77.14.7890-7902.2003
   Gohy ST, 2014, AM J RESP CRIT CARE, V190, P509, DOI 10.1164/rccm.201311-1971OC
   Guo JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32154
   Guo JY, 2016, DNA CELL BIOL, V35, P301, DOI 10.1089/dna.2015.3165
   Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Ji LK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01024
   Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001
   Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10
   Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108
   Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999
   Lu L, 2011, J VIROL, V85, P10542, DOI 10.1128/JVI.05441-11
   Mariani V, 2009, VET IMMUNOL IMMUNOP, V131, P278, DOI 10.1016/j.vetimm.2009.04.006
   Pal K, 2005, J GEN VIROL, V86, P2347, DOI 10.1099/vir.0.80690-0
   Pyzik M, 2017, P NATL ACAD SCI USA, V114, pE2862, DOI 10.1073/pnas.1618291114
   Qian SJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02272
   Ratajczak E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/428618
   Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y
   Schneeman TA, 2005, J IMMUNOL, V175, P376, DOI 10.4049/jimmunol.175.1.376
   Schulz KS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00498
   Temeeyasen G, 2018, VIROLOGY, V517, P188, DOI 10.1016/j.virol.2017.11.024
   Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100
   Vegh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036286
   Wang L, 2018, VIRULENCE, V9, P1685, DOI 10.1080/21505594.2018.1536632
   Wang Y, 2016, SCAND J IMMUNOL, V83, P235, DOI 10.1111/sji.12416
   Xia L, 2017, J VIROL, V91, DOI [10.1128/JVI.01256-17, 10.1128/jvi.01256-17]
   Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034
   Ye LL, 2008, DEV COMP IMMUNOL, V32, P966, DOI 10.1016/j.dci.2008.01.008
   Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742
   Zhang Q, 2018, RES VET SCI, V119, P109, DOI 10.1016/j.rvsc.2018.06.008
   Zhang X, 2015, VIRUS RES, V200, P56, DOI 10.1016/j.virusres.2014.12.013
   Zhang X, 2014, VET MICROBIOL, V172, P443, DOI 10.1016/j.vetmic.2014.05.034
   Zhang X, 2007, VIROLOGY, V365, P324, DOI 10.1016/j.virol.2007.04.009
   Zhao SS, 2014, VIRUS RES, V192, P34, DOI 10.1016/j.virusres.2014.08.014
   Zhou YR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00940
NR 47
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 21
PY 2020
VL 10
AR 3085
DI 10.3389/fmicb.2019.03085
PG 12
WC Microbiology
SC Microbiology
GA KI2KZ
UT WOS:000511179100001
PM 32038538
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Yang, TJ
   Chang, YC
   Ko, TP
   Draczkowski, P
   Chien, YC
   Chang, YC
   Wu, KP
   Khoo, KH
   Chang, HW
   Hsu, STD
AF Yang, Tzu-Jing
   Chang, Yen-Chen
   Ko, Tzu-Ping
   Draczkowski, Piotr
   Chien, Yu-Chun
   Chang, Yuan-Chih
   Wu, Kuen-Phon
   Khoo, Kay-Hooi
   Chang, Hui-Wen
   Hsu, Shang-Te Danny
TI Cryo-EM analysis of a feline coronavirus spike protein reveals a unique
   structure and camouflaging glycans
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cryoelectron microscopy; mass spectrometry; protein glycosylation;
   alphacoronavirus; feline infectious peritonitis virus
ID DC-SIGN; CRYSTAL-STRUCTURE; VIRUS; GLYCOPROTEIN; RECOGNITION;
   GLYCOSYLATION; BINDING; IDENTIFICATION; GLYCOPEPTIDE; INFECTION
AB Feline infectious peritonitis virus (FIPV) is an alphacoronavirus that causes a nearly 100% mortality rate without effective treatment. Here we report a 3.3-A cryoelectron microscopy (cryo-EM) structure of the serotype I FIPV spike (S) protein, which is responsible for host recognition and viral entry. Mass spectrometry provided site-specific compositions of densely distributed high-mannose and complex-type N-glycans that account for 1/4 of the total molecular mass; most of the N-glycans could be visualized by cryo-EM. Specifically, the N-glycans that wedge between 2 galectin-like domains within the S1 subunit of FIPV S protein result in a unique propeller-like conformation, underscoring the importance of glycosylation in maintaining protein structures. The cleavage site within the S2 subunit responsible for activation also showed distinct structural features and glycosylation. These structural insights provide a blueprint for a bettermolecular understanding of the pathogenesis of FIP.
C1 [Yang, Tzu-Jing; Chang, Yen-Chen; Ko, Tzu-Ping; Draczkowski, Piotr; Chien, Yu-Chun; Wu, Kuen-Phon; Khoo, Kay-Hooi; Hsu, Shang-Te Danny] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.
   [Yang, Tzu-Jing; Chien, Yu-Chun; Khoo, Kay-Hooi; Hsu, Shang-Te Danny] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.
   [Chang, Yen-Chen; Chang, Hui-Wen] Natl Taiwan Univ, Grad Inst Mol & Comparat Pathobiol, Sch Vet Med, Taipei 10617, Taiwan.
   [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan.
RP Hsu, STD (reprint author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.; Hsu, STD (reprint author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.; Chang, HW (reprint author), Natl Taiwan Univ, Grad Inst Mol & Comparat Pathobiol, Sch Vet Med, Taipei 10617, Taiwan.
EM huiwenchang@ntu.edu.tw; sthsu@gate.sinica.edu.tw
RI Hsu, Shang-Te Danny/L-2826-2014; Khoo, Kay-Hooi/E-1989-2019;
   Draczkowski, Piotr/N-6157-2014; Wu, Kuen-Phon/B-7983-2009; CHANG,
   HUI-WEN/C-9058-2017
OI Hsu, Shang-Te Danny/0000-0002-7231-0185; Khoo,
   Kay-Hooi/0000-0003-2906-406X; Yang, Tzu-Jing/0000-0003-1798-7764; Ko,
   Tzu-Ping/0000-0003-1794-2638; Draczkowski, Piotr/0000-0002-9408-2670;
   Wu, Kuen-Phon/0000-0002-1525-6004; CHANG, HUI-WEN/0000-0001-8877-1886
FU Academia Sinica Cryo-EM Center [AS-CFII-108-110]; Ministry of Science
   and Technology (MOST), TaiwanMinistry of Science and Technology, Taiwan
   [MOST 106-2311-B-002-028-MY3, 107-2628-M-001-005-MY3]; National Taiwan
   UniversityNational Taiwan University [108L7842]; Taiwan Protein Project
   [AS-KPQ-105-TPP]; Academia SinicaAcademia Sinica - Taiwan
FX We are thankful for the excellent support from the Academia Sinica
   Common Mass Spectrometry Facilities for glycan analyses, Academia Sinica
   Cryo-EM Center (Grant AS-CFII-108-110) for cryo-EM data collection, and
   Academia Sinica Grid Computing for cryo-EM data processing. This work
   was supported by the Ministry of Science and Technology (MOST), Taiwan
   (Grants MOST 106-2311-B-002-028-MY3 to H.-W.C.; 107-2628-M-001-005-MY3
   to S.-T.D.H.), National Taiwan University (108L7842 to H.-W.C.), Taiwan
   Protein Project (AS-KPQ-105-TPP), and intramural funding from Academia
   Sinica (to S.-T.D.H. and K.-H.K.).
CR Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002
   Balint A, 2014, VET MICROBIOL, V169, P154, DOI 10.1016/j.vetmic.2013.10.015
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Benetka V, 2004, VET MICROBIOL, V99, P31, DOI 10.1016/j.vetmic.2003.07.010
   Boileau MJ, 2010, VET CLIN N AM-FOOD A, V26, P123, DOI 10.1016/j.cvfa.2009.10.003
   BOTARELLI P, 1991, J IMMUNOL, V147, P3128
   Carbone FR, 1997, GLYCOBIOLOGY, V7, P725, DOI 10.1093/glycob/7.6.725-d
   CAVANAGH D, 1983, J GEN VIROL, V64, P1187, DOI 10.1099/0022-1317-64-5-1187
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chien CTH, 2017, MOLECULES, V22, DOI 10.3390/molecules22081357
   DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990
   Dimitrov JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002095
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364
   Hohdatsu T, 1998, ARCH VIROL, V143, P839, DOI 10.1007/s007050050336
   Jaimes JA, 2018, VIROLOGY, V517, P108, DOI 10.1016/j.virol.2017.12.027
   Kipar A, 2014, VET PATHOL, V51, P505, DOI 10.1177/0300985814522077
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200
   Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a
   Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004
   Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808
   Pedersen NC, 2014, VET J, V201, P133, DOI 10.1016/j.tvjl.2014.04.016
   Pedersen NC, 2014, VET J, V201, P123, DOI 10.1016/j.tvjl.2014.04.017
   Ritchie G, 2010, VIROLOGY, V399, P257, DOI 10.1016/j.virol.2009.12.020
   Satoh R, 2011, VACCINE, V29, P1791, DOI 10.1016/j.vaccine.2010.12.106
   Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9
   Selby M, 1999, J IMMUNOL, V162, P669
   Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009
   Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0
   Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259
   Van Breedam W, 2014, FEMS MICROBIOL REV, V38, P598, DOI 10.1111/1574-6976.12052
   Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293
   Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988
   Wasik BR, 2016, TRENDS MICROBIOL, V24, P991, DOI 10.1016/j.tim.2016.07.005
   Werdelin O, 2002, P NATL ACAD SCI USA, V99, P9611, DOI 10.1073/pnas.152345899
   Xiong XL, 2018, J VIROL, V92
   Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zheng J, 2018, VIROLOGY, V513, P65, DOI 10.1016/j.virol.2017.10.003
   Zheng Q, 2006, BIOCHEMISTRY-US, V45, P15205, DOI 10.1021/bi061686w
   Zhou YC, 2010, J VIROL, V84, P8753, DOI 10.1128/JVI.00554-10
NR 47
TC 0
Z9 0
U1 26
U2 26
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 21
PY 2020
VL 117
IS 3
BP 1438
EP 1446
DI 10.1073/pnas.1908898117
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KF0YH
UT WOS:000508977600035
PM 31900356
OA Green Published, Bronze
DA 2020-04-03
ER

PT J
AU Wu, AM
   Yu, B
   Zhang, KY
   Xu, ZW
   Wu, D
   He, J
   Luo, JQ
   Luo, YH
   Yu, J
   Zheng, P
   Che, LQ
   Mao, XB
   Huang, ZQ
   Wang, L
   Zhao, J
   Chen, DW
AF Wu, Aimin
   Yu, Bing
   Zhang, Keying
   Xu, Zhiwen
   Wu, De
   He, Jun
   Luo, Junqiu
   Luo, Yuheng
   Yu, Jie
   Zheng, Ping
   Che, Lianqiang
   Mao, Xiangbing
   Huang, Zhiqing
   Wang, Lan
   Zhao, Jun
   Chen, Daiwen
TI Transmissible gastroenteritis virus targets Paneth cells to inhibit the
   self-renewal and differentiation of Lgr5 intestinal stem cells via Notch
   signaling
SO CELL DEATH & DISEASE
LA English
DT Article
ID CORONAVIRUS; CRYPT; HOMEOSTASIS; SUPPRESSES; ACTIVATION; INDUCTION;
   GENES
AB Infection with transmissible gastroenteritis virus (TGEV) has been associated with villous atrophy within 48 h, which seriously disrupts intestinal homeostasis. However, the underlying mechanisms remain elusive. In this study, we found that TGEV infection severely disrupted intestinal homeostasis via inhibition of self-renewal and differentiation in Lgr5 intestinal stem cells (ISCs). Profoundly, TGEV-encoded NSP10/NSP16 protein complex-mediated the inactivation of Notch signaling provided a mechanistic explanation for this phenomenon. Initial invasions by TGEV-targeted Paneth cells through aminopeptidase N (APN) receptor, then inducing mitochondrial damage and ROS generation in them, ultimately causing Paneth cell decrease and loss of Notch factors (DII4 and Hes5), which are essential for Lgr5 ISCs self-renewal and differentiation. Interestingly, loss of Notch signaling induced goblet cells differentiation at the cost of absorptive enterocytes and promoted mucins secretion, which accelerated TGEV replication. Therefore, the more differentiation of goblet cells, the greater TGEV infection in jejunum. These results provide a detailed mechanistic pathway by which villous atrophy sharply occurs in TGEV-infected jejunum within 48 h. Thus, the pathogenesis of TGEV can be described as a "bottom up scenario", which is contrary to the traditional "top down" hypothesis. Together, our findings provide a potential link between diarrheal virus infection and crypt cells response that regulates Paneth cells function and Lgr5 ISCs fate and could be exploited for therapeutic application.
C1 [Wu, Aimin; Yu, Bing; Zhang, Keying; Wu, De; He, Jun; Luo, Junqiu; Luo, Yuheng; Yu, Jie; Zheng, Ping; Che, Lianqiang; Mao, Xiangbing; Huang, Zhiqing; Wang, Lan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Peoples R China.
   [Wu, Aimin; Yu, Bing; Zhang, Keying; Wu, De; He, Jun; Luo, Junqiu; Luo, Yuheng; Yu, Jie; Zheng, Ping; Che, Lianqiang; Mao, Xiangbing; Huang, Zhiqing; Wang, Lan; Chen, Daiwen] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr China Minist Edu, Chengdu, Peoples R China.
   [Xu, Zhiwen; Zhao, Jun] Sichuan Agr Univ, Coll Vet Med, Chengdu, Peoples R China.
RP Chen, DW (reprint author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Peoples R China.
EM dwchen@sicau.edu.cn
FU China National Key Research & Development Project [2016YFD0501204];
   China Agricultural Research System on Pigs [CARS-35]
FX This work was supported by China National Key Research & Development
   Project (2016YFD0501204) and China Agricultural Research System on Pigs
   (CARS-35).
CR Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004
   Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086
   CHARLEY B, 1988, J VIROL, V62, P8, DOI 10.1128/JVI.62.1.8-11.1988
   Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Date S, 2015, ANNU REV CELL DEV BI, V31, P269, DOI 10.1146/annurev-cellbio-100814-125218
   Dayton TL, 2017, CELL RES, V27, P851, DOI 10.1038/cr.2017.59
   Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08
   Ding L, 2014, BIOCHEM BIOPH RES CO, V445, P497, DOI 10.1016/j.bbrc.2014.02.039
   Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031
   Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y
   Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007
   Huang C, 2011, J VIROL, V85, P638, DOI 10.1128/JVI.01806-10
   Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35
   Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Li B, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1987-1
   Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17
   Menachery VD, 2014, VIRUS RES, V194, P191, DOI 10.1016/j.virusres.2014.09.009
   Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254
   Nusse YM, 2018, NATURE, V559, P109, DOI 10.1038/s41586-018-0257-1
   Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005
   PENSAERT M, 1970, ARCH GES VIRUSFORSCH, V31, P321, DOI 10.1007/BF01253767
   Rathinam VAK, 2018, TRENDS MOL MED, V24, P304, DOI 10.1016/j.molmed.2018.01.004
   Rodriguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673
   Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637
   Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018
   Schwegmann-Wessels C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-435
   Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017
   Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001
   Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070
   Valenta T, 2016, CELL REP, V15, P911, DOI 10.1016/j.celrep.2016.03.088
   van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031
   van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659
   van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581
   VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763
   Xia L, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1012-9
   Xue M, 2017, ANTIVIR RES, V142, P68, DOI 10.1016/j.antiviral.2017.03.006
   Yan KS, 2017, CELL STEM CELL, V21, P78, DOI 10.1016/j.stem.2017.06.014
   Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737
   Zhao XM, 2018, MOL CELL PROTEOMICS, V17, P190, DOI 10.1074/mcp.RA117.000432
   Zhou YR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00940
NR 44
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 20
PY 2020
VL 11
IS 1
AR 40
DI 10.1038/s41419-020-2233-6
PG 16
WC Cell Biology
SC Cell Biology
GA KI6FP
UT WOS:000511445500005
PM 31959773
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Do, VT
   Jang, J
   Park, J
   Dao, HT
   Kim, K
   Hahn, TW
AF Van Tan Do
   Jang, Jisung
   Park, Jeongho
   Hoai Thu Dao
   Kim, Kiju
   Hahn, Tae-Wook
TI Recombinant adenovirus carrying a core neutralizing epitope of porcine
   epidemic diarrhea virus and heat-labile enterotoxin B of Escherichia
   coli as a mucosal vaccine
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID IMMUNE-RESPONSES; TRACE AMOUNT; SUBUNIT; PROTEIN; EXPRESSION;
   IDENTIFICATION; CORONAVIRUS; ANTIBODIES; OUTBREAK; ADJUVANT
AB Porcine epidemic diarrhea virus (PEDV) targets the intestinal mucosa in pigs. To protect against PEDV invasion, a mucosal vaccine is utilized effectively. In this study, we generated a recombinant adenovirus vaccine encoding the heat-labile enterotoxin B (LTB) and the core neutralizing epitope (COE) of PEDV (rAd-LTB-COE). The fusion protein LTB-COE was successfully expressed by the recombinant adenovirus in HEK293 cells, and the immunogenicity of the vaccine candidate was assessed in BALB/c mice and piglets. Three intramuscular or oral vaccinations with rAd-LTB-COE at two-week intervals induced robust humoral and mucosal immune responses. Moreover, a cell-mediated immune response was promoted in immunized mice, and the neutralizing antibody inhibited both the vaccine strain and the emerging PEDV isolate. Immunization experiments in piglets revealed that rAd-LTB-COE was immunogenic and induced good immune responses in piglets. Further studies are required to evaluate the efficacy of rAd-LTB-COE against a highly virulent PEDV challenge.
C1 [Van Tan Do; Park, Jeongho; Hoai Thu Dao; Kim, Kiju; Hahn, Tae-Wook] Kangwon Natl Univ, Coll Vet Med, Dept Vet Med, 1 Gangwondehaekgil, Chuncheon Si 24341, Gangwon Do, South Korea.
   [Van Tan Do; Park, Jeongho; Hoai Thu Dao; Kim, Kiju; Hahn, Tae-Wook] Kangwon Natl Univ, Inst Vet Sci, 1 Gangwondehaekgil, Chuncheon Si 24341, Gangwon Do, South Korea.
   [Jang, Jisung] Gangwon Vet Serv Lab, Chunchon, South Korea.
   [Park, Jeongho] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.
RP Hahn, TW (reprint author), Kangwon Natl Univ, Coll Vet Med, Dept Vet Med, 1 Gangwondehaekgil, Chuncheon Si 24341, Gangwon Do, South Korea.; Hahn, TW (reprint author), Kangwon Natl Univ, Inst Vet Sci, 1 Gangwondehaekgil, Chuncheon Si 24341, Gangwon Do, South Korea.
EM twhahn@kangwon.ac.kr
CR Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612
   Bagdasarian MM, 1999, VACCINE, V17, P441, DOI 10.1016/S0264-410X(98)00216-3
   BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401
   Callebaut P, 1996, J GEN VIROL, V77, P309, DOI 10.1099/0022-1317-77-2-309
   Chang SH, 2002, MOL CELLS, V14, P295
   Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13
   Cho YY, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00505-14
   Cruz DJM, 2008, VIRUS RES, V132, P192, DOI 10.1016/j.virusres.2007.10.015
   Douglas JT, 2007, MOL BIOTECHNOL, V36, P71, DOI 10.1007/s12033-007-0021-5
   FERGUSON A, 1995, CLIN EXP IMMUNOL, V99, P70
   Ge JW, 2012, CAN J MICROBIOL, V58, P1258, DOI 10.1139/w2012-098
   Hashigucci K, 1996, VACCINE, V14, P113, DOI 10.1016/0264-410X(95)00174-Y
   Huy NX, 2011, MOL BIOTECHNOL, V48, P201, DOI 10.1007/s12033-010-9359-1
   Jawale CV, 2014, CLIN VACCINE IMMUNOL, V21, P799, DOI 10.1128/CVI.00016-14
   Jeon BW, 2012, VET IMMUNOL IMMUNOP, V150, P149, DOI 10.1016/j.vetimm.2012.09.006
   Kang TJ, 2006, PROTEIN EXPRES PURIF, V46, P16, DOI 10.1016/j.pep.2005.07.026
   Kang TJ, 2004, PROTEIN EXPRES PURIF, V38, P129, DOI 10.1016/j.pep.2004.07.014
   Lavelle EC, 1995, ADV DRUG DELIVER REV, V18, P5, DOI 10.1016/0169-409X(95)00048-C
   Lee C-M, 2015, ACTA PSYCHOPATHOLOGI, V1, P13
   Lee S, 2015, VIRUS RES, V208, P215, DOI 10.1016/j.virusres.2015.07.010
   Lin HX, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0529-z
   Liu RY, 2005, VIRUS RES, V112, P24, DOI 10.1016/j.virusres.2005.02.009
   Lv C, 2016, VIRUS ADAPT TREAT, V8, P1, DOI [10.2147/vaat.s107275, DOI 10.2147/VAAT.S107275]
   Mestecky J, 1997, Behring Inst Mitt, P33
   Pan YF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-195
   PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606
   Song DS, 2007, RES VET SCI, V82, P134, DOI 10.1016/j.rvsc.2006.03.007
   Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166
   SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992
   Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675
   Sun DB, 2007, ACTA VIROL, V51, P149
   Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022
   Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259
   TAMURA S, 1994, VACCINE, V12, P1083, DOI 10.1016/0264-410X(94)90177-5
   Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491
   Wang XN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110312
   Wesley RD, 2004, VACCINE, V22, P3427, DOI 10.1016/j.vaccine.2004.02.040
   Yu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054952
NR 38
TC 0
Z9 0
U1 14
U2 14
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAR
PY 2020
VL 165
IS 3
BP 609
EP 618
DI 10.1007/s00705-019-04492-7
EA JAN 2020
PG 10
WC Virology
SC Virology
GA KL5GP
UT WOS:000507697000001
PM 31950289
OA Bronze
DA 2020-04-03
ER

PT J
AU Sungsuwan, S
   Jongkaewwattana, A
   Jaru-Ampornpan, P
AF Sungsuwan, Suttipun
   Jongkaewwattana, Anan
   Jaru-Ampornpan, Peera
TI Nucleocapsid proteins from other swine enteric coronaviruses
   differentially modulate PEDV replication
SO VIROLOGY
LA English
DT Article
DE Porcine epidemic diarrhea virus; Swine coronavirus; Nucleocapsid protein
ID PORCINE EPIDEMIC DIARRHEA; TRANSMISSIBLE GASTROENTERITIS VIRUS; RNA
   PACKAGING SIGNAL; C-TERMINAL DOMAINS; INFECTION ETIOLOGY;
   CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; GENOME SEQUENCE; BINDING DOMAIN;
   INFLUENZA-A
AB Porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV) and porcine deltacoronavirus (PDCoV) share tropism for swine intestinal epithelial cells. Whether mixing of viral components during co-infection alters pathogenic outcomes or viral replication is not known. In this study, we investigated how different coronavirus nucleocapsid (CoV N) proteins interact and affect PEDV replication. We found that PDCoV N and TGEV N can competitively interact with PEDV N. However, the presence of PDCoV or TGEV N led to very different outcomes on PEDV replication. While PDCoV N significantly suppresses PEDV replication, overexpression of TGEV N, like that of PEDV N, increases production of PEDV RNA and virions. Despite partial interchangeability in nucleocapsid oligomerization and viral RNA synthesis, endogenous PEDV N cannot be replaced in the production of infectious PEDV particles. Results from this study give insights into functional compatibilities and evolutionary relationship between CoV viral proteins during viral co-infection and co-evolution.
C1 [Sungsuwan, Suttipun; Jongkaewwattana, Anan; Jaru-Ampornpan, Peera] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Res Team, Pathum Thani 12120, Thailand.
RP Jaru-Ampornpan, P (reprint author), NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Res Team, Pathum Thani 12120, Thailand.
EM peera.jar@biotec.or.th
FU BIOTEC's Fellow Grant [P-15-51261]
FX The authors would like to thank Dr. Qigai He for anti-PEDV S antibody,
   and Benjamas Liwnaree for technical assistance. We thank the members of
   Virology and Cell Technology Research Team, especially Dr. Samaporn
   Teeravechyan, for critical comments and language help on the manuscript.
   This work was supported by BIOTEC's Fellow Grant [grant number
   P-15-51261].
CR AOKI H, 1984, J GEN VIROL, V65, P1385, DOI 10.1099/0022-1317-65-8-1385
   Bag S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044803
   Baker SF, 2014, J VIROL, V88, P10778, DOI 10.1128/JVI.01440-14
   Chang CK, 2016, DRUG DISCOV TODAY, V21, P562, DOI 10.1016/j.drudis.2015.11.015
   Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009
   Chang CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065045
   Chang CK, 2009, J VIROL, V83, P2255, DOI 10.1128/JVI.02001-08
   Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069
   Cong YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06062-w
   Cui L, 2015, J VIROL, V89, P9029, DOI 10.1128/JVI.01331-15
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   Ding Z, 2017, ONCOTARGET, V8, P49655, DOI 10.18632/oncotarget.17912
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   Dong N, 2015, EMERG INFECT DIS, V21, P2254, DOI 10.3201/eid2112.150283
   Enjuanes L, 2000, VIRUS TAXONOMY CLASS, P827
   Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Gimenez-Lirola LG, 2017, J CLIN MICROBIOL, V55, P1426, DOI [10.1128/jcm.02507-16, 10.1128/JCM.02507-16]
   He RT, 2004, VIRUS RES, V105, P121, DOI 10.1016/j.virusres.2004.05.002
   He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074
   Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005
   Hsin WC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0449-x
   Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b
   Hurst KR, 2013, J VIROL, V87, P9159, DOI 10.1128/JVI.01275-13
   Hurst KR, 2010, J VIROL, V84, P10276, DOI 10.1128/JVI.01287-10
   Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005
   Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363
   Jaru-Ampornpan P, 2017, J VIROL, V91, DOI [10.1128/JVI.01660-16, 10.1128/jvi.01660-16]
   Jaru-Ampornpan P, 2014, BIOCHEM BIOPH RES CO, V443, P296, DOI 10.1016/j.bbrc.2013.11.100
   Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06
   Jengarn J, 2015, J GEN VIROL, V96, P2206, DOI 10.1099/vir.0.000184
   Jung K, 2016, VIRUS RES, V226, P50, DOI 10.1016/j.virusres.2016.04.009
   Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017
   Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219
   Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002
   Kuo L, 2016, J VIROL, V90, P4357, DOI 10.1128/JVI.03212-15
   Kuo L, 2014, J VIROL, V88, P4451, DOI 10.1128/JVI.03866-13
   Lee S, 2014, GENOME ANNOUNCEMENTS, V2
   Lin CM, 2015, J VIROL, V89, P3332, DOI 10.1128/JVI.03196-14
   Liwnaree B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212632
   Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016
   Ma YL, 2010, PROTEIN CELL, V1, P688, DOI 10.1007/s13238-010-0079-x
   Ma YM, 2016, VET MICROBIOL, V186, P90, DOI 10.1016/j.vetmic.2016.02.004
   MASTERS PS, 1994, J VIROL, V68, P328, DOI 10.1128/JVI.68.1.328-337.1994
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000
   Narayanan K, 2003, VIRUS RES, V98, P131, DOI 10.1016/j.virusres.2003.08.021
   Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650
   Tripathi D, 2015, VIROLOGY, V478, P137, DOI 10.1016/j.virol.2015.01.009
   Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10
   Wang D, 2016, VIRUS RES, V226, P7, DOI 10.1016/j.virusres.2016.05.026
   Wang JB, 2013, EMERG INFECT DIS, V19, P2048, DOI 10.3201/eid1912.121088
   Wanitchang A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030282
   Xu W, 2018, J VIROL, V92, DOI 10.1128/JVI.00825-18
   Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034
   Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000
   Yu IM, 2006, J BIOL CHEM, V281, P17134, DOI 10.1074/jbc.M602107200
   Zhao SS, 2014, VIRUS RES, V192, P34, DOI 10.1016/j.virusres.2014.08.014
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046
   Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09
NR 67
TC 0
Z9 0
U1 9
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 15
PY 2020
VL 540
BP 45
EP 56
DI 10.1016/j.virol.2019.11.007
PG 12
WC Virology
SC Virology
GA KF1IK
UT WOS:000509003900006
PM 31756532
OA Bronze
DA 2020-04-03
ER

PT J
AU Eickmann, M
   Gravemann, U
   Handke, W
   Tolksdorf, F
   Reichenberg, S
   Muller, TH
   Seltsam, A
AF Eickmann, Markus
   Gravemann, Ute
   Handke, Wiebke
   Tolksdorf, Frank
   Reichenberg, Stefan
   Mueller, Thomas H.
   Seltsam, Axel
TI Inactivation of three emerging viruses - severe acute respiratory
   syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah
   virus - in platelet concentrates by ultraviolet C light and in plasma by
   methylene blue plus visible light
SO VOX SANGUINIS
LA English
DT Article; Early Access
DE ultraviolet light; methylene blue; pathogen inactivation; plasma;
   platelet concentrates
ID FRESH-FROZEN PLASMA; PATHOGEN INACTIVATION; REDUCTION; SYSTEM;
   EPIDEMIOLOGY; TRANSMISSION; INFECTIVITY
AB Background Emerging viruses like severe acute respiratory syndrome coronavirus (SARS-CoV), Crimean-Congo haemorrhagic fever virus (CCHFV) and Nipah virus (NiV) have been identified to pose a potential threat to transfusion safety. In this study, the ability of the THERAFLEX UV-Platelets and THERAFLEX MB-Plasma pathogen inactivation systems to inactivate these viruses in platelet concentrates and plasma, respectively, was investigated. Materials and methods Blood products were spiked with SARS-CoV, CCHFV or NiV, and then treated with increasing doses of UVC light (THERAFLEX UV-Platelets) or with methylene blue (MB) plus increasing doses of visible light (MB/light; THERAFLEX MB-Plasma). Samples were taken before and after treatment with each illumination dose and tested for residual infectivity. Results Treatment with half to three-fourths of the full UVC dose (0 center dot 2 J/cm(2)) reduced the infectivity of SARS-CoV (>= 3 center dot 4 log), CCHFV (>= 2 center dot 2 log) and NiV (>= 4 center dot 3 log) to the limit of detection (LOD) in platelet concentrates, and treatment with MB and a fourth of the full light dose (120 J/cm(2)) decreased that of SARS-CoV (>= 3 center dot 1 log), CCHFV (>= 3 center dot 2 log) and NiV (>= 2 center dot 7 log) to the LOD in plasma. Conclusion Our study demonstrates that both THERAFLEX UV-Platelets (UVC) and THERAFLEX MB-Plasma (MB/light) effectively reduce the infectivity of SARS-CoV, CCHFV and NiV in platelet concentrates and plasma, respectively.
C1 [Eickmann, Markus] Philipps Univ Marburg, Inst Virol, Marburg, Germany.
   [Gravemann, Ute; Handke, Wiebke; Mueller, Thomas H.; Seltsam, Axel] German Red Cross Blood Serv NSTOB, Springe, Germany.
   [Tolksdorf, Frank; Reichenberg, Stefan] Maco Pharma Int GmbH, Langen, Germany.
RP Seltsam, A (reprint author), German Red Cross Blood Serv NSTOB, Inst Springe, Eldagsener Str 38, D-31832 Springe, Germany.
EM axel.seltsam@bsd-nstob.de
RI Reichenberg, Stefan/AAB-3159-2020
OI Muller, Thomas H./0000-0002-5417-6787
FU German Red Cross Blood Services (Deutsche Forschungsgemeinschaft der
   Blutspendedienste des Deutschen Roten Kreuzes); Macopharma S.A.S.
FX This work was supported by the German Red Cross Blood Services (Deutsche
   Forschungsgemeinschaft der Blutspendedienste des Deutschen Roten
   Kreuzes) and Macopharma S.A.S.
CR Agafonov A P, 2004, Dokl Biol Sci, V394, P58, DOI 10.1023/B:DOBS.0000017131.06970.74
   Ang BSP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01875-17
   ARNASON NA, 2019, [No title captured], DOI DOI 10.1111/TRF.15575
   Bahar B, 2020, BRIT J HAEMATOL, V188, P465, DOI 10.1111/bjh.16187
   Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006
   Castro E, 2008, VOX SANG, V95, P290
   Castro E, 2014, TRANSFUSION, V54, P2207, DOI 10.1111/trf.12598
   Conger NG, 2015, EMERG INFECT DIS, V21, P23, DOI 10.3201/eid2101.141413
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dunstan RA, 2008, AUST NZ J PUBL HEAL, V32, P354, DOI 10.1111/j.1753-6405.2008.00254.x
   Eickmann M, 2018, TRANSFUSION, V58, P2202, DOI 10.1111/trf.14652
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Gravemann U, 2019, TRANSFUSION, V59, P1324, DOI 10.1111/trf.15119
   Gravemann U, 2018, TRANSFUSION, V58, P2669, DOI 10.1111/trf.14957
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Kim S, 2018, TRANSFUSION, V58, P758, DOI 10.1111/trf.14464
   McCullough J, 2019, TRANSFUSION, V59, P1132, DOI 10.1111/trf.15103
   MOHR H, 1995, IMMUNOL INVEST, V24, P73, DOI 10.3109/08820139509062763
   Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x
   Nikolay B, 2019, NEW ENGL J MED, V380, P1804, DOI 10.1056/NEJMoa1805376
   Olschlager S, 2011, J CLIN VIROL, V50, P90, DOI 10.1016/j.jcv.2010.09.018
   Politis C, 2014, TRANSFUSION MED, V24, P316, DOI 10.1111/tme.12144
   Seghatchian J, 2008, TRANSFUS APHER SCI, V38, P271, DOI 10.1016/j.transci.2008.04.004
   Seghatchian J, 2011, TRANSFUS MED HEMOTH, V38, P55, DOI 10.1159/000323786
   Seltsam A, 2013, BRIT J HAEMATOL, V162, P442, DOI 10.1111/bjh.12403
   Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845
   Sharma V, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2010
   Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Wild TF, 2009, PATHOL BIOL, V57, P188, DOI 10.1016/j.patbio.2008.04.006
   Williamson LM, 2003, TRANSFUSION, V43, P1322, DOI 10.1046/j.1537-2995.2003.00483.x
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
NR 34
TC 0
Z9 0
U1 50
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0042-9007
EI 1423-0410
J9 VOX SANG
JI Vox Sang.
DI 10.1111/vox.12888
EA JAN 2020
PG 6
WC Hematology
SC Hematology
GA KB7BT
UT WOS:000506646700001
PM 31930543
OA Bronze
DA 2020-04-03
ER

PT J
AU Ryu, JH
   Shin, SU
   Choi, KS
AF Ryu, Ji-Hyoung
   Shin, Seung-Uk
   Choi, Kyoung-Seong
TI Molecular surveillance of viral pathogens associated with diarrhea in
   pre-weaned Korean native calves
SO TROPICAL ANIMAL HEALTH AND PRODUCTION
LA English
DT Article; Early Access
DE Calf diarrhea; Bovine coronavirus; Bovine norovirus; Bovine group a
   rotavirus; Bovine torovirus
ID A ROTAVIRUS STRAINS; NEONATAL CALF DIARRHEA; BOVINE CORONAVIRUS; FECAL
   SPECIMENS; DAIRY CALVES; WINTER DYSENTERY; TOROVIRUS; CATTLE;
   NOROVIRUSES; INFECTIONS
AB Calf diarrhea causes severe economic losses in the cattle industry worldwide. This study investigated the prevalence of bovine coronavirus (BCoV), bovine norovirus (BNoV), bovine group A rotavirus (BoRVA), and bovine torovirus (BToV) in calves aged <= 60 days, regardless of diarrhea, across nine different regions in the Republic of Korea (ROK) and reported associations between these viruses and diarrhea. Fecal samples were collected rectally from 689 calves: normal (n = 360) and diarrheic (n = 329). BNoV (84/689, 12.2%) was the most prevalent regardless of diarrhea, followed by BCoV (37/689, 5.4%), BToV (15/689, 2.2%), and BoRVA (13/689, 1.9%). Although BCoV (P = 0.032) and BoRVA (P = 0.007) were significantly associated with diarrhea in pre-weaned calves, BNoV and BToV showed no association. Infection by the four pathogens had no relationship with calf age; BoRVA was detected only in calves aged < 30 days, but this finding was not statistically significant. Phylogenetic analysis revealed that BCoV isolates obtained in this study were distinct from the other known BCoVs, and all BNoV isolates belonged to GIII.2 genotype; genetic variations in BNoVs are present in the ROK. BoRVA isolates distributed in the ROK were assigned to G6P[5]. Within the P[5] genotype, our isolates were divided into two lineages: P[5]-III and P[5]-VIII. P[5]- VIII lineage was dominant in pre-weaned Korean native calves. Our BToV isolates were more closely related to a European isolate, B145, than to Japanese isolates. Here, BNoV was frequently identified in calves, suggesting its non-significant contribution to calf diarrhea, whereas BCoV and BoRVA were responsible for calf diarrhea in the ROK. Consequently, our results highlight the importance of rapid diagnosis against these viruses in calf diarrhea.
C1 [Ryu, Ji-Hyoung; Shin, Seung-Uk; Choi, Kyoung-Seong] Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Anim Sci & Biotechnol, Sangju 37224, South Korea.
   [Ryu, Ji-Hyoung] Anim & Plant Quarantine Agcy, Foreign Anim Dis Div, Gimcheon 39660, South Korea.
RP Choi, KS (reprint author), Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Anim Sci & Biotechnol, Sangju 37224, South Korea.
EM kschoi3@knu.ac.kr
OI Choi, Kyoung-Seong/0000-0002-2271-5360
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [2018R1D1A1B07048271]
FX This research was supported by the National Research Foundation of Korea
   (NRF), funded by the Korea government (MSIP) (No. 2018R1D1A1B07048271).
CR Aita T, 2012, ARCH VIROL, V157, P423, DOI 10.1007/s00705-011-1183-9
   Alferi AF, 2004, VET MICROBIOL, V99, P167, DOI 10.1016/j.vetmic.2003.10.029
   Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589
   ATHANASSIOUS R, 1994, CAN VET J, V35, P163
   Badaracco A, 2013, INFECT GENET EVOL, V18, P18, DOI 10.1016/j.meegid.2013.04.023
   Bartels CJM, 2010, PREV VET MED, V93, P162, DOI 10.1016/j.prevetmed.2009.09.020
   Bendali F, 1999, VET RES, V30, P509
   Bidokhti MRM, 2012, VET J, V193, P386, DOI 10.1016/j.tvjl.2011.12.015
   Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001
   CLARK MA, 1993, BRIT VET J, V149, P51, DOI 10.1016/S0007-1935(05)80210-6
   Collins PJ, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-13
   Di Martino B, 2014, ARCH VIROL, V159, P2717, DOI 10.1007/s00705-014-2109-0
   Dian ZQ, 2017, J GEN VIROL, V98, P1163, DOI 10.1099/jgv.0.000807
   Duckmanton L, 1998, J CLIN MICROBIOL, V36, P1266, DOI 10.1128/JCM.36.5.1266-1270.1998
   ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989
   Ferragut F, 2016, INFECT GENET EVOL, V40, P144, DOI 10.1016/j.meegid.2016.02.034
   Fukai K, 2004, J VET MED SCI, V66, P1413, DOI 10.1292/jvms.66.1413
   Gebregiorgis A, 2016, TROP ANIM HEALTH PRO, V48, P273, DOI 10.1007/s11250-015-0946-9
   Gulacti I, 2014, ARCH VIROL, V159, P1623, DOI 10.1007/s00705-014-1977-7
   GUNTHER H, 1987, ARCH EXP VET MED, V41, P934
   HECKERT RA, 1990, VET MICROBIOL, V22, P187, DOI 10.1016/0378-1135(90)90106-6
   Hoet AE, 2002, AM J VET RES, V63, P342, DOI 10.2460/ajvr.2002.63.342
   ISEGAWA Y, 1993, MOL CELL PROBE, V7, P277, DOI 10.1006/mcpr.1993.1041
   Ito M, 2016, INFECT GENET EVOL, V38, P90, DOI 10.1016/j.meegid.2015.12.013
   Kirisawa R, 2007, J VET MED SCI, V69, P471, DOI 10.1292/jvms.69.471
   KOOPMANS M, 1991, AM J VET RES, V52, P1769
   Lojkic I, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0511-9
   Lyoo KS, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1723-6
   Manuja BK, 2008, VIRUS RES, V138, P36, DOI 10.1016/j.virusres.2008.08.006
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   Meganck V, 2015, PREV VET MED, V118, P64, DOI 10.1016/j.prevetmed.2014.11.007
   Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027
   Mohamed FF, 2017, ARCH VIROL, V162, P129, DOI 10.1007/s00705-016-3088-0
   Park J, 2018, ASIAN PAC J TROP BIO, V8, P1, DOI 10.4103/2221-1691.221037
   Park SJ, 2007, ZOONOSES PUBLIC HLTH, V54, P223, DOI 10.1111/j.1863-2378.2007.01045.x
   Park SI, 2007, VET MICROBIOL, V124, P125, DOI 10.1016/j.vetmic.2007.03.010
   Park SI, 2011, J VET MED SCI, V73, P479, DOI 10.1292/jvms.10-0280
   Park SJ, 2008, VET MICROBIOL, V126, P364, DOI 10.1016/j.vetmic.2007.07.012
   Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189
   Pourasgari F, 2018, ARCH VIROL, V163, P1271, DOI 10.1007/s00705-018-3716-y
   REYNOLDS DJ, 1986, VET REC, V119, P34, DOI 10.1136/vr.119.2.34
   Ryu JH, 2019, TROP ANIM HEALTH PRO, V51, P2085, DOI 10.1007/s11250-019-01882-6
   SAIF LJ, 1990, CORNELL VET, V80, P303
   Smiley JR, 2003, J CLIN MICROBIOL, V41, P3089, DOI 10.1128/JCM.41.7.3089-3099.2003
   SNODGRASS DR, 1986, VET REC, V119, P39, DOI 10.1136/vr.119.2.39
   SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939
   Thomas C, 2014, ARCH VIROL, V159, P83, DOI 10.1007/s00705-013-1795-3
   TORRESMEDINA A, 1985, VET CLIN N AM-FOOD A, V1, P471, DOI 10.1016/S0749-0720(15)31297-4
   Tsunemitsu H, 1999, ARCH VIROL, V144, P167, DOI 10.1007/s007050050493
   Turan T, 2018, J VET RES, V62, P129, DOI 10.2478/jvetres-2018-0021
   Uhde FL, 2008, VET REC, V163, P362
   van der Poel WHM, 2003, VET MICROBIOL, V92, P297, DOI 10.1016/S0378-1135(02)00421-2
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
   WOODE GN, 1982, VET MICROBIOL, V7, P221, DOI 10.1016/0378-1135(82)90036-0
NR 54
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0049-4747
EI 1573-7438
J9 TROP ANIM HEALTH PRO
JI Trop. Anim. Health Prod.
DI 10.1007/s11250-019-02181-w
EA JAN 2020
PG 10
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA KV8AU
UT WOS:000520701400001
PM 31927690
OA Bronze
DA 2020-04-03
ER

PT J
AU Wolff, GG
AF Wolff, Greg G.
TI Influenza vaccination and respiratory virus interference among
   Department of Defense personnel during the 2017-2018 influenza season
SO VACCINE
LA English
DT Article
DE Influenza vaccine; Virus interference; Department of Defense;
   Respiratory illness
ID TEST-NEGATIVE DESIGN; UNITED-STATES; PROTECTION
AB Purpose: Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined.
   Results: We compared vaccination status of 2880 people with non-influenza respiratory viruses to 3240 people with pan-negative results. Comparing vaccinated to non-vaccinated patients, the adjusted odds ratio for non-flu viruses was 0.97 (95% confidence interval (CI): 0.86, 1.09; p = 0.60). Additionally, the vaccination status of 3349 cases of influenza were compared to three different control groups: all controls (N = 6120), non-influenza positive controls (N = 2880), and pan-negative controls (N = 3240). The adjusted ORs for the comparisons among the three control groups did not vary much (range: 0.46-0.51).
   Conclusions: Receipt of influenza vaccination was not associated with virus interference among our population. Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections. Published by Elsevier Ltd.
C1 [Wolff, Greg G.] Armed Forces Hlth Surveillance Branch Air Force S, 2510 5th St,Bldg 840, Wright Patterson AFB, OH 45433 USA.
RP Wolff, GG (reprint author), Armed Forces Hlth Surveillance Branch Air Force S, 2510 5th St,Bldg 840, Wright Patterson AFB, OH 45433 USA.
EM gregory.wolff.3@us.af.mil
CR [Anonymous], 2016, CDC INFL A SUBT KIT
   [Anonymous], 2017, BIOF FILMARRAY RESP
   [Anonymous], 2016, NXTAG RESP PATH PAN
   [Anonymous], 2016, CDC INFL A B SUBT KI
   Centers for Disease Control and Prevention, 2019, SEAS INFL VACC EFF 2
   Coleman Robert, 2018, MSMR, V25, P16
   Cooper M., 2014, VACC REL BIOL PROD A
   Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e
   Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307
   Defense Health Agency, 2018, SEAS INFL VACC PROGR, P1
   Feng S, 2017, EPIDEMIOLOGY, V28, P514, DOI 10.1097/EDE.0000000000000670
   Foppa IM, 2016, INT J EPIDEMIOL, V45, P2052, DOI 10.1093/ije/dyw022
   Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026
   Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/nejmoa1700153, 10.1056/NEJMoa1700153]
   Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053
   McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647
   National Vaccine Information Center, 2019, WHAT IS HIST INFL VA
   Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736
   Rikin S, 2018, VACCINE, V36, P1958, DOI 10.1016/j.vaccine.2018.02.105
   Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064
   Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379
   Suzuki M, 2014, EPIDEMIOL INFECT, V142, P2642, DOI 10.1017/S0950268814000107
   Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574
NR 23
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 10
PY 2020
VL 38
IS 2
BP 350
EP 354
DI 10.1016/j.vaccine.2019.10.005
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KG0DU
UT WOS:000509612700033
PM 31607599
OA Bronze
DA 2020-04-03
ER

PT J
AU Carter, DC
   Wright, B
   Jerome, WG
   Rose, JP
   Wilson, E
AF Carter, Daniel C.
   Wright, Brenda
   Jerome, W. Gray
   Rose, John P.
   Wilson, Ellen
TI A Unique Protein Self-Assembling Nanoparticle with Significant
   Advantages in Vaccine Development and Production
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID HERPES-SIMPLEX-VIRUS; IDIOPATHIC PULMONARY-FIBROSIS; ANTIBODY-RESPONSES;
   DNA
AB Nanoparticles are playing an increasingly powerful role in vaccine development. Here, we report the repurposing of nonstructural proteins 10 and 11 (hereafter NSP10) from the replicase polyprotein 1a (pp1a) of the human SARS coronavirus (severe acute respiratory syndrome) as a novel self-assembling platform for bioengineered nanoparticles for a variety of applications including vaccines. NSP10 represents a 152 amino acid, 17 kD zinc finger transcription/regulatory protein which self-assembles to form a spherical 84 angstrom diameter nanoparticle with dodecahedral trigonal 32 point symmetry. As a self-assembling nanoparticle, NSP10 possesses numerous advantages in vaccine development and antigen display, including the unusual particle surface disposition of both the N- and C-termini. Each set of N- or C-termini is spatially disposed in a tetrahedral arrangement and positioned at optimal distances from the 3-fold axes (8-10 angstrom) to nucleate and stabilize the correct folding of complex helical or fibrous trimeric receptors, such as those responsible for viral tropism and cell infection. An application example in the exploratory development of a therapeutic vaccine for idiopathic pulmonary fibrosis (IPF), including preliminary analysis and immunogenic properties, is presented. The use of this system could accelerate the discovery and development of vaccines for a number of human, livestock, and veterinary applications.
C1 [Carter, Daniel C.; Wright, Brenda; Wilson, Ellen] Albumin Therapeut LLC, 895 Martin Rd SW, Huntsville, AL 35824 USA.
   [Carter, Daniel C.] New Century Pharmaceut Inc, 895 Martin Rd SW, Huntsville, AL 35824 USA.
   [Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, U2206 MCN,1161 21st Ave, Nashville, TN USA.
   [Rose, John P.] Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA.
RP Carter, DC (reprint author), Albumin Therapeut LLC, 895 Martin Rd SW, Huntsville, AL 35824 USA.; Carter, DC (reprint author), New Century Pharmaceut Inc, 895 Martin Rd SW, Huntsville, AL 35824 USA.
EM dcarter@albuminbio.com
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA68485, DK20593, DK58404, DK59637,
   EY08126]
FX Electron microscopy was performed in part through the use of the
   Vanderbilt University Cell Imaging Shared Resource Center (supported by
   NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126).
CR ABLASHI DV, 1976, CANCER RES, V36, P701
   Awasthi S, 2015, J VIROL, V89, P8497, DOI 10.1128/JVI.01089-15
   Cairns TM, 2015, J VIROL, V89, P9213, DOI 10.1128/JVI.01213-15
   Carter D. C., 2006, U S Patent, Patent No. [7,097,841, 7097841]
   Carter D. C., 2018, Patent No. 15768250
   Cohen J, 2013, SCIENCE, V341, P1168, DOI 10.1126/science.341.6151.1171
   Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP
   Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277
   Fickenscher H, 2001, PHILOS T R SOC B, V356, P545, DOI 10.1098/rstb.2000.0780
   Folcik VA, 2014, MODERN PATHOL, V27, P851, DOI 10.1038/modpathol.2013.198
   Hensel MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02257-16
   Kanekiyo M, 2015, CELL, V162, P1090, DOI 10.1016/j.cell.2015.07.043
   Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202
   King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582
   Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751
   Li C. Q., 2006, IND BIOTECHNOL, V2, P143, DOI DOI 10.1089/IND.2006.2.143
   Li L, 2017, CURR ISSUES MOL BIOL, V22, P17, DOI 10.21775/cimb.022.017
   Li L, 2016, EXPERT REV VACCINES, V15, P313, DOI 10.1586/14760584.2016.1124762
   Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012
   Ma GG, 2013, VET MICROBIOL, V167, P123, DOI 10.1016/j.vetmic.2013.06.018
   Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC
   Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC
   Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008
   Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200
   Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL
   Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584
   Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06
   Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003
   Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120
   Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294
   Weed DJ, 2017, ADV ANAT EMBRYOL CEL, V223, P29, DOI 10.1007/978-3-319-53168-7_2
   Williams KJ, 2014, VET PATHOL, V51, P372, DOI 10.1177/0300985814521838
   Zhao YN, 2019, ARCH VIROL, V164, P1371, DOI 10.1007/s00705-019-04201-4
NR 33
TC 0
Z9 0
U1 16
U2 16
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PD JAN 4
PY 2020
VL 2020
AR 4297937
DI 10.1155/2020/4297937
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA KC6GC
UT WOS:000507272700003
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Bai, DC
   Fang, LR
   Xia, SJ
   Ke, WT
   Wang, J
   Wu, XL
   Fang, PX
   Xiao, SB
AF Bai, Dongcheng
   Fang, Liurong
   Xia, Sijin
   Ke, Wenting
   Wang, Jing
   Wu, Xiaoli
   Fang, Puxian
   Xiao, Shaobo
TI Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral
   replication
SO VIROLOGY
LA English
DT Article
DE Porcine deltacoronavirus; Ca2+ influx; Ca2+ channel blocker; Viral
   replication
ID ION-CHANNEL ACTIVITY; CA2+ INFLUX; PROTEIN; CELLS; SWINE;
   IDENTIFICATION; CORONAVIRUSES; MITOCHONDRIA; HOMEOSTASIS; PREVALENCE
AB Ionic calcium (Ca2+) is a versatile intracellular second messenger that plays important roles in cellular physiological and pathological processes. Porcine deltacoronavirus (PDCoV) is an emerging enteropathogenic coronavirus that causes serious vomiting and diarrhea in suckling piglets. In this study, the role of Ca2+ to PDCoV infection was investigated. PDCoV infection was found to upregulate intracellular Ca2+ concentrations of IPI-21 cells. Chelating extracellular Ca2+ by EGTA inhibited PDCoV replication, and this inhibitory effect was overcome by replenishment with CaCl2. Treatment with Ca2+ channel blockers, particularly the L-type Ca2+ channel blocker diltiazem hydrochloride, inhibited PDCoV infection significantly. Mechanistically, diltiazem hydrochloride reduces PDCoV infection by inhibiting the replication step of the viral replication cycle. Additionally, knockdown of CACNA1S, the L-type Ca2+ voltage-gated channel subunit, inhibited PDCoV replication. The combined results demonstrate that PDCoV modulates calcium influx to favor its replication.
C1 [Bai, Dongcheng; Fang, Liurong; Xia, Sijin; Ke, Wenting; Wang, Jing; Wu, Xiaoli; Fang, Puxian; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Bai, Dongcheng; Fang, Liurong; Xia, Sijin; Ke, Wenting; Wang, Jing; Wu, Xiaoli; Fang, Puxian; Xiao, Shaobo] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
RP Fang, LR (reprint author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.
EM fanglr@mail.hzau.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31730095, U1704231, 31902247]; National Key R&D
   Program of China [2016YFD0500103]; Special Project for Technology
   Innovation of Hubei Province [2017ABA138]
FX This work was supported by the National Natural Science Foundation of
   China (31730095, U1704231, 31902247), the National Key R&D Program of
   China (2016YFD0500103), and the Special Project for Technology
   Innovation of Hubei Province (2017ABA138).
CR Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Brault C, 2013, VIRUSES-BASEL, V5, P954, DOI 10.3390/v5030954
   Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015
   Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17
   Ciechonska M, 2014, J VIROL, V88, P6137, DOI 10.1128/JVI.00121-14
   CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5
   De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216
   Dionicio CL, 2018, VIRUS RES, V245, P17, DOI 10.1016/j.virusres.2017.11.029
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   Dong N, 2015, EMERG INFECT DIS, V21, P2254, DOI 10.3201/eid2112.150283
   EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4
   Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177
   Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Fang PX, 2016, VIROLOGY, V499, P170, DOI 10.1016/j.virol.2016.09.015
   Fujioka Y, 2018, CELL HOST MICROBE, V23, P809, DOI 10.1016/j.chom.2018.04.015
   Gaspers LD, 2014, CELL REP, V9, P1209, DOI 10.1016/j.celrep.2014.10.033
   Giorgi C, 2008, CURR MOL MED, V8, P119
   Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361
   Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110
   Hyser JM, 2013, J VIROL, V87, P13579, DOI 10.1128/JVI.02629-13
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Jung K, 2018, RES VET SCI, V119, P99, DOI 10.1016/j.rvsc.2018.06.009
   Jung K, 2017, ARCH VIROL, V162, P2357, DOI 10.1007/s00705-017-3351-z
   Jung K, 2016, VET MICROBIOL, V182, P57, DOI 10.1016/j.vetmic.2015.10.022
   Kabir ZD, 2016, J PHYSIOL-LONDON, V594, P5823, DOI 10.1113/JP270673
   Kraus RL, 1998, J BIOL CHEM, V273, P27205, DOI 10.1074/jbc.273.42.27205
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Lee YJ, 2018, VIRUS RES, V253, P112, DOI 10.1016/j.virusres.2018.06.008
   Leyrat C, 2014, STRUCTURE, V22, P136, DOI 10.1016/j.str.2013.10.013
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Liang Q, 2019, VIRUSES, V11, pE573
   Lipscombe D, 2015, CURR MOL PHARMACOL, V8, P22, DOI 10.2174/1874467208666150507103215
   Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106
   Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820
   Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15
   Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.140526, 10.3201/eid2008.14-0526]
   Qin P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050455
   Robin G, 2015, J PHYSIOL-LONDON, V593, P4781, DOI 10.1113/JP270252
   Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8
   Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528
   Surya W, 2015, VIRUS RES, V201, P61, DOI 10.1016/j.virusres.2015.02.023
   Verdia-Baguena C, 2013, BBA-BIOMEMBRANES, V1828, P2026, DOI 10.1016/j.bbamem.2013.05.008
   Wang K, 2012, FEBS LETT, V586, P384, DOI 10.1016/j.febslet.2012.01.005
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/JVI.01055-17, 10.1128/jvi.01055-17]
   Wang XL, 2019, VET MICROBIOL, V233, P21, DOI 10.1016/j.vetmic.2019.04.014
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Xie SQ, 2011, CELL RES, V21, P1271, DOI 10.1038/cr.2011.112
   Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x
   Zhang JL, 2019, J BIOL CHEM, V294, P9830, DOI 10.1074/jbc.RA119.007779
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
   Zhang RH, 2014, BBA-BIOMEMBRANES, V1838, P1088, DOI 10.1016/j.bbamem.2013.07.025
   Zhou HY, 2017, ANGEW CHEM INT EDIT, V56, P12908, DOI 10.1002/anie.201705769
   Zhu XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0068-3
NR 60
TC 0
Z9 0
U1 17
U2 17
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 2
PY 2020
VL 539
BP 38
EP 48
DI 10.1016/j.virol.2019.10.011
PG 11
WC Virology
SC Virology
GA JY4GC
UT WOS:000504374300005
PM 31670218
OA Bronze
DA 2020-04-03
ER

PT J
AU Fu, JY
   Chen, R
   Hu, JF
   Qu, H
   Zhao, YJ
   Cao, SJ
   Wen, XT
   Wen, YP
   Wu, R
   Zhao, Q
   Ma, XP
   Huang, XB
AF Fu, Jiayu
   Chen, Rui
   Hu, Jingfei
   Qu, Huan
   Zhao, Yujia
   Cao, Sanjie
   Wen, Xintian
   Wen, Yiping
   Wu, Rui
   Zhao, Qin
   Ma, Xiaoping
   Huang, Xiaobo
TI Identification of a Novel Linear B-Cell Epitope on the Nucleocapsid
   Protein of Porcine Deltacoronavirus
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE porcine deltacoronavirus; nucleocapsid; monoclonal antibodies
ID EPIDEMIC DIARRHEA VIRUS; LINKED-IMMUNOSORBENT-ASSAY; INFECTION; SWINE;
   DISCOVERY; ALPHACORONAVIRUS; CORONAVIRUSES; PREVALENCE; REACTIVITY;
   ANTIBODIES
AB Porcine deltacoronavirus (PDCoV), first identified in 2012, is a swine enteropathogen now found in many countries. The nucleocapsid (N) protein, a core component of PDCoV, is essential for virus replication and is a significant candidate in the development of diagnostics for PDCoV. In this study, monoclonal antibodies (mAbs) were generated and tested for reactivity with three truncations of the full protein (N1, N2, N3) that contained partial overlaps; of the five monoclonals chosen tested, each reacted with only the N3 truncation. The antibody designated 4E88 had highest binding affinity with the N protein and was chosen for in-depth examination. The 4E88 epitope was located to amino acids 308-AKPKQQKKPKK-318 by testing the 4E88 monoclonal for reactivity with a series of N3 truncations, then the minimal epitope, 309-KPKQQKKPK-317 (designated EP-4E88), was pinpointed by testing the 4E88 monoclonal for reactivity with a series of synthetic peptides of this region. Homology analysis showed that the EP-4E88 sequence is highly conserved among PDCoV strains, and also shares high similarity with sparrow coronavirus (HKU17), Asian leopard cat coronavirus (ALCCoV), quail coronavirus (UAE-HKU30), and sparrow deltacoronavirus (SpDCoV). Of note, the PDCoV EP-4E88 sequence shared very low similarity (<22.2%) with other porcine coronaviruses (PEDV, TGEV, PRCV, SADS-CoV, PHEV), demonstrating that it is an epitope that can be used for distinguishing PDCoV and other porcine coronavirus. 3D structural analysis revealed that amino acids of EP-4E88 were in close proximity and may be exposed on the surface of the N protein.
C1 [Fu, Jiayu; Chen, Rui; Hu, Jingfei; Qu, Huan; Zhao, Yujia; Cao, Sanjie; Wen, Xintian; Wen, Yiping; Wu, Rui; Zhao, Qin; Huang, Xiaobo] Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu 611130, Peoples R China.
   [Cao, Sanjie; Ma, Xiaoping; Huang, Xiaobo] Minist Agr, Sichuan Sci Observat Expt Stn Vet Drugs & Vet Dia, Chengdu 611130, Peoples R China.
   [Cao, Sanjie; Huang, Xiaobo] Sichuan Agr Univ, Natl Teaching & Expt Ctr Anim, Chengdu 611130, Peoples R China.
RP Huang, XB (reprint author), Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu 611130, Peoples R China.; Huang, XB (reprint author), Minist Agr, Sichuan Sci Observat Expt Stn Vet Drugs & Vet Dia, Chengdu 611130, Peoples R China.; Huang, XB (reprint author), Sichuan Agr Univ, Natl Teaching & Expt Ctr Anim, Chengdu 611130, Peoples R China.
EM huangxiaobo@sicau.edu.cn
OI WU, RUI/0000-0001-7791-4167
FU National Key Research and Development Program of China [2016YFD0500700]
FX This study was supported by the National Key Research and Development
   Program of China (award 2016YFD0500700).
CR BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0
   BERNARD S, 1989, VET MICROBIOL, V21, P1, DOI 10.1016/0378-1135(89)90013-8
   Chang CY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39844-5
   Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9
   Chen CW, 2017, JOVE-J VIS EXP, DOI 10.3791/55417
   Chen CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126121
   Chen Q, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0108-z
   Chen R, 2020, VIRUS RES, V276, DOI 10.1016/j.virusres.2019.197834
   Cong YY, 2020, J VIROL, V94, DOI 10.1128/JVI.01925-19
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Gimenez-Lirola LG, 2017, J CLIN MICROBIOL, V55, P1426, DOI [10.1128/jcm.02507-16, 10.1128/JCM.02507-16]
   Guo H, 2006, J GEN VIROL, V87, P217, DOI 10.1099/vir.0.81393-0
   Hou XL, 2007, VET MICROBIOL, V123, P86, DOI 10.1016/j.vetmic.2007.02.014
   Hsin WC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0449-x
   Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852
   Jung K, 2016, VIRUS RES, V226, P50, DOI 10.1016/j.virusres.2016.04.009
   Lau SKP, 2018, J VIROL, V92, DOI [10.1128/JVI.00265-18, 10.1128/jvi.00265-18]
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Leung DTM, 2004, J INFECT DIS, V190, P379, DOI 10.1086/422040
   Li CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36288
   Li GW, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00278-14
   Li K, 2019, ANTIVIR RES, V166, P11, DOI 10.1016/j.antiviral.2019.03.010
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Lin CM, 2015, J VIROL, V89, P3332, DOI 10.1128/JVI.03196-14
   Ma YM, 2016, VET MICROBIOL, V186, P90, DOI 10.1016/j.vetmic.2016.02.004
   Marthaler D, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00218-14
   Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.140526, 10.3201/eid2008.14-0526]
   Okda F, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0716-6
   Pan YF, 2017, VET MICROBIOL, V211, P15, DOI 10.1016/j.vetmic.2017.09.020
   Potocnakova L, 2016, J IMMUNOL RES, DOI 10.1155/2016/6760830
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Su MJ, 2016, J VET MED SCI, V78, P601, DOI 10.1292/jvms.15-0533
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39010
   Wang LY, 2016, ARCH VIROL, V161, P171, DOI 10.1007/s00705-015-2627-4
   Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wang XL, 2019, VET MICROBIOL, V233, P21, DOI 10.1016/j.vetmic.2019.04.014
   Wang YW, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00945-15
   Woo PCY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.37
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Xie WT, 2019, J GEN VIROL, V100, P206, DOI 10.1099/jgv.0.001216
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yang WT, 2019, APPL MICROBIOL BIOT, V103, P3705, DOI 10.1007/s00253-019-09702-5
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zhao YJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111074
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046
NR 50
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 2
PY 2020
VL 21
IS 2
AR 648
DI 10.3390/ijms21020648
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA KO2KZ
UT WOS:000515380000278
PM 31963776
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Lin, CY
   Hwang, D
   Chiu, NC
   Weng, LC
   Liu, HF
   Mu, JJ
   Liu, CP
   Chi, H
AF Lin, Chien-Yu
   Hwang, David
   Chiu, Nan-Chang
   Weng, Li-Chuan
   Liu, Hsin-Fu
   Mu, Jung-Jung
   Liu, Chang-Pan
   Chi, Hsin
TI Increased Detection of Viruses in Children with Respiratory Tract
   Infection Using PCR
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE respiratory virus; polymerase chain reaction; PCR; respiratory syncytial
   virus; human metapneumovirus; multiplex quantitative real-time RT-PCR
ID REAL-TIME PCR; COMMUNITY-ACQUIRED PNEUMONIA; SYNCYTIAL-VIRUS; REQUIRING
   HOSPITALIZATION; HUMAN METAPNEUMOVIRUS; YOUNG-CHILDREN; MULTIPLEX PCR;
   INFLUENZA-A; DIAGNOSIS; ANTIBIOTICS
AB Respiratory viruses are a common cause of respiratory tract infection (RTI), particularly in neonates and children. Rapid and accurate diagnosis of viral infections could improve clinical outcomes and reduce the use of antibiotics and treatment sessions. Advances in diagnostic technology contribute to the accurate detection of viruses. We performed a multiplex real-time polymerase chain reaction (PCR) to investigate the viral etiology in pediatric patients and compared the detection rates with those determined using traditional antigen tests and virus cultures. Fifteen respiratory viruses were included in our investigation: respiratory syncytial virus A/B (RSV), influenza virus A (FluA) and influenza virus B (FluB), human metapneumovirus (MPV), enterovirus (EV), human parainfluenza virus (PIV) types 1-4, human rhinovirus (RV), human coronavirus OC43, NL63, and 229E, human adenovirus (ADV), and human bocavirus (Boca). In total, 474 specimens were collected and tested. Respiratory viruses were detected more frequently by PCR (357, 75.3%) than they were by traditional tests (229, 49.3%). The leading pathogens were RSV (113, 23.8%), RV (72, 15.2%), PIV3 (53, 11.2%), FluA (51, 10.8%), and ADV (48, 10.1%). For children younger than 5 years, RSV and RV were most prevalent; for children older than 5 years, FluA and ADV were the most frequently detected. Of the specimens, 25.8% (92/357) were coinfected with two or more viruses. RV, Boca, PIV2, FluB, and PIV4 had higher rates of coinfection; MPV and PIV1 had the lowest rates of coinfection (9.1% and 5.3%). To conclude, the detection power of PCR was better than that of traditional antigen tests and virus cultures when considering the detection of respiratory viruses. RSV and RV were the leading viral pathogens identified in the respiratory specimens. One-quarter of the positive specimens were coinfected with two or more viruses. In the future, further application of PCR may contribute to the rapid and accurate diagnosis of respiratory viruses and could improve patient outcomes.
C1 [Lin, Chien-Yu] Hsinchu MacKay Mem Hosp, Dept Pediat, Hsinchu 30071, Taiwan.
   [Lin, Chien-Yu; Chiu, Nan-Chang; Liu, Chang-Pan; Chi, Hsin] MacKay Med Coll, Dept Med, New Taipei 25160, Taiwan.
   [Hwang, David; Chiu, Nan-Chang; Chi, Hsin] MacKay Childrens Hosp, Dept Pediat, Taipei 10449, Taiwan.
   [Hwang, David; Chiu, Nan-Chang; Chi, Hsin] MacKay Mem Hosp, Taipei 10449, Taiwan.
   [Chiu, Nan-Chang; Liu, Chang-Pan; Chi, Hsin] MacKay Jr Coll Med Nursing & Management, Dept Med, Taipei 11260, Taiwan.
   [Weng, Li-Chuan; Liu, Hsin-Fu; Liu, Chang-Pan; Chi, Hsin] MacKay Mem Hosp, Dept Med Res, New Taipei 25160, Taiwan.
   [Mu, Jung-Jung] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei 10050, Taiwan.
RP Chi, H (reprint author), MacKay Med Coll, Dept Med, New Taipei 25160, Taiwan.; Chi, H (reprint author), MacKay Childrens Hosp, Dept Pediat, Taipei 10449, Taiwan.; Chi, H (reprint author), MacKay Mem Hosp, Taipei 10449, Taiwan.; Chi, H (reprint author), MacKay Jr Coll Med Nursing & Management, Dept Med, Taipei 11260, Taiwan.; Chi, H (reprint author), MacKay Mem Hosp, Dept Med Res, New Taipei 25160, Taiwan.
EM mmhped.lin@gmail.com; Ckdarpay@gmail.com; ncc88@mmh.org.tw;
   lichuan@mmh.org.tw; hsinfu@mmh.org.tw; jjmu@cdc.gov.tw;
   cpliu@mmh.org.tw; chi.4531@mmh.org.tw
OI Lin, Chien-Yu/0000-0003-4630-8724; Chi, Hsin/0000-0002-2385-344X; Liu,
   Hsin-Fu/0000-0003-0082-2269
FU MacKay Memorial Hospital, Taipei, Taiwan [MMH-103-65]
FX This study is supported by MacKay Memorial Hospital, Taipei, Taiwan
   (Project number: MMH-103-65). This study was approved by the
   Institutional Review Board of the MacKay Memorial Hospital, Taipei,
   Taiwan (approval no. 14MMHIS030).
CR Babakir-Mina M, 2013, APMIS, V121, P746, DOI 10.1111/apm.12091
   Bennett NJ, 2012, J PEDIATR-US, V161, P814, DOI 10.1016/j.jpeds.2012.05.001
   Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89
   Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9
   Breakell R, 2018, EUR J PEDIATR, V177, P47, DOI 10.1007/s00431-017-3034-5
   Charles PGP, 2008, CURR OPIN PULM MED, V14, P176, DOI 10.1097/MCP.0b013e3282f7642f
   Chen HZ, 2017, BIOMED RES INT, DOI 10.1155/2017/7320859
   Chen Y, 2011, J CLIN MICROBIOL, V49, P1653, DOI 10.1128/JCM.02184-10
   Chi H, 2011, J FORMOS MED ASSOC, V110, P388, DOI 10.1016/S0929-6646(11)60057-0
   Chidlow GR, 2009, VIRUSES-BASEL, V1, P42, DOI 10.3390/v1010042
   Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247
   Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054
   Ferronato AE, 2012, CLINICS, V67, P1001, DOI 10.6061/clinics/2012(09)03
   Hsu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110166
   Huang ASE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132160
   Huang HS, 2018, CLIN MICROBIOL INFEC, V24, P1055, DOI 10.1016/j.cmi.2017.11.018
   Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276
   Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245
   Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870
   Jiang WJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2891-x
   Kim HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198902
   Krause JC, 2014, DTSCH ARZTEBL INT, V111, P639, DOI 10.3238/arztebl.2014.0639
   Kuypers J, 2006, J CLIN MICROBIOL, V44, P2382, DOI 10.1128/JCM.00216-06
   Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07
   Lee JH, 2012, CLIN TRANSPLANT, V26, P736, DOI 10.1111/j.1399-0012.2012.01607.x
   Garcia-Garcia ML, 2012, PEDIATR INFECT DIS J, V31, P808, DOI 10.1097/INF.0b013e3182568c67
   Ma YJ, 2015, J MICROBIOL IMMUNOL, V48, P632, DOI 10.1016/j.jmii.2014.08.003
   Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004
   McCaig LF, 2003, EMERG INFECT DIS, V9, P432
   Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701
   Mills JM, 2011, J HOSP INFECT, V77, P248, DOI 10.1016/j.jhin.2010.11.019
   Minejima E, 2016, EXPERT REV ANTI-INFE, V14, P1065, DOI 10.1080/14787210.2016.1233814
   Nolan VG, 2018, J INFECT DIS, V218, P179, DOI 10.1093/infdis/jix641
   Ortiz-Hernandez AA, 2019, INFLUENZA OTHER RESP, V13, P36, DOI 10.1111/irv.12606
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Scheltema NM, 2017, LANCET GLOB HEALTH, V5, pE984, DOI 10.1016/S2214-109X(17)30344-3
   Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457
   Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596
   Sim SA, 2018, BIOL BLOOD MARROW TR, V24, P1490, DOI 10.1016/j.bbmt.2018.03.004
   Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2
   Stefanska I, 2013, ADV EXP MED BIOL, V756, P291, DOI 10.1007/978-94-007-4549-0_36
   Sung CC, 2011, J MICROBIOL IMMUNOL, V44, P184, DOI 10.1016/j.jmii.2011.01.025
   Tanday S, 2016, LANCET RESP MED, V4, P179, DOI 10.1016/S2213-2600(16)00060-6
   Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004
   Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4
   van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7
   Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012
   Yoshida LM, 2013, EUR RESPIR J, V42, P461, DOI 10.1183/09031936.00101812
NR 50
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN 2
PY 2020
VL 17
IS 2
AR 564
DI 10.3390/ijerph17020564
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KQ3LG
UT WOS:000516827400185
PM 31952364
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU More, GD
   Dunowska, M
   Acke, E
   Cave, NJ
AF More, G. D.
   Dunowska, M.
   Acke, E.
   Cave, N. J.
TI A serological survey of canine respiratory coronavirus in New Zealand
SO NEW ZEALAND VETERINARY JOURNAL
LA English
DT Article
DE Canine respiratory coronavirus; ELISA; seroprevalence; New Zealand;
   survey
ID GROUP-2 CORONAVIRUS; INFLUENZA-VIRUS; PREVALENCE; DOGS; DISEASE
AB Aims: To determine the seroprevalence of canine respiratory coronavirus (CRCoV) in New Zealand dogs, and to explore associations with age, sex, breed, month, and geographical region of sampling and reported presence of clinical signs suggestive of respiratory disease.
   Methods: A total of 1,015 canine serum samples were randomly selected from submissions to a diagnostic laboratory between March and December 2014, and were analysed for CRCoV antibodies using a competitive ELISA. Logistic regression analysis was used to determine associations between seroprevalence of CRCoV and breed category, age, sex, sampling month, region, and reported health status of dogs.
   Results: Overall, 538/1,015 (53.0%) samples were seropositive for CRCoV, with 492/921 (53.4%) positive dogs in the North Island and 46/94 (49%) in the South Island. Age of dog, sampling month, region, and presence of abnormal respiratory signs were included in the initial logistic regression model. Seroprevalence was higher in dogs aged >= 3 compared with <= 2 years (p<0.01). The lowest seroprevalence was observed in July (30/105; 28.5%) and August (32/100; 32%), and the highest in June (74/100; 74%). Seroprevalence in dogs from Auckland was higher than in dogs from the Hawkes Bay, Manawatu, Marlborough, and Waikato regions (p<0.05). Abnormal respiratory signs (coughing, nasal discharge, or sneezing) were reported for 28/1,015 (2.8%) dogs sampled. Seroprevalence for CRCoV tended to be higher among dogs with respiratory signs (67.9 (95% CI=47.6-83.4)%) than dogs with no reported respiratory signs (52.6 (95% CI=49.5-55.7)%).
   Conclusions: Serological evidence of infection with CRCoV was present in more than half of the dogs tested from throughout New Zealand. Differences in CRCoV seroprevalence between regions and lack of seasonal pattern indicate that factors other than external temperatures may be important in the epidemiology of CRCoV in New Zealand.
C1 [More, G. D.; Dunowska, M.; Acke, E.; Cave, N. J.] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand.
   [Acke, E.] Vet Med Lab GmbH, IDEXX Labs, Ludwigsburg, Germany.
RP Dunowska, M (reprint author), Massey Univ, Sch Vet Sci, Palmerston North, New Zealand.
EM m.dunowska@massey.ac.nz
FU New Zealand Greyhound Racing Association
FX Sincere thanks to Raewynne Pearson and Adrienne French for supplying the
   serum samples for ELISA and to Janis Bridges for help with statistical
   analysis. This study was partly funded by the New Zealand Greyhound
   Racing Association.
CR An DJ, 2010, J VET MED SCI, V72, P1217, DOI 10.1292/jvms.10-0067
   Decaro N, 2007, VET MICROBIOL, V121, P225, DOI 10.1016/j.vetmic.2006.12.001
   Ellis JA, 2005, CAN VET J, V46, P447
   Erles K, 2005, ARCH VIROL, V150, P1493, DOI 10.1007/s00705-005-0533-x
   Erles K, 2003, VIROLOGY, V310, P216, DOI 10.1016/S0042-6822(03)00160-0
   Eyles K, 2008, VET CLIN N AM-SMALL, V38, P815, DOI 10.1016/j.cvsm.2008.02.008
   Kaneshima T, 2006, J VET MED SCI, V68, P21, DOI 10.1292/jvms.68.21
   Knesl O, 2009, NEW ZEAL VET J, V57, P295, DOI 10.1080/00480169.2009.58624
   Mitchell JA, 2017, VET MICROBIOL, V212, P31, DOI 10.1016/j.vetmic.2017.10.019
   Priestnall SL, 2007, J VET DIAGN INVEST, V19, P176, DOI 10.1177/104063870701900206
   Priestnall SL, 2006, VET MICROBIOL, V115, P43, DOI 10.1016/j.vetmic.2006.02.008
   Soma T, 2008, VET REC, V163, P368, DOI 10.1136/vr.163.12.368
   Sowman HR, 2018, NEW ZEAL VET J, V66, P236, DOI 10.1080/00480169.2018.1490214
NR 13
TC 0
Z9 0
U1 43
U2 44
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0048-0169
EI 1176-0710
J9 NEW ZEAL VET J
JI N. Z. Vet. J.
PD JAN 2
PY 2020
VL 68
IS 1
BP 54
EP 59
DI 10.1080/00480169.2019.1667282
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA JS8RS
UT WOS:000500569700001
PM 31513753
OA Bronze
DA 2020-04-03
ER

PT J
AU Adams, N
AF Adams, Neal
TI Cracking the code to the 2019 novel coronavirus (COVID-19): Lessons from
   the eye
SO EYE REPORTS
LA English
DT Article
ID ANGIOTENSIN-CONVERTING ENZYME; DIABETIC-RETINOPATHY; ACE2;
   OVEREXPRESSION
AB With the recent March 11, 2020 declaration of a pandemic by the World Health Organization (WHO), further attention has turned to understanding and managing the outbreak of infectious disease termed coronavirus disease 2019 (COVID-19) caused by the novel coronavirus identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 gains entry into human cells through its ability to bind to a human ACE2 protein. Through our understanding of diabetic retinopathy, there are genetic-based variations in ACE2 levels that confer varying risk profiles for diabetic retinopathy. Similarly, emerging research suggests ACE2 levels confer varying risk profiles for COVID-19. Using data comparisons between geographic prevalence rates of diabetic retinopathy and existing COVID-19 mortality rates may enable improved predictions of the rates of spread of COVID-19 in various geographic regions. The goal of this report is to encourage cross-disciplinary horizontal vision in the field of medicine and science in order to further progress in managing and treating human disease.
C1 [Adams, Neal] Eye Reports, 2101 Med Pk Dr Ste 303, Silver Spring, MD 20902 USA.
RP Adams, N (reprint author), Eye Reports, 2101 Med Pk Dr Ste 303, Silver Spring, MD 20902 USA.
EM editor@eyereports.org
CR Barry JM, 2004, THE GREAT INFLUENZA
   Burrell LM, 2013, CLIN SCI, V124, P65, DOI 10.1042/CS20120269
   Cai G., 2020, TOBACCO USE DISPARIT
   Cao Y, 2020, CELL DISCOVERY NATUR, V6, P1
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Chen Y, 2020, BIOCH BIOPHYSICAL RE
   Dominguez JM, 2016, AM J PATHOL, V186, P1688, DOI 10.1016/j.ajpath.2016.01.023
   Duan YQ, 2018, STEM CELLS, V36, P1430, DOI 10.1002/stem.2848
   Foureaux G, 2015, BRAZ J MED BIOL RES, V48, P1109, DOI 10.1590/1414-431X20154583
   Fu XY, 2017, INVEST OPHTH VIS SCI, V58, P3018, DOI 10.1167/iovs.17-21546
   Hoffmann M, 2020, CELL, V181, P1
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li WH, 2007, VIROLOGY, V367, P367, DOI 10.1016/j.virol.2007.04.035
   Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640
   Meng N, 2015, EYE, V29, P266, DOI 10.1038/eye.2014.254
   Qui Y, 2016, SCI REPORTS NATURE R, V6, P31912
   Rice GI, 2006, HYPERTENSION, V48, P914, DOI 10.1161/01.HYP.0000244543.91937.79
   Sabanayagam C, 2019, LANCET DIABETES ENDO, V7, P140, DOI 10.1016/S2213-8587(18)30128-1
   Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024
   Tikellis C, 2004, CURR EYE RES, V29, P419, DOI 10.1080/02713680490517944
   Verma A, 2019, MOL THER-METH CLIN D, V14, P161, DOI 10.1016/j.omtm.2019.06.007
   Verma A, 2012, MOL THER, V20, P28, DOI 10.1038/mt.2011.155
   World Health Organization, 2020, 54 WHO
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
   Zhang K, 2013, RETINA, P925
   Zhang Q, 2018, MEDICINE, V97, P1
   Zhao Y, SINGLE CELL RNA EXPR
NR 30
TC 0
Z9 0
U1 0
U2 0
PU OPHTHOSCIENCE PUBL
PI BALTIMORE
PA OPHTHOSCIENCE PUBL, BALTIMORE, MA 00000 USA
SN 2039-4748
EI 2039-4756
J9 EYE REP
JI Eye Rep.
PY 2020
VL 6
IS 1
BP S1
EP S6
PG 6
WC Ophthalmology
SC Ophthalmology
GA KV3WI
UT WOS:000520413500001
DA 2020-04-03
ER

PT J
AU Arvind, B
   Medigeshi, GR
   Kapil, A
   Xess, I
   Singh, U
   Lodha, R
   Kabra, SK
AF Arvind, Balaji
   Medigeshi, Guruprasad R.
   Kapil, Arti
   Xess, Immaculata
   Singh, Urvashi
   Lodha, Rakesh
   Kabra, Sushil Kumar
TI Aetiological agents for pulmonary exacerbations in children with cystic
   fibrosis: An observational study from a tertiary care centre in northern
   India
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
ID ANTIMICROBIAL SUSCEPTIBILITY; NONTUBERCULOUS MYCOBACTERIA; RESPIRATORY
   PATHOGENS; PREVALENCE; COLONIZATION; FREQUENCY; SAMPLES; FUNGI
AB Background & objectives: Pulmonary disease is the main cause of morbidity and mortality in cystic fibrosis (CF). The infection occurs with a unique spectrum of bacterial pathogens that are usually acquired in an age-dependent fashion. The objective of this study was to find out the aetiological agents in respiratory specimens from children with CF during pulmonary exacerbation and relate with demographic variables. Methods: In this observational study, airway secretions from children (n=104) with CF presenting with pulmonary exacerbations were collected and tested for bacteria, fungi, mycobacteria and viral pathogens using appropriate laboratory techniques. The frequencies of isolation of various organisms were calculated and associated with various demographic profiles. Results: Bacteria were isolated in 37 (35.5%) and viral RNA in 27 (29.3%) children. Pseudomonas was the most common bacteria grown in 31 (29.8%) followed by Burkholderia cepacia complex (Bcc) in three (2.8%) patients. Among viruses, Rhinovirus was the most common, identified in 16 (17.4%) samples followed by coronavirus in four (4.3%). Fungi and mycobacteria were isolated from 23 (22.1%) and four (3.8%) children, respectively. Aspergillus flavus was the most common fungus isolated in 13 (12.5%) children. Interpretation & conclusions: Pseudomonas was the most common organism isolated during exacerbation. Non-tuberculous mycobacteria were not isolated, whereas infection with Bcc and Mycobacterium tuberculosis was observed, which could probably have a role in CF morbidity. Polymicrobial infections were associated with severe exacerbations.
C1 [Arvind, Balaji; Lodha, Rakesh; Kabra, Sushil Kumar] All India Inst Med Sci, Dept Pediat, New Delhi 110029, India.
   [Kapil, Arti; Xess, Immaculata; Singh, Urvashi] All India Inst Med Sci, Dept Microbiol, New Delhi, India.
   [Medigeshi, Guruprasad R.] Translat Hlth Sci & Technol Inst, Faridabad, Haryana, India.
RP Kabra, SK (reprint author), All India Inst Med Sci, Dept Pediat, New Delhi 110029, India.
EM skkabra@hotmail.com
CR Asner S, 2012, J CYST FIBROS, V11, P433, DOI 10.1016/j.jcf.2012.04.006
   Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA, P230
   Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241
   De Bel A, 2013, J CLIN MICROBIOL, V51, P4204, DOI 10.1128/JCM.02035-13
   Filkins LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005258
   Folescu TW, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0148-2
   FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003
   Gulla KM, 2019, J TROP PEDIATRICS, V65, P176, DOI 10.1093/tropej/fmy033
   Gungor O, 2013, MYCOSES, V56, P123, DOI 10.1111/j.1439-0507.2012.02221.x
   Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942
   Kabra SK, 2007, PEDIATR PULM, V42, P1087, DOI 10.1002/ppul.20677
   Kapoor V, 2006, J CYST FIBROS, V5, P43, DOI 10.1016/j.jcf.2005.10.002
   Lambiase A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-4
   Mehta S, 1968, Indian Pediatr, V5, P185
   Montagna MT, 2011, J PREV MED HYG, V52, P209
   Munoz C, 1996, Enferm Infecc Microbiol Clin, V14, P142
   Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC
   Paixao VA, 2010, BRAZ J INFECT DIS, V14, P406, DOI 10.1590/S1413-86702010000400016
   Patil N, 2015, N AM J MED SCI, V7, P233, DOI 10.4103/1947-2714.157494
   Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665
   Quintas Sofia, 2003, Rev Port Pneumol, V9, P337
   Ranganathan SC, 2017, AM J RESP CRIT CARE, V195, P1567, DOI 10.1164/rccm.201606-1107CI
   Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132
   Sanders DB, 2017, J CYST FIBROS, V16, P592, DOI 10.1016/j.jcf.2017.04.005
   Santana Maria Angélica, 2003, Braz J Infect Dis, V7, P69, DOI 10.1590/S1413-86702003000100008
   Seddon P, 2009, EMERG INFECT DIS, V19, P1128
   Valenza G, 2008, J CYST FIBROS, V7, P123, DOI 10.1016/j.jcf.2007.06.006
   Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498
   WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194
   WOOD RE, 1976, AM REV RESPIR DIS, V113, P833
NR 30
TC 0
Z9 0
U1 3
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JAN
PY 2020
VL 151
IS 1
BP 65
EP 70
DI 10.4103/ijmr.IJMR_1275_18
PG 6
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA KT6OZ
UT WOS:000519135000008
PM 32134016
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Beury, D
   Flechon, L
   Maurier, F
   Caboche, S
   Varre, JS
   Touzet, H
   Faure, K
   Dubuisson, J
   Hot, D
   Guery, B
   Goffard, A
AF Beury, Delphine
   Flechon, Lea
   Maurier, Florence
   Caboche, Segolene
   Varre, Jean-Stephane
   Touzet, Helene
   Faure, Karine
   Dubuisson, Jean
   Hot, David
   Guery, Benoit
   Goffard, Anne
TI Use of whole-genome sequencing in the molecular investigation of
   care-associated HCoV-OC43 infections in a hematopoietic stem cell
   transplant unit
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Human coronavirus; Whole genome sequencing; Hematopoietic cell
   transplant; Care-associated infections; Phylogenetic analyses
ID RESPIRATORY-TRACT INFECTIONS; HUMAN CORONAVIRUS; CLINICAL IMPACT;
   SINGLE-CENTER; EPIDEMIOLOGY; ALIGNMENT; REVEALS; PHYLOGENIES;
   RECIPIENTS; DIVERSITY
AB Background: While respiratory viral infections are recognized as a frequent cause of illness in hematopoietic stem cell transplantation (HSCT) recipients, HCoV - OC43 infections have rarely been investigated as healthcare-associated infections in this population.
   Objectives: In this report, HOW - OC43 isolates collected from HSCT patients were retrospectively characterized to identify potential clusters of infection that may stand for a hospital transmission.
   Study design: Whole-genome and S gene sequences were obtained from nasal swabs using next-generation sequencing and phylogenetic trees were constructed. Similar identity matrix and determination of the most common ancestor were used to compare clusters of patient's sequences. Amino acids substitutions were analysed.
   Results: Genotypes B, E, F and G were identified. Two clusters of patients were defined from chronological data and phylogenetic trees. Analyses of amino acids substitutions of the S protein sequences identified substitutions specific for genotype F strains circulating among European people.
   Conclusions: HCoV - OC43 may be implicated in healthcare-associated infections.
C1 [Beury, Delphine; Maurier, Florence; Caboche, Segolene; Dubuisson, Jean; Hot, David; Goffard, Anne] Univ Lille, U1019 UMR8204 Ctr Infect & Immun Lille, Inst Pasteur Lille, CHU Lille, F-59000 Lille, France.
   [Flechon, Lea] Univ Lille, Inst Pasteur Lille, CHU Lille, INRIA, Lille, France.
   [Varre, Jean-Stephane; Touzet, Helene] Univ Lille, CRIStAL Ctr Rech Informat Signal & Automat Lille, INRIA, CNRS,UMR 9189, Lille, France.
   [Faure, Karine] CHU Lille, Malad Infect, F-59000 Lille, France.
   [Faure, Karine] Univ Lille, Relat Hote Pathogenes, Rech Translat, EA 7366, F-59000 Lille, France.
   [Guery, Benoit] Lausanne Univ Hosp, Dept Med, Infect Dis Unit, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.
   [Guery, Benoit] Univ Lausanne, Dept Med, Infect Dis Unit, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.
RP Goffard, A (reprint author), Univ Lille, U1019 UMR8204 Ctr Infect & Immun Lille, Inst Pasteur Lille, CHU Lille, F-59000 Lille, France.
EM delphine.beury@pasteur-lille.fr; lea.flechon.etu@univ-lille.fr;
   florence.maurier@pasteur-lille.fr; segolene.caboche@pasteur-lille.fr;
   jean-stephane.varre@lifl.fr; helene.touzet@lifl.fr;
   karine.faure@univ-lille.fr; jean.dubuisson@ibl.cnrs.fr;
   david.hot@pasteur-lille.fr; Benoit.Guery@unil.ch;
   anne.goffard@univ-lille.fr
RI Hot, David/M-6775-2016; Dubuisson, Jean/E-6813-2016
OI Hot, David/0000-0002-2361-0616; Dubuisson, Jean/0000-0003-1626-7693
FU Lille Hospital University; CNRSCentre National de la Recherche
   Scientifique (CNRS); Lille University (PEPS 2015)
FX This work was supported by a Lille Hospital University grant (EPICoV)
   and by CNRS and Lille University (PEPS 2015).
CR Alhamlan FS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011865
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Cardoso T, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-40
   Choi JH, 2013, J KOREAN MED SCI, V28, P36, DOI 10.3346/jkms.2013.28.1.36
   Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Esbenshade JC, 2013, INFECT CONT HOSP EP, V34, P373, DOI 10.1086/669857
   Gagneur A, 2002, J HOSP INFECT, V51, P59, DOI 10.1053/jhin.2002.1179
   Gagneur A, 2008, EUR J PEDIATR, V167, P1427, DOI 10.1007/s00431-008-0687-0
   Garbino J, 2006, CLIN INFECT DIS, V43, P1009, DOI 10.1086/507898
   Gerna G, 2006, J MED VIROL, V78, P938, DOI 10.1002/jmv.20645
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hakki M, 2015, J CLIN VIROL, V68, P1, DOI 10.1016/j.jcv.2015.04.012
   Hand J, 2018, EMERG INFECT DIS, V24, P1964, DOI 10.3201/eid2410.180862
   Hassoun A, 2015, AM J INFECT CONTROL, V43, P865, DOI 10.1016/j.ajic.2015.04.195
   Hays JP, 1998, J VIROL METHODS, V75, P179, DOI 10.1016/S0166-0934(98)00116-5
   Hutspardol S, 2015, BIOL BLOOD MARROW TR, V21, P1802, DOI 10.1016/j.bbmt.2015.06.015
   Kin N, 2016, INFECT GENET EVOL, V40, P186, DOI 10.1016/j.meegid.2016.03.006
   Kin N, 2015, VIRUSES-BASEL, V7, P2358, DOI 10.3390/v7052358
   Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Loubet P, 2017, J CLIN VIROL, V91, P52, DOI 10.1016/j.jcv.2017.04.001
   Pinana JL, 2018, BIOL BLOOD MARROW TR, V24, P563, DOI 10.1016/j.bbmt.2017.11.001
   Mackay IM, 2012, VIRUSES-BASEL, V4, P637, DOI 10.3390/v4040637
   Majumder MS, 2017, T ROY SOC TROP MED H, V111, P261, DOI 10.1093/trstmh/trx046
   Maurier F, 2019, VIROLOGY, V531, P141, DOI 10.1016/j.virol.2019.03.006
   Mikulska M, 2014, ANN HEMATOL, V93, P669, DOI 10.1007/s00277-013-1912-0
   Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152
   Ogimi C, 2017, J INFECT DIS, V216, P203, DOI 10.1093/infdis/jix264
   Ogimi C, 2017, CLIN INFECT DIS, V64, P1532, DOI 10.1093/cid/cix160
   Oong XY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.132
   Silva C.S., 2014, VIROL MYCOL INFECT D, V2014, DOI [10.4172/2161-0517.S2-004, DOI 10.4172/2161-0517.S2-004]
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Taboada BT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01256-16
   Tong SX, 2004, J INFECT DIS, V190, P1127, DOI 10.1086/422849
   Weedon KM, 2013, SCAND J INFECT DIS, V45, P297, DOI 10.3109/00365548.2012.726738
   Zhang SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191789
   Zhang Y, 2015, J INFECTION, V70, P641, DOI 10.1016/j.jinf.2014.12.005
   Zhu Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0171-5
NR 42
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2020
VL 122
AR 104206
DI 10.1016/j.jcv.2019.104206
PG 9
WC Virology
SC Virology
GA JX4VW
UT WOS:000503734800009
PM 31783264
OA Bronze
DA 2020-04-03
ER

PT J
AU Bittar, C
   Machado, RRG
   Comelis, MT
   Bueno, LM
   Beguelini, MR
   Morielle-Versute, E
   Nogueira, ML
   Rahal, P
AF Bittar, Cintia
   Guaragna Machado, Rafael Rahal
   Comelis, Manuela Tosi
   Bueno, Larissa Mayumi
   Beguelini, Mateus Rodrigues
   Morielle-Versute, Eliana
   Nogueira, Mauricio Lacerda
   Rahal, Paula
TI Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from
   Brazil
SO MICROBIAL ECOLOGY
LA English
DT Article
DE Bats; Coronavirus; Alphacoronavirus; Phylogeny
ID INTERACTIVE TREE; SEQUENCE ALIGNMENT; GENETIC DIVERSITY; ONLINE TOOL;
   LIFE ITOL; CORONAVIRUSES; DISPLAY; IDENTIFICATION; PREVALENCE;
   ANNOTATION
AB Bats are flying mammals distributed worldwide known to host several types of Coronavirus (CoV). Since they were reported as the probable source of spillover of highly pathogenic CoV into the human population, investigating the circulation of this virus in bats around the world became of great importance. We analyzed samples from 103 bats from two distinct regions in Brazil. Coronavirus from the Alphacoronavirus genus was detected in 12 animals, 11 from Sao Jose do Rio Preto-SP region and 1 from Barreiras-BA region, resulting in a prevalence of 17.18% and 2.56% respectively. The virus was detected not only in intestines but also in lungs and liver. Phylogenetic analysis based on nsP12 genomic region suggests that the sequences group according to host family and sampling location. Studies on the circulation of these viruses in bats remain important to understand the ecology and evolutionary relationship of these pathogens.
C1 [Bittar, Cintia; Guaragna Machado, Rafael Rahal; Comelis, Manuela Tosi; Bueno, Larissa Mayumi; Beguelini, Mateus Rodrigues; Morielle-Versute, Eliana; Rahal, Paula] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias Letras & Ciencias Exatas IBILCE, Campus Sao Jose do Rio Preto, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Beguelini, Mateus Rodrigues] UFOB, CCBS, Rua Prof Jose Seabra de Lemos 316, BR-47808021 Barreiras, BA, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Bittar, C (reprint author), Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias Letras & Ciencias Exatas IBILCE, Campus Sao Jose do Rio Preto, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM cibittar@gmail.com
RI ; Rahal, Paula/D-3871-2012; Nogueira, Mauricio/B-7599-2012; Bittar,
   Cintia/A-5042-2015
OI Beguelini, Mateus/0000-0002-9568-4446; Rahal, Paula/0000-0001-5693-6148;
   Nogueira, Mauricio/0000-0003-1102-2419; Bittar,
   Cintia/0000-0002-2048-4589
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP 2015/09704-6];
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [CNPq 165802/2015-4]
FX This work was funded by FAPESP (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo) and CNPq (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico). Grant numbers: FAPESP 2015/09704-6 and CNPq
   165802/2015-4.
CR Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6
   Adams RA, 2013, BAT EVOLUTION ECOLOG
   Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0
   Anthony SJ, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex012
   Arnone IS, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2015-0026
   Asano KM, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0581-8
   August TA, 2012, VECTOR-BORNE ZOONOT, V12, P530, DOI 10.1089/vbz.2011.0829
   Goes LGB, 2016, INFECT GENET EVOL, V44, P510, DOI 10.1016/j.meegid.2016.07.034
   Goes LGB, 2013, EMERG INFECT DIS, V19, P1711, DOI 10.3201/eid1910.130525
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642
   CftUotGftCaUoL, 2011, ANIMALS
   Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0
   Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11
   Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13
   Corman VM, 2013, J GEN VIROL, V94, P1984, DOI 10.1099/vir.0.054841-0
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491
   Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526
   Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186
   Feldhamer GA, 2005, MAMMALOGY ADAPTATION
   Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439
   Goffard A, 2015, VIRUSES-BASEL, V7, P6279, DOI 10.3390/v7122937
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95
   Hu B, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0422-1
   Hu D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11384-w
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Hutterer RIT, 2005, BAT MIGRATIONS EUROP
   IBGE, 2007, IBGE I BRAS GEOGR ES
   Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009
   LaVal RK, 1973, REVISION NEOTROPICAL
   Lelli D, 2013, VIRUSES-BASEL, V5, P2679, DOI 10.3390/v5112679
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201
   Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753
   Luo Y, 2018, VIROL SIN, V33, P87, DOI 10.1007/s12250-018-0017-2
   Miranda JMD, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1383.1.4
   Nogueira Marcelo Rodrigues, 2014, Check List, V10, P808
   Osborne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019156
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224
   Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005
   QGIS, 2018, QGIS DEV TEAM QGIS G
   Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06
   Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013
   Vizotto L. D., 1973, CHAVE DETERMINACAO Q
   Wacharapluesadee S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0289-1
   Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   Wilson DE, 2005, MAMMAL SPECIES WORLD
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 60
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0095-3628
EI 1432-184X
J9 MICROB ECOL
JI Microb. Ecol.
PD JAN
PY 2020
VL 79
IS 1
BP 203
EP 212
DI 10.1007/s00248-019-01391-x
PG 10
WC Ecology; Marine & Freshwater Biology; Microbiology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology;
   Microbiology
GA KL2DQ
UT WOS:000513239900018
PM 31144002
OA Bronze
DA 2020-04-03
ER

PT J
AU Bouwman, KM
   Parsons, LM
   Berends, AJ
   de Vries, RP
   Cipollo, JF
   Verheije, MH
AF Bouwman, Kim M.
   Parsons, Lisa M.
   Berends, Alinda J.
   de Vries, Robert P.
   Cipollo, John F.
   Verheije, Monique H.
TI Three Amino Acid Changes in Avian Coronavirus Spike Protein Allow
   Binding to Kidney Tissue
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE coronavirus; infectious bronchitis virus; receptor-binding domain;
   receptors; spike protein; virus-host interactions
ID INFECTIOUS-BRONCHITIS VIRUS; N-GLYCOLYLNEURAMINIC ACID; SECONDARY
   STRUCTURE; RECEPTOR; STRAIN; GENE; DETERMINANT; SPECIFICITY; ATTACHMENT;
   TROPISM
AB Infectious bronchitis virus (IBV) infects ciliated epithelial cells in the chicken respiratory tract. While some IBV strains replicate locally, others can disseminate to various organs, including the kidney. Here, we elucidate the determinants for kidney tropism by studying interactions between the receptor-binding domain (RBD) of the viral attachment protein spike from two IBV strains with different tropisms. Recombinantly produced RBDs from the nephropathogenic IBV strain QX and from the nonnephropathogenic strain M41 bound to the epithelial cells of the trachea. In contrast, only QX-RBD binds more extensively to cells of the digestive tract, urogenital tract, and kidneys. While removal of sialic acids from tissues prevented binding of all proteins to all tissues, binding of QX-RBD to trachea and kidney could not be blocked by preincubation with synthetic alpha-2,3-linked sialic acids. The lack of binding of QX-RBD to a previously identified IBV-M41 receptor was confirmed by enzyme-linked immunosorbent assay (ELISA), demonstrating that tissue binding of QX-RBD is dependent on a different sialylated glycan receptor. Using chimeric RBD proteins, we discovered that the region encompassing amino acids 99 to 159 of QX-RBD was required to establish kidney binding. In particular, QX-RBD amino acids 110 to 112 (KIP) were sufficient to render IBV-M41 with the ability to bind to kidney, while the reciprocal mutations in IBV-QX abolished kidney binding completely. Structural analysis of both RBDs suggests that the receptor-binding site for QX is located at a different location on the spike than that of M41.
   IMPORTANCE Infectious bronchitis virus is the causative agent of infectious bronchitis in chickens. Upon infection of chicken flocks, the poultry industry faces substantial economic losses by diminished egg quality and increased morbidity and mortality of infected animals. While all IBV strains infect the chicken respiratory tract via the ciliated epithelial layer of the trachea, some strains can also replicate in the kidneys, dividing IBV into the following two pathotypes: nonnephropathogenic (example, IBV-M41) and nephropathogenic viruses (including IBV-QX). Here, we set out to identify the determinants for the extended nephropathogenic tropism of IBV-QX. Our data reveal that each pathotype makes use of a different sialylated glycan ligand, with binding sites on opposite sides of the attachment protein. This knowledge should facilitate the design of antivirals to prevent coronavirus infections in the field.
C1 [Bouwman, Kim M.; Berends, Alinda J.; Verheije, Monique H.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Div Pathol, Utrecht, Netherlands.
   [Parsons, Lisa M.; Cipollo, John F.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [de Vries, Robert P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Chem Biol & Drug Discovery, Utrecht, Netherlands.
RP Bouwman, KM (reprint author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Div Pathol, Utrecht, Netherlands.
EM m.bouwman@uu.nl; m.h.verheije@uu.nl
OI de Vries, Robert/0000-0002-1586-4464
FU MEERVOUD grant from the NWO; ERCEuropean Research Council (ERC);
   Beijerinck Premium of the Royal Dutch Academy of Sciences (KNAW)
FX Monique H. Verheije is a recipient of a MEERVOUD grant from the NWO and
   Robert P. de Vries is a recipient of an ERC starting grant and a
   Beijerinck Premium of the Royal Dutch Academy of Sciences (KNAW).
CR Armesto M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007384
   Bakkers MJG, 2017, CELL HOST MICROBE, V21, P356, DOI 10.1016/j.chom.2017.02.008
   Bande F, 2017, ANIM HEALTH RES REV, V18, P70, DOI 10.1017/S1466252317000044
   Benyeda Z, 2010, J COMP PATHOL, V143, P276, DOI 10.1016/j.jcpa.2010.04.007
   Bouwman KM, 2019, J VIROL, V93, DOI [10.1128/JVI.00067-19, 10.1128/jvi.00067-19]
   Broszeit F, 2019, CELL REP, V27, P3284, DOI 10.1016/j.celrep.2019.05.048
   Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003
   de Wit JJ, 2018, AVIAN PATHOL, V47, P140, DOI 10.1080/03079457.2017.1387231
   El Rahman SA, 2009, AVIAN PATHOL, V38, P41, DOI 10.1080/03079450802632049
   Gough RE, 2008, VET REC, V162, P99, DOI 10.1136/vr.162.3.99
   Leyson C, 2016, VIROLOGY, V498, P218, DOI 10.1016/j.virol.2016.08.030
   Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15
   Liu SW, 2004, AVIAN PATHOL, V33, P321, DOI 10.1080/0307945042000220697
   MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7
   NIESTERS HGM, 1986, VIRUS RES, V5, P253, DOI 10.1016/0168-1702(86)90022-5
   Parsons LM, 2019, J BIOL CHEM, V294, P7797, DOI 10.1074/jbc.RA119.007532
   Peighambari SM, 2000, AVIAN DIS, V44, P759, DOI 10.2307/1593047
   Peng WJ, 2017, CELL HOST MICROBE, V21, P23, DOI 10.1016/j.chom.2016.11.004
   Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018
   Promkuntod N, 2013, VIRUS RES, V177, P127, DOI 10.1016/j.virusres.2013.09.006
   Raj GD, 1997, AVIAN PATHOL, V26, P677, DOI 10.1080/03079459708419246
   Schultze B, 1996, J VIROL, V70, P5634, DOI 10.1128/JVI.70.8.5634-5637.1996
   Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009
   Shen CI, 2010, VET RES, V41, DOI 10.1051/vetres/2009054
   SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
   VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q
   Villarreal LYB, 2007, AVIAN DIS, V51, P974, DOI 10.1637/7983-041307.1
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Wickramasinghe INA, 2015, J VIROL, V89, P8783, DOI 10.1128/JVI.00745-15
   Wickramasinghe INA, 2011, J VIROL, V85, P8903, DOI 10.1128/JVI.05112-11
   Wickramasinghe INA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128893
   Yu L, 2001, AVIAN DIS, V45, P416, DOI 10.2307/1592981
   YuDong W, 1998, CHINESE J ANI QUARAN, V15, P1
NR 34
TC 0
Z9 0
U1 18
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 2
AR e01363-19
DI 10.1128/JVI.01363-19
PG 14
WC Virology
SC Virology
GA KA4SO
UT WOS:000505787400014
PM 31694947
OA Other Gold, Green Published
DA 2020-04-03
ER

PT J
AU Chen, S
   Tian, J
   Li, ZJ
   Kang, HT
   Zhang, JK
   Huang, JP
   Yin, H
   Hu, XL
   Qu, LD
AF Chen, Si
   Tian, Jin
   Li, Zhijie
   Kang, Hongtao
   Zhang, Jikai
   Huang, Jiapei
   Yin, Hang
   Hu, Xiaoliang
   Qu, Liandong
TI Feline Infectious Peritonitis Virus Nsp5 Inhibits Type I Interferon
   Production by Cleaving NEMO at Multiple Sites
SO VIRUSES-BASEL
LA English
DT Article
DE DF2; type I IFN; nsp5; NEMO; cleavage
ID NF-KAPPA-B; EPIDEMIC DIARRHEA VIRUS; QUALITY-OF-LIFE; SURVIVAL-TIME;
   CORONAVIRUS; PROTEIN; CLEAVAGE; CATS; PREVALENCE; MUTATIONS
AB Feline infectious peritonitis (FIP), caused by virulent feline coronavirus, is the leading infectious cause of death in cats. The type I interferon (type I IFN)-mediated immune responses provide host protection from infectious diseases. Several coronaviruses have been reported to evolve diverse strategies to evade host IFN response. However, whether feline infectious peritonitis virus (FIPV) antagonizes the type I IFN signaling remains unclear. In this study, we demonstrated that FIPV strain DF2 infection not only failed to induce interferon-beta (IFN-beta) and interferon-stimulated gene (ISG) production, but also inhibited Sendai virus (SEV) or polyinosinic-polycytidylic acid (poly(I:C))-induced IFN-beta production. Subsequently, we found that one of the non-structural proteins encoded by the FIPV genome, nsp5, interrupted type I IFN signaling in a protease-dependent manner by cleaving the nuclear factor kappa B (NF-kappa B) essential modulator (NEMO) at three sites-glutamine132 (Q132), Q205, and Q231. Further investigation revealed that the cleavage products of NEMO lost the ability to activate the IFN-beta promoter. Mechanistically, the nsp5-mediated NEMO cleavage disrupted the recruitment of the TRAF family member-associated NF-kappa B activator (TANK) to NEMO, which reduced the phosphorylation of interferon regulatory factor 3 (IRF3), leading to the inhibition of type I IFN production. Our research provides new insights into the mechanism for FIPV to counteract host innate immune response.
C1 [Chen, Si; Tian, Jin; Li, Zhijie; Kang, Hongtao; Zhang, Jikai; Huang, Jiapei; Yin, Hang; Hu, Xiaoliang; Qu, Liandong] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.
RP Hu, XL; Qu, LD (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.
EM phdchensi@163.com; tj6049345@126.com; lizhijie@caas.cn;
   kanghongtao@caas.cn; 15776628009@163.com; sicaujiapeihuang@163.com;
   yinhvri@163.com; huxiaoliang@caas.cn; quliandong@caas.cn
FU State Key Laboratory of Veterinary Biotechnology Foundation
   [SKLVBP2018002]
FX This work was funded by the State Key Laboratory of Veterinary
   Biotechnology Foundation (SKLVBP2018002).
CR Adedeji AO, 2014, CURR OPIN VIROL, V8, P45, DOI 10.1016/j.coviro.2014.06.002
   Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200
   Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606
   Chang HW, 2010, J GEN VIROL, V91, P415, DOI 10.1099/vir.0.016485-0
   Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200
   Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3
   Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758
   Chuck CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027228
   Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   De Clercq Erik, 2006, Expert Rev Anti Infect Ther, V4, P291, DOI 10.1586/14787210.4.2.291
   De Groot-Mijnes JDF, 2005, J VIROL, V79, P1036, DOI 10.1128/JVI.79.2.1036-1044.2005
   Dean GA, 2003, VET MICROBIOL, V97, P1, DOI 10.1016/j.vetmic.2003.08.010
   Dedeurwaerder A, 2014, J GEN VIROL, V95, P393, DOI 10.1099/vir.0.058743-0
   Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157
   Felten S, 2017, J FELINE MED SURG, V19, P321, DOI 10.1177/1098612X15623824
   Fischer Y, 2011, J VET INTERN MED, V25, P1270, DOI 10.1111/j.1939-1676.2011.00806.x
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   HofmannLehmann R, 1996, CLIN DIAGN LAB IMMUN, V3, P554, DOI 10.1128/CDLI.3.5.554-562.1996
   HOHDATSU T, 1992, J VET MED SCI, V54, P557, DOI 10.1292/jvms.54.557
   Huang C, 2014, J VIROL, V88, P10934, DOI 10.1128/JVI.01396-14
   Huang L, 2015, J BIOL CHEM, V290, P27618, DOI 10.1074/jbc.M115.660761
   John SES, 2015, BIOORG MED CHEM LETT, V25, P5072, DOI 10.1016/j.bmcl.2015.10.023
   Kennedy M, 2001, VET MICROBIOL, V81, P227, DOI 10.1016/S0378-1135(01)00354-6
   Kim Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005531
   Kim Y, 2015, J VIROL, V89, P4942, DOI 10.1128/JVI.03688-14
   Kindler E, 2014, CURR OPIN MICROBIOL, V20, P69, DOI 10.1016/j.mib.2014.05.005
   Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12
   Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11
   Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17
   Murphy BG, 2018, VET MICROBIOL, V219, P226, DOI 10.1016/j.vetmic.2018.04.026
   OLSEN CW, 1993, VET MICROBIOL, V36, P1, DOI 10.1016/0378-1135(93)90126-R
   Pearson M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100906
   Pedersen NC, 2015, VET MICROBIOL, V175, P157, DOI 10.1016/j.vetmic.2014.10.025
   Pedersen NC, 2014, VET J, V201, P123, DOI 10.1016/j.tvjl.2014.04.017
   Pedersen NC, 2009, VIRUSES-BASEL, V1, P166, DOI 10.3390/v1020166
   Qian SH, 2017, J VIROL, V91, DOI [10.1128/JVI.00823-17, 10.1128/jvi.00823-17]
   Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004
   Ritz S, 2007, J VET INTERN MED, V21, P1193, DOI 10.1892/06-302.1
   Rottier PJM, 2005, J VIROL, V79, P14122, DOI 10.1128/JVI.79.22.14122-14130.2005
   Sangl L, 2019, J FELINE MED SURG, V21, P133, DOI 10.1177/1098612X18762883
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939
   Tian J, 2018, J VIROL, V92, DOI [10.1128/JVI.00047-18, 10.1128/jvi.00047-18]
   Tian J, 2015, INFECT GENET EVOL, V34, P352, DOI 10.1016/j.meegid.2015.06.003
   Vennema H, 1998, VIROLOGY, V243, P150, DOI 10.1006/viro.1998.9045
   Wang D, 2016, J VIROL, V90, P2090, DOI 10.1128/JVI.02514-15
   Wang D, 2014, J VIROL, V88, P10252, DOI 10.1128/JVI.00869-14
   Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010
   Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465
NR 53
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 43
DI 10.3390/v12010043
PG 15
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700054
PM 31905881
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Chen, WL
   Lan, Y
   Yuan, XZ
   Deng, XL
   Li, YP
   Cai, XL
   Li, LY
   He, RY
   Tan, YZ
   Deng, XZ
   Gao, M
   Tang, GF
   Zhao, LZ
   Wang, JL
   Fan, QH
   Wen, CY
   Tong, YW
   Tang, YB
   Hu, FY
   Li, F
   Tang, XP
AF Chen, Weilie
   Lan, Yun
   Yuan, Xiaozhen
   Deng, Xilong
   Li, Yueping
   Cai, Xiaoli
   Li, Liya
   He, Ruiying
   Tan, Yizhou
   Deng, Xizi
   Gao, Ming
   Tang, Guofang
   Zhao, Lingzhai
   Wang, Jinlin
   Fan, Qinghong
   Wen, Chunyan
   Tong, Yuwei
   Tang, Yangbo
   Hu, Fengyu
   Li, Feng
   Tang, Xiaoping
TI Detectable 2019-nCoV viral RNA in blood is a strong indicator for the
   further clinical severity
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE 2019-ncov; laboratory test; blood viral RNA; pharyngeal swab; anal swab
ID CORONAVIRUS; PNEUMONIA; WUHAN
AB The novel coronavirus (2019-nCoV) infection caused pneumonia. we retrospectively analyzed the virus presence in the pharyngeal swab, blood, and the anal swab detected by real-time PCR in the clinical lab. Unexpectedly, the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). Importantly, all of the 6 patients with detectable viral RNA in the blood cohort progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity (p-value = 0.0001). Meanwhile, 8 of the 11 patients with annal swab virus-positive was in severe clinical stage. However, the concentration of viral RNA in the anal swab (Ct value = 24 + 39) was higher than in the blood (Ct value = 34 + 39) from patient 2, suggesting that the virus might replicate in the digestive tract. Altogether, our results confirmed the presence of virus RNA in extra-pulmonary sites.
C1 [Chen, Weilie; Lan, Yun; Yuan, Xiaozhen; Deng, Xilong; Li, Yueping; Cai, Xiaoli; Li, Liya; He, Ruiying; Tan, Yizhou; Deng, Xizi; Gao, Ming; Tang, Guofang; Zhao, Lingzhai; Wang, Jinlin; Fan, Qinghong; Wen, Chunyan; Tong, Yuwei; Tang, Yangbo; Hu, Fengyu; Li, Feng; Tang, Xiaoping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Dong Rd, Guangzhou 510060, Guangdong, Peoples R China.
RP Hu, FY; Li, F; Tang, XP (reprint author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Dong Rd, Guangzhou 510060, Guangdong, Peoples R China.
EM gz8h_lifeng@126.com; gz8hhfy@126.com; tangxiaopinggz@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81670536, 81770593]; National Science and
   Technology Major Project [2017ZX10202203-004-002]
FX We declare no competing interest. We thank all the physicians and nurses
   who cared these patients. This work was supported by National Natural
   Science Foundation of China Grant (No. 81670536 and 81770593) and by the
   National Science and Technology Major Project (2017ZX10202203-004-002).
CR Chen L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE005, DOI 10.3760/cma.j.issn.1001-0939.2020.0005
   Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Holshue M.L, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2001191, DOI 10.1056/NEJM0A2001191]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
NR 10
TC 0
Z9 0
U1 44
U2 44
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 469
EP 473
DI 10.1080/22221751.2020.1732837
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KR3MS
UT WOS:000517523100001
PM 32102625
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Doki, T
   Tarusawa, T
   Hohdatsu, T
   Takano, T
AF Doki, Tomoyoshi
   Tarusawa, Tomoyo
   Hohdatsu, Tsutomu
   Takano, Tomomi
TI In Vivo Antiviral Effects of U18666A Against Type I Feline Infectious
   Peritonitis Virus
SO PATHOGENS
LA English
DT Article
DE feline coronavirus; feline infectious peritonitis; U18666A; cationic
   amphiphilic drug; antiviral agent
ID CHOLESTEROL TRANSPORT INHIBITOR; CORONAVIRUS; PATHOGENESIS;
   RECOMBINATION; PROTEIN; DISEASE; UPDATE
AB Background: The cationic amphiphilic drug U18666A inhibits the proliferation of type I FIPV in vitro. In this study, we evaluated the in vivo antiviral effects of U18666A by administering it to SPF cats challenged with type I FIPV. Methods: Ten SPF cats were randomly assigned to two experimental groups. FIPV KU-2 were inoculated intraperitoneally to cats. The control group was administered PBS, and the U18666A-treated group was administered U18666A subcutaneously at 2.5 mg/kg on day 0, and 1.25 mg/kg on days 2 and 4 after viral inoculation. Results: Two of the five control cats administered PBS alone developed FIP. Four of the five cats administered U18666A developed no signs of FIP. One cat that temporarily developed fever, had no other clinical symptoms, and no gross lesion was noted on an autopsy after the end of the experiment. The FIPV gene was detected intermittently in feces and saliva regardless of the development of FIP or administration of U18666A. Conclusions: When U18666A was administered to cats experimentally infected with type I FIPV, the development of FIP might be suppressed compared with the control group. However, the number of animals with FIP is too low to establish anti-viral effect of U18666A in cats.
C1 [Doki, Tomoyoshi; Tarusawa, Tomoyo; Hohdatsu, Tsutomu; Takano, Tomomi] Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan.
RP Takano, T (reprint author), Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan.
EM doki@vmas.kitasato-u.ac.jp; kitasato.denbyo+taru@gmail.com;
   hohdatsu@vmas.kitasato-u.ac.jp; takanot@vmas.kitasato-u.ac.jp
OI Takano, Tomomi/0000-0002-3468-0708
FU KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [16H05039]; Ministry of Education,
   Culture, Sports, Science and Technology, JapanMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)
FX This work was in part supported by KAKENHI (Grants-in-Aid for Scientific
   Research (B), No. 16H05039) from the Ministry of Education, Culture,
   Sports, Science and Technology, Japan.
CR Addie DD, 2003, J GEN VIROL, V84, P2735, DOI 10.1099/vir.0.19129-0
   CENEDELLA RJ, 1982, EPILEPSIA, V23, P257, DOI 10.1111/j.1528-1157.1982.tb06190.x
   De Groot R., 2012, VIRUS TAXONOMY, P784, DOI DOI 10.1016/B978-0-12-384684-6.00066-5
   Decaro N, 2009, J VIROL, V83, P15332, DOI 10.1128/JVI.01937-08
   Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16
   Herrewegh AAPM, 1998, J VIROL, V72, P4508, DOI 10.1128/JVI.72.5.4508-4514.1998
   HOHDATSU T, 1992, J VET MED SCI, V54, P557, DOI 10.1292/jvms.54.557
   Jaimes JA, 2018, VIROLOGY, V517, P108, DOI 10.1016/j.virol.2017.12.027
   Kim Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005531
   Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12
   Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601
   Kummrow M, 2005, CLIN DIAGN LAB IMMUN, V12, P1209, DOI 10.1128/CDLI.12.10.1209-1215.2005
   Murphy BG, 2018, VET MICROBIOL, V219, P226, DOI 10.1016/j.vetmic.2018.04.026
   Pedersen NC, 2019, J FELINE MED SURG, V21, P271, DOI 10.1177/1098612X19825701
   Pedersen NC, 2018, J FELINE MED SURG, V20, P378, DOI 10.1177/1098612X17729626
   Pedersen NC, 2015, VET MICROBIOL, V175, P157, DOI 10.1016/j.vetmic.2014.10.025
   Pedersen NC, 2014, VET J, V201, P133, DOI 10.1016/j.tvjl.2014.04.016
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Sabino C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060524
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Takano T, 2008, J VET MED SCI, V70, P1315, DOI 10.1292/jvms.70.1315
   Takano T, 2019, J VET MED SCI, V81, P911, DOI 10.1292/jvms.18-0702
   Takano T, 2019, VET RES, V50, DOI 10.1186/s13567-019-0625-3
   Takano T, 2017, ANTIVIR RES, V145, P96, DOI 10.1016/j.antiviral.2017.07.022
   Tasker S, 2018, J FELINE MED SURG, V20, P228, DOI 10.1177/1098612X18758592
   Tekes G, 2016, ADV VIRUS RES, V96, P193, DOI 10.1016/bs.aivir.2016.08.002
   Terada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106534
   Terada Y, 2012, J GEN VIROL, V93, P1930, DOI 10.1099/vir.0.043992-0
   Whittaker GR, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00463-17
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
NR 30
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD JAN
PY 2020
VL 9
IS 1
AR 67
DI 10.3390/pathogens9010067
PG 12
WC Microbiology
SC Microbiology
GA KL0NU
UT WOS:000513130300016
PM 31963705
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Dong, WY
   Xie, WT
   Liu, YB
   Sui, BK
   Zhang, H
   Liu, LR
   Tan, YB
   Tong, XH
   Fu, ZF
   Yin, P
   Fang, LR
   Peng, GQ
AF Dong, Wanyu
   Xie, Wenting
   Liu, Yunbo
   Sui, Baokun
   Zhang, Hao
   Liu, Liran
   Tan, Yubei
   Tong, Xiaohan
   Fu, Zhen F.
   Yin, Ping
   Fang, Liurong
   Peng, Guiqing
TI Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly
   through p38 mitogen-activated protein kinase pathways
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Receptor tyrosine kinase inhibitor; Virus-host interaction; Comparative
   phosphoproteomic; Anti-coronaviral therapy
ID PORCINE EPIDEMIC DIARRHEA; TRANSMISSIBLE GASTROENTERITIS; NUCLEOCAPSID
   PROTEIN; CORONAVIRUS REPLICATION; SIGNALING PATHWAYS; VIRUS-REPLICATION;
   PHOSPHORYLATION; CELLS; INFECTION; SARS
AB Emerging coronaviruses (CoVs) primarily cause severe gastroenteric or respiratory diseases in humans and animals, and no approved therapeutics are currently available. Here, A9, a receptor tyrosine kinase inhibitor (RTKI) of the tyrphostin class, is identified as a robust inhibitor of transmissible gastroenteritis virus (TGEV) infection in cell-based assays. Moreover, A9 exhibited potent antiviral activity against the replication of various CoVs, including murine hepatitis virus (MHV), porcine epidemic diarrhea virus (PEDV) and feline infectious peritonitis virus (FIPV). We further performed a comparative phosphoproteomic analysis to investigate the mechanism of action of A9 against TGEV infection in vitro. We specifically identified p38 and JNK1, which are the downstream molecules of receptor tyrosine kinases (RTKs) required for efficient TGEV replication, as A9 targets through plaque assays, qRT-PCR and Western blotting assays. p38 and JNK1 inhibitors and RNA interference further showed that the inhibitory activity of A9 against TGEV infection was mainly mediated by the p38 mitogen-activated protein kinase (MAPK) signaling pathway. All these findings indicated that the RTKI A9 directly inhibits TGEV replication and that its inhibitory activity against TGEV replication mainly occurs by targeting p38, which provides vital clues to the design of novel drugs against CoVs.
C1 [Dong, Wanyu; Xie, Wenting; Liu, Yunbo; Sui, Baokun; Zhang, Hao; Liu, Liran; Tan, Yubei; Tong, Xiaohan; Fu, Zhen F.; Fang, Liurong; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.
   [Dong, Wanyu; Xie, Wenting; Liu, Yunbo; Sui, Baokun; Zhang, Hao; Liu, Liran; Tan, Yubei; Tong, Xiaohan; Fu, Zhen F.; Fang, Liurong; Peng, Guiqing] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China.
   [Dong, Wanyu; Yin, Ping] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Ctr Plant Gene Res, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.
   [Dong, Wanyu] Zhejiang A&F Univ, Coll Anim Sci & Technol, Dept Vet Med, Hangzhou 311300, Peoples R China.
   [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA.
RP Peng, GQ (reprint author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.
EM penggq@mail.hzau.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31802207, 31722056]; National Key RD Plan of China
   [2016YFD0500103, 2018YFD0500100]; Huazhong Agricultural University
   Scientific & Technological Self-Innovation Foundation [2662015JQ003,
   2662017PY028]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 31802207 and 31722056), the National Key R&D Plan of
   China (Program No. 2016YFD0500103 and 2018YFD0500100) and the Huazhong
   Agricultural University Scientific & Technological Self-Innovation
   Foundation (Program No. 2662015JQ003 and 2662017PY028).
CR Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342
   Baker J., 2012, FAMILY CORONAVIRIDAE, P806
   Banerjee S, 2002, J VIROL, V76, P5937, DOI 10.1128/JVI.76.12.5937-5948.2002
   Basu A, 2011, J VIROL, V85, P3106, DOI 10.1128/JVI.01456-10
   Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06
   Calvo E, 2005, J GEN VIROL, V86, P2255, DOI 10.1099/vir.0.80975-0
   Carbone CJ, 2012, P NATL ACAD SCI USA, V109, P19226, DOI 10.1073/pnas.1211491109
   Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x
   Cencic R, 2011, J VIROL, V85, P6381, DOI 10.1128/JVI.00078-11
   Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Falzarano D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01686
   Gan F, 2017, CHEMOSPHERE, V182, P630, DOI 10.1016/j.chemosphere.2017.05.030
   Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015
   Hu WW, 2016, ONCOTARGET, V7, P12206, DOI 10.18632/oncotarget.7723
   Kim Y, 2015, VIROLOGY, V484, P181, DOI 10.1016/j.virol.2015.06.007
   Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14
   Kono M, 2008, ANTIVIR RES, V77, P150, DOI 10.1016/j.antiviral.2007.10.011
   Kumar N, 2011, ANTIMICROB AGENTS CH, V55, P5553, DOI 10.1128/AAC.00725-11
   Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10
   Lee C, 2016, VIRUS RES, V222, P1, DOI 10.1016/j.virusres.2016.05.018
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mizutani T, 2005, BBA-MOL BASIS DIS, V1741, P4, DOI 10.1016/j.bbadis.2005.04.004
   Neuman BW, 2014, VIRUS RES, V194, P49, DOI 10.1016/j.virusres.2013.12.004
   PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0
   Pritchard GC, 1999, VET REC, V144, P616
   Ramajayam R, 2010, BIOORG MED CHEM LETT, V20, P3569, DOI 10.1016/j.bmcl.2010.04.118
   Regan AD, 2009, VIROLOGY, V384, P135, DOI 10.1016/j.virol.2008.11.006
   Roussidis AE, 2002, IN VIVO, V16, P459
   Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8
   Shin GC, 2007, VIRUS RES, V127, P71, DOI 10.1016/j.virusres.2007.03.019
   Spencer KA, 2008, VIROLOGY, V370, P373, DOI 10.1016/j.virol.2007.08.016
   Stantchev TS, 2007, VIRUS RES, V123, P178, DOI 10.1016/j.virusres.2006.09.004
   Tong Tommy R., 2009, Infectious Disorders - Drug Targets, V9, P223
   Vela EM, 2008, ANTIVIR RES, V77, P153, DOI 10.1016/j.antiviral.2007.09.005
   White TC, 2007, VIRUS RES, V126, P139, DOI 10.1016/j.virusres.2007.02.008
   Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009
   Yang L., 2018, J VIROL, V92
   YURA Y, 1993, ARCH VIROL, V132, P451, DOI 10.1007/BF01309554
   Zachos G, 2001, J VIROL, V75, P2710, DOI 10.1128/JVI.75.6.2710-2728.2001
   Zhang Y, 2012, J VIROL METHODS, V185, P61, DOI 10.1016/j.jviromet.2012.05.030
   Zhou YC, 2011, ANTIVIR RES, V92, P187, DOI 10.1016/j.antiviral.2011.07.016
NR 47
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2020
VL 173
AR UNSP 104651
DI 10.1016/j.antiviral.2019.104651
PG 11
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KH6JO
UT WOS:000510757900007
PM 31751591
OA Bronze
DA 2020-04-03
ER

PT J
AU Haider, N
   Yavlinsky, A
   Simons, D
   Osman, AY
   Ntoumi, F
   Zumla, A
   Kock, R
AF Haider, Najmul
   Yavlinsky, Alexei
   Simons, David
   Osman, Abdinasir Yusuf
   Ntoumi, Francine
   Zumla, Alimuddin
   Kock, Richard
TI Passengers' destinations from China: low risk of Novel Coronavirus
   (2019-nCoV) transmission into Africa and South America
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE 2019-nCoV; Africa; China; risk map; transmission; Wuhan; COVID-19;
   SARS-COV-2
AB Novel Coronavirus (2019-nCoV [SARS-COV-2]) was detected in humans during the last week of December 2019 at Wuhan city in China, and caused 24 554 cases in 27 countries and territories as of 5 February 2020. The objective of this study was to estimate the risk of transmission of 2019-nCoV through human passenger air flight from four major cities of China (Wuhan, Beijing, Shanghai and Guangzhou) to the passengers' destination countries. We extracted the weekly simulated passengers' end destination data for the period of 1-31 January 2020 from FLIRT, an online air travel dataset that uses information from 800 airlines to show the direct flight and passengers' end destination. We estimated a risk index of 2019-nCoV transmission based on the number of travellers to destination countries, weighted by the number of confirmed cases of the departed city reported by the World Health Organization (WHO). We ranked each country based on the risk index in four quantiles (4(th) quantile being the highest risk and 1(st) quantile being the lowest risk). During the period, 388 287 passengers were destined for 1297 airports in 168 countries or territories across the world. The risk index of 2019-nCoV among the countries had a very high correlation with the WHO-reported confirmed cases (0.97). According to our risk score classification, of the countries that reported at least one Coronavirus-infected pneumonia (COVID-19) case as of 5 February 2020, 24 countries were in the 4(th) quantile of the risk index, two in the 3(rd) quantile, one in the 2(nd) quantile and none in the 1(st) quantile. Outside China, countries with a higher risk of 2019-nCoV transmission are Thailand, Cambodia, Malaysia, Canada and the USA, all of which reported at least one case. In pan-Europe, UK, France, Russia, Germany and Italy; in North America, USA and Canada; in Oceania, Australia had high risk, all of them reported at least one case. In Africa and South America, the risk of transmission is very low with Ethiopia, South Africa, Egypt, Mauritius and Brazil showing a similar risk of transmission compared to the risk of any of the countries where at least one case is detected. The risk of transmission on 31 January 2020 was very high in neighbouring Asian countries, followed by Europe (UK, France, Russia and Germany), Oceania (Australia) and North America (USA and Canada). Increased public health response including early case recognition, isolation of identified case, contract tracing and targeted airport screening, public awareness and vigilance of health workers will help mitigate the force of further spread to naive countries.
C1 [Haider, Najmul; Simons, David; Osman, Abdinasir Yusuf; Kock, Richard] Univ London, Royal Vet Coll, Hawkshead Lane, Hatfield, Herts, England.
   [Yavlinsky, Alexei] UCL, Inst Hlth Informat, London, England.
   [Ntoumi, Francine] FCRM, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Zumla, Alimuddin] UCL Ctr Clin Microbiol, Dept Infect, Div Infect & Immun, Royal Free campus, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
RP Haider, N (reprint author), Univ London, Royal Vet Coll, Hawkshead Lane, Hatfield, Herts, England.
EM nhaider@rvc.ac.uk
RI Haider, Najmul/F-6083-2015
OI Haider, Najmul/0000-0002-5980-3460
FU European and Developing Countries Clinical Trials Partnership (EDCTP2)
   programme under Horizon 2020, the European Union's Framework Programme
   for Research and Innovation [RIA2016E-1609]; National Institutes of
   Health Research (NIHR)National Institute for Health Research (NIHR);
   EDCTP (CANTAM2)
FX All authors are part of PANDORA-ID-NET Consortium (EDCTP Reg/Grant
   RIA2016E-1609) funded by the European and Developing Countries Clinical
   Trials Partnership (EDCTP2) programme which is supported under Horizon
   2020, the European Union's Framework Programme for Research and
   Innovation. AZ is in receipt of a National Institutes of Health Research
   (NIHR) senior investigator award and the PANDORA-ID-NET. FN and AZ
   acknowledge support from EDCTP (CANTAM2). We acknowledge the Eco Health
   Alliance for making FLIRT data publicly available.
CR Alliance EH, 2016, FLIRT PROD ECOHEALTH
   Bogoch Isaac I, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa011
   Brautigam D, 2018, J AFR ECON, V27, P29, DOI 10.1093/jae/ejy013
   Chen N, 2020, LANCET LONDON ENGLAN, V6736, P1
   Chinazzi M, 2020, PRELIMINARY ASSESSME, P1
   Huff AS, 2016, NEW HOR MANAG ORGAN, P1
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Johns Hopkins Center for Health Security, 2020, GLOB HLTH SEC IND
   Johns Hopkins University, COR COVID 19 GLOB CA
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Mccloskey B, 2020, EPIDEMIOLOGY INFECT, V148, P3
   ProMED, 2020, UND PNEUM CHIN HU 01
   Rothe C, 2020, NEW ENGL J MED, P2019
   WANG JE, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11133566
   Wang X, 2014, ARXIV14110983
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 17
TC 0
Z9 0
U1 19
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2020
VL 148
AR e41
DI 10.1017/S0950268820000424
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KS2HG
UT WOS:000518130400001
PM 32100667
OA Other Gold, Green Accepted, Bronze, Green Published
DA 2020-04-03
ER

PT J
AU Han, ZX
   Xu, LW
   Ren, MT
   Sheng, J
   Ma, TX
   Sun, JF
   Zhao, Y
   Liu, SW
AF Han, Zongxi
   Xu, Liwen
   Ren, Mengting
   Sheng, Jie
   Ma, Tianxin
   Sun, Junfeng
   Zhao, Yan
   Liu, Shengwang
TI Genetic, antigenic and pathogenic characterization of avian
   coronaviruses isolated from pheasants (Phasianus colchicus) in China
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Pheasant coronavirus; Infectious bronchitis virus; S1 gene; Complete
   genome; Adaption and evolution
ID INFECTIOUS-BRONCHITIS VIRUS; ALTERED PATHOGENICITY; KB REGION;
   IDENTIFICATION; RECOMBINATION; GENOTYPE; EMERGENCE; CHICKENS; SEQUENCE;
   PHYLOGENY
AB Two viruses were isolated in 2017 from commercial pheasants with severe clinical signs and mortality in Shandong and Anhui provinces, China, respectively. We examined the pathogenic effects of the viruses in chicken embryos and the size and morphology of the virus particles, performed phylogenetic analysis based on the S1 gene and complete genomic sequences, and examined the antibody responses against infectious bronchitis virus (IBV). The results suggested that the viruses 10623/17 and 10710/17 were avian coronaviruses and were identified as pheasant coronaviruses (PhCoV), with greatest similarity to IBV. Further investigations of the antigenicity, complete genome organization, substitutions in multiple genes, and viral pathogenicity, replication, and shedding in chickens and pheasants showed obvious differences between PhCoV and IBV in terms of antigenicity, and viral pathogenicity, replication, and shedding in chickens and pheasants. The close genetic relationship, but obvious differences between PhCoVs and IBVs suggested the IBVs could be the ancestors of PhCoVs, and that PhCoVs isolated from different outbreaks may have evolved independently from IBVs circulating in the specific region by adaption in pheasants. This hypothesis was supported by analysis of the S1 gene fragments of the two PhCoVs isolated in the current study, as well as PhCoVs isolated in the UK and selected IBV strains. Such analyses indicated different evolution patterns and different tissue tropisms between PhCoVs isolated in different outbreaks. Further studies are needed to confirm this hypothesis by studying the complete genomic sequences of PhCoVs from different outbreaks and the pathogenicity of IBVs in pheasants to compare and clarify the relationships between PhCoVs and IBVs.
C1 [Han, Zongxi; Xu, Liwen; Ren, Mengting; Sheng, Jie; Ma, Tianxin; Sun, Junfeng; Zhao, Yan; Liu, Shengwang] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.
RP Liu, SW (reprint author), Chinese Acad Agr Sci, Div Avian Infect Dis, Natl Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Peoples R China.
EM liushengwang@caas.cn
FU National Key Research and Development Program of China [2017YFD0500105];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31872503]; China Agriculture Research System
   [CARS-40-K18]; National "Twelfth Five-Year" Plan for Science &
   Technology Support [2015BAD12B03]; Provincial Supported Science
   Foundation of Heilongjiang Province for The National Key Technology RD
   Program [GX16B003]
FX This work was supported by grants from the National Key Research and
   Development Program of China (2017YFD0500105), the National Natural
   Science Foundation of China Grant (31872503), the China Agriculture
   Research System (No. CARS-40-K18), National "Twelfth Five-Year" Plan for
   Science & Technology Support (2015BAD12B03) and the Provincial Supported
   Science Foundation of Heilongjiang Province for The National Key
   Technology R&D Program (GX16B003).The authors declare that they have no
   competing interests.
CR ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441
   Brown PA, 2016, J GEN VIROL, V97, P110, DOI 10.1099/jgv.0.000338
   Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005
   CAVANAGH D, 1992, AVIAN PATHOL, V21, P401, DOI 10.1080/03079459208418858
   Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651
   Cavanagh D, 1999, AVIAN PATHOL, V28, P593, DOI 10.1080/03079459994399
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chaharaein B, 2009, MICROBIOL RES, V164, P174, DOI 10.1016/j.micres.2007.01.001
   Chen YQ, 2017, VET MICROBIOL, V198, P108, DOI 10.1016/j.vetmic.2016.12.017
   Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11
   Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432
   de Groot RJ, 2012, VIRUS TAXONOMY, P806
   de Haan CAM, 2004, J VIROL, V78, P6048, DOI 10.1128/JVI.78.11.6048-6054.2004
   Ducatez Mariette F, 2016, Avian Pathol, V45, P602, DOI 10.1080/03079457.2016.1211834
   Gohm DS, 2000, AVIAN PATHOL, V29, P143, DOI 10.1080/03079450094171
   Gough RE, 1996, VET REC, V138, P208, DOI 10.1136/vr.138.9.208
   Guo HB, 2014, VET MICROBIOL, V168, P88, DOI 10.1016/j.vetmic.2013.11.002
   Guy James S., 2008, V454, P109, DOI 10.1007/978-1-59745-181-9_10
   Han ZX, 2016, VIRUS RES, V213, P140, DOI 10.1016/j.virusres.2015.11.021
   Han ZX, 2013, VIRUS RES, V171, P54, DOI 10.1016/j.virusres.2012.10.028
   Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006
   Hughes AL, 2011, ARCH VIROL, V156, P1823, DOI 10.1007/s00705-011-1061-5
   Jackwood MW, 2010, VIROLOGY, V398, P98, DOI 10.1016/j.virol.2009.11.044
   JIA W, 1995, ARCH VIROL, V140, P259, DOI 10.1007/BF01309861
   Jiang L, 2017, INFECT GENET EVOL, V54, P437, DOI 10.1016/j.meegid.2017.08.006
   Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0
   KUSTERS JG, 1990, VACCINE, V8, P605, DOI 10.1016/0264-410X(90)90018-H
   KUSTERS JG, 1989, VIROLOGY, V169, P217, DOI 10.1016/0042-6822(89)90058-5
   Leopardi S, 2018, INFECT GENET EVOL, V58, P279, DOI 10.1016/j.meegid.2018.01.012
   Lewis CS, 2015, J GEN VIROL, V96, P1358, DOI 10.1099/vir.0.000084
   Li HX, 2016, INFECT GENET EVOL, V45, P230, DOI 10.1016/j.meegid.2016.09.006
   LISTER SA, 1985, VET REC, V117, P612, DOI 10.1136/vr.117.23.612
   Liu SW, 2008, AVIAN DIS, V52, P306, DOI 10.1637/8110-091307-ResNote.1
   Liu SW, 2008, GENE, V412, P12, DOI 10.1016/j.gene.2008.01.004
   Liu SW, 2009, VACCINE, V27, P4630, DOI 10.1016/j.vaccine.2009.05.072
   Liu SW, 2005, J GEN VIROL, V86, P719, DOI 10.1099/vir.0.80546-0
   Liu SW, 2004, AVIAN PATHOL, V33, P321, DOI 10.1080/0307945042000220697
   Liu XL, 2013, VET MICROBIOL, V162, P429, DOI 10.1016/j.vetmic.2012.10.027
   Ma TX, 2019, VET MICROBIOL, V230, P178, DOI 10.1016/j.vetmic.2019.01.020
   Mardani K, 2008, J VIROL, V82, P2013, DOI 10.1128/JVI.01694-07
   Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07
   Moscoso H, 2004, AVIAN DIS, V48, P841, DOI 10.1637/7215-060104
   Papineau A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42355-y
   Pennycott TW, 2000, VET REC, V146, P273, DOI 10.1136/vr.146.10.273
   Raj GD, 1997, AVIAN PATHOL, V26, P677, DOI 10.1080/03079459708419246
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859
   Satoh R, 2011, VACCINE, V29, P1791, DOI 10.1016/j.vaccine.2010.12.106
   SCHALK A. F., 1931, Journal of the American Veterinary Medical Association, V78, P413
   SPACKMAN D, 1983, VET REC, V113, P354, DOI 10.1136/vr.113.15.354
   Sun L, 2007, VIRUS RES, V130, P121, DOI 10.1016/j.virusres.2007.06.003
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Torres CA, 2017, POULTRY SCI, V96, P717, DOI 10.3382/ps/pew332
   Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015
   Woo PCY, 2014, J VIROL, V88, P1318, DOI 10.1128/JVI.02351-13
   Xu QQ, 2016, AVIAN PATHOL, V45, P54, DOI 10.1080/03079457.2015.1118435
   Zhao WJ, 2017, VET MICROBIOL, V198, P9, DOI 10.1016/j.vetmic.2016.11.014
   Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3
NR 58
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD JAN
PY 2020
VL 240
AR 108513
DI 10.1016/j.vetmic.2019.108513
PG 14
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA KG0FH
UT WOS:000509616600009
PM 31902509
OA Bronze
DA 2020-04-03
ER

PT J
AU Jones, RM
   Bleasdale, SC
   Maita, D
   Brosseau, LM
AF Jones, Rachael M.
   Bleasdale, Susan C.
   Maita, Dayana
   Brosseau, Lisa M.
CA CDC Prevention Epictr Program
TI A systematic risk-based strategy to select personal protective equipment
   for infectious diseases
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Job hazard analysis; High-consequence infections; Intubation; Infection
   prevention; Exposure; Industrial hygiene
ID ISOLATION GOWNS; CARE; TRANSMISSION; CONTAMINATION; PREPAREDNESS;
   PRECAUTIONS; INTUBATION; BARRIERS
AB Background: Personal protective equipment (PPE) is a primary strategy to protect health care personnel (HCP) from infectious diseases. When transmission-based PPE ensembles are not appropriate, HCP must recognize the transmission pathway of the disease and anticipate the exposures to select PPE. Because guidance for this process is extremely limited, we proposed a systematic, risk-based approach to the selection and evaluation of PPE ensembles to protect HCP against infectious diseases.
   Methods: The approach used in this study included the following 4 steps: (1) job hazard analysis, (2) infectious disease hazard analysis, (3) selection of PPE, and (4) evaluation of selected PPE. Selected PPE should protect HCP from exposure, be usable by HCP, and fit for purpose.
   Results: The approach was demonstrated for the activity of intubation of a patient with methicillin-resistant Staphylococcus aureus or Severe Acute Respiratory Syndrome coronavirus. As expected, the approach led to the selection of different ensembles of PPE for these 2 pathogens.
   Discussion: A systematic risk-based approach to the selection of PPE will help health care facilities and HCP select PPE when transmission-based precautions are not appropriate. Owing to the complexity of PPE ensemble selection and evaluation, a team with expertise in infectious diseases, occupational health, the health care activity, and related disciplines, such as human factors, should be engaged.
   Conclusions: Participation, documentation, and transparency are necessary to ensure the decisions can be communicated, critiqued, and understood by HCP. (C) 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Jones, Rachael M.; Brosseau, Lisa M.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL USA.
   [Bleasdale, Susan C.; Maita, Dayana] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA.
   [Jones, Rachael M.] Univ Utah, Sch Med, Dept Family & Prevent Med, 391 Chipeta Way,Suite C, Salt Lake City, UT 84108 USA.
RP Jones, RM (reprint author), Univ Utah, Sch Med, Dept Family & Prevent Med, 391 Chipeta Way,Suite C, Salt Lake City, UT 84108 USA.
EM rachael.jones@utah.edu
OI Jones, Rachael M./0000-0003-1611-7900
FU NCEZID CDC HHS [U54 CK000445]
CR American Standards for Testing and Materials [ASTM], 2015, D631910 ASTM INT AST
   American Standards for Testing and Materials [ASTM], 2015, D357805 ASTM INT AST
   American Standards for Testing and Materials [ASTM], 2015, D357709 ASTM INT AST
   Balci FSK, 2016, AM J INFECT CONTROL, V44, P104, DOI 10.1016/j.ajic.2015.07.042
   Bleasdale SC, 2019, J OCCUP ENVIRON HYG, V16, P582, DOI 10.1080/15459624.2019.1628966
   Bollinger N., 2004, NIOSH RESP SELECTION
   Centers for Disease Control and Prevention, STAND PREC ALL PAT C
   Centers for Disease Control and Prevention, GUID PERS PROT EQ PP
   Chosewood CL, 2009, BIOSAFETY MICROBIOLO
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Dorman LE, 2009, EUR J APPL PHYSIOL, V105, P463, DOI 10.1007/s00421-008-0924-2
   Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC
   Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x
   Garner Alan, 2004, Emerg Med Australas, V16, P108, DOI 10.1111/j.1742-6723.2004.00560.x
   Grillet G, 2015, J INFECTION, V71, P703, DOI 10.1016/j.jinf.2015.09.003
   Gudgin Dickson E., 2013, PERSONAL PROTECTIVE
   Haamann F, 2011, INT ARCH OCC ENV HEA, V84, P259, DOI 10.1007/s00420-010-0610-7
   Hall S, 2018, J HOSP INFECT, V99, P218, DOI 10.1016/j.jhin.2018.01.002
   Herlihey TA, 2016, INFECT CONT HOSP EP, V37, P1022, DOI 10.1017/ice.2016.124
   International Safety Equipment Association, EYE FAC PROT SEL TOO
   Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001
   Jones RM, 2015, J OCCUP ENVIRON MED, V57, P501, DOI 10.1097/JOM.0000000000000448
   Kilinc FS, 2015, J ENG FIBER FABR, V10, P180
   Kinlay J, 2015, AM J INFECT CONTROL, V43, P169, DOI 10.1016/j.ajic.2014.11.002
   Koo A, 2018, MIL MED, V183, P216, DOI 10.1093/milmed/usx215
   Kwon JH, 2017, INFECT CONT HOSP EP, V38, P1077, DOI 10.1017/ice.2017.121
   National Institute for Occupational Safety and Health, NIOSH PERS PROT EQ I
   O'Connell KP, 2004, CLIN MICROBIOL INFEC, V10, P322, DOI 10.1111/j.1198-743X.2004.00848.x
   Occupational Safety and Health Administration, OSHAS INF DIS REG FR
   Roughton J, 2011, JOB HAZARD ANAL GUID
   Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007
   Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013
   Sprcher AG, 2015, J INFECT DIS S, V212, P98
   Spruce L, 2017, ASSOC OPER ROOM NURS, V106, P306, DOI 10.1016/j.aorn.2017.08.001
   Weber RT, 2019, ANN WORK EXPOS HEAL, V63, P784, DOI 10.1093/annweh/wxz048
   Yiannakis EP, 2015, J HOSP INFECT, V91, P8, DOI 10.1016/j.jhin.2015.06.009
   Zartarian V, 2005, J EXPO ANAL ENV EPID, V15, P1, DOI 10.1038/sj.jea.7500411
NR 38
TC 0
Z9 0
U1 23
U2 23
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JAN
PY 2020
VL 48
IS 1
BP 46
EP 51
DI 10.1016/j.ajic.2019.06.023
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KC9HK
UT WOS:000507481900009
PM 31358421
OA Bronze
DA 2020-04-03
ER

PT J
AU Kelman, M
   Barrs, VR
   Norris, JM
   Ward, MP
AF Kelman, Mark
   Barrs, Vanessa R.
   Norris, Jacqueline M.
   Ward, Michael P.
TI Socioeconomic, geographic and climatic risk factors for canine
   parvovirus infection and euthanasia in Australia
SO PREVENTIVE VETERINARY MEDICINE
LA English
DT Article
DE Canine parvovirus; Climate; Socioeconomics; Remoteness
ID CLINICAL SIGNS; DOMESTIC DOGS; ENTERITIS; DIAGNOSIS; EPIDEMIOLOGY;
   PUPPIES; URBAN; CORONAVIRUS; VACCINATION; DISEASE
AB Infection of canids with canine parvovirus (CPV) can result in severe, often fatal disease. This study aimed to examine climatic, socioeconomic and geographic risk factors for CPV infection and CPV-associated euthanasia in Australia. Australian veterinary hospital responses (534; 23.5 %) to a national veterinary survey of CPV case occurrences and euthanasias in 2016 were used. Severe caseloads ( > 40 cases per annum) were reported by 26 (11 %) hospitals (median 60 cases; IQR 50-110). Case reporting, case numbers, and without-treatment euthanasia were significantly associated with disadvantage across all Socio-Economic Index for Areas quintiles (p < 0.0001) the greater the disadvantage, the more reports. Strong negative correlations were found between case numbers and the Index of Relative Socioeconomic Disadvantage (r(SP) = -0.3357, p < 0.0001) and also between euthanasia and the Index of Education and Occupation (r(SP) = -0.3762, p < 0.0001). Hospitals in more remote areas were also more likely to report cases and to euthanize without treatment (p < 0.0001). Of the climate variables, temperature of the hottest month was most strongly positively correlated with case numbers (r(SP) = 0.421, p < 0.0001), and lower annual rainfall was associated with more case-reporting hospitals (p < 0.0001). These results confirm that socioeconomic disadvantage is a significant risk-factor for CPV infection and outcome, and high temperature may also contribute to risk.
C1 [Kelman, Mark; Barrs, Vanessa R.; Norris, Jacqueline M.; Ward, Michael P.] Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW 2006, Australia.
RP Kelman, M (reprint author), POB 96, Peregian Beach, Qld 4573, Australia.
EM kelmanscientific@gmail.com
OI Barrs, Vanessa/0000-0001-6761-8022
CR Acosta-Jamett G, 2015, VET MICROBIOL, V178, P260, DOI 10.1016/j.vetmic.2015.05.012
   Allison AB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004475
   Altman KD, 2017, VET MICROBIOL, V210, P8, DOI 10.1016/j.vetmic.2017.08.019
   [Anonymous], 2017, VET REC, V180, DOI [10.1136/vr.j2638.527.2-527, DOI 10.1136/VR.J2638.527.2-527]
   Australian Bureau of Statistics, 2016, AUSTR STAT GEOGR STA
   Australian Bureau of Statistics, 2018, TECHN PAP SOC IND AR
   Australian Veterinary Association, NEED VET SERV RUR AU
   Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003
   Brady S, 2012, VET J, V193, P522, DOI 10.1016/j.tvjl.2012.01.025
   BRUNNER CJ, 1985, COMP CONT EDUC PRACT, V7, P979
   Burns K., 2013, J AM VET MED ASSOC, V242, P278
   CARMAN S, 1982, CAN J COMP MED, V46, P33
   Castro TX, 2007, ARQ BRAS MED VET ZOO, V59, P333, DOI 10.1590/S0102-09352007000200010
   Day MJ, 1999, J SMALL ANIM PRACT, V40, P561, DOI 10.1111/j.1748-5827.1999.tb03022.x
   de Castro TX, 2007, INT J APPL RES VET M, V5, P72
   Denholm KM, 2001, AUST VET J, V79, P98, DOI 10.1111/j.1751-0813.2001.tb10708.x
   Duijvestijn M, 2016, VET MICROBIOL, V195, P115, DOI 10.1016/j.vetmic.2016.09.006
   Finkelstein A., 2016, IS AM PET HLTH CARE
   Freisl M, 2017, VET J, V219, P15, DOI 10.1016/j.tvjl.2016.11.011
   Freiwald A, 2014, PREV VET MED, V115, P198, DOI 10.1016/j.prevetmed.2014.03.025
   Goddard A, 2010, VET CLIN N AM-SMALL, V40, P1041, DOI 10.1016/j.cvsm.2010.07.007
   GORDON JC, 1986, AM J VET RES, V47, P1464
   Hemy M, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7090067
   Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011
   HORNER GW, 1983, NEW ZEAL VET J, V31, P164
   Hoskins JD, 1997, VET MED-US, V92, P694
   Houston DM, 1996, J AM VET MED ASSOC, V208, P542
   Kalli I, 2010, RES VET SCI, V89, P174, DOI 10.1016/j.rvsc.2010.02.013
   Kelman M, 2019, TRANSBOUND EMERG DIS, V66, P299, DOI 10.1111/tbed.13022
   Ling M, 2012, VET MICROBIOL, V158, P280, DOI 10.1016/j.vetmic.2012.02.034
   Orozco MM, 2014, J ZOO WILDLIFE MED, V45, P555, DOI 10.1638/2013-0230R1.1
   Mustiana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124092
   Mylonakis ME, 2016, VET MED-RES REP, V7, P91, DOI 10.2147/VMRR.S80971
   OSULLIVAN G, 1984, AUST VET J, V61, P1, DOI 10.1111/j.1751-0813.1984.tb07119.x
   PARRISH CR, 1982, VET MICROBIOL, V7, P317, DOI 10.1016/0378-1135(82)90011-6
   Pollock R.V.H., 1981, CANINE PARVOVIRUS HO
   POLLOCK RVH, 1982, CORNELL VET, V72, P103
   Pratelli A, 1999, J VET DIAGN INVEST, V11, P550, DOI 10.1177/104063879901100615
   Prittie J, 2004, J VET EMERG CRIT CAR, V14, P167, DOI 10.1111/j.1534-6935.2004.04020.x
   Rika-Heke T, 2015, VET J, V205, P87, DOI 10.1016/j.tvjl.2015.03.012
   Rubel D, 2005, VET PARASITOL, V133, P339, DOI 10.1016/j.vetpar.2005.06.002
   Schoeman JP, 2013, NEW ZEAL VET J, V61, P217, DOI 10.1080/00480169.2013.776451
   Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102
   SMITH JR, 1980, AUST VET J, V56, P149, DOI 10.1111/j.1751-0813.1980.tb05661.x
   SOS YJ, 1983, AUST VET PRACT, V13, P32
   STUDDERT MJ, 1983, AUST VET J, V60, P197, DOI 10.1111/j.1751-0813.1983.tb09581.x
   Zhao ZQ, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0753-1
   Zicola A, 2012, J SMALL ANIM PRACT, V53, P297, DOI 10.1111/j.1748-5827.2011.01178.x
   Zourkas E, 2015, VET MICROBIOL, V181, P198, DOI 10.1016/j.vetmic.2015.10.009
NR 49
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-5877
EI 1873-1716
J9 PREV VET MED
JI Prev. Vet. Med.
PD JAN
PY 2020
VL 174
AR 104816
DI 10.1016/j.prevetmed.2019.104816
PG 13
WC Veterinary Sciences
SC Veterinary Sciences
GA KH0BT
UT WOS:000510314100010
PM 31739219
OA Bronze
DA 2020-04-03
ER

PT J
AU Kleine-Weber, H
   Schroeder, S
   Kruger, N
   Prokscha, A
   Naim, HY
   Muller, MA
   Drosten, C
   Pohlmann, S
   Hoffmann, M
AF Kleine-Weber, Hannah
   Schroeder, Simon
   Krueger, Nadine
   Prokscha, Alexander
   Naim, Hassan Y.
   Mueller, Marcel A.
   Drosten, Christian
   Poehlmann, Stefan
   Hoffmann, Markus
TI Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle
   East respiratory syndrome coronavirus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Middle East respiratory syndrome coronavirus; spike glycoprotein;
   dipeptidyl peptidase 4; polymorphisms; receptor binding
ID DROMEDARY CAMELS; MERS CORONAVIRUS; NEUTRALIZING ANTIBODIES;
   SAUDI-ARABIA; RECEPTOR; IV; INHIBITORS; PROTEIN; COV; OUTBREAK
AB Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates viral entry into target cells. For this, MERS-CoV S engages the host cell protein dipeptidyl peptidase 4 (DPP4, CD26) and the interface between MERS-CoV S and DPP4 has been resolved on the atomic level. Here, we asked whether naturally-occurring polymorphisms in DPP4, that alter amino acid residues required for MERS-CoV S binding, influence cellular entry of MERS-CoV. By screening of public databases, we identified fourteen such polymorphisms. Introduction of the respective mutations into DPP4 revealed that all except one (Delta 346-348) were compatible with robust DPP4 expression. Four polymorphisms (K267E, K267N, A291P and Delta 346-348) strongly reduced binding of MERS-CoV S to DPP4 and S protein-driven host cell entry, as determined using soluble S protein and S protein bearing rhabdoviral vectors, respectively. Two polymorphisms (K267E and A291P) were analyzed in the context of authentic MERS-CoV and were found to attenuate viral replication. Collectively, we identified naturally-occurring polymorphisms in DPP4 that negatively impact cellular entry of MERS-CoV and might thus modulate MERS development in infected patients.
C1 [Kleine-Weber, Hannah; Poehlmann, Stefan; Hoffmann, Markus] German Primate Ctr, Infect Biol Unit, Gottingen, Germany.
   [Kleine-Weber, Hannah; Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.
   [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Charite Univ Med Berlin, Berlin, Germany.
   [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Free Univ Berlin, Berlin, Germany.
   [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Humboldt Univ, Berlin, Germany.
   [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Krueger, Nadine] Univ Vet Med Hannover, Inst Virol, Hannover, Germany.
   [Krueger, Nadine] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany.
   [Prokscha, Alexander; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany.
   [Mueller, Marcel A.; Drosten, Christian] German Ctr Infect Res, Associated Partner Charite, Berlin, Germany.
   [Mueller, Marcel A.] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
RP Pohlmann, S; Hoffmann, M (reprint author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.; Pohlmann, S (reprint author), Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.
EM spoehlmann@dpz.eu; mhoffmann@dpz.eu
RI Hoffmann, Markus/J-7836-2018; Pohlmann, Stefan/H-2395-2011
OI Hoffmann, Markus/0000-0003-4603-7696; Mueller,
   Marcel/0000-0003-2242-5117; Pohlmann, Stefan/0000-0001-6086-9136; Naim,
   Hassan/0000-0003-4884-8425
FU Bundesminister-ium fur Bildung und ForschungFederal Ministry of
   Education & Research (BMBF) [01KI1723D, 01KI1723A]
FX This work was supported, including the efforts of Stefan Pohlmann and
   Christian Drosten, by the Bundesminister-ium fur Bildung und Forschung
   [grant numbers 01KI1723D and 01KI1723A], network project RAPID
   (Risikobewertung bei prapandemischen respiratorischen
   Infek-tionserkrankungen). The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280
   Aghili N, 2012, NEUROPEPTIDES, V46, P367, DOI 10.1016/j.npep.2012.10.001
   Ahmed RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154369
   Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Anoop S, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000393
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x
   Brinkmann C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189073
   Chu DK, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES.2015.20.49.30086
   Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596
   Deacon CF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00080
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Fagbo SF, 2015, EMERG INFECT DIS, V21, P1981, DOI 10.3201/eid2111.150944
   Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110
   Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13
   Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X
   Hoffmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152134
   Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942
   Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004
   Hunt SE, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay119
   Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18
   Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781
   Korea Centers for Disease Control and Prevention, 2015, Osong Public Health Res Perspect, V6, P269, DOI 10.1016/j.phrp.2015.08.006
   Land Henrik, 2018, Methods Mol Biol, V1685, P43, DOI 10.1007/978-1-4939-7366-8_4
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0
   Mortier A, 2016, J LEUKOCYTE BIOL, V99, P955, DOI 10.1189/jlb.3MR0915-401R
   Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010
   Park HY, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.25.21169
   Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469
   Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reinhold D, 1997, IMMUNOL LETT, V58, P29, DOI 10.1016/S0165-2478(97)02716-8
   Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Shahwan K, 2013, VIRUSES-BASEL, V5, P1924, DOI 10.3390/v5081924
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shirato K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01326
   Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13
   Song WF, 2014, VIROLOGY, V471, P49, DOI 10.1016/j.virol.2014.10.006
   Valerio CM, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0226-0
   van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14
   Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92
   WHO, MERS SIT UPD
   Widagdo W, 2016, J VIROL, V90, P4838, DOI 10.1128/JVI.02994-15
   Xiao PF, 2014, CHINESE CHEM LETT, V25, P673, DOI 10.1016/j.cclet.2014.03.047
   Xing XM, 2016, NEUROPEPTIDES, V60, P1, DOI 10.1016/j.npep.2016.08.005
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 57
TC 0
Z9 0
U1 8
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 155
EP 168
DI 10.1080/22221751.2020.1713705
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KF6BT
UT WOS:000509325900001
PM 31964246
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Lau, SKP
   Li, KSM
   Luk, HKH
   He, ZR
   Teng, JLL
   Yuen, KY
   Wernery, U
   Woo, PCY
AF Lau, Susanna K. P.
   Li, Kenneth S. M.
   Luk, Hayes Kam Hei
   He, Zirong
   Teng, Jade L. L.
   Yuen, Kwok-Yung
   Wernery, Ulrich
   Woo, Patrick C. Y.
TI Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and
   Hybrid Camels from Dubai
SO MSPHERE
LA English
DT Article
DE Bactrian camel; hybrid camel; MERS coronavirus; antibody
ID DIPEPTIDYL PEPTIDASE 4; MERS-COV; BETACORONAVIRUS; ABSENCE; DROMEDARIES;
   INFECTION; MONGOLIA; RECEPTOR; REGION
AB So far, dromedary camels are the only known animal reservoir for Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV). Previous published serological studies showed that sera of Bactrian camels were all negative for MERS-CoV antibodies. However, a recent study revealed that direct inoculation of Bactrian camels intranasally with MERS-CoV can lead to infection with abundant virus shedding and seroconversion. In this study, we examined the presence of MERS-CoV antibodies in Bactrian and hybrid camels in Dubai, the United Arab Emirates (where dromedaries are also present), and Bactrian camels in Xinjiang, China (where dromedaries are absent). For the 29 serum samples from Bactrian camels in Dubai tested by the MERS-CoV spike (S) protein-based enzyme-linked immunosorbent assay (S-ELISA) and neutralization antibody test, 14 (48%) and 12 (41%), respectively, were positive for MERS-CoV antibodies. All the 12 serum samples that were positive with the neutralization antibody test were also positive for the S-ELISA. For the 11 sera from hybrid camels in Dubai tested with the S-ELISA and neutralization antibody test, 6 (55%) and 9 (82%), respectively, were positive for MERS-CoV antibodies. All the 6 serum samples that were positive for the S-ELISA were also positive with the neutralization antibody test. There was a strong correlation between the antibody levels detected by S-ELISA and neutralizing antibody titers, with a Spearman coefficient of 0.6262 (P < 0.0001; 95% confidence interval, 0.5062 to 0.7225). All 92 Bactrian camel serum samples from Xinjiang were negative for MERS-CoV antibodies tested using both S-ELISA and the neutralization antibody test. Bactrian and hybrid camels are potential sources of MERS-CoV infection.
   IMPORTANCE Since its first appearance in 2012, Middle East respiratory syndrome (MERS) has affected >25 countries, with >2,400 cases and an extremely high fatality rate of >30%. The total number of mortalities due to MERS is already greater than that due to severe acute respiratory syndrome. MERS coronavirus (MERS-CoV) has been confirmed to be the etiological agent. So far, dromedaries are the only known animal reservoir for MERS-CoV. Previously published serological studies showed that sera of Bactrian camels were all negative for MERS-CoV antibodies. In this study, we observed that 41% of the Bactrian camel sera and 55% of the hybrid camel sera from Dubai (where dromedaries are also present), but none of the sera from Bactrian camels in Xinjiang (where dromedaries are absent), were positive for MERS-CoV antibodies. Based on these results, we conclude that in addition to dromedaries, Bactrian and hybrid camels are also potential sources of MERS-CoV infection.
C1 [Lau, Susanna K. P.; Teng, Jade L. L.; Yuen, Kwok-Yung; Woo, Patrick C. Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.
   [Lau, Susanna K. P.; Teng, Jade L. L.; Yuen, Kwok-Yung; Woo, Patrick C. Y.] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Peoples R China.
   [Lau, Susanna K. P.; Yuen, Kwok-Yung; Woo, Patrick C. Y.] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Peoples R China.
   [Lau, Susanna K. P.; Li, Kenneth S. M.; Luk, Hayes Kam Hei; He, Zirong; Teng, Jade L. L.; Yuen, Kwok-Yung; Woo, Patrick C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China.
   [Wernery, Ulrich] Cent Vet Res Lab, Dubai, U Arab Emirates.
RP Woo, PCY (reprint author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.; Woo, PCY (reprint author), Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Peoples R China.; Woo, PCY (reprint author), Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Peoples R China.; Woo, PCY (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China.; Wernery, U (reprint author), Cent Vet Res Lab, Dubai, U Arab Emirates.
EM cvrl@cvrl.ae; pcywoo@hku.hk
FU Theme-based Research Scheme, University Grant Committee [T11-707/15-R];
   University Development Fund; University of Hong KongUniversity of Hong
   Kong; Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, Ministry of Education, ChinaMinistry of Education,
   China
FX This work is partly supported by the Theme-based Research Scheme
   (project no. T11-707/15-R), University Grant Committee; the University
   Development Fund, The University of Hong Kong; and the Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   Ministry of Education, China.
CR Adney DR, 2019, EMERG MICROBES INFEC, V8, P717, DOI 10.1080/22221751.2019.1618687
   Adney DR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030212
   Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032
   Chan SMS, 2015, EMERG INFECT DIS, V21, P1269, DOI 10.3201/eid2107.150178
   Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115
   Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13
   Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283
   LAU SKP, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11110980
   Lau SKP, 2018, J INFECT DIS, V218, P197, DOI 10.1093/infdis/jiy018
   Lau SKP, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.129
   Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13
   Liu RQ, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.73
   Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746
   Miguel E, 2016, EMERG INFECT DIS, V22, P555, DOI 10.3201/eid2203.151284
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6
   Shirato K, 2015, JPN J INFECT DIS, V68, P256, DOI 10.7883/yoken.JJID.2015.094
   Wang L, 2019, J VIROL, V93, DOI 10.1128/JVI.02014-18
   Wernery U, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.74
   Woo PCY, 2014, EMERG INFECT DIS, V20, P560, DOI 10.3201/eid2004.131769
   Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 23
TC 0
Z9 0
U1 8
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2020
VL 5
IS 1
AR e00898-19
DI 10.1128/mSphere.00898-19
PG 6
WC Microbiology
SC Microbiology
GA KH7SM
UT WOS:000510849900039
PM 31969478
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Li, B
   Si, HR
   Zhu, Y
   Yang, XL
   Anderson, DE
   Shi, ZL
   Wang, LF
   Zhou, P
AF Li, Bei
   Si, Hao-Rui
   Zhu, Yan
   Yang, Xing-Lou
   Anderson, Danielle E.
   Shi, Zheng-Li
   Wang, Lin-Fa
   Zhou, Peng
TI Discovery of Bat Coronaviruses through Surveillance and Probe
   Capture-Based Next-Generation Sequencing
SO MSPHERE
LA English
DT Article
DE bat; coronavirus; genome; enrichment; next-generation sequencing
AB Coronaviruses (CoVs) of bat origin have caused two pandemics in this century. Severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV both originated from bats, and it is highly likely that bat coronaviruses will cause future outbreaks. Active surveillance is both urgent and essential to predict and mitigate the emergence of these viruses in humans. Next-generation sequencing (NGS) is currently the preferred methodology for virus discovery to ensure unbiased sequencing of bat CoVs, considering their high genetic diversity. However, unbiased NGS is an expensive methodology and is prone to missing low-abundance CoV sequences due to the high background level of nonviral sequences present in surveillance field samples. Here, we employ a capture-based NGS approach using baits targeting most of the CoV species. Using this technology, we effectively reduced sequencing costs by increasing the sensitivity of detection. We discovered nine full genomes of bat CoVs in this study and revealed great genetic diversity for eight of them.
   IMPORTANCE Active surveillance is both urgent and essential to predict and mitigate the emergence of bat-origin CoV in humans and livestock. However, great genetic diversity increases the chance of homologous recombination among CoVs. Performing targeted PCR, a common practice for many surveillance studies, would not reflect this diversity. NGS, on the other hand, is an expensive methodology and is prone to missing low-abundance CoV sequences. Here, we employ a capture-based NGS approach using baits targeting all CoVs. Our work demonstrates that targeted, cost-effective, large-scale, genome-level surveillance of bat CoVs is now highly feasible.
C1 [Li, Bei; Si, Hao-Rui; Zhu, Yan; Yang, Xing-Lou; Shi, Zheng-Li; Zhou, Peng] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.
   [Si, Hao-Rui] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Anderson, Danielle E.; Wang, Lin-Fa] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
RP Zhou, P (reprint author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, CAS Key Lab Special Pathogens, Wuhan, Peoples R China.; Wang, LF (reprint author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
EM linfa.wang@duke-nus.edu.sg; peng.zhou@wh.iov.cn
RI ; ?, ??/A-1013-2013
OI Wang, Lin-Fa/0000-0003-2752-0535; ?, ??/0000-0001-8089-163X
FU China National Science and Technology Major Project on Infectious
   Diseases [2018ZX10305409-004-001]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [81822028,
   81661148058]; Strategic Priority Research Program of the CAS
   [XDB29010204, XDB29010101]; NRF [NRF2016NRFNSFC002-013,
   NRF2012NRF-CRP001-056]; CD-PHRG [CDPHRG/0006/2014]; NMRC [ZRRF16006];
   MINDEF [DIRP20159016102060]
FX This study was supported by the China National Science and Technology
   Major Project on Infectious Diseases (grant number
   2018ZX10305409-004-001 to P.Z.), the National Natural Science Foundation
   of China (Excellent Young Scholars grants number 81822028 and
   81661148058 to P.Z.), and the Strategic Priority Research Program of the
   CAS (grants number XDB29010204 to P.Z. and XDB29010101 to Z.-L.S.). The
   work conducted at Duke-NUS was supported in part by NRF grant numbers
   NRF2016NRFNSFC002-013 and NRF2012NRF-CRP001-056, CD-PHRG grant number
   CDPHRG/0006/2014, NMRC grant number ZRRF16006, and MINDEF grant number
   DIRP20159016102060 to L.-F.W. and D.E.A.
CR Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Gaudin M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02924
   Ge XY, 2016, VIROL SIN, V31, P31, DOI 10.1007/s12250-016-3713-9
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   ICTV, 2018, VIRUS TAXONOMY 2018
   Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009
   Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05
   Lim XF, 2019, J GEN VIROL, V100, P1363, DOI 10.1099/jgv.0.001307
   Luo CM, 2018, J VIROL, V92, DOI 10.1128/JVI.00116-18
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   Noyes NR, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0361-8
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Wang L-F, 2015, BATS VIRUSES NEW FRO
   Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803
   Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang W, 2019, EMERG MICROBES INFEC, V8, P1528, DOI 10.1080/22221751.2019.1679610
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
NR 25
TC 0
Z9 0
U1 9
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2020
VL 5
IS 1
AR e00807-19
DI 10.1128/mSphere.00807-19
PG 10
WC Microbiology
SC Microbiology
GA KH7SM
UT WOS:000510849900030
PM 31996413
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Li, ET
   Yan, FH
   Huang, P
   Chi, H
   Xu, SN
   Li, GH
   Liu, CY
   Feng, N
   Wang, HL
   Zhao, YK
   Yang, ST
   Xia, XZ
AF Li, Entao
   Yan, Feihu
   Huang, Pei
   Chi, Hang
   Xu, Shengnan
   Li, Guohua
   Liu, Chuanyu
   Feng, Na
   Wang, Hualei
   Zhao, Yongkun
   Yang, Songtao
   Xia, Xianzhu
TI Characterization of the Immune Response of MERS-CoV Vaccine Candidates
   Derived from Two Different Vectors in Mice
SO VIRUSES-BASEL
LA English
DT Article
DE MERS-CoV; recombinant rabies virus; bacterium-like particle; immune
   response
ID RECEPTOR-BINDING DOMAIN; NEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY;
   SPIKE PROTEIN; RABIES; CORONAVIRUS; INDUCE; PARTICLES; IMMUNOGENICITY;
   IMMUNIZATION
AB Middle East respiratory syndrome (MERS) is an acute, high-mortality-rate, severe infectious disease caused by an emerging MERS coronavirus (MERS-CoV) that causes severe respiratory diseases. The continuous spread and great pandemic potential of MERS-CoV make it necessarily important to develop effective vaccines. We previously demonstrated that the application of Gram-positive enhancer matrix (GEM) particles as a bacterial vector displaying the MERS-CoV receptor-binding domain (RBD) is a very promising MERS vaccine candidate that is capable of producing potential neutralization antibodies. We have also used the rabies virus (RV) as a viral vector to design a recombinant vaccine by expressing the MERS-CoV S1 (spike) protein on the surface of the RV. In this study, we compared the immunological efficacy of the vaccine candidates in BALB/c mice in terms of the levels of humoral and cellular immune responses. The results show that the rabies virus vector-based vaccine can induce remarkably earlier antibody response and higher levels of cellular immunity than the GEM particles vector. However, the GEM particles vector-based vaccine candidate can induce remarkably higher antibody response, even at a very low dose of 1 mu g. These results indicate that vaccines constructed using different vaccine vector platforms for the same pathogen have different rates and trends in humoral and cellular immune responses in the same animal model. This discovery not only provides more alternative vaccine development platforms for MERS-CoV vaccine development, but also provides a theoretical basis for our future selection of vaccine vector platforms for other specific pathogens.
C1 [Li, Entao; Xia, Xianzhu] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China.
   [Li, Entao; Yan, Feihu; Huang, Pei; Chi, Hang; Xu, Shengnan; Li, Guohua; Liu, Chuanyu; Feng, Na; Zhao, Yongkun; Yang, Songtao; Xia, Xianzhu] Chinese Acad Agr Sci, Changchun Vet Res Inst, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun 130122, Peoples R China.
   [Huang, Pei; Xu, Shengnan; Liu, Chuanyu; Xia, Xianzhu] Jilin Agr Univ, Anim Sci & Technol Coll, Changchun 130118, Peoples R China.
   [Li, Guohua; Xia, Xianzhu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi 832003, Peoples R China.
   [Wang, Hualei; Xia, Xianzhu] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China.
   [Xia, Xianzhu] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.
RP Xia, XZ (reprint author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China.; Yang, ST; Xia, XZ (reprint author), Chinese Acad Agr Sci, Changchun Vet Res Inst, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun 130122, Peoples R China.; Xia, XZ (reprint author), Jilin Agr Univ, Anim Sci & Technol Coll, Changchun 130118, Peoples R China.; Xia, XZ (reprint author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi 832003, Peoples R China.; Xia, XZ (reprint author), Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China.; Xia, XZ (reprint author), Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.
EM liet0706@163.com; yanfh1990@gmail.com; hp19932015@163.com;
   chamm@163.com; xsn881222@163.com; histliguohua@163.com;
   liucy5201314@hotmail.com; fengna0308@126.com; wh1831125@163.com;
   zhaoyongkun1976@126.com; yst62041@163.com; xiaxzh@cae.cn
OI xu, shengnan/0000-0002-1800-0741
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31902306]; National Project for Prevention and
   Control of Transboundary Animal Diseases [2017YFD0501804]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 31902306) and the National Project for Prevention and
   Control of Transboundary Animal Diseases (Grant No. 2017YFD0501804).
CR Abreu-Mota T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06741-w
   Al-amri SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44875
   Audouy SAL, 2007, VACCINE, V25, P2497, DOI 10.1016/j.vaccine.2006.09.026
   Barefoot B, 2008, VACCINE, V26, P6108, DOI 10.1016/j.vaccine.2008.09.007
   Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11
   Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006
   Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343
   Caputo Antonella, 2008, Current Drug Delivery, V5, P230, DOI 10.2174/156720108785914961
   Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13
   Chi H, 2017, VACCINE, V35, P2069, DOI 10.1016/j.vaccine.2017.02.063
   Cliquet F, 2004, DEV BIOLOGICALS, V119, P185
   Du LY, 2017, EXPERT OPIN THER TAR, V21, P131, DOI 10.1080/14728222.2017.1271415
   Gaudin Y, 2000, J CELL BIOL, V150, P601, DOI 10.1083/jcb.150.3.601
   Guo XJ, 2015, IMMUNOLOGY, V145, P476, DOI 10.1111/imm.12462
   Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283
   Heine SJ, 2015, IMMUNOL CELL BIOL, V93, P641, DOI 10.1038/icb.2015.24
   Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715
   Jia WX, 2019, EMERG MICROBES INFEC, V8, P760, DOI 10.1080/22221751.2019.1620083
   Kanchan V, 2007, BIOMATERIALS, V28, P5344, DOI 10.1016/j.biomaterials.2007.08.015
   Kawasaki Y, 2004, AM J KIDNEY DIS, V44, P42, DOI 10.1053/j.ajkd.2004.03.029
   Ki M, 2015, EPIDEMIOL HLTH, V37, DOI DOI 10.4178/epih/e2015033
   Li ET, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090799
   Li PC, 2016, VACCINE, V34, P696, DOI 10.1016/j.vaccine.2015.09.007
   Liu RQ, 2017, J INTEGR AGR, V16, P2264, DOI [10.1016/S2095-3119(17)61660-5, 10.1016/s2095-3119(17)61660-5]
   Lopez-Sagaseta J, 2016, COMPUT STRUCT BIOTEC, V14, P58, DOI 10.1016/j.csbj.2015.11.001
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15
   McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003
   McGettigan JP, 2001, J VIROL, V75, P4430, DOI 10.1128/JVI.75.9.4430-4434.2001
   Miyaji EN, 2011, BRAZ J MED BIOL RES, V44, P500, DOI 10.1590/S0100-879X2011007500064
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Nganou-Makamdop K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-50
   Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x
   Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040
   Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131
   Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072
   Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7
   Saluja V, 2010, EUR J PHARM BIOPHARM, V76, P470, DOI 10.1016/j.ejpb.2010.08.003
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Takayama-Ito M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006398
   Van Braeckel-Budimir N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00282
   van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015
   Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15
   Wang C, 2017, ONCOTARGET, V8, P12686, DOI 10.18632/oncotarget.8475
   Wang C, 2017, ANTIVIR RES, V140, P55, DOI 10.1016/j.antiviral.2016.12.019
   Wang HL, 2015, VIRUS GENES, V50, P299, DOI 10.1007/s11262-014-1160-y
   Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92
   Willet M, 2015, J INFECT DIS, V212, pS414, DOI 10.1093/infdis/jiv251
   Wirblich C, 2017, J VIROL, V91, DOI 10.1128/JVI.02040-16
   Xue XH, 2014, VIRUS GENES, V48, P411, DOI 10.1007/s11262-014-1049-9
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng GC, 2009, PROTEOMICS, V9, P1538, DOI 10.1002/pmic.200800528
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
NR 53
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 125
DI 10.3390/v12010125
PG 12
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700104
PM 31968702
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Ma-Lauer, Y
   Zheng, Y
   Malesevic, M
   von Brunn, B
   Fischer, G
   von Brunn, A
AF Ma-Lauer, Yue
   Zheng, Yu
   Malesevic, Miroslav
   von Brunn, Brigitte
   Fischer, Gunter
   von Brunn, Albrecht
TI Influences of cyclosporin A and non-immunosuppressive derivatives on
   cellular cyclophilins and viral nucleocapsid protein during human
   coronavirus 229E replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE HCoV-229E; Coronavirus nucleocapsid; Cyclophilin A/B; Cyclophilin
   inhibitors; Broad-spectrum antiviral
ID HEPATITIS-C VIRUS; HOST; INHIBITION; BINDING; INFECTION; POTENT
AB The well-known immunosuppressive drug cyclosporin A inhibits replication of various viruses including coronaviruses by binding to cellular cyclophilins thus inactivating their cis-trans peptidyl-prolyl isomerase function. Viral nucleocapsid proteins are inevitable for genome encapsidation and replication. Here we demonstrate the interaction between the N protein of HCoV-229E and cyclophilin A, not cyclophilin B. Cyclophilin inhibitors abolish this interaction. Upon infection, cyclophilin A stays evenly distributed throughout the cell, whereas cyclophilin B concentrates at ER-bleb-like structures. We further show the inhibitory potential of non-immunosuppressive CsA derivatives Alisporivir, NIM811, compound 3 on HCoV-229E-GFP and -Luciferase replication in human Huh-7.5 hepatoma cells at 18 and 48 h time points post infection with EC50 s at low micromolar ranges. Thus, non-immunosuppressive CsA derivatives effectively inhibit HCoV-229E replication suggesting them as possible candidates for the treatment of HCoV infection. The interruption of interaction between CypA and N protein by CsA and its derivatives suggest a mechanism how CypA inhibitors suppress viral replication.
C1 [Ma-Lauer, Yue; Zheng, Yu; von Brunn, Brigitte; von Brunn, Albrecht] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Munich, Germany.
   [Ma-Lauer, Yue; Zheng, Yu; von Brunn, Brigitte; von Brunn, Albrecht] German Ctr Infect Res DZIF, Partner Site Munich, D-80336 Munich, Germany.
   [Malesevic, Miroslav] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.
   [Fischer, Gunter] Max Planck Inst Biophys Chem Goettingen, Bo Halle, Germany.
RP von Brunn, A (reprint author), Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Pettenkoferstr 9a, D-80336 Munich, Germany.
EM vonbrunn@mvp.lmu.de
FU "Bundesministerium fuer Bildung und Forschung" of the German Government
   [RAPID 01Kl1723C]; German Center for Infection Research (DZIF, partner
   site Munich) [TTU EI 01.806]; Friedrich-Baur-Stiftung; Novartis AG
   (Basel, Switzerland)
FX This work was supported by grants of the "Bundesministerium fuer Bildung
   und Forschung" of the German Government (RAPID 01Kl1723C), the German
   Center for Infection Research (DZIF, partner site Munich, project code
   TTU EI 01.806) to AvB and by a grant of the Friedrich-Baur-Stiftung to
   Y. M.-L. The technical support by Javier Carbajo-Lozoya and D.R. Bairad
   is highly appreciated. We are grateful to C. Rice (Center for the Study
   of Hepatitis C, The Rockefeller University, New York, USA), D.A.
   Feigelstock (Center for Biologics Evaluation and Research, Bethesda, MD,
   USA) and R. Bartenschlager (Molecular Virology, Universitatsklinikum
   Heidelberg, Germany) for providing Huh-7.5, Huh-7D and Huh-7-Lunet
   cells, respectively. ALV and NIM811 were generously provided by Novartis
   AG (Basel, Switzerland).
CR Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010
   Carbajo-Lozoya J, 2014, VIRUS RES, V184, P44, DOI 10.1016/j.virusres.2014.02.010
   Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002
   Cervantes-Barragan L, 2010, MBIO, V1, DOI 10.1128/mBio.00171-10
   Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009
   Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Wilde AH, 2018, VIROLOGY, V517, P148, DOI 10.1016/j.virol.2017.11.022
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0
   de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12
   de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0
   dePaulis A, 1996, J ALLERGY CLIN IMMUN, V98, P152, DOI 10.1016/S0091-6749(96)70237-3
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Feigelstock DA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-44
   Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3
   Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005
   Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946
   Hopkins S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI 10.1016/j.bbagen.2014.11.011
   Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09
   Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360
   Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06
   LaFemina RL, 2014, ANTIMICROB AGENTS CH, V58, P4251, DOI 10.1128/AAC.03406-14
   LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0
   LEGRUE SJ, 1986, SCIENCE, V234, P68, DOI 10.1126/science.3749892
   Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Luo C, 2004, BIOCHEM BIOPH RES CO, V321, P557, DOI 10.1016/j.bbrc.2004.07.003
   Ma-Lauer Y, 2016, P NATL ACAD SCI USA, V113, pE5192, DOI 10.1073/pnas.1603435113
   Malesevic M, 2013, J MED CHEM, V56, P7302, DOI 10.1021/jm4007577
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   Membreno FE, 2013, CLIN LIVER DIS, V17, P129, DOI 10.1016/j.cld.2012.09.008
   Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008
   Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07
   Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331
   Prell E, 2013, CHEMBIOCHEM, V14, P63, DOI 10.1002/cbic.201200621
   PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466
   Saphire ACS, 2000, IMMUNOL RES, V21, P211, DOI 10.1385/IR:21:2-3:211
   Sastre P, 2011, CLIN VACCINE IMMUNOL, V18, P113, DOI 10.1128/CVI.00355-10
   Tanaka Y, 2017, J GEN VIROL, V98, P190, DOI 10.1099/jgv.0.000663
   von Brunn A, 2015, CURR OPIN VIROL, V14, P56, DOI 10.1016/j.coviro.2015.08.004
   von Hahn T, 2012, GASTROENTEROLOGY, V143, P439, DOI 10.1053/j.gastro.2012.04.053
   Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28
   Zhou DJ, 2012, BIOCHEM BIOPH RES CO, V424, P647, DOI 10.1016/j.bbrc.2012.07.024
NR 50
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2020
VL 173
AR UNSP 104620
DI 10.1016/j.antiviral.2019.104620
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KH6JO
UT WOS:000510757900001
PM 31634494
OA Bronze
DA 2020-04-03
ER

PT J
AU Malik, YS
   Sircar, S
   Bhat, S
   Sharun, K
   Dhama, K
   Dadar, M
   Tiwari, R
   Chaicumpa, W
AF Malik, Yashpal Singh
   Sircar, Shubhankar
   Bhat, Sudipta
   Sharun, Khan
   Dhama, Kuldeep
   Dadar, Maryam
   Tiwari, Ruchi
   Chaicumpa, Wanpen
TI Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary
   perspective based on genome analysis and recent developments
SO VETERINARY QUARTERLY
LA English
DT Article
DE Coronavirus; 2019-nCoV; Severe Acute Respiratory Syndrome CoV; Middle
   East Respiratory Syndrome CoV; Public Health Emergency; genetic
   analyses; zoonoses; reservoir host; therapeutics; vaccines
ID RESPIRATORY SYNDROME CORONAVIRUS; VACCINE; THREAT; VIRUS; COV
AB Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade's first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as 'Public Health Emergency of International Concern' on January 30(th), 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas.
C1 [Malik, Yashpal Singh; Sircar, Shubhankar; Bhat, Sudipta] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Sharun, Khan] ICAR Indian Vet Res Inst, Div Surg, Bareilly, Uttar Pradesh, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Dadar, Maryam] AREEO, Razi Vaccine & Serum Res Inst, Karaj, Iran.
   [Tiwari, Ruchi] Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwa, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Chaicumpa, Wanpen] Mahidol Univ, Siriraj Hosp, Ctr Res Excellence Therapeut Proteins & Antibody, Dept Parasitol,Fac Med, Bangkok, Thailand.
RP Malik, YS (reprint author), ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.; Dhama, K (reprint author), ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
EM malikyps@gmail.com; kdhama@rediffmail.com; wanpen.cha@mahidol.ac.th
RI sircar, Shubhankar/D-3691-2019; Sharun, Khan/A-3084-2019; Dhama,
   Kuldeep/B-7852-2015
OI sircar, Shubhankar/0000-0002-1947-4463; Sharun,
   Khan/0000-0003-1040-3746; Dhama, Kuldeep/0000-0001-7469-4752; Malik,
   Yashpal/0000-0002-2832-4854
CR Alagaili A.N., 2014, MBIO, V5, DOI DOI 10.1128/MBIO.00884-14
   Callaway E, 2020, NATURE, V577, P605, DOI 10.1038/d41586-020-00166-6
   Cheng VCC, 2020, J HOSP INFECT, V104, P254, DOI 10.1016/j.jhin.2020.01.010
   Cohen J, 2020, SCIENCE, V367, P492, DOI 10.1126/science.367.6477.492
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Groot RJ, 2012, VIRUS TAXONOMY, P806
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Gouilh MA, 2018, VIROLOGY, V517, P88, DOI 10.1016/j.virol.2018.01.014
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946
   Jiang SB, 2005, EMERG INFECT DIS, V11, P1016, DOI 10.3201/1107.050219
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Letko MC, 2020, FUNCTIONAL ASSESSMEN, DOI [10.1101/2020.01.22.915660, DOI 10.1101/2020.01.22.915660]
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M308
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Pillaiyar Thanigaimalai, 2020, Drug Discov Today, DOI 10.1016/j.drudis.2020.01.015
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   World Health Organization, 2015, MIDDL E RESP SYNDR C
   World Health Organization, 2020, NOV COR 2019 NCOV AD
   World Health Organization, 2020, NOV COR 2019 NCOV SI
   Zaher NH, 2020, ACTA PHARMACEUT, V70, P145, DOI 10.2478/acph-2020-0024
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou P, 2020, PREPRINT, DOI [10.1101/2020.01.22.914952v1, DOI 10.1101/2020.01.22.914952V1]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 35
TC 0
Z9 0
U1 40
U2 40
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0165-2176
EI 1875-5941
J9 VET QUART
JI Vet. Q.
PD JAN 1
PY 2020
VL 40
IS 1
BP 68
EP 76
DI 10.1080/01652176.2020.1727993
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA KQ4DI
UT WOS:000516874900001
PM 32036774
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Noh, JW
   Yoo, KB
   Kwon, YD
   Hong, JH
   Lee, Y
   Park, K
AF Noh, Jin-Won
   Yoo, Ki-Bong
   Kwon, Young Dae
   Hong, Jin Hyuk
   Lee, Yejin
   Park, Kisoo
TI Effect of Information Disclosure Policy on Control of Infectious
   Disease: MERS-CoV Outbreak in South Korea
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Middle East respiratory syndrome; MERS-CoV; infectious disease;
   prevention; information disclosure policy
ID INTERRUPTED TIME-SERIES; SARS
AB This study examined the effect of disclosing a list of hospitals with Middle East respiratory syndrome coronavirus (MERS-CoV) patients on the number of laboratory-confirmed MERS-CoV cases in South Korea. MERS-CoV data from 20 May 2015 to 5 July 2015 were from the Korean Ministry of Health & Welfare website and analyzed using segmented linear autoregressive error models for interrupted time series. This study showed that the number of laboratory-confirmed cases was increased by 9.632 on 5 June (p < 0.001). However, this number was significantly decreased following disclosure of a list of hospitals with MERS-CoV cases (Estimate = -0.699; p < 0.001). Disclosing the list of hospitals exposed to MERS-CoV was critical to the prevention of further infection. It reduced the number of confirmed MERS-CoV cases. Thus, providing accurate and timely information is a key to critical care response.
C1 [Noh, Jin-Won] Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan 31116, South Korea.
   [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth, NL-9713 GZ Groningen, Netherlands.
   [Yoo, Ki-Bong] Yonsei Univ, Dept Hlth Adm, Coll Hlth Sci, Wonju 26493, South Korea.
   [Kwon, Young Dae] Catholic Univ Korea, Dept Humanities & Social Med, Coll Med, Seoul 06591, South Korea.
   [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul 06591, South Korea.
   [Hong, Jin Hyuk] Korea Univ, Dept Biostat, Coll Med, Seoul 02841, South Korea.
   [Lee, Yejin] Eulji Univ, Dept Healthcare Management, Seongnam 13135, South Korea.
   [Park, Kisoo] Korea Univ, Coll Med, Inst Occupat & Environm Hlth, Seoul 02841, South Korea.
RP Park, K (reprint author), Korea Univ, Coll Med, Inst Occupat & Environm Hlth, Seoul 02841, South Korea.
EM jinwon.noh@gmail.com; ykbong@yonsei.ac.kr; healthcare@catholic.ac.kr;
   hongjh0513@korea.ac.kr; yiye1110@gmail.com; blesspark@naver.com
RI ; Kwon, Young Dae/T-1591-2017
OI Park, Kisoo/0000-0002-7976-6572; Yoo, Ki-Bong/0000-0002-2955-6948; Kwon,
   Young Dae/0000-0002-8781-6832; Lee, Yejin/0000-0002-1782-0406
FU Ministry of Health & Welfare, Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea [HL19C0007]
FX This study was supported by a grant (HL19C0007) of the Korean Mental
   Health Technology R&D Project funded by the Ministry of Health &
   Welfare, Republic of Korea.
CR [Anonymous], 2015, NATURE, V523, P502, DOI 10.1038/523502a
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Choi JS, 2016, AM J INFECT CONTROL, V44, P480, DOI 10.1016/j.ajic.2015.10.032
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Fung ICH, 2015, WEST PAC SURVEILL RE, V6, P1, DOI [10.5365/WPSAR.2015.6.2.011, 10.5365/wpsar.2015.6.2.011]
   Hui DS, 2015, LANCET RESP MED, V3, P509, DOI 10.1016/S2213-2600(15)00238-6
   Lee K.-M., 2015, KOREAN TIMES SEOUL
   Ministry of Health & Welfare, MIDDL E RESP SYNDR I
   Moran K., 2015, EPIDEMIOL HLTH, V37, pe2015033
   Naylor CD, 2004, JAMA-J AM MED ASSOC, V291, P2483, DOI 10.1001/jama.291.20.2483
   Shin J.-H., 2015, KOREA MULLING DISCLO
   The Organisation for Economic Co-operation and Development, 2015, OECD HLTH DAT ORG EC
   Verma S, 2004, ANN ACAD MED SINGAP, V33, P743
   Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x
   Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007
NR 15
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2020
VL 17
IS 1
AR 305
DI 10.3390/ijerph17010305
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KF7AG
UT WOS:000509391500305
PM 31906369
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Qian, SJ
   Jia, XC
   Gao, ZT
   Zhang, WD
   Xu, QR
   Li, ZL
AF Qian, Shaoju
   Jia, Xiangchao
   Gao, Zitong
   Zhang, Weida
   Xu, Qingrong
   Li, Zili
TI Isolation and Identification of Porcine Deltacoronavirus and Alteration
   of Immunoglobulin Transport Receptors in the Intestinal Mucosa of
   PDCoV-Infected Piglets
SO VIRUSES-BASEL
LA English
DT Article
DE Porcine deltacoronavirus; Neonatal Fc receptor; polymeric immunoglobulin
   receptor; NF-kappa B
ID NEONATAL FC-RECEPTOR; FUNCTIONAL EXPRESSION; PIGS; PATHOGENICITY;
   DIARRHEA; PATHOGENESIS; PREVALENCE; THAILAND; BETA; IGG
AB Porcine deltacoronavirus (PDCoV) is a porcine enteropathogenic coronavirus that causes watery diarrhea, vomiting, and frequently death in piglets, causing serious economic losses to the pig industry. The strain CHN-JS-2017 was isolated and identified by cytopathology, immunofluorescence assays, transmission electron microscopy, and sequence analysis. A nucleotide sequence alignment showed that the whole genome of CHN-JS-2017 is 97.4%-99.6% identical to other PDCoV strains. The pathogenicity of the CHN-JS-2017 strain was investigated in orally inoculated five-day-old piglets; the piglets developed acute, watery diarrhea, but all recovered and survived. CHN-JS-2017 infection-induced microscopic lesions were observed, and viral antigens were detected mainly by immunohistochemical staining in the small intestine. The neonatal Fc receptor (FcRn) and polymeric immunoglobulin receptor (pIgR) are crucial immunoglobulin (Ig) receptors for the transcytosis ofimmunoglobulin G (IgG), IgA, or IgM. Importantly, CHN-JS-2017 infected five-day-old piglets could significantly down-regulate the expression of FcRn, pIgR, and nuclear factor-kappa B (NF-kappa B)in the intestinal mucosa. Note that the level of FcRn mRNA in the intestinal mucosa of normal piglets is positively correlated with pIgR and NF-kappa B. At the same time, the expressions of FcRn, pIgR, and NF-kappa B mRNA are also positively correlated in infected piglets. These results may help explain the immunological and pathological changes associated with porcine deltacorononirus infection.
C1 [Qian, Shaoju; Jia, Xiangchao; Gao, Zitong; Zhang, Weida; Xu, Qingrong; Li, Zili] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.
   [Xu, Qingrong; Li, Zili] Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Peoples R China.
   [Xu, Qingrong; Li, Zili] Minist Agr Peoples Republ China, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Peoples R China.
RP Li, ZL (reprint author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.; Li, ZL (reprint author), Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Peoples R China.; Li, ZL (reprint author), Minist Agr Peoples Republ China, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Peoples R China.
EM qianshaoju@webmail.hzau.edu.cn; jiaxianghcao@webmail.hzau.edu.cn;
   zitongGao@webmail.hzau.edu.cn; ZhangWD171215@webmail.hzau.edu.cn;
   XuQingRong@mail.hzau.edu.cn; lizili@mail.hzau.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31572500]
FX This work was supported by the National Natural Science Foundation of
   China (31572500 to Z.L.).
CR Chen F, 2015, GENOME ANNOUNC, V3
   Chen J, 2019, VIRUS GENES, V55, P520, DOI 10.1007/s11262-019-01673-z
   Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]
   Guo JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32154
   Hu H, 2016, ARCH VIROL, V161, P3421, DOI 10.1007/s00705-016-3056-8
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Ji LK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01024
   Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001
   Jung K, 2015, EMERG INFECT DIS, V21, P650, DOI 10.3201/eid2104.141859
   Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Li D, 2017, ZOOL RES, V38, P44, DOI 10.13918/j.issn.2095-8137.2017.007
   Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108
   Liu BJ, 2018, TRANSBOUND EMERG DIS, V65, P874, DOI 10.1111/tbed.12821
   Liu XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10865-y
   Liu XD, 2008, J IMMUNOL, V181, P449, DOI 10.4049/jimmunol.181.1.449
   Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999
   Lorsirigool A, 2017, VIRUS GENES, V53, P240, DOI 10.1007/s11262-016-1413-z
   Luo JY, 2016, VIROLOGY, V495, P10, DOI 10.1016/j.virol.2016.04.025
   Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002
   Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.140526, 10.3201/eid2008.14-0526]
   Pal K, 2005, J GEN VIROL, V86, P2347, DOI 10.1099/vir.0.80690-0
   Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Temeeyasen G, 2018, VIROLOGY, V517, P188, DOI 10.1016/j.virol.2017.11.024
   Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237
   Vitosh-Sillman S, 2016, J VET DIAGN INVEST, V28, P486, DOI 10.1177/1040638716654200
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wang Y, 2016, SCAND J IMMUNOL, V83, P235, DOI 10.1111/sji.12416
   Wang Y.W, 2015, GENOME ANNOUNC, V3
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Xu ZC, 2019, VET MICROBIOL, V228, P226, DOI 10.1016/j.vetmic.2018.12.012
   Xu ZC, 2018, VIROL SIN, V33, P131, DOI 10.1007/s12250-018-0003-8
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
NR 36
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 2020
DI 10.3390/v12010079
PG 13
WC Virology
SC Virology
GA KH8KC
UT WOS:000510898300001
PM 31936476
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Ralph, R
   Lew, J
   Zeng, TS
   Francis, M
   Xue, B
   Roux, M
   Ostadgavahi, AT
   Rubino, S
   Dawe, NJ
   Al-Ahdal, MN
   Kelvin, DJ
   Richardson, CD
   Kindrachuk, J
   Falzarano, D
   Kelvin, AA
AF Ralph, Robyn
   Lew, Jocelyne
   Zeng, Tiansheng
   Francis, Magie
   Xue, Bei
   Roux, Melissa
   Ostadgavahi, Ali Toloue
   Rubino, Salvatore
   Dawe, Nicholas J.
   Al-Ahdal, Mohammed N.
   Kelvin, David J.
   Richardson, Christopher D.
   Kindrachuk, Jason
   Falzarano, Darryl
   Kelvin, Alyson A.
TI 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human
   transmission, travel-related cases, and vaccine readiness
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE 2019-nCoV; coronavirus; Wuhan; human-to-human transmission; vaccine
   readiness
ID RESPIRATORY SYNDROME CORONAVIRUS; MERS-COV INFECTION; SARS-CORONAVIRUS;
   SAUDI-ARABIA; HEALTH-CARE; WEB SERVER; RECEPTOR; PROTEIN; MODEL;
   DETERMINANTS
AB On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that humanto-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronaviruglaboratory-diagnostics-for-novel-coronavirus.
C1 [Ralph, Robyn; Lew, Jocelyne; Falzarano, Darryl] Vaccine & Infect Dis Org, Int Vaccine Ctr VIDO InterVac, Saskatoon, SK, Canada.
   [Ralph, Robyn; Falzarano, Darryl] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada.
   [Zeng, Tiansheng; Xue, Bei; Kelvin, David J.] Shantou Univ, Int Inst Infect & Immun, Med Coll, Shantou, Guangdong, Peoples R China.
   [Francis, Magie; Xue, Bei; Roux, Melissa; Ostadgavahi, Ali Toloue; Dawe, Nicholas J.; Kelvin, David J.; Richardson, Christopher D.; Kelvin, Alyson A.] Dalhousie Univ, Fac Med, Dept Microbiol & Immunol, Halifax, NS, Canada.
   [Rubino, Salvatore] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol Sperimentale & Clin, Sassari, Italy.
   [Al-Ahdal, Mohammed N.] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia.
   [Kelvin, David J.; Richardson, Christopher D.; Kelvin, Alyson A.] IWK Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada.
   [Kindrachuk, Jason] Univ Manitoba, Dept Med Microbiol, Lab Emerging & Re Emerging Viruses, Winnipeg, MB, Canada.
   [Kelvin, Alyson A.] Dalhousie Univ, Fac Med, Dept Pediat, Div Infect Dis, Halifax, NS, Canada.
RP Kelvin, AA (reprint author), Dalhousie Univ, Dept Pediat, Fac Med, IWK Hlth Ctr, 5980 Univ Ave,4th Floor,R4020, Halifax, NS B3K 6R8, Canada.; Kelvin, AA (reprint author), Canadian Ctr Vaccinol, 5980 Univ Ave,4th Floor,R4020, Halifax, NS B3K 6R8, Canada.
EM akelvin@dal.ca
RI Ribeiro, Nuno/AAH-2299-2020
FU Tier 2 Canada Research Chair in the Molecular Pathogenesis of Emerging
   and Re-Emerging Viruses by the Canadian Institutes of Health Research
   [950-231498]; IWK Health Centre [602975]; Nova Scotia Health Research
   Foundation [602932]; LKSF; Canada Foundation for Innovation (JELF)Canada
   Foundation for Innovation; DMRF (Dalhousie Medical Research Foundation);
   Government of Canada through Canada Foundation for Innovation - Major
   Science Initiatives; Government of Saskatchewan through Innovation
   Saskatchewan; Canadian Institutes for Health ResearchCanadian Institutes
   of Health Research (CIHR) [PJT 388665]
FX Research into the novel coronavirus genome (2019-nCoV) was led by Dr.
   Yong-Zhen Zhang at the the Shanghai Public Health Clinical Center &
   School of Public Health, in collaboration with the Central Hospital of
   Wuhan, Huazhong University of Science and Technology, the Wuhan Center
   for Disease Control and Prevention, the National Institute for
   Communicable Disease Control and Prevention, the Chinese Center for
   Disease Control, and the University of Sydney, Sydney, Australia. We
   would like to thank and acknowledge the researchers who were working to
   identify this pathogen and make the data publically available.
   Specifically, we acknowledge the National Institute for Viral Disease
   Control and Prevention, China CDC; Wuhan Institute of Virology, Chinese
   Academy of Sciences; Institute of Pathogen Biology, Chinese Academy of
   Medical Sciences & Peking Union Medical College; and Wuhan Jinyintan
   Hospital. In addition, we acknowledge GISAID (https://www.gisaid.org/)
   for providing a platform that allows data to be freely shared. J.K. is
   funded by a Tier 2 Canada Research Chair in the Molecular Pathogenesis
   of Emerging and Re-Emerging Viruses provided by the Canadian Institutes
   of Health Research (Grant no. 950-231498). A.A.K. is funded by the IWK
   Health Centre (Grant no. 602975) and Nova Scotia Health Research
   Foundation (Grant no. 602932). DJK is a Tier 1 Canada Research Chair in
   Translational Vaccinology and Inflammation. Support for DJK was provided
   by LKSF, Canada Foundation for Innovation (JELF), and DMRF (Dalhousie
   Medical Research Foundation). VIDO-InterVac receives operational funding
   from the Government of Canada through Canada Foundation for Innovation
   -Major Science Initiatives and the Government of Saskatchewan through
   Innovation Saskatchewan. D.F. receives support from Canadian Institutes
   for Health Research (PJT 388665).
CR Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609
   Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14
   Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021
   Al-Ahmadi H, 2005, INT J QUAL HEALTH C, V17, P331, DOI 10.1093/intqhc/mzi046
   Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226
   Alagaili A.N., 2014, MBIO, V5, DOI DOI 10.1128/MBIO.00884-14
   AlBarrak AM, 2012, SAUDI MED J, V33, P1265
   Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13
   Anderson RM, 2004, PHILOS T ROY SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490
   [Anonymous], PYMOL MOL GRAPHICS S
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Banner D, 2012, J INFECT DEV COUNTR, V6, P465
   Bhattacharya D, 2016, NUCLEIC ACIDS RES, V44, pW406, DOI 10.1093/nar/gkw336
   Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan PKS, 2013, J THORAC DIS, V5, pS118, DOI 10.3978/j.issn.2072-1439.2013.06.19
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hart BJ, 2014, J GEN VIROL, V95, P571, DOI 10.1099/vir.0.061911-0
   Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536
   Hunter JC, 2016, EMERG INFECT DIS, V22, P647, DOI 10.3201/eid2204.151615
   Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365
   Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14
   Li LF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5169-3
   Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640
   Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004
   Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a
   Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005
   Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   van Doremalen N, 2015, ANTIVIR RES, V122, P28, DOI 10.1016/j.antiviral.2015.07.005
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Walston S, 2008, ANN SAUDI MED, V28, P243
   Weber David S, 2019, Arch Biochem Biophys, V672, P108053, DOI 10.1016/j.abb.2019.07.018
   Wentworth DE, 2004, EMERG INFECT DIS, V10, P1293, DOI 10.3201/eid1007.031119
   Widagdo W, 2016, J VIROL, V90, P4838, DOI 10.1128/JVI.02994-15
   Willman M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121119
   World Health Organization (WHO), 2020, DIAGN NOV COR
   Wu F, 2020, NOVEL CORONAVIRUS AS
   Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 67
TC 0
Z9 0
U1 30
U2 30
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JAN
PY 2020
VL 14
IS 1
BP 3
EP +
DI 10.3855/jidc.12425
PG 16
WC Infectious Diseases
SC Infectious Diseases
GA KK7ZU
UT WOS:000512957400002
PM 32088679
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Rong, XM
   Yang, L
   Chu, HD
   Fan, M
AF Rong, Xinmiao
   Yang, Liu
   Chu, Huidi
   Fan, Meng
TI Effect of delay in diagnosis on transmission of COVID-19
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE COVID-19; delay in diagnosis; dynamic model; hospital resources
AB The outbreak of COVD-19 caused by SiRS-CoV-2 in Wuhan and other cities of China is a growing global concern. Delay in diagnosis and limited hospital resources lead to a rapid spread of COVID-19. In this study, we investigate the effect of delay in diagnosis on the disease transmission with a new formulated dynamic model. Sensitivity analyses and numerical simulations reveal that, improving the proportion of timely diagnosis and shortening the waiting time for diagnosis can not eliminate COVID-19 but can effectively decrease the basic reproduction number, significantly reduce the transmission risk, and effectively prevent the endemic of COVID-19, e.g., shorten the peak time and reduce the peak value of new confirmed cases and new infection, decrease the cumulative number of confirmed cases and total infection. More rigorous prevention measures and better treatment of patients are needed to control its further spread, e.g., increasing available hospital beds, shortening the period from symptom onset to isolation of patients, quarantining and isolating the suspected cases as well as all confirmed patients.
C1 [Rong, Xinmiao; Yang, Liu; Chu, Huidi; Fan, Meng] Northeast Normal Univ, Ctr Math Biosci, Sch Math & Stat, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.
   [Fan, Meng] Northeast Normal Univ, Natl Ctr Appl Math Jilin, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.
RP Fan, M (reprint author), Northeast Normal Univ, Ctr Math Biosci, Sch Math & Stat, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.; Fan, M (reprint author), Northeast Normal Univ, Natl Ctr Appl Math Jilin, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.
EM mfan@nenu.edu.cn
FU National Natural Science Foundation of P. R. ChinaNational Natural
   Science Foundation of China [11671072, 11271065]
FX This research was supported by National Natural Science Foundation of P.
   R. China (Nos. 11671072, 11271065).
CR Ai S., 2020, POPULATION MOVEMENT
   [Anonymous], 2020, INF POP WUH
   Bai Y., 2020, EPIDEMIC PREDICTION
   Bogoch I. I., 2020, J TRAVEL MED
   Carpenter TE, 2011, J VET DIAGN INVEST, V23, P26, DOI 10.1177/104063871102300104
   Chowell D, 2015, LANCET INFECT DIS, V15, P148, DOI 10.1016/S1473-3099(14)71084-9
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Health Commission of Hubei Province, 2020, PREV MEAS WUH
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Imai N, 2020, ESTIMATING POTENTIAL
   Lai S., 2020, ASSESSING SPREAD RIS
   Liu T., BIORXIV, P2020
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   National Health Commission of the People's Republic of China, 2020, DAT CONF CAS COVID 1
   National Health Commission of the People's Republic of China, 2020, SIT REP PNEUM CAS CU
   National Health Commission of the People's Republic of China, PREV CONTR NOV COR P, P2020
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Okeke IN, 2014, J INFECT DEV COUNTR, V8, P1148, DOI 10.3855/jidc.4636
   Park S. W., 2020, RECONCILING EARLY OU
   Read J. M., 2020, NOVEL CORONAVIRUS 20
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Tang B., 2020, EVOLUTION QUARANTINE
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   The State Council the People's Republic of China, 2020, ANN PREV CONTR HEADQ
   Tian H., 2020, EARLY EVALUATION THE
   Uys PW, 2009, J CLIN MICROBIOL, V47, P1484, DOI 10.1128/JCM.02289-08
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   WHO, CLIN MAN SEV AC RESP
   World Health Organization, PNEUM UNKN CAUS CHIN
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
NR 32
TC 0
Z9 0
U1 8
U2 8
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2020
VL 17
IS 3
BP 2725
EP 2740
DI 10.3934/mbe.2020149
PG 16
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA KU7DN
UT WOS:000519873900049
OA Other Gold
DA 2020-04-03
ER

PT J
AU Sanchez, CM
   Pascual-Iglesias, A
   Sola, I
   Zuniga, S
   Enjuanes, L
AF Sanchez, Carlos M.
   Pascual-Iglesias, Alejandro
   Sola, Isabel
   Zuniga, Sonia
   Enjuanes, Luis
TI Minimum Determinants of Transmissible Gastroenteritis Virus Enteric
   Tropism Are Located in the N-Terminus of Spike Protein
SO PATHOGENS
LA English
DT Article
DE transmissible gastroenteritis virus; tropism; recombinant virus; enteric
   tropism
ID GLYCOSAMINOGLYCAN-BINDING VARIANTS; HEPARAN-SULFATE; VIRULENCE
   ATTENUATION; JAPANESE ENCEPHALITIS; E2 GLYCOPROTEIN; ANTIGENIC SITES;
   SINDBIS VIRUS; S PROTEIN; CORONAVIRUS; IMMUNOGENICITY
AB Transmissible gastroenteritis virus (TGEV) is an enteric coronavirus causing high morbidity and mortality in porcine herds worldwide, that possesses both enteric and respiratory tropism. The ability to replicate in the enteric tract directly correlates with virulence, as TGEVs with an exclusive respiratory tropism are attenuated. The tissue tropism is determined by spike (S) protein, although the molecular bases for enteric tropism remain to be fully characterized. Both pAPN and sialic acid binding domains (aa 506-655 and 145-155, respectively) are necessary but not sufficient for enteric tract infection. Using a TGEV infectious cDNA and enteric (TGEV-SC11) or respiratory (TGEV-SPTV) isolates, encoding a full-length S protein, a set of chimeric recombinant viruses, with a sequential modification in S protein amino terminus, was engineered. In vivo tropism, either enteric, respiratory or both, was studied by inoculating three-day-old piglets and analyzing viral titers in lung and gut. The data indicated that U655 >G change in S gene (S219A in S protein) was required to confer enteric tropism to a respiratory virus that already contains the pAPN and sialic acid binding domains in its S protein. Moreover, an engineered virus containing U655>G and a 6 nt insertion at position 1124 (Y374-T375insND in S protein) was genetically stable after passage in cell cultures, and increased virus titers in gut by 1000-fold. We postulated that the effect of these residues in enteric tropism may be mediated by the modification of both glycosaminoglycan binding and S protein structure.
C1 [Sanchez, Carlos M.; Pascual-Iglesias, Alejandro; Sola, Isabel; Zuniga, Sonia; Enjuanes, Luis] Natl Ctr Biotechnol CNB CSIC, Dept Mol & Cell Biol, Campus Univ Autonoma Madrid,Darwin 3, Madrid 28049, Spain.
RP Zuniga, S; Enjuanes, L (reprint author), Natl Ctr Biotechnol CNB CSIC, Dept Mol & Cell Biol, Campus Univ Autonoma Madrid,Darwin 3, Madrid 28049, Spain.
EM csanchez@cnb.csic.es; alejandro.pascual@cnb.csic.es; isola@cnb.csic.es;
   szuniga@cnb.csic.es; L.Enjuanes@cnb.csic.es
OI Enjuanes, Luis/0000-0002-0854-0226; Zuniga, Sonia/0000-0003-2549-6826
FU Government of Spain (AEI/FEDER, UE) [BIO2013-42869-R, BIO2016-75549-R];
   European Zoonotic Anticipation and Preparedness Initiative (ZAPI)
   [IMI_JU_115760]; U.S. National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [2P01AI060699]
FX This research was funded by grants from the Government of Spain
   (BIO2013-42869-R and BIO2016-75549-R AEI/FEDER, UE), the European
   Zoonotic Anticipation and Preparedness Initiative (ZAPI)
   (IMI_JU_115760), and the U.S. National Institutes of Health (NIH)
   (2P01AI060699 awarded to L.E. and I.S.).
CR Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516
   Almazan Fernando, 2008, V454, P275, DOI 10.1007/978-1-59745-181-9_20
   Aquino RS, 2016, FRONT BIOSCI-LANDMRK, V21, P1260, DOI 10.2741/4455
   Ballesteros ML, 1997, VIROLOGY, V227, P378, DOI 10.1006/viro.1996.8344
   Becares M, 2014, VIROLOGY, V464, P274, DOI 10.1016/j.virol.2014.07.027
   Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546
   Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000
   CALLEBAUT P, 1988, J GEN VIROL, V69, P1725, DOI 10.1099/0022-1317-69-7-1725
   Chattha KS, 2015, ANNU REV ANIM BIOSCI, V3, P375, DOI 10.1146/annurev-animal-022114-111038
   CORREA I, 1990, J GEN VIROL, V71, P271, DOI 10.1099/0022-1317-71-2-271
   de Groot RJ, 2012, VIRUS TAXONOMY, P806
   DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994
   Enjuanes L, 2016, ADV VIRUS RES, V96, P245, DOI 10.1016/bs.aivir.2016.08.003
   Enjuanes L., 2008, ENCY VIROLOGY, P419
   GARWES DJ, 1975, J GEN VIROL, V29, P25, DOI 10.1099/0022-1317-29-1-25
   GARWES DJ, 1976, J GEN VIROL, V32, P283, DOI 10.1099/0022-1317-32-2-283
   GEBAUER F, 1991, VIROLOGY, V183, P225, DOI 10.1016/0042-6822(91)90135-X
   Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077
   Hain KS, 2016, J GEN VIROL, V97, P2719, DOI 10.1099/jgv.0.000586
   Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557
   Hu XL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0387-8
   Huan CC, 2015, ARCH VIROL, V160, P1621, DOI 10.1007/s00705-015-2408-0
   JIMENEZ G, 1986, J VIROL, V60, P131
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997
   Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Ribes JM, 2011, VIROLOGY, V410, P107, DOI 10.1016/j.virol.2010.10.036
   MCCLURKIN AW, 1966, CAN J COMP MED VET S, V30, P190
   Miura TA, 2008, J VIROL, V82, P755, DOI 10.1128/JVI.01851-07
   Oh J, 2014, ARCH VIROL, V159, P2977, DOI 10.1007/s00705-014-2163-7
   Ortego J, 2003, VIROLOGY, V308, P13, DOI 10.1016/S0042-6822(02)00096-X
   PENSAERT M, 1986, VET QUART, V8, P257, DOI 10.1080/01652176.1986.9694050
   Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phillips JJ, 1999, J VIROL, V73, P7752, DOI 10.1128/JVI.73.9.7752-7760.1999
   Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859
   SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997
   Sanchez CM, 1999, J VIROL, V73, P7607
   Schwegmann-Wessels C, 2002, J VIROL, V76, P6037, DOI 10.1128/JVI.76.12.6037-6043.2002
   Sheahan T, 2008, J VIROL, V82, P8721, DOI 10.1128/JVI.00818-08
   Sola I, 2003, J VIROL, V77, P4357, DOI 10.1128/JVI.77.7.4357-4369.2003
   van Beurden SJ, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0775-8
   Wang G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040313
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174
   Yuan XM, 2017, ARCH VIROL, V162, P3779, DOI 10.1007/s00705-017-3548-1
NR 52
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD JAN
PY 2020
VL 9
IS 1
AR 2
DI 10.3390/pathogens9010002
PG 13
WC Microbiology
SC Microbiology
GA KL0NU
UT WOS:000513130300043
PM 31861369
OA DOAJ Gold
DA 2020-04-03
ER

PT J
AU Singh, S
   Singh, R
   Singh, KP
   Singh, V
   Malik, YPS
   Kamdi, B
   Singh, R
   Kashyap, G
AF Singh, Shailendra
   Singh, Rajendra
   Singh, K. P.
   Singh, V
   Malik, Y. P. S.
   Kamdi, Bhupesh
   Singh, Rahul
   Kashyap, Gayatri
TI Immunohistochemical and molecular detection of natural cases of bovine
   rotavirus and coronavirus infection causing enteritis in dairy calves
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Rotavirus; Coronavirus; RT-PCR; Immunohistochemistory
ID WINTER DYSENTERY; CALF DIARRHEA; PREVALENCE; PATHOLOGY
AB Bovine rotavirus (BRoV) and bovine coronavirus (BCoV) are major enteric viral pathogens responsible for calve diarrhoea. They are widespread both in dairy and beef cattle throughout the world and causing huge economic losses. The diagnosis of these agents is very difficult due to non-specific nature of lesions and the involvement of some intrinsic and extrinsic risk factors. We performed postmortem of 45 calves, which was below three months of age. Out of 45 necropscid calves, three (6.66%) cases were positive for BRoV and four (8.88%) cases were found positive for BCoV, screened by reverse transcriptase polymerase chain reaction (RT-PCR). Further RT-PCR positive cases were confirmed by immunohistochemistry (IHC) in paraffin-embedded intestinal tissue sections. Three cases of enteritis caused by BRoV showed the hallmark lesions of the shortening and fusion of villi, denudation and infiltration of mononuclear cells in the lamina propria. The BRoV antigen distribution was prominent within the lining epithelium of the villi, peyer's patches in the ileum and strong immunoreactions in the lymphocytes and some macrophages of the mesenteric lymph nodes. Four cases in which BCoV was detected, grossly lesions characterized by colonic mucosa covered with thick, fibrinous and diphtheritic membrane. Histopathologically, jejunum showed skipping lesion of micro-abscesses in crypts. The BCoV antigen distribution was prominent within the necrotic crypts in the jejunum and cryptic micro-abscesses in the colon and ileum. It is the first report of BRoV and BCoV antigen demonstration in the jejunum, colon, ileum, Peyer's patches and mesenteric lymph nodes of naturally infected calves from India by using IHC.
C1 [Singh, Shailendra; Singh, Rajendra; Singh, K. P.; Singh, V; Kamdi, Bhupesh; Singh, Rahul; Kashyap, Gayatri] ICAR Indian Vet Res Inst, Div Pathol, Izatnagar 243122, Uttar Pradesh, India.
   [Malik, Y. P. S.] ICAR Indian Vet Res Inst, Div Biol Standardizat, Izatnagar 243122, Uttar Pradesh, India.
RP Singh, S; Singh, R; Singh, R (reprint author), Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India.
EM drshailendravet78@gmail.com; rajendra_singh5747@rediffmail.com;
   rahulsingh.vet@gmail.com
OI Singh, Rahul/0000-0001-5904-804X
CR Anjan Mondal, 2013, Advances in Animal and Veterinary Sciences, V1, P18
   ATHANASSIOUS R, 1994, CAN VET J, V35, P163
   Barry AF, 2009, BRAZ ARCH BIOL TECHN, V52, P45, DOI 10.1590/S1516-89132009000700006
   BELLINZONI RC, 1987, J CLIN MICROBIOL, V25, P952, DOI 10.1128/JCM.25.5.952-954.1987
   Boileau MJ, 2010, VET CLIN N AM-FOOD A, V26, P123, DOI 10.1016/j.cvfa.2009.10.003
   Cho YI, 2014, J VET SCI, V15, P1, DOI 10.4142/jvs.2014.15.1.1
   Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006
   Dash SK, 2011, VET WORLD, V4, P554, DOI 10.5455/vetworld.2011.554-556
   Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x
   Field P.M., 2015, AHL NEWSL, V19, P3
   Gay C.C., 2012, DIARRHOEA NEONATAL R
   Gruenberg W., 2014, MERCK VET MANUAL
   Gumusova Semra Okur, 2007, Medycyna Weterynaryjna, V63, P62
   Jubb K., 2007, PALMERS PATHOLOY DOM, V1, P546
   Kashyap G, 2018, MICROB PATHOGENESIS, V121, P22, DOI 10.1016/j.micpath.2018.04.038
   Kashyap G, 2018, INDIAN J ANIM RES, V52, P99, DOI [10.18805/ijar.B-3411, 10.18805/ijar.b-3411]
   Kim HJ, 2011, VET MICROBIOL, V152, P291, DOI 10.1016/j.vetmic.2011.05.017
   Luna L.G., 1972, HISTOLOGICAL STAININ, P32
   Mahendran M., 2008, J IMMUNOL IMMUNOPATH, V10, P1
   Malik S, 2005, I C COMP SYST APPLIC
   McGavin M.D., 2007, PATHOLOGICAL BASIS V
   Park SJ, 2007, ARCH VIROL, V152, P1885, DOI 10.1007/s00705-007-1005-2
   Radostits O.M., 2007, VET MED
   Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004
   Razzaque MA, 2009, PAK VET J, V29, P1
   REYNOLDS DJ, 1985, RES VET SCI, V38, P264, DOI 10.1016/S0034-5288(18)31791-0
   SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991
   Singh S., 2018, J ANIM RES, V8, P925
   Uhde FL, 2008, VET REC, V163, P362
   USDA.Dairy, 2008, DAIR 2007 2, P57
   Windeyer MC, 2012, J DAIRY SCI, V95, P6731, DOI 10.3168/jds.2012-5828
NR 31
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JAN
PY 2020
VL 138
AR 103814
DI 10.1016/j.micpath.2019.103814
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KK0YK
UT WOS:000512477100016
PM 31639467
OA Bronze
DA 2020-04-03
ER

PT J
AU Tsou, P
   Vadivelan, A
   Kovvuri, M
   Garg, N
   Thangavelu, M
   Wang, Y
   Raj, S
AF Tsou, P.
   Vadivelan, A.
   Kovvuri, M.
   Garg, N.
   Thangavelu, M.
   Wang, Y.
   Raj, S.
TI Association between multiple respiratory viral infections and pediatric
   intensive care unit admission among infants with bronchiolitis
SO ARCHIVES DE PEDIATRIE
LA English
DT Article
DE Bronchiolitis; Infants; Pediatric intensive care; Multiple respiratory
   viral
ID INCREASED DISEASE SEVERITY; SYNCYTIAL VIRUS; CHILDREN; HOSPITALIZATIONS;
   ETIOLOGY; IMPACT; DURATION; TRACT; AGE; PCR
AB Background: It is unclear whether multiple respiratory viral infections are associated with more severe bronchiolitis requiring pediatric intensive care unit (PICU) admission. We aimed to identify the association between multiple respiratory viral infections and PICU admission among infants with bronchiolitis.
   Methods: We performed a 1:1 case-control study enrolling previously healthy full-term infants (<= 12 months) with bronchiolitis admitted to the PICU as cases and those to the general pediatric ward as controls from 2015 to 2017. Multiplex polymerase chain reaction (PCR) was used for detection of the respiratory viruses. We summarized the characteristics of infants admitted to the PICU and the general pediatric unit. Multivariable logistic regression analysis was used to fit the association between multiple respiratory viral infections (>= 2 strains) and PICU admission.
   Results: A total of 135 infants admitted to the PICU were compared with 135 randomly selected control infants admitted to the general pediatric unit. The PICU patients were younger (median: 2.2 months, interquartile range: 1.3-4.2) than the general ward patients (median: 3.2 months, interquartile range: 1.6-6.4). Respiratory syncytial virus (74.1%), rhinovirus (28.9%), and coronavirus (5.9%) were the most common viruses for bronchiolitis requiring PICU admission. Patients with bronchiolitis admitted to the PICU tended to have multiple viral infections compared with patients on the general ward (23.0% vs. 10.4%, P < 0.001). In the multivariable logistic regression analysis, bronchiolitis with multiple viral infections was associated with higher odds of PICU admission (adjusted odds ratio: 2.56, 95% confidence interval: 1.17-5.57, P = 0.02).
   Conclusion: Infants with multiviral bronchiolitis have higher odds of PICU admission compared with those with a single or nondetectable viral infection. (C) 2019 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.
C1 [Tsou, P.; Vadivelan, A.; Kovvuri, M.; Garg, N.; Thangavelu, M.; Wang, Y.] Texas A&M Coll Med, Driscoll Childrens Hosp, Dept Pediat, 3533 S Alameda St, Corpus Christi, TX 78411 USA.
   [Raj, S.] Texas A&M Coll Med, Driscoll Childrens Hosp, Dept Crit Care Med, Corpus Christi, TX 78411 USA.
RP Tsou, P (reprint author), Texas A&M Coll Med, Driscoll Childrens Hosp, Dept Pediat, 3533 S Alameda St, Corpus Christi, TX 78411 USA.
EM poyangtsou@gmail.com
CR Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057
   Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552
   Chen YW, 2014, J MICROBIOL IMMUNOL, V47, P116, DOI 10.1016/j.jmii.2012.08.012
   Florin TA, 2017, LANCET, V389, P211, DOI 10.1016/S0140-6736(16)30951-5
   Ghazaly M, 2018, EUR J PEDIATR, V177, P913, DOI 10.1007/s00431-018-3138-6
   Hanada S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02640
   Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877
   Jartti T, 2009, PEDIATR INFECT DIS J, V28, P311, DOI 10.1097/INF.0b013e31818ee0c1
   Krause JC, 2014, DTSCH ARZTEBL INT, V111, P639, DOI 10.3238/arztebl.2014.0639
   Leber AL, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01945-17, 10.1128/jcm.01945-17]
   Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223
   Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132
   Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669
   Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596
   Munywoki PK, 2015, EPIDEMIOL INFECT, V143, P804, DOI 10.1017/S0950268814001393
   Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014
   Oymar K, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-23
   Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC
   Pelletier AJ, 2006, PEDIATRICS, V118, P2418, DOI 10.1542/peds.2006-1193
   Doan Q, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006452.pub3
   Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935
   Robinson RF, 2008, AM J HEALTH-SYST PH, V65, pS3, DOI 10.2146/ajhp080438
   Robledo-Aceves M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010057
   Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440
   Wishaupt JO, 2011, PEDIATRICS, V128, pE1113, DOI 10.1542/peds.2010-2779
   Wu PS, 2011, EXPERT REV ANTI-INFE, V9, P731, DOI [10.1586/ERI.11.92, 10.1586/eri.11.92]
NR 26
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0929-693X
EI 1769-664X
J9 ARCH PEDIATRIE
JI Arch. Pediatr.
PD JAN
PY 2020
VL 27
IS 1
BP 39
EP 44
DI 10.1016/j.arcped.2019.11.006
PG 6
WC Pediatrics
SC Pediatrics
GA KK0XE
UT WOS:000512473900008
PM 31780096
OA Bronze
DA 2020-04-03
ER

PT J
AU Uhart, M
   Vanstreels, RET
   Gallo, L
   Cook, RA
   Karesh, WB
AF Uhart, Marcela
   Thijl Vanstreels, Ralph Eric
   Gallo, Luciana
   Cook, Robert A.
   Karesh, William B.
TI SEROLOGICAL SURVEY FOR SELECT INFECTIOUS AGENTS IN WILD MAGELLANIC
   PENGUINS (SPHENISCUS MAGELLANICUS) IN ARGENTINA, 1994-2008
SO JOURNAL OF WILDLIFE DISEASES
LA English
DT Article
DE Adaptive management; environmental stressors; health; penguin; seabird;
   serology; South America; Sphenisciformes
ID NEWCASTLE-DISEASE VIRUS; WEST-NILE-VIRUS; PYGOSCELIS-ADELIAE;
   CHLAMYDIA-PSITTACI; MOLECULAR CHARACTERIZATION; SALMONELLA-ENTERITIDIS;
   ROCKHOPPER PENGUINS; COASTAL PATAGONIA; HEALTH EVALUATION;
   SUB-ANTARCTICA
AB Despite being the most numerous penguin species in South America, exposure of the Magellanic Penguin (Spheniscus magellanicus) to pathogens has not yet been thoroughly assessed. We collected serum from 1,058 Magellanic Penguins at 10 breeding colonies along the entire latitudinal range of this species in Argentina. The work spanned 10 breeding seasons over 15 yr (1994-2008). Sera were tested for antibodies to select infectious agents. Antibodies reacting against 16 pathogens were detected (seroprevalence): Aspergillus sp. (15.1%), Chlamydia psittaci (6.5%), Salmonella Pullorum (3.1%), Salmonella Typhimurium (81.3%), Aviadenovirus sp. (18.1%), Duck atadenovirus A (23.6%), Anatid herpesvirus 1 (0.7%), Avian orthoreovirus (3.3%), Avian coronavirus M41 (43.5%), Avian coronavirus C46 (59.8%), Avian coronavirus A99 (37.4%), Avian coronavirus JMK (40.2%), Tremovirus A (0.3%), Avian avulavirus 1 (44.0%), Avian avulavirus 2 (43.8%), and Avian avulavirus 3 (46.6%). No antibodies were detected against nine infectious agents: Gallid alphaherpesvirus 1, Gallid alphaherpesvirus 2, Infectious bursal disease virus, Avastrovirus 2, West Nile virus, Eastern equine encephalitis virus, Venezuelan equine encephalitis virus, Western equine encephalitis virus, and Influenza A virus. While restricted by limitations inherent to serological methods, our results provide baseline knowledge for a key species in the South Atlantic Ocean. This information is valuable for adaptive conservation management in a time of increasing environmental stressors affecting the Patagonian Sea, one of the world's richest pelagic seabird communities.
C1 [Uhart, Marcela; Thijl Vanstreels, Ralph Eric] Univ Calif Davis, Sch Vet Med, One Hlth Inst, 1089 Vet Med Dr,VM3B, Davis, CA 95616 USA.
   [Uhart, Marcela; Cook, Robert A.; Karesh, William B.] Wildlife Conservat Soc, Field Vet Program, 2300 Southern Blvd, Bronx, NY 10460 USA.
   [Thijl Vanstreels, Ralph Eric] Inst Pesquisa & Reabilitac Animais Marinhos, Rodovia BR-262 Km 0, BR-29140130 Cariacica, ES, Brazil.
   [Gallo, Luciana] Consejo Nacl Invest Cient & Tecn, Inst Biol Organismos Marinos, Blvd Brown 2915,U9120ACD, Puerto Madryn, Chubut, Argentina.
   [Cook, Robert A.] Sci Based Support Consulting, 28 Sassinoro Blvd, Cortlandt Manor, NY 10567 USA.
   [Karesh, William B.] EcoHlth Alliance, 460 W 34th St,17th Floor, New York, NY 10001 USA.
RP Uhart, M (reprint author), Univ Calif Davis, Sch Vet Med, One Hlth Inst, 1089 Vet Med Dr,VM3B, Davis, CA 95616 USA.; Uhart, M (reprint author), Wildlife Conservat Soc, Field Vet Program, 2300 Southern Blvd, Bronx, NY 10460 USA.
EM muhart@ucdavis.edu
FU Wildlife Conservation Society; Fundacion Patagonia Natural; One Health
   Institute at University of California, DavisUniversity of California
   System
FX We thank W. Conway, G. Harris, V. Greco, L. Starr, K. Poppe, W. Weisman,
   A. Yang, H. Lee, J. Rosario, S. Rosenberg, E. Frere, P. Gandini, R.
   (Bebote) Vera, C. Marull, L. Pozzi, P. de Diego, V. Rago, F. Quintana,
   S. Harris, D. Boersma, M. Di Martino, and L. Beltramino for their
   valuable contributions. We thank Direccion de Conservacion y Areas
   Protegidas and Direccion de Fauna y Flora Silvestre of Chubut Province,
   Consejo Agrario of Santa Cruz Province, and Direccion de Fauna y Flora
   de Tierra del Fuego for issuing permits. J. Copello, J. L. Machinea, and
   M. Soriano generously allowed us access to their properties and
   supported our work. This study was funded by Wildlife Conservation
   Society, Fundacion Patagonia Natural, and One Health Institute at
   University of California, Davis.
CR ADAIR BM, 1986, AVIAN PATHOL, V15, P677, DOI 10.1080/03079458608436330
   ALEXANDER DJ, 1989, ARCH VIROL, V109, P135, DOI 10.1007/BF01310525
   Alley MR, 2017, J WILDLIFE DIS, V53, P102, DOI 10.7589/2015-07-195
   Andersen A, 2003, DIS POULTRY, P863
   Andersen Arthur A., 2007, P303, DOI 10.1002/9780470344668.ch15
   AUSTIN FJ, 1993, J WILDLIFE DIS, V29, P568, DOI 10.7589/0090-3558-29.4.568
   Barriga GP, 2016, EMERG INFECT DIS, V22, P2221, DOI 10.3201/eid2212.161076
   BirdLife International, 2018, SPHEN MAG, DOI [10.2305/IUCN.UK.2018-2.RLTS.T22697822A132605485.EN, DOI 10.2305/IUCN.UK.2018-2.RLTS.T22697822A132605485.EN]
   Burco JD, 2014, J ZOO WILDLIFE MED, V45, P29, DOI 10.1638/2012-0051R1.1
   Callison SA, 2001, AVIAN DIS, V45, P492, DOI 10.2307/1592994
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   COCKBURN TA, 1947, J COMP PATHOL THERAP, V57, P77, DOI 10.1016/S0368-1742(47)80011-6
   Converse Kathryn A., 2007, P360, DOI 10.1002/9780470344668.ch20
   Cooper John, 2009, Marine Ornithology, V37, P193
   Cranfield MR., 2003, ZOO WILD ANIMAL MED, V5, P103
   da Silva RP, 2015, J ZOO WILDLIFE MED, V46, P667, DOI 10.1638/2013-0092.1
   Daoust Pierre-Yves, 2007, P270, DOI 10.1002/9780470344668.ch13
   de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260
   Boersma PD, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P233
   Dougnac C, 2015, EPIDEMIOL INFECT, V143, P1187, DOI 10.1017/S0950268814002052
   Falabella Valeria, 2009, ATLAS PATAGONIAN SEA
   Fitzgerald Scott D., 2007, P182, DOI 10.1002/9780470344668.ch8
   Fornells LAMG, 2012, VET MICROBIOL, V156, P429, DOI 10.1016/j.vetmic.2011.11.026
   Franca M, 2012, AVIAN DIS, V56, P160, DOI 10.1637/9836-061911-Reg.1
   Frere E., 2000, Hornero, V15, P93
   Frere Esteban, 2005, Hornero, V20, P35
   Friend M., 1999, FIELD MANUAL WILDLIF
   Gallo L, 2019, POLAR BIOL, V42, P733, DOI 10.1007/s00300-019-02467-7
   Gallo L, 2013, J WILDLIFE DIS, V49, P492, DOI 10.7589/2011-10-310
   Gallo-Vaulet M, 2017, P 4 EUR M AN CHALM Z, P14
   Gandini Patricia Alejandra, 1998, Ornitologia Neotropical, V9, P13
   GARCIA OG, 2013, DIS POULTRY, P161
   Gardner H, 1997, NATURE, V387, P245, DOI 10.1038/387245a0
   Gast RK., 2013, DIS POULTRY, P693
   Gauthier-Clerc M, 2002, POLAR BIOL, V25, P316, DOI 10.1007/s00300-001-0346-7
   Gedye KR, 2018, NEW ZEAL VET J, V66, P162, DOI 10.1080/00480169.2018.1439779
   Giaccardi M, 2004, ORNITOL NEOTROP, V15, P93
   Godoy C, 2013, P 8 INT PENG C BRIST, P78
   Gonzalez-Acuna D, 2013, POLAR BIOL, V36, P1749, DOI 10.1007/s00300-013-1394-5
   Gough RE, 2002, VET REC, V151, P422, DOI 10.1136/vr.151.14.422
   Graczyk TK, 1995, MYCOPATHOLOGIA, V131, P179, DOI 10.1007/BF01102898
   Grimaldi W, 2018, POLAR BIOL, V41, P2023, DOI 10.1007/s00300-018-2342-1
   Grimaldi WW, 2015, EMU, V115, P185, DOI 10.1071/MU14068
   GULKA CM, 1984, J WILDLIFE DIS, V20, P1
   Hansen Wallace R., 2007, P87, DOI 10.1002/9780470344668.ch4
   Hess M., 2013, DIS POULTRY, P290
   Hollmen Tuula, 2007, P177, DOI 10.1002/9780470344668.ch7
   Hughes LA, 2009, EMERG INFECT DIS, V15, P1091, DOI 10.3201/eid1507.090067
   Hurt AC, 2014, MBIO, V5, DOI 10.1128/mBio.01098-14
   International Union for Conservation of Nature, 2018, INT UN CONS NAT RED
   Isaksson J, 2015, POLAR BIOL, V38, P1931, DOI 10.1007/s00300-015-1748-2
   Ivanics E, 2001, AVIAN PATHOL, V30, P201, DOI 10.1080/03079450120054604
   Iveson JB, 2009, EPIDEMIOL INFECT, V137, P858, DOI 10.1017/S0950268808001222
   Jackwood M. W., 2013, DIS POULTRY, P139, DOI DOI 10.1002/9781119421481
   Jencek JE, 2012, J AVIAN MED SURG, V26, P225, DOI 10.1647/2010-046R1.1
   Jones M., 2013, DIS POULTRY, P351
   Kane OJ, 2012, J WILDLIFE DIS, V48, P790, DOI 10.7589/0090-3558-48.3.790
   Kane OJ, 2010, WATERBIRDS, V33, P415, DOI 10.1675/063.033.0321
   Karesh WB, 1999, J ZOO WILDLIFE MED, V30, P25
   Khomenko S, 2018, FOCUS, V12, P1
   Lee EN, 2002, POULTRY SCI, V81, P632, DOI 10.1093/ps/81.5.632
   Lee SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157032
   Lee SY, 2014, VIRUSES-BASEL, V6, P2052, DOI 10.3390/v6052052
   LEIGHTON JP, 2007, INFECT DIS WILD BIRD, P3
   Ludwig GV, 2002, AM J TROP MED HYG, V67, P67, DOI 10.4269/ajtmh.2002.67.67
   McFerran JB, 2000, REV SCI TECH OIE, V19, P589, DOI 10.20506/rst.19.2.1238
   Metwally SASD, 2013, DIS POULTRY, P431
   Miller G. D., 2001, Marine Ornithology, V29, P43
   Miller P.J., 2013, DIS POULTRY, V13, P89, DOI DOI 10.1002/9781119421481.CH3.(HTTPS://D0I.0RG/)
   Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10
   Moreno V, 2009, B VET, V9, P1
   MORGAN IR, 1981, AVIAN DIS, V25, P1019, DOI 10.2307/1590077
   Nayak B, 2012, VACCINE, V30, P2220, DOI 10.1016/j.vaccine.2011.12.090
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Niemeyer C., 2015, ADV ANIMAL SCI ZOOLO, V7, P81
   Niemeyer C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178811
   Nunes CF, 2012, BRAZ ARCH BIOL TECHN, V55, P537, DOI 10.1590/S1516-89132012000400008
   Odend'hal S., 1983, GEOGRAPHICAL DISTRIB
   Office International des Epizooties, 1996, MAN STAND DIAGN TEST
   Okeson DM, 2007, J ZOO WILDLIFE MED, V38, P240, DOI 10.1638/1042-7260(2007)038[0240:AROFBS]2.0.CO;2
   Olsen B, 1996, LANCET, V348, P1319, DOI 10.1016/S0140-6736(05)65807-2
   Padilla LR, 2003, J ZOO WILDLIFE MED, V34, P278, DOI 10.1638/02-076
   Palmgren H, 2000, EPIDEMIOL INFECT, V125, P257, DOI 10.1017/S0950268899004586
   Panackal AA, 2010, CLIN INFECT DIS, V50, P1588, DOI 10.1086/652761
   Parsons NJ, 2016, ONDERSTEPOORT J VET, V83, DOI 10.4102/ojvr.v83i1.1147
   Parsons NJ, 2015, DIS AQUAT ORGAN, V116, P149, DOI 10.3354/dao02907
   Purchase HG, 1989, LAB MANUAL ISOLATION
   Rebstock GA, 2016, POPUL ECOL, V58, P105, DOI 10.1007/s10144-015-0523-0
   Rettig PT, 1986, P ASS AV VET, P165
   SALINAS J, 1993, J VET MED B, V40, P239, DOI 10.1111/j.1439-0450.1993.tb00134.x
   Savelieff MG, 2018, VET CLIN PATH, V47, P342, DOI 10.1111/vcp.12644
   Schat K. A., 2013, DIS POULTRY, P515
   Shivaprasad H, 2013, DIS POULTRY, P678
   Smith KM, 2008, AVIAN DIS, V52, P130, DOI 10.1637/8265-071007-Reg
   Suarez D., 2013, DIS POULTRY, P486
   Vanstreels RET, 2017, PARASITOLOGY, V144, P698, DOI 10.1017/S0031182016002407
   Thomazelli LM, 2010, VET MICROBIOL, V146, P155, DOI 10.1016/j.vetmic.2010.05.006
   Trathan PN, 2015, CONSERV BIOL, V29, P31, DOI 10.1111/cobi.12349
   Travis EK, 2006, J WILDLIFE DIS, V42, P625, DOI 10.7589/0090-3558-42.3.625
   Tsunekuni R, 2014, VET IMMUNOL IMMUNOP, V160, P184, DOI 10.1016/j.vetimm.2014.05.001
   Tuttle AD, 2005, JAVMA-J AM VET MED A, V226, P2059, DOI 10.2460/javma.2005.226.2059
   Varsani A, 2015, J GEN VIROL, V96, P851, DOI 10.1099/vir.0.000038
   Varsani A, 2014, J GEN VIROL, V95, P1352, DOI 10.1099/vir.0.064436-0
   Villanueva C, 2012, J ORNITHOL, V153, P219, DOI 10.1007/s10336-011-0730-1
   Wallace RS., 2014, FOWLERS ZOO WILDLIFE, V8, P82
   WILLIAMS JE, 1976, AVIAN DIS, V20, P728, DOI 10.2307/1589453
   Xavier MO, 2011, CIEN ANIM BRAS, V12, P520
   Yorio P., 1998, Marine Ornithology, V26, P11
   Zanetti F, 2005, AVIAN DIS, V49, P546, DOI 10.1637/7381-051605R.1
NR 109
TC 0
Z9 0
U1 7
U2 7
PU WILDLIFE DISEASE ASSOC, INC
PI LAWRENCE
PA 810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA
SN 0090-3558
EI 1943-3700
J9 J WILDLIFE DIS
JI J. Wildl. Dis.
PD JAN
PY 2020
VL 56
IS 1
BP 66
EP 81
DI 10.7589/2019-01-022
PG 16
WC Veterinary Sciences
SC Veterinary Sciences
GA KA7BG
UT WOS:000505950900007
PM 31237822
DA 2020-04-03
ER

PT J
AU Hoang, VT
   Sow, D
   Belhouchat, K
   Dao, TL
   Ly, TDA
   Fenollar, F
   Yezli, S
   Alotaibi, B
   Raoult, D
   Parola, P
   de Santi, VP
   Gautret, P
AF Van-Thuan Hoang
   Sow, Doudou
   Belhouchat, Khadidja
   Dao, Thi-Loi
   Tran Duc Anh Ly
   Fenollar, Florence
   Yezli, Saber
   Alotaibi, Badriah
   Raoult, Didier
   Parola, Philippe
   de Santi, Vincent Pommier
   Gautret, Philippe
TI Environmental investigation of respiratory pathogens during the Hajj
   2016 and 2018
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Hajj; Respiratory pathogens; Environmental sampling; Human rhinovirus;
   Klebsiella pneumoniae; Streptococcus pneumoniae
ID STREPTOCOCCUS-PNEUMONIAE; INFECTIONS; PILGRIMS; TRANSMISSION;
   TUBERCULOSIS; SURFACES; DISEASES; SPREAD
AB Background: Respiratory tract infections are common in the context of the Hajj pilgrimage and respiratory pathogens can be transmitted via contact with contaminated surfaces. We sampled surfaces during the Hajj to detect the presence of respiratory bacteria and viruses.
   Methods: Frequently touched surfaces at Mecca, Mina, Arafat and Medina were sampled. The common respiratory pathogens were tested by qPCR.
   Results: 70/142 (49.3%) environmental samples collected were positive for at least one respiratory pathogen. Among the positive samples, Klebsiella pneumoniae was the bacterium most frequently tested positive (57.1%), followed by Streptococcus pneumoniae (12.9%), Staphylococcus aureus (10.0%) and Haemophilus influenzae (7.1%). 32.9% positive samples tested positive for rhinovirus and 1.4% for coronavirus. Surfaces with the highest rates of positive samples were kitchen tables (100%), water fountain faucet (73.3%) and edge of water coolers lid (84.6%). Samples collected in Mina were the most frequently contaminated with 68.8% being positive for at least one pathogen and 18.8% positive for a combination of multiple pathogens.
   Conclusion: These preliminary results indicate that respiratory pathogens are common in environmental surfaces from areas frequented by Hajj pilgrims. Further larger-scale studies are needed to better assess the possible role of environmental respiratory pathogens in respiratory infections in Hajj pilgrims.
C1 [Van-Thuan Hoang; Sow, Doudou; Belhouchat, Khadidja; Dao, Thi-Loi; Tran Duc Anh Ly; Fenollar, Florence; Parola, Philippe; de Santi, Vincent Pommier; Gautret, Philippe] Aix Marseille Univ, VITROME, SSA, AP HM,IRD, Marseille, France.
   [Van-Thuan Hoang; Sow, Doudou; Belhouchat, Khadidja; Dao, Thi-Loi; Tran Duc Anh Ly; Fenollar, Florence; Raoult, Didier; Parola, Philippe; de Santi, Vincent Pommier; Gautret, Philippe] IHU Mediterranee Infect, Marseille, France.
   [Van-Thuan Hoang; Dao, Thi-Loi] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam.
   [Sow, Doudou] Univ Cheikh Anta Diop, Fac Med, Serv Parasitol Mycol, Dakar, Senegal.
   [Yezli, Saber; Alotaibi, Badriah] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
   [Raoult, Didier] Aix Marseille Univ, MEPHI, Marseille, France.
   [de Santi, Vincent Pommier] French Mil Ctr Epidemiol & Publ Hlth Marseille, Marseille, France.
RP Gautret, P (reprint author), Inst Hosp Univ Mediterranee Infect, VITROME, 19-21 Blvd Jean Moulin, F-13385 Marseille 05, France.
EM philippe.gautret@ap-hm.fr
OI Ly, Tran Duc Anh/0000-0001-8432-8254
FU Institut Hospitalo-Universitaire (IHU) Mediterranee Infection; National
   Research Agency under the program " Investissements d'avenir "French
   National Research Agency (ANR) [ANR-10-IAHU-03]; Region
   Provence-Alpes-Cote d'AzurRegion Provence-Alpes-Cote d'Azur; European
   funding FEDER PRIMI
FX This study was supported by the Institut Hospitalo-Universitaire (IHU)
   Mediterranee Infection, the National Research Agency under the program "
   Investissements d'avenir ", reference ANR-10-IAHU-03, the Region
   Provence-Alpes-Cote d'Azur and European funding FEDER PRIMI.
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   AFIFI MM, 2013, INT J BIOL CHEM, V7, P58, DOI DOI 10.3923/ijbc.2013.58.68
   Al-Orainey IO, 2013, SAUDI MED J, V34, P676
   Al-Tawfiq JA, 2018, TRAVEL MED INFECT DI, V23, P6, DOI 10.1016/j.tmaid.2018.04.007
   Al-Tawfiq JA, 2013, CURR OPIN PULM MED, V19, P192, DOI 10.1097/MCP.0b013e32835f1ae8
   Angelakis Emmanouil, 2014, BMC Res Notes, V7, P892, DOI 10.1186/1756-0500-7-892
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06
   Dowell SF, 2004, CLIN INFECT DIS, V39, P652, DOI 10.1086/422652
   Fernstrom A, 2013, J PATHOG, DOI [10.1155/2013/493960, 10.1155/013/493960]
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P92, DOI 10.1016/j.tmaid.2015.12.008
   Givon-Lavi N, 2002, J INFECT DIS, V186, P1608, DOI 10.1086/345556
   Ibrahim NKR, 2008, J EGYPT PUBLIC HEAL, V83, P15
   Ikonen N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3150-5
   Killingley B, 2016, J INFECT PUBLIC HEAL, V9, P278, DOI 10.1016/j.jiph.2015.10.009
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   La Rosa G, 2013, ANN I SUPER SANITA, V49, P124, DOI 10.4415/ANN_13_02_03
   Madani TA, 2006, ANN SAUDI MED, V26, P346, DOI 10.5144/0256-4947.2006.346
   Memish ZA, 2015, CLIN MICROBIOL INFEC, V21, pe1, DOI [10.1016/j.cmi.2015.02.008. 571, DOI 10.1016/J.CMI.2015.02.008.571.E1-8]
   Memish ZA, 2014, AM J INFECT CONTROL, V42, P1266, DOI 10.1016/j.ajic.2014.07.027
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Ninove N, 2011, PLOS ONE, V6
   Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363
   van Doremalen N, 2013, EUROSURVEILLANCE, V18
   Hoang VT, 2019, TRAVEL MED INFECT DI, V30, P32, DOI 10.1016/j.tmaid.2019.03.003
   Hoang VT, 2019, TRAVEL MED INFECT DI, V31, DOI 10.1016/j.tmaid.2018.10.021
   Hoang VT, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0650-9
   Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475
   Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04
   Winther B, 2007, J MED VIROL, V79, P1606, DOI 10.1002/jmv.20956
   Yezli S, 2012, J CHEMOTHERAPY, V24, P1, DOI 10.1179/1120009X12Z.0000000001
   Yezli S, 2011, FOOD ENVIRON VIROL, V3, P1, DOI 10.1007/s12560-011-9056-7
   Zafar MA, 2017, CELL HOST MICROBE, V21, P73, DOI 10.1016/j.chom.2016.12.005
NR 33
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2020
VL 33
AR 101500
DI 10.1016/j.tmaid.2019.101500
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KR7EL
UT WOS:000517778600007
PM 31600567
OA Bronze
DA 2020-04-03
ER

PT J
AU Wang, XW
   Wang, M
   Zhan, J
   Liu, QY
   Fang, LL
   Zhao, CY
   Jiang, P
   Li, YF
   Bai, J
AF Wang, Xian-Wei
   Wang, Mi
   Zhan, Jing
   Liu, Qian-Yu
   Fang, Lin-lin
   Zhao, Chen-yao
   Jiang, Ping
   Li, Yu-Feng
   Bai, Juan
TI Pathogenicity and immunogenicity of a new strain of porcine epidemic
   diarrhea virus containing a novel deletion in the N gene
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Genetic characteristics; Pathogenicity; Immunogenicity; Porcine epidemic
   diarrhea virus; Novel deletion; N gene
ID NUCLEOCAPSID PROTEIN; SPIKE PROTEIN; CORONAVIRUS; ANTIGENICITY
AB Since late 2010, highly virulent PEDV G2-genotype strains have emerged globally extracting heavy losses on the pork industries of numerous countries. We investigated the characteristics of a field strain of PEDV (PEDV strain SH) isolated from a piglet with severe diarrhea on a farm in Shanghai China. Whole genome sequencing and analysis revealed that the SH strain belonged to subtype G2b and has a unique 12-aa deletion (aa 399-410) including the antigenic epitope NEP-1C9 (aa 398-406) of the N protein. PEDV SH strain is highly pathogenic to challenged newborn piglets, resulting in 100 % morbidity and mortality. Pathological examination revealed significant villus atrophy in the jejuna of infected piglets. Mice inoculated with inactivated PEDV SH produced antibodies against the N protein, but no antibodies against the deletions. These results illustrated that deletion of the NEP-1C9 epitope had no effect on the immunogenicity or pathogenicity of PEDV, providing evidence of the necessity to monitor the genetic diversity of the virus. Our study also contributes to development of candidate for vaccines and diagnostics that could differentiate pigs seropositive due to vaccination by conventional strains from wild virus infection.
C1 [Wang, Xian-Wei; Wang, Mi; Zhan, Jing; Liu, Qian-Yu; Fang, Lin-lin; Zhao, Chen-yao; Jiang, Ping; Li, Yu-Feng; Bai, Juan] Nanjing Agr Univ, Key Lab Anim Dis Diagnost & Immunol, MOE Joint Int Res Lab Anim Hlth & Food Safety, Coll Vet Med,Minist Agr, Nanjing 210095, Peoples R China.
   [Wang, Xian-Wei; Jiang, Ping; Li, Yu-Feng; Bai, Juan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.
RP Wang, XW (reprint author), Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Dis Diagnost & Immunol, Minist Agr, Nanjing 210095, Peoples R China.
EM xwwang@njau.edu.cn
FU National Key Research and Development Program of China [2016YFD0500104];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31502086]; Fundamental Research Funds for the
   Central UniversitiesFundamental Research Funds for the Central
   Universities [KJQN201619]; Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD); Ministry of
   AgricultureGida Tarim Ve Hayvancilik Bakanligi [CARS-35]
FX This work was supported by grants from the National Key Research and
   Development Program of China (2016YFD0500104), the National Natural
   Science Foundation of China (31502086), the Fundamental Research Funds
   for the Central Universities (KJQN201619), the Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD) and The
   Ministry of Agriculture (CARS-35).
CR Ayudhya SNN, 2012, TRANSBOUND EMERG DIS, V59, P9, DOI 10.1111/j.1865-1682.2011.01309.x
   Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003
   Cavanagh D, 2003, AVIAN PATHOL, V32, P567, DOI 10.1080/03079450310001621198
   CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1
   Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2
   Chen PF, 2019, INFECT GENET EVOL, V69, P153, DOI 10.1016/j.meegid.2019.01.022
   Chen X, 2012, VIRUS GENES, V45, P499, DOI 10.1007/s11262-012-0794-x
   DEBOUCK P, 1980, AM J VET RES, V41, P219
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   Fan BC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44209
   Ge FF, 2013, ARCH VIROL, V158, P2227, DOI 10.1007/s00705-013-1722-7
   Hoang H, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.01049-13
   Hou YX, 2017, J VIROL, V91, DOI 10.1128/JVI.00227-17
   Jaru-Ampornpan P, 2017, J VIROL, V91, DOI [10.1128/JVI.01660-16, 10.1128/jvi.01660-16]
   Lee DK, 2010, VIRUS RES, V149, P175, DOI 10.1016/j.virusres.2010.01.015
   Lee S, 2017, VET MICROBIOL, V207, P248, DOI 10.1016/j.vetmic.2017.06.019
   Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002
   Li ZL, 2012, VIRUS GENES, V45, P181, DOI 10.1007/s11262-012-0735-8
   Lin CM, 2017, VET MICROBIOL, V201, P62, DOI 10.1016/j.vetmic.2017.01.015
   Lin CM, 2016, VIRUS RES, V226, P20, DOI 10.1016/j.virusres.2016.05.023
   Lin CM, 2015, J VIROL, V89, P3332, DOI 10.1128/JVI.03196-14
   Liu XS, 2019, VET MICROBIOL, V230, P278, DOI 10.1016/j.vetmic.2019.02.018
   Marthaler D, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00555-13
   Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a
   Ojkic D, 2015, CAN VET J, V56, P149
   Park SJ, 2007, VIRUS GENES, V35, P55, DOI 10.1007/s11262-006-0036-1
   PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606
   SHAN Y, 2018, J ZHEJIANG UNIV SC B, V19, P570, DOI DOI 10.1631/JZUS.B1700283
   Singh M, 1999, J GEN VIROL, V80, P1959, DOI 10.1099/0022-1317-80-8-1959
   Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1
   Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675
   SUEYOSHI M, 1995, J COMP PATHOL, V113, P59, DOI 10.1016/S0021-9975(05)80069-6
   Sun J, 2018, VET MICROBIOL, V221, P81, DOI 10.1016/j.vetmic.2018.05.021
   Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259
   Sun YK, 2019, INFECT GENET EVOL, V70, P24, DOI 10.1016/j.meegid.2019.02.013
   Wang D, 2016, VIRUS RES, V226, P7, DOI 10.1016/j.virusres.2016.05.026
   Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39010
   Xie WT, 2019, J GEN VIROL, V100, P206, DOI 10.1099/jgv.0.001216
   Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034
   Zhang QY, 2016, VET MICROBIOL, V197, P93, DOI 10.1016/j.vetmic.2016.11.010
   Zhang QY, 2016, MICROB PATHOGENESIS, V97, P27, DOI 10.1016/j.micpath.2016.05.011
NR 41
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD JAN
PY 2020
VL 240
AR 108511
DI 10.1016/j.vetmic.2019.108511
PG 11
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA KG0FH
UT WOS:000509616600003
PM 31902508
OA Bronze
DA 2020-04-03
ER

PT J
AU Yang, CY
   Wang, J
AF Yang, Chayu
   Wang, Jin
TI A mathematical model for the novel coronavirus epidemic in Wuhan, China
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE COVID-19; compartmental modeling; basic reproduction number
ID PERSISTENCE; IMPACT
AB We propose a mathematical model to investigate the current outbreak of the coronavirus disease 2019 (COVID-19) in Wuhan, China. Our model describes the multiple transmission pathways in the infection dynamics, and emphasizes the role of the environmental reservoir in the transmission and spread of this disease. Our model also employs non-constant transmission rates which change with the epidemiological status and environmental conditions and which reflect the impact of the on-going disease control measures. We conduct a detailed analysis of this model, and demonstrate its application using publicly reported data. Among other findings, our analytical and numerical results indicate that the coronavirus infection would remain endemic, which necessitates long-term disease prevention and intervention programs.
C1 [Yang, Chayu; Wang, Jin] Univ Tennessee, Dept Math, 615 McCallie Ave, Chattanooga, TN 37403 USA.
RP Wang, J (reprint author), Univ Tennessee, Dept Math, 615 McCallie Ave, Chattanooga, TN 37403 USA.
EM Jin-Wang02@utc.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R15GM131315]
FX This work is partially supported by the National Institutes of Health
   under grant number 1R15GM131315. The authors are grateful to the
   handling editor and reviewers for their helpful comments that have
   improved the quality of the original manuscript.
CR [Anonymous], 2020, WHO STATEMENT REGARD
   Centers for Disease Control and Prevention, 2019 NOV COR
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Ellerin T., 2020, HARVARD HLTH BL 0125
   Gao DZ, 2011, MATH BIOSCI, V232, P110, DOI 10.1016/j.mbs.2011.05.001
   Geller C, 2012, VIRUSES-BASEL, V4, P3044, DOI 10.3390/v4113044
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Imai N., 2020, TRANSMISSIBILITY 201
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   LaSalle J. P., 1976, REGIONAL C SERIES AP
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   MY Li, 1999, CAN APPL MATH Q, V7, P409
   Read JM, 2020, NOVEL CORONAVIRUS 20
   Rothe C, 2020, N ENGL J MED
   Sahin A., 2020, EURASIAN J MED ONCOL, V4, P1
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Shuai ZS, 2013, SIAM J APPL MATH, V73, P1513, DOI 10.1137/120876642
   Spencer J. A., 2020, EPIDEMIOLOGICAL PARA
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   THIEME HR, 1993, SIAM J MATH ANAL, V24, P407, DOI 10.1137/0524026
   Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yang CY, 2019, MATH BIOSCI ENG, V16, P5226, DOI 10.3934/mbe.2019261
   Zhao Chenhui, 2020, Int J Neurosci, P1, DOI 10.1080/00207454.2020.1744599
   Zhou P, 2020, BIORXIV
   Zhu H., 2020, BIORXIV
NR 27
TC 0
Z9 0
U1 3
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2020
VL 17
IS 3
BP 2708
EP 2724
DI 10.3934/mbe.2020148
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA KU7DN
UT WOS:000519873900048
OA Other Gold
DA 2020-04-03
ER

PT J
AU Yang, YL
   Meng, F
   Qin, P
   Herrler, G
   Huang, YW
   Tang, YD
AF Yang, Yue-Lin
   Meng, Fandan
   Qin, Pan
   Herrler, Georg
   Huang, Yao-Wei
   Tang, Yan-Dong
TI Trypsin promotes porcine deltacoronavirus mediating cell-to-cell fusion
   in a cell type-dependent manner
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE PDCoV; trypsin; entry; virus release; cell-to-cell fusion
ID EPIDEMIC DIARRHEA VIRUS; GENOMIC CHARACTERIZATION; CORONAVIRUS; STRAIN;
   SWINE; BETACORONAVIRUS; PROPAGATION; REPLICATION; THAILAND; RELEASE
AB Porcine deltacoronavirus (PDCoV) is a newly emerging threat to the global porcine industry. PDCoV has been successfully isolated using various medium additives including trypsin, and although we know it is important for viral replication, the mechanism has not been fully elucidated. Here, we systematically investigated the role of trypsin in PDCoV replication including cell entry, cell-to-cell membrane fusion and virus release. Using pseudovirus entry assays, we demonstrated that PDCoV entry is not trypsin dependent. Furthermore, unlike porcine epidemic diarrhea virus (PEDV), in which trypsin is important for the release of virus from infected cells, PDCoV release was not affected by trypsin. We also demonstrated that trypsin promotes PDCoV replication by enhancing cell-to-cell membrane fusion. Most importantly, our study illustrates two distinct spreading patterns from infected cells to uninfected cells during PDCoV transmission, and the role of trypsin in PDCoV replication in cells with different virus spreading types. Overall, these results clarify that trypsin promotes PDCoV replication by mediating cell-to-cell fusion transmission but is not crucial for viral entry. This knowledge can potentially contribute to improvement of virus production efficiency in culture, not only for vaccine preparation but also to develop antiviral treatments.
C1 [Yang, Yue-Lin; Meng, Fandan; Tang, Yan-Dong] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Peoples R China.
   [Qin, Pan; Huang, Yao-Wei] Zhejiang Univ, Coll Anim Sci, Minist Agr, Inst Prevent Vet Med, Hangzhou, Peoples R China.
   [Qin, Pan; Huang, Yao-Wei] Zhejiang Univ, Coll Anim Sci, Minist Agr, Key Lab Anim Virol, Hangzhou, Peoples R China.
   [Herrler, Georg] Univ Vet Med Hannover, Inst Virol, Hannover, Germany.
RP Tang, YD (reprint author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Peoples R China.; Huang, YW (reprint author), Zhejiang Univ, Inst Prevent Vet Med, Hangzhou 310058, Peoples R China.; Huang, YW (reprint author), Zhejiang Univ, Dept Vet Med, Minist Agr, Key Lab Anim Virol, Hangzhou 310058, Peoples R China.
EM yhuang@zju.edu.cn; tangyandong2008@163.com
FU National Key Research and Development Programme of China
   [2016YFD0500100]; National Natural Science Foundation for Young
   Scientists of ChinaNational Natural Science Foundation of China
   [31802205]
FX This study was funded by National Key Research and Development Programme
   of China [grant number 2016YFD0500100] and the National Natural Science
   Foundation for Young Scientists of China [grant number 31802205].
CR Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13
   Chung HC, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.01706-16, 10.1128/genomea.01706-16]
   Dong N, 2016, VET MICROBIOL, V196, P98, DOI 10.1016/j.vetmic.2016.10.022
   He BA, 2014, J VIROL, V88, P7070, DOI 10.1128/JVI.00631-14
   HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Jang G, 2017, TRANSBOUND EMERG DIS, V64, P1364, DOI 10.1111/tbed.12690
   Jung K, 2017, ARCH VIROL, V162, P2357, DOI 10.1007/s00705-017-3351-z
   Jung K, 2016, VIRUS RES, V226, P50, DOI 10.1016/j.virusres.2016.04.009
   Lau SKP, 2012, J VIROL, V86, P5481, DOI 10.1128/JVI.06927-11
   Lee JH, 2016, TRANSBOUND EMERG DIS, V63, P248, DOI 10.1111/tbed.12490
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Li GW, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00278-14
   Li WT, 2018, P NATL ACAD SCI USA, V115, pE5135, DOI 10.1073/pnas.1802879115
   Liang QQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060573
   Liu C, 2016, J BIOL CHEM, V291, P24779, DOI 10.1074/jbc.M116.740746
   Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15
   Madapong A, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00408-16
   Mai K, 2018, TRANSBOUND EMERG DIS, V65, P166, DOI 10.1111/tbed.12644
   Marthaler D, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00218-14
   Niederwerder MC, 2018, TRANSBOUND EMERG DIS, V65, P660, DOI 10.1111/tbed.12823
   Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012
   Qin P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050455
   Saeng-Chuto K, 2017, TRANSBOUND EMERG DIS, V64, P3, DOI 10.1111/tbed.12585
   Saeng-chuto K, 2017, ARCH VIROL, V162, P2103, DOI 10.1007/s00705-017-3331-3
   Shi W, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050114
   Shirato K, 2011, J VIROL, V85, P7872, DOI 10.1128/JVI.00464-11
   Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020
   Tang YD, 2014, J VIROL, V88, P12296, DOI 10.1128/JVI.01379-14
   Le VP, 2018, ARCH VIROL, V163, P203, DOI 10.1007/s00705-017-3594-8
   Wang B, 2018, J VIROL, V92, DOI [10.1128/JVI.00318-18, 10.1128/jvi.00318-18]
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Wang QH, 2019, CURR OPIN VIROL, V34, P39, DOI 10.1016/j.coviro.2018.12.001
   Wang T. Y., 2018, ONCOTARGET, V9, P12174
   Wang XP, 2013, J VIROL METHODS, V193, P383, DOI 10.1016/j.jviromet.2013.06.035
   Wang YW, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00945-15
   Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Xu ZC, 2018, VIROL SIN, V33, P131, DOI 10.1007/s12250-018-0003-8
   Zhang JL, 2019, J BIOL CHEM, V294, P9830, DOI 10.1074/jbc.RA119.007779
   Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18
   Zhu XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0068-3
   Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14
NR 43
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 457
EP 468
DI 10.1080/22221751.2020.1730245
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KR3AF
UT WOS:000517490100001
PM 32090689
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Yin, FL
   Lv, JH
   Zhang, XJ
   Xia, XY
   Wu, JH
AF Yin, Fulian
   Lv, Jiahui
   Zhang, Xiaojian
   Xia, Xinyu
   Wu, Jianhong
TI COVID-19 information propagation dynamics in the Chinese Sina-microblog
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE COVID-19; dynamic model; prediction; Sina-microblog
ID RUMOR SPREADING MODEL; EPIDEMIC MODEL; DIFFUSION; MECHANISM
AB The outbreak of a novel coronavirus (COVID-19) generated an outbreak of public opinions in the Chinese Sina-microblog. To help in designing effective communication strategies during a major public health emergency, we propose a multiple-information susceptible-discussing-immune (M-SDI) model in order to understand the patterns of key information propagation on social networks. We develop the M-SDI model, based on the public discussion quantity and take into account of the behavior that users may re-enter another related topic or Weibo after discussing one. Data fitting using the real data of COVID-19 public opinion obtained from Chinese Sina-microblog can parameterize the model to make accurate prediction of the public opinion trend until the next major news item occurs. The reproduction ratio has fallen from 1.7769 and maintained around 0.97, which reflects the peak of public opinion has passed but it will continue for a period of time.
C1 [Yin, Fulian; Lv, Jiahui; Zhang, Xiaojian; Xia, Xinyu] Commun Univ China, Coll Informat & Commun Engn, Beijing 100024, Peoples R China.
   [Wu, Jianhong] York Univ, Lab Ind & Appl Math, Toronto, ON M3J 1P3, Canada.
RP Wu, JH (reprint author), York Univ, Lab Ind & Appl Math, Toronto, ON M3J 1P3, Canada.
EM wujhhida@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [61801440]; Natural Science and Engineering Research
   Council of CanadaNatural Sciences and Engineering Research Council of
   Canada; Canada Research Chair ProgramCanada Research Chairs; Fundamental
   Research Funds for the Central UniversitiesFundamental Research Funds
   for the Central Universities; High quality and Cutting-edge Disciplines
   Construction Project for Universities in Beijing (Internet Information,
   Communication University of China)
FX The work was supported by the National Natural Science Foundation of
   China (Grant numbers: 61801440), the Natural Science and Engineering
   Research Council of Canada, the Canada Research Chair Program (JWu), the
   Fundamental Research Funds for the Central Universities and the High
   quality and Cutting -edge Disciplines Construction Project for
   Universities in Beijing (Internet Information, Communication University
   of China).
CR [Anonymous], 2020, SINA MICROBLOG  0121
   Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1
   Cheng JJ, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2012-30483-5
   Huang JJ, 2013, I C SERV SYST SERV M, P170, DOI 10.1109/ICSSSM.2013.6602630
   KERMACK WO, 1991, B MATH BIOL, V53, P33, DOI 10.1007/BF02464423
   LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5
   Liu J, 2014, LECT NOTES ARTIF INT, V8722, P69, DOI 10.1007/978-3-319-10554-3_7
   Lu ZH, 2003, ACTA MATH SCI, V23, P440
   Qi Gao, 2012, User Modeling, Adaptation, and Personalization. Proceedings 20th International Conference, UMAP 2012, P88, DOI 10.1007/978-3-642-31454-4_8
   Qian Z, 2015, PHYSICA A, V429, P95, DOI 10.1016/j.physa.2015.02.022
   Rui XB, 2018, PHYSICA A, V506, P254, DOI 10.1016/j.physa.2018.04.062
   Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6
   Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102
   Wang JJ, 2014, PHYSICA A, V398, P43, DOI 10.1016/j.physa.2013.12.004
   Wang YQ, 2013, COMMUN THEOR PHYS, V59, P510, DOI 10.1088/0253-6102/59/4/21
   Xia CY, 2009, FRONT COMPUT SCI CHI, V3, P361, DOI 10.1007/s11704-009-0057-8
   Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025
   Xiong F, 2012, PHYS LETT A, V376, P2103, DOI 10.1016/j.physleta.2012.05.021
   Yin FL, 2019, MATH BIOSCI ENG, V16, P5380, DOI 10.3934/mbe.2019268
   Zan YL, 2018, CHAOS SOLITON FRACT, V110, P191, DOI 10.1016/j.chaos.2018.03.021
   Zhang N, 2014, PHYSICA A, V415, P333, DOI 10.1016/j.physa.2014.07.023
   ZHANG XZ, 2013, RES J APPL SCI ENG T, V6, P102
   Zhang Y, 2015, DISCRETE DYN NAT SOC, DOI 10.1155/2015/649814
   Zhao L., 2014, DISCRETE DYN NAT SOC, V2014, P1
   Zhao LJ, 2012, PHYSICA A, V391, P2444, DOI 10.1016/j.physa.2011.12.008
   Zhong Nanshan, 2020, SINAMICROBLOG   0120
NR 26
TC 0
Z9 0
U1 3
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2020
VL 17
IS 3
BP 2676
EP 2692
DI 10.3934/mbe.2020146
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA KU7DN
UT WOS:000519873900046
OA Other Gold
DA 2020-04-03
ER

PT J
AU Zhang, JY
   Han, YR
   Shi, HY
   Chen, JF
   Zhang, X
   Wang, XB
   Zhou, L
   Liu, JB
   Zhang, JL
   Ji, ZY
   Jing, ZY
   Ma, JY
   Shi, D
   Feng, L
AF Zhang, Jiyu
   Han, Yuru
   Shi, Hongyan
   Chen, Jianfei
   Zhang, Xin
   Wang, Xiaobo
   Zhou, Ling
   Liu, Jianbo
   Zhang, Jialin
   Ji, Zhaoyang
   Jing, Zhaoyang
   Ma, Jingyun
   Shi, Da
   Feng, Li
TI Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase-
   and cyclophilin D- dependent
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE SADS-CoV; apoptosis; apoptosis-inducing factor; pathogenesis
ID MITOCHONDRIAL PERMEABILITY TRANSITION; PROGRAMMED CELL-DEATH; MURINE
   CORONAVIRUS; MATRIX PROTEIN; CYTOCHROME-C; INFLUENZA-A; VIRUS;
   ACTIVATION; INFECTION; BAX
AB Swine acute diarrhea syndrome coronavirus (SADS-CoV), a newly discovered enteric coronavirus, is the aetiological agent that causes severe clinical diarrhea and intestinal pathological damage in piglets. To understand the effect of SADS-CoV on host cells, we characterized the apoptotic pathways and elucidated mechanisms underlying the process of apoptotic cell death after SADS-CoV infection. SADS-CoV-infected cells showed evidence of apoptosis in vitro and in vivo. The use of a pan-caspase inhibitor resulted in the inhibition of SADS-CoV-induced apoptosis and reduction in SADS-CoV replication, suggestive of the association of a caspase-dependent pathway. Furthermore, SADS-CoV infection activated the initiators caspase-8 and -9 and upregulated FasL and Bid cleavage, demonstrating a crosstalk between the extrinsic and intrinsic pathways. However, the proapoptotic proteins Bax and Cytochrome c (Cyt c) relocalized to the mitochondria and cytoplasm, respectively, after infection by SADS-CoV. Moreover, Vero E6 and IPI-2I cells treated with cyclosporin A (CsA), an inhibitor of mitochondrial permeability transition pore (MPTP) opening, were completely protected from SADS-CoV-induced apoptosis and viral replication, suggesting the involvement of cyclophilin D (CypD) in these processes. Altogether, our results indicate that caspase-dependent FasL (extrinsic)- and mitochondria (intrinsic)- mediated apoptotic pathways play a central role in SADS-CoV-induced apoptosis that facilitates viral replication. In summary, these findings demonstrate mechanisms by which SADS-CoV induces apoptosis and improve our understanding of SADS-CoV pathogenesis.
C1 [Zhang, Jiyu; Han, Yuru; Shi, Hongyan; Chen, Jianfei; Zhang, Xin; Wang, Xiaobo; Liu, Jianbo; Zhang, Jialin; Ji, Zhaoyang; Jing, Zhaoyang; Shi, Da; Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Haping Rd 678, Harbin 150069, Peoples R China.
   [Zhou, Ling; Ma, Jingyun] South China Agr Univ, Coll Anim Sci, Wushan Rd 483, Guangzhou 510642, Peoples R China.
RP Shi, D; Feng, L (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Haping Rd 678, Harbin 150069, Peoples R China.; Ma, JY (reprint author), South China Agr Univ, Coll Anim Sci, Wushan Rd 483, Guangzhou 510642, Peoples R China.
EM majy2400@scau.edu.cn; shida@caas.cn; fengli@caas.cn
FU China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2017M610136]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31572541, 31602072];
   Natural Science Foundation of Heilongjiang Province of ChinaNatural
   Science Foundation of Heilongjiang Province [C2017079, C2018066]; State
   Key Laboratory of Veterinary Biotechnology Foundation [SKLVBP2018002]
FX The China Postdoctoral Science Foundation (2017M610136), the National
   Natural Science Foundation of China (31572541 and 31602072), the Natural
   Science Foundation of Heilongjiang Province of China (C2017079 and
   C2018066), and the State Key Laboratory of Veterinary Biotechnology
   Foundation (SKLVBP2018002) supported this study.
CR Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Bartz SR, 1999, J VIROL, V73, P1956, DOI 10.1128/JVI.73.3.1956-1963.1999
   Bitzer M, 1999, J VIROL, V73, P702, DOI 10.1128/JVI.73.1.702-708.1999
   Chen CJ, 2002, VIROLOGY, V302, P321, DOI 10.1006/viro.2002.1626
   Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007
   Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160
   Clarke P, 2009, NAT REV MICROBIOL, V7, P144, DOI 10.1038/nrmicro2071
   Connolly PF, 2017, CELL DEATH DIFFER, V24, P1401, DOI 10.1038/cdd.2017.59
   Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551
   De Martino L, 2010, VET MICROBIOL, V141, P36, DOI 10.1016/j.vetmic.2009.09.001
   de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12
   Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08
   Deszcz L, 2005, J GEN VIROL, V86, P1379, DOI 10.1099/vir.0.80754-0
   Ding L, 2012, VET MICROBIOL, V158, P12, DOI 10.1016/j.vetmic.2012.01.017
   Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x
   Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998
   ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0
   Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0
   Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081
   Gadaleta P, 2005, VIRUS RES, V109, P65, DOI 10.1016/j.virusres.2004.10.007
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5
   Han YR, 2019, VIRUS RES, V273, DOI 10.1016/j.virusres.2019.197752
   Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8
   Hierholzer JC, 1996, VIRUS ISOLATION QUAN
   HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994
   Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Kambara H, 2011, VIROLOGY, V412, P211, DOI 10.1016/j.virol.2011.01.011
   Kassis R, 2004, J VIROL, V78, P6543, DOI 10.1128/JVI.78.12.6543-6555.2004
   Kim Y, 2014, VIROLOGY, V460, P180, DOI 10.1016/j.virol.2014.04.040
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001
   Lee YJ, 2018, VIRUS RES, V253, P112, DOI 10.1016/j.virusres.2018.06.008
   Li XD, 2004, J GEN VIROL, V85, P3261, DOI 10.1099/vir.0.80243-0
   Lin CH, 2009, APOPTOSIS, V14, P864, DOI 10.1007/s10495-009-0371-5
   Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001
   Liu Y, 2003, J VIROL, V77, P11952, DOI 10.1128/JVI.77.22.11952-11963.2003
   Liu Y, 2007, VIROLOGY, V360, P364, DOI 10.1016/j.virol.2006.10.044
   Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200
   Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0
   Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080
   Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2
   O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833
   Otera H., 2012, INT J CELL BIOL, V2012, P1, DOI [10.1155/2012/82167622536251, DOI 10.1155/2012/82167622536251]
   Parquet MD, 2001, FEBS LETT, V500, P17
   Pearce AF, 2009, J VIROL, V83, P9102, DOI 10.1128/JVI.00436-09
   Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331
   Poole BD, 2004, J VIROL, V78, P7775, DOI 10.1128/JVI.78.14.7775-7783.2004
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3
   Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21
   Shi D, 2017, SCI REP-UK, V7, DOI 10.1038/srep39700
   Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004
   SIDDELL S, 1983, J GEN VIROL, V64, P761, DOI 10.1099/0022-1317-64-4-761
   St-Louis MC, 2005, VET RES, V36, P213, DOI 10.1051/vetres:2004059
   Suh DH, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00041
   Tepper CG, 1999, BLOOD, V94, P1727, DOI 10.1182/blood.V94.5.1727.417k03_1727_1737
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   Wang XD, 2001, GENE DEV, V15, P2922
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Xue M, 2018, J VIROL, V92, DOI [10.1128/JVI.00431-18, 10.1128/jvi.00431-18]
   Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zhirnov OP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P534, DOI 10.1023/A:1015542110798
   Zhou GY, 2000, J VIROL, V74, P9048, DOI 10.1128/JVI.74.19.9048-9053.2000
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853
NR 70
TC 0
Z9 0
U1 14
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 439
EP 456
DI 10.1080/22221751.2020.1722758
PG 18
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KR2ZK
UT WOS:000517488000001
PM 32090691
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zhang, MJ
   Li, W
   Zhou, P
   Liu, DJ
   Luo, R
   Jongkaewwattana, A
   He, QG
AF Zhang, Mengjia
   Li, Wan
   Zhou, Peng
   Liu, Dejian
   Luo, Rui
   Jongkaewwattana, Anan
   He, Qigai
TI Genetic manipulation of porcine deltacoronavirus reveals insights into
   NS6 and NS7 functions: a novel strategy for vaccine design
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE PDCoV; infectous clone; accessory protein; pathogenesis; vaccine
ID LENGTH INFECTIOUS CDNA; OPEN READING FRAME; REVERSE GENETICS; AVIAN
   CORONAVIRUSES; PROTEIN; GENOME; DIARRHEA; IDENTIFICATION; REPLICATION;
   DISCOVERY
AB Porcine deltacoronavirus (PDCoV) is an emerging swine coronavirus that causes severe diarrhea, resulting in high mortality in neonatal piglets. Despite widespread outbreaks in many countries, no effective PDCoV vaccines are currently available. Here, we generated, for the first time, a full-length infectious cDNA clone of PDCoV. We further manipulated the infectious clone by replacing the NS6 gene with a green fluorescent protein (GFP) to generate rPDCoV-Delta NS6-GFP; likewise, rPDCoV-Delta NS7 was constructed by removing the ATG start codons of the NS7 gene. Growth kinetics studies suggest that rPDCoV-Delta NS7 could replicate similarly to that of the wild-type PDCoV, whereas rPDCoV-Delta NS6-GFP exhibited a substantial reduction of viral titer in vitro and in vivo. Piglets inoculated with rPDCoV-Delta NS7 or wild-type PDCoV showed similar diarrheic scores and pathological injury. In contrast, rPDCoV-Delta NS6-GFP-infected piglets did not show any clinical signs, indicating that the NS6 protein is an important virulence factor of PDCoV and that the NS6-deficient mutant virus might be a promising live-attenuated vaccine candidate. Taken together, the reverse genetics platform described here not only provides more insights into the role of PDCoV accessory proteins in viral replication and pathogenesis, but also allows the development of novel vaccines against PDCoV infection.
C1 [Zhang, Mengjia; Li, Wan; Zhou, Peng; Liu, Dejian; Luo, Rui; He, Qigai] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Zhang, Mengjia; Li, Wan; Zhou, Peng; Liu, Dejian; Luo, Rui; He, Qigai] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
   [Jongkaewwattana, Anan] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Lab, Pathum Thani, Thailand.
RP He, QG (reprint author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; He, QG (reprint author), Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
EM he628@mail.hzau.edu.cn
FU National Key Research and Development Program of China [2018YFD0501102];
   China Agriculture Research System [CARS-35]; Applied Basic Research
   Project of Wuhan [2017020201010227]
FX This study was supported by the National Key Research and Development
   Program of China [grant number 2018YFD0501102], China Agriculture
   Research System [CARS-35] and Applied Basic Research Project of Wuhan
   [Grant No. 2017020201010227].
CR Beall A, 2016, MBIO, V7, DOI 10.1128/mBio.01451-15
   BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chen FZ, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01284-15
   Cruz JLG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002090
   de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412
   Dijkman R, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-106
   Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08
   DUARTE M, 1994, VIROLOGY, V198, P466, DOI 10.1006/viro.1994.1058
   ELEOUET JF, 1995, VIROLOGY, V206, P817, DOI 10.1006/viro.1995.1004
   Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]
   Fang PX, 2017, J GEN VIROL, V98, P173, DOI 10.1099/jgv.0.000690
   Fang PX, 2016, VIROLOGY, V499, P170, DOI 10.1016/j.virol.2016.09.015
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fischer F, 1997, J VIROL, V71, P996, DOI 10.1128/JVI.71.2.996-1003.1997
   Haijema BJ, 2004, J VIROL, V78, P3863, DOI 10.1128/JVI.78.8.3863-3871.2004
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852
   Lee S, 2015, VIRUS RES, V208, P136, DOI 10.1016/j.virusres.2015.06.013
   Lee S, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01191-14
   Li GW, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00278-14
   Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013
   Marthaler D., 2014, GENOME ANNOUNC, V2014, P2, DOI DOI 10.1128/GEN0MEA.00218-14
   Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.140526, 10.3201/eid2008.14-0526]
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17
   Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110
   Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399
   Tan YJ, 2006, ANTIVIR RES, V72, P78, DOI 10.1016/j.antiviral.2006.05.010
   Wang LY, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00291-14
   Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756
   Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08
   Youn S, 2005, VIROLOGY, V332, P206, DOI 10.1016/j.virol.2004.10.045
   Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000
   Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005
   Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100
   Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002
   Zhai SL, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0591-6
   Zhang MJ, 2019, ARCH VIROL, V164, P413, DOI 10.1007/s00705-018-4081-6
NR 41
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
DI 10.1080/22221751.2019.1701391
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KH1BI
UT WOS:000510381200003
PM 31859605
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zhang, YF
   Han, L
   Xia, L
   Yuan, YX
   Hu, H
AF Zhang, Yunfei
   Han, Li
   Xia, Lu
   Yuan, Yixin
   Hu, Hui
TI Assessment of hemagglutination activity of porcine deltacoronavirus
SO JOURNAL OF VETERINARY SCIENCE
LA English
DT Article
DE Porcine deltacoronavirus; hemagglutination; trypsin; neuraminidase
ID EPIDEMIC DIARRHEA VIRUS
AB Porcine deltacoronavirus (PDCoV) is an emerging swine enteric coronavirus that causes diarrhea in piglets. However, the biological characteristics of PDCoV are unclear. In this study, the hemagglutination (HA) abilities of two PDCoV strains (CH-01 and HNZK-04) were investigated. Our results showed that PDCoV has the ability to agglutinate rabbit erythrocytes after virion pretreatment with trypsin or neuraminidase. Additionally, the HA assay results showed a significant positive correlation with the infectious viral titer. Our results suggest that assessing the HA activity of PDCoV may be a useful diagnostic method for investigating and surveilling PDCoV infections.
C1 [Zhang, Yunfei; Han, Li; Xia, Lu; Yuan, Yixin; Hu, Hui] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China.
   [Hu, Hui] Key Lab Anim Derived Food Safety Henan Prov, Zhengzhou 450002, Peoples R China.
RP Hu, H (reprint author), Henan Agr Univ, 63 Nongye Rd, Zhengzhou 450002, Henan, Peoples R China.
EM huhui2001@163.com
FU National Key Research and Development Program of China
   [2016YFD0500102-1, 2018YFD0500100]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [31772773,
   U1704231]
FX This study was supported by funds from the National Key Research and
   Development Program of China (2016YFD0500102-1 and 2018YFD0500100) and
   the National Natural Science Foundation of China (No. 31772773 and
   U1704231).
CR Brian DA, 1995, CORONAVIRIDAE, P165
   Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15
   Krempl C, 1995, Adv Exp Med Biol, V380, P371
   Krempl C, 1998, ADV EXP MED BIOL, V440, P563
   Li WT, 2016, VIRUS RES, V226, P117, DOI 10.1016/j.virusres.2016.05.031
   Lin CM, 2015, J VIROL, V89, P3332, DOI 10.1128/JVI.03196-14
   Mahmood MS, 2004, PAK VET J, V24, P662
   Mai K, 2018, TRANSBOUND EMERG DIS, V65, P166, DOI 10.1111/tbed.12644
   Niederwerder MC, 2018, TRANSBOUND EMERG DIS, V65, P660, DOI 10.1111/tbed.12823
   Park JE, 2010, ARCH VIROL, V155, P595, DOI 10.1007/s00705-010-0620-5
   Ryu WS, 2017, MOLECULAR VIROLOGY OF HUMAN PATHOGENIC VIRUSES, P47, DOI 10.1016/B978-0-12-800838-6.00004-7
   Schultze B, 1995, Adv Exp Med Biol, V380, P367
   Zhang JQ, 2016, VIRUS RES, V226, P71, DOI 10.1016/j.virusres.2016.05.028
NR 13
TC 0
Z9 0
U1 2
U2 2
PU KOREAN SOC VETERINARY SCIENCE
PI SEOUL
PA SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 08826, SOUTH
   KOREA
SN 1229-845X
EI 1976-555X
J9 J VET SCI
JI J. Vet. Sci.
PD JAN
PY 2020
VL 21
IS 1
AR e12
DI 10.4142/jvs.2020.21.e12
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA KF0NB
UT WOS:000508946800012
PM 31940691
OA DOAJ Gold, Green Published
DA 2020-04-03
ER

PT J
AU Zhou, WK
   Wang, AL
   Xia, F
   Xiao, YN
   Tang, SY
AF Zhou, Weike
   Wang, Aili
   Xia, Fan
   Xiao, Yanni
   Tang, Sanyi
TI Effects of media reporting on mitigating spread of COVID-19 in the ear y
   phase of the outbreak
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE COVID-19; media reporting; mathematical model; basic reproduction
   number; sensitivity analysis
AB The 2019 novel coronavirus disease (COVID-19) is running rampantly in China and is swiftly spreading to other countries in the world, which causes a great concern on the global public health. The absence of specific therapeutic treatment or effective vaccine against COVID-19 call for other avenues of the prevention and control measures. Media reporting is thought to be effective to curb the spreading of an emergency disease in the early stage. Cross-correlation analysis based on our collected data demonstrated a strong correlation between media data and the infection case data. Thus we proposed a deterministic dynamical model to examine the interaction of the disease progression and the media reports and to investigate the effectiveness of media reporting on mitigating the spread of COVID-19. The basic reproduction number was estimated as 5.3167 through parameterization of the model with the number of cumulative confirmed cases, the number of cumulative deaths and the daily number of media items. Sensitivity analysis suggested that, during the early phase of the COVID-19 outbreak, enhancing the response rate of the media reporting to the severity of COVID-19, and enhancing the response rate of the public awareness to the media reports, both can bring forward the peak time and reduce the peak size of the infection significantly. These findings suggested that besides improving the medical levels, media coverage can be considered as an effective way to mitigate the disease spreading during the initial stage of an outbreak.
C1 [Zhou, Weike; Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian 710062, Peoples R China.
   [Wang, Aili] Baoji Univ Arts & Sci, Sch Math & Informat Sci, Baoji 721013, Peoples R China.
   [Xia, Fan; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
RP Tang, SY (reprint author), Shaanxi Normal Univ, Coll Math & Informat Sci, Xian 710062, Peoples R China.; Xiao, YN (reprint author), Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
EM yxiao@mail.xjtu.edu.cn; sytang@snnu.edu.cn
FU China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2019M663611]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [11801013, 11631012,
   61772017]
FX This research was funded by the China Postdoctoral Science Foundation
   (grant number 2019M663611 (WZ)), and by the National Natural Science
   Foundation of China (grant numbers: 11801013(AW), 11631012
   (YX,ST),61772017(ST)).
CR Backer J. A., 2020, INCUBATION PERIOD 20
   Box GE, 2015, TIME SERIES ANAL FOR
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chinese Center for Disease Control and Prevention, REP 2019 NCOV
   de Silva UC, 2009, EUROSURVEILLANCE, V14, P11
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54
   Kristiansen IS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-48
   Liu Yang, 2020, J Neurosurg, P1, DOI 10.3171/2019.12.JNS192187
   Roth DZ, 2011, SOCIAL DISTANCING PA
   Shen L, 2020, J MED ECON, DOI 10.1080/13696998.2020.1717500
   Shen M. W., 2020, BIORXIV
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P113
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
   Zhou P., 2020, BIORXIV, DOI [10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952, 10.1101/2020.01.22.914952.]
NR 17
TC 0
Z9 0
U1 4
U2 4
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2020
VL 17
IS 3
BP 2693
EP 2707
DI 10.3934/mbe.2020147
PG 15
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA KU7DN
UT WOS:000519873900047
OA Other Gold
DA 2020-04-03
ER

EF